Citrus Sinensis ID: 014871
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFT8 | 505 | Cyclin-dependent kinase C | yes | no | 0.942 | 0.778 | 0.778 | 1e-178 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.949 | 0.771 | 0.760 | 1e-171 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | yes | no | 0.966 | 0.785 | 0.770 | 1e-165 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.820 | 0.658 | 0.8 | 1e-159 | |
| Q6ZAG3 | 324 | Cyclin-dependent kinase C | no | no | 0.517 | 0.666 | 0.622 | 3e-75 | |
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.623 | 0.454 | 0.498 | 1e-74 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.630 | 0.368 | 0.522 | 3e-73 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.707 | 0.195 | 0.430 | 2e-69 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.609 | 0.170 | 0.490 | 2e-69 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.609 | 0.205 | 0.486 | 1e-68 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 624 bits (1609), Expect = e-178, Method: Compositional matrix adjust.
Identities = 323/415 (77%), Positives = 349/415 (84%), Gaps = 22/415 (5%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 106 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 165
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 166 KGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMW 225
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FKP+R +KR
Sbjct: 226 SVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFKPARPLKR 285
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 286 RVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYESSHE 345
Query: 250 YQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNHPMNNAPP 304
+QTKK+RQQQRQ+EEA KRQKL H P H RLPP+QH GQSH HW +GPNHP NNAPP
Sbjct: 346 FQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHWPAGPNHPTNNAPP 405
Query: 305 PVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPY 363
VP GP H+ YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPPQGRG PY
Sbjct: 406 QVPAGPSHNFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPPQGRGAPY 459
Query: 364 AGAGMPANGPRGPASG-YGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 417
GPRGP+ G YGVGP +Y+Q GQYG S + + RNQQYGWQQ
Sbjct: 460 VA------GPRGPSGGPYGVGPPNYTQGGQYGGSGSS---GRGQNQRNQQYGWQQ 505
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 601 bits (1549), Expect = e-171, Method: Compositional matrix adjust.
Identities = 318/418 (76%), Positives = 345/418 (82%), Gaps = 22/418 (5%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 106 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 165
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 166 KGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMW 225
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K SR +KR
Sbjct: 226 SVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSRPLKR 285
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 286 RVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYESSHE 345
Query: 250 YQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPNHPM-NNA 302
+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPNHPM NNA
Sbjct: 346 FQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPNHPMNNNA 405
Query: 303 PPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRG 360
PPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+ YPPQGRG
Sbjct: 406 PPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGAYPPQGRG 460
Query: 361 PPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQ 416
PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQQYGWQ
Sbjct: 461 APYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQQYGWQ 512
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1496), Expect = e-165, Method: Compositional matrix adjust.
Identities = 319/414 (77%), Positives = 340/414 (82%), Gaps = 11/414 (2%)
Query: 9 TDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68
+GNKY+GS YMVFEYMDHDLTGLADRPG+RFTVPQIKCYM+QLLTGLHYCHVNQVLHRD
Sbjct: 105 IEGNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQVLHRD 164
Query: 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 128
IKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG+T+YGPAVDM
Sbjct: 165 IKGSNLLIDNEGNLKLADFGLARSFSSDHNGNLTNRVITLWYRPPELLLGSTRYGPAVDM 224
Query: 129 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 188
WSVGCIFAELLNGKPIL GKNE EQLSKIFELCG+PDE IWPGV+KMP YN+FKP R MK
Sbjct: 225 WSVGCIFAELLNGKPILTGKNEPEQLSKIFELCGTPDELIWPGVTKMPWYNNFKPQRPMK 284
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 248
RRV+E F+HFD+HAL+LLEKML LDPSQRISAKDALD+EYFWTDPLPCDPKSLPKYE+SH
Sbjct: 285 RRVKESFKHFDQHALDLLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYEASH 344
Query: 249 EYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPG 308
E+QTKK+RQQQRQ EEA KRQKL HP PH RLPPIQ+ GQ H P PM+NA PPV
Sbjct: 345 EFQTKKKRQQQRQAEEAAKRQKLQHPPPHSRLPPIQNPGQPHQIR-PGQPMHNA-PPVAA 402
Query: 309 GPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQ---GRGPPYAG 365
GP HHY KPRG PGG NRYP G GGY NPNRGGQGGGY + PYP Q P G
Sbjct: 403 GPS-HHYAKPRG-PGGPNRYPQGGNQGGY-NPNRGGQGGGYGSGPYPQQGRGPPPYPGGG 459
Query: 366 AGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPN-QMGGSRN-QQYG-WQ 416
G G SGYGVG +Y Q G YG S GRGPN GGSRN QQYG WQ
Sbjct: 460 MGGAGGPRGGGGSGYGVGGPNYQQGGPYGASGPGRGPNYNQGGSRNQQQYGNWQ 513
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1446), Expect = e-159, Method: Compositional matrix adjust.
Identities = 276/345 (80%), Positives = 300/345 (86%), Gaps = 3/345 (0%)
Query: 11 GNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
GNKY+GS YMVFEYMDHDLTGLADRPG+RFTVPQIKCYMKQLLTGLHYCH+NQVLHRDIK
Sbjct: 107 GNKYKGSIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMKQLLTGLHYCHINQVLHRDIK 166
Query: 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
GSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG+TKYGPAVDMWS
Sbjct: 167 GSNLLIDNEGNLKLADFGLARSFSNDHNGNLTNRVITLWYRPPELLLGSTKYGPAVDMWS 226
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
VGCIFAELLNGKPILPGKNE EQLSKIF++CG+PDE+ WPGV+KMP YN+FKP R +KRR
Sbjct: 227 VGCIFAELLNGKPILPGKNEPEQLSKIFDVCGTPDESNWPGVTKMPWYNNFKPPRQLKRR 286
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEY 250
V+E F+HFDR AL+LLEKML LDP+QRISA+DALD+EYFW+DPLPCDPKSLPKYESSHE+
Sbjct: 287 VKEYFKHFDRLALDLLEKMLTLDPAQRISAQDALDAEYFWSDPLPCDPKSLPKYESSHEF 346
Query: 251 QTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGP 310
QTKK+RQQ RQ +EA KRQK HPQPHGRLPPIQ GQ H P PMNN P+ GP
Sbjct: 347 QTKKKRQQMRQADEAAKRQKTQHPQPHGRLPPIQQTGQPHPQIRPGQPMNNPHAPMAAGP 406
Query: 311 GHHHYGKPRGPPGGANRYPS-GNQSGGYNNPNRGGQGGGYSNAPY 354
G HHY KPRG PGG++RYP GNQ GGY N G GG Y NAPY
Sbjct: 407 G-HHYAKPRG-PGGSSRYPQGGNQGGGYPNRGGQGGGGSYGNAPY 449
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6ZAG3|CDKC3_ORYSJ Cyclin-dependent kinase C-3 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 282 bits (722), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 140/225 (62%), Positives = 169/225 (75%), Gaps = 9/225 (4%)
Query: 9 TDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP-QIKCYMKQLLTGLHYCHVNQVLHR 67
+D YRG YMVFEYMDHDL + L + P Q+K YM+QLL GLHYCHVN VLHR
Sbjct: 105 SDDYMYRGDIYMVFEYMDHDL-----KKVLHHSTPSQVKYYMEQLLKGLHYCHVNNVLHR 159
Query: 68 DIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
DIKG+NLLI G L KLADFGLAR F+ D + TN VITLWYRPPELLLGAT Y AV
Sbjct: 160 DIKGANLLISGGGKLLKLADFGLARPFTRD--GSFTNHVITLWYRPPELLLGATNYAEAV 217
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
D+WSVGCIFAE L KP+ PG+ E EQLSKIFELCG P+E WPGVSK+P Y +P+
Sbjct: 218 DIWSVGCIFAEFLLRKPLFPGRTEQEQLSKIFELCGFPNEENWPGVSKLPLYKTIRPTTP 277
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231
KRR+R++F +FD HA++L+++ML+L+P++RISA DAL + YF T
Sbjct: 278 TKRRLRDIFHNFDSHAVDLIDRMLILNPTERISAHDALCAAYFIT 322
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (717), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 133/267 (49%), Positives = 179/267 (67%), Gaps = 7/267 (2%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
LE ++ S Y+VF+YMDHDL GLA P ++F+ ++KC M+QL++GL +CH VL
Sbjct: 180 LEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVL 239
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 125
HRDIKGSNLLID+ G LK+ADFGLA F +H +T+RV+TLWYR PELLLGAT YG
Sbjct: 240 HRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVG 299
Query: 126 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH---FK 182
+D+WS GCI AELL G+PI+PG+ E EQL KI++LCGSP E W K + H +K
Sbjct: 300 IDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYW----KKGKFTHGAIYK 355
Query: 183 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 242
P KR +RE F+ F +L L++ +L ++P R +A AL SE+F ++P C+P LP
Sbjct: 356 PREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLP 415
Query: 243 KYESSHEYQTKKRRQQQRQHEEATKRQ 269
KY S E K+R ++ R+ A+K Q
Sbjct: 416 KYPPSKEIDAKRRDEETRRQRAASKAQ 442
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 275 bits (704), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 138/264 (52%), Positives = 178/264 (67%), Gaps = 1/264 (0%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
LE ++ GS Y++FEYM+HDL GLA PG+ F+ QIKCYMKQLL GL +CH VL
Sbjct: 225 LEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVL 284
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 125
HRDIKGSNLL+D+ NLK+ DFGLA + LT+RV+TLWYRPPELLLG+T YG
Sbjct: 285 HRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVT 344
Query: 126 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 185
VD+WS GCI AEL GKPI+PG+ E EQL KIF+LCGSP E W +SK+P FKP +
Sbjct: 345 VDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK-ISKLPHATIFKPQQ 403
Query: 186 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 245
KR V E F+ AL L+E +L ++P R + AL+SE+F T PL DP SLPKY+
Sbjct: 404 PYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQ 463
Query: 246 SSHEYQTKKRRQQQRQHEEATKRQ 269
E K + ++ ++ ++ + +Q
Sbjct: 464 PRKEIDVKAQEEEAKRKKDTSSKQ 487
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 136/316 (43%), Positives = 183/316 (57%), Gaps = 21/316 (6%)
Query: 7 ETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
+ D K +G+ Y+VFEYMDHDL GL + + F IK +M+QL+ GL YCH LH
Sbjct: 776 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYCHKKNFLH 835
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
RDIK SN+L++N G +KLADFGLAR +S + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 836 RDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGEERYTPAI 895
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
D+WS GCI EL KPI E QL I +CGSP +WP V K+P +N KP +
Sbjct: 896 DVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFNTMKPKKQ 955
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSLPKYE 245
+R++RE F AL+L + ML LDPS+R +A+ AL E+ +P P LP ++
Sbjct: 956 YRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRDVEPSKMPPPDLPLWQ 1015
Query: 246 SSHEYQTKKRRQQQRQHEEATKRQKLHHPQ--------------PHGRLPPIQHAGQSHH 291
HE +KKRR +Q+Q + P+ P G LPP Q QS+
Sbjct: 1016 DCHELWSKKRR-RQKQMGMTDDLSTIKAPRKDLSLGLDDSRTNTPQGVLPPAQLKSQSNS 1074
Query: 292 -----WSGPNHPMNNA 302
+GP P+N++
Sbjct: 1075 NVAPVITGPGQPLNHS 1090
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 125/255 (49%), Positives = 165/255 (64%), Gaps = 1/255 (0%)
Query: 7 ETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
+ D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQL+ GL YCH LH
Sbjct: 799 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYCHKKNFLH 858
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
RDIK SN+L++N G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 859 RDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYTPAI 918
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 919 DVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 978
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP-CDPKSLPKYE 245
+RR+RE F AL+LL+ ML LDPS+R +A+ L S++ L DP LP ++
Sbjct: 979 YRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMDPPDLPHWQ 1038
Query: 246 SSHEYQTKKRRQQQR 260
HE +KKRR+Q++
Sbjct: 1039 DCHELWSKKRRRQRQ 1053
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 260 bits (665), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 124/255 (48%), Positives = 164/255 (64%), Gaps = 1/255 (0%)
Query: 7 ETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
+ D K +G+ Y+VFEYMDHDL GL + ++F+ IK +MKQL+ GL YCH LH
Sbjct: 781 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIKSFMKQLMEGLEYCHKKNFLH 840
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
RDIK SN+L++N G +KLADFGLAR +S + + TN+VITLWYRPPELLLG +Y PA+
Sbjct: 841 RDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGEERYTPAI 900
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 901 DVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 960
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSLPKYE 245
+RR+RE F AL+LL+ ML LDPS+R +A+ L S++ D LP ++
Sbjct: 961 YRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVDVCKMATPDLPHWQ 1020
Query: 246 SSHEYQTKKRRQQQR 260
HE +KKRR+Q++
Sbjct: 1021 DCHELWSKKRRRQRQ 1035
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | ||||||
| 350537283 | 512 | cyclin dependent kinase C [Solanum lycop | 0.976 | 0.794 | 0.770 | 1e-179 | |
| 15238114 | 505 | cyclin-dependent kinase C-1 [Arabidopsis | 0.942 | 0.778 | 0.778 | 1e-176 | |
| 255553496 | 516 | ATP binding protein, putative [Ricinus c | 0.976 | 0.788 | 0.774 | 1e-176 | |
| 225435987 | 517 | PREDICTED: cyclin-dependent kinase C-1-l | 0.976 | 0.787 | 0.789 | 1e-174 | |
| 297794099 | 514 | cyclin-dependent kinase C_2 [Arabidopsis | 0.952 | 0.772 | 0.775 | 1e-174 | |
| 356501366 | 516 | PREDICTED: cyclin-dependent kinase C-2-l | 0.976 | 0.788 | 0.767 | 1e-173 | |
| 297811129 | 505 | cyclin-dependent kinase C_1 [Arabidopsis | 0.944 | 0.780 | 0.763 | 1e-173 | |
| 224086673 | 513 | predicted protein [Populus trichocarpa] | 0.990 | 0.805 | 0.747 | 1e-169 | |
| 15238314 | 513 | cyclin-dependent kinase C-2 [Arabidopsis | 0.949 | 0.771 | 0.760 | 1e-169 | |
| 145334903 | 460 | cyclin-dependent kinase C-2 [Arabidopsis | 0.949 | 0.860 | 0.760 | 1e-168 |
| >gi|350537283|ref|NP_001234799.1| cyclin dependent kinase C [Solanum lycopersicum] gi|15215944|emb|CAC51391.1| cyclin dependent kinase C [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 315/409 (77%), Positives = 342/409 (83%), Gaps = 2/409 (0%)
Query: 9 TDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68
D NKY+G+ YMVFEYMDHDLTGLADRPGLRFT+PQIKCYMKQLLTGLHYCH+NQVLHRD
Sbjct: 106 IDSNKYKGNIYMVFEYMDHDLTGLADRPGLRFTIPQIKCYMKQLLTGLHYCHINQVLHRD 165
Query: 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 128
IKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLGATKYGPAVDM
Sbjct: 166 IKGSNLLIDNEGNLKLADFGLARSFSGDHNANLTNRVITLWYRPPELLLGATKYGPAVDM 225
Query: 129 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 188
WSVGCIFAELL GKPILPGKNE EQL+KIFELCG+PDE WPGVSK+P Y+ FKP+R MK
Sbjct: 226 WSVGCIFAELLFGKPILPGKNEPEQLNKIFELCGTPDEINWPGVSKIPWYSKFKPARPMK 285
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 248
RRVREVFRHFDRHAL+LL+KML LDPSQRI AKDALD EYFWTDPLPCDP+SLPKYESSH
Sbjct: 286 RRVREVFRHFDRHALDLLDKMLNLDPSQRICAKDALDGEYFWTDPLPCDPRSLPKYESSH 345
Query: 249 EYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPG 308
E+QTKK+RQQQRQ+EE KR KL HPQ H RLPPIQ G S HW G H M+N+ P +
Sbjct: 346 EFQTKKKRQQQRQNEEMAKRHKLQHPQQHSRLPPIQQPGHSQHWGGSTHQMSNSQPAISA 405
Query: 309 GPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGM 368
G GHH +GKPRG GG+NRYP G GG +RG QGGGYS+ YPPQGR PP+ G+G+
Sbjct: 406 GAGHHQFGKPRG-TGGSNRYPPGGNPGGGYYQDRGAQGGGYSSGAYPPQGRAPPFPGSGL 464
Query: 369 PANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 417
A SG GP +YSQSGQYG S AGRG NQM G+RNQQYGWQQ
Sbjct: 465 -APSGPRGPSGGYGGPPNYSQSGQYGGSGAGRGSNQMSGNRNQQYGWQQ 512
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238114|ref|NP_196589.1| cyclin-dependent kinase C-1 [Arabidopsis thaliana] gi|75334961|sp|Q9LFT8.1|CDKC1_ARATH RecName: Full=Cyclin-dependent kinase C-1; Short=CDKC;1 gi|14030693|gb|AAK53021.1|AF375437_1 AT5g10270/F18D22_40 [Arabidopsis thaliana] gi|8953408|emb|CAB96683.1| cdc2-like protein kinase [Arabidopsis thaliana] gi|21464557|gb|AAM52233.1| AT5g10270/F18D22_40 [Arabidopsis thaliana] gi|332004132|gb|AED91515.1| cyclin-dependent kinase C-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1609), Expect = e-176, Method: Compositional matrix adjust.
Identities = 323/415 (77%), Positives = 349/415 (84%), Gaps = 22/415 (5%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 106 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 165
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 166 KGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMW 225
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FKP+R +KR
Sbjct: 226 SVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFKPARPLKR 285
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 286 RVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYESSHE 345
Query: 250 YQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNHPMNNAPP 304
+QTKK+RQQQRQ+EEA KRQKL H P H RLPP+QH GQSH HW +GPNHP NNAPP
Sbjct: 346 FQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHWPAGPNHPTNNAPP 405
Query: 305 PVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPY 363
VP GP H+ YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPPQGRG PY
Sbjct: 406 QVPAGPSHNFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPPQGRGAPY 459
Query: 364 AGAGMPANGPRGPASG-YGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 417
GPRGP+ G YGVGP +Y+Q GQYG S + + RNQQYGWQQ
Sbjct: 460 VA------GPRGPSGGPYGVGPPNYTQGGQYGGSGSS---GRGQNQRNQQYGWQQ 505
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255553496|ref|XP_002517789.1| ATP binding protein, putative [Ricinus communis] gi|223543061|gb|EEF44596.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1605), Expect = e-176, Method: Compositional matrix adjust.
Identities = 320/413 (77%), Positives = 350/413 (84%), Gaps = 6/413 (1%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
DGNKY+G YMVFEYMDHDLTGLADRPG++F+VPQIKCYM+QLLTGLHYCHVNQVLHRDI
Sbjct: 105 DGNKYKGGIYMVFEYMDHDLTGLADRPGMKFSVPQIKCYMRQLLTGLHYCHVNQVLHRDI 164
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARSFS +HN LTNRVITLWYRPPELLLG TKYGPAVDMW
Sbjct: 165 KGSNLLIDNEGNLKLADFGLARSFSNEHNANLTNRVITLWYRPPELLLGTTKYGPAVDMW 224
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELL GKPI PGK+E EQ++KIFELCG+PDE WPGVSKMP YN+FKP+R MKR
Sbjct: 225 SVGCIFAELLYGKPIFPGKDEPEQINKIFELCGAPDEVNWPGVSKMPWYNNFKPNRPMKR 284
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
R+R++FR FDRHALELLEKML LDPSQRISAKDALD+EYFWTDPLPCDPKSLPKYESSHE
Sbjct: 285 RLRDLFRGFDRHALELLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYESSHE 344
Query: 250 YQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSH--HWSGPNHPMNNAPPPVP 307
+QTKK+RQQQRQHEE KRQKL HPQ HGRLPPIQ +GQ+H SGPN M+++ PV
Sbjct: 345 FQTKKKRQQQRQHEENAKRQKLQHPQQHGRLPPIQQSGQAHVQMRSGPNQQMHSSQAPVA 404
Query: 308 GGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNR---GGQGGGYSNAPYPPQGRGPPYA 364
GP HHYGKPRGP GG RYP SGGYN+PNR GG GGGY + PYPPQGR PPY
Sbjct: 405 AGPS-HHYGKPRGPAGGPGRYPPSGTSGGYNHPNRGGGGGGGGGYGSGPYPPQGRAPPYG 463
Query: 365 GAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 417
+GMP G +SGYGVG +Y Q YG+S AGRG N MGG+RNQQYGWQQ
Sbjct: 464 SSGMPGAPRGGGSSGYGVGAPNYPQGAPYGSSGAGRGSNMMGGNRNQQYGWQQ 516
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435987|ref|XP_002272429.1| PREDICTED: cyclin-dependent kinase C-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1594), Expect = e-174, Method: Compositional matrix adjust.
Identities = 327/414 (78%), Positives = 356/414 (85%), Gaps = 7/414 (1%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
DGNKY+G YMVFEYMDHDLTGLADRPG+RF+VPQIKCYM+QLLTGLHYCHVNQVLHRDI
Sbjct: 105 DGNKYKGGIYMVFEYMDHDLTGLADRPGMRFSVPQIKCYMRQLLTGLHYCHVNQVLHRDI 164
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG T+YGPAVDMW
Sbjct: 165 KGSNLLIDNEGNLKLADFGLARSFSNDHNGNLTNRVITLWYRPPELLLGTTRYGPAVDMW 224
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELL+GKPI PGK+E EQL+KIFELCG+PDE WPGVSK+P Y++FKP+R MKR
Sbjct: 225 SVGCIFAELLHGKPIFPGKDEPEQLNKIFELCGAPDEVNWPGVSKIPWYSNFKPTRPMKR 284
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
R+REVFRHFDRHALELLE+ML LDPSQRISAKDALD+EYFWTDPLPCDPKSLPKYESSHE
Sbjct: 285 RLREVFRHFDRHALELLERMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYESSHE 344
Query: 250 YQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHW--SGPNHPMN-NAPPPV 306
+QTKK+RQQQRQH+E KRQKL HPQ H RLPPIQ +GQ H +GPN PM+ + PPV
Sbjct: 345 FQTKKKRQQQRQHDETAKRQKLQHPQQHARLPPIQQSGQVHAQMRAGPNQPMHGGSQPPV 404
Query: 307 PGGPGHHHYGKPRGPPGGANRYP-SGNQSGGYNNPNR--GGQGGGYSNAPYPPQGRGPPY 363
GP HHYGKPRGP GG +RYP SGN SGGYN+PNR G GGGY N P+PPQGRGPPY
Sbjct: 405 AAGPS-HHYGKPRGPSGGPSRYPQSGNPSGGYNHPNRGGQGGGGGYGNGPFPPQGRGPPY 463
Query: 364 AGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 417
A +GMP GPRG SGYGVG +Y Q G Y S AGRG N MGG+RNQ YGWQQ
Sbjct: 464 ASSGMPGAGPRGGGSGYGVGAPNYPQGGPYSGSGAGRGSNMMGGNRNQNYGWQQ 517
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297794099|ref|XP_002864934.1| cyclin-dependent kinase C_2 [Arabidopsis lyrata subsp. lyrata] gi|297310769|gb|EFH41193.1| cyclin-dependent kinase C_2 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1587), Expect = e-174, Method: Compositional matrix adjust.
Identities = 325/419 (77%), Positives = 350/419 (83%), Gaps = 22/419 (5%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 106 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 165
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARSFS+DH+ LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 166 KGSNLLIDNEGNLKLADFGLARSFSHDHSGNLTNRVITLWYRPPELLLGATKYGPAIDMW 225
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELLNGKPILPGK E+EQL+KI+ELCGSPDE WPGVSKMP Y K SR +KR
Sbjct: 226 SVGCIFAELLNGKPILPGKTESEQLNKIYELCGSPDENNWPGVSKMPWYGQMKSSRPLKR 285
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE++RHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 286 RVREIYRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYESSHE 345
Query: 250 YQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQH-AGQSH---HW-SGPNHPM-NNA 302
+QTKK+RQQ R +EEA K+QKL H PQ H RLPP QH GQSH HW +GPNHPM NNA
Sbjct: 346 FQTKKKRQQMRHNEEAAKKQKLQHPPQQHSRLPPQQHGVGQSHAAPHWPAGPNHPMNNNA 405
Query: 303 PPP-VP-GGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGR 359
PPP +P GGPG H+YGKPRG G NRY PSGNQ GGYNN +R GGYSN YPPQGR
Sbjct: 406 PPPQIPAGGPGGHYYGKPRGGAPGQNRYPPSGNQPGGYNNQSR----GGYSNGAYPPQGR 461
Query: 360 GPPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQ 416
G PYA GPRGP+ GYGVGP S G+ +GRG N MGG+RNQQYGWQ
Sbjct: 462 GAPYAA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQQYGWQ 514
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501366|ref|XP_003519496.1| PREDICTED: cyclin-dependent kinase C-2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1583), Expect = e-173, Method: Compositional matrix adjust.
Identities = 317/413 (76%), Positives = 344/413 (83%), Gaps = 6/413 (1%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
DGNKY+G YMVFEYMDHDLTGLADRPG+RFTVPQIKCYM+QLLTGLHYCHVNQVLHRDI
Sbjct: 105 DGNKYKGGIYMVFEYMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQVLHRDI 164
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARSFS D N LTNRVITLWYRPPELLLG TKYGPAVDMW
Sbjct: 165 KGSNLLIDNEGNLKLADFGLARSFSNDQNANLTNRVITLWYRPPELLLGTTKYGPAVDMW 224
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELL GKPI PGK+E EQL+KI+ELCG+P+E WPGVSK+P YN F P+R MKR
Sbjct: 225 SVGCIFAELLQGKPIFPGKDEPEQLNKIYELCGAPNEVNWPGVSKIPYYNKFMPTRPMKR 284
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
R+R+VFRHFD HALELLEKML LDPSQRI+AKDALD+EYFWTDPLPCDPKSLPKYESSHE
Sbjct: 285 RLRDVFRHFDHHALELLEKMLTLDPSQRITAKDALDAEYFWTDPLPCDPKSLPKYESSHE 344
Query: 250 YQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQ-SHHWSGPNHPMNNAPPPVPG 308
+QTKK+RQQQRQ+EE KRQK+ HPQPH RLPPIQ GQ + SGPN P++ + P V
Sbjct: 345 FQTKKKRQQQRQNEEMAKRQKMQHPQPHTRLPPIQQPGQHAQMRSGPNQPIHGSQPQVSA 404
Query: 309 GPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQ-GGGYSNAPYPPQGRGPPYAGA 366
GP HHYGKPRGP GG RY P+GN GGY++PNR GQ G GY + PYPPQGRG PY
Sbjct: 405 GP-THHYGKPRGPSGGPGRYPPNGNPGGGYSHPNRAGQGGSGYGSGPYPPQGRGAPYGSN 463
Query: 367 GMPANGPRGP-ASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRN-QQYGWQQ 417
MP GPRG ASGY P Q G YG SAAGRG N MGG+RN QQYGWQQ
Sbjct: 464 SMPGGGPRGSGASGYVGAPNYPQQGGPYGGSAAGRGSNMMGGNRNQQQYGWQQ 516
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811129|ref|XP_002873448.1| cyclin-dependent kinase C_1 [Arabidopsis lyrata subsp. lyrata] gi|297319285|gb|EFH49707.1| cyclin-dependent kinase C_1 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 316/414 (76%), Positives = 335/414 (80%), Gaps = 20/414 (4%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 106 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 165
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARSFS+DH+ LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 166 KGSNLLIDNEGNLKLADFGLARSFSHDHSGNLTNRVITLWYRPPELLLGATKYGPAIDMW 225
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE IWPGVSKMP YN+FKP+R +KR
Sbjct: 226 SVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDENIWPGVSKMPWYNNFKPARPLKR 285
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE FRHFDRHALELLEKML+LDPSQRISAKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 286 RVREFFRHFDRHALELLEKMLVLDPSQRISAKDALDAEYFWTDPLPCDPKSLPTYESSHE 345
Query: 250 YQTKKRRQQQRQHEEATKRQKLHH-PQPHGRLPPIQHAGQSH---HW-SGPNHPMNNAPP 304
+QTKK+RQQQRQ+EEA KRQK+ H PQ H RLPP+QH GQSH HW +GPNHP NNAPP
Sbjct: 346 FQTKKKRQQQRQNEEAAKRQKVQHPPQQHSRLPPLQHGGQSHAAPHWPAGPNHPTNNAPP 405
Query: 305 PVPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPY 363
VP GP HH YGKPRGPP G NRY PSGNQSGGYN GGYS+ YPPQGRG PY
Sbjct: 406 QVPAGPSHHFYGKPRGPP-GPNRYPPSGNQSGGYNQSR-----GGYSSGSYPPQGRGAPY 459
Query: 364 AGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQQ 417
GPR G Q G + RNQQYGWQQ
Sbjct: 460 VA------GPR--GPSGGGYGVGPPNYTQGGQYGGSGSSGRGQNPRNQQYGWQQ 505
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086673|ref|XP_002307926.1| predicted protein [Populus trichocarpa] gi|222853902|gb|EEE91449.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1549), Expect = e-169, Method: Compositional matrix adjust.
Identities = 314/420 (74%), Positives = 344/420 (81%), Gaps = 7/420 (1%)
Query: 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
DGNKY+G YMVFEYMDHDLTGLADRPG+RF+VPQIKCYM+QLLTGLHYCHVNQ
Sbjct: 95 VLCAIADGNKYKGGIYMVFEYMDHDLTGLADRPGMRFSVPQIKCYMRQLLTGLHYCHVNQ 154
Query: 64 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 123
VLHRDIKGSNLLIDNEGNLKLADFGLARSFS DHN LTNRVITLWYRPPELLLG TKYG
Sbjct: 155 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNANLTNRVITLWYRPPELLLGTTKYG 214
Query: 124 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 183
PAVDMWSVGCIFAELL+GKPI PGK+E EQL+KIFELCG+PDE WPGVSK+P YN+ KP
Sbjct: 215 PAVDMWSVGCIFAELLHGKPIFPGKDEPEQLNKIFELCGAPDEFNWPGVSKIPWYNNLKP 274
Query: 184 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 243
+R MKRR+REVFRHFDR+ALELLEKML LDPS+RISAKDALD+EYFWTDPLPC+PKSLPK
Sbjct: 275 TRPMKRRLREVFRHFDRNALELLEKMLTLDPSERISAKDALDAEYFWTDPLPCNPKSLPK 334
Query: 244 YESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSH--HWSGPNHPMNN 301
YE+SHE+QTKK+RQQ RQHEE KRQKL H Q HGRLPP Q +GQ+H SGPN P+++
Sbjct: 335 YEASHEFQTKKKRQQLRQHEENAKRQKLQHQQQHGRLPPTQQSGQAHPQMRSGPNQPLHS 394
Query: 302 APPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNR-GGQGGGYSNAPYPPQGRG 360
+ PPV GP HHYGKPRGP GG RYP SGGYN+PNR G GGY + PYPPQGR
Sbjct: 395 SQPPVAAGPS-HHYGKPRGPAGGPGRYPPSGTSGGYNHPNRGGQGSGGYGSGPYPPQGRA 453
Query: 361 PPYAGAGMPANGPRGPASGYGVGPQ--SYSQSG-QYGNSAAGRGPNQMGGSRNQQYGWQQ 417
PPY + MP P G G G G +Y Q G YG S AGRG N MGG+RNQQYGWQQ
Sbjct: 454 PPYGSSSMPGAPPHGSGGGSGYGVGGPNYPQGGPPYGGSGAGRGSNMMGGNRNQQYGWQQ 513
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238314|ref|NP_201301.1| cyclin-dependent kinase C-2 [Arabidopsis thaliana] gi|152013386|sp|Q8W4P1.2|CDKC2_ARATH RecName: Full=Cyclin-dependent kinase C-2; Short=CDKC;2 gi|13430444|gb|AAK25844.1|AF360134_1 putative cdc2 protein kinase [Arabidopsis thaliana] gi|8843760|dbj|BAA97308.1| cdc2-like protein kinase [Arabidopsis thaliana] gi|14532732|gb|AAK64067.1| putative cdc2 protein kinase [Arabidopsis thaliana] gi|332010592|gb|AED97975.1| cyclin-dependent kinase C-2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1549), Expect = e-169, Method: Compositional matrix adjust.
Identities = 318/418 (76%), Positives = 345/418 (82%), Gaps = 22/418 (5%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 106 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 165
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 166 KGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMW 225
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K SR +KR
Sbjct: 226 SVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSRPLKR 285
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 286 RVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYESSHE 345
Query: 250 YQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPNHPM-NNA 302
+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPNHPM NNA
Sbjct: 346 FQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPNHPMNNNA 405
Query: 303 PPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRG 360
PPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+ YPPQGRG
Sbjct: 406 PPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGAYPPQGRG 460
Query: 361 PPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQ 416
PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQQYGWQ
Sbjct: 461 APYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQQYGWQ 512
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145334903|ref|NP_001078797.1| cyclin-dependent kinase C-2 [Arabidopsis thaliana] gi|332010593|gb|AED97976.1| cyclin-dependent kinase C-2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1543), Expect = e-168, Method: Compositional matrix adjust.
Identities = 318/418 (76%), Positives = 345/418 (82%), Gaps = 22/418 (5%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 53 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 112
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 113 KGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMW 172
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K SR +KR
Sbjct: 173 SVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSRPLKR 232
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 233 RVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYESSHE 292
Query: 250 YQTKKRRQQQRQHEEATKRQKLHHP-QPHGRLPPIQH-AGQSHH---W-SGPNHPM-NNA 302
+QTKK+RQQ R +EEA K+QKL HP Q H RLPP QH GQSH W +GPNHPM NNA
Sbjct: 293 FQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSHAAPLWPAGPNHPMNNNA 352
Query: 303 PPP-VPGGPGHHHYGKPRGPPGGANRY-PSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRG 360
PPP +P G GH++ GKPRG NRY PSGNQ+GGYNN +R GGYS+ YPPQGRG
Sbjct: 353 PPPQIPAG-GHYYGGKPRGGAPVPNRYPPSGNQTGGYNNQSR----GGYSSGAYPPQGRG 407
Query: 361 PPYAGAGMPANGPRGPASGYGVGP--QSYSQSGQYGNSAAGRGPNQMGGSRNQQYGWQ 416
PY GPRGP+ GYGVGP S G+ +GRG N MGG+RNQQYGWQ
Sbjct: 408 APYGA------GPRGPSGGYGVGPPNYSQGGGQYGGSGGSGRGQNPMGGARNQQYGWQ 459
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | ||||||
| TAIR|locus:2177744 | 513 | CDKC2 "cyclin dependent kinase | 0.673 | 0.547 | 0.837 | 1.2e-151 | |
| TAIR|locus:2145397 | 505 | CDKC;1 "cyclin-dependent kinas | 0.678 | 0.560 | 0.836 | 4e-151 | |
| DICTYBASE|DDB_G0273721 | 694 | cdk9-2 "CDK family protein kin | 0.671 | 0.403 | 0.527 | 4e-85 | |
| DICTYBASE|DDB_G0273207 | 694 | cdk9-1 "CDK family protein kin | 0.671 | 0.403 | 0.527 | 4e-85 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.640 | 0.414 | 0.547 | 1.8e-76 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.565 | 0.406 | 0.582 | 3.1e-74 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.616 | 0.359 | 0.535 | 7.6e-74 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.577 | 0.392 | 0.561 | 1.4e-73 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.565 | 0.340 | 0.594 | 5.9e-73 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.565 | 0.318 | 0.590 | 1.2e-72 |
| TAIR|locus:2177744 CDKC2 "cyclin dependent kinase group C2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 1.2e-151, Sum P(2) = 1.2e-151
Identities = 237/283 (83%), Positives = 252/283 (89%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 106 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 165
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 166 KGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMW 225
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELLNGKPILPGK E EQL+KI+ELCGSPDE+ WPGVSKMP YN K SR +KR
Sbjct: 226 SVGCIFAELLNGKPILPGKTENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSRPLKR 285
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE++RHFDRHALELLEKML+LDPSQRI AKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 286 RVREIYRHFDRHALELLEKMLVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYESSHE 345
Query: 250 YQTKKXXXXXXXHEEATKRQKLHHPQP-HGRLPPIQHA-GQSH 290
+QTKK +EEA K+QKL HPQ H RLPP QH GQSH
Sbjct: 346 FQTKKKRQQMRHNEEAAKKQKLQHPQQQHSRLPPQQHGVGQSH 388
|
|
| TAIR|locus:2145397 CDKC;1 "cyclin-dependent kinase C;1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 4.0e-151, Sum P(2) = 4.0e-151
Identities = 240/287 (83%), Positives = 257/287 (89%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D NKY+G YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI
Sbjct: 106 DNNKYKGGIYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 165
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
KGSNLLIDNEGNLKLADFGLARS+S+DH LTNRVITLWYRPPELLLGATKYGPA+DMW
Sbjct: 166 KGSNLLIDNEGNLKLADFGLARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMW 225
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCIFAELL+ KPILPGKNE EQL+KIFELCGSPDE +WPGVSKMP +N+FKP+R +KR
Sbjct: 226 SVGCIFAELLHAKPILPGKNEQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFKPARPLKR 285
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
RVRE FRHFDRHALELLEKML+LDP+QRISAKDALD+EYFWTDPLPCDPKSLP YESSHE
Sbjct: 286 RVREFFRHFDRHALELLEKMLVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYESSHE 345
Query: 250 YQTKKXXXXXXXHEEATKRQKLHHPQ-PHGRLPPIQHAGQSH---HW 292
+QTKK +EEA KRQKL HP H RLPP+QH GQSH HW
Sbjct: 346 FQTKKKRQQQRQNEEAAKRQKLQHPPLQHSRLPPLQHGGQSHAAPHW 392
|
|
| DICTYBASE|DDB_G0273721 cdk9-2 "CDK family protein kinase 9" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 4.0e-85, Sum P(2) = 4.0e-85
Identities = 153/290 (52%), Positives = 197/290 (67%)
Query: 12 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP-QIKCYMKQLLTGLHYCHVNQVLHRDIK 70
N ++GS YMVFEYMDHDL GL D P ++ P QIKCY+KQLL GL YCH N VLHRDIK
Sbjct: 283 NNHKGSVYMVFEYMDHDLNGLMDSPAFKYFAPGQIKCYLKQLLEGLDYCHRNNVLHRDIK 342
Query: 71 GSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
GSNLL+DN G LKLADFGLAR F S + LTNRVITLWYRPPELLLG YGP +DMW
Sbjct: 343 GSNLLLDNNGILKLADFGLARPFNSSEKKQILTNRVITLWYRPPELLLGTFHYGPEIDMW 402
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCI AELL+ K + PG+N +QL KI+++CGSP+ WP +P ++ KP R
Sbjct: 403 SVGCIMAELLSKKTLFPGRNSIDQLDKIYQVCGSPNANNWPEAMDLPFWDALKPKREYNS 462
Query: 190 -RVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 243
+++ ++H F + A +LL+K+L +DP +RI+A +ALD +YFWTDP+P +PK LP+
Sbjct: 463 LSLKDFYQHENPSFFTKEAFDLLDKLLCMDPKKRITASEALDHQYFWTDPMPVNPKDLPQ 522
Query: 244 YESSHEYQTKKXXXXXXXHEEATKRQKLHHPQPHGRLPPIQHAGQS--HH 291
Y S HEY+TKK ++ + Q+ QP + Q+ G + HH
Sbjct: 523 YPSCHEYRTKKRLRQQNQNQNQQQNQQQQQQQPQNQHQQSQYQGANVNHH 572
|
|
| DICTYBASE|DDB_G0273207 cdk9-1 "CDK family protein kinase 9" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 4.0e-85, Sum P(2) = 4.0e-85
Identities = 153/290 (52%), Positives = 197/290 (67%)
Query: 12 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVP-QIKCYMKQLLTGLHYCHVNQVLHRDIK 70
N ++GS YMVFEYMDHDL GL D P ++ P QIKCY+KQLL GL YCH N VLHRDIK
Sbjct: 283 NNHKGSVYMVFEYMDHDLNGLMDSPAFKYFAPGQIKCYLKQLLEGLDYCHRNNVLHRDIK 342
Query: 71 GSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
GSNLL+DN G LKLADFGLAR F S + LTNRVITLWYRPPELLLG YGP +DMW
Sbjct: 343 GSNLLLDNNGILKLADFGLARPFNSSEKKQILTNRVITLWYRPPELLLGTFHYGPEIDMW 402
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
SVGCI AELL+ K + PG+N +QL KI+++CGSP+ WP +P ++ KP R
Sbjct: 403 SVGCIMAELLSKKTLFPGRNSIDQLDKIYQVCGSPNANNWPEAMDLPFWDALKPKREYNS 462
Query: 190 -RVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 243
+++ ++H F + A +LL+K+L +DP +RI+A +ALD +YFWTDP+P +PK LP+
Sbjct: 463 LSLKDFYQHENPSFFTKEAFDLLDKLLCMDPKKRITASEALDHQYFWTDPMPVNPKDLPQ 522
Query: 244 YESSHEYQTKKXXXXXXXHEEATKRQKLHHPQPHGRLPPIQHAGQS--HH 291
Y S HEY+TKK ++ + Q+ QP + Q+ G + HH
Sbjct: 523 YPSCHEYRTKKRLRQQNQNQNQQQNQQQQQQQPQNQHQQSQYQGANVNHH 572
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 1.8e-76, Sum P(2) = 1.8e-76
Identities = 149/272 (54%), Positives = 183/272 (67%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
S Y+VFEYMDHDL GLA PG++F+ PQ+KCYM+QLL+GLH+CH VLHRDIKGSNLLI
Sbjct: 210 SLYLVFEYMDHDLVGLASIPGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLI 269
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
D+ G LK+ADFGLA F + LT+RV+TLWYRPPELLLGA YG VD+WS GCI
Sbjct: 270 DSNGVLKIADFGLATFFDPQNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILG 329
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
EL +GKPIL GK E EQL KIF+LCGSP E W + K+P F+P+ RRV E+F+
Sbjct: 330 ELYSGKPILAGKTEVEQLHKIFKLCGSPTEDYWRKL-KLPPSAAFRPALPYGRRVAEMFK 388
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKXX 256
+ L LLE +L +DP +R SA AL+SEYF T+P CDP SLPKY S E K
Sbjct: 389 DLPTNVLSLLEALLSIDPDRRGSAARALESEYFRTEPFACDPSSLPKYPPSKEIDAKIRD 448
Query: 257 XXXXXH--EEATKRQKLHHPQPHGR--LPPIQ 284
+E +RQ + H R +PP++
Sbjct: 449 DAKRQRPTQEKHERQDSQTRRSHERKLIPPVK 480
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 749 (268.7 bits), Expect = 3.1e-74, P = 3.1e-74
Identities = 138/237 (58%), Positives = 173/237 (72%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
S Y+VFEYM+HDL+GLA GL+F +PQ+KC+MKQLL+GL +CH VLHRDIKGSNLLI
Sbjct: 187 SLYLVFEYMEHDLSGLAATQGLKFDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLI 246
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
DN+G LK+ADFGLA + T+T+RV+TLWYRPPELLLGAT YG VD+WS GCI A
Sbjct: 247 DNDGILKIADFGLATFYDPKQKQTMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMA 306
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
ELL GKP++PG+ E EQL KIF+LCGSP ++ W ++P FKP KR V E F
Sbjct: 307 ELLAGKPVMPGRTEVEQLHKIFKLCGSPSDSYWKKY-RLPNATLFKPQHPYKRCVAEAFN 365
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTK 253
F ++ L+E +L +DP+ R ++ AL+SE+F T+PLPCDP SLPKY S E K
Sbjct: 366 GFTPSSVHLVETLLTIDPADRGTSTSALNSEFFTTEPLPCDPSSLPKYPPSKELNVK 422
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 7.6e-74, Sum P(2) = 7.6e-74
Identities = 142/265 (53%), Positives = 174/265 (65%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
LE ++ GS Y++FEYM+HDL GLA PG+ F+ QIKCYMKQLL GL +CH VL
Sbjct: 225 LEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVL 284
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 125
HRDIKGSNLL+D+ NLK+ DFGLA + LT+RV+TLWYRPPELLLG+T YG
Sbjct: 285 HRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVT 344
Query: 126 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 185
VD+WS GCI AEL GKPI+PG+ E EQL KIF+LCGSP E W +SK+P FKP +
Sbjct: 345 VDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK-ISKLPHATIFKPQQ 403
Query: 186 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 245
KR V E F+ AL L+E +L ++P R + AL+SE+F T PL DP SLPKY+
Sbjct: 404 PYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQ 463
Query: 246 SSHEYQTKKXXXXXXXHEEATKRQK 270
E K EE KR+K
Sbjct: 464 PRKEIDVK-------AQEEEAKRKK 481
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 1.4e-73, P = 1.4e-73
Identities = 136/242 (56%), Positives = 176/242 (72%)
Query: 12 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71
+K GS ++VFEYM+HDL+GLA RPG++FT PQIKC+MKQLL GL +CH +LHRDIKG
Sbjct: 209 SKLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKG 268
Query: 72 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
SNLL++N+G LK+ DFGLA + D + LT+RV+TLWYR PELLLG+T+YGPA+D+WSV
Sbjct: 269 SNLLVNNDGVLKIGDFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSV 328
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
GCI AEL KPI+PG+ E EQ+ KIF+LCGSP E W +K P +KP KR +
Sbjct: 329 GCILAELFVCKPIMPGRTEVEQMHKIFKLCGSPSEEFW-NTTKFPQATSYKPQHPYKRVL 387
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQ 251
E F++ +L+LL+K+L ++P +R SA L SE+F T+PLPC SLPKY S E
Sbjct: 388 LETFKNLSSSSLDLLDKLLSVEPEKRCSASSTLLSEFFTTEPLPCHISSLPKYPPSKELD 447
Query: 252 TK 253
K
Sbjct: 448 AK 449
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 5.9e-73, P = 5.9e-73
Identities = 141/237 (59%), Positives = 170/237 (71%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
S Y+VFEYM+HDL GLA P ++F+ Q+KCY++QLL GL +CH VLHRDIKGSNLLI
Sbjct: 207 SLYLVFEYMEHDLAGLASHPAIKFSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLI 266
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
DN G LK+ADFGLA F LT+RV+TLWYRPPELLLGAT+YG AVD+WS GCI A
Sbjct: 267 DNSGVLKIADFGLASFFDPRQTQPLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILA 326
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
EL GKPI+PG+ E EQL KIF+LCGSP E W S++P FKP++ KR V E F+
Sbjct: 327 ELYAGKPIMPGRTEVEQLHKIFKLCGSPTEDYWVK-SRLPHATIFKPTQPYKRLVGETFK 385
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTK 253
F + AL LLE +L ++P R +A AL SE+F T PLPCDP SLPKY S E +
Sbjct: 386 EFPQPALALLETLLSVNPDDRGTATAALKSEFFSTRPLPCDPSSLPKYPPSKELDAR 442
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 1.2e-72, P = 1.2e-72
Identities = 140/237 (59%), Positives = 169/237 (71%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
S Y+VFEYMDHDL GL+ PG++FT PQ+KCYM+QLL+GL +CH VLHRDIKGSNLLI
Sbjct: 286 SLYLVFEYMDHDLLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLI 345
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
D++G LK+ADFGLA F + +LT+ V+TLWYRPPELLLGA+ YG VD+WS GCI
Sbjct: 346 DSKGVLKIADFGLATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILG 405
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
EL GKPILPGK E EQL KIF+LCGSP E W K+P+ FK + +R+V E+F+
Sbjct: 406 ELYAGKPILPGKTEVEQLHKIFKLCGSPTENYWRK-QKLPSSAGFKTAIPYRRKVSEMFK 464
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTK 253
F L LLE +L +DP R SA AL+SEYF T P CDP +LPKY S E K
Sbjct: 465 DFPASVLSLLETLLSIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEIDAK 521
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFT8 | CDKC1_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7783 | 0.9424 | 0.7782 | yes | no |
| Q5JK68 | CDKC2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7705 | 0.9664 | 0.7855 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.22 | 0.991 |
| 3rd Layer | 2.7.11.23 | 0.991 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00007988001 | SubName- Full=Chromosome undetermined scaffold_1171, whole genome shotgun sequence; (516 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 417 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-150 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-112 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-108 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-100 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-98 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-96 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-96 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-95 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-86 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-86 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-85 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-78 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-75 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-75 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-74 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-72 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-71 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-71 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-70 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-69 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-68 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-66 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-65 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-62 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-60 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-60 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-59 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-59 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-57 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-57 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-57 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-55 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-55 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-54 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-53 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-53 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-50 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-50 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-50 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-49 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-48 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-46 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-45 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-45 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-45 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-44 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-44 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-43 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-42 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-41 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-40 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-38 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-36 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-32 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-30 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-28 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-04 | |
| pfam06682 | 317 | pfam06682, DUF1183, Protein of unknown function (D | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| pfam02084 | 239 | pfam02084, Bindin, Bindin | 0.002 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.002 | |
| pfam06375 | 561 | pfam06375, BLVR, Bovine leukaemia virus receptor ( | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 426 bits (1099), Expect = e-150
Identities = 146/219 (66%), Positives = 170/219 (77%), Gaps = 1/219 (0%)
Query: 12 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71
+K +GS YMVFEYMDHDLTGL D P ++FT QIKCYMKQLL GL Y H N +LHRDIKG
Sbjct: 69 SKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKG 128
Query: 72 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
SN+LI+N+G LKLADFGLAR ++ ++ TNRVITLWYRPPELLLGAT+YGP VDMWSV
Sbjct: 129 SNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSV 188
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
GCI AEL GKPI G E EQL KIFELCGSP + WPGVSK+P + + KP + KRR+
Sbjct: 189 GCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRL 248
Query: 192 REVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYF 229
RE F+H D AL+LL+K+L LDP +RISA AL EYF
Sbjct: 249 REFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 330 bits (849), Expect = e-112
Identities = 105/213 (49%), Positives = 140/213 (65%), Gaps = 2/213 (0%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+VFEY D DL D+ + IK M QLL GL YCH +++LHRD+K N+LI
Sbjct: 72 KLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ +G LKLADFGLAR+F T T+ V+TLWYR PE+LLG+ Y AVD+WSVGCIFA
Sbjct: 132 NRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFA 190
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
E++ GKP+ PG +E +QL KIF++ G+P E WPGV+K+P Y P + + +V
Sbjct: 191 EMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP-PKDLEKVLP 249
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
D ++LL KML +P++RISAK+AL YF
Sbjct: 250 RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 321 bits (826), Expect = e-108
Identities = 110/228 (48%), Positives = 147/228 (64%), Gaps = 3/228 (1%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+ + +VFE+M+ DL + + T IK YM L GL Y H N +LHRD+K +NL
Sbjct: 74 KSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL 133
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
LI ++G LKLADFGLARSF + +T++V+T WYR PELL GA YG VDMWSVGCI
Sbjct: 134 LIASDGVLKLADFGLARSFGSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCI 192
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
FAELL P LPG ++ +QL KIFE G+P E WPGV+ +P Y FKP ++++
Sbjct: 193 FAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFP--PTPLKQI 250
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 242
F AL+LL+++L L+P++RI+A+ AL+ YF DP P P LP
Sbjct: 251 FPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 300 bits (770), Expect = e-100
Identities = 104/213 (48%), Positives = 141/213 (66%), Gaps = 3/213 (1%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
YMV EY++HDL L + F ++KC M QLL+G+ + H N +LHRD+K SNLL++N
Sbjct: 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN 141
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
G LK+ DFGLAR + T V+TLWYR PELLLGA +Y A+DMWSVGCIFAEL
Sbjct: 142 RGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 198
L KP+ PGK+E +QL+KIF+L G+P E IWPG S++P ++ ++R+ F
Sbjct: 201 LTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL 260
Query: 199 --DRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ +LL ++L DP++RISA+DAL YF
Sbjct: 261 SLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 295 bits (757), Expect = 3e-98
Identities = 112/227 (49%), Positives = 143/227 (62%), Gaps = 14/227 (6%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
RGS YMV YMDHDL+GL + P ++ T QIKCYM QLL G++Y H N +LHRDIK +N+
Sbjct: 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANI 146
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNT------------LTNRVITLWYRPPELLLGATKY 122
LIDN+G LK+ADFGLAR YD TN V+T WYRPPELLLG +Y
Sbjct: 147 LIDNQGILKIADFGLARP--YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204
Query: 123 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 182
AVD+W +GC+FAE+ +PIL GK++ +QL IF+LCG+P E WPG +P
Sbjct: 205 TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVH 264
Query: 183 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
R + E F L+LL K+L LDP +R++A DAL+ YF
Sbjct: 265 SFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 1e-96
Identities = 113/228 (49%), Positives = 156/228 (68%), Gaps = 5/228 (2%)
Query: 7 ETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
+ T N+Y+GS Y+VFE+ +HDL GL ++FT+ +IK MK LL GL+Y H N++LH
Sbjct: 83 KATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILH 142
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYG 123
RD+K +N+LI +G LKLADFGLAR+FS N N TNRV+TLWYRPPELLLG YG
Sbjct: 143 RDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYG 202
Query: 124 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 183
P +DMW GCI AE+ PI+ G E QL+ I +LCGS +WPGV K+ + +
Sbjct: 203 PPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMEL 262
Query: 184 SRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ KR+V+E + + D HAL+L++K+L+LDP++RI A AL+ ++F
Sbjct: 263 PQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 289 bits (741), Expect = 6e-96
Identities = 116/222 (52%), Positives = 152/222 (68%)
Query: 7 ETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
+ D K +G+ Y+VFEYMDHDL GL + + F+ IK +MKQLL GL+YCH LH
Sbjct: 80 DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
RDIK SN+L++N+G +KLADFGLAR ++ + + TN+VITLWYRPPELLLG +YGPA+
Sbjct: 140 RDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAI 199
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
D+WS GCI EL KPI E QL I LCGSP +WP V K+P +N KP +
Sbjct: 200 DVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 259
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228
+RR+RE F AL+LL+ ML LDPS+R +A++AL+S +
Sbjct: 260 YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 289 bits (742), Expect = 1e-95
Identities = 110/236 (46%), Positives = 152/236 (64%), Gaps = 16/236 (6%)
Query: 20 MVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79
+V + M DL + DR +R T Q+KC + Q+L GL+ H +HRD+ +N+ I+++
Sbjct: 97 LVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155
Query: 80 GNLKLADFGLARSFSYD-------------HNNTLTNRVITLWYRPPELLLGATKYGPAV 126
G K+ADFGLAR + Y +T++V+TLWYR PELL+GA KY AV
Sbjct: 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV 215
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
DMWSVGCIFAELL GKP+ PG+NE +QL +IFEL G+P+E WP K+P Y F P
Sbjct: 216 DMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR-- 273
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 242
+ ++ +F + A++LL+ +L L+P +RISAK+AL EYF +DPLPCDP LP
Sbjct: 274 KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 1e-86
Identities = 111/232 (47%), Positives = 149/232 (64%), Gaps = 9/232 (3%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
S ++V EY + DL L D F+ Q+KC M QLL GL Y H N ++HRD+K SNLL+
Sbjct: 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
++G LK+ADFGLAR++ +T +V+TLWYR PELLLG T Y A+DMW+VGCI A
Sbjct: 142 TDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILA 200
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK----PSRTMKRRVR 192
ELL KP+LPGK+E EQL I +L G+P+E+IWPG S +P F P +K +
Sbjct: 201 ELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK-- 258
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKY 244
F L LL +LM DP +R +A++AL+S YF PLPC+P+ +P +
Sbjct: 259 --FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTF 308
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 2e-86
Identities = 108/214 (50%), Positives = 146/214 (68%), Gaps = 7/214 (3%)
Query: 19 YMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+VFE++D DL D P P IK Y+ QLL G+ YCH ++VLHRD+K NLLID
Sbjct: 74 YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID 133
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
EG LKLADFGLAR+F T T+ V+TLWYR PE+LLG+ +Y VD+WS+GCIFAE
Sbjct: 134 REGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS--RTMKRRVREVF 195
++N +P+ PG +E +QL +IF G+PDE +WPGV+ +P Y KP+ + ++ + +V
Sbjct: 193 MVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY---KPTFPKWARQDLSKVV 249
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ D L+LL KML+ DP++RISAK AL YF
Sbjct: 250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 3e-85
Identities = 102/216 (47%), Positives = 142/216 (65%), Gaps = 10/216 (4%)
Query: 19 YMVFEYMDHDLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+V EYM DL+ + +RP Q+K YM+ LL G+ Y H N ++HRD+K +NLL
Sbjct: 75 VLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
I +G LK+ADFGLAR FS + +++V T WYR PELL GA KY P VD+W+VGCIF
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIF 191
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN--HFKPSRTMKRRVRE 193
AELLNG P+ PG+N+ EQL+ +F G+P+E WPG++ +P YN F S+ + + E
Sbjct: 192 AELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPI--PLEE 249
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+F AL+LL+ +L+ DPS+R+SA +AL YF
Sbjct: 250 IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 2e-78
Identities = 101/215 (46%), Positives = 132/215 (61%), Gaps = 1/215 (0%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+G Y+VFE+MD DL L IK Y+ QLL GL +CH + +LHRD+K NL
Sbjct: 70 KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
LI+ EG LKLADFGLARSF T+ V+T WYR PELLLG Y VD+WSVGCI
Sbjct: 130 LINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCI 188
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
FAELL+ +P+ PGK+E +QL KIF G+PD +WP + + F + + ++
Sbjct: 189 FAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKL 248
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
F + AL+LL +ML DP +RI+A+ AL YF
Sbjct: 249 FPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 1e-75
Identities = 91/214 (42%), Positives = 128/214 (59%), Gaps = 11/214 (5%)
Query: 19 YMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+VFE++D DL + PGL IK M+QLL G+ + H ++++HRD+K N+L
Sbjct: 82 TLVFEHVDQDLATYLSKCPKPGL--PPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNIL 139
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
+ ++G +K+ADFGLAR Y LT+ V+TLWYR PE+LL ++ Y VDMWSVGCIF
Sbjct: 140 VTSDGQVKIADFGLARI--YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIF 196
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
AEL +P+ G +EA+QL KIF++ G P E WP +P + F R +
Sbjct: 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP-RSSFPSYTP--RSFKSFV 253
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
L+LL+KML +P +RISA +AL YF
Sbjct: 254 PEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 3e-75
Identities = 101/212 (47%), Positives = 142/212 (66%), Gaps = 4/212 (1%)
Query: 20 MVFEYMDHDLTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+VFEYMD DL D G+R + +K + QLL G+ +CH N+VLHRD+K NLLI+
Sbjct: 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN 134
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
G LKLADFGLAR+F NT +N V+TLWYR P++LLG+ Y ++D+WSVGCI AE
Sbjct: 135 KRGELKLADFGLARAFGIP-VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAE 193
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
++ G+P+ PG N +QL KIF + G+P E+ WPG+S++P Y P R + ++++F H
Sbjct: 194 MITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP-RYPPQDLQQLFPH 252
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
D ++LL ++L L+P RISA DAL +F
Sbjct: 253 ADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 232 bits (592), Expect = 7e-74
Identities = 102/214 (47%), Positives = 139/214 (64%), Gaps = 7/214 (3%)
Query: 19 YMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+VFE++ DL D P +P IK Y+ QLL GL +CH ++VLHRD+K NLLI+
Sbjct: 75 YLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 134
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
EG +KLADFGLAR+F T T+ V+TLWYR PE+LLG Y AVD+WS+GCIFAE
Sbjct: 135 TEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 193
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS--RTMKRRVREVF 195
++ + + PG +E +QL +IF G+PDE +WPGV+ +P Y KPS + ++ +V
Sbjct: 194 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY---KPSFPKWARQDFSKVV 250
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
D +LL +ML DP++RISAK AL +F
Sbjct: 251 PPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 6e-72
Identities = 97/213 (45%), Positives = 131/213 (61%), Gaps = 4/213 (1%)
Query: 20 MVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79
+VFEY+D DL D G ++ ++ ++ QLL GL YCH +VLHRD+K NLLI
Sbjct: 80 LVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER 139
Query: 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 139
G LKLADFGLAR+ S + T +N V+TLWYRPP++LLG+T+Y ++DMW VGCIF E+
Sbjct: 140 GELKLADFGLARAKSVP-SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA 198
Query: 140 NGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 198
G+P+ PG + +QL KIF + G+P E WPGVS P + + R +
Sbjct: 199 TGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRL 258
Query: 199 DR--HALELLEKMLMLDPSQRISAKDALDSEYF 229
DR H EL K L +P +RISA +A+ YF
Sbjct: 259 DRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 2e-71
Identities = 99/218 (45%), Positives = 138/218 (63%), Gaps = 14/218 (6%)
Query: 19 YMVFEYMDHDLTGLAD--RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y++FE++ DL D G +K Y+ Q+L G+ +CH +VLHRD+K NLLI
Sbjct: 75 YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134
Query: 77 DNEGNLKLADFGLARSFS-----YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
DN+G +KLADFGLAR+F Y H V+TLWYR PE+LLG+ +Y VD+WS+
Sbjct: 135 DNKGVIKLADFGLARAFGIPVRVYTH------EVVTLWYRAPEVLLGSPRYSTPVDIWSI 188
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G IFAE+ KP+ G +E +QL +IF + G+P E +WPGV+ +P Y + P K +
Sbjct: 189 GTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWK-KGSL 247
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
R ++ D L+LLEKML+ DP++RISAK AL+ YF
Sbjct: 248 RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 3e-71
Identities = 105/213 (49%), Positives = 140/213 (65%), Gaps = 4/213 (1%)
Query: 19 YMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+VFEY+D DL D P IK Y+ Q+L G+ YCH ++VLHRD+K NLLID
Sbjct: 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136
Query: 78 NEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
N LKLADFGLAR+F T T+ V+TLWYR PE+LLG+ Y VD+WSVGCIFA
Sbjct: 137 RRTNALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFA 195
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
E++N KP+ PG +E ++L KIF + G+P+E WPGV+ +P Y P + + + V
Sbjct: 196 EMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFP-KWPPKDLATVVP 254
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ ++LL KML LDPS+RI+A+ AL+ EYF
Sbjct: 255 TLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 4e-70
Identities = 101/231 (43%), Positives = 140/231 (60%), Gaps = 12/231 (5%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHV 61
+E + + S Y+VFEY+D DL D PG IK +M QLL G+ +CH
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 62 NQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 120
+ V+HRD+K NLL+D + LK+AD GL R+FS + T+ ++TLWYR PE+LLG+T
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGST 187
Query: 121 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 180
Y VD+WSVGCIFAE+ +P+ PG +E +QL IF+L G+P E +WPGVSK+ ++
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE 247
Query: 181 FK--PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
F + + R L+LL+KML DP++RISAK AL YF
Sbjct: 248 FPQWKPQDLSR----AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 4e-69
Identities = 99/216 (45%), Positives = 128/216 (59%), Gaps = 13/216 (6%)
Query: 20 MVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79
+VFEY D DL D +K +M QLL GL +CH + VLHRD+K NLLI+
Sbjct: 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135
Query: 80 GNLKLADFGLARSF-----SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
G LKLADFGLAR+F Y V+TLWYRPP++L GA Y ++DMWS GCI
Sbjct: 136 GELKLADFGLARAFGIPVRCYSA------EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 189
Query: 135 FAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
FAEL N G+P+ PG + +QL +IF L G+P E WPGVSK+P Y + V
Sbjct: 190 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNV 249
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
V + +LL+ +L+ +P QRISA++AL YF
Sbjct: 250 VPKLNST-GRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 218 bits (559), Expect = 4e-68
Identities = 87/216 (40%), Positives = 130/216 (60%), Gaps = 8/216 (3%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E M+ DL + + T I+ ++ Q+L GL Y H V+HRD+K SN+L+++
Sbjct: 80 YIVTELMETDLHKVI-KSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS 138
Query: 79 EGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+LK+ DFGLAR D + LT V+T WYR PELLL +++Y A+D+WSVGCIFA
Sbjct: 139 NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFA 198
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSP-DETI-WPGVSKMPAY-NHFKPSRTMKRRVRE 193
ELL KP+ PG++ +QL+ I E+ G+P +E + + K Y K+ + +
Sbjct: 199 ELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKP--KKPLSK 256
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+F A++LLEKML+ DP +RI+A +AL Y
Sbjct: 257 LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 1e-66
Identities = 77/212 (36%), Positives = 112/212 (52%), Gaps = 31/212 (14%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EY + DL L + G R + + + Y++Q+L+ L Y H ++HRD+K N+L+D
Sbjct: 73 YLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLD 131
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+G++KLADFGLAR D LT V T Y PE+LLG YG AVD+WS+G I E
Sbjct: 132 EDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILYE 188
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
LL GKP PG + QL ++F+ G P P
Sbjct: 189 LLTGKPPFPGDD---QLLELFKKIGKPKPPFPPPEWD----------------------- 222
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A +L+ K+L+ DP +R++A++AL +F
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 2e-65
Identities = 96/260 (36%), Positives = 141/260 (54%), Gaps = 49/260 (18%)
Query: 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLAD--RPGLRFTVPQ--IKCYMKQLLTGLHYCH 60
FLE D S Y++F+Y +HDL + R R ++P +K + Q+L G+HY H
Sbjct: 71 FLEHADK-----SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125
Query: 61 VNQVLHRDIKGSNLLIDNEGN----LKLADFGLARSF------SYDHNNTLTNRVITLWY 110
N VLHRD+K +N+L+ EG +K+ D GLAR F D + V+T+WY
Sbjct: 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV----VVTIWY 181
Query: 111 RPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELC 161
R PELLLGA Y A+D+W++GCIFAELL +PI G+ +QL +IFE+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 162 GSPDETIWPGVSKMPAY---------NHFKPS---RTMKRRVREVFRHFDRHALELLEKM 209
G+P E WP + KMP Y + + + M++ + D +LL K+
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP-----DSQGFDLLRKL 296
Query: 210 LMLDPSQRISAKDALDSEYF 229
L DP++RI+A++AL+ YF
Sbjct: 297 LEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 4e-65
Identities = 91/224 (40%), Positives = 131/224 (58%), Gaps = 23/224 (10%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+VFEYM+ DL + R + V + M QLL L Y H V+HRD+K SN+L+++
Sbjct: 85 YLVFEYMETDLHAVI-RANILEDV-HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS 142
Query: 79 EGNLKLADFGLARSFS----YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
+ +KLADFGLARS S N LT+ V T WYR PE+LLG+T+Y VDMWSVGCI
Sbjct: 143 DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSP-DETI--------WPGVSKMPAYNHFKPSR 185
E+L GKP+ PG + QL KI E+ G P E I + +P+ +P +
Sbjct: 203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPS----RPRK 258
Query: 186 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ E+ AL+LL+K+L+ +P++R++A++AL+ Y
Sbjct: 259 PLD----ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 3e-62
Identities = 74/218 (33%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 14 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+ Y+V EY + DL G + + K Q+L GL Y H N ++HRD+K
Sbjct: 69 DKDHLYLVMEYCEGGDLFDY-LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPE 127
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N+L+D G +K+ADFGLA+ +++LT V T WY PE+LLG YGP VD+WS+G
Sbjct: 128 NILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLG 186
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFE-LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
I ELL GKP G+N +QL I L + S
Sbjct: 187 VILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE-------------- 232
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A +L++K L DPS+R +A++ L +F
Sbjct: 233 ----------AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 4e-60
Identities = 80/212 (37%), Positives = 119/212 (56%), Gaps = 3/212 (1%)
Query: 19 YMVFEYMDHDLTGL-ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y VFEYM+ +L L DR G F+ I+ + Q+L GL + H + HRD+K NLL+
Sbjct: 74 YFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS 133
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+K+ADFGLAR T+ V T WYR PE+LL +T Y VD+W++GCI AE
Sbjct: 134 GPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
L +P+ PG +E +QL KI + G+P + WP K+ + F+ + + ++ +
Sbjct: 192 LYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPN 251
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A++L++ ML DP +R +A AL YF
Sbjct: 252 ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 4e-60
Identities = 78/222 (35%), Positives = 119/222 (53%), Gaps = 8/222 (3%)
Query: 13 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+ +G Y+VFEY++ L L + ++ Y+ QLL + YCH + ++HRDIK
Sbjct: 70 RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPE 129
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N+L+ G LKL DFG AR+ + LT+ V T WYR PELL+G T YG VD+W++G
Sbjct: 130 NILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIG 189
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-----PSRTM 187
CI AELL+G+P+ PG ++ +QL I + G + S P + ++
Sbjct: 190 CIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESL 249
Query: 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+RR AL+ L+ L +DP +R++ + L YF
Sbjct: 250 ERRYPGK---VSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 2e-59
Identities = 98/216 (45%), Positives = 129/216 (59%), Gaps = 7/216 (3%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
S +VFEY+D DL D G + +K ++ QLL GL+YCH +VLHRD+K NLLI
Sbjct: 78 SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI 137
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+T Y +DMW VGCIF
Sbjct: 138 NERGELKLADFGLARAKSIP-TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFY 196
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
E+ G+P+ PG EQL IF + G+P E WPG+ + FK K R +
Sbjct: 197 EMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL---SNEEFKSYNYPKYRADCLHN 253
Query: 197 H---FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
H D ELL K+L + +RISA++A+ YF
Sbjct: 254 HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 3e-59
Identities = 93/213 (43%), Positives = 130/213 (61%), Gaps = 7/213 (3%)
Query: 20 MVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79
+VFEY+D DL D G ++ +K +M QLL GL YCH ++LHRD+K NLLI+ +
Sbjct: 80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK 139
Query: 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 139
G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+T+Y +DMW VGCI E+
Sbjct: 140 GELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA 198
Query: 140 NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH-- 197
G+P+ PG E+L IF L G+P E WPG++ + F+ + R + + H
Sbjct: 199 TGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT---SNEEFRSYLFPQYRAQPLINHAP 255
Query: 198 -FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
D ++LL +L+ + RISA+ AL YF
Sbjct: 256 RLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-57
Identities = 89/232 (38%), Positives = 129/232 (55%), Gaps = 7/232 (3%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V M DL + + + I+ + Q+L GL Y H ++HRD+K SN+ ++
Sbjct: 96 YLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 153
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR + +T V T WYR PE++L Y VD+WSVGCI AEL
Sbjct: 154 DCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFRH 197
L GK + PG + +QL +I L G+PDE + +S A N+ + M ++ +EVF
Sbjct: 210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSG 269
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
+ A++LLEKML+LDP +RI+A +AL Y P D P Y+ S E
Sbjct: 270 ANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYDQSFE 321
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-57
Identities = 95/216 (43%), Positives = 134/216 (62%), Gaps = 7/216 (3%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
S +VFEY+D DL D G ++ +K ++ Q+L GL YCH +VLHRD+K NLLI
Sbjct: 78 SLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI 137
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ G LKLADFGLAR+ S T +N V+TLWYRPP++LLG+++Y +DMW VGCIF
Sbjct: 138 NERGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFF 196
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
E+ +G+P+ PG ++L IF L G+P E WPG+S + + FK K + + +
Sbjct: 197 EMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS---SNDEFKNYNFPKYKPQPLIN 253
Query: 197 H---FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
H D +ELL K L + +RISA++A+ YF
Sbjct: 254 HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 3e-57
Identities = 90/240 (37%), Positives = 136/240 (56%), Gaps = 9/240 (3%)
Query: 1 MTCTF-LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 59
+TC + ++ + Y+ E M+ DL + R G T + ++ Q+L GL Y
Sbjct: 64 ITCLYDMDIVFPGNFNE-LYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELL 116
H VLHRD+K NLL++ + LK+ DFGLAR FS + +T V T WYR PE++
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 117 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 176
L Y A+D+WSVGCI AELL KP+ GK+ +QL++I ++ G+PDE +
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241
Query: 177 AYNHFKPSRTM-KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 233
A N+ + + K+ +F + + AL+LLEK+L DP++RIS ++AL+ Y W DP
Sbjct: 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 4e-57
Identities = 102/221 (46%), Positives = 136/221 (61%), Gaps = 10/221 (4%)
Query: 15 RGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
+ + VFEYM DL + PG ++ +M QLL GL Y H +LHRD+K N
Sbjct: 75 KETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQN 133
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
LLI G LKLADFGLAR+ S + T ++ V+TLWYRPP++LLGAT Y A+D+W GC
Sbjct: 134 LLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGC 192
Query: 134 IFAELLNGKPILPGKNEA-EQLSKIFELCGSPDETIWPGVSKMPAYNH--FKPSRTMKRR 190
IF E+L G+P PG ++ EQL KI+ + G P E WPGVSK+P Y F P + ++
Sbjct: 193 IFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKP--QQ 250
Query: 191 VREVFRHFDR--HALELLEKMLMLDPSQRISAKDALDSEYF 229
+R V++ R A +L +MLM+ P RISA+DAL YF
Sbjct: 251 LRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-55
Identities = 96/213 (45%), Positives = 126/213 (59%), Gaps = 11/213 (5%)
Query: 20 MVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
+VFE++D DL D+ PGL IK M+Q L GL + H N ++HRD+K N+L+
Sbjct: 84 LVFEHVDQDLRTYLDKVPPPGL--PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ G +KLADFGLAR +S LT V+TLWYR PE+LL +T Y VDMWSVGCIFA
Sbjct: 142 TSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFA 198
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
E+ KP+ G +EA+QL KIF+L G P E WP +P F P R V+ V
Sbjct: 199 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA-FSPRG--PRPVQSVVP 255
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ +LL +ML +P +RISA AL +F
Sbjct: 256 EIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 2e-55
Identities = 92/212 (43%), Positives = 128/212 (60%), Gaps = 3/212 (1%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V+E MD DL + R + + ++ QLL GL Y H VLHRD+K SNLL++
Sbjct: 85 YIVYELMDTDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+LK+ DFGLAR+ S + +T V+T WYR PELLL ++Y A+D+WSVGCIFAEL
Sbjct: 144 NCDLKICDFGLARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP-SRTMKRRVREVFRH 197
L KP+ PGK+ QL I EL GSP E + A + + T ++ +F H
Sbjct: 203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH 262
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ A++LLEKML+ DPS+RI+ ++AL Y
Sbjct: 263 ANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 1e-54
Identities = 83/218 (38%), Positives = 121/218 (55%), Gaps = 11/218 (5%)
Query: 19 YMVFEYMDHDLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V + M+ DL + +D+P T I+ ++ QLL GL Y H V+HRD+K SNLL+
Sbjct: 84 YVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV 140
Query: 77 DNEGNLKLADFGLAR---SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
+ + L++ DFG+AR S +H +T V T WYR PELLL +Y A+DMWSVGC
Sbjct: 141 NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGC 200
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK--PSRTMKRRV 191
IFAE+L + + PGKN QL I + GSP E + + + + P +
Sbjct: 201 IFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQ-PVPW 259
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
++F AL+LL +ML DP +RI+ + AL +
Sbjct: 260 SKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-53
Identities = 96/216 (44%), Positives = 132/216 (61%), Gaps = 10/216 (4%)
Query: 20 MVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79
+VFEY+ DL D+ +K ++ QLL GL Y H +LHRD+K NLLI +
Sbjct: 80 LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT 139
Query: 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 139
G LKLADFGLAR+ S ++T +N V+TLWYRPP++LLG+T+Y +DMW VGCIF E++
Sbjct: 140 GELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
Query: 140 NGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM---KRRVREVF 195
G PG K+ +QL +IF + G+P+E WPGV +P HFKP R + +R+ +
Sbjct: 199 QGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP---HFKPERFTLYSPKNLRQAW 255
Query: 196 RHFD--RHALELLEKMLMLDPSQRISAKDALDSEYF 229
HA +L K+L P R+SA+ AL EYF
Sbjct: 256 NKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 9e-53
Identities = 87/214 (40%), Positives = 130/214 (60%), Gaps = 7/214 (3%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E M+ DL L L + I+ ++ Q+L GL Y H VLHRD+K SNLL++
Sbjct: 84 YIVQELMETDLYKLIKTQHL--SNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141
Query: 79 EGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+LK+ DFGLAR +H++T LT V T WYR PE++L + Y A+D+WSVGCI A
Sbjct: 142 NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILA 201
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV--REV 194
E+L+ +P+ PGK+ QL+ I + G+P + + + A N+ K S K +V ++
Sbjct: 202 EMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIK-SLPFKPKVPWNKL 260
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228
F + D AL+LL+KML +P +RI+ ++AL Y
Sbjct: 261 FPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 3e-50
Identities = 87/224 (38%), Positives = 125/224 (55%), Gaps = 24/224 (10%)
Query: 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
G +VFE MD +L L G + +P+ +K YM QLL L + H N + HRDIK N
Sbjct: 73 GRLALVFELMDMNLYELIK--GRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPEN 130
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
+LI ++ LKLADFG R Y T + T WYR PE LL YGP +D+W+VGC
Sbjct: 131 ILIKDD-ILKLADFGSCRGI-YSKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGC 187
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM-----K 188
+F E+L+ P+ PG NE +Q++KI ++ G+PD + F+ SR M
Sbjct: 188 VFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV---------LKKFRKSRHMNYNFPS 238
Query: 189 RR---VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
++ +R++ + L+LL+K+L DP +RI+AK AL YF
Sbjct: 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 6e-50
Identities = 89/223 (39%), Positives = 130/223 (58%), Gaps = 19/223 (8%)
Query: 19 YMVFEYMDHDL-TGLADRPGLRFTVPQ-IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y V E + DL L RP Q I+ ++ Q+L GL Y H V+HRD+K SN+LI
Sbjct: 86 YFVTELLGTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI 141
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ +LK+ DFGLAR + +T V T +YR PE++L KY VD+WS GCIFA
Sbjct: 142 NENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFA 197
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR---- 192
E+L GKP+ PGK+ Q S I +L G+P + + ++ + + N + +++ +R
Sbjct: 198 EMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV---INTICSENTLRFVQSLPKREPVPFS 254
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 233
E F++ D A++LLEKML+ DP +RISA +AL Y + DP
Sbjct: 255 EKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 9e-50
Identities = 84/229 (36%), Positives = 121/229 (52%), Gaps = 6/229 (2%)
Query: 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
S Y+V EYM+ DL + ++ + + +M QLL GL Y H VLHRD+K +N+ I
Sbjct: 90 SVYIVQEYMETDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 77 DNEG-NLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
+ E LK+ DFGLAR Y H L+ ++T WYR P LLL Y A+DMW+ GC
Sbjct: 148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 207
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
IFAE+L GKP+ G +E EQ+ I E E + + +R +R+
Sbjct: 208 IFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD 267
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD-PKSL 241
+ + AL+ LE++L +P R++A++AL Y P D P SL
Sbjct: 268 LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSL 316
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 5e-49
Identities = 82/219 (37%), Positives = 124/219 (56%), Gaps = 16/219 (7%)
Query: 19 YMVFEYMDHD-LTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
++VFEY DH L L P VP IK + Q L +++CH + +HRD+K N+L
Sbjct: 76 HLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENIL 132
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
I +G +KL DFG AR + + T+ V T WYR PELL+G T+YGP VD+W++GC+F
Sbjct: 133 ITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVF 191
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF-----KPSRTMKRR 190
AELL G+P+ PGK++ +QL I + G + P ++ + N F P +
Sbjct: 192 AELLTGQPLWPGKSDVDQLYLIRKTLGD----LIPRHQQIFSTNQFFKGLSIPEPETREP 247
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ F + AL L+ L +DP++R+S ++ L+ YF
Sbjct: 248 LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 7e-48
Identities = 99/270 (36%), Positives = 138/270 (51%), Gaps = 25/270 (9%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+VFE M+ DL + + T + ++ QLL L Y H V HRD+K N+L +
Sbjct: 80 YVVFELMESDLHQVI-KANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA 138
Query: 79 EGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCI 134
+ LK+ DFGLAR D + T+ V T WYR PEL G+ +KY PA+D+WS+GCI
Sbjct: 139 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCI 197
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK-RRVRE 193
FAE+L GKP+ PGKN QL I +L G+P V A + R + +
Sbjct: 198 FAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQ 257
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE---SSH-- 248
F + D AL LLE++L DP R +A++AL YF K L K E S+
Sbjct: 258 KFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF---------KGLAKVEREPSAQPI 308
Query: 249 ---EYQTKKRRQQQRQHEEATKRQKLH-HP 274
E++ ++RR + E R+ L HP
Sbjct: 309 TKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-46
Identities = 80/225 (35%), Positives = 126/225 (56%), Gaps = 28/225 (12%)
Query: 19 YMVFEYMDHD-LTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+VFE++DH L L P GL + ++ Y+ Q+L G+ +CH + ++HRDIK N+L+
Sbjct: 76 YLVFEFVDHTVLDDLEKYPNGLDESR--VRKYLFQILRGIEFCHSHNIIHRDIKPENILV 133
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
G +KL DFG AR+ + T+ V T WYR PELL+G TKYG AVD+W+VGC+
Sbjct: 134 SQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVT 192
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCG------------SPDETIWPGVSKMPAYNHFKPS 184
E+L G+P+ PG ++ +QL I + G +P ++ G+ ++P +P
Sbjct: 193 EMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP---LFAGM-RLPEVKEIEP- 247
Query: 185 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+++R F L+L ++ L +DP R S+ L E+F
Sbjct: 248 --LEKR----FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 81/222 (36%), Positives = 115/222 (51%), Gaps = 23/222 (10%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E M DL + P + +K ++ Q+L GL Y H +LHRDIK NLL+++
Sbjct: 80 YVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS 138
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
LK+ DFGLAR D + +T V+T +YR PE+L+G+ Y AVD+WSVGCIFAEL
Sbjct: 139 NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDET------------IWPGVSKMPAYNHFKPSRT 186
L + + ++ +QL I +L G+P I G K P+
Sbjct: 199 LGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLP------- 251
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228
+ + A+ LL +ML+ DP +RISA DAL Y
Sbjct: 252 ---VLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-45
Identities = 93/217 (42%), Positives = 133/217 (61%), Gaps = 19/217 (8%)
Query: 20 MVFEYMDHDLTGLADR---PGLRFTVP--QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+VFE++D DLT D+ PG VP IK M QLL GL + H ++V+HRD+K N+
Sbjct: 86 LVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
L+ + G +KLADFGLAR +S+ LT+ V+TLWYR PE+LL ++ Y VD+WSVGCI
Sbjct: 142 LVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCI 198
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF--KPSRTMKRRVR 192
FAE+ KP+ G ++ +QL KI ++ G P E WP +P F K ++ +++ V
Sbjct: 199 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR-QAFHSKSAQPIEKFVT 257
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
++ D +LL K L +P++RISA AL YF
Sbjct: 258 DI----DELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 88/233 (37%), Positives = 133/233 (57%), Gaps = 17/233 (7%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
+E + + RG Y+VFEY++ ++ L + +++ Y+ QL+ +H+CH N ++
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 125
HRDIK NLLI + LKL DFG AR+ S N T V T WYR PELLLGA YG A
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKA 181
Query: 126 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS-PDETI--------WPGVSKMP 176
VDMWSVGCI EL +G+P+ PG++E +QL I ++ G P E + + G+ + P
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL-RFP 240
Query: 177 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A NH ++++RR + L+L++ +L L+P+ R + L+ F
Sbjct: 241 AVNH---PQSLERRYLGILSGV---LLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 86/253 (33%), Positives = 133/253 (52%), Gaps = 8/253 (3%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V +M DL L + + +I+ + Q+L GL Y H ++HRD+K NL ++
Sbjct: 96 YLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE 153
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR ++ +T V+T WYR PE++L Y VD+WSVGCI AE+
Sbjct: 154 DCELKILDFGLARQ----TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP-SRTMKRRVREVFRH 197
L GKP+ G + +QL +I ++ G+P + + A N+ K R K+ R + +
Sbjct: 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPN 269
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQ 257
+ A+ +LEKML+LD RI+A +AL YF P D P Y+ S + + +
Sbjct: 270 ANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLEE 329
Query: 258 QQR-QHEEATKRQ 269
+R E Q
Sbjct: 330 WKRLTFTEILSFQ 342
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 79/237 (33%), Positives = 125/237 (52%), Gaps = 12/237 (5%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V YM DL + G + +++ + Q+L GL Y H ++HRD+K NL ++
Sbjct: 96 YLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR + +T V+T WYR PE++L Y VD+WSVGCI AE+
Sbjct: 153 DCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP-SRTMKRRVREVFRH 197
L GK + GK+ +QL++I ++ G P + A ++ K + ++ +F
Sbjct: 209 LTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK 268
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL--PCDPKSLPKYESSHEYQT 252
A++LLEKML LD +R++A +AL+ YF D + Y+ S E +
Sbjct: 269 ASPQAVDLLEKMLELDVDKRLTATEALEHPYF--DSFRDADEETEQQPYDDSLENEK 323
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 84/232 (36%), Positives = 129/232 (55%), Gaps = 7/232 (3%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V M DL + + + ++ + QLL GL Y H ++HRD+K SN+ ++
Sbjct: 96 YLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE 153
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ L++ DFGLAR ++ +T V T WYR PE++L Y VD+WSVGCI AEL
Sbjct: 154 DCELRILDFGLARQ----ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFRH 197
L GK + PG + +QL +I E+ G+P + +S A + + M ++ ++++FR
Sbjct: 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRG 269
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
+ A++LLEKML+LD +RISA +AL YF P D Y+ S E
Sbjct: 270 ANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDESPE 321
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 6e-42
Identities = 88/250 (35%), Positives = 128/250 (51%), Gaps = 8/250 (3%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V M DL + L T ++ + Q+L GL Y H ++HRD+K SNL ++
Sbjct: 98 YLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 155
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR ++ +T V T WYR PE++L Y VD+WSVGCI AEL
Sbjct: 156 DCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM-KRRVREVFRH 197
L G+ + PG + +QL I L G+P + +S A N+ + M K VF
Sbjct: 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 271
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQ 257
+ A++LLEKML+LD +RI+A AL YF P D Y+ S E + +
Sbjct: 272 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDE 331
Query: 258 QQRQ-HEEAT 266
+ ++E
Sbjct: 332 WKSLTYDEVI 341
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 1e-41
Identities = 85/242 (35%), Positives = 132/242 (54%), Gaps = 31/242 (12%)
Query: 19 YMVFEYMDHDL--------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
+++F+Y +HDL A++ ++ +K + Q+L G+HY H N VLHRD+K
Sbjct: 76 WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLK 135
Query: 71 GSNLLIDNEG----NLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGP 124
+N+L+ EG +K+AD G AR F+ L V+T WYR PELLLGA Y
Sbjct: 136 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTK 195
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDETIWPGVSKM 175
A+D+W++GCIFAELL +PI + E +QL +IF + G P + W + KM
Sbjct: 196 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKM 255
Query: 176 PAYNHF-KPSRTMKRRVREVFRHFDRHALE-------LLEKMLMLDPSQRISAKDALDSE 227
P Y K R + ++ ++H ++ LL+K+L +DP++RI+++ AL
Sbjct: 256 PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315
Query: 228 YF 229
YF
Sbjct: 316 YF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 46/126 (36%), Positives = 67/126 (53%), Gaps = 3/126 (2%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V EY + L L + + +I + Q+L GL Y H N ++HRD+K N
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPEN 122
Query: 74 LLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
+L+D+ G +KLADFGL++ + + L V T Y PE+LLG Y D+WS+G
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181
Query: 133 CIFAEL 138
I EL
Sbjct: 182 VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-40
Identities = 84/242 (34%), Positives = 131/242 (54%), Gaps = 31/242 (12%)
Query: 19 YMVFEYMDHDL--------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
+++F+Y +HDL A++ ++ +K + Q+L G+HY H N VLHRD+K
Sbjct: 76 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK 135
Query: 71 GSNLLIDNEG----NLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGP 124
+N+L+ EG +K+AD G AR F+ L V+T WYR PELLLGA Y
Sbjct: 136 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTK 195
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDETIWPGVSKM 175
A+D+W++GCIFAELL +PI + E +QL +IF + G P + W + KM
Sbjct: 196 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKM 255
Query: 176 PAYNHF-KPSRTMKRRVREVFRHFDRH-------ALELLEKMLMLDPSQRISAKDALDSE 227
P ++ K R + ++ ++H A LL+K+L +DP +RI+++ A+
Sbjct: 256 PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315
Query: 228 YF 229
YF
Sbjct: 316 YF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 8e-38
Identities = 65/305 (21%), Positives = 106/305 (34%), Gaps = 30/305 (9%)
Query: 13 KYRGSTYMVFEYMD-HDLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
+ GS Y+V EY+D L L + G + + + Q+L+ L Y H ++HRDI
Sbjct: 68 QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDI 127
Query: 70 KGSNLLIDNEGN-LKLADFGLARSFSYD-----HNNTLTNRVITLWYRPPELLLGAT--K 121
K N+L+D +G +KL DFGLA+ + V T Y PE+LLG +
Sbjct: 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY 187
Query: 122 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 181
+ D+WS+G ELL G P G+ + S+ +
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK------------------IILE 229
Query: 182 KPSRTMKRRVREVFRHFDRHAL-ELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 240
P+ ++ + A +LL+K+L DP R+S+ L + L S
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
Query: 241 LPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMN 300
+ + + S H +
Sbjct: 290 DLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSS 349
Query: 301 NAPPP 305
+
Sbjct: 350 SLLLS 354
|
Length = 384 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 77/238 (32%), Positives = 120/238 (50%), Gaps = 37/238 (15%)
Query: 19 YMVFEYMDHDLTGLA----DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y+V E MD +L + D + + + Y Q+L G+ + H ++HRD+K SN+
Sbjct: 97 YLVMELMDANLCQVIQMDLDHERMSYLL-----Y--QMLCGIKHLHSAGIIHRDLKPSNI 149
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
++ ++ LK+ DFGLAR+ +T V+T +YR PE++LG Y VD+WSVGCI
Sbjct: 150 VVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 206
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDE--------TIWPGVSKMPAYNHFKPSRT 186
E++ G + PG + +Q +KI E G+P + T+ V P Y +
Sbjct: 207 MGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY----AGYS 262
Query: 187 MKRRVREVF-----RHFDR----HALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 233
+ +V ++ A +LL KML++DP +RIS DAL Y W DP
Sbjct: 263 FEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 76/239 (31%), Positives = 120/239 (50%), Gaps = 32/239 (13%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN+++ +
Sbjct: 102 YLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 158
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR+ N +T V+T +YR PE++LG Y VD+WSVGCI EL
Sbjct: 159 DCTLKILDFGLARTACT--NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEL 215
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPD--------ETIWPGVSKMPAYNHFK-------- 182
+ G I G + +Q +K+ E G+P T+ V P Y
Sbjct: 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDW 275
Query: 183 --PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCD 237
PS + + +++ A +LL KML++DP +RIS +AL Y W DP +
Sbjct: 276 IFPSESERDKLKT------SQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 328
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 69/219 (31%), Positives = 101/219 (46%), Gaps = 41/219 (18%)
Query: 13 KYRGS-------TYMVF-EYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
+Y GS T +F EY+ L+ L + G + P I+ Y +Q+L GL Y H N
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 64 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKY 122
++HRDIKG+N+L+D++G +KLADFG A+ T V T ++ PE++ G +Y
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEY 180
Query: 123 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFELCGSPDETIWPGVSKMPAYNHF 181
G A D+WS+GC E+ GKP L KI P+ +P +
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE---------IPEHLS- 230
Query: 182 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 220
E + F L K L DP +R +A
Sbjct: 231 -----------EEAKDF-------LRKCLRRDPKKRPTA 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 75/246 (30%), Positives = 123/246 (50%), Gaps = 34/246 (13%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN+++ +
Sbjct: 105 YIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 161
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR+ +T V+T +YR PE++LG Y VD+WSVGCI E+
Sbjct: 162 DCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 218
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSP--------DETIWPGVSKMPAYNHFK-------- 182
+ G + PG + +Q +K+ E G+P T+ V P Y +
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 278
Query: 183 --PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCD- 237
P+ + +++ A +LL KML++D S+RIS +AL Y W DP +
Sbjct: 279 LFPADSEHNKLKA------SQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 332
Query: 238 -PKSLP 242
P +P
Sbjct: 333 PPPKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 34/206 (16%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EY +L + G RF+ + + Y +++ L Y H +++RD+K N+L+D
Sbjct: 69 YLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD 127
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+G++KL DFGLA+ S + + T T T Y PE+LLG YG AVD WS+G + E
Sbjct: 128 ADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYE 185
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
+L GKP ++ E KI L + P +
Sbjct: 186 MLTGKPPFYAEDRKEIYEKI--LKDPL---------RFPEF------------------- 215
Query: 198 FDRHALELLEKMLMLDPSQRISAKDA 223
A +L+ +L DP++R+ + A
Sbjct: 216 LSPEARDLISGLLQKDPTKRLGSGGA 241
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 73/235 (31%), Positives = 121/235 (51%), Gaps = 32/235 (13%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E MD +L + + ++ + Q+L G+ + H ++HRD+K SN+++ +
Sbjct: 98 YLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR+ +T V+T +YR PE++LG Y VD+WSVGCI E+
Sbjct: 155 DCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 211
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSP--------DETIWPGVSKMPAY----------NH 180
+ K + PG++ +Q +K+ E G+P T+ V P Y +
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271
Query: 181 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 233
P+ + +++ A +LL KML++DP++RIS +AL Y W DP
Sbjct: 272 LFPADSEHNKLKA------SQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 56/192 (29%), Positives = 81/192 (42%), Gaps = 35/192 (18%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDH 97
F QI + QL L Y H ++LHRDIK N+ + + G +KL DFG+++ S D
Sbjct: 100 FPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159
Query: 98 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
T+ V T +Y PEL Y D+WS+GC+ EL K G+N E KI
Sbjct: 160 AKTV---VGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI 215
Query: 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217
L G +P + + S ++ L+ +L DP +R
Sbjct: 216 --LKGQYP--------PIP--SQY--SSELR---------------NLVSSLLQKDPEER 246
Query: 218 ISAKDALDSEYF 229
S L S +
Sbjct: 247 PSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 38/211 (18%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EY+ DL L + G + Y+ +++ L Y H N ++HRD+K N+LID
Sbjct: 69 YLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID 127
Query: 78 NEGNLKLADFGLA------RSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWS 130
+ G+LKL DFGL+ R + + + R++ T Y PE++LG + VD WS
Sbjct: 128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWS 186
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+GCI E L G P G+ E I L G + WP + +
Sbjct: 187 LGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIE---WP--EDVEVSD----------- 228
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAK 221
A++L+ K+L+ DP +R+ AK
Sbjct: 229 ----------EAIDLISKLLVPDPEKRLGAK 249
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 74/209 (35%), Positives = 109/209 (52%), Gaps = 22/209 (10%)
Query: 45 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLA-------RSFSYD 96
+K Y QL L Y H + HRD+K NLLID N LKL DFG A RS SY
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY- 230
Query: 97 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156
+ + +YR PEL+LGAT Y +D+WS+GCI AE++ G PI G++ +QL +
Sbjct: 231 --------ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR 282
Query: 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPS 215
I ++ G+P E ++ P Y K + +++VF + A+ + + L +P
Sbjct: 283 IIQVLGTPTEDQLKEMN--PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPL 340
Query: 216 QRISAKDALDSEYFWTDPLPCDPKSLPKY 244
+R++ +AL +F PC LPKY
Sbjct: 341 KRLNPIEALADPFFDDLRDPC--IKLPKY 367
|
Length = 440 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 64/219 (29%), Positives = 92/219 (42%), Gaps = 37/219 (16%)
Query: 13 KYRGSTY------MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
KY GS +V E+ L L T QI K+LL GL Y H N ++
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 125
HRDIK +N+L+ ++G +KL DFGL+ S V T ++ PE++ G Y
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVING-KPYDYK 177
Query: 126 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 185
D+WS+G EL GKP EL P + + A N R
Sbjct: 178 ADIWSLGITAIELAEGKP------------PYSEL--PPMKAL-----FKIATNGPPGLR 218
Query: 186 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
+ + F+ F L+K L +P +R +A+ L
Sbjct: 219 N-PEKWSDEFKDF-------LKKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 13 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71
++V EYMD LT + + +R PQI +++L GL Y H V+HRDIK
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKS 144
Query: 72 SNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
N+L+ +G++KLADFG A + + + N++ V T ++ PE++ YGP VD+W
Sbjct: 145 DNILLSKDGSVKLADFGFAAQLTKEKSKRNSV---VGTPYWMAPEVIKR-KDYGPKVDIW 200
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
S+G + E+ G+P P E P ++ +K P
Sbjct: 201 SLGIMCIEMAEGEP--PYLRE------------PPLRALFLITTKGI------PPLKNPE 240
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 243
+ F+ F L K L+ DP +R SA++ L + C +
Sbjct: 241 KWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFL---KKACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 52/228 (22%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y V EY + +L + G + Y ++L L Y H ++HRD+K N+L+D
Sbjct: 78 YFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLW-------------------YRPPELLLG 118
+ ++K+ DFG A+ + + T Y PELL
Sbjct: 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196
Query: 119 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 178
G + D+W++GCI ++L GKP G NE KI +L P
Sbjct: 197 -KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE-----------YSFP-- 242
Query: 179 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226
+F A +L+EK+L+LDP R+ + D
Sbjct: 243 -----------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 19 YMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHYCHV-----NQVLHRDI 69
Y+V EY + DL L + I + QLL L+ CH N VLHRD+
Sbjct: 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDL 136
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
K +N+ +D N+KL DFGLA+ +D + T V T +Y PE L Y D+W
Sbjct: 137 KPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSPEQLNHM-SYDEKSDIW 194
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
S+GC+ EL P +N+ + SKI E G
Sbjct: 195 SLGCLIYELCALSPPFTARNQLQLASKIKE-----------G------------------ 225
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
+ R + + E+++ ML +DP +R S ++ L
Sbjct: 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 30/185 (16%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F P I+ Y +Q+L GL Y H +HRDIKG+N+L+D G +KLADFG+A+ +
Sbjct: 99 FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FS 156
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159
+ + ++ PE++ YG A D+WS+GC E+ GKP ++ E ++ +F+
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFK 213
Query: 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 219
+ S + +P + H A + + K L DPS R +
Sbjct: 214 IGRSKE---------LP----------------PIPDHLSDEAKDFILKCLQRDPSLRPT 248
Query: 220 AKDAL 224
A + L
Sbjct: 249 AAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 50/140 (35%), Positives = 75/140 (53%), Gaps = 14/140 (10%)
Query: 13 KYRGST------YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
KY GS Y++ EY ++ L + + G F + Y+ Q+L GL Y H V+
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVI 121
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL--GATKYG 123
HRDIK +N+L +G +KLADFG+A + + + V T ++ PE++ GA+
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSGAST-- 178
Query: 124 PAVDMWSVGCIFAELLNGKP 143
A D+WS+GC ELL G P
Sbjct: 179 -ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
+F+ Q+K ++ +++ L Y H ++HRDIK N+L+D +G++ + DF +A + D
Sbjct: 96 KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK--NEAEQLSK 156
T+ T Y PE+L Y AVD WS+G E L GK G +Q+
Sbjct: 156 T--TSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212
Query: 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216
E + D S A++ + K+L DP +
Sbjct: 213 KQE---TADVLYPATWST--------------------------EAIDAINKLLERDPQK 243
Query: 217 RIS--AKDALDSEYF 229
R+ KD + YF
Sbjct: 244 RLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI- 106
Y +Q+L G+ Y H N ++HRDIKG+N+L D+ GN+KL DFG ++ ++ + +
Sbjct: 109 YTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 107 -TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 165
T ++ PE++ G YG D+WSVGC E+L KP E E ++ IF++ P
Sbjct: 169 GTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 224
Query: 166 ETIWPGVSKMPAYNHFKPSRTMKRRVR------EVFRHFD 199
P S + RT + E+ RHF
Sbjct: 225 NPQLP--SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 71/218 (32%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 16 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSN 73
G +V EYMD L L + G P + +Q+L GL Y H ++HRDIK SN
Sbjct: 72 GEISIVLEYMDGGSLADLLKKVGK-IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN 130
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGATKYGPAVDMWS 130
LLI+++G +K+ADFG+++ NTL V T+ Y PE + G + Y A D+WS
Sbjct: 131 LLINSKGEVKIADFGISKVLE----NTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWS 185
Query: 131 VGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
+G E GK P LP Q S FEL M A P
Sbjct: 186 LGLTLLECALGKFPFLP----PGQPS-FFEL--------------MQAICDGPPPSLPAE 226
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 227
FR F + L DP +R SA + L
Sbjct: 227 EFSPEFRDF-------ISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 35/194 (18%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F ++ +++Q+L GL+Y H ++HRDIKG+N+L+DN+G +K++DFG+++ + +
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162
Query: 100 TLTNRVI-----TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154
T TN ++++ PE ++ T Y D+WS+GC+ E+L GK P + QL
Sbjct: 163 TKTNGARPSLQGSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQL 218
Query: 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 214
IF++ + I PS + A++ LEK +D
Sbjct: 219 QAIFKIGENASPEI--------------PS------------NISSEAIDFLEKTFEIDH 252
Query: 215 SQRISAKDALDSEY 228
++R +A + L +
Sbjct: 253 NKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 8e-21
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 48/211 (22%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
Y+V EY++ D L G +P+ K Y+ +++ G+ H ++HRDIK NLL
Sbjct: 73 YLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL 129
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGC 133
ID G+LKL DFGL+R N L N+ T Y PE +LG D WS+GC
Sbjct: 130 IDQTGHLKLTDFGLSR-------NGLENKKFVGTPDYLAPETILGVGD-DKMSDWWSLGC 181
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV-- 191
+ E L G P AE +F+ + RR+
Sbjct: 182 VIFEFLFGYPPF----HAETPDAVFD-------------------------NILSRRINW 212
Query: 192 -REVFRHFDRHALELLEKMLMLDPSQRISAK 221
EV A++L+ ++L +DP++R+ A
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 51/229 (22%)
Query: 13 KYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
KY GS +++ EY DL +PG + I ++++L GL Y H
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPG-KLDETYIAFILREVLLGLEYLHEE 117
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 119
+HRDIK +N+L+ EG++KLADFG++ + +T++ R V T ++ PE++
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKRNTFVGTPFWMAPEVIKQ- 172
Query: 120 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 179
+ Y D+WS+G EL G+P L + L I P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI------PKN------------- 213
Query: 180 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228
P + + F+ F + L DP +R SAK+ L ++
Sbjct: 214 --NPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 6e-20
Identities = 50/134 (37%), Positives = 78/134 (58%), Gaps = 10/134 (7%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNT--LTNR 104
Y +QLL GL Y H NQ++HRD+KG+NLLID+ G L++ADFG A + +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 105 VI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC-- 161
++ T+ + PE+L G +YG + D+WSVGC+ E+ KP + + L+ IF++
Sbjct: 168 LLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226
Query: 162 -GSPD--ETIWPGV 172
+P E + PG+
Sbjct: 227 TTAPSIPEHLSPGL 240
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 41/128 (32%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 35 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 94
G RF ++ + +Q+L GL Y H +LHRD+K NLL+D +G K++DFG+++
Sbjct: 101 TYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159
Query: 95 --YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152
YD++ ++ + W P + + Y VD+WS+GC+ E+ G+ P +E E
Sbjct: 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR--PWSDE-E 216
Query: 153 QLSKIFEL 160
++ +F+L
Sbjct: 217 AIAAMFKL 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 34/189 (17%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
F+ P+ Y ++ GL Y H N++++RD+K NLL+D EG +K+ADFGL +
Sbjct: 97 VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFG 155
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
+ + T + PE+L T Y AVD W +G + E+L G+ PG +E E I
Sbjct: 156 DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214
Query: 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218
DE +P R R A+ ++ ++L +P +R+
Sbjct: 215 N-----DEVRYP-------------------------RFLSREAISIMRRLLRRNPERRL 244
Query: 219 SA--KDALD 225
+ KDA D
Sbjct: 245 GSGEKDAED 253
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 52/193 (26%), Positives = 78/193 (40%), Gaps = 43/193 (22%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
+I + Q L GL Y H N+ +HRDIK N+L++ EG KLADFG+ S N
Sbjct: 100 EIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRN 157
Query: 104 RVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162
VI T ++ PE++ Y D+WS+G E+ GKP P
Sbjct: 158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKP--P---------------- 198
Query: 163 SPDETIWPGVSKMPAYNHFKPSRTM---KRRVREVFRHFDRHALEL---LEKMLMLDPSQ 216
Y+ P R + + ++ + E ++K L+ DP +
Sbjct: 199 ---------------YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEE 243
Query: 217 RISAKDALDSEYF 229
R SA L +
Sbjct: 244 RPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 42/107 (39%), Positives = 59/107 (55%), Gaps = 11/107 (10%)
Query: 45 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-- 102
I+ Y QLL GL Y H + ++HRDIK +N+ +D+ G +KL DFG A NNT T
Sbjct: 101 IRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK---NNTTTMG 157
Query: 103 ----NRVITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKP 143
+ T Y PE++ G +G A D+WS+GC+ E+ GK
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 45/125 (36%), Positives = 69/125 (55%), Gaps = 6/125 (4%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD--HNNTLTNRV 105
Y +Q+L G+ Y H N ++HRDIKG+N+L D+ GN+KL DFG ++ + +
Sbjct: 111 YTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 106 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 165
T ++ PE++ G YG D+WSVGC E+L KP E E ++ IF++ P
Sbjct: 171 GTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPT 226
Query: 166 ETIWP 170
+ P
Sbjct: 227 NPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 44/223 (19%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
YM+ EY+ R RF+ Y +++ L Y H ++++RD+K N+L+D
Sbjct: 77 YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
EG++KL DFG A+ D TL T Y PE ++ + + AVD W++G + E+
Sbjct: 137 EGHIKLTDFGFAKKLR-DRTWTLCG---TPEYLAPE-VIQSKGHNKAVDWWALGILIYEM 191
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 198
L G P N KI L G + +P RH
Sbjct: 192 LVGYPPFFDDNPFGIYEKI--LAGKLE---FP-------------------------RHL 221
Query: 199 DRHALELLEKMLMLDPSQRI-----SAKDALDSEYF----WTD 232
D +A +L++K+L++D ++R+ A D + +F W D
Sbjct: 222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 45/208 (21%)
Query: 19 YMVFEYMD--------HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
YM+ EY D GL D RF Y+ ++ Y H +++RD+K
Sbjct: 69 YMLMEYCLGGELWTILRDR-GLFDEYTARF-------YIACVVLAFEYLHNRGIIYRDLK 120
Query: 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
NLL+D+ G +KL DFG A+ T T T Y PE++L Y +VD WS
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKL-KSGQKTWT-FCGTPEYVAPEIILN-KGYDFSVDYWS 177
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+G + ELL G+P P + E +I+ I G P
Sbjct: 178 LGILLYELLTGRP--PFGEDDEDPMEIYND-------ILKGN-----GKLEFP------- 216
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRI 218
+ D+ A +L++++L +P +R+
Sbjct: 217 -----NYIDKAAKDLIKQLLRRNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 54/168 (32%), Positives = 72/168 (42%), Gaps = 31/168 (18%)
Query: 19 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EYM DL L R F + Y+ +L+ L H +HRDIK N+LID
Sbjct: 77 YLVMEYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 78 NEGNLKLADFGLARSF----------SYDHNNTLTNRVITLW------------------ 109
+G++KLADFGL + + HN + V+
Sbjct: 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPD 195
Query: 110 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
Y PE+L G T YG D WS+G I E+L G P E +KI
Sbjct: 196 YIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 1 MTCTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 60
+ CTF + + + + V EY++ + +F +P+ Y +++ GL + H
Sbjct: 61 LYCTF-------QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 61 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 120
+++RD+K N+L+D +G++K+ADFG+ + T T T Y PE+LLG
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLG-Q 171
Query: 121 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 180
KY +VD WS G + E+L G+ G +E E I D +P A +
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-----RMDNPCYPRWLTREAKDI 226
Query: 181 F------KPSRTM--KRRVRE--VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+P R + K +R+ FR D ALE E ++P + K A D F
Sbjct: 227 LVKLFVREPERRLGVKGDIRQHPFFREIDWSALEERE----IEPPFKPKVKSANDCSNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-18
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 35/196 (17%)
Query: 32 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ + G F + Y+ Q+++ + Y H +LHRDIK N+ + G +KL DFG+++
Sbjct: 90 IVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK 149
Query: 92 SFS--YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN 149
Y T+ V T +Y PEL G KY D+W++GC+ ELL K N
Sbjct: 150 ILGSEYSMAETV---VGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATN 205
Query: 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKM 209
+ KI + +P +++ S + V +
Sbjct: 206 PLNLVVKIVQGNYTPVVSVY--------------SSELISLVHS---------------L 236
Query: 210 LMLDPSQRISAKDALD 225
L DP +R +A + LD
Sbjct: 237 LQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 7/129 (5%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS--YDHNNTLTNRV 105
Y +Q+L G+ Y H N ++HRDIKG+N+L D+ GN+KL DFG ++ + +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 106 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 165
T ++ PE++ G YG D+WSV C E+L KP E E ++ IF++ P
Sbjct: 171 GTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
Query: 166 ETIWP-GVS 173
+ + P GVS
Sbjct: 227 KPMLPDGVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 45/204 (22%)
Query: 19 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EY+ +L + G RF P + Y Q++ L Y H +++RD+K NLL+D
Sbjct: 77 YLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD 135
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLW----YRPPELLLGATKYGPAVDMWSVGC 133
++G +K+ DFG A+ + R TL Y PE++L YG AVD W++G
Sbjct: 136 SDGYIKITDFGFAKR--------VKGRTYTLCGTPEYLAPEIILS-KGYGKAVDWWALGI 186
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
+ E+L G P P + +I+E I G + P
Sbjct: 187 LIYEMLAGYP--PFF--DDNPIQIYEK-------ILEGKVRFP----------------- 218
Query: 194 VFRHFDRHALELLEKMLMLDPSQR 217
F A +L+ +L +D ++R
Sbjct: 219 --SFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 43/103 (41%), Positives = 61/103 (59%), Gaps = 3/103 (2%)
Query: 43 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTL 101
I Y KQ+L GL Y H NQ++HRDIKG N+L++ G +K++DFG ++ + + T
Sbjct: 108 QTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167
Query: 102 TNRVITLWYRPPELL-LGATKYGPAVDMWSVGCIFAELLNGKP 143
T TL Y PE++ G YG D+WS+GC E+ GKP
Sbjct: 168 TFTG-TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 49/201 (24%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
R QI +L L + H V+HRDIK ++L+ ++G +KL+DFG S +
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-- 168
Query: 99 NTLTNR---VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155
+ R V T ++ PE ++ YG VD+WS+G + E+++G+P
Sbjct: 169 --VPRRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEP------------ 213
Query: 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHA-------LELLEK 208
P +N P + M +R+R+ ++ L++
Sbjct: 214 --------------------PYFNE-PPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDR 251
Query: 209 MLMLDPSQRISAKDALDSEYF 229
ML+ DP+QR +A + L+ +
Sbjct: 252 MLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 32/182 (17%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
RF P+ + Y +++ GL + H +++RD+K N+L+D+EG++K+ADFG+ +
Sbjct: 92 RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
T T T Y PE+L YGPAVD W++G + E+L G+ G +E E I
Sbjct: 152 TTST-FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209
Query: 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218
E DE +P R + A +L+ L +P +R+
Sbjct: 210 E-----DEVRYP-------------------------RWLSKEAKSILKSFLTKNPEKRL 239
Query: 219 SA 220
Sbjct: 240 GC 241
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-17
Identities = 55/186 (29%), Positives = 83/186 (44%), Gaps = 33/186 (17%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR-----SFSYDHNNTLT 102
Y KQ+L G+ Y H N V+HRDIKG+N+++ G +KL DFG AR H+N L
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 103 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162
+ T ++ PE ++ + YG D+WS+GC E+ GKP L ++L+ +F
Sbjct: 167 SMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF---- 218
Query: 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 222
I MP F A++ + L D +R SA
Sbjct: 219 ----YIGAHRGLMPRLPD----------------SFSAAAIDFVTSCLTRDQHERPSALQ 258
Query: 223 ALDSEY 228
L ++
Sbjct: 259 LLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 47/189 (24%), Positives = 86/189 (45%), Gaps = 33/189 (17%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
FT +++ Y+ +++ L + H +++RDIK N+L+D+EG++ L DFGL++ F +
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 99 NTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKP---ILPGKNEAEQL 154
+ T+ Y PE++ G + + AVD WS+G + ELL G + +N ++
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 214
S+ P P + A + ++K+L DP
Sbjct: 221 SRRILKSKPP----------FP-------------------KTMSAEARDFIQKLLEKDP 251
Query: 215 SQRISAKDA 223
+R+ A A
Sbjct: 252 KKRLGANGA 260
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 45/125 (36%), Positives = 69/125 (55%), Gaps = 6/125 (4%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI- 106
Y +Q+L G+ Y H N ++HRDIKG+N+L D+ GN+KL DFG ++ + R +
Sbjct: 111 YTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 107 -TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 165
T ++ PE++ G YG D+WS+GC E+L KP E E ++ IF++ P
Sbjct: 171 GTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPT 226
Query: 166 ETIWP 170
P
Sbjct: 227 NPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 29/181 (16%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
QI ++ L L + H NQV+HRDIK N+L+ +G++KL DFG + + + T
Sbjct: 116 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST- 174
Query: 104 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163
V T ++ PE++ YGP VD+WS+G + E++ G+P P NE +
Sbjct: 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEP--PYLNE------------N 219
Query: 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223
P ++ + A N P ++ +FR F L + L +D +R SAK+
Sbjct: 220 PLRALY-----LIATNG-TPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKEL 266
Query: 224 L 224
L
Sbjct: 267 L 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y V EY++ DL + G +F PQ Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIF 135
+EG++K+ADFG+ + D +T R T Y PE ++ YG +VD W+ G +
Sbjct: 136 SEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAPE-IIAYQPYGKSVDWWAYGVLL 191
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGS-PDETIWPGVSKMPAYNHFKPSRTM------K 188
E+L G+P G++E E I E S P VS PS+ + +
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGE 251
Query: 189 RRVRE--VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235
R +RE FR D LE E P ++ K A + + F+T P
Sbjct: 252 RDIREHAFFRRIDWDKLENREIQPPFKP--KVCGKGAENFDKFFTRGQP 298
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 48/147 (32%), Positives = 70/147 (47%), Gaps = 6/147 (4%)
Query: 17 STYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+ Y+V EY DL L +R +F + Y+ +L+ +H H +HRDIK N+L
Sbjct: 75 NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL-----GATKYGPAVDMWS 130
ID G++KLADFG A + + V T Y PE+L G YG D WS
Sbjct: 135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWS 194
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKI 157
+G I E++ G+ A+ + I
Sbjct: 195 LGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 38 LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 97
R QI + +L L Y H V+HRDIK ++L+ +G +KL+DFG S D
Sbjct: 112 TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171
Query: 98 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
+ V T ++ PE ++ T YG VD+WS+G + E+++G+P + + + ++
Sbjct: 172 PKR-KSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229
Query: 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217
+ SP P ++ V R F LE+ML +P +R
Sbjct: 230 RD---SP-----------------PPKLKNAHKISPVLRDF-------LERMLTREPQER 262
Query: 218 ISAKDALDSEYFWTDPLP 235
+A++ LD + LP
Sbjct: 263 ATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 41/208 (19%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI- 106
YM ++ + H +HRD+K N LID G++KL DFGL++ T N V+
Sbjct: 106 YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-----TYANSVVG 160
Query: 107 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 166
+ Y PE+L G Y VD WS+GC+ E L G P G P+E
Sbjct: 161 SPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGST--------------PNE 205
Query: 167 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF---DRHALELLEKMLMLDPSQRI-SAKD 222
T + + K + +R F D A +L+ K++ DPS+R S +D
Sbjct: 206 T----------WENLKYWKETLQRPVYDDPRFNLSDE-AWDLITKLIN-DPSRRFGSLED 253
Query: 223 ALDSEYF----WTDPLPCDPKSLPKYES 246
+ +F W + P +P+ ES
Sbjct: 254 IKNHPFFKEVDWNELRELKPPFVPELES 281
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 46/137 (33%), Positives = 66/137 (48%), Gaps = 7/137 (5%)
Query: 4 TFLETTDGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 61
F E+ + + G Y+V EY D + + + G F I + Q+ G+ + H
Sbjct: 62 AFKESFEAD---GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 121
+VLHRDIK N+ + G +KL DFG AR + T V T +Y PPE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWEN-MP 176
Query: 122 YGPAVDMWSVGCIFAEL 138
Y D+WS+GCI EL
Sbjct: 177 YNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
+F P+ + Y ++ L + H + V++RD+K N+L+D EG+ KLADFG+ + +
Sbjct: 92 KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNG 150
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
T T T Y PE +L +YGP+VD W++G + E++ G+P NE + I
Sbjct: 151 VTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
Query: 159 ELCGSPDETIWP------GVSKMPAY---NHFK-----PSRTMKRRVRE--VFRHFDRHA 202
D+ ++P VS + A+ N K S+ + +++ F+ D
Sbjct: 210 H-----DDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264
Query: 203 LELLEKMLMLDPSQRISAKDA--LDSEYFWTDPL--PCDP 238
LE + P + + +D D ++ +P+ P DP
Sbjct: 265 LEQRKIKPPFKPKIK-TKRDVNNFDQDFTKEEPVLTPVDP 303
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 29/155 (18%)
Query: 3 CTFLETTDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQ-------IKCYMKQ 51
+F+ ++V Y+ D+ ++ + P+ I +K+
Sbjct: 66 TSFVV-------GDELWLVMPYLSGGSLLDI--------MKSSYPRGGLDEAIIATVLKE 110
Query: 52 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITL 108
+L GL Y H N +HRDIK N+L+ +G++K+ADFG++ S + + T R V T
Sbjct: 111 VLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
+ PE++ Y D+WS G EL G
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 9e-16
Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 29/186 (15%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
QI ++ L L + H NQV+HRDIK N+L+ +G++KL DFG + + + T
Sbjct: 116 QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST- 174
Query: 104 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163
V T ++ PE++ YGP VD+WS+G + E++ G+P +N L I
Sbjct: 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ 227
Query: 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223
A N P ++ +FR F L + L +D +R SAK+
Sbjct: 228 -------------ATNG-TPELQNPEKLSPIFRDF-------LNRCLEMDVEKRGSAKEL 266
Query: 224 LDSEYF 229
L +
Sbjct: 267 LQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
RF + + Y ++ + L + H +++RD+K N+L+D+EG+ KLADFG+ + ++
Sbjct: 92 RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
T T T Y PE +L YGP+VD W++G + E+L G +NE + I
Sbjct: 152 TTST-FCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209
Query: 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR----------EVFRH--FDRHALELL 206
DE ++P A + K T +R + RH F E L
Sbjct: 210 N-----DEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264
Query: 207 EKMLMLDP-SQRISAKDAL---DSEYFWTDPL--PCDPKSLP 242
+ + P RI +++ + D ++ DP+ P + LP
Sbjct: 265 NRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLP 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 47/147 (31%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 15 RGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
+G +V EY + H L L + G Q+ + Q+L GL + H ++LHRDIK
Sbjct: 71 KGKLNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIK 128
Query: 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
NL +D N+K+ D G+A+ S D+ N V T +Y PE L Y D+W+
Sbjct: 129 SLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDVWA 186
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKI 157
+G + E GK N+ + KI
Sbjct: 187 LGVVLYECCTGKHPFDANNQGALILKI 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 29/186 (15%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
QI ++ L L + H NQV+HRDIK N+L+ +G++KL DFG + + + T
Sbjct: 116 QIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST- 174
Query: 104 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163
V T ++ PE++ YGP VD+WS+G + E++ G+P +N L I
Sbjct: 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ 227
Query: 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223
A N P R+ VFR F L + L +D +R SAK+
Sbjct: 228 -------------ATNG-TPELQNPERLSAVFRDF-------LNRCLEMDVDRRGSAKEL 266
Query: 224 LDSEYF 229
L +
Sbjct: 267 LQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
QI ++ L L + H NQV+HRDIK N+L+ +G++KL DFG + + + +
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-ST 175
Query: 104 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163
V T ++ PE++ YGP VD+WS+G + E++ G+P +N L I
Sbjct: 176 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ 228
Query: 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223
A N P ++ +FR F L + L +D +R SAK+
Sbjct: 229 -------------ATNG-TPELQNPEKLSAIFRDF-------LNRCLDMDVEKRGSAKEL 267
Query: 224 LDSEYF 229
L ++
Sbjct: 268 LQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 49 MKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL 108
++++L L Y H V+HRDIK +N+L+ N GN+KL DFG+A N +++ T
Sbjct: 107 IREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNSSKRSTF 161
Query: 109 ----WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
++ PE++ Y D+WS+G E+ G P
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 36/194 (18%)
Query: 37 GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF--S 94
G + Q+ + QLL G+HY H ++LHRD+K N+ + N LK+ DFG++R S
Sbjct: 100 GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGS 158
Query: 95 YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154
D T T T +Y PE L Y D+WS+GCI E+ G+N +
Sbjct: 159 CDLATTFTG---TPYYMSPE-ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV 214
Query: 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 214
+I E P+ ++ + R +++ ML DP
Sbjct: 215 LRIVE----------------------GPTPSLPET-------YSRQLNSIMQSMLNKDP 245
Query: 215 SQRISAKDALDSEY 228
S R SA + L + +
Sbjct: 246 SLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 46/142 (32%), Positives = 75/142 (52%), Gaps = 4/142 (2%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y V EY++ DL + G +F P Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
EG++K+ADFG+ + + T T T Y PE++ YG +VD W+ G + E
Sbjct: 136 AEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYE 193
Query: 138 LLNGKPILPGKNEAEQLSKIFE 159
+L G+P G++E E I E
Sbjct: 194 MLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 67/261 (25%), Positives = 112/261 (42%), Gaps = 48/261 (18%)
Query: 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 61
CTF +T + + V E+++ DL G RF + + Y +++ GL + H
Sbjct: 63 CTF-QTKE------HLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHS 114
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK 121
+++RD+K N+++D +G++K+ADFG+ + + N T T Y PE+L G K
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG-LK 172
Query: 122 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 181
Y +VD WS G + E+L G+ G +E E I D +P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-----RVDTPHYP----------- 216
Query: 182 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF-----WT--DPL 234
R + + ++LEK+ DP++R+ + F WT +
Sbjct: 217 --------------RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKR 262
Query: 235 PCDPKSLPKYESSHEYQTKKR 255
DP PK +S +Y R
Sbjct: 263 ELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 38 LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 97
RF + + Y +++ GL + H +++RD+K N+L+D +G++K+ADFG+ +
Sbjct: 91 GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150
Query: 98 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
T T Y PE+L G KY +VD WS G + E+L G+ G++E
Sbjct: 151 GKAST-FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------- 201
Query: 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217
DE ++ P + P R + A + L K+ DP++R
Sbjct: 202 -------DELFDSILNDRPHF----P------------RWISKEAKDCLSKLFERDPTKR 238
Query: 218 ISAK-DALDSEYF----WT--DPLPCDPKSLPKYESSHEYQ 251
+ D +F W + P PK +S +
Sbjct: 239 LGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDAS 279
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 54/162 (33%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 16 GSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
G ++V EY D DL +R G+ F+ QI + Q+ GL + H ++LHRDIK N
Sbjct: 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQN 131
Query: 74 LLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
+ + G + KL DFG+AR + D V T +Y PE+ Y D+WS+G
Sbjct: 132 IFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLG 189
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 174
C+ EL K G N QL + ++C I P S+
Sbjct: 190 CVLYELCTLKHPFEG-NNLHQL--VLKICQGYFAPISPNFSR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 48/261 (18%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F+ + + Y ++++ L Y H V++RD+K NL++D +G++K+ DFGL +
Sbjct: 92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGA 150
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+FE
Sbjct: 151 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLFE 205
Query: 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 218
L I + P R A LL +L DP QR+
Sbjct: 206 L-------ILMEEIRFP-------------------RTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 219 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQ- 269
AK+ ++ +F W D + K P ++ +T R EE T +
Sbjct: 240 GGPEDAKEIMEHRFFASINWQDVV--QKKLEPPFKPQVTSETDTRYFD----EEFTAQSI 293
Query: 270 KLHHPQPHGRLPPIQHAGQSH 290
+ P + L +Q + H
Sbjct: 294 TITPPDRYDSLGLLQLEERPH 314
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 12/138 (8%)
Query: 14 YRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
Y +++ E+ D L + T PQI+ +Q+L L++ H ++V+HRD+K
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGAT----KYGPA 125
N+L+ +G++KLADFG+ S + +TL R + T ++ PE++ T Y
Sbjct: 133 NILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK 188
Query: 126 VDMWSVGCIFAELLNGKP 143
D+WS+G EL +P
Sbjct: 189 ADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 47/142 (33%), Positives = 76/142 (53%), Gaps = 4/142 (2%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y V EY++ DL + G RF P Y ++ GL + H +++RD+K N+++D
Sbjct: 77 YFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+EG++K+ADFG+ + +D T T T Y PE ++ YG +VD W+ G + E
Sbjct: 136 SEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYE 193
Query: 138 LLNGKPILPGKNEAEQLSKIFE 159
+L G+ G++E E I E
Sbjct: 194 MLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 45/138 (32%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 19 YMVFEYMDH----DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
++V E DL + G R I +++ L GL Y H N+V+HRDIKG N+
Sbjct: 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAV------D 127
L+ +KL DFG++ D N I T ++ PE++ A P D
Sbjct: 145 LLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPEVI--ACDEQPDASYDARSD 200
Query: 128 MWSVGCIFAELLNGKPIL 145
+WS+G EL +GKP L
Sbjct: 201 VWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 43 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 102
QI ++ L GL Y H +HRDIKG+N+L+ +G++KLADFG++ + T+
Sbjct: 101 LQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIA 156
Query: 103 NR---VITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKP 143
R + T ++ PE+ K Y D+W++G EL +P
Sbjct: 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 40/170 (23%), Positives = 68/170 (40%), Gaps = 36/170 (21%)
Query: 15 RGSTYMVFEYMDH-DL-------TGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVL 65
Y+V EYM+ DL + P ++ + + Q+ G+ Y + +
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFV 127
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLGATKYG 123
HRD+ N L+ + +K++DFGL+R + D+ T + + W PE L +
Sbjct: 128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APESLKDG-IFT 185
Query: 124 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 173
D+WS G + E IF L +P +PG+S
Sbjct: 186 SKSDVWSFGVLLWE-------------------IFTLGATP----YPGLS 212
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
FT + + Y ++++ L Y H V++RDIK NL++D +G++K+ DFGL + D
Sbjct: 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 150
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159
T+ T Y PE+L YG AVD W +G + E++ G+ LP N+ + ++FE
Sbjct: 151 TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--RLFE 205
Query: 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 218
L +E +P R A LL +L DP QR+
Sbjct: 206 LI-LMEEIRFP-------------------------RTLSPEAKSLLAGLLKKDPKQRLG 239
Query: 219 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKR 255
AK+ ++ +F W D + K LP ++ + R
Sbjct: 240 GGPSDAKEVMEHRFFLSINWQDVV--QKKLLPPFKPQVTSEVDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 32 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
LA + + I + +L + Y H N+++HRDIK N+ I++ G++ L DFG A
Sbjct: 173 LAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AA 229
Query: 92 SFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG------KPI 144
F D N N T+ PE LL YGPAVD+WS G + E+ K
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288
Query: 145 LPGKNEAE-QLSKIFELCGS-PDE-TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRH 201
L G +++ Q+ I G+ P+E I + Y + K R ++ +
Sbjct: 289 LDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL 348
Query: 202 ALE---LLEKMLMLDPSQRISAKDALDSEYFWT--DPLP 235
++ L+ KML D R SA+ LD F DP P
Sbjct: 349 PIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP 387
|
Length = 391 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 57/189 (30%), Positives = 84/189 (44%), Gaps = 36/189 (19%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR--SFSYD 96
RF + + + Y +LL L H V++RD+K N+L+D +G++ L DFGL + D
Sbjct: 89 RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148
Query: 97 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156
NT T Y PELLLG Y AVD W++G + E+L G P +N E K
Sbjct: 149 KTNTFCG---TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK 204
Query: 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216
I + + +P FDR A +LL +L DP++
Sbjct: 205 ILQ-----EPLRFPD-------------------------GFDRDAKDLLIGLLSRDPTR 234
Query: 217 RISAKDALD 225
R+ A +
Sbjct: 235 RLGYNGAQE 243
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 40/162 (24%), Positives = 63/162 (38%), Gaps = 30/162 (18%)
Query: 16 GSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
+V EYM DL L ++ + + Q+ G+ Y +HRD+ N
Sbjct: 74 EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARN 133
Query: 74 LLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPE-LLLGATKYGPAVDMWSV 131
L+ +K++DFGL+R + D+ ++ W PE L G K+ D+WS
Sbjct: 134 CLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLKEG--KFTSKSDVWSF 190
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 173
G + E IF L P +PG+S
Sbjct: 191 GVLLWE-------------------IFTLGEEP----YPGMS 209
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 46/153 (30%), Positives = 67/153 (43%), Gaps = 24/153 (15%)
Query: 43 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 102
I Y QL + L + H +++HRDIK +N+ I G +KL D GL R FS
Sbjct: 106 RTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAH 164
Query: 103 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL----------------LNGK---- 142
+ V T +Y PE + Y D+WS+GC+ E+ L K
Sbjct: 165 SLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC 223
Query: 143 --PILPGKNEAEQLSKIFELCGSPDETIWPGVS 173
P LP + +E+L + C +PD P +S
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 66/226 (29%), Positives = 94/226 (41%), Gaps = 20/226 (8%)
Query: 13 KYRGSTYMVFEYMDHDLTGL--------ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 64
+ +TYM+ + D DL DRP L+ Q + MKQLL + Y H ++
Sbjct: 233 RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK----QTRAIMKQLLCAVEYIHDKKL 288
Query: 65 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 124
+HRDIK N+ ++ +G + L DFG A F + V T+ PE+L G Y
Sbjct: 289 IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCE 347
Query: 125 AVDMWSVGCIFAELLNGKPILP----GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 180
D+WS G I ++L+ P G +QL KI + DE K+ Y
Sbjct: 348 ITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYID 406
Query: 181 FKPSRTMKRRVREVFRHFDRHA-LEL-LEKMLMLDPSQRISAKDAL 224
V + R+ A E L KML D R A + L
Sbjct: 407 SAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452
|
Length = 501 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 38/126 (30%), Positives = 70/126 (55%), Gaps = 5/126 (3%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
+++ +Y++ T L+ R RF +++ Y +++ L + H +++RDIK N+L+
Sbjct: 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL 138
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIF 135
D+ G++ L DFGL++ F D + T+ Y P+++ G + AVD WS+G +
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198
Query: 136 AELLNG 141
ELL G
Sbjct: 199 YELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 32/184 (17%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F+ +++ Y +++ L + H +++RDIK N+L+D+EG++ L DFGL++ F +
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP--ILPG-KNEAEQLSK 156
+ T+ Y PE++ G +G AVD WS+G + ELL G L G +N ++S+
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216
C P P++ + A +LL K+L DP +
Sbjct: 222 RILKCDPP----------FPSFIGPE-------------------AQDLLHKLLRKDPKK 252
Query: 217 RISA 220
R+ A
Sbjct: 253 RLGA 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 40/161 (24%), Positives = 66/161 (40%), Gaps = 29/161 (18%)
Query: 16 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y+V EYM+ DL + + ++ + + Q+ G+ Y +HRD+ N
Sbjct: 74 EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNC 133
Query: 75 LIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPE-LLLGATKYGPAVDMWSVG 132
L+ +K++DFGL+R + D+ ++ W PE L G K+ D+WS G
Sbjct: 134 LVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKEG--KFTSKSDVWSFG 190
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 173
+ E IF L P +PG+S
Sbjct: 191 VLLWE-------------------IFTLGEQP----YPGMS 208
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 59/233 (25%), Positives = 90/233 (38%), Gaps = 23/233 (9%)
Query: 14 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
T MV + DL + + Q KQ+L GL Y H +++HRD+K N
Sbjct: 128 SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTEN 187
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
+ I++ + + D G A+ L V T PE+L KY D+WS G
Sbjct: 188 IFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET---NAPEVLARD-KYNSKADIWSAG 243
Query: 133 CIFAELL----------NGKPILPGKNEAEQLSKIFELCG-SPDETIWPGVSKMPAYNHF 181
+ E+L P K+ L KI P+E +P F
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE--FPRDPGSRLVRGF 301
Query: 182 KPSRTMKRRVREVFRHFDRHALE-----LLEKMLMLDPSQRISAKDALDSEYF 229
+++R+ + F R L L+ KML D + R SA++ L+ F
Sbjct: 302 IEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 10 DGNKYRGSTYMVFEYMD-HDLT-GLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVL 65
DGNK +V EY DL+ ++ R R +P+ I QLL GL H ++L
Sbjct: 70 DGNKL----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGP 124
HRD+K +N+L+ +K+ D G+++ + I T Y PE+ G Y
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVWKG-RPYSY 180
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
D+WS+GC+ E+ P ++ + K+
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 37/187 (19%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F + Y Q++ GL + H ++++RD+K N+L+D+ GN++++D GLA
Sbjct: 92 FPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK--GGK 149
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159
+ R T Y PE+L G Y +VD +++GC E++ G+ P + E++ K
Sbjct: 150 KIKGRAGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRS--PFRQRKEKVEK--- 203
Query: 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV---FRH-FDRHALELLEKMLMLDPS 215
+KRR E+ + F A +L E +L DP
Sbjct: 204 -------------------------EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238
Query: 216 QRISAKD 222
+R+ +
Sbjct: 239 KRLGCRG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F+ + + Y ++++ L Y H ++++RD+K NL++D +G++K+ DFGL + D
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AA 150
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+FE
Sbjct: 151 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLFE 205
Query: 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI- 218
L D K P R A LL +L+ DP++R+
Sbjct: 206 LILMED-------IKFP-------------------RTLSADAKSLLSGLLIKDPNKRLG 239
Query: 219 ----SAKDALDSEYF----WTDPLPCDPKSLPKYESSHEYQTKKR 255
AK+ + +F W D D K +P ++ +T R
Sbjct: 240 GGPDDAKEIMRHSFFTGVNWQDVY--DKKLVPPFKPQVTSETDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 10/133 (7%)
Query: 15 RGSTYMVFEYMDH-DLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
G+ Y+V +Y + DL + + G+ F QI + Q+ L + H ++LHRDIK
Sbjct: 71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQ 130
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNT--LTNRVI-TLWYRPPELLLGATKYGPAVDMW 129
N+ + +G +KL DFG+AR N+T L I T +Y PE+ Y D+W
Sbjct: 131 NIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSPEICEN-RPYNNKSDIW 185
Query: 130 SVGCIFAELLNGK 142
++GC+ E+ K
Sbjct: 186 ALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 2/100 (2%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
QI +K++L GL Y H + +HRDIK +N+L+ +G++KLADFG+A + D
Sbjct: 102 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNT 160
Query: 104 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
V T ++ PE ++ + Y D+WS+G EL G+P
Sbjct: 161 FVGTPFWMAPE-VIQQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 40/117 (34%), Positives = 64/117 (54%), Gaps = 14/117 (11%)
Query: 34 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93
+RP T PQI+ KQ L L+Y H N+++HRD+K N+L +G++KLADFG+
Sbjct: 97 ERP---LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGV---- 149
Query: 94 SYDHNNTLTNR---VITLWYRPPELLLGATK----YGPAVDMWSVGCIFAELLNGKP 143
S + T+ R + T ++ PE+++ T Y D+WS+G E+ +P
Sbjct: 150 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 37/111 (33%), Positives = 61/111 (54%), Gaps = 11/111 (9%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
T PQI+ +Q+L L Y H +++HRD+K N+L+ +G++KLADFG+ S +
Sbjct: 107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVK 162
Query: 100 TLTNR---VITLWYRPPELLLGAT----KYGPAVDMWSVGCIFAELLNGKP 143
TL R + T ++ PE+++ T Y D+WS+G E+ +P
Sbjct: 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + + +HN
Sbjct: 93 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNG 151
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159
T + T Y PE +L Y VD W +G + E+L G P +N AE I
Sbjct: 152 TTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
Query: 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 219
KP + +K + RH LLE +L D ++R+
Sbjct: 211 ----------------------KPLQ-LKPNITNSARH-------LLEGLLQKDRTKRLG 240
Query: 220 AKD 222
AKD
Sbjct: 241 AKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 31/192 (16%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
R QI +L L Y H V+HRDIK ++L+ ++G +KL+DFG S +
Sbjct: 114 RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
+ V T ++ PE ++ YG VD+WS+G + E+++G+P P NE
Sbjct: 174 KR-KSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEP--PYFNE-------- 221
Query: 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMK-RRVREVFRHFDRHALELLEKMLMLDPSQR 217
P + M P R +V V R F L+ ML+ +PSQR
Sbjct: 222 -----------PPLQAMRRIRDNLPPRVKDSHKVSSVLRGF-------LDLMLVREPSQR 263
Query: 218 ISAKDALDSEYF 229
+A++ L +
Sbjct: 264 ATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 14/153 (9%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V EYM DL + G + T+ + Q+ G+ Y +HRD+ N
Sbjct: 73 GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARN 132
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITL------WYRPPELLLGATKYGPAVD 127
L+ +K++DFGL+R D R W PE L K+ D
Sbjct: 133 CLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWM-APESLK-DGKFTSKSD 186
Query: 128 MWSVGCIFAELL-NGKPILPGKNEAEQLSKIFE 159
+WS G + E+ G+ PG + E L + +
Sbjct: 187 VWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 45/131 (34%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 19 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
YMV EYM DL L + +P+ + Y +++ L H +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 132
+D G+LKLADFG + V T Y PE+L G YG D WSVG
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 133 CIFAELLNGKP 143
E+L G
Sbjct: 235 VFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
RF+ + K Y+ +L+ L + H +++RD+K N+L+D G++ L DFGL+++ D
Sbjct: 92 RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-- 149
Query: 99 NTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 141
N TN T Y PE+LL Y VD WS+G + E+ G
Sbjct: 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 5/144 (3%)
Query: 19 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V +Y + DL L + R + Y+ +++ +H H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGC 133
G+++LADFG + D + V T Y PE+L G KYGP D WS+G
Sbjct: 137 MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 196
Query: 134 IFAELLNGKPILPGKNEAEQLSKI 157
E+L G+ ++ E KI
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 36/207 (17%)
Query: 16 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
G Y++ EY+ +L +R G+ F Y+ ++ L + H +++RD+K N+
Sbjct: 73 GKLYLILEYLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGC 133
L+D +G++KL DFGL + H T+T+ T+ Y PE+L+ + +G AVD WS+G
Sbjct: 132 LLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM-RSGHGKAVDWWSLGA 188
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
+ ++L G P +N + + KI + G +P Y
Sbjct: 189 LMYDMLTGAPPFTAENRKKTIDKILK-----------GKLNLPPY--------------- 222
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISA 220
A +LL+K+L +PS R+ A
Sbjct: 223 ----LTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 31/192 (16%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
R QI +L L H V+HRDIK ++L+ ++G +KL+DFG S +
Sbjct: 112 RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
+ V T ++ PE L+ YGP VD+WS+G + E+++G+P P NE
Sbjct: 172 RR-KSLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP--PYFNE-------- 219
Query: 159 ELCGSPDETIWPGVSKMPAY-NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217
P + M ++ P +V + F L+++L+ DP+QR
Sbjct: 220 -----------PPLKAMKMIRDNLPPKLKNLHKVSPSLKGF-------LDRLLVRDPAQR 261
Query: 218 ISAKDALDSEYF 229
+A + L +
Sbjct: 262 ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 43/125 (34%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 37 GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 96
G R P I + + L GL + HVN+ +HRD+KG+N+L+ EG +KL DFG++ +
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177
Query: 97 HNNTLTNRVITLWYRPP----ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152
T+ W P E L +T Y D+WS+G EL +G P L +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPLADLHPMR 236
Query: 153 QLSKI 157
L KI
Sbjct: 237 ALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 2/119 (1%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + +H+
Sbjct: 92 SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHS 150
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
T + T Y PE+L Y VD W +G + E+L G P ++ AE I
Sbjct: 151 KTTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 38/141 (26%), Positives = 54/141 (38%), Gaps = 38/141 (26%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
FT + + Y+ + + + H +HRDIK NLL+D +G++KL+DFGL H
Sbjct: 98 FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 100 TL---------------------TNRVITLW----------------YRPPELLLGATKY 122
+ R W Y PE+ L T Y
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGY 216
Query: 123 GPAVDMWSVGCIFAELLNGKP 143
D WS+G I E+L G P
Sbjct: 217 NKECDWWSLGVIMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y ++ GL H ++++RD+K N+L+D+ G+++++D GLA T+ RV T
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRVGT 164
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150
+ Y PE ++ +Y + D W +GC+ E++ GK + E
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 48/171 (28%), Positives = 70/171 (40%), Gaps = 33/171 (19%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVI 106
+ Q+L LH+ H +LHRD+K N+L+D +K+ DFG+++ S + V
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS--SKSKAYTVVG 163
Query: 107 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 166
T Y PEL G Y D+W++GC+ EL + K N + KI
Sbjct: 164 TPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS------- 215
Query: 167 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217
F P + R R L+ ML LDPS+R
Sbjct: 216 ------------GTFAP---ISDRYSPDLRQ-------LILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 24/148 (16%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y QL + L + H +V+HRDIK +N+ I G +KL D GL R FS + V T
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGT 169
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK----------------------PIL 145
+Y PE + Y D+WS+GC+ E+ + P L
Sbjct: 170 PYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228
Query: 146 PGKNEAEQLSKIFELCGSPDETIWPGVS 173
P + +E+L ++ +C +PD P ++
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 39/118 (33%), Positives = 64/118 (54%), Gaps = 2/118 (1%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
FT +K Y+ +L L + H +++RD+K N+L+D EG++KL DFGL++ S DH
Sbjct: 95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEK 153
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
+ T+ Y PE ++ + + D WS G + E+L G GK+ E ++ I
Sbjct: 154 KAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 2/100 (2%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
QI ++++L GL Y H + +HRDIK +N+L+ G +KLADFG+A + D
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNT 160
Query: 104 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
V T ++ PE ++ + Y D+WS+G EL G+P
Sbjct: 161 FVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 69/269 (25%), Positives = 107/269 (39%), Gaps = 60/269 (22%)
Query: 1 MTCTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 59
M C+F ET + MV EY++ D L G V + Y + + L Y
Sbjct: 66 MFCSF-ET------KRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYL 117
Query: 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR-------SFSYDHNNTLTNRVI------ 106
H ++HRD+K NLLI + G++KL DFGL++ + Y+ + R
Sbjct: 118 HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 107 -TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 165
T Y PE++L YG VD W++G I E L G G E ++ D
Sbjct: 178 GTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----D 231
Query: 166 ETIWP-GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
+ WP G +PA A +L+ ++L +P +R+ A
Sbjct: 232 DIEWPEGDEALPA-----------------------DAQDLISRLLRQNPLERLGTGGAF 268
Query: 225 D---SEYF----WTDPLPCDPKSLPKYES 246
+ +F W L + +P+ ES
Sbjct: 269 EVKQHRFFLGLDWNGLLRQKAEFIPQLES 297
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 35 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 94
G R I + L GL + H N+++HRD+KG+N+L+ EG +KL DFG++ +
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 95 YDHNNTLTNRVITLWYRPPELLLGATKYGPA----VDMWSVGCIFAELLNGKPILPGKNE 150
T+ V T ++ PE++ +Y + D+WS+G EL +G P L +
Sbjct: 180 STRLRRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF---D 235
Query: 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHF 181
+ +F++ +P T+ ++NHF
Sbjct: 236 MHPVKTLFKIPRNPPPTLLHPEKWCRSFNHF 266
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 24/148 (16%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y QL + + + H +V+HRDIK +N+ I G +KL D GL R FS + V T
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGT 169
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAEL-----------LN-----------GKPIL 145
+Y PE + Y D+WS+GC+ E+ +N P L
Sbjct: 170 PYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228
Query: 146 PGKNEAEQLSKIFELCGSPDETIWPGVS 173
P ++ +E+L ++ +C PD P +
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 28/178 (15%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y Q+ G+ + H +++RD+K N+L+D++GN +L+D GLA T+T R T
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 167
Y PE+L Y VD +++GC E++ G+ P K+ E+++K +E
Sbjct: 158 NGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGR--TPFKDHKEKVAK--------EEL 206
Query: 168 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
RT++ V+ ++F + ++ L P R+ +++ D
Sbjct: 207 K---------------RRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 53 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 112
L GL Y H +++HRDIK SN+L+ +G +KL DFG++ T T T +Y
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMA 171
Query: 113 PELLLGATKYGPAVDMWSVGCIFAELLNGK-PILP 146
PE + G Y D+WS+G E+ + P P
Sbjct: 172 PERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 8/149 (5%)
Query: 14 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKG 71
G + EYMD L + R + +L GL Y H ++++HRD+K
Sbjct: 70 NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKP 129
Query: 72 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
SN+L+++ G +KL DFG++ T V T Y PE + G Y D+WS+
Sbjct: 130 SNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAPERIQG-NDYSVKSDIWSL 185
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFEL 160
G EL G+ P E + IFEL
Sbjct: 186 GLSLIELATGR--FPYPPENDPPDGIFEL 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 32/103 (31%), Positives = 57/103 (55%), Gaps = 3/103 (2%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y ++L GL H ++RD+K N+L+D+ G+++++D GLA ++ RV T
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGT 164
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150
+ Y PE +L +Y + D W +GC+ E++ G+ G+ E
Sbjct: 165 VGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 2/99 (2%)
Query: 45 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 104
I ++++L GL Y H + +HRDIK +N+L+ +G++KLADFG+A + D
Sbjct: 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTF 161
Query: 105 VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
V T ++ PE ++ + Y D+WS+G EL G+P
Sbjct: 162 VGTPFWMAPE-VIKQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 46/129 (35%), Positives = 61/129 (47%), Gaps = 10/129 (7%)
Query: 19 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
YMV EYM DL L + VP+ + Y +++ L H +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 132
+D G+LKLADFG + + V T Y PE+L G YG D WSVG
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 133 CIFAELLNG 141
E+L G
Sbjct: 235 VFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 65/234 (27%), Positives = 90/234 (38%), Gaps = 18/234 (7%)
Query: 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
+ +++ + MV DL DR G + Q ++LL L Y H
Sbjct: 146 RAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG-PLPLEQAITIQRRLLEALAYLHGR 204
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR--VITLWYRPPELLLGAT 120
++HRD+K N+ +D N L DFG A H +T TL PE LL
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLD-AHPDTPQCYGWSGTLETNSPE-LLALD 262
Query: 121 KYGPAVDMWSVGCIFAELLNGKPILPGK---NEAEQLSKIFELCGSPDETIWPGVSKMPA 177
Y D+WS G + E+ L GK + + QL I C +P
Sbjct: 263 PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNGSTNL 321
Query: 178 YNHFK-------PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
HFK P T+ +R+ H D L+ KML D R SA+D L
Sbjct: 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMD--VEYLIAKMLTFDQEFRPSAQDIL 373
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 47/129 (36%), Positives = 60/129 (46%), Gaps = 10/129 (7%)
Query: 19 YMVFEYM-DHDLTGLADRPGLRFTVPQ--IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
YMV EYM DL L + VP+ K Y +++ L H ++HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVG 132
+D G+LKLADFG V T Y PE+L G YG D WSVG
Sbjct: 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 133 CIFAELLNG 141
E+L G
Sbjct: 235 VFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 5/145 (3%)
Query: 19 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V +Y + DL L + R + Y+ +++ + H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGC 133
G+++LADFG D + V T Y PE+L G KYGP D WS+G
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGV 196
Query: 134 IFAELLNGKPILPGKNEAEQLSKIF 158
E+L G+ ++ E KI
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 34/102 (33%), Positives = 60/102 (58%), Gaps = 3/102 (2%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F+ +++ Y +++ GL + H V++RD+K +N+L+D G+++++D GLA FS +
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 141
V T Y PE+L T Y + D +S+GC+ +LL G
Sbjct: 154 A---SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 34/109 (31%), Positives = 62/109 (56%), Gaps = 4/109 (3%)
Query: 34 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93
+ PG F P+ Y Q+++GL + H ++++RD+K N+L+DN+GN++++D GLA
Sbjct: 90 ENPG--FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147
Query: 94 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 142
+ T T + PELL G +Y +VD +++G E++ +
Sbjct: 148 KDGQSKT-KGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 3/102 (2%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F+ +++ Y +++ GL + H V++RD+K +N+L+D G+++++D GLA FS +
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 141
V T Y PE+L Y + D +S+GC+ +LL G
Sbjct: 154 A---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 52 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYR 111
++ GL Y ++LHRD+K SN+L++ G +KL DFG++ N+ V T Y
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYM 160
Query: 112 PPELLLGATKYGPAVDMWSVGCIFAELLNGK 142
PE + G +YG D+WS+G F EL G+
Sbjct: 161 APERISG-EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 5/135 (3%)
Query: 37 GLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 95
RFT +I Q++ L Y H +++HRD+ +N+++ + + + DFGLA+
Sbjct: 107 KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ- 165
Query: 96 DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155
+ LT+ V T+ Y PE++ YG D+W+ GCI ++ +P N +
Sbjct: 166 -PESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT 223
Query: 156 KIFELCGSP-DETIW 169
KI E P E ++
Sbjct: 224 KIVEAVYEPLPEGMY 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 34/146 (23%), Positives = 65/146 (44%), Gaps = 5/146 (3%)
Query: 15 RGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+ ++V EYM + L L +R G + + + + Y N +HRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAAR 129
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N L+ + +K++DFGLAR D + + + PPE+ +++ D+WS G
Sbjct: 130 NCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFG 188
Query: 133 CIFAELLN-GKPILPGKNEAEQLSKI 157
+ E+ + GK + +E + +
Sbjct: 189 VLMWEVFSEGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V EYM L L D G +P + Q+ G+ Y +HRD++ +N+L+
Sbjct: 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV 135
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNR----VITLWYRPPELLLGATKYGPAVDMWSVG 132
+ K+ADFGLAR +N T R W P L G ++ D+WS G
Sbjct: 136 GDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFG 190
Query: 133 CIFAELLN-GKPILPGKNEAEQLSKI 157
+ EL+ G+ PG N E L ++
Sbjct: 191 ILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 46/223 (20%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + ++
Sbjct: 93 FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSD 151
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159
T T T Y PE++ Y VD W +G + E+L G P ++ AE I
Sbjct: 152 TTTTFCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210
Query: 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 219
+ PG S A +LE++L D +R+
Sbjct: 211 ----KPLVLRPGASLT--------------------------AWSILEELLEKDRQRRLG 240
Query: 220 AKDAL----DSEYF----WTD------PLPCDPKSLPKYESSH 248
AK+ + +F WTD P P +P + S+
Sbjct: 241 AKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISN 283
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 43/188 (22%)
Query: 35 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 94
R RF K Y +L+ Y H +++RD+K NLL+DN+G++K+ DFG A+
Sbjct: 110 RKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK-- 167
Query: 95 YDHNNTLTNRVITLW----YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150
+ +R TL Y PE ++ + +G AVD W++G + E + G P P ++
Sbjct: 168 ------VPDRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP--PFFDD 218
Query: 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 210
+I+ E I G K P FD A +L++ +L
Sbjct: 219 TP--FRIY-------EKILAGRLKFP-------------------NWFDGRARDLVKGLL 250
Query: 211 MLDPSQRI 218
D ++R+
Sbjct: 251 QTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 41/122 (33%), Positives = 69/122 (56%), Gaps = 7/122 (5%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
F+ + + Y ++++ L Y H + V++RD+K NL++D +G++K+ DFGL + D
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 150
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
T+ T Y PE +L YG AVD W +G + E++ G+ LP N+ + K+F
Sbjct: 151 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--KLF 205
Query: 159 EL 160
EL
Sbjct: 206 EL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 19 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V +Y + DL L + R + Y+ +++ + H +HRDIK N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLL----GATKYGPAVDMWSV 131
G+++LADFG + T+ + V T Y PE+L G +YGP D WS+
Sbjct: 137 KNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL 194
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKI 157
G E+L G+ ++ E KI
Sbjct: 195 GVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 11/100 (11%)
Query: 50 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL---TNRVI 106
+Q+L+G+ Y H ++HRDIK SNLLI++ N+K+ADFG++R T+ + V
Sbjct: 175 RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL----AQTMDPCNSSVG 230
Query: 107 TLWYRPPELL---LGATKY-GPAVDMWSVGCIFAELLNGK 142
T+ Y PE + L Y G A D+WS+G E G+
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 41/109 (37%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 110
L GL Y H ++ +HRDIK N+L+ G +KLADFG A S N+ V T ++
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS--PANSF---VGTPYW 177
Query: 111 RPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
PE++L +Y VD+WS+G EL KP L N L I
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 30/103 (29%), Positives = 58/103 (56%), Gaps = 3/103 (2%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
F + Y ++ GL H ++++RD+K N+L+D+ G+++++D GLA
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 142
T+ RV T+ Y PE++ +Y + D W++GC+ E++ G+
Sbjct: 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 40/107 (37%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 53 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 112
L GL Y H + ++HRDIK N+L+ G +KLADFG A S + V T ++
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMA 189
Query: 113 PELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
PE++L +Y VD+WS+G EL KP L N L I
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 50/168 (29%), Positives = 69/168 (41%), Gaps = 45/168 (26%)
Query: 19 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y V +Y+ D+ L R G+ F + Y+ +L + H +HRDIK N+LID
Sbjct: 77 YFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 135
Query: 78 NEGNLKLADFGLARSFSYDHNN-----------------------------TLTNR---- 104
+G++KL DFGL F + H++ L R
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 105 ---------VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
V T Y PE+LL T Y D WSVG I E+L G+P
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 40/107 (37%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 53 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 112
L GL Y H + ++HRDIK N+L+ G +KLADFG A S + V T ++
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMA 185
Query: 113 PELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
PE++L +Y VD+WS+G EL KP L N L I
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 36/143 (25%), Positives = 61/143 (42%), Gaps = 22/143 (15%)
Query: 13 KYRGSTY--------MVFEY-----MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC 59
KY+G ++ EY + L D+ L ++ + Q+ G+ Y
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL----KRLLLFSSQICKGMDYL 125
Query: 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELL 116
+ +HRD+ N+L+++E +K++DFGLA+ D + WY P L
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 117 LGATKYGPAVDMWSVGCIFAELL 139
+K+ A D+WS G EL
Sbjct: 186 T--SKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 41/125 (32%), Positives = 60/125 (48%), Gaps = 22/125 (17%)
Query: 52 LLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFG--------LARSFSYDHNNTLT 102
+L GL Y ++++HRD+K SN+L+++ G +KL DFG +A SF
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--------- 158
Query: 103 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162
V T Y PE L G T Y D+WS+G E+ G+ +P + E L +F
Sbjct: 159 --VGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPV 214
Query: 163 SPDET 167
S E
Sbjct: 215 SEGEA 219
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y++ EYM L L G + +P++ + Q+ G+ Y +HRD++ +N+L+
Sbjct: 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV 136
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV---DMWSVGC 133
K+ADFGLAR + + + PE A +G D+WS G
Sbjct: 137 SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE----AINFGSFTIKSDVWSFGI 192
Query: 134 IFAELLN-GKPILPGKNEAEQLSKI 157
+ E++ GK PG + ++ +S +
Sbjct: 193 LLYEIVTYGKIPYPGMSNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 29/171 (16%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y +L GL ++++RD+K N+L+D+ G+++++D GLA T+ RV T
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGT 164
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 167
+ Y PE ++ KY + D W +GC+ E++ G+ P + E++ + +E
Sbjct: 165 VGYMAPE-VINNEKYTFSPDWWGLGCLIYEMIQGQS--PFRKRKERVKR--------EEV 213
Query: 168 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218
R +K E F A + +L +P +R+
Sbjct: 214 ----------------DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 2/95 (2%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y ++ L++ H +++RD+K N+L+D EG++KL D+G+ + + T T T
Sbjct: 101 YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGT 159
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 142
Y PE+L G YG +VD W++G + E++ G+
Sbjct: 160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 10/111 (9%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV----- 105
Q+L +H+ H ++HRDIK +N+L+ + G +KL DFG FS + T+++ V
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG----FSKMYAATVSDDVGRTFC 206
Query: 106 ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156
T +Y PE+ Y DM+S+G + ELL K G+N E + K
Sbjct: 207 GTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y ++ L+Y H +++RD+K N+L+D+EG++KL D+G+ + +T + T
Sbjct: 101 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGT 159
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS---P 164
Y PE+L G YG +VD W++G + E++ G+ F++ GS P
Sbjct: 160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR-------------SPFDIVGSSDNP 205
Query: 165 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218
D+ + ++ + R++ + V + F L DP +R+
Sbjct: 206 DQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF-----------LNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
QI ++ L GL+Y H +HRDIKG+N+L+ + G++KLADFG++ + T+
Sbjct: 107 QIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT----ATIAK 162
Query: 104 R---VITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKP 143
R + T ++ PE+ K Y D+W+VG EL +P
Sbjct: 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 38/121 (31%), Positives = 62/121 (51%), Gaps = 2/121 (1%)
Query: 19 YMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EYM + L G RF Q+ K + G+ Y Q +HRD+ N L+D
Sbjct: 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD 134
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
++G +K++DFGL+R D + + + PPE+LL +K+ D+W+ G + E
Sbjct: 135 DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWE 193
Query: 138 L 138
+
Sbjct: 194 V 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 41/186 (22%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLARSF---- 93
+ + ++K ++QL+ L+ H + ++H DIK N+L D + + L D+GL +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 94 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153
YD TL Y PE + G Y + D W+VG + ELL GK P K
Sbjct: 165 CYDG---------TLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGK--HPFKE---- 208
Query: 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 213
DE + + + K ++ ++A + ++ ML +
Sbjct: 209 ---------DEDEEL--DLESLLKRQQKKLPFI---------KNVSKNANDFVQSMLKYN 248
Query: 214 PSQRIS 219
+ R++
Sbjct: 249 INYRLT 254
|
Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 22/142 (15%)
Query: 13 KYRG--------STYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
KY+G ++ EY+ L L D P + + Q+ + +Q+ G+ Y H
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 64 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI------TLWYRPPELLL 117
+HRD+ N+L+DN+ +K+ DFGLA++ H RV WY L
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAVE--CL 182
Query: 118 GATKYGPAVDMWSVGCIFAELL 139
K+ A D+WS G ELL
Sbjct: 183 KENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 43/156 (27%), Positives = 61/156 (39%), Gaps = 47/156 (30%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-------- 99
YM + + + H +HRDIK N+LID G++KL+DFGL+ F H++
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 100 ---------------------TLTNR-VITLW----------------YRPPELLLGATK 121
T++++ I W Y PE+ L
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QG 224
Query: 122 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
YG D WS+G I E L G P +N E KI
Sbjct: 225 YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
QI ++ L GL Y H +HRDIKG+N+L+ + G++KLADFG+A + T+
Sbjct: 107 QIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT----ATIAK 162
Query: 104 R---VITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKP 143
R + T ++ PE+ Y D+W+VG EL +P
Sbjct: 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-----NNTLT 102
Y Q+ G+ Y Q +HRD+ N+L+++E +K+ DFGL ++ D + L
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 103 NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 139
+ V WY P L+ +K+ A D+WS G ELL
Sbjct: 174 SPV--FWYAPECLI--QSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 12/146 (8%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V EYM L L G +PQ+ Q+ +G+ Y +HRD++ +N+L+
Sbjct: 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 135
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNR----VITLWYRPPELLLGATKYGPAVDMWSVG 132
K+ADFGLAR +N T R W P L G ++ D+WS G
Sbjct: 136 GENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFG 190
Query: 133 CIFAEL-LNGKPILPGKNEAEQLSKI 157
+ EL G+ PG E L ++
Sbjct: 191 ILLTELTTKGRVPYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 2/105 (1%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
F P+ + Y ++ + + Y H +++RD+K N+L+D++G++ L DFGL + +
Sbjct: 92 CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPE 150
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
T + T Y PE +L Y VD W +G + E+L G P
Sbjct: 151 ETTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 31/170 (18%)
Query: 18 TYMVFEY-MDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+V +Y +L L R PG + + Y ++L L Y H+ +++RD+K N+L
Sbjct: 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENIL 135
Query: 76 IDNEGNLKLADFGLA---------------RSFSYDHNNTLTNRVI-------------T 107
+ G++ L+DF L+ + N++ + T
Sbjct: 136 LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGT 195
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
Y PE++ G +G AVD W++G + E+L G G N E S I
Sbjct: 196 EEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI 244
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 37/107 (34%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 53 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP 112
L GL Y H + ++HRD+K N+L+ G +KL DFG A + V T ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMA 179
Query: 113 PELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
PE++L +Y VD+WS+G EL KP L N L I
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V EYM L L G + +PQ+ Q+ G+ Y +HRD+ N+L+
Sbjct: 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV 136
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP---AVDMWSVGC 133
K+ADFGLAR D + + PE A YG D+WS G
Sbjct: 137 GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE----AANYGRFTIKSDVWSFGI 192
Query: 134 IFAELLN-GKPILPGKNEAEQLSKI 157
+ E++ G+ PG E L ++
Sbjct: 193 LLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 42/109 (38%), Positives = 61/109 (55%), Gaps = 8/109 (7%)
Query: 52 LLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 110
+L GL Y +Q++HRD+K SN+L+++ G +KL DFG++ N+ V T Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 168
Query: 111 RPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIF 158
PE L G T Y D+WS+G EL G+ PI P +A++L IF
Sbjct: 169 MSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 29/95 (30%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y ++ L++ H +++RD+K N+L+D +G++KL D+G+ + +T + T
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGT 159
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 142
Y PE+L G +YG +VD W++G + E++ G+
Sbjct: 160 PNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 34/223 (15%)
Query: 14 YRGSTYMVFEYMDHD-LTGLADRPG-LRFTV-PQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
+ M E+MD L + + G + + +I + + LT L+ H +++HRDIK
Sbjct: 74 NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIK 131
Query: 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
SN+L+++ G +KL DFG++ +T V T Y PE + G KY D+WS
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGELINSIADTF---VGTSTYMSPERIQGG-KYTVKSDVWS 187
Query: 131 VGCIFAELLNGKPILPGKNEAEQLS----KIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
+G EL GK N + I +L + P R
Sbjct: 188 LGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------------LQQIVQEPPPRL 233
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
F + ++ L+ DP++R + + F
Sbjct: 234 PSSD-------FPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 4/142 (2%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V E M + L L G +PQ+ Q+ +G+ Y +HRD+ N+L+
Sbjct: 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV 136
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
K+ADFGLAR D + + PE L ++ D+WS G +
Sbjct: 137 GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLT 195
Query: 137 ELLN-GKPILPGKNEAEQLSKI 157
E++ G+ PG AE L ++
Sbjct: 196 EIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 38/110 (34%), Positives = 52/110 (47%), Gaps = 7/110 (6%)
Query: 56 LHYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 114
LHY V+HRD+K SN+L+D GN+KL DFG++ T + Y PE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA--YMAPE 184
Query: 115 LLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFEL 160
+ KY D+WS+G EL G+ K E E L+KI +
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE 234
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 43/185 (23%), Positives = 71/185 (38%), Gaps = 31/185 (16%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
Q+ + Q+ L Y H +LHRD+K N+ + +K+ D G+AR + + +
Sbjct: 103 QVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMAST 161
Query: 104 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163
+ T +Y PE L Y D+W++GC E+ K K+ + +I E
Sbjct: 162 LIGTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE---- 216
Query: 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223
K+P + + + EL+ ML P +R S K
Sbjct: 217 ---------GKLP----------------PMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
Query: 224 LDSEY 228
L Y
Sbjct: 252 LRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 50/176 (28%), Positives = 70/176 (39%), Gaps = 49/176 (27%)
Query: 15 RGSTYMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
+ + Y V +Y+ D+ L R + F + Y+ +L + H +HRDIK N
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDN 131
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNN---------------------------------T 100
+LID +G++KL DFGL F + HN+ T
Sbjct: 132 ILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKT 191
Query: 101 LTNR-------------VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
L R V T Y PE+LL Y D WSVG I E+L G+P
Sbjct: 192 LEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQP 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 35/144 (24%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 15 RGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+ Y++ E+M L L G + +P++ + Q+ G+ + +HRD++ +
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 131
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV---DMW 129
N+L+ K+ADFGLAR + + + PE A +G D+W
Sbjct: 132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE----AINFGSFTIKSDVW 187
Query: 130 SVGCIFAELLN-GKPILPGKNEAE 152
S G + E++ G+ PG + E
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 51/144 (35%), Positives = 67/144 (46%), Gaps = 29/144 (20%)
Query: 50 KQLLTGLHYCHV-------NQVLHRDIKGSNLLID-----------NEGNL------KLA 85
+QLL L YCH +VLHRD+K N+ + NL K+
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 86 DFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKPI 144
DFGL+++ + + + V T +Y PELLL TK Y DMW++GCI EL +GK
Sbjct: 185 DFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 145 LPGKNEAEQLSKIFELCGSPDETI 168
N QL I EL PD I
Sbjct: 243 FHKANNFSQL--ISELKRGPDLPI 264
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 52/186 (27%), Positives = 73/186 (39%), Gaps = 49/186 (26%)
Query: 19 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y V +Y+ D+ L R G+ F + Y+ +L + H +HRDIK N+LID
Sbjct: 77 YFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID 135
Query: 78 NEGNLKLADFGLARSFSYDHNNT---------------------------------LTNR 104
+G++KL DFGL F + H++ L R
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR 195
Query: 105 -------------VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151
V T Y PE+LL T Y D WSVG I E+L G+P +
Sbjct: 196 AARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL 254
Query: 152 EQLSKI 157
E K+
Sbjct: 255 ETQMKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 52 LLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWY 110
++ GL Y ++++HRD+K SN+L+++ G +KL DFG++ N+ V T Y
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSY 168
Query: 111 RPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIF--ELCGSPDET 167
PE L G T Y D+WS+G E+ G+ PI P +A++L +F + G P E+
Sbjct: 169 MSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAES 225
Query: 168 IWPGVSKMPA 177
+ P
Sbjct: 226 ETSPRPRPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 50 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TL 108
+++L GL + H ++V+HRDIKG N+L+ +KL DFG+ S D N I T
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTP 185
Query: 109 WYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPIL 145
++ PE++ Y D+WS+G E+ G P L
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 14/131 (10%)
Query: 49 MKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKLADFGLARSFSYDHNN-----T 100
M Q+L L H ++HRD+K N+++ + K+ DFG+ + T
Sbjct: 85 MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 101 LTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159
T V+ T Y PE L G P D+++ G IF E L G+ ++ G + AE L +
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPV-TPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL- 202
Query: 160 LCGSPDETIWP 170
SP + P
Sbjct: 203 ---SPVDVSLP 210
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 36/116 (31%), Positives = 51/116 (43%), Gaps = 19/116 (16%)
Query: 55 GLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLW---- 109
L Y H V+HRD+K SN+LI+ G +KL DFG++ L + V
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVDSVAKTIDAGC 166
Query: 110 --YRPPELLLGATK---YGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFE 159
Y PE + Y D+WS+G EL G+ P K +QL ++ E
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 14/138 (10%)
Query: 13 KYRGSTY--------MVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
KY+G Y +V EY+ L + R ++ Y Q+ G+ Y +
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 64 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGAT 120
+HRD+ N+L+++E +K+ DFGL + D WY P L +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES--LTES 186
Query: 121 KYGPAVDMWSVGCIFAEL 138
K+ A D+WS G + EL
Sbjct: 187 KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
Y Q++ Y +++RD+K NLL+D +G +K+ DFG A+ + R T
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYT 187
Query: 108 LWYRP----PELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
L P PE+LL +G A D W++G E+L G P
Sbjct: 188 LCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 10/140 (7%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y++ EYM++ + L G++ T+ ++ Q+ G+ + +HRD++ +N+L+
Sbjct: 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV 135
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP---AVDMWSVGC 133
K+ADFGLAR + + + PE A YG D+WS G
Sbjct: 136 SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE----AINYGTFTIKSDVWSFGI 191
Query: 134 IFAELLN-GKPILPGKNEAE 152
+ E++ G+ PG E
Sbjct: 192 LLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 28/74 (37%), Positives = 43/74 (58%), Gaps = 2/74 (2%)
Query: 19 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EY+ D+ L G F Y+ ++ L Y H + ++HRD+K N+LI
Sbjct: 80 YLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138
Query: 78 NEGNLKLADFGLAR 91
NEG++KL DFGL++
Sbjct: 139 NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 12/146 (8%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V E+M L L + G +PQ+ Q+ G+ Y +HRD++ +N+L+
Sbjct: 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV 135
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNR----VITLWYRPPELLLGATKYGPAVDMWSVG 132
+ K+ADFGLAR +N T R W P L G ++ D+WS G
Sbjct: 136 GDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFG 190
Query: 133 CIFAELLN-GKPILPGKNEAEQLSKI 157
+ EL+ G+ PG E L ++
Sbjct: 191 ILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 36/142 (25%), Positives = 61/142 (42%), Gaps = 24/142 (16%)
Query: 20 MVFEYMDH-DLT---------------------GLADRPGLRFTVPQIKCYMKQLLTGLH 57
++FEYM + DL L + + C KQ+ G+
Sbjct: 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144
Query: 58 YCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELL 116
Y + +HRD+ N L+ +K+ADFGL+R+ +S D+ N I + + PPE +
Sbjct: 145 YLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI 204
Query: 117 LGATKYGPAVDMWSVGCIFAEL 138
+Y D+W+ G + E+
Sbjct: 205 FYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 7e-08
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 50 KQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TL 108
+++L GL + H ++V+HRDIKG N+L+ +KL DFG+ S D N I T
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTP 175
Query: 109 WYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPIL 145
++ PE++ Y D+WS+G E+ G P L
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 13/102 (12%)
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITLWYRPPELLL- 117
+++HRD+K SN+L+D GN+KL DFG L S + + Y PE +
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP------YMAPERIDP 181
Query: 118 -GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKI 157
Y D+WS+G E+ GK P N +QL+++
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV 223
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 42/152 (27%), Positives = 66/152 (43%), Gaps = 22/152 (14%)
Query: 20 MVFEYMDHD---------------LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 64
MVFEYM H L G D + T+ Q+ Q+ +G+ Y
Sbjct: 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF 143
Query: 65 LHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYG 123
+HRD+ N L+ +K+ DFG++R +S D+ ++ + + PPE +L K+
Sbjct: 144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFT 202
Query: 124 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155
D+WS G + E+ GK QLS
Sbjct: 203 TESDIWSFGVVLWEIFT-----YGKQPWYQLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLW 109
Q+ G+ Y + +HRD+ N L+ +K++DFGL+R +S D+ + ++ +
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR 191
Query: 110 YRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ PPE +L K+ D+WS G + E+
Sbjct: 192 WMPPEAILYG-KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 9e-08
Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 20 MVFEYMDH------------DLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
MVFEYM H D +A+ T Q+ +Q+ G+ Y +H
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH 143
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKYGPA 125
RD+ N L+ +K+ DFG++R +S D+ + ++ + + PPE ++ K+
Sbjct: 144 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTE 202
Query: 126 VDMWSVGCIFAELL 139
D+WS+G + E+
Sbjct: 203 SDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 33/122 (27%), Positives = 60/122 (49%), Gaps = 4/122 (3%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V E+M++ L L R G + + + + + G+ Y N +HRD+ N L+
Sbjct: 75 YIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ G +K++DFG+ R D + + + + PPE+ +KY D+WS G +
Sbjct: 134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMW 192
Query: 137 EL 138
E+
Sbjct: 193 EV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 4/124 (3%)
Query: 20 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+V EYM++ L + +FTV Q+ ++ + +G+ Y +HRD+ N+L+++
Sbjct: 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS 141
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
K++DFGL+R D T R I + + PE + K+ A D+WS G +
Sbjct: 142 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMW 200
Query: 137 ELLN 140
E+++
Sbjct: 201 EVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 37/183 (20%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR----SFSYDHNNTLTNRVI 106
Q++ L H +++HRD+K +N+ + G +KL DFG ++ S S D ++
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG--- 233
Query: 107 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 166
T +Y PE L +Y DMWS+G I ELL G ++ E + ++ L G D
Sbjct: 234 TPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LYGKYDP 290
Query: 167 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226
P S M A LL+ +L +P+ R + + L +
Sbjct: 291 FPCPVSSGMKA---------------------------LLDPLLSKNPALRPTTQQLLHT 323
Query: 227 EYF 229
E+
Sbjct: 324 EFL 326
|
Length = 478 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 55/237 (23%), Positives = 89/237 (37%), Gaps = 29/237 (12%)
Query: 14 YRGSTYMVFEYMDH----DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
Y+V M + DL GL I +K +L L Y H +HR +
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--IAFILKDVLNALDYIHSKGFIHRSV 127
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-------NRVITLWYRPPELL----LG 118
K S++L+ +G + L+ + S H + V L + PE+L G
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186
Query: 119 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP----DETIWPGVSK 174
Y D++SVG EL NG +P K+ + ++ G+ D++ +P
Sbjct: 187 ---YNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 175 MPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ + R + R F H + +E L DP R SA L+ +F
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 43 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT 102
Q+ +QLL+ + Y H ++HRDIK N+L++ ++ L DFG A F+ +T
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPF 318
Query: 103 NRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+ I T+ PE+L G Y P+VD+WS G + E
Sbjct: 319 HYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 39/140 (27%), Positives = 59/140 (42%), Gaps = 25/140 (17%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLW 109
Q+ G+ Y + +HRD+ N+L+ + +K+ADFGLAR + D+ TN + +
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207
Query: 110 YRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 169
+ PE L Y D+WS G + E IF L GSP +
Sbjct: 208 WMAPEALFDRI-YTHQSDVWSFGVLLWE-------------------IFTLGGSP----Y 243
Query: 170 PGVSKMPAYNHFKPSRTMKR 189
PGV + K M +
Sbjct: 244 PGVPVEELFKLLKEGHRMDK 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 10/140 (7%)
Query: 23 EYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82
EY +D+ + D T + Q+ G+ Y + +HRD+ N+L+ +
Sbjct: 121 EY-SYDIARVPDEQ---MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVM 176
Query: 83 KLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--L 139
K+ADFGLAR + D+ TN + + + PE L Y D+WS G + E+ L
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTL 235
Query: 140 NGKPILPGKNEAEQLSKIFE 159
G P PG E+L K+ +
Sbjct: 236 GGSP-YPGI-PVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 12/173 (6%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V E M + L R +V Q+ + + G+ Y +++HRD+ N+L+
Sbjct: 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV 133
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+G K++DFGLAR S +N+ ++ W P L K+ D+WS G +
Sbjct: 134 SEDGVAKVSDFGLARVGSMGVDNS---KLPVKWTAPEALKHK--KFSSKSDVWSYGVLLW 188
Query: 137 ELLN-GK---PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 185
E+ + G+ P + K E + K + + P+ M + +P +
Sbjct: 189 EVFSYGRAPYPKMSLKEVKECVEKGYRM-EPPEGCPADVYVLMTSCWETEPKK 240
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 39/152 (25%), Positives = 59/152 (38%), Gaps = 35/152 (23%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH-- 97
T + + Y+ + + + H +HRDIK NLL+D++G++KL+DFGL H
Sbjct: 98 LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157
Query: 98 ----------------NNTLTNRVITLWYR----------------PPELLLGATKYGPA 125
N + R W R PE+ + T Y
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKL 216
Query: 126 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
D WS+G I E+L G P + E K+
Sbjct: 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 44 QIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN 103
+K + +++ L H ++ RD+ +N+L+D+ G+++L F + ++
Sbjct: 86 CVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS----EVEDSCDG 141
Query: 104 RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 145
+ Y PE + G ++ A D WS+G I ELL GK ++
Sbjct: 142 EAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 40/177 (22%), Positives = 67/177 (37%), Gaps = 32/177 (18%)
Query: 16 GSTYMVFEYMD----------HDLTGLADRPGLRF----TVPQIKCYMKQLLTGLHYCHV 61
G+ YM EYMD T LR V +K ++
Sbjct: 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--------- 122
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT- 120
++HRD+K +N+L++ G +KL DFG++ + T + Y PE +
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT---NIGCQSYMAPERIKSGGP 178
Query: 121 ----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 173
Y D+WS+G E+ G+ P + A +++ + T+ G S
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 38/142 (26%), Positives = 59/142 (41%), Gaps = 5/142 (3%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y++ E M+ L L G V + Q+ G+ Y +HRD+ N+L+
Sbjct: 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV 137
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ K+ADFGLAR D + ++ W P G + D+WS G +
Sbjct: 138 GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLY 195
Query: 137 ELLN-GKPILPGKNEAEQLSKI 157
E+ G+ PG N E +I
Sbjct: 196 EMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 18/137 (13%)
Query: 20 MVFEYMDH------------DLTGLADRPGLR----FTVPQIKCYMKQLLTGLHYCHVNQ 63
MVFEYM H D L D + + Q+ Q+ +G+ Y
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 143
Query: 64 VLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGATKY 122
+HRD+ N L+ +K+ DFG++R +S D+ + ++ + + PPE ++ K+
Sbjct: 144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKF 202
Query: 123 GPAVDMWSVGCIFAELL 139
D+WS G I E+
Sbjct: 203 TTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 38/144 (26%), Positives = 55/144 (38%), Gaps = 35/144 (24%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH---------- 97
Y+ + + + H +HRDIK NLL+D +G++KL+DFGL H
Sbjct: 106 YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 98 --------NNTLTNRVITLW----------------YRPPELLLGATKYGPAVDMWSVGC 133
N + R W Y PE+ + T Y D WS+G
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGV 224
Query: 134 IFAELLNGKPILPGKNEAEQLSKI 157
I E+L G P + E K+
Sbjct: 225 IMYEMLIGYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLW 109
Q+ G+ Y + +HRD+ N+L+ + +K+ADFGLAR + D+ TN + +
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201
Query: 110 YRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKPILPG 147
+ PE L Y D+WS G + E+ L G P PG
Sbjct: 202 WMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 19/142 (13%)
Query: 20 MVFEYMDHDLTGLADR---PGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
MV E L L DR L F + + Y Q+ G+ Y + +HRD+ N+L
Sbjct: 72 MVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL 129
Query: 76 IDNEGNLKLADFGLARSF--SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
+ ++ +K+ DFGL R+ + DH + + + PE L + A D+W G
Sbjct: 130 LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGV 188
Query: 134 IFAEL----------LNGKPIL 145
E+ L+G IL
Sbjct: 189 TLWEMFTYGEEPWAGLSGSQIL 210
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 24/91 (26%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLW 109
Q+ G+ Y + +H+D+ N+LI + ++K++D GL+R +S D+ ++ +
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 110 YRPPELLLGATKYGPAVDMWSVGCIFAELLN 140
+ PPE ++ K+ D+WS G + E+ +
Sbjct: 192 WMPPEAIMYG-KFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 34/124 (27%), Positives = 61/124 (49%), Gaps = 6/124 (4%)
Query: 20 MVFEYMDHDLTG--LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++ EYM++ L D G F+ Q+ ++ + G+ Y +HRD+ N+L++
Sbjct: 83 IITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN 141
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
+ K++DFGL+R D T T I + + PE + K+ A D+WS G +
Sbjct: 142 SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVM 200
Query: 136 AELL 139
E++
Sbjct: 201 WEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 20 MVFEYMD----------HDLTGLADRPGLRFTVPQIKCYMK-QLLTGLHYCHVNQVLHRD 68
M+ EYM+ H+ A++ + +M Q+ +G+ Y +HRD
Sbjct: 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD 155
Query: 69 IKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAV 126
+ N L+ +K+ADFG++R+ +S D+ V+ + W +LLG K+ A
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTAS 213
Query: 127 DMWSVGCIFAELLN 140
D+W+ G E+L
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 38/103 (36%), Positives = 52/103 (50%), Gaps = 3/103 (2%)
Query: 45 IKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 104
IK M+Q+LTGL H ++HRDIK NLL+ +G +K+ DFG A N
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 105 VITLWYRPPELLLGATKY--GPAVDMWSVGCIFAELLNGKPIL 145
++ Y PPE L+ PA M ++ FA L G+P L
Sbjct: 371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFA-WLYGRPDL 412
|
Length = 507 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 32/125 (25%), Positives = 54/125 (43%), Gaps = 7/125 (5%)
Query: 16 GSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V EYM + L R T+ Q + + G+ Y +HRD+ N
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARN 132
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
+L+ + K++DFGLA+ S + + ++ W P L K+ D+WS G
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREK--KFSTKSDVWSFGI 187
Query: 134 IFAEL 138
+ E+
Sbjct: 188 LLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 36/138 (26%), Positives = 64/138 (46%), Gaps = 16/138 (11%)
Query: 16 GSTYMVFEYMDH-DLTGL-------------ADRPGLRFTVPQIKCYMKQLLTGLHYCHV 61
MVFEYM+H DL D P T+ Q+ Q+ +G+ Y
Sbjct: 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPELLLGAT 120
+HRD+ N L+ + +K+ DFG++R ++ D+ + ++ + + PPE ++
Sbjct: 141 QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YR 199
Query: 121 KYGPAVDMWSVGCIFAEL 138
K+ D+WS G + E+
Sbjct: 200 KFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 2/125 (1%)
Query: 15 RGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
R +VFE+M+H L+ +F+ + + G+ Y + V+HRD+ N
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
L+ +K++DFG+ R D + T + + PE + +KY D+WS G
Sbjct: 131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE-VFSFSKYSSKSDVWSFGV 189
Query: 134 IFAEL 138
+ E+
Sbjct: 190 LMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 16/134 (11%)
Query: 20 MVFEYMDH-DLTGLADRPGLRFT------VPQIK----CYMK-QLLTGLHYCHVNQVLHR 67
M+ EYM++ DL + + T +P + YM Q+ +G+ Y +HR
Sbjct: 94 MITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153
Query: 68 DIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLGATKYGPA 125
D+ N L+ N +K+ADFG++R+ +S D+ V+ + W +LLG K+ A
Sbjct: 154 DLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTA 211
Query: 126 VDMWSVGCIFAELL 139
D+W+ G E+
Sbjct: 212 SDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 28/133 (21%), Positives = 52/133 (39%), Gaps = 12/133 (9%)
Query: 18 TYMVFEYMDH-DLTGL--ADRPGLRFTVP-------QIKCYMKQLLTGLHYCHVNQVLHR 67
T +V E M DL + RP + ++ G+ Y + +HR
Sbjct: 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143
Query: 68 DIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
D+ N ++ + +K+ DFG+ R D+ ++ + + PE L +
Sbjct: 144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKS 202
Query: 127 DMWSVGCIFAELL 139
D+WS G + E+
Sbjct: 203 DVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLW 109
Q+ G+ Y + +HRD+ N+L+ + +K+ADFGLAR D+ +N + +
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK 201
Query: 110 YRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKP 143
+ PE L Y D+WS G + E+ L G P
Sbjct: 202 WMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 5/96 (5%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN- 98
V +K Q+ G+ Y +HRD+ N+L+ N K++DFG++R+ +
Sbjct: 92 IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
Query: 99 --NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
T R WY P + G K+ D+WS G
Sbjct: 152 YRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 24/92 (26%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL- 108
Q+ G+ + + V+H+D+ N+L+ ++ N+K++D GL R ++ D+ + N ++ +
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140
W P ++ G K+ D+WS G + E+ +
Sbjct: 192 WMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 9/138 (6%)
Query: 16 GSTYMVFEYMDH-DLTGLADRPGLRF-TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
G ++ EY + DL R F T+ + + Q+ G+ + +HRD+ N
Sbjct: 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 171
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSV 131
+L+ + +K+ DFGLAR D N + R+ W P + Y D+WS
Sbjct: 172 VLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSY 229
Query: 132 GCIFAEL--LNGKPILPG 147
G + E+ L P PG
Sbjct: 230 GILLWEIFSLGSNP-YPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 48/184 (26%), Positives = 72/184 (39%), Gaps = 39/184 (21%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
T+ + CY Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 100 TLTNRV-ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
+ L + PE + Y D+WS G + E IF
Sbjct: 236 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWE-------------------IF 275
Query: 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE--VFRHFDRHALELLEKMLML---D 213
L SP +PGV K RR++E R D E+ + ML +
Sbjct: 276 SLGASP----YPGV---------KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322
Query: 214 PSQR 217
PSQR
Sbjct: 323 PSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 59/246 (23%), Positives = 84/246 (34%), Gaps = 60/246 (24%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y V Y+ + L GL I+ M+Q+L L H ++HRD+K N++
Sbjct: 233 YNVEPYLLGKVQDLP--KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 79 E-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG------------------- 118
G+ K+ D G A N Y P E LL
Sbjct: 291 GSGSFKIIDLGAAADLRVGIN-----------YIPKEFLLDPRYAAPEQYIMSTQTPSAP 339
Query: 119 ----ATKYGPAV---------DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD 165
AT P + D++S G IF ++ P L + Q ++ +
Sbjct: 340 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM--AFPNLRSDSNLIQFNRQLKRND--- 394
Query: 166 ETIWPGVSKMPAYNHFKPSRTMK--RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223
+ A+ R RR EV ELL+ M+ QRISAK A
Sbjct: 395 -------YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA 447
Query: 224 LDSEYF 229
L YF
Sbjct: 448 LAHPYF 453
|
Length = 566 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 19/49 (38%), Positives = 27/49 (55%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 96
Y QL T L Y + +HRDI N+L+ + +KL DFGL+R +
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLW 109
Q+ G+ Y H V+H+DI N +ID E +K+ D L+R F D++ N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE----- 179
Query: 110 YRP-----PELLLGATKYGPAVDMWSVGCIFAEL 138
RP E L+ +Y A D+WS G + EL
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 35/129 (27%), Positives = 64/129 (49%), Gaps = 6/129 (4%)
Query: 15 RGSTYM-VFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+ M + EYM++ L +FTV Q+ ++ + +G+ Y +HRD+
Sbjct: 76 KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAAR 135
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNR--VITLWYRPPELLLGATKYGPAVDMWS 130
N+L+++ K++DFGL+R D T T + I + + PE + K+ A D+WS
Sbjct: 136 NILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPE-AIAYRKFTSASDVWS 193
Query: 131 VGCIFAELL 139
G + E++
Sbjct: 194 FGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 3/122 (2%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
T+ + CY Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 100 TLT-NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 157
+ + L + PE + Y D+WS G + E+ + G PG E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289
Query: 158 FE 159
+
Sbjct: 290 LK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 43/139 (30%), Positives = 62/139 (44%), Gaps = 12/139 (8%)
Query: 16 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
GS +V YM H DL TV + + Q+ G+ Y + +HRD+ N
Sbjct: 70 GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNC 129
Query: 75 LIDNEGNLKLADFGLARSFSYD------HNNTLTNRVITLWYRPPELLLGATKYGPAVDM 128
++D +K+ADFGLAR YD HN+T ++ W L K+ D+
Sbjct: 130 MLDESFTVKVADFGLARDI-YDKEYYSVHNHT-GAKLPVKWMALES--LQTQKFTTKSDV 185
Query: 129 WSVGCIFAELLN-GKPILP 146
WS G + EL+ G P P
Sbjct: 186 WSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 23/198 (11%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMK---QLLTGLHYCHVNQVLHRDIK 70
+G Y+V EYM L D R +V C +K + + Y N +HRD+
Sbjct: 72 KGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLA 129
Query: 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
N+L+ + K++DFGL + S + T ++ W P L K+ D+WS
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--EKKFSTKSDVWS 184
Query: 131 VGCIFAELLN-GK---PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
G + E+ + G+ P +P K+ ++ K +++ +PD P V Y+ K
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAPDGC--PPV----VYDVMKQCWH 237
Query: 187 MKRRVREVFRHFDRHALE 204
+ R F R LE
Sbjct: 238 LDAATRPSFLQL-REQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 31/141 (21%), Positives = 64/141 (45%), Gaps = 4/141 (2%)
Query: 1 MTCTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH 60
M ++E D N++ S ++ + + + + + Q+ +G+ Y
Sbjct: 96 MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155
Query: 61 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITL-WYRPPELLLG 118
+HRD+ N L+ +K+ADFG++R+ ++ D+ V+ + W +L+G
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG 215
Query: 119 ATKYGPAVDMWSVGCIFAELL 139
K+ A D+W+ G E+L
Sbjct: 216 --KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 30/106 (28%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
+FTV Q+ ++ + G+ Y +HRD+ N+L+++ K++DFGL+R D +
Sbjct: 102 QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
Query: 99 N-TLTNRV---ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140
+ T T+ + I + + PE + K+ A D+WS G + E+++
Sbjct: 162 DPTYTSSLGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 54/205 (26%), Positives = 79/205 (38%), Gaps = 32/205 (15%)
Query: 53 LTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS-----------YDHNNTL 101
L GL+Y H N +HR+IK S++LI +G + L+ GL+ +S YD
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 102 TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIFEL 160
T+ + W P L Y D++SVG EL G+ P L K+
Sbjct: 169 TS--VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP 226
Query: 161 CGSP-DETIWP---------------GVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE 204
SP D T +P G+ + + T +R + F
Sbjct: 227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN 286
Query: 205 LLEKMLMLDPSQRISAKDALDSEYF 229
L+E L DP +R SA L +F
Sbjct: 287 LVELCLQQDPEKRPSASSLLSHAFF 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 30/108 (27%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 41 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 100
TV + M Q+ G+ Y +HRD+ N+L+ N+ K++DFGL+++ D ++
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSY 151
Query: 101 LTNRVITLW---YRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKP 143
R W + PE + K+ D+WS G E + KP
Sbjct: 152 YKARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 65/238 (27%)
Query: 16 GSTYMVFEYMDH-DLTGL--ADRP--------GLRFTVPQIKCY-----MKQLLTGLHYC 59
G Y+V EY H +L A RP R + Q+ G+ +
Sbjct: 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148
Query: 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY-DHNNTLTNRVITLWYRPPELLLG 118
+ +HRD+ N+L+ + +K+ADFGLAR + D+ TN + + + PE L
Sbjct: 149 ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD 208
Query: 119 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 178
Y D+WS G + E IF L GSP +PG+ +
Sbjct: 209 RV-YTHQSDVWSFGVLLWE-------------------IFTLGGSP----YPGIPVEELF 244
Query: 179 NHFKPSRTMKRRV---REVFRHFDRHALELLEKMLMLD-----PSQRISAK---DALD 225
K M++ +E++ LM D PSQR + K + LD
Sbjct: 245 KLLKEGYRMEKPQNCTQELY-------------HLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99
T Q+ + + TG+ Y Q +HRD+ N+L+ K+ADFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKP 143
T+ R+ W L + Y D+WS G + E+ L G P
Sbjct: 176 TM-GRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 33/124 (26%), Positives = 55/124 (44%), Gaps = 7/124 (5%)
Query: 19 YMVFEYMDHDLTGLAD--RPGLRFTVPQIK-CYM-KQLLTGLHYCHVNQVLHRDIKGSNL 74
Y++ E+M + L D R R V + YM Q+ + + Y +HRD+ N
Sbjct: 78 YIITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
L+ +K+ADFGL+R + D + + PE L K+ D+W+ G +
Sbjct: 136 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVL 194
Query: 135 FAEL 138
E+
Sbjct: 195 LWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 108
Q+ G+ Y +++HRD+ N+L+ + ++K+ DFGLAR D + +V
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSP 164
W +L ++ D+WS G EL+ KP +P + + L K L P
Sbjct: 177 WMALESIL--HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
Query: 165 DETI 168
TI
Sbjct: 235 ICTI 238
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 29/128 (22%), Positives = 56/128 (43%), Gaps = 5/128 (3%)
Query: 15 RGSTYM-VFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
RG+T M V EYM + L + + Q+ + L +G+ Y +H+ +
Sbjct: 77 RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAH 136
Query: 73 NLLIDNEGNLKLADFG-LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
+L++++ K++ F L S T++ + LW P + + A D+WS
Sbjct: 137 KVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSF 194
Query: 132 GCIFAELL 139
G + E++
Sbjct: 195 GIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 21/149 (14%)
Query: 13 KYRGSTYMVFEYMDHD----------------LTGLADRPGLRFTVPQIKCYMKQLLTGL 56
++RG Y+ EY H +A+ + Q+ + + G+
Sbjct: 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 137
Query: 57 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 116
Y Q +HRD+ N+L+ K+ADFGL+R T+ R+ W
Sbjct: 138 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWMAIES-- 194
Query: 117 LGATKYGPAVDMWSVGCIFAEL--LNGKP 143
L + Y D+WS G + E+ L G P
Sbjct: 195 LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 10/120 (8%)
Query: 34 DRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92
D P R T+ + + Q+ G+ Y +++HRD+ N+L+ +K++DFGL+R
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 93 FSYDHNNTLT---NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKPILPG 147
Y+ ++ + R+ W L Y D+WS G + E+ L G P PG
Sbjct: 177 V-YEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 12/185 (6%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL 108
Q+ G+ Y +++HRD+ N+L+ + ++K+ DFGLAR D N ++
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSP 164
W + K+ D+WS G EL+ GKP +P + + L K L P
Sbjct: 177 WMALE--CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234
Query: 165 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
TI + + + SR + +E+ F R A + ++ L++ R+
Sbjct: 235 ICTIDVYMVMVKCWMIDADSRP---KFKELAAEFSRMARD-PQRYLVIQGDDRMKLPSPN 290
Query: 225 DSEYF 229
DS++F
Sbjct: 291 DSKFF 295
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 41 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-- 98
T I + Q+ G+ Y +HRD+ N+L+ + K++DFGL+++ D N
Sbjct: 93 TEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152
Query: 99 -NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+ WY P + K+ D+WS G + E
Sbjct: 153 KAKTHGKWPVKWYAPE--CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 31/129 (24%), Positives = 51/129 (39%), Gaps = 11/129 (8%)
Query: 19 YMVFEYM-DHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V E + L + R TV ++ G+ Y +HRD+ N L+
Sbjct: 68 YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG 127
Query: 78 NEGNLKLADFGLARSFSYDHNNTLT-----NRVITLWYRPPELLLGATKYGPAVDMWSVG 132
LK++DFG++R + T ++ W P L G +Y D+WS G
Sbjct: 128 ENNVLKISDFGMSRE---EEGGIYTVSDGLKQIPIKWTAPEALNYG--RYTSESDVWSYG 182
Query: 133 CIFAELLNG 141
+ E +
Sbjct: 183 ILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 27/134 (20%)
Query: 41 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT 100
T+ + Y Q+ G+ + + +HRD+ N+L+ +K+ DFGLAR D +
Sbjct: 171 TLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230
Query: 101 LTN--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
R+ W P + Y D+WS G + E IF
Sbjct: 231 RKGDARLPLKWMAPESIF--DKVYTTQSDVWSFGVLLWE-------------------IF 269
Query: 159 ELCGSPDETIWPGV 172
L SP +PGV
Sbjct: 270 SLGASP----YPGV 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 6/128 (4%)
Query: 24 YMDHDLT-GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82
Y+D D+T + + L + + Q+ G+ + +HRD+ N+L+ +
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 83 KLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140
K+ DFGLAR D N + R+ W P + Y D+WS G + E+ +
Sbjct: 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFS 311
Query: 141 -GKPILPG 147
G PG
Sbjct: 312 LGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 31/123 (25%), Positives = 52/123 (42%), Gaps = 7/123 (5%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V E + D G R V ++ ++ G+ Y +HRD+ N L+
Sbjct: 69 YIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT 128
Query: 78 NEGNLKLADFGLARSFS---YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
+ LK++DFG++R Y + ++ W P L G +Y D+WS G +
Sbjct: 129 EKNVLKISDFGMSREEEDGVYASTGGM-KQIPVKWTAPEALNYG--RYSSESDVWSFGIL 185
Query: 135 FAE 137
E
Sbjct: 186 LWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 25/91 (27%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 108
Q+ G+ Y +++HRD+ N+L+ ++K+ DFGLA+ D +V
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELL 139
W +L Y D+WS G EL+
Sbjct: 177 WMALESILHR--IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 8/107 (7%)
Query: 55 GLHYCHVNQVLHRDIKGSNLLIDNEGN-----LKLADFGLARS-FSYDHNNTLTNRVITL 108
G Y +HRD+ N L+ +G +K+ DFGLAR + D+ ++ +
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 154
+ PE LL K+ D+WS G + E+L G+ P N E L
Sbjct: 178 RWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 5/100 (5%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 108
Q+ G+ + +HRD+ N+L+ + K+ DFGLAR D N + R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 147
W P + Y D+WS G + E+ + GK PG
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 50/223 (22%), Positives = 83/223 (37%), Gaps = 61/223 (27%)
Query: 55 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS----------FSYD------HN 98
+ Y H VLHRD+K N+L+ G + + D+G A D +
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 99 NTLTNRVI-TLWYRPPELLLGATKYGPA---VDMWSVGCIFAELLNGKPILPGKNEAEQL 154
T+ +++ T Y PE LLG PA D++++G I ++L P + + +
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGV----PASESTDIYALGVILYQMLTLS--FPYRRKKGR- 237
Query: 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 214
KI S + I ++ Y RE+ + A+ K L +DP
Sbjct: 238 -KI-----SYRDVI-LSPIEVAPY-------------REIPPFLSQIAM----KALAVDP 273
Query: 215 SQRISAKDAL----------DSEYFWTDPLPCDPKSLPKYESS 247
++R S+ L E+ L KS K+
Sbjct: 274 AERYSSVQELKQDLEPHLQGSPEWTVKATLMTKKKSCWKFYEP 316
|
Length = 932 |
| >gnl|CDD|219133 pfam06682, DUF1183, Protein of unknown function (DUF1183) | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 31/106 (29%), Positives = 34/106 (32%), Gaps = 16/106 (15%)
Query: 316 GKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRG 375
G GP Y G GG GG GGG P PP + P G
Sbjct: 182 GVRGGPRPERAGYGGGGGGGGG-----GGGGGGSGPGPPPPGFKSSFPP----PYGPGAG 232
Query: 376 PASGYGVGPQSYSQSGQYGNSAAGRGPNQMGG-------SRNQQYG 414
P+SGYG G Q G G G G + N YG
Sbjct: 233 PSSGYGSGGTRSGQGGWGPGFWTGLGAGGALGYLFGSRRNNNSSYG 278
|
This family consists of several eukaryotic proteins of around 360 residues in length. The function of this family is unknown. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 30/119 (25%), Positives = 48/119 (40%), Gaps = 5/119 (4%)
Query: 32 LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
L+D T + + Q+ G+ + +HRD+ N+L+ +K+ DFGLAR
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
Query: 92 SFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 147
+D N W P + Y D+WS G + E+ + G PG
Sbjct: 286 DIMHDSNYVSKGSTFLPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 34/124 (27%), Positives = 53/124 (42%), Gaps = 8/124 (6%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTN--RVITL 108
Q+ G++Y +++HRD+ N+L+ ++K+ DFGLA+ D +V
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPI--LPGKNEAEQLSKIFELCGSP 164
W +L Y D+WS G EL+ KP +P + L K L P
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234
Query: 165 DETI 168
TI
Sbjct: 235 ICTI 238
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 55 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPE 114
G+ Y Q +HRD+ N+L+ K+ADFGL+R T+ R+ W
Sbjct: 124 GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWMAIES 182
Query: 115 LLLGATKYGPAVDMWSVGCIFAEL--LNGKP 143
L + Y D+WS G + E+ L G P
Sbjct: 183 --LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 9e-04
Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 18/159 (11%)
Query: 6 LETTDGNKYRGSTYMVFEYMDH-DL------TGLADRPGLRFTVPQIKCYMKQLLTGLHY 58
L+T + Y S ++ +M H DL + L D P T +K +M + +G+ Y
Sbjct: 70 LQTVESEGYP-SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGMEY 127
Query: 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL-- 116
+HRD+ N +++ N+ +ADFGL++ Y+ + R+ + P + +
Sbjct: 128 LSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKM---PVKWIAI 183
Query: 117 --LGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 152
L Y D+WS G E+ G+ PG +E
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 19/51 (37%), Positives = 28/51 (54%)
Query: 43 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93
IK MK +LT L Y H + + H DIK N+++D + D+G+A F
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 56/211 (26%), Positives = 84/211 (39%), Gaps = 42/211 (19%)
Query: 51 QLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGN----------------LKLADFGLARSF 93
Q L Y H ++H D+K N+L++ +++ D G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----G 294
Query: 94 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153
D ++ T V T YR PE++LG + + DMWS+GCI EL GK + + E
Sbjct: 295 CCDERHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 154 LSKIFE-LCGSPDETIWPGVSKMPA----YN---HFKPSRTMK--------RRVREVFRH 197
L + + L P E W G YN +P K R VREV R
Sbjct: 354 LHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR- 410
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEY 228
D +L+ +L D +R++A+ Y
Sbjct: 411 -DDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNN-TLTNRVITL 108
Q+ G+ + +HRD+ N+LI EG L K+ DFGLAR D N + + + L
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAEL--LNGKP 143
+ PE + Y D+WS G + E+ L G P
Sbjct: 306 KWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 23/92 (25%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT--L 108
Q+ G++Y ++++HR++ N+L+ ++ +++ADFG+A D + T
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140
W +L G +Y D+WS G E+++
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 31/111 (27%), Positives = 35/111 (31%), Gaps = 5/111 (4%)
Query: 304 PPVPGGPGHHHYGKPRGPPGGANRYPSGNQ--SGGYNNPNRGGQGGGYSNAPYPPQGRGP 361
P + + P NR NQ S G N RG G Y PQ G
Sbjct: 462 PQNQRRQQNRGRQSSQPPRQQQNRSNQNNQRQSQGPNQGPRGQGGYNLRPRTYQPQRYG- 520
Query: 362 PYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQ 412
G G N SG G Q Q GN + GP + G R Q
Sbjct: 521 --GGQGRRWNPNPYRQSGQGRSQQQQPQPEARGNQSRTPGPGRGQGGRGNQ 569
|
Length = 582 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 21/89 (23%), Positives = 44/89 (49%), Gaps = 2/89 (2%)
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLW 109
++ G+ Y + N+ +HRD+ N ++ + +K+ DFG+ R + D+ ++ +
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 110 YRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ PE L + D+WS G + E+
Sbjct: 187 WMSPESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 49 MKQLLTGLHYCHVNQVLHRDIKGSNLLI----DNEGN---LKLADFGLARSFSYDHNNTL 101
KQL + LHY +++H ++ G N+L+ NEG +KL+D G+ + +
Sbjct: 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL-----SR 161
Query: 102 TNRVITLWYRPPELL-LGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSK 156
RV + + PE + G A D WS G E+ NG+ L + +E+
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|216868 pfam02084, Bindin, Bindin | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 24/84 (28%), Positives = 30/84 (35%), Gaps = 2/84 (2%)
Query: 315 YGKPRGPPGGANRYPSGNQ--SGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANG 372
Y + P G YP+ Q GY N GG GG G P G G + G
Sbjct: 7 YPQAMNPQMGGGNYPAPGQPAQQGYANQGMGGPVGGGGGPGAGGGAPGGPVGGGGGGSGG 66
Query: 373 PRGPASGYGVGPQSYSQSGQYGNS 396
P G G + S+ Y +S
Sbjct: 67 PPGGGEVAGEAEDAMSEFDDYSSS 90
|
Length = 239 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 23/84 (27%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 55 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRPP 113
G+ Y +HRD+ N L+ LK++DFG++R ++++ ++ W P
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE 164
Query: 114 ELLLGATKYGPAVDMWSVGCIFAE 137
L G +Y D+WS G + E
Sbjct: 165 ALNYG--RYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|115057 pfam06375, BLVR, Bovine leukaemia virus receptor (BLVR) | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 28/137 (20%), Positives = 54/137 (39%), Gaps = 10/137 (7%)
Query: 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218
E SP++ P V K K + K + R+ + + + L L P+
Sbjct: 182 ETSKSPEKGDVPAVEKKSKKPK-KKEKKEKEKERDKDKKKEVEGFKSLLLALDDSPASAA 240
Query: 219 SAKDALDSEYFWT-----DPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHH 273
S +A ++ T D + E + + K+++Q+++ EE K++K HH
Sbjct: 241 SVAEADEASLANTVSGTAPDSEPDEPKDAEAEETKKSPKHKKKKQRKEKEEKKKKKKHHH 300
Query: 274 PQPHGR----LPPIQHA 286
+ H P+Q+
Sbjct: 301 HRCHHSDGGAEQPVQNG 317
|
This family consists of several bovine specific leukaemia virus receptors which are thought to function as transmembrane proteins, although their exact function is unknown. Length = 561 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 33/134 (24%), Positives = 57/134 (42%), Gaps = 18/134 (13%)
Query: 20 MVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMK---QLLTGLHYCHVNQVLHRDIKGSNL 74
+V E+ DL L G+ + Q + ++ +GL + H +H D+ N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 75 LIDNEGNLKLADFGLARS-FSYDHNNTLTNRVITLWYRPPEL-------LLGA--TKYGP 124
+ + ++K+ D+GLA + D+ T + L + PEL LL TK
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS- 190
Query: 125 AVDMWSVGCIFAEL 138
++WS+G EL
Sbjct: 191 --NIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.92 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.85 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.63 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.63 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.59 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.57 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.56 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.54 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.51 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.26 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.25 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.22 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.16 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.16 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.04 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.77 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.7 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.68 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.63 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.62 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.56 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.07 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.72 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.61 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.35 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.1 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.66 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.65 | |
| KOG0921 | 1282 | consensus Dosage compensation complex, subunit MLE | 96.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.32 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.44 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.43 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.35 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.19 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.08 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.04 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.81 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.68 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.64 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.93 | |
| PLN02236 | 344 | choline kinase | 93.93 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.84 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.71 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.71 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 93.51 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 93.29 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.26 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.23 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 93.04 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.01 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.15 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.83 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 90.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 89.96 | |
| KOG0921 | 1282 | consensus Dosage compensation complex, subunit MLE | 89.72 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 89.59 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-57 Score=440.01 Aligned_cols=260 Identities=62% Similarity=1.098 Sum_probs=249.2
Q ss_pred cEeecccCceec--CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++.+.-..+ +.+|||||||++||..++...+..|++.+|++||+|||.||+|||.+||+|||||.+|||||++|+
T Consensus 177 NIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~ 256 (560)
T KOG0600|consen 177 NIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV 256 (560)
T ss_pred cccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC
Confidence 788888887777 799999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||||+.+.......+++++.|+||++||+|++...|+.++|+||+||||.||++|+++|.+.++.+++.+|+++|
T Consensus 257 LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc 336 (560)
T KOG0600|consen 257 LKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC 336 (560)
T ss_pred EEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence 99999999998887777789999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 241 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~~~~~ 241 (417)
|+|.+..|+ ..++|.+..+++....++.+.+.++.++..+++||.+||.+||++|.||.++|+++||++.+++|++..+
T Consensus 337 GSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~L 415 (560)
T KOG0600|consen 337 GSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSL 415 (560)
T ss_pred CCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccC
Confidence 999999999 8999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHHHHHHH
Q 014871 242 PKYESSHEYQTKKRRQQQRQHEE 264 (417)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~ 264 (417)
+++...++...|+++++.++...
T Consensus 416 p~y~~s~E~~~K~r~e~~r~~~~ 438 (560)
T KOG0600|consen 416 PKYPPSHELDAKRRREQKRRNKG 438 (560)
T ss_pred CCCCcchhHHHHHHHHHhhcccc
Confidence 99999999999988887766553
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=369.71 Aligned_cols=246 Identities=46% Similarity=0.815 Sum_probs=216.0
Q ss_pred cEeecccC--ceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDG--NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~--~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++.++ ....+.+|||||||+.||..++..-..+|.+.++++++.|+|.||+|||.+.|+|||||++|+|+++.|.
T Consensus 136 NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~ 215 (419)
T KOG0663|consen 136 NIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI 215 (419)
T ss_pred CeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc
Confidence 56655533 2344579999999999999999988788999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+|+.+... ....+..+.|+||+|||.+++...|+.++|+||+|||+.||+++++.|++..+.+++.+|++++
T Consensus 216 lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 216 LKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred EEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence 999999999988743 4567778889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhh--hhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 239 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~~~ 239 (417)
+.|.+..|++...++..+...-.......++..+.. +++...+||..+|.+||.+|.||+|+|+|.||...++++++.
T Consensus 295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~ 374 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPS 374 (419)
T ss_pred CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChh
Confidence 999999999999998766444333333334444433 569999999999999999999999999999999999999999
Q ss_pred CCCCCCCchHH
Q 014871 240 SLPKYESSHEY 250 (417)
Q Consensus 240 ~~~~~~~~~~~ 250 (417)
.++++....+.
T Consensus 375 ~~Pt~P~k~~~ 385 (419)
T KOG0663|consen 375 MFPTWPAKSEQ 385 (419)
T ss_pred hcCCCcccccc
Confidence 99998865543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=355.78 Aligned_cols=241 Identities=42% Similarity=0.764 Sum_probs=218.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-|||+++|+|-+++++.||+||++.+|...++.....|+...|+.|+.+++.||+|||++.|+||||||+|+||+.+|.+
T Consensus 61 ~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~l 140 (318)
T KOG0659|consen 61 PNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQL 140 (318)
T ss_pred cchhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcE
Confidence 37999999999999999999999999999999988899999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+.+..... ..+..+.|.||+|||.+++...|+..+||||+|||++||+.+.+.|++.++.+++..|+..+|
T Consensus 141 KiADFGLAr~f~~p~~-~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 141 KIADFGLARFFGSPNR-IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred EeecccchhccCCCCc-ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 9999999998875433 344458899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 242 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~~~~~~ 242 (417)
+|.+..|+.+..++.|..++-.. ......++...+.+++||+.+||.+||.+|+|+.|+|+|+||+..+.++.+..++
T Consensus 220 TP~~~~WP~~~~lpdY~~~~~~P--~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 220 TPTPDQWPEMTSLPDYVKIQQFP--KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLP 297 (318)
T ss_pred CCCcccCccccccccHHHHhcCC--CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCc
Confidence 99999999999999998776221 1122237778889999999999999999999999999999999999998887776
Q ss_pred CCCC
Q 014871 243 KYES 246 (417)
Q Consensus 243 ~~~~ 246 (417)
....
T Consensus 298 ~p~~ 301 (318)
T KOG0659|consen 298 IPST 301 (318)
T ss_pred CCcc
Confidence 5443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=381.83 Aligned_cols=227 Identities=34% Similarity=0.622 Sum_probs=206.3
Q ss_pred cEeecccCceecC-eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRG-STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~-~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++.+.+.+.+ ++|+|||||+.+|.++++.++..|+++.|+.||.|||+||+|||++|++|||||||||||.....|
T Consensus 70 niikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~i 149 (538)
T KOG0661|consen 70 NIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVI 149 (538)
T ss_pred cchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccccee
Confidence 7899999999988 999999999999999999998889999999999999999999999999999999999999977799
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+.+.. ....+.++.|+||+|||+|+....|+.++|||++|||++|+.+-+++|+|.++.+++.+|.+++|
T Consensus 150 KiaDFGLARev~S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLG 227 (538)
T KOG0661|consen 150 KIADFGLAREVRS--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLG 227 (538)
T ss_pred Eeccccccccccc--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhC
Confidence 9999999998764 44677899999999999999989999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.|+...|+.-..+...-+++........+..+....+.++.+||.+||.+||++||||.++|+|+||...
T Consensus 228 tP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 228 TPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred CCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 9999999875544444455544455566777777899999999999999999999999999999999643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=350.03 Aligned_cols=225 Identities=36% Similarity=0.653 Sum_probs=196.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|+|.+++.|+-+..+|||||||+.++++.+++.-..++...++.|++||+.|+.|||++++||||||||||||+.++.+|
T Consensus 62 NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvK 141 (396)
T KOG0593|consen 62 NLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVK 141 (396)
T ss_pred hHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEE
Confidence 78899999999999999999999999999888666799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|||||+|+.+.. .....+.++.|.||+|||.+.+...|+..+||||+|||+.||++|.+.|++.++.+++..|...+|.
T Consensus 142 LCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~ 220 (396)
T KOG0593|consen 142 LCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGN 220 (396)
T ss_pred eccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcc
Confidence 999999998775 5567788899999999999999899999999999999999999999999999999999999999887
Q ss_pred CCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.......-....+.|.-.. +...-.......+..++..++||+++||.+||.+|++.+++|.|+||
T Consensus 221 L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 221 LIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred cCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 6554433333333333222 22222334455566778899999999999999999999999999999
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=341.20 Aligned_cols=230 Identities=44% Similarity=0.786 Sum_probs=205.0
Q ss_pred cccEeecccCceecC------eEEEEEcCCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 2 TCTFLETTDGNKYRG------STYMVFEYMDHDLTGLADRPG---LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 2 ~cniv~~~~~~~~~~------~~yiV~Ey~~g~l~~~~~~~~---~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
.|+||.+++.+..+. .+||||||++-+|-.+++... ..++...|+.+++|||.||+|||+++|+||||||.
T Consensus 70 ~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQ 149 (323)
T KOG0594|consen 70 ANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQ 149 (323)
T ss_pred CcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcc
Confidence 355888888777777 899999999999999888755 35888999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 152 (417)
||||+++|.+||+|||+|+.+.- .....+..+.|.||+|||++++...|+..+||||+|||++||+++++.|++.++.+
T Consensus 150 NlLi~~~G~lKlaDFGlAra~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ 228 (323)
T KOG0594|consen 150 NLLISSSGVLKLADFGLARAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID 228 (323)
T ss_pred eEEECCCCcEeeeccchHHHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH
Confidence 99999999999999999997653 33446777889999999999998899999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
++.+|+++++.|.+..|+.+..++.|+..-........+....+..+.+..||+.+||..+|.+|.|++.+|.|+||...
T Consensus 229 ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 229 QLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 99999999999999999999999998864444444556666666777899999999999999999999999999999654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=360.69 Aligned_cols=198 Identities=29% Similarity=0.437 Sum_probs=175.3
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||+++++|++++++|||+|+|..+.+..+.+..+.|+|.+++.|++||+.||.|||+++|||||||..||||+++.+||
T Consensus 79 nIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 79 NIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred cEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEE
Confidence 89999999999999999999999644444444666799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||||..+.... ....+.|||+.|+||||+.. ..++..+||||+|||||.||+|++||..++-.+++.+|......
T Consensus 159 IgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~ 236 (592)
T KOG0575|consen 159 IGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS 236 (592)
T ss_pred ecccceeeeecCcc-cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc
Confidence 99999999876443 34567899999999999985 67899999999999999999999999999999999999653221
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
++..++.+++|||++||..||.+|||+++||+|+||+..-
T Consensus 237 ------------------------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 237 ------------------------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred ------------------------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 2235788999999999999999999999999999995543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=337.27 Aligned_cols=233 Identities=39% Similarity=0.649 Sum_probs=193.4
Q ss_pred cEeecccCcee-----cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKY-----RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~-----~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
|||.+.+++.- -+.+|||+|+|+.+|...+... ..|++..++.++.|||.||+|+|+.+|+||||||.|+|++.
T Consensus 82 NIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~ 160 (359)
T KOG0660|consen 82 NIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA 160 (359)
T ss_pred CcceEEeecccccccccceeEEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc
Confidence 56666666554 5579999999998888777654 35999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCC-CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+..+||||||+|+..... ....++..+.|.||+|||+++....|+.++||||+||||+|||+|++.|++.+..+++..|
T Consensus 161 ~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI 240 (359)
T KOG0660|consen 161 DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI 240 (359)
T ss_pred CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 999999999999876432 2345678899999999999998889999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 236 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~ 236 (417)
.+++++|++.............-.+ .....+..+..++...++.++|||++||..||.+|+|++|+|+||||..-..+.
T Consensus 241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 9999999876655444211100000 011224456777888999999999999999999999999999999997655544
Q ss_pred C
Q 014871 237 D 237 (417)
Q Consensus 237 ~ 237 (417)
+
T Consensus 321 d 321 (359)
T KOG0660|consen 321 D 321 (359)
T ss_pred c
Confidence 4
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=343.03 Aligned_cols=202 Identities=30% Similarity=0.451 Sum_probs=168.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--- 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~--- 79 (417)
|||++++.|+.....||||||++| +|.+.+.. ++.+.+..-+.+++|||.||.|||++||+||||||+||||..+
T Consensus 237 ~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 237 NIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred CEEEEeeeeecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc
Confidence 689999999999999999999986 55555554 4569999999999999999999999999999999999999876
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHH-HHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSK 156 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~~~~ 156 (417)
-.+||+|||+|+... ....+.+.|||+.|.||||+... ..+..++||||||||||-+|+|.+||.+..... ...+
T Consensus 316 ~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred eEEEecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 459999999999865 34566788999999999999753 234568999999999999999999998765544 4455
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
|..--..+ ....|..+++++++||..||..||++|+|+.|+|+||||+..+.
T Consensus 394 I~~G~y~f--------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 394 ILKGRYAF--------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred HhcCcccc--------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 53321111 12345678999999999999999999999999999999976443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=335.29 Aligned_cols=196 Identities=28% Similarity=0.388 Sum_probs=167.2
Q ss_pred cEeecccCceecCe-EEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGS-TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~-~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~ 81 (417)
+||++|.+|..++. ++|+||||+++.++.+.+..++++|..+.+++.+||+||.|||+ ++||||||||+||||+..|+
T Consensus 138 yIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe 217 (364)
T KOG0581|consen 138 YIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE 217 (364)
T ss_pred CeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC
Confidence 68999999999996 99999999976555555555679999999999999999999996 89999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-----ChHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-----NEAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~-----~~~~~~~~ 156 (417)
|||||||.++.+.+. ...+.+||..|||||.+.+ ..|+.++||||||++++||.+|+.||... +..+++..
T Consensus 218 VKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~ 293 (364)
T KOG0581|consen 218 VKICDFGVSGILVNS---IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA 293 (364)
T ss_pred EEeccccccHHhhhh---hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH
Confidence 999999999876543 5567899999999999987 68999999999999999999999999874 44455555
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh-hhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
|.. .+.+. +.. .|++++++||..||++||.+|+|+.++|+|+|++..
T Consensus 294 Iv~---~ppP~--------------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 294 IVD---EPPPR--------------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred Hhc---CCCCC--------------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 532 22111 112 388899999999999999999999999999999653
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=353.24 Aligned_cols=228 Identities=29% Similarity=0.530 Sum_probs=186.5
Q ss_pred cccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 2 TCTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 2 ~cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
+-|||+++|+|.+++|+|||+|+++.+|.++++.+.. .|+...++.|+.|||++|.+||+.+|||+|||||||||.+-+
T Consensus 247 ~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 247 KYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK 326 (586)
T ss_pred CeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC
Confidence 4689999999999999999999999999999987654 499999999999999999999999999999999999997654
Q ss_pred --CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 --NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 --~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.|||+|||.|+.... ...+.+.++.|+||||+++ ..|+.+.||||||||++||++|.++|+++++.++++.|.
T Consensus 327 r~~vKVIDFGSSc~~~q----~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~ 401 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQ----RVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII 401 (586)
T ss_pred cCceeEEecccccccCC----cceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence 599999999987542 3337788999999999998 789999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCCCccccC-------CCchh-------------------------hhhhHHHhhh-hhhHHHHHH
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHF-------KPSRT-------------------------MKRRVREVFR-HFDRHALEL 205 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-------------------------~~~~~~~~~~-~~~~~~~~L 205 (417)
+++|.|+....+...+...|.+- +.... ....+..... .-...+.||
T Consensus 402 e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~df 481 (586)
T KOG0667|consen 402 EVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDF 481 (586)
T ss_pred HHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHH
Confidence 99999887654433332111100 00000 0001111112 234678999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 206 LEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 206 i~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
|++||.+||.+|+|+.++|+|+||....+
T Consensus 482 lk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 482 LKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHhccCchhcCCHHHHhcCcccccccc
Confidence 99999999999999999999999975443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=347.43 Aligned_cols=197 Identities=30% Similarity=0.460 Sum_probs=175.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||++.||+++.+.++|+|+||+.++ |++++.++ +.|++.+++++|+||+.||.|||..+|+||||||+|+|||..++
T Consensus 72 pnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n 150 (786)
T KOG0588|consen 72 PNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN 150 (786)
T ss_pred CCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC
Confidence 38999999999999999999999865 55555554 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
|||+|||+|... .....+.+.||++.|.|||++.+..+.+.++||||||||||.||+|+.||++.|-..++.++..
T Consensus 151 IKIADFGMAsLe--~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~-- 226 (786)
T KOG0588|consen 151 IKIADFGMASLE--VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR-- 226 (786)
T ss_pred Eeeeccceeecc--cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc--
Confidence 999999999753 3455677889999999999999988889999999999999999999999999998888888743
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
...++...++.++.+||++||..||++|+|.+||++|||+...
T Consensus 227 ----------------------------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 227 ----------------------------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ----------------------------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 3344456789999999999999999999999999999999654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=338.37 Aligned_cols=196 Identities=32% Similarity=0.523 Sum_probs=174.8
Q ss_pred EeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||++|.-|.+..++|+|+||+. |+|++++.+-+ .|++..++.|+.||+.||+|||++|||||||||||||||.|+++|
T Consensus 136 ivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 136 IVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred eEEEEEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEE
Confidence 7899999999999999999997 68888887765 699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCC------------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 84 LADFGLARSFSYDHNN------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 84 L~DFGla~~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
|+|||.|+.+...... ...+.|||..|.+||+|.. ...+..+|||+||||||.||.|.+||.+.|+.
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 9999999876532211 1255899999999999875 68899999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.++++|+++...+ ...|++.++|||+++|..||++|+|+.+|.+|+||..
T Consensus 294 liFqkI~~l~y~f------------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 294 LIFQKIQALDYEF------------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHHHHHHHhcccC------------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999998765433 2357789999999999999999999999999999965
Q ss_pred C
Q 014871 232 D 232 (417)
Q Consensus 232 ~ 232 (417)
.
T Consensus 344 V 344 (604)
T KOG0592|consen 344 V 344 (604)
T ss_pred C
Confidence 3
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=310.90 Aligned_cols=223 Identities=48% Similarity=0.940 Sum_probs=197.2
Q ss_pred eecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 13 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 13 ~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
.++..+||||++|+.+|..++.....+|+..+|+++|++++.||.|+|++.|+|||+|++|+||+.++.+||+|||+|+.
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 35667999999999999999998888999999999999999999999999999999999999999999999999999987
Q ss_pred ccCC---CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 014871 93 FSYD---HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 169 (417)
Q Consensus 93 ~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 169 (417)
++.. .....++++.|++|+.||.+++...|+.+.|||..|||+.||+++.+.|.+.++..++..|..+|++.....|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 7533 2344677889999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCchhh---hhhHHHhhhh--hhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 170 PGVSKMPAYNHFKPSRTM---KRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
+.+.+++.|......... .+.+....+. -+.++.|||++||..||.+|+++.++|+|.|||.++.+
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 999999998876433221 2222222221 25689999999999999999999999999999998876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.98 Aligned_cols=197 Identities=31% Similarity=0.469 Sum_probs=174.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-C
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-G 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-~ 80 (417)
.||+++++++.....+|||||||.+ +|++.+.+ ..++.|.+++++|+||+.||+|||++||+|||||++||||+.+ +
T Consensus 80 pnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~ 158 (370)
T KOG0583|consen 80 PNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG 158 (370)
T ss_pred CCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC
Confidence 3899999999999999999999986 88888877 6689999999999999999999999999999999999999999 9
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
++||+|||++.... .......+.+||+.|+|||++.+.. +.+.++||||||||||.|++|+.||...+...++.+|..
T Consensus 159 ~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~ 237 (370)
T KOG0583|consen 159 NLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK 237 (370)
T ss_pred CEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 99999999998763 3455777889999999999998865 456899999999999999999999999888888888744
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhh-hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..- .+...+ +.++++||++||..||.+|+|+.+|++|+||+.
T Consensus 238 ~~~------------------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 GEF------------------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCc------------------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 211 112234 789999999999999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=325.15 Aligned_cols=197 Identities=28% Similarity=0.449 Sum_probs=171.0
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
.||+++..|+...++|||+||+.|+.+.....+...|+|+.++.|+..|+.||.|||++|||||||||||||||.+|.|+
T Consensus 86 Fiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~ 165 (357)
T KOG0598|consen 86 FIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIK 165 (357)
T ss_pred cEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEE
Confidence 47889999999999999999999755555555555799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||||+...... ....+.|||+.|||||++++ ..|+.++|.|||||++|||++|.+||.+.+.....++|...-
T Consensus 166 LtDFgL~k~~~~~~-~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-- 241 (357)
T KOG0598|consen 166 LTDFGLCKEDLKDG-DATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-- 241 (357)
T ss_pred EeccccchhcccCC-CccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--
Confidence 99999998654332 34445899999999999997 589999999999999999999999999999999999986522
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI----SAKDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp----ta~elL~h~~f~~ 231 (417)
.......++.++++||+++|..||++|. .+.+|.+|+||..
T Consensus 242 ---------------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 242 ---------------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ---------------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 1112233788999999999999999996 6899999999954
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=312.11 Aligned_cols=232 Identities=39% Similarity=0.734 Sum_probs=193.1
Q ss_pred cEeecccCcee-cCeEEEEEcCCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKY-RGSTYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~-~~~~yiV~Ey~~g~l~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
|||.+..+|-. ++.+||++||++.+|+..+.. ....++...++.++.|||.||+|||++=|+||||||.||||..
T Consensus 88 nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmg 167 (438)
T KOG0666|consen 88 NVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMG 167 (438)
T ss_pred cchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEec
Confidence 55555555555 889999999999999998763 2345899999999999999999999999999999999999988
Q ss_pred C----CCEEEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh--
Q 014871 79 E----GNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-- 150 (417)
Q Consensus 79 ~----~~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-- 150 (417)
+ |.|||+|||+|+.+...-.. .....+.|.||+|||.+++...|+.++|||++|||+.|||+-.+.|.+..+
T Consensus 168 dgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~ 247 (438)
T KOG0666|consen 168 DGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKI 247 (438)
T ss_pred cCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhc
Confidence 8 89999999999988653322 233456799999999999999999999999999999999999999987543
Q ss_pred -------HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhh-------hhhHHHhhhhhhHHHHHHHHHhcccCCCC
Q 014871 151 -------AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM-------KRRVREVFRHFDRHALELLEKMLMLDPSQ 216 (417)
Q Consensus 151 -------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 216 (417)
.+++.+|+++++.|.+..|+...++|++.+....... ...+-...+.-++.+.+||.+||..||.+
T Consensus 248 ~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~k 327 (438)
T KOG0666|consen 248 KTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIK 327 (438)
T ss_pred ccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchh
Confidence 4689999999999999999999999998543222111 11222233334566999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCC
Q 014871 217 RISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 217 Rpta~elL~h~~f~~~~~~ 235 (417)
|+|++++|+|+||.+++++
T Consensus 328 RIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 328 RITAEQALEHPYFTEDPLP 346 (438)
T ss_pred hccHHHHhcccccccCCCC
Confidence 9999999999999999776
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.88 Aligned_cols=225 Identities=40% Similarity=0.770 Sum_probs=189.2
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+...+.+||||||++++|...+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 64 niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~k 143 (288)
T cd07871 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELK 143 (288)
T ss_pred CEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence 78999999999999999999999999888876666689999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+++..... ........++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.
T Consensus 144 l~DfG~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 222 (288)
T cd07871 144 LADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGT 222 (288)
T ss_pred ECcCcceeeccCC-CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999764322 222344567999999999876567899999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+....|+.......+...................++.++++||++||..||++|+|++|+|+|+||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 223 PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 988888876654433332211111122233345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.42 Aligned_cols=198 Identities=27% Similarity=0.423 Sum_probs=171.6
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--- 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~--- 79 (417)
|||++.+-+...+..|||+|+|+|+.+. .+..+ .-++|..+..+++|||++|.|||.++|||||+||+|+||...
T Consensus 71 ~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~ 149 (355)
T KOG0033|consen 71 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKG 149 (355)
T ss_pred cEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCC
Confidence 6899999999999999999999975444 44433 568999999999999999999999999999999999999643
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
.-|||+|||+|..+. .......++||+.|||||++.. ..|+..+|||++|||||.||.|++||.+.+...++..|..
T Consensus 150 A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~ 226 (355)
T KOG0033|consen 150 AAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA 226 (355)
T ss_pred CceeecccceEEEeC--CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 349999999999877 3344556889999999999986 6899999999999999999999999999999999999987
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.....+...| .++++++++||++||..||.+|+|+.|+|+|||+..
T Consensus 227 g~yd~~~~~w--------------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 227 GAYDYPSPEW--------------------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred cccCCCCccc--------------------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 5555444333 357789999999999999999999999999999954
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=308.87 Aligned_cols=193 Identities=29% Similarity=0.437 Sum_probs=171.5
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKL 84 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL 84 (417)
+++++.-+.+.+++||||||+.|+.++-+.++..+|++..++.|+.||+.||+|||+++|++|||||||||||.+|.+||
T Consensus 106 lv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 106 LVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred eEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEE
Confidence 45666789999999999999998877777776678999999999999999999999999999999999999999999999
Q ss_pred eeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 014871 85 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 164 (417)
Q Consensus 85 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~ 164 (417)
+|||+|+.+.. ...+.|||+.|+|||++.. +.|+.++|.|||||++|||+.|.+||...+...++.+|.+.--
T Consensus 186 tDFGFAK~v~~----rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-- 258 (355)
T KOG0616|consen 186 TDFGFAKRVSG----RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-- 258 (355)
T ss_pred EeccceEEecC----cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--
Confidence 99999988653 3567899999999999986 7899999999999999999999999999999999999966321
Q ss_pred CCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 014871 165 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWTD 232 (417)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~~ 232 (417)
.++..++.+++|||+++|+.|-.+|. ...||.+|+||...
T Consensus 259 ----------------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 259 ----------------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred ----------------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 22345888999999999999999994 56899999999653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=332.19 Aligned_cols=197 Identities=29% Similarity=0.537 Sum_probs=170.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.|-+++.+|+|||||++ +|.+.+... .|+|.+|+.|++++|.||+|||.+||+|||||.+|||++.+|++
T Consensus 331 NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~v 408 (550)
T KOG0578|consen 331 NIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSV 408 (550)
T ss_pred HHHHHHHHhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcE
Confidence 789999999999999999999996 555555433 49999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|..+..... ...+.+||+.|||||++.. ..|++++||||||++++||+-|.+||-.++...-+..|... +
T Consensus 409 KltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g 485 (550)
T KOG0578|consen 409 KLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G 485 (550)
T ss_pred EEeeeeeeeccccccC-ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-C
Confidence 9999999988775443 5667899999999999986 78999999999999999999999999988887777776432 2
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+.- .....++..++|||.+||..|+++|++|.|||+|+||..
T Consensus 486 ~P~l--------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 486 TPKL--------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CCCc--------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 2211 123458899999999999999999999999999999943
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=317.65 Aligned_cols=226 Identities=34% Similarity=0.588 Sum_probs=186.4
Q ss_pred ccEeecccCceecC-----eEEEEEcCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 3 CTFLETTDGNKYRG-----STYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 3 cniv~~~~~~~~~~-----~~yiV~Ey~~g~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
+|||++...|.... .+.+|||||..+|...+.. .+.+++.-.|+-|+.||+.||.|||+.||+||||||.||
T Consensus 77 pNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNl 156 (364)
T KOG0658|consen 77 PNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNL 156 (364)
T ss_pred cCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheE
Confidence 68888886665443 3468999999999888774 456799999999999999999999999999999999999
Q ss_pred EEcCC-CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 75 LIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 75 Ll~~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
|+|.+ +.+||||||.|+.+... ....++.+|+.|+|||.+++.+.|+.+.||||.|||+.||+.|++.|++++..++
T Consensus 157 LvD~~tg~LKicDFGSAK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ 234 (364)
T KOG0658|consen 157 LVDPDTGVLKICDFGSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ 234 (364)
T ss_pred EEcCCCCeEEeccCCcceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH
Confidence 99976 88999999999987643 3346788999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHH-hhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+..|.+++|.|.........- .|.+++-..-....+.+ +....+.++.||+.++|..+|++|.++.|+|.|+||.+-
T Consensus 235 L~eIik~lG~Pt~e~I~~mn~--~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 235 LVEIIKVLGTPTREDIKSMNP--NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HHHHHHHhCCCCHHHHhhcCc--ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 999999999987654332221 11122211111222222 456788999999999999999999999999999999543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.34 Aligned_cols=202 Identities=30% Similarity=0.509 Sum_probs=168.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||++|..|.++.++||||||+.| |+..++.+.+ .|++..++.|+.+++.||+.||+.|+|||||||+|+|||..|++
T Consensus 202 ~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 202 WVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred cEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCE
Confidence 589999999999999999999985 6666777665 59999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCC--------------------C--C-----c-------------------ccccccccCCCCchhh
Q 014871 83 KLADFGLARSFSYDH--------------------N--N-----T-------------------LTNRVITLWYRPPELL 116 (417)
Q Consensus 83 kL~DFGla~~~~~~~--------------------~--~-----~-------------------~~~~~gt~~y~aPE~l 116 (417)
||+|||||+-+.... . . . ....+||+.||||||+
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 999999985322100 0 0 0 0134899999999999
Q ss_pred cCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh
Q 014871 117 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196 (417)
Q Consensus 117 ~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (417)
++ ..|+..+|+||||||+||||.|.+||.+.+..++.++|+. |...-..|. -.
T Consensus 361 l~-kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP~-----------------~~ 413 (550)
T KOG0605|consen 361 LG-KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFPE-----------------EV 413 (550)
T ss_pred hc-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCCC-----------------cC
Confidence 98 5699999999999999999999999999999999999975 111111110 01
Q ss_pred hhhHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 014871 197 HFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWTDPL 234 (417)
Q Consensus 197 ~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~h~~f~~~~~ 234 (417)
.++.+++|||.+||. ||++|.. ++||.+||||+....
T Consensus 414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 414 DLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred cccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 256799999999999 9999984 899999999976543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=314.61 Aligned_cols=229 Identities=40% Similarity=0.720 Sum_probs=184.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+.....+||||||+.+++.+.+.+....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 63 ~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 142 (303)
T cd07869 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGEL 142 (303)
T ss_pred CCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 47888899999999999999999999998887766679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-EAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-~~~~~~~i~~~~ 161 (417)
||+|||+++..... ........+|..|+|||++.+...++.++||||||||+|||++|+.||.+.. ..+.+..+....
T Consensus 143 kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 221 (303)
T cd07869 143 KLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221 (303)
T ss_pred EECCCCcceeccCC-CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 99999998754322 2223445679999999998765668899999999999999999999998754 456677777777
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh--hhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+.+....|+.....+.+............+...+. .++..+++||++||+.||++|+|+.|+|+|+||...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 222 GTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred CCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 77777777766554443222111111122222222 245789999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=299.41 Aligned_cols=198 Identities=27% Similarity=0.443 Sum_probs=173.9
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
+||++.|.|+.+..+++|+|+|..+.++........++|++.+++|+||+++++|||.++||||||||+|||+|++.++|
T Consensus 84 ~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 84 YIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred cEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceE
Confidence 68999999999999999999998665555555556799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
|+|||+|+.+. ....+...|||+.|+|||.+.. ...|+..+|+|++|||+|.||.|.+||......-+++.|.
T Consensus 164 isDFGFa~~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 164 ISDFGFACQLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred EeccceeeccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 99999999875 3456778899999999999864 2357889999999999999999999999888888888887
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+--..+....| .+++..++|||.+||+.||.+|+|++|+|.||||
T Consensus 242 eGkyqF~speW--------------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 242 EGKYQFRSPEW--------------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred hcccccCCcch--------------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 75444444333 3567789999999999999999999999999999
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=309.26 Aligned_cols=225 Identities=36% Similarity=0.663 Sum_probs=177.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.++.++.+||||||+.++++..+.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~k 140 (287)
T cd07848 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLK 140 (287)
T ss_pred cccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEE
Confidence 68889999999999999999999988887776556799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+++..............+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.+..+.
T Consensus 141 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07848 141 LCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP 219 (287)
T ss_pred EeeccCcccccccccccccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence 99999998765433333344578999999999976 56899999999999999999999999998888877777666555
Q ss_pred CCCCCCCCCCCCCccccCC--CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFK--PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.....+......+.+.... ...............++.++++||++||..||++|+|++++|+|+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 4332222111111111000 00000111223344578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=279.88 Aligned_cols=227 Identities=41% Similarity=0.773 Sum_probs=206.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-|||+.++.-..++.+-+|+|||+.+|-.++..-+..+....++.++.|++.||.|||+++|+||||||.|+||+.+|++
T Consensus 61 knivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngel 140 (292)
T KOG0662|consen 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGEL 140 (292)
T ss_pred cceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcE
Confidence 48999999999999999999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+|+.+.-. ..-.+..+.|+||++|.++++.+-|+.+.|+||.|||+.|+.. |++.|++.+-.+++.+|+.++
T Consensus 141 kladfglarafgip-vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l 219 (292)
T KOG0662|consen 141 KLADFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_pred EecccchhhhcCCc-eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh
Confidence 99999999987632 2234456779999999999998889999999999999999996 999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.+.+..|+...+++.|..+-. ......+.++...++..-+||++++|..+|.+|++++++|+|+||..
T Consensus 220 g~p~ed~wps~t~lpdyk~yp~-ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 220 GTPTEDQWPSMTKLPDYKPYPI-YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCCccccCCccccCCCCcccCC-ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 9999999999999998875532 23345567777888889999999999999999999999999999954
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=310.96 Aligned_cols=229 Identities=40% Similarity=0.768 Sum_probs=188.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+..+++.||||||+++++...+......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 64 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~ 143 (309)
T cd07872 64 ANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGEL 143 (309)
T ss_pred CCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 37889999999999999999999999988887766679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++...... .......+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+
T Consensus 144 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 222 (309)
T cd07872 144 KLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG 222 (309)
T ss_pred EECccccceecCCCc-cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999997643222 2223446789999999987656789999999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+....|+.......+.++................++.++++||++||..||.+|+|+.|+|+|+||...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 8888877766543322222111111111222334578899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=310.55 Aligned_cols=203 Identities=29% Similarity=0.481 Sum_probs=161.5
Q ss_pred ccEeecccCceecC--eEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-
Q 014871 3 CTFLETTDGNKYRG--STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~--~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~- 78 (417)
.|||+++....... .++|+|||+.+ +|.+++.+.+..|++..|+++.+|||+||+|||++||||||||++||||+.
T Consensus 74 p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~ 153 (313)
T KOG0198|consen 74 PNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS 153 (313)
T ss_pred CCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC
Confidence 57889888755555 59999999985 777777765547999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccC--CCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-ChHHHHH
Q 014871 79 EGNLKLADFGLARSFSY--DHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLS 155 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~-~~~~~~~ 155 (417)
++.+||+|||+++.... ..........||+.|||||++........++|||||||+++||+||+.||... ...+.+-
T Consensus 154 ~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~ 233 (313)
T KOG0198|consen 154 NGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL 233 (313)
T ss_pred CCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH
Confidence 68999999999987663 22233445788999999999985222345999999999999999999999864 2222222
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
.+.. .. ....+...++.++++||++||..||++||||+++|+|+|.....
T Consensus 234 ~ig~---~~-------------------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 234 LIGR---ED-------------------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHhc---cC-------------------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 2211 10 01123345888999999999999999999999999999996543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=307.82 Aligned_cols=200 Identities=29% Similarity=0.484 Sum_probs=171.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--- 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~--- 79 (417)
|||+++|+.+.++++|||||||+ |||.+++.+.+ +++|+.++.++.||+.||++||+++||||||||.||||+..
T Consensus 70 nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~ 148 (429)
T KOG0595|consen 70 NIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARN 148 (429)
T ss_pred ceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCC
Confidence 89999999999999999999999 56666666554 79999999999999999999999999999999999999865
Q ss_pred ---CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 80 ---GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 80 ---~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
-.+||+|||+|+... ......+.+|++.|||||++.. ..|+.|+|+||+|+|||+|++|+.||...+..+.+..
T Consensus 149 ~~~~~LKIADFGfAR~L~--~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~ 225 (429)
T KOG0595|consen 149 DTSPVLKIADFGFARFLQ--PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY 225 (429)
T ss_pred CCCceEEecccchhhhCC--chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence 358999999999876 3445667899999999999974 6899999999999999999999999999999988876
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
+.... ..+..+...++..+.+|+..+|..++.+|.+..+-+.|++.+..+.
T Consensus 226 ~~k~~---------------------------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 226 IKKGN---------------------------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred Hhccc---------------------------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence 64311 1112223345667789999999999999999999999999987663
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=303.16 Aligned_cols=220 Identities=40% Similarity=0.705 Sum_probs=179.3
Q ss_pred cEeecccCce-----ecCeEEEEEcCCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNK-----YRGSTYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~-----~~~~~yiV~Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+. ....+||||||+.++|..++... ...+++.+++.++.||+.||+|||+++|+||||||+|||++
T Consensus 65 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~ 144 (290)
T cd07862 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 144 (290)
T ss_pred CcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc
Confidence 6777776653 34568999999999988887653 34589999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... .......+|..|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+
T Consensus 145 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i 221 (290)
T cd07862 145 SSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 221 (290)
T ss_pred CCCCEEEccccceEeccCC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 9999999999999765432 23344567999999999876 57899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+..+.+....|+.....+... + ..........+...++..+++||.+||+.||++|||+.++|+|+||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 222 LDVIGLPGEEDWPRDVALPRQA-F--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHhCCCChhhchhhhcccchh-c--cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 9888877666665543322111 0 0111223344455688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=323.71 Aligned_cols=195 Identities=27% Similarity=0.463 Sum_probs=170.3
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKL 84 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL 84 (417)
++.++.+|..+.++|+||||+.|+.+..+.+. ..|++..++.|+..|+.||.|||++||||||||.+|||||.+|.+||
T Consensus 431 L~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~-~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 431 LVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT-DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred EeecccccccCCeEEEEEEecCCCcEEEEEec-ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEe
Confidence 46788999999999999999998664444443 46999999999999999999999999999999999999999999999
Q ss_pred eeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 014871 85 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 164 (417)
Q Consensus 85 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~ 164 (417)
+|||+++..-.. ....++.+||+.|||||++.+ ..|+.++|.|||||+|||||.|..||+++++.++.+.|+..
T Consensus 510 ADFGlcKe~m~~-g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d---- 583 (694)
T KOG0694|consen 510 ADFGLCKEGMGQ-GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND---- 583 (694)
T ss_pred cccccccccCCC-CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----
Confidence 999999875533 336678899999999999987 68999999999999999999999999999999999999652
Q ss_pred CCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 014871 165 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWTD 232 (417)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~~ 232 (417)
+.. .+..++.++.++|+++|.+||++|.. +.+|..||||+..
T Consensus 584 -~~~-------------------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 584 -EVR-------------------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred -CCC-------------------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 111 12347889999999999999999985 5899999999654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=316.95 Aligned_cols=196 Identities=30% Similarity=0.504 Sum_probs=172.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||++++.|+...++|+|+|||.|+|..++.. +..|+|+.++.+..|++.||.|||+++|+|||+||.||||+..+.+|
T Consensus 62 niv~m~esfEt~~~~~vVte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~K 140 (808)
T KOG0597|consen 62 NIVEMLESFETSAHLWVVTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLK 140 (808)
T ss_pred chhhHHHhhcccceEEEEehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCcee
Confidence 89999999999999999999999977766655 45699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|||||+|+.... ....++...||+.|||||++.+ ..|+..+|+||||||+|||+.|++||...+-..+...|...
T Consensus 141 lcdFg~Ar~m~~-~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--- 215 (808)
T KOG0597|consen 141 LCDFGLARAMST-NTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--- 215 (808)
T ss_pred echhhhhhhccc-CceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---
Confidence 999999998764 3345566788999999999985 78999999999999999999999999988877777777541
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+..|+ .+++..++.||+.+|.+||.+|+|..+++.|+|++..
T Consensus 216 --~v~~p-------------------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 216 --PVKPP-------------------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred --CCCCc-------------------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 22222 2477899999999999999999999999999998654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.84 Aligned_cols=240 Identities=46% Similarity=0.864 Sum_probs=197.3
Q ss_pred cEeecccCceec--CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|++++++.+... +.+||||||++++|.+++......+++.++..++.||+.||+|||+++++||||||+|||+++++.
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~ 146 (309)
T cd07845 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC 146 (309)
T ss_pred CCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 566667666544 568999999999988888765567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... ........+..|+|||++.+...++.++|||||||++|||++|+.||.+.+..+.+..+.+.+
T Consensus 147 ~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~ 225 (309)
T cd07845 147 LKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL 225 (309)
T ss_pred EEECccceeeecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999998764322 222333457889999998765668999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 241 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~~~~~ 241 (417)
+.+....|+.....+.+..+.........+...+..++.++++||.+||..||++|+|++|+|+|+||....+++.+..+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~ 305 (309)
T cd07845 226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMM 305 (309)
T ss_pred CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcC
Confidence 98888888776665544433322222223344445578899999999999999999999999999999999998887776
Q ss_pred CCC
Q 014871 242 PKY 244 (417)
Q Consensus 242 ~~~ 244 (417)
+.+
T Consensus 306 ~~~ 308 (309)
T cd07845 306 PTF 308 (309)
T ss_pred CCC
Confidence 654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.20 Aligned_cols=228 Identities=41% Similarity=0.766 Sum_probs=187.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+...+.+||||||+.++|...+.+....+++..++.++.||+.||+|||+++|+|+||||+|||++.++.+
T Consensus 64 ~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~ 143 (301)
T cd07873 64 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGEL 143 (301)
T ss_pred CCcceEEEEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcE
Confidence 48899999999999999999999999988887766679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++....... .......++..|+|||++.+...++.++|||||||++|||++|+.||...+..+.+..+.....
T Consensus 144 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~ 222 (301)
T cd07873 144 KLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222 (301)
T ss_pred EECcCcchhccCCCC-CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999999997643222 2223345688999999987656688999999999999999999999999998888888888888
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+....|+.......+..+................++..+++||.+||..||.+|+|++|+|+|+||..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred CCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 877777766544332222222111122223344567889999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=302.32 Aligned_cols=227 Identities=35% Similarity=0.678 Sum_probs=172.5
Q ss_pred ccEeecccCcee--cCeEEEEEcCCCCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 3 CTFLETTDGNKY--RGSTYMVFEYMDHDLTGLADRP--------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 3 cniv~~~~~~~~--~~~~yiV~Ey~~g~l~~~~~~~--------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
.|||++++.+.. ...+||||||+++++..++... ...+++.+++.++.||+.||+|||+++|+||||||+
T Consensus 58 ~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~ 137 (317)
T cd07868 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA 137 (317)
T ss_pred CCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHH
Confidence 367788777643 4578999999999988776421 235899999999999999999999999999999999
Q ss_pred cEEE----cCCCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 014871 73 NLLI----DNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP 146 (417)
Q Consensus 73 NILl----~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~ 146 (417)
|||+ +.++.+||+|||+|+.+..... ......++|..|+|||++.+...++.++||||||||+|||++|++||.
T Consensus 138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred HEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 4557899999999987543221 223345779999999999875678999999999999999999999997
Q ss_pred CCCh---------HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCC--------chhhhhhHHHhhhhhhHHHHHHHHHh
Q 014871 147 GKNE---------AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP--------SRTMKRRVREVFRHFDRHALELLEKM 209 (417)
Q Consensus 147 ~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~Li~~~ 209 (417)
...+ .+++..+++..+.+....|.....++....... ...............+.++++||++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 297 (317)
T cd07868 218 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 297 (317)
T ss_pred CCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHH
Confidence 6543 356778888888877777766554433211100 00000111111123456789999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 014871 210 LMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 210 L~~dP~~Rpta~elL~h~~f 229 (417)
|..||++|+|++|+|+||||
T Consensus 298 L~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 298 LTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=296.14 Aligned_cols=225 Identities=43% Similarity=0.768 Sum_probs=184.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+...+.+|||+||++++++..+.+....+++.+++.++.||+.||+|||+++|+||||||+|||++.++++
T Consensus 59 ~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~ 138 (284)
T cd07839 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGEL 138 (284)
T ss_pred CCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcE
Confidence 47899999999999999999999999988887666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~p-f~~~~~~~~~~~i~~~~ 161 (417)
||+|||+++...... .......++..|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+...+
T Consensus 139 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
T cd07839 139 KLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 217 (284)
T ss_pred EECccchhhccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHh
Confidence 999999997654221 2223445688999999987755678999999999999999998766 56677777888888888
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+.++...|+.....+.+..+.. ......+.+....++.++++||++||..||.+|||++++++|+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 218 GTPTEESWPGVSKLPDYKPYPM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCChHHhHHhhhcccccccCC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 8777776765555444322211 111222344456688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=293.52 Aligned_cols=221 Identities=42% Similarity=0.704 Sum_probs=178.7
Q ss_pred ccEeecccCcee-----cCeEEEEEcCCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKY-----RGSTYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~-----~~~~yiV~Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
-||+++++.+.. ...+|+||||+.+++..++.+. ...+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 62 ~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred CCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 367888876654 3468999999999888877653 3359999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+.++.+||+|||+++..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+++|...+..+.+.+
T Consensus 142 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (288)
T cd07863 142 TSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218 (288)
T ss_pred CCCCCEEECccCccccccCc--ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence 99999999999999765422 12234567899999999976 5689999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+....+.+....|+.....+... +. .............++..+++||.+||..||++|+|+.|+++|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 219 IFDLIGLPPEDDWPRDVTLPRGA-FS--PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHhCCCChhhCcccccccccc-cC--CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 98888777666665443322110 10 111223445556688899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=298.75 Aligned_cols=222 Identities=25% Similarity=0.424 Sum_probs=173.6
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-----
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN----- 78 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~----- 78 (417)
+|.+.++|.+++++|||+|.++-++.+++..++ ..|+...|+.+.+|||++++|||+++++|-||||||||+.+
T Consensus 153 cv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 466779999999999999999989999888754 46999999999999999999999999999999999999842
Q ss_pred ---------------CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCC
Q 014871 79 ---------------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143 (417)
Q Consensus 79 ---------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~ 143 (417)
+-.|||+|||.|+...... ...+.|..|+|||++++ ..++..+||||+||||+||.+|..
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccce
Confidence 2248999999998654322 55677999999999998 789999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCC----------------CchhhhhhHHHhhhhhhHHHHHHHH
Q 014871 144 ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK----------------PSRTMKRRVREVFRHFDRHALELLE 207 (417)
Q Consensus 144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~Li~ 207 (417)
+|...++.+.++.+..+++.++........+...+...+ .............+.....+.|||+
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 999999999888888888865544333221111111000 0000011111111223456889999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCC
Q 014871 208 KMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 208 ~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+||..||.+|+|+.|+|.||||..
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhc
Confidence 999999999999999999999964
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=302.59 Aligned_cols=230 Identities=37% Similarity=0.583 Sum_probs=173.1
Q ss_pred cEeecccCceec-----CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYR-----GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~-----~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
||+++++++... .++|||||||+++|...+.+.. .+++.+++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 60 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~ 138 (338)
T cd07859 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA 138 (338)
T ss_pred CEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 677777665432 3589999999999888776543 5999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
++.+||+|||+++....... ......++|..|+|||++.+. ..++.++||||||||+|||++|+.||.+.+...++.
T Consensus 139 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~ 218 (338)
T cd07859 139 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218 (338)
T ss_pred CCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence 99999999999976432221 122345789999999988642 468899999999999999999999999999888888
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
.+.+..+.+....+..+........+. ............+..++..+.+||.+||..||++|||++|+|+|+||.....
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 219 LITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 877777665544332221100000000 0000001122233456788999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=303.87 Aligned_cols=201 Identities=27% Similarity=0.410 Sum_probs=165.3
Q ss_pred cEeecccCcee--cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKY--RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~--~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||+++++..+ ..++|||+|||..+.....-.....|++.+++.|++.++.||+|||.+|||||||||+|+||+++|+
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 66777755543 3479999999997655444433334999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccC----CCCCcccccccccCCCCchhhcC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 014871 82 LKLADFGLARSFSY----DHNNTLTNRVITLWYRPPELLLG---ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154 (417)
Q Consensus 82 vkL~DFGla~~~~~----~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~ 154 (417)
|||+|||.+..+.. .....+...+||+.|+|||.+.. ....+.+.|||||||+||.|+.|+.||.+....++.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999986632 22234455789999999999876 234578999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+|++..-.+.+ ...+.++++|||++||.+||++|+++.||..|+|....
T Consensus 329 ~KIvn~pL~fP~----------------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 DKIVNDPLEFPE----------------------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhcCcccCCC----------------------------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999763222211 11366789999999999999999999999999999654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=289.18 Aligned_cols=186 Identities=27% Similarity=0.406 Sum_probs=158.1
Q ss_pred cEeeccc-CceecCe-EEEEEcCCC-CCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCc
Q 014871 4 TFLETTD-GNKYRGS-TYMVFEYMD-HDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHV--NQ--VLHRDIKGSN 73 (417)
Q Consensus 4 niv~~~~-~~~~~~~-~yiV~Ey~~-g~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~--~g--ivHrDlkp~N 73 (417)
|||+++. .|..++. ++||||||+ |||...+. +..+.++|..|++++.|||.||..||. .. |+||||||.|
T Consensus 79 NIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaN 158 (375)
T KOG0591|consen 79 NIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPAN 158 (375)
T ss_pred hHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchh
Confidence 7788886 5555555 899999998 57777654 355679999999999999999999999 55 9999999999
Q ss_pred EEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 74 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
|+|+.+|.|||.|||+++.++... ....+.+||+.||+||++.+ ..|+.++||||+||++|||+.-++||.+++-.++
T Consensus 159 IFl~~~gvvKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L 236 (375)
T KOG0591|consen 159 IFLTANGVVKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL 236 (375)
T ss_pred eEEcCCCceeeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH
Confidence 999999999999999999887433 34456899999999999986 6899999999999999999999999999998888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhh-hhhhHHHHHHHHHhcccCCCCCCCH
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISA 220 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Li~~~L~~dP~~Rpta 220 (417)
..+|.+....+ ++ ..+|.++..||..||..|++.||+.
T Consensus 237 ~~KI~qgd~~~-----------------------------~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 237 CKKIEQGDYPP-----------------------------LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHcCCCCC-----------------------------CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 88886532211 12 4588899999999999999999984
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.02 Aligned_cols=196 Identities=26% Similarity=0.399 Sum_probs=162.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+...+++||||||+.++ |...+. ....+++.+++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 55 p~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~ 133 (323)
T cd05571 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH 133 (323)
T ss_pred CCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC
Confidence 36788888999999999999999864 544444 4456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++..... .......++|..|+|||++.+ ..++.++||||||||+|||++|+.||...+.......+....
T Consensus 134 ~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05571 134 IKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211 (323)
T ss_pred EEEeeCCCCcccccC-CCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998753321 222334578999999999876 578999999999999999999999998887766665553210
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
. .+...++.++++||++||..||++|+ ++.+|++|+||..
T Consensus 212 ~------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 212 I------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred C------------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 0 11124677899999999999999999 8999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.77 Aligned_cols=203 Identities=30% Similarity=0.456 Sum_probs=175.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-- 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-- 79 (417)
-|||.+++.|+.+..+|||||+|.| .|++.+.+. .++|..+..+++||+.+|+|||+.||+||||||+|||+...
T Consensus 96 pniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 96 PNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDE 173 (382)
T ss_pred CCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccC
Confidence 3899999999999999999999996 455555544 49999999999999999999999999999999999999654
Q ss_pred --CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 80 --GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 80 --~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+.+|++|||+|..... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.++......|
T Consensus 174 ~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i 250 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI 250 (382)
T ss_pred CCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH
Confidence 3699999999988764 556778899999999999985 68999999999999999999999999999998888888
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPC 236 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~ 236 (417)
......+....|+ .++..+++||++||..||.+|+|+.++|+|||+.......
T Consensus 251 ~~~~~~f~~~~w~--------------------------~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 251 LRGDFDFTSEPWD--------------------------DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred HcCCCCCCCCCcc--------------------------ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 6655444544444 4667999999999999999999999999999997654433
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=295.17 Aligned_cols=201 Identities=28% Similarity=0.436 Sum_probs=166.4
Q ss_pred EeecccCceecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+..+|..|+.+..+|+|||||.| +|..++.+ .++.|+++.++.|+..|+.||+|||-.|||+||||||||||.++|+|
T Consensus 139 lPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 139 LPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHI 218 (459)
T ss_pred cchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcE
Confidence 34678899999999999999986 55555543 56679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccC---------------------------------C-C---------------------CCcccccccc
Q 014871 83 KLADFGLARSFSY---------------------------------D-H---------------------NNTLTNRVIT 107 (417)
Q Consensus 83 kL~DFGla~~~~~---------------------------------~-~---------------------~~~~~~~~gt 107 (417)
.|+||.|+..... . . .......|||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT 298 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT 298 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence 9999998743210 0 0 0111235789
Q ss_pred cCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhh
Q 014871 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 187 (417)
Q Consensus 108 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (417)
-.|+|||++.+ ...+.++|+|+|||+|||||+|..||.+.+..+++..|+...-.+...
T Consensus 299 hEYlAPEvI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~-------------------- 357 (459)
T KOG0610|consen 299 HEYLAPEVIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE-------------------- 357 (459)
T ss_pred cccccceeeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--------------------
Confidence 99999999998 568999999999999999999999999999999998886532221111
Q ss_pred hhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCCC
Q 014871 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRIS----AKDALDSEYFWTDPL 234 (417)
Q Consensus 188 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt----a~elL~h~~f~~~~~ 234 (417)
..++..++|||+++|.+||++|+. |.||.+|+||....+
T Consensus 358 --------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 358 --------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred --------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 136679999999999999999998 999999999976544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=283.79 Aligned_cols=200 Identities=27% Similarity=0.356 Sum_probs=161.2
Q ss_pred cEeecccCce----ecCeEEEEEcCCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNK----YRGSTYMVFEYMDHDLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~----~~~~~yiV~Ey~~g~l~~~~~~--~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
|||.++|+|+ ....+.||||.|+|+.++..+. .+..|+|.++..|++||+.||.|||+.+|.||||||||+|..
T Consensus 116 ~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt 195 (400)
T KOG0604|consen 116 HIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYT 195 (400)
T ss_pred ceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeee
Confidence 5666665544 4567889999999876665443 344599999999999999999999999999999999999986
Q ss_pred CC---CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh----
Q 014871 78 NE---GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---- 150 (417)
Q Consensus 78 ~~---~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~---- 150 (417)
.. ..+||+|||+|+.... ...+.+.+.|+.|.|||++.. .+|+..+|+||+|||+|.||||.+||.+..-
T Consensus 196 ~t~~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais 272 (400)
T KOG0604|consen 196 TTSPNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272 (400)
T ss_pred cCCCCcceEecccccccccCC--CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCC
Confidence 54 3599999999987542 345667788999999998864 6799999999999999999999999987543
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
..+-++|..-...+++.. |..+|++++|||+++|..+|++|.|+.++++|+|+.
T Consensus 273 pgMk~rI~~gqy~FP~pE--------------------------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPE--------------------------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred hhHHhHhhccCccCCChh--------------------------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 334455544333333333 345788999999999999999999999999999996
Q ss_pred CC
Q 014871 231 TD 232 (417)
Q Consensus 231 ~~ 232 (417)
..
T Consensus 327 ~~ 328 (400)
T KOG0604|consen 327 QY 328 (400)
T ss_pred cc
Confidence 54
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=292.99 Aligned_cols=227 Identities=44% Similarity=0.793 Sum_probs=190.7
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+...+.+|+||||+.++|.+++......+++.+++.++.||+.+|+|||+++|+|+||||+||+++.++.++
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~ 139 (286)
T cd07832 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLK 139 (286)
T ss_pred CCcceeeEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEE
Confidence 57888888888999999999997788888776666799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||++...............++..|+|||++.+...++.++|||||||++|||++|.++|.+.++.+.+..+....+.
T Consensus 140 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~ 219 (286)
T cd07832 140 IADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT 219 (286)
T ss_pred EeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCC
Confidence 99999998765443333445577899999999876556789999999999999999999999999999999999888888
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+....|+....+..+............+...+...+.++++||++||..||++|+|++++|+|+||.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 8777777666555444333322223334555667789999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=308.73 Aligned_cols=228 Identities=35% Similarity=0.551 Sum_probs=177.8
Q ss_pred cEeecccCceecC-----eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYRG-----STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~~-----~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
||+++++.+...+ ++||||||+.++|...+... ..|++.+++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 60 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~ 138 (372)
T cd07853 60 NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS 138 (372)
T ss_pred CcCCHhheecCCCccccceEEEEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC
Confidence 6788888877766 89999999999888877654 46999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||+++.............++|..|+|||++.+...++.++||||||||+|||++|+.||.+.+..+++..+.
T Consensus 139 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 139 NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred CCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999999999986543333334445678999999999875668999999999999999999999999999999999998
Q ss_pred HhcCCCCCCCCCCCCCCC-c-cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMP-A-YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+.++.+....+....... . ................+...++.++++||.+||..||++|+|+.|+|+|+||...
T Consensus 219 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 219 DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 887766543221110000 0 0000000000011112234467899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=294.35 Aligned_cols=210 Identities=24% Similarity=0.370 Sum_probs=167.5
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||+++..|.++..+|+||.||. |++++++...- ..|.|..|+.|++++|+||.|||.+|-||||||+.||||+.+|.
T Consensus 85 NIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~ 164 (516)
T KOG0582|consen 85 NIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT 164 (516)
T ss_pred CcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc
Confidence 89999999999999999999998 56666665421 23999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC---cccccccccCCCCchhhcC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
|||+|||.+..+.....+ ...+.++|+.|||||++.. ...|+.|+|||||||+..||.+|..||..-....++-..
T Consensus 165 VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t 244 (516)
T KOG0582|consen 165 VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT 244 (516)
T ss_pred EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999987655432221 1145689999999999543 356999999999999999999999999887776665333
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
. -+.+.... . ...-.+..+.++..++++|..||.+||++||||+++|+|+||+...
T Consensus 245 L--qn~pp~~~---t---------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 245 L--QNDPPTLL---T---------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred h--cCCCCCcc---c---------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 2 22222111 0 0011222345777999999999999999999999999999997653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.17 Aligned_cols=226 Identities=29% Similarity=0.505 Sum_probs=172.2
Q ss_pred ccEeecccCce--------ecCeEEEEEcCCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014871 3 CTFLETTDGNK--------YRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71 (417)
Q Consensus 3 cniv~~~~~~~--------~~~~~yiV~Ey~~g~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp 71 (417)
.|||++++.+. ....+||||||+.+++..++. +....+++..++.++.||+.||+|||+++|+||||||
T Consensus 119 ~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp 198 (440)
T PTZ00036 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKP 198 (440)
T ss_pred CCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCH
Confidence 35666655432 223578999999998877654 3455699999999999999999999999999999999
Q ss_pred CcEEEcCCC-CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 014871 72 SNLLIDNEG-NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150 (417)
Q Consensus 72 ~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 150 (417)
+||||+.++ .+||+|||+|+.+.... .....++|+.|+|||++.+...++.++||||||||||||++|++||.+.+.
T Consensus 199 ~NILl~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred HHEEEcCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999998665 69999999998754322 233457799999999988766799999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHH-HhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR-EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+.+.++.+.++.+....+.... +.|............+. .+....+.++++||.+||..||++|+|+.|+|+|+||
T Consensus 277 ~~~~~~i~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 277 VDQLVRIIQVLGTPTEDQLKEMN--PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhc--hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 99999998887776543322111 11111111100111122 2234567899999999999999999999999999999
Q ss_pred CCC
Q 014871 230 WTD 232 (417)
Q Consensus 230 ~~~ 232 (417)
...
T Consensus 355 ~~~ 357 (440)
T PTZ00036 355 DDL 357 (440)
T ss_pred Hhh
Confidence 653
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.37 Aligned_cols=224 Identities=44% Similarity=0.837 Sum_probs=182.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~--~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+..++.+|+||||+.+++..++... +..+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~ 139 (285)
T cd07861 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV 139 (285)
T ss_pred CEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc
Confidence 789999999999999999999998888877543 256999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++...... ........++..|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+.+..
T Consensus 140 ~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~ 218 (285)
T cd07861 140 IKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRIL 218 (285)
T ss_pred EEECcccceeecCCC-cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 999999998765322 1222334568899999998765667899999999999999999999999998888888888777
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+.+....|+.......+...... ............++.++++||++||..||++|||+.+|++|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 219 GTPTEDVWPGVTSLPDYKNTFPK-WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCCChhhhhcchhhHHHHhhccc-cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 77777777655544333221111 11122233445588999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=301.14 Aligned_cols=201 Identities=24% Similarity=0.383 Sum_probs=159.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+++++.++.++.+||||||+.+ +|...+.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~ 144 (332)
T cd05614 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHV 144 (332)
T ss_pred CcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCE
Confidence 578888899999999999999986 56565544 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.+...........++|..|+|||++.+...++.++||||||||||||++|+.||...........+.....
T Consensus 145 kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 224 (332)
T cd05614 145 VLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224 (332)
T ss_pred EEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh
Confidence 99999999876443333344567899999999998655688999999999999999999999975433222111111100
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
..+ ..+...++..+++||++||..||++|+ +++++++|+||..
T Consensus 225 ~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 225 KCD--------------------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred cCC--------------------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 000 011123677899999999999999999 8899999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=299.63 Aligned_cols=197 Identities=29% Similarity=0.514 Sum_probs=178.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-cCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI-DNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl-~~~~~ 81 (417)
|||++|+.....-.+|||+|+-++ +|.+++.+....|.|+.+++||+||+.|+.|||+..||||||||+||++ ..-|-
T Consensus 78 NiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGl 157 (864)
T KOG4717|consen 78 NIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGL 157 (864)
T ss_pred CeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCc
Confidence 899999999999999999999985 8999999988899999999999999999999999999999999999865 56688
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
|||.|||++..+. ....+++.||++.|-|||++++..+..+++||||||||||.|+||++||...|+.+.+..|+++-
T Consensus 158 VKLTDFGFSNkf~--PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK 235 (864)
T KOG4717|consen 158 VKLTDFGFSNKFQ--PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK 235 (864)
T ss_pred eEeeeccccccCC--CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc
Confidence 9999999997765 44567888999999999999998888899999999999999999999999999999999996632
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
. .+..+++.++++||..||..||.+|.|.++|..++|++..
T Consensus 236 Y------------------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 236 Y------------------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred c------------------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 2 2345688999999999999999999999999999999643
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=299.00 Aligned_cols=196 Identities=24% Similarity=0.427 Sum_probs=164.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++++...+.+||||||+.+ +|...+. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 56 ~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~ 134 (320)
T cd05590 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH 134 (320)
T ss_pred CchhceeeEEEcCCEEEEEEcCCCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc
Confidence 3788899999999999999999986 5554444 3456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+....
T Consensus 135 ~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 135 CKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred EEEeeCCCCeecCcC-CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 999999998764322 222334578999999999875 578999999999999999999999999998887777664311
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta------~elL~h~~f~~ 231 (417)
.. ....++.++++||++||..||++|+++ +++++|+||..
T Consensus 213 ~~------------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 213 VV------------------------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CC------------------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 00 012356789999999999999999998 99999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.93 Aligned_cols=196 Identities=30% Similarity=0.462 Sum_probs=163.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+...+.+||||||+.+ +|.+.+.+ ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 53 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~ 131 (312)
T cd05585 53 PFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH 131 (312)
T ss_pred CcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc
Confidence 3788899999999999999999986 55555544 446999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++...... ......++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+....
T Consensus 132 ~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~ 209 (312)
T cd05585 132 IALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP 209 (312)
T ss_pred EEEEECcccccCccCC-CccccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 9999999997543221 22334578999999999986 578999999999999999999999999888777666654310
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI---SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp---ta~elL~h~~f~~ 231 (417)
. .+...++.++++||.+||..||++|+ ++.++|+|+||..
T Consensus 210 ~------------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 210 L------------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred C------------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 0 11123677899999999999999997 5899999999964
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=302.65 Aligned_cols=230 Identities=25% Similarity=0.326 Sum_probs=170.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.|||++++.+..+...|+|||++.++|...+... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 143 pnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~v 221 (391)
T PHA03212 143 PSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221 (391)
T ss_pred CCCCCEeEEEEECCeeEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCE
Confidence 4789999999999999999999999888777654 358999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-------ChHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-------NEAEQLS 155 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~-------~~~~~~~ 155 (417)
||+|||+|+.............++|+.|+|||++.+ ..++.++||||||||||||++|+.+|... ....++.
T Consensus 222 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~ 300 (391)
T PHA03212 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300 (391)
T ss_pred EEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH
Confidence 999999997543322233345678999999999876 57899999999999999999999776533 2344566
Q ss_pred HHHHhcCCCCCCCCCCCCC-CC-cccc-C--CCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSK-MP-AYNH-F--KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~-~~-~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
.+....+.+.......... +. .+.. . .......+........++.++.+||++||..||++|+|++|+|+|+||.
T Consensus 301 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred HHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 6666655543222110000 00 0000 0 0000000000111123567899999999999999999999999999997
Q ss_pred CCCC
Q 014871 231 TDPL 234 (417)
Q Consensus 231 ~~~~ 234 (417)
..+.
T Consensus 381 ~~~~ 384 (391)
T PHA03212 381 DIPD 384 (391)
T ss_pred cCCC
Confidence 6443
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=294.15 Aligned_cols=226 Identities=36% Similarity=0.707 Sum_probs=171.7
Q ss_pred cEeecccCce--ecCeEEEEEcCCCCCHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 4 TFLETTDGNK--YRGSTYMVFEYMDHDLTGLADR--------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 4 niv~~~~~~~--~~~~~yiV~Ey~~g~l~~~~~~--------~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
|||++++++. .+..+||||||+.+++++.+.. ....+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 59 niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~N 138 (317)
T cd07867 59 NVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPAN 138 (317)
T ss_pred CeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHH
Confidence 6777777663 4567899999999998877642 12248899999999999999999999999999999999
Q ss_pred EEE----cCCCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 014871 74 LLI----DNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG 147 (417)
Q Consensus 74 ILl----~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 147 (417)
||+ +.++.+||+|||+++....... ......++|..|+|||++.+...++.++|||||||++|||++|++||..
T Consensus 139 il~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 139 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred EEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 999 4567899999999987643221 1223456799999999997655689999999999999999999999976
Q ss_pred CCh---------HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCc--------hhhhhhHHHhhhhhhHHHHHHHHHhc
Q 014871 148 KNE---------AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS--------RTMKRRVREVFRHFDRHALELLEKML 210 (417)
Q Consensus 148 ~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~Li~~~L 210 (417)
..+ ..++..+...++.+....|......+.+...... ..............+..+++||.+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 298 (317)
T cd07867 219 RQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298 (317)
T ss_pred ccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHh
Confidence 443 3556777788887777777665554433221110 00011111111234677999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 014871 211 MLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 211 ~~dP~~Rpta~elL~h~~f 229 (417)
..||.+|+|+.|+|+||||
T Consensus 299 ~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 299 TMDPTKRITSEQALQDPYF 317 (317)
T ss_pred ccCcccccCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=297.90 Aligned_cols=195 Identities=26% Similarity=0.453 Sum_probs=161.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+++++.+..++++||||||+.+ +|...+.. ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 57 ~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~ 135 (316)
T cd05620 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHI 135 (316)
T ss_pred CccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCE
Confidence 678888999999999999999986 55555544 4569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.... ........++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+.....
T Consensus 136 kl~Dfg~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (316)
T cd05620 136 KIADFGMCKENVF-GDNRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213 (316)
T ss_pred EeCccCCCeeccc-CCCceeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999999875321 1223344578999999999976 5789999999999999999999999998887776665532110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-KDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-~elL~h~~f~~ 231 (417)
.+...++.++++||++||..||++|+++ +++++|+||..
T Consensus 214 ------------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 214 ------------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 0111256789999999999999999997 58999999955
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.84 Aligned_cols=222 Identities=23% Similarity=0.344 Sum_probs=167.8
Q ss_pred cEeecccCceec-CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCC-
Q 014871 4 TFLETTDGNKYR-GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 4 niv~~~~~~~~~-~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~- 80 (417)
+++++++.+... +++|||||++.++|++++.+.+ .|++.+++.|+.||+.||+|||+ .|||||||||+||||+.++
T Consensus 192 ~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 192 PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred ceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCc
Confidence 356666666543 5789999999999998877653 59999999999999999999998 5999999999999998765
Q ss_pred ---------------CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 014871 81 ---------------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 145 (417)
Q Consensus 81 ---------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf 145 (417)
.+||+|||++.... ......++|..|+|||++.+ ..++.++||||||||||||++|+.||
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999886432 22344678999999999986 57899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCC---Cccc---cCCCchhhhhhHHH------hh-hhhhHHHHHHHHHhccc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKM---PAYN---HFKPSRTMKRRVRE------VF-RHFDRHALELLEKMLML 212 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~~~------~~-~~~~~~~~~Li~~~L~~ 212 (417)
.+.+..+.+..+.+.++.+...++..+... ..+. ...+... ...+.. +. ...+..++|||++||.+
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTD-PKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCC-HHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 999999999888888877654432211100 0000 0000000 000000 00 01256788999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 014871 213 DPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 213 dP~~Rpta~elL~h~~f~~~ 232 (417)
||++|+|++|||+||||...
T Consensus 425 dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 425 DRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred ChhhCCCHHHHhcCcccccc
Confidence 99999999999999999653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.39 Aligned_cols=197 Identities=24% Similarity=0.403 Sum_probs=161.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+..++.+||||||+.++.+.........+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 55 p~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 134 (328)
T cd05593 55 PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHI 134 (328)
T ss_pred CCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcE
Confidence 36788888999999999999999864444344444569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+ ..++.++|||||||+||+|++|+.||...+..+....+....
T Consensus 135 kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~- 211 (328)
T cd05593 135 KITDFGLCKEGITD-AATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED- 211 (328)
T ss_pred EEecCcCCccCCCc-ccccccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-
Confidence 99999998753321 222334568999999999876 578999999999999999999999998877766655542210
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
..+...++.++.+||++||..||++|+ ++.+|++|+||..
T Consensus 212 -----------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 212 -----------------------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred -----------------------------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 011234677899999999999999997 8999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=298.97 Aligned_cols=197 Identities=26% Similarity=0.403 Sum_probs=163.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+..++++||||||+.++.+.........+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 55 p~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 134 (323)
T cd05595 55 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHI 134 (323)
T ss_pred CCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCE
Confidence 47888999999999999999999865444444444569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+.....
T Consensus 135 kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~ 212 (323)
T cd05595 135 KITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 212 (323)
T ss_pred EecccHHhccccCC-CCccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999998753221 222334568999999999876 5789999999999999999999999988877766665532110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
.+...++.++++||++||..||++|+ ++.++++|+||..
T Consensus 213 ------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 213 ------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 01124677899999999999999998 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=288.51 Aligned_cols=226 Identities=43% Similarity=0.788 Sum_probs=183.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+..+++.||||||+.++|...+.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 63 ~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~ 142 (291)
T cd07844 63 ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGEL 142 (291)
T ss_pred cceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCE
Confidence 57899999999999999999999999988887665579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-EAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-~~~~~~~i~~~~ 161 (417)
||+|||+++....... ......++..|+|||++.+...++.++|||||||++|+|++|+.+|.... ..+.+..+.+..
T Consensus 143 kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 221 (291)
T cd07844 143 KLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221 (291)
T ss_pred EECccccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhc
Confidence 9999999875432211 12223457889999998765568899999999999999999999998766 567777788888
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhh--HHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFD--RHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+.+....|........+...................++ .++.+||.+||..||++|||+.++|+|+||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88777777766655444333222111222333333455 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.30 Aligned_cols=193 Identities=25% Similarity=0.411 Sum_probs=162.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+..++.+||||||+.+ +|.+.+.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 78 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~ 156 (329)
T PTZ00263 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH 156 (329)
T ss_pred CCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC
Confidence 3788999999999999999999986 55555554 446999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++..... ....++|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.+..
T Consensus 157 ~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 231 (329)
T PTZ00263 157 VKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231 (329)
T ss_pred EEEeeccCceEcCCC----cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence 999999999865422 223568999999999976 568999999999999999999999999888777666664311
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
. .+...++..+++||++||..||++|++ +++|++|+||..
T Consensus 232 --~----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 232 --L----------------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred --c----------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 0 011125678899999999999999997 799999999954
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.74 Aligned_cols=192 Identities=28% Similarity=0.432 Sum_probs=162.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+..++++||||||+.+ +|.+++.+ ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 62 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~ 140 (291)
T cd05612 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHI 140 (291)
T ss_pred cHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCE
Confidence 688889999999999999999985 56665554 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... ....++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....-
T Consensus 141 kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 215 (291)
T cd05612 141 KLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL 215 (291)
T ss_pred EEEecCcchhccCC----cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Confidence 99999999765422 223568999999999876 5689999999999999999999999999888777766643110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
.+...++..+++||++||..||.+|++ ++|+++|+||..
T Consensus 216 ------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 216 ------------------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred ------------------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 011235678999999999999999995 999999999954
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=297.30 Aligned_cols=196 Identities=26% Similarity=0.430 Sum_probs=163.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+|++++++++.++++||||||+.+ +|...+. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 56 p~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~ 134 (321)
T cd05591 56 PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH 134 (321)
T ss_pred CCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC
Confidence 4688899999999999999999986 5544444 3456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+....
T Consensus 135 ~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 135 CKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred EEEeecccceecccC-CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998754322 222334568999999999875 578999999999999999999999999999888877764311
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-------CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-------SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-------ta~elL~h~~f~~ 231 (417)
.. ....++.++++||++||..||++|+ ++.++++|+||..
T Consensus 213 ~~------------------------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 213 VL------------------------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CC------------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 00 0112567899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=296.17 Aligned_cols=196 Identities=27% Similarity=0.458 Sum_probs=162.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++..+++||||||+.+ +|...+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 56 p~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~ 134 (316)
T cd05592 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH 134 (316)
T ss_pred CCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC
Confidence 3788889999999999999999986 55544443 446999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++...... ......++|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 135 ~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05592 135 IKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR 212 (316)
T ss_pred EEEccCcCCeECCCCC-CccccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999997643222 23344578999999999976 568999999999999999999999999988877776653311
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH-HHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-KDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-~elL~h~~f~~ 231 (417)
.. +...++.++.+||++||..||++|+++ .++++|+||..
T Consensus 213 ~~------------------------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 213 PH------------------------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred CC------------------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 00 112356788999999999999999986 58899999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=299.73 Aligned_cols=222 Identities=32% Similarity=0.547 Sum_probs=167.2
Q ss_pred cEeecccCceecC------eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~------~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+...+ .+||||||+++++...+.. .+++.++..++.||+.||+|||+++|+||||||+||||+
T Consensus 81 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~ 157 (359)
T cd07876 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 157 (359)
T ss_pred CEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 6777877765443 5799999999998877643 489999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... ........+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 158 ~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~ 234 (359)
T cd07876 158 SDCTLKILDFGLARTACT--NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 234 (359)
T ss_pred CCCCEEEecCCCcccccc--CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999976432 222334577999999999976 57899999999999999999999999998888887777
Q ss_pred HHhcCCCCCCCCCCCCC--------CCccccCCCchh----hhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSK--------MPAYNHFKPSRT----MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+..+.+....+..... .+.+........ ............+..+++||.+||..||++|+|+.|+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 77666554322211100 000000000000 000000111234678999999999999999999999999
Q ss_pred CCCCCC
Q 014871 226 SEYFWT 231 (417)
Q Consensus 226 h~~f~~ 231 (417)
|+||..
T Consensus 315 hp~~~~ 320 (359)
T cd07876 315 HPYITV 320 (359)
T ss_pred Cchhhh
Confidence 999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.55 Aligned_cols=197 Identities=24% Similarity=0.360 Sum_probs=162.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+++++.++..+++||||||+.+ +|...+. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~ 135 (330)
T cd05586 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHI 135 (330)
T ss_pred cCcceEEEEecCCeEEEEEcCCCCChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE
Confidence 577888889999999999999986 5555554 34569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+...++.++||||||||+|+|++|+.||...+..+.+..+.....
T Consensus 136 kl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 214 (330)
T cd05586 136 ALCDFGLSKANLTD-NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214 (330)
T ss_pred EEecCCcCcCCCCC-CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999998754322 22233457899999999997655689999999999999999999999998887776666532110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp----ta~elL~h~~f~~ 231 (417)
.. + ...++.++++||++||..||.+|+ ++.++++|+||..
T Consensus 215 ~~-----------~------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 215 RF-----------P------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CC-----------C------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 00 0 012577899999999999999998 7999999999964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.15 Aligned_cols=231 Identities=47% Similarity=0.840 Sum_probs=189.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+...+.+||||||+.++|..++.+....+++.++..++.||++||+|||+++|+|+||||+|||++.++.+|
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 63 NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred CChhhhheeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEE
Confidence 68888899999999999999997788887766554699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+++...... ........+..|+|||.+.+...++.++||||||||+|||++|.++|.+.+..+.+.++......
T Consensus 143 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~ 221 (298)
T cd07841 143 LADFGLARSFGSPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT 221 (298)
T ss_pred EccceeeeeccCCC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCC
Confidence 99999997764322 22233355788999999876566889999999999999999999999998888888888888777
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 237 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~ 237 (417)
+....|+.......+...... ........+...+.++++||.+||..||++|+|+.|+|+|+||...+.+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 222 PTEENWPGVTSLPDYVEFKPF--PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred Cchhhhhhccccccccccccc--CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 777777665554433222211 122234455667889999999999999999999999999999988776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.51 Aligned_cols=192 Identities=26% Similarity=0.367 Sum_probs=162.7
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.+...+.+||||||+.+ +|..++.+ ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 92 ~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred CCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCE
Confidence 688899999999999999999975 56555544 4569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.... .....++|+.|+|||++.+ ..++.++||||||||+|||++|+.||...+.......+.....
T Consensus 171 kL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 245 (340)
T PTZ00426 171 KMTDFGFAKVVDT----RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII 245 (340)
T ss_pred EEecCCCCeecCC----CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999999976542 2234578999999999976 5689999999999999999999999998887777666643211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
. +...++..+++||++||..||++|+ |++++++|+||..
T Consensus 246 ~------------------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 246 Y------------------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred C------------------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 0 1123567899999999999999996 8999999999965
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=294.15 Aligned_cols=222 Identities=36% Similarity=0.639 Sum_probs=171.6
Q ss_pred cEeecccCcee------cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKY------RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~------~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++++.. ...+|++||++.++|...+.. ..+++.+++.++.||+.||+|||+++|+||||||+||||+
T Consensus 75 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~ 152 (343)
T cd07878 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152 (343)
T ss_pred chhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC
Confidence 56777766543 246799999998888776653 3599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... .....++|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+
T Consensus 153 ~~~~~kl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 153 EDCELRILDFGLARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCCCEEEcCCccceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999999986542 2334578999999999987567899999999999999999999999999888888888
Q ss_pred HHhcCCCCCCCCCCCCCCCc--cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+..+.+....+........ +.... ...........+...++.+++||.+||..||++|+|+.|+|+|+||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 77666554333222211000 00000 0000112333444567789999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=284.56 Aligned_cols=226 Identities=64% Similarity=1.126 Sum_probs=193.6
Q ss_pred cEeecccCceec--CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|++++++.+..+ +.+||||||+.++|..++.+....+++.+++.++.||+.||+|||+++++|+||||+|||+++++.
T Consensus 59 ~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~ 138 (287)
T cd07840 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV 138 (287)
T ss_pred CeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC
Confidence 678888888887 899999999999988888776567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++...............++..|+|||.+.+...++.++|||||||++|||++|+.||...+....+..+.+.+
T Consensus 139 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~ 218 (287)
T cd07840 139 LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218 (287)
T ss_pred EEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999999987654433233445668889999988765568899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhh-hHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
..+....|+....+.....+.............+..+ +.++++||++||..||++|||++++++|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 8888888887776655555555544455555555554 8999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.47 Aligned_cols=196 Identities=26% Similarity=0.395 Sum_probs=161.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+..++.+||||||+.++.+.........+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+
T Consensus 56 ~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~ 135 (325)
T cd05594 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 135 (325)
T ss_pred CCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCE
Confidence 6778888999999999999999865444444444569999999999999999999997 799999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+ ..++.++||||||||||||++|+.||...+.......+.....
T Consensus 136 kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05594 136 KITDFGLCKEGIKD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213 (325)
T ss_pred EEecCCCCeecCCC-CcccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999998754322 222334568999999999976 5789999999999999999999999988877666655532110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
.+...++.++.+||++||..||++|+ ++.++++|+||..
T Consensus 214 ------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 214 ------------------------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 01123677899999999999999997 9999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=294.81 Aligned_cols=195 Identities=26% Similarity=0.486 Sum_probs=162.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+.+++++...+++||||||+.+ +|...+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 62 ~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 140 (324)
T cd05587 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI 140 (324)
T ss_pred ceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCE
Confidence 477888899999999999999986 55555544 4469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+.+..+.+...
T Consensus 141 kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 218 (324)
T cd05587 141 KIADFGMCKENIFG-GKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218 (324)
T ss_pred EEeecCcceecCCC-CCceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999998753221 222334568999999999986 5689999999999999999999999998888777777643211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~h~~f~~ 231 (417)
. +...++.++++||++||..||++|+++ .++++|+||..
T Consensus 219 ~------------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 219 S------------------------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred C------------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0 112367789999999999999999976 89999999954
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=294.75 Aligned_cols=196 Identities=25% Similarity=0.414 Sum_probs=162.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+..++.+||||||+.++.+.........+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+|
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k 140 (323)
T cd05584 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVK 140 (323)
T ss_pred chhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEE
Confidence 78889999999999999999998644443333445689999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+++...... ......++|..|+|||++.+ ..++.++||||||||||||++|+.||...+....+..+.....
T Consensus 141 l~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~- 217 (323)
T cd05584 141 LTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL- 217 (323)
T ss_pred EeeCcCCeecccCC-CcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99999987543222 22234568999999999876 5688999999999999999999999998887776666643110
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
.+...++.++.+||++||..||++|+ ++.++++|+||..
T Consensus 218 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 218 -----------------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 01123567899999999999999999 8999999999965
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=296.47 Aligned_cols=222 Identities=31% Similarity=0.538 Sum_probs=168.5
Q ss_pred cEeecccCcee------cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKY------RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~------~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+.. ...+||||||+++++...+.. .+++.++..++.||+.||+|||+++|+||||||+|||++
T Consensus 84 ~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 160 (364)
T cd07875 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160 (364)
T ss_pred CccccceeecccccccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC
Confidence 56666655543 346899999999998887753 489999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... .......++|..|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+.++
T Consensus 161 ~~~~~kL~DfG~a~~~~~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 237 (364)
T cd07875 161 SDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237 (364)
T ss_pred CCCcEEEEeCCCccccCC--CCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999976432 122334577999999999986 57899999999999999999999999999999988888
Q ss_pred HHhcCCCCCCCCCCCCC--------CCccccCCCchhh----hhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSK--------MPAYNHFKPSRTM----KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+..+.+....+..... .+.+..+...... ...........+..+++||.+||..||++|+|+.|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 87776654433222211 0111110000000 00001111224568899999999999999999999999
Q ss_pred CCCCCC
Q 014871 226 SEYFWT 231 (417)
Q Consensus 226 h~~f~~ 231 (417)
|+||..
T Consensus 318 hp~~~~ 323 (364)
T cd07875 318 HPYINV 323 (364)
T ss_pred Cccccc
Confidence 999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=286.82 Aligned_cols=225 Identities=46% Similarity=0.830 Sum_probs=183.8
Q ss_pred cEeecccCceec--CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+.+++.+... +.+||||||+.++|..++......+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.
T Consensus 65 ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~ 144 (293)
T cd07843 65 NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI 144 (293)
T ss_pred CEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc
Confidence 577777777666 899999999999888887765556999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... .......++..|+|||++.+...++.++|||||||++|+|++|+.+|...+..+.+.++...+
T Consensus 145 ~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 223 (293)
T cd07843 145 LKICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223 (293)
T ss_pred EEEeecCceeeccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999998765332 222334568889999998765557899999999999999999999999999999999999888
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhh--hhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+.+....|+....++..............+...+.. ++..+++||++||..||++|||+.|+|+|+||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred CCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 888777777666555443322222222222333333 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=294.10 Aligned_cols=206 Identities=27% Similarity=0.445 Sum_probs=163.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-+||.+||+.-.++.+||||||=+.||-..+.+...-+....++.|.+|||.+|.++|++||||.||||.|+||-. |.+
T Consensus 420 ~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~L 498 (677)
T KOG0596|consen 420 DKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRL 498 (677)
T ss_pred ceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeE
Confidence 3689999999999999999999999999888877665666799999999999999999999999999999999876 689
Q ss_pred EEeeccCcccccCCCC-CcccccccccCCCCchhhcCC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 83 KLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 83 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
||+|||+|..+..+.. ....+.+||..||+||.+... .+.++++||||||||||+|++|++||..- .
T Consensus 499 KLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~ 576 (677)
T KOG0596|consen 499 KLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--I 576 (677)
T ss_pred EeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--H
Confidence 9999999988765433 234457899999999998641 23578999999999999999999999532 2
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..++++..+...-.+..++.... ..++.++++.||..||++|||+.+||+|+|...
T Consensus 577 n~~aKl~aI~~P~~~Iefp~~~~------------------------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 577 NQIAKLHAITDPNHEIEFPDIPE------------------------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHHHHHhhcCCCccccccCCCC------------------------chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 23344433222212222222211 123899999999999999999999999999976
Q ss_pred CCCC
Q 014871 232 DPLP 235 (417)
Q Consensus 232 ~~~~ 235 (417)
.+.+
T Consensus 633 ~~i~ 636 (677)
T KOG0596|consen 633 QPIP 636 (677)
T ss_pred cccc
Confidence 5443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=287.42 Aligned_cols=193 Identities=25% Similarity=0.436 Sum_probs=168.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
+||.+|+.|+.++.++|||||..++.+..++.....|++.+++.||+||+.|+.|||.++|+|||||.+|||||.++++|
T Consensus 114 hII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 114 HIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred ceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCee
Confidence 68999999999999999999998654444444445799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||++..+. ....+.++||++.|.+||++.+..+-++.+|.|||||+||.|++|..||++.+...++++|..-...
T Consensus 194 IADFGLSNly~--~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr 271 (668)
T KOG0611|consen 194 IADFGLSNLYA--DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR 271 (668)
T ss_pred eeccchhhhhc--cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc
Confidence 99999997654 4557788999999999999998777789999999999999999999999999999988888542211
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.. .-+.++.-||+-||..||++|.|++||..|=|.
T Consensus 272 EP-------------------------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 272 EP-------------------------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred CC-------------------------------CCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 11 123467899999999999999999999999886
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=285.60 Aligned_cols=227 Identities=50% Similarity=0.923 Sum_probs=189.7
Q ss_pred ccEeecccCceecC----------eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 3 CTFLETTDGNKYRG----------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 3 cniv~~~~~~~~~~----------~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
.||+++++.+.... .+||||||++++++.++......+++.++..++.||+.||+|||+++|+|+||||+
T Consensus 66 ~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ 145 (302)
T cd07864 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCS 145 (302)
T ss_pred CCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 47777777666544 89999999999988888766557999999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 152 (417)
||++++++.+||+|||++................+..|++||++.+...++.++|||||||+++||++|+++|...+..+
T Consensus 146 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~ 225 (302)
T cd07864 146 NILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225 (302)
T ss_pred HEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999999999987654332222334557889999988765567899999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+..+.+.++.+....|+.....+.+..........+.+...+..++..+++||.+||..||++|||++++++|+||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 226 QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 99999998888888888777666555444444444445555566678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=288.25 Aligned_cols=200 Identities=22% Similarity=0.368 Sum_probs=161.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.+|+++++.+...+++|+|||||.+ +|...+.. ....+++.++..++.||+.||+|||+++|+||||||+|||+++++
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~ 139 (285)
T cd05631 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG 139 (285)
T ss_pred CcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC
Confidence 4688899999999999999999986 55545443 334699999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||+++..... ......++|..|+|||++.+ ..++.++|||||||+||||++|+.||...+.......+...
T Consensus 140 ~~kl~Dfg~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~ 216 (285)
T cd05631 140 HIRISDLGLAVQIPEG--ETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR 216 (285)
T ss_pred CEEEeeCCCcEEcCCC--CeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH
Confidence 9999999999765322 22334578999999999986 57899999999999999999999999887654433333221
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
.... .......++.++.+||++||..||++|+| ++++++|+||..
T Consensus 217 ~~~~--------------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 217 VKED--------------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred hhcc--------------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 1110 01122346789999999999999999997 899999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=293.18 Aligned_cols=195 Identities=28% Similarity=0.427 Sum_probs=162.9
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++++...+++||||||+.++.+....+. ..|++.++..++.||+.||+|||+++|+||||||+||||+.++.+|
T Consensus 63 ~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred ChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEE
Confidence 788899999999999999999987544444333 3699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 142 L~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T cd05589 142 IADFGLCKEGMGF-GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR 219 (324)
T ss_pred eCcccCCccCCCC-CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999998754322 222344678999999999876 57899999999999999999999999998887777766431110
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
....++..+.+||++||..||++|+ ++.++++|+||..
T Consensus 220 ------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 220 ------------------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred ------------------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 1123577889999999999999999 7999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=294.96 Aligned_cols=195 Identities=26% Similarity=0.414 Sum_probs=162.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+..++.+||||||+.+ +|...+. ....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~ 135 (323)
T cd05575 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHV 135 (323)
T ss_pred CCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcE
Confidence 678888999999999999999986 4544444 34569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.... ........++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 136 kl~Dfg~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 213 (323)
T cd05575 136 VLTDFGLCKEGIE-HSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213 (323)
T ss_pred EEeccCCCccccc-CCCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999875432 1223344568999999999876 5789999999999999999999999998887777666643110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~h~~f~~ 231 (417)
.+...++..+.+||++||..||++|+++ .++++|+||..
T Consensus 214 ------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 214 ------------------------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 0112356789999999999999999987 69999999954
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=293.01 Aligned_cols=201 Identities=24% Similarity=0.382 Sum_probs=164.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++..+++||||||+.+ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 62 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 140 (333)
T cd05600 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHI 140 (333)
T ss_pred CCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCE
Confidence 678888999999999999999986 56555543 4469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.... .....++|..|+|||++.+ ..++.++||||||||+|||++|+.||...+..+.+..+.....
T Consensus 141 kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 215 (333)
T cd05600 141 KLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215 (333)
T ss_pred EEEeCcCCccccc----ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc
Confidence 9999999976543 2334578999999999986 5789999999999999999999999998888777666643211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
......+ . .....++.++.+||.+||..+|++|+|+.+|++|+||...
T Consensus 216 ~~~~~~~---------~-------------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 216 TLQRPVY---------D-------------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred cccCCCC---------C-------------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 1110000 0 0002367789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=295.48 Aligned_cols=199 Identities=23% Similarity=0.360 Sum_probs=159.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+++++.+...+++|||||||.+ +|..++.+ ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~v 140 (363)
T cd05628 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHV 140 (363)
T ss_pred CcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCE
Confidence 678888999999999999999986 55555554 4469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC----------------------------------CcccccccccCCCCchhhcCCCCCCCccch
Q 014871 83 KLADFGLARSFSYDHN----------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDM 128 (417)
Q Consensus 83 kL~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~Di 128 (417)
||+|||+++.+..... ......+||..|+|||++.+ ..++.++||
T Consensus 141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~Dv 219 (363)
T cd05628 141 KLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDW 219 (363)
T ss_pred EEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhh
Confidence 9999999875432110 01123578999999999986 578999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHH
Q 014871 129 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEK 208 (417)
Q Consensus 129 wSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~ 208 (417)
||||||||||++|+.||.+.+..+.+.++........ .+. ...++.++++||.+
T Consensus 220 wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~p~-----------------------~~~~s~~~~~li~~ 273 (363)
T cd05628 220 WSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI---FPP-----------------------EVPISEKAKDLILR 273 (363)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc---CCC-----------------------cCCCCHHHHHHHHH
Confidence 9999999999999999999888887777754211110 000 01256789999999
Q ss_pred hcccCCC---CCCCHHHHhcCCCCCC
Q 014871 209 MLMLDPS---QRISAKDALDSEYFWT 231 (417)
Q Consensus 209 ~L~~dP~---~Rpta~elL~h~~f~~ 231 (417)
||. ++. .|++++||++|+||..
T Consensus 274 l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 274 FCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred HcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 876 444 4589999999999965
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=295.60 Aligned_cols=196 Identities=30% Similarity=0.473 Sum_probs=174.8
Q ss_pred cEeecccCceecCe-EEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYRGS-TYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~~~-~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
|||++++.|..++. +|||||||+| ++.+.+.+.. ..|+++.+..|+.||+.||.|||++.|+|||||+.|||+..++
T Consensus 64 ~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~ 143 (426)
T KOG0589|consen 64 NIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK 143 (426)
T ss_pred CeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC
Confidence 79999999999999 9999999996 6666666544 6799999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.|||.|||+|+...... ....+.+||+.||+||++.+ .+|+.++|||||||++|||++-++.|.+.+...++.+|.+.
T Consensus 144 ~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~ 221 (426)
T KOG0589|consen 144 KVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG 221 (426)
T ss_pred ceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc
Confidence 99999999999876432 35567889999999999886 78999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
...+... .++.+++.||+.||..+|+.||++.+||.+|...
T Consensus 222 ~~~Plp~-----------------------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 222 LYSPLPS-----------------------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred cCCCCCc-----------------------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 6444332 3677899999999999999999999999997763
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=292.54 Aligned_cols=195 Identities=28% Similarity=0.492 Sum_probs=162.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||++++++++..+++||||||+.+ +|...+. ....+++.++..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~ 135 (318)
T cd05570 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHI 135 (318)
T ss_pred CccceeeEEEcCCEEEEEEcCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcE
Confidence 788899999999999999999986 5544444 34469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+....+.....
T Consensus 136 kl~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~ 213 (318)
T cd05570 136 KIADFGMCKEGILG-GVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213 (318)
T ss_pred EecccCCCeecCcC-CCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999998753221 122234568999999999976 5789999999999999999999999998887776666533110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~h~~f~~ 231 (417)
.+...++..+++||++||..||++|+|+ .++++|+||..
T Consensus 214 ------------------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 214 ------------------------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred ------------------------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0112356789999999999999999999 99999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=281.89 Aligned_cols=223 Identities=37% Similarity=0.618 Sum_probs=176.4
Q ss_pred ccEeecccCceec--CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYR--GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~--~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+++++.+... +.+||||||+.+++++.+......+++.++..++.||+.||+|||+++|+||||||+||+++. +
T Consensus 58 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~ 136 (282)
T cd07831 58 PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D 136 (282)
T ss_pred CCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C
Confidence 3778888888877 899999999999999888765557999999999999999999999999999999999999999 9
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||+++...... ......++..|+|||++.....++.++|||||||++|||++|..||.+.+..+.+..+.+.
T Consensus 137 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~ 214 (282)
T cd07831 137 ILKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214 (282)
T ss_pred CeEEEecccccccccCC--CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHH
Confidence 99999999997654322 2223456889999998765456788999999999999999999999999988888888777
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+.+.+.+....... ....+.........+......++.++++||.+||..||++|||+.++|+|+||
T Consensus 215 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 215 LGTPDAEVLKKFRKS-RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCCCCHHHHHhhccc-ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 766554331111100 00111111111222344445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=291.76 Aligned_cols=196 Identities=26% Similarity=0.465 Sum_probs=162.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+|+.+++++...+.+||||||+.+ +|...+.+ ...+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~ 139 (323)
T cd05616 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH 139 (323)
T ss_pred CeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc
Confidence 3567788899999999999999985 56555544 346999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++..... .......++|+.|+|||++.. ..++.++|||||||++|||++|+.||.+.+..+++..+.+..
T Consensus 140 ~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05616 140 IKIADFGMCKENMWD-GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217 (323)
T ss_pred EEEccCCCceecCCC-CCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 999999999754321 122334568999999999976 678999999999999999999999999988887777765421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
.. +...++.++++||.+||..||++|++ ..++++|+||..
T Consensus 218 ~~------------------------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 218 VA------------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred CC------------------------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 10 11235678999999999999999997 489999999954
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=293.50 Aligned_cols=197 Identities=26% Similarity=0.394 Sum_probs=163.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.++..+.+||||||+.++.+..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 56 ~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~ 135 (325)
T cd05602 56 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 135 (325)
T ss_pred CCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCE
Confidence 46888889999999999999999874444443344569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 136 kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05602 136 VLTDFGLCKENIEH-NGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213 (325)
T ss_pred EEccCCCCcccccC-CCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc
Confidence 99999999754322 223344578999999999976 5789999999999999999999999998888777776643210
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHH----HHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK----DALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~----elL~h~~f~~ 231 (417)
.+...++..+++||++||..||.+|+++. ++++|+||..
T Consensus 214 ------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 214 ------------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 01123677899999999999999999875 8999999943
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.80 Aligned_cols=196 Identities=28% Similarity=0.479 Sum_probs=161.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+..++.+||||||+.+ +|..++.+ ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 57 ~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~ 135 (316)
T cd05619 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHI 135 (316)
T ss_pred cCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCE
Confidence 678888999999999999999985 66555544 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+.....
T Consensus 136 kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05619 136 KIADFGMCKENMLG-DAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP 213 (316)
T ss_pred EEccCCcceECCCC-CCceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999998753221 122334568999999999876 5789999999999999999999999998887776665532100
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~-elL~h~~f~~~ 232 (417)
.....++.++++||.+||..||++|+++. ++++|+||...
T Consensus 214 ------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 214 ------------------------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred ------------------------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 00112567899999999999999999996 89999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=294.73 Aligned_cols=199 Identities=26% Similarity=0.430 Sum_probs=160.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++..+++|||||||.+ +|.+++.+ ...|++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~ 140 (364)
T cd05599 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHI 140 (364)
T ss_pred CCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE
Confidence 688899999999999999999986 55555544 4469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC-------------------------------------cccccccccCCCCchhhcCCCCCCCc
Q 014871 83 KLADFGLARSFSYDHNN-------------------------------------TLTNRVITLWYRPPELLLGATKYGPA 125 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~ 125 (417)
||+|||+++.+...... .....++|+.|+|||++.. ..++.+
T Consensus 141 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 219 (364)
T cd05599 141 KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKE 219 (364)
T ss_pred EEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCe
Confidence 99999998754321100 1112468999999999876 578999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHH
Q 014871 126 VDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALEL 205 (417)
Q Consensus 126 ~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 205 (417)
+||||||||+|||++|+.||...+..+.+..+.+..... ..+. ...++.++++|
T Consensus 220 ~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~---------~~~~-----------------~~~~s~~~~~l 273 (364)
T cd05599 220 CDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETL---------QFPD-----------------EVPLSPEAKDL 273 (364)
T ss_pred eeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCcc---------CCCC-----------------CCCCCHHHHHH
Confidence 999999999999999999999888777766664311100 0000 01357789999
Q ss_pred HHHhcccCCCCCCC---HHHHhcCCCCCC
Q 014871 206 LEKMLMLDPSQRIS---AKDALDSEYFWT 231 (417)
Q Consensus 206 i~~~L~~dP~~Rpt---a~elL~h~~f~~ 231 (417)
|++||. +|.+|++ +.++|+|+||..
T Consensus 274 i~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 274 IKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred HHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999997 9999998 999999999965
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=284.58 Aligned_cols=226 Identities=50% Similarity=0.920 Sum_probs=182.5
Q ss_pred cEeecccCce--------ecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 014871 4 TFLETTDGNK--------YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75 (417)
Q Consensus 4 niv~~~~~~~--------~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NIL 75 (417)
||+++++.+. ....+|+||||+..++...+......+++.+++.++.||++||+|||+++|+|+||||+|||
T Consensus 68 ~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil 147 (311)
T cd07866 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANIL 147 (311)
T ss_pred CccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 4555555443 33457999999999998888776667999999999999999999999999999999999999
Q ss_pred EcCCCCEEEeeccCcccccCCCCC----------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 014871 76 IDNEGNLKLADFGLARSFSYDHNN----------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 145 (417)
Q Consensus 76 l~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf 145 (417)
+++++.+||+|||+++........ ..+..+++..|+|||++.+...++.++||||||||+|||++|+++|
T Consensus 148 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred ECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 999999999999999765432211 1123356788999999876556899999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+.......+...++.+.+..|+.....+..................+..++..+.+||++||..||++|+|+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 99999999999999888887777776665554433222222233344445567788999999999999999999999999
Q ss_pred CCCC
Q 014871 226 SEYF 229 (417)
Q Consensus 226 h~~f 229 (417)
|+||
T Consensus 308 ~~~f 311 (311)
T cd07866 308 HPYF 311 (311)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=292.59 Aligned_cols=201 Identities=26% Similarity=0.393 Sum_probs=164.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+++++.+..++++||||||+.+ +|.+++.+....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~ 141 (330)
T cd05601 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHI 141 (330)
T ss_pred CCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCE
Confidence 577888889999999999999975 6777766654579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
||+|||++..............++|..|+|||++.. ...++.++||||||||+|||++|+.||...+....+.++
T Consensus 142 kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i 221 (330)
T cd05601 142 KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221 (330)
T ss_pred EeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH
Confidence 999999998765333323334568999999999863 245788999999999999999999999988887777766
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
........ ++ ....++.++++||++||. ||++|+|+.++++|+||..
T Consensus 222 ~~~~~~~~---~~-----------------------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 222 MNFQRFLK---FP-----------------------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HcCCCccC---CC-----------------------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 54211100 00 001356789999999998 9999999999999999964
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=282.04 Aligned_cols=225 Identities=44% Similarity=0.726 Sum_probs=175.7
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+...+..|+||||+.++++..+......+++.+++.++.||+.||+|||+++|+|+||||+|||++.++++|
T Consensus 64 ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~ 143 (291)
T cd07870 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELK 143 (291)
T ss_pred CEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEE
Confidence 78888999999999999999999999888776555689999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIFELCG 162 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~~~~~~i~~~~~ 162 (417)
|+|||+++...... .......++..|+|||++.+...++.++|||||||++|+|++|+.||...+. .+.+..+....+
T Consensus 144 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~ 222 (291)
T cd07870 144 LADFGLARAKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG 222 (291)
T ss_pred EeccccccccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcC
Confidence 99999987643222 1223345688999999987655678899999999999999999999976543 455666666667
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhh--hhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH--FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+.+..+......+.+................+.. .+..+.+||++||..||++|+|+.|++.|+||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred CCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 66666665555444332221111111112222221 25688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=294.75 Aligned_cols=201 Identities=27% Similarity=0.376 Sum_probs=164.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++++...+++|||||||.+ +|..++.. ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred CcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCE
Confidence 578888899999999999999975 56655543 358999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+++.............++|+.|+|||++... ..++.++|||||||+||||++|+.||.+.+....+.++.+
T Consensus 182 kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05596 182 KLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred EEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 9999999987543332233456789999999998653 2478899999999999999999999999888777777654
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 232 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~h~~f~~~ 232 (417)
..... .++. ...++.++++||++||..+|++ |+|++||++|+||+..
T Consensus 262 ~~~~~---~~~~-----------------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 262 HKNSL---TFPD-----------------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCcC---CCCC-----------------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 21110 0100 0135779999999999999988 9999999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.42 Aligned_cols=196 Identities=23% Similarity=0.402 Sum_probs=156.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||++++++++.++.+|||||||.+ +|...+.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 56 p~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~ 134 (329)
T cd05588 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH 134 (329)
T ss_pred CCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC
Confidence 3788999999999999999999986 55555543 456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh--------HH-
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--------AE- 152 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~--------~~- 152 (417)
+||+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+
T Consensus 135 ~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05588 135 IKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212 (329)
T ss_pred EEECcCccccccccC-CCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH
Confidence 999999998753221 223344578999999999986 5789999999999999999999999963211 11
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC------HHHHhcC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDS 226 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt------a~elL~h 226 (417)
....+... ...+...++.++++||++||..||++|+| +.++++|
T Consensus 213 ~~~~~~~~------------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 213 LFQVILEK------------------------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHcC------------------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11111110 00112346778999999999999999987 7999999
Q ss_pred CCCCC
Q 014871 227 EYFWT 231 (417)
Q Consensus 227 ~~f~~ 231 (417)
+||..
T Consensus 263 p~~~~ 267 (329)
T cd05588 263 PFFRN 267 (329)
T ss_pred CCCCC
Confidence 99954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=269.76 Aligned_cols=193 Identities=29% Similarity=0.470 Sum_probs=171.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~-~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||++.|..|.++..+||++||.. +.++..+. ....+|++.....|++|++.||.|||.++||||||||+|+|++.++.
T Consensus 83 nilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~ 162 (281)
T KOG0580|consen 83 NILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE 162 (281)
T ss_pred cHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC
Confidence 78999999999999999999997 45665554 35567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||.+.... .....+.|||..|.+||...+ ..++..+|+|++|++.||+|.|.+||...+..+.+++|.+..
T Consensus 163 lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~ 238 (281)
T KOG0580|consen 163 LKIADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD 238 (281)
T ss_pred eeccCCCceeecC---CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc
Confidence 9999999987643 345567899999999999986 678999999999999999999999999999999999997643
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
... ...++..+.|||.+||.++|.+|.+..|+++|+|+.
T Consensus 239 ~~~------------------------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 239 LKF------------------------------PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ccC------------------------------CcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 222 235788999999999999999999999999999984
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=295.99 Aligned_cols=199 Identities=30% Similarity=0.461 Sum_probs=159.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+||++++.+..++++|||||||.+ +|..++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 62 ~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~ 140 (382)
T cd05625 62 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHI 140 (382)
T ss_pred cCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 688999999999999999999985 666666544 468999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC----------------------------------------------CcccccccccCCCCchhh
Q 014871 83 KLADFGLARSFSYDHN----------------------------------------------NTLTNRVITLWYRPPELL 116 (417)
Q Consensus 83 kL~DFGla~~~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~l 116 (417)
||+|||+|+.+..... ......++|+.|+|||++
T Consensus 141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 220 (382)
T cd05625 141 KLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220 (382)
T ss_pred EEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh
Confidence 9999999854321000 001224689999999999
Q ss_pred cCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh
Q 014871 117 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196 (417)
Q Consensus 117 ~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (417)
.+ ..++.++||||||||||||++|+.||.+.+..+...++........ .+ ...
T Consensus 221 ~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------~p-----------------~~~ 273 (382)
T cd05625 221 LR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH---------IP-----------------PQA 273 (382)
T ss_pred cC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC---------CC-----------------Ccc
Confidence 76 5789999999999999999999999998887776666543211110 00 012
Q ss_pred hhhHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCC
Q 014871 197 HFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWT 231 (417)
Q Consensus 197 ~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~h~~f~~ 231 (417)
.+++++++||.+|+ .||++|++ +.++++|+||..
T Consensus 274 ~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 274 KLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 36778999999986 59999997 999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=279.65 Aligned_cols=224 Identities=45% Similarity=0.872 Sum_probs=184.8
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+...+..||||||+.+++.+++.... ..+++.++..++.||+.||+|||+++|+|+||||+||++++++.
T Consensus 59 ~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~ 138 (284)
T cd07836 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE 138 (284)
T ss_pred CEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc
Confidence 7899999999999999999999999888776543 45899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++....... ......++..|++||++.+...++.++|||||||++|+|++|+.+|.+.+..+.+..+.+..
T Consensus 139 ~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (284)
T cd07836 139 LKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM 217 (284)
T ss_pred EEEeecchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 99999999976543221 22334568899999998765567889999999999999999999999999889999988888
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
..+....|......+.+........ ......+...++..+++||.+||..||++|+|+.++++|+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 218 GTPTESTWPGISQLPEYKPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCCChhhHHHHhcCchhcccccCCC-hHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8887777765554443332211111 122344455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=293.59 Aligned_cols=201 Identities=28% Similarity=0.379 Sum_probs=163.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+.+|||||||.+ +|.+++.. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred CEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCE
Confidence 788999999999999999999985 66666543 258999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCC---CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+|..............++|..|+|||++.... .++.++|||||||+||||++|+.||...+....+.++..
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 182 KLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred EEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999999876433332334567899999999987532 378899999999999999999999999888777777654
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 232 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~h~~f~~~ 232 (417)
...... ++. ...++..+++||.+||..++.+ |+|+.|+++|+||...
T Consensus 262 ~~~~~~---~p~-----------------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 262 HKNSLN---FPE-----------------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred CCcccC---CCC-----------------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 221110 100 0125778999999999866544 8999999999999664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=286.88 Aligned_cols=236 Identities=47% Similarity=0.874 Sum_probs=194.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+...+.+|+||||+.++|.+.+... ..+++..+..++.||+.||+|||+++|+|+|||++|||++.++.+
T Consensus 80 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 80 ENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred cceeeeeEEEecCCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 3788888999999999999999999888877653 459999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCC-------------CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 014871 83 KLADFGLARSFSYD-------------HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN 149 (417)
Q Consensus 83 kL~DFGla~~~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 149 (417)
||+|||+++..... .........++..|+|||++.+...++.++|||||||++|||++|+.||.+.+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998765411 11122233457889999998765567899999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
..+.+..+.+..+.+....|+....++.+..+... ...........++.++++||.+||..||++|+|++|+|.|+||
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcC--CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 99999999998888887777766655544433221 1223344455678899999999999999999999999999999
Q ss_pred CCCCCCCCCCCC
Q 014871 230 WTDPLPCDPKSL 241 (417)
Q Consensus 230 ~~~~~~~~~~~~ 241 (417)
+......+...+
T Consensus 317 ~~~~~~~~~~~~ 328 (335)
T PTZ00024 317 KSDPLPCDPSQL 328 (335)
T ss_pred CCCCCCCCcccC
Confidence 988777654443
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=294.71 Aligned_cols=201 Identities=28% Similarity=0.427 Sum_probs=158.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+||++++.+...+++|||||||.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 61 ~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~ 139 (381)
T cd05626 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH 139 (381)
T ss_pred CCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC
Confidence 4789999999999999999999975 566665543 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC----------------------------------------------CcccccccccCCCCchh
Q 014871 82 LKLADFGLARSFSYDHN----------------------------------------------NTLTNRVITLWYRPPEL 115 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~ 115 (417)
+||+|||+++.+..... ......++|..|+|||+
T Consensus 140 ~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~ 219 (381)
T cd05626 140 IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219 (381)
T ss_pred EEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHH
Confidence 99999999864321100 00123468999999999
Q ss_pred hcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhh
Q 014871 116 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195 (417)
Q Consensus 116 l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (417)
+.+ ..++.++||||||||||||++|+.||...+..+....+....... ..+ ..
T Consensus 220 ~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~~-----------------~~ 272 (381)
T cd05626 220 LLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------HIP-----------------PQ 272 (381)
T ss_pred HcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------CCC-----------------CC
Confidence 976 568999999999999999999999999888766665554311110 000 01
Q ss_pred hhhhHHHHHHHHHhccc--CCCCCCCHHHHhcCCCCCC
Q 014871 196 RHFDRHALELLEKMLML--DPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 196 ~~~~~~~~~Li~~~L~~--dP~~Rpta~elL~h~~f~~ 231 (417)
..++.++++||.+||.. ++.+|+|+.+|++|+||..
T Consensus 273 ~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 273 VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 13678999999997655 4445999999999999954
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.70 Aligned_cols=228 Identities=24% Similarity=0.306 Sum_probs=170.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.|||++++.+...+.+||||||+.++|+.++.. ...|++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 146 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~ 224 (392)
T PHA03207 146 RAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENA 224 (392)
T ss_pred CCccceeeeEeeCCEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCE
Confidence 478999999999999999999999999888743 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIF 158 (417)
Q Consensus 83 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~---~~~~~~~i~ 158 (417)
||+|||+++....... ......++|..|+|||++.. ..++.++||||||||||||++|+.||.+.. ....+..+.
T Consensus 225 ~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~ 303 (392)
T PHA03207 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII 303 (392)
T ss_pred EEccCccccccCcccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH
Confidence 9999999976543222 12234578999999999875 568999999999999999999999997654 345566666
Q ss_pred HhcCCCCCCCCCCCCC--CCccccCCCchhhhhhHHHhh--hhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSK--MPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+.++............ ...+..+.............+ ..++.++.+||++||..||++|+|+.|||.|+||...
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 304 RCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 6554432221110000 000000000000000011111 2356788999999999999999999999999999654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=291.93 Aligned_cols=200 Identities=31% Similarity=0.468 Sum_probs=165.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-+|+++++.+..++++||||||+.+ +|..++.+. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~ 139 (350)
T cd05573 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH 139 (350)
T ss_pred CCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC
Confidence 3688899999999999999999975 666666554 56999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCC----------------------------CCcccccccccCCCCchhhcCCCCCCCccchhhHHH
Q 014871 82 LKLADFGLARSFSYDH----------------------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133 (417)
Q Consensus 82 vkL~DFGla~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~ 133 (417)
+||+|||+++...... .......++|..|+|||++.+ ..++.++|||||||
T Consensus 140 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~ 218 (350)
T cd05573 140 IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGV 218 (350)
T ss_pred EEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecch
Confidence 9999999997654332 112334568999999999986 57899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccC
Q 014871 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 213 (417)
Q Consensus 134 il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 213 (417)
|||||++|+.||...+..+...++....... ..+. ...++.++++||++||. |
T Consensus 219 il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---------~~p~-----------------~~~~~~~~~~li~~ll~-d 271 (350)
T cd05573 219 ILYEMLYGFPPFYSDTLQETYNKIINWKESL---------RFPP-----------------DPPVSPEAIDLICRLLC-D 271 (350)
T ss_pred hhhhhccCCCCCCCCCHHHHHHHHhccCCcc---------cCCC-----------------CCCCCHHHHHHHHHHcc-C
Confidence 9999999999999888777766665421110 0000 01157789999999997 9
Q ss_pred CCCCCC-HHHHhcCCCCCC
Q 014871 214 PSQRIS-AKDALDSEYFWT 231 (417)
Q Consensus 214 P~~Rpt-a~elL~h~~f~~ 231 (417)
|.+|++ ++++|+|+||..
T Consensus 272 p~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 272 PEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred hhhcCCCHHHHhcCCCcCC
Confidence 999999 999999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=293.20 Aligned_cols=196 Identities=23% Similarity=0.367 Sum_probs=161.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.++.++.+||||||+.++.+.........+++.+++.++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~k 136 (325)
T cd05604 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV 136 (325)
T ss_pred CCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence 67888899999999999999998654444444445799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 137 L~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~- 213 (325)
T cd05604 137 LTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL- 213 (325)
T ss_pred EeecCCcccCCCC-CCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-
Confidence 9999998753221 223344578999999999876 5789999999999999999999999998887777666543100
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~h~~f~~ 231 (417)
.+...++..+.+||++||..||.+|+++ .++++|+||..
T Consensus 214 -----------------------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 214 -----------------------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred -----------------------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 0112356688999999999999999976 59999999954
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.70 Aligned_cols=196 Identities=23% Similarity=0.392 Sum_probs=155.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++++...+.+||||||+.++.+.........+++..++.++.||+.||+|||+++|+||||||+||||+.++.+|
T Consensus 57 ~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~k 136 (329)
T cd05618 57 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 136 (329)
T ss_pred cCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEE
Confidence 68889999999999999999998644443333445699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---------hHHHH
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---------EAEQL 154 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~---------~~~~~ 154 (417)
|+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||.... .....
T Consensus 137 L~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 214 (329)
T cd05618 137 LTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 214 (329)
T ss_pred EeeCCccccccCC-CCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH
Confidence 9999998754321 222334578999999999986 578999999999999999999999995211 01111
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC------HHHHhcCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDSEY 228 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt------a~elL~h~~ 228 (417)
..+... ...+...++..+++||++||..||++|+| +.++++|+|
T Consensus 215 ~~i~~~------------------------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05618 215 QVILEK------------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 264 (329)
T ss_pred HHHhcC------------------------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence 111110 00122346778999999999999999998 589999999
Q ss_pred CCC
Q 014871 229 FWT 231 (417)
Q Consensus 229 f~~ 231 (417)
|+.
T Consensus 265 f~~ 267 (329)
T cd05618 265 FRN 267 (329)
T ss_pred CCC
Confidence 954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.41 Aligned_cols=196 Identities=26% Similarity=0.403 Sum_probs=162.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||.++|..|-....++|+||||++ ++++++.. +..+.|.++..++++++.||.|||.++.+|||||+.|||+..+|.+
T Consensus 72 ~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~v 150 (467)
T KOG0201|consen 72 NITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDV 150 (467)
T ss_pred hHHhhhhheeecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcE
Confidence 566888999999999999999986 55555554 4456999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++.......... .+.+||++||||||+.. ..|+.++||||||++++||++|.+|+........+..|-
T Consensus 151 kl~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp---- 224 (467)
T KOG0201|consen 151 KLADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP---- 224 (467)
T ss_pred EEEecceeeeeechhhcc-ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc----
Confidence 999999998876554444 77899999999999985 689999999999999999999999997665522222110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
... ...+-..+++.+++||..||.+||+.||||.+||+|+|++.
T Consensus 225 ---k~~----------------------PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 225 ---KSA----------------------PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---CCC----------------------CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 000 01111247889999999999999999999999999999965
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=278.31 Aligned_cols=226 Identities=33% Similarity=0.615 Sum_probs=173.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+.....+||||||++++++..+.+....+++.+++.++.||+.+|+|||+++|+|+||||+||+++.++.+
T Consensus 60 ~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~ 139 (286)
T cd07847 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQI 139 (286)
T ss_pred CCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcE
Confidence 37899999999999999999999998888776666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++........ ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 140 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07847 140 KLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218 (286)
T ss_pred EECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999987643221 222345688999999987656688999999999999999999999998887776666554443
Q ss_pred CCCCCCCCCCCCCCccccC-CCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHF-KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
...............+... .+...........+..++..+.+||.+||..||++|||+.+++.|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 3211100000000000000 000011112333455678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=281.69 Aligned_cols=224 Identities=45% Similarity=0.836 Sum_probs=179.9
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+..|+||||+.++|...+... ...+++.+++.++.||+.||+|||+++++|+||+|+||+++.++.+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~ 139 (284)
T cd07860 60 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI 139 (284)
T ss_pred CCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 678888999999999999999998887776543 3468999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++...... ........++..|+|||++.+...++.++|||||||++|||++|+.||...++.+.+.++++..+
T Consensus 140 ~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07860 140 KLADFGLARAFGVP-VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 218 (284)
T ss_pred EEeeccchhhcccC-ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998765322 12223345688899999887655578899999999999999999999999998888888888888
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+....|+.....+.+...... ............++.++++||.+||..||++|||++++|+|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKPSFPK-WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCChhhhhhhhHHHHHHhhccc-ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 7777666654433322111100 00112233344578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=291.00 Aligned_cols=223 Identities=30% Similarity=0.534 Sum_probs=166.7
Q ss_pred cEeecccCceec------CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYR------GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~------~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+... ..+||||||+++++...+.. .+++.++..++.||+.||+|||++||+||||||+||||+
T Consensus 77 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~ 153 (355)
T cd07874 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_pred chhceeeeeeccccccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC
Confidence 566666655433 45799999999998877653 489999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (355)
T cd07874 154 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_pred CCCCEEEeeCcccccCCCc--cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999764322 22334577999999999976 57899999999999999999999999999888888777
Q ss_pred HHhcCCCCCCCCCCCCC--------CCccccCCCchh----hhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSK--------MPAYNHFKPSRT----MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.++.+....+..... .+.+........ ............+.++++||.+||..||++|||+.|||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 77665543322221110 000000000000 000001112234568899999999999999999999999
Q ss_pred CCCCCCC
Q 014871 226 SEYFWTD 232 (417)
Q Consensus 226 h~~f~~~ 232 (417)
|+||...
T Consensus 311 hp~~~~~ 317 (355)
T cd07874 311 HPYINVW 317 (355)
T ss_pred Ccchhcc
Confidence 9999543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=279.41 Aligned_cols=225 Identities=45% Similarity=0.806 Sum_probs=185.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
+|+++++.+...+.+|+||||+.+++...+......+++.++..++.||+.+|+|||+++|+|+||||+||+++.++.+|
T Consensus 59 ~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~ 138 (283)
T cd05118 59 NIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLK 138 (283)
T ss_pred CcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEE
Confidence 67888888999999999999999999888877666799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||++....... .......++..|+|||.+.+...++.++|||||||++|+|++|+.+|...+..+.+.++.+..+.
T Consensus 139 l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~ 217 (283)
T cd05118 139 LADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT 217 (283)
T ss_pred EeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999987765432 12233456888999999876547899999999999999999999999999998988888888887
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+....|.....+..+..+................++.++++||.+||..||.+||++.+++.|+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 777666665543222211111111122244456688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=282.47 Aligned_cols=215 Identities=51% Similarity=0.959 Sum_probs=171.0
Q ss_pred cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccccc
Q 014871 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 94 (417)
Q Consensus 15 ~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~ 94 (417)
....||||||+.+++.+.+......+++.+++.++.||+.||+|||+++|+|+||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 34569999999999988887766679999999999999999999999999999999999999999999999999997654
Q ss_pred CCCC---CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 014871 95 YDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 171 (417)
Q Consensus 95 ~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 171 (417)
.... .......++..|+|||++.+...++.++|||||||++|||++|+.+|.+.+....+..+..+++......|+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 1222345688899999987655578899999999999999999999999998888888888888877777766
Q ss_pred CCCCCccccCCCchhhhhhHHHhh--hhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 172 VSKMPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
......+................. ...+..+++||.+||..||++|||++++|+|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 654433322221111111111111 1246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.03 Aligned_cols=200 Identities=27% Similarity=0.423 Sum_probs=159.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+...+++|||||||.+ +|..++.+ ...+++..++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 61 p~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~ 139 (377)
T cd05629 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH 139 (377)
T ss_pred CCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC
Confidence 3689999999999999999999975 66666554 456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC----------------------------------------------cccccccccCCCCchh
Q 014871 82 LKLADFGLARSFSYDHNN----------------------------------------------TLTNRVITLWYRPPEL 115 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~----------------------------------------------~~~~~~gt~~y~aPE~ 115 (417)
+||+|||+++.+...... .....++|+.|+|||+
T Consensus 140 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 219 (377)
T cd05629 140 IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219 (377)
T ss_pred EEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHH
Confidence 999999999643211000 0012468999999999
Q ss_pred hcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhh
Q 014871 116 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195 (417)
Q Consensus 116 l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (417)
+.+ ..++.++||||||||||||++|+.||...+..+.+..+....... .++. .
T Consensus 220 ~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~-----------------------~ 272 (377)
T cd05629 220 FLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL---YFPD-----------------------D 272 (377)
T ss_pred Hcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc---CCCC-----------------------C
Confidence 976 578999999999999999999999999888877776664311100 0000 0
Q ss_pred hhhhHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCC
Q 014871 196 RHFDRHALELLEKMLMLDPSQR---ISAKDALDSEYFWT 231 (417)
Q Consensus 196 ~~~~~~~~~Li~~~L~~dP~~R---pta~elL~h~~f~~ 231 (417)
..++.++++||++||. +|.+| +|+.|+++|+||..
T Consensus 273 ~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 273 IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 1356789999999998 77665 59999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.43 Aligned_cols=224 Identities=44% Similarity=0.814 Sum_probs=179.7
Q ss_pred cEeecccCceecCe-----EEEEEcCCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 4 TFLETTDGNKYRGS-----TYMVFEYMDHDLTGLADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 4 niv~~~~~~~~~~~-----~yiV~Ey~~g~l~~~~~~~----~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
||+++++.+..... +||||||+++++..++... ...+++.+++.++.||+.||+|||+++|+||||||+||
T Consensus 62 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ni 141 (295)
T cd07837 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141 (295)
T ss_pred CccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence 77888888877766 8999999999888877543 23589999999999999999999999999999999999
Q ss_pred EEcC-CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 75 LIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 75 Ll~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
|++. ++.+||+|||+++.+.... .......++..|+|||++.+...++.++|||||||++|+|++|..||.+.++.+.
T Consensus 142 l~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~ 220 (295)
T cd07837 142 LVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ 220 (295)
T ss_pred EEecCCCeEEEeecccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9998 8899999999987653221 1222335688899999987655688999999999999999999999999999888
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+.+++.....+....|+.......+...... ...........++.++.+||.+||..||.+|+|+.|+|.|+||.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 221 LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQW--KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHHHHhCCCChhhCcchhhccchhhcCcc--cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 8888887777777666655443332211100 11123334456888999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=296.18 Aligned_cols=190 Identities=26% Similarity=0.461 Sum_probs=160.3
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-cCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI-DNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl-~~~~~v 82 (417)
|+++..+.+....++|+|||++.+.++-..+...+.+. .++..|+++|+.||.|||++|||||||||+|||+ ++.++|
T Consensus 377 niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~l 455 (612)
T KOG0603|consen 377 NIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHL 455 (612)
T ss_pred cceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcE
Confidence 78999999999999999999999876655555444455 8888999999999999999999999999999999 588899
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~~~~i~~~~ 161 (417)
+|+|||.++..... ..+.+-|..|.|||++.. ..|++++||||||+|||+||+|+.||...... ++..+|
T Consensus 456 rltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---- 526 (612)
T KOG0603|consen 456 RLTYFGFWSELERS----CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---- 526 (612)
T ss_pred EEEEechhhhCchh----hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----
Confidence 99999999876533 444566999999999984 78999999999999999999999999887766 333333
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.+.. ...+|..++|||+.||+.||.+|+++.+++.|+||..
T Consensus 527 ~~~~~----------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 527 QMPKF----------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred cCCcc----------------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 22111 1347889999999999999999999999999999933
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.69 Aligned_cols=196 Identities=22% Similarity=0.348 Sum_probs=160.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+...+.+|||||||.++.+.........+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+|
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~k 136 (321)
T cd05603 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV 136 (321)
T ss_pred CccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence 78888899999999999999998644443333445699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+++..... .......++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+.....
T Consensus 137 l~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~- 213 (321)
T cd05603 137 LTDFGLCKEGVEP-EETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL- 213 (321)
T ss_pred EccCCCCccCCCC-CCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-
Confidence 9999998753221 222344568999999999875 5789999999999999999999999998877666655532100
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~h~~f~~ 231 (417)
.+....+..+.+||.+||..||.+|+++ .++++|+||..
T Consensus 214 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 214 -----------------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 0112345688999999999999999875 59999999953
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=279.63 Aligned_cols=201 Identities=21% Similarity=0.338 Sum_probs=158.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
.+|+++++.+..+.++||||||+.+ +|...+. .....+++.++..++.||+.||+|||+++|+||||||+|||++.
T Consensus 53 ~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 132 (280)
T cd05608 53 RFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN 132 (280)
T ss_pred CcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 4688888889999999999999986 5544442 23456999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||++....... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 133 ~~~~~l~dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 210 (280)
T cd05608 133 DGNVRISDLGLAVELKDGQ-SKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210 (280)
T ss_pred CCCEEEeeCccceecCCCC-ccccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence 9999999999997654322 22234567999999999986 578999999999999999999999998755432222222
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
....... ......++..+.+||.+||..||++|+ |++++++|+||..
T Consensus 211 ~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 211 QRILNDS--------------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HhhcccC--------------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 1110000 011224677899999999999999999 8899999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=276.39 Aligned_cols=226 Identities=34% Similarity=0.651 Sum_probs=178.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+...+.+||||||+.++++..+.+....+++.++..++.||+.+|+|||+++|+|+||+++||++++++.+|
T Consensus 61 ~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~k 140 (288)
T cd07833 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLK 140 (288)
T ss_pred CeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEE
Confidence 78899999999999999999999988887766666699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||++..............+++..|+|||++.....++.++|||||||++|+|++|+.+|...+..+.+..+...++.
T Consensus 141 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 220 (288)
T cd07833 141 LCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220 (288)
T ss_pred EEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998765443323344567889999999987447899999999999999999999999988888877777766655
Q ss_pred CCCCCCCCCCCCCccccCCC-chhhhhhHH-HhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKP-SRTMKRRVR-EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.....+........+..... ......... .....++.++++||++||..||++|||++++++|+||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 44332222221111111000 000011111 2223458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=294.50 Aligned_cols=200 Identities=29% Similarity=0.450 Sum_probs=159.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+|+++++.++.++.+|||||||.+ +|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ 139 (376)
T cd05598 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH 139 (376)
T ss_pred CCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC
Confidence 3688899999999999999999985 566666544 46899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC------------------------------------------CcccccccccCCCCchhhcCC
Q 014871 82 LKLADFGLARSFSYDHN------------------------------------------NTLTNRVITLWYRPPELLLGA 119 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~------------------------------------------~~~~~~~gt~~y~aPE~l~~~ 119 (417)
+||+|||+|..+..... ......+||+.|+|||++.+
T Consensus 140 ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 218 (376)
T cd05598 140 IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR- 218 (376)
T ss_pred EEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-
Confidence 99999999854321000 00113468999999999976
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhh
Q 014871 120 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFD 199 (417)
Q Consensus 120 ~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (417)
..++.++||||||||||||++|+.||.+.+..+....+........ .+ ....++
T Consensus 219 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------~~-----------------~~~~~s 272 (376)
T cd05598 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH---------IP-----------------SQAKLS 272 (376)
T ss_pred CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcccc---------CC-----------------CCCCCC
Confidence 5789999999999999999999999998887776655532111000 00 012367
Q ss_pred HHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCC
Q 014871 200 RHALELLEKMLMLDPSQRI---SAKDALDSEYFWT 231 (417)
Q Consensus 200 ~~~~~Li~~~L~~dP~~Rp---ta~elL~h~~f~~ 231 (417)
.++++||.+|+ .+|.+|+ |+.++++|+||..
T Consensus 273 ~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 273 REASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred HHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 78999999976 5999999 9999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.32 Aligned_cols=223 Identities=24% Similarity=0.335 Sum_probs=162.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+..++.+||||||+++ +|.+++.+ ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~ 142 (331)
T cd06649 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE 142 (331)
T ss_pred CCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc
Confidence 788999999999999999999986 55555543 44699999999999999999999986 6999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++...... ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+....
T Consensus 143 ~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 218 (331)
T cd06649 143 IKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPV 218 (331)
T ss_pred EEEccCccccccccc---ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence 999999999765422 2234567999999999976 568999999999999999999999998776655433322111
Q ss_pred CCCCCCCCCCCCCCCc------ccc---CCCchhhhhhHHHh---------hhhhhHHHHHHHHHhcccCCCCCCCHHHH
Q 014871 162 GSPDETIWPGVSKMPA------YNH---FKPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDA 223 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~------~~~---~~~~~~~~~~~~~~---------~~~~~~~~~~Li~~~L~~dP~~Rpta~el 223 (417)
.......+........ ... .............+ ...++.++++||++||.+||++|||+.||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el 298 (331)
T cd06649 219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 298 (331)
T ss_pred cccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH
Confidence 1111111111000000 000 00000000000000 11367899999999999999999999999
Q ss_pred hcCCCCCC
Q 014871 224 LDSEYFWT 231 (417)
Q Consensus 224 L~h~~f~~ 231 (417)
|+|+||..
T Consensus 299 l~h~~~~~ 306 (331)
T cd06649 299 MNHTFIKR 306 (331)
T ss_pred hcChHHhh
Confidence 99999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=278.66 Aligned_cols=220 Identities=34% Similarity=0.586 Sum_probs=178.1
Q ss_pred cEeecccCceecC------eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~------~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
|||+.+..|+-.. ..|+|||||+.++-.++. ..+.-..++.++.|+|.|++|||+.||+||||||+||++.
T Consensus 76 nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~ 152 (369)
T KOG0665|consen 76 NIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN 152 (369)
T ss_pred ceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec
Confidence 6777776665544 579999999999988776 3478899999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.+..+||+|||+|+.... .-..+..+.|..|+|||++++. .|.+.+||||+|||+.||++|+-.|++....+++.++
T Consensus 153 ~~~~lKi~dfg~ar~e~~--~~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki 229 (369)
T KOG0665|consen 153 SDCTLKILDFGLARTEDT--DFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI 229 (369)
T ss_pred chhheeeccchhhcccCc--ccccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH
Confidence 999999999999976432 2466778899999999999984 5999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCC-ccccCCCchhhhhhHHHhh------------hhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 158 FELCGSPDETIWPGVSKMP-AYNHFKPSRTMKRRVREVF------------RHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
.+.++.+++....+..... .|..-.+... .....+.+ +.-...+++|+.+||..||++|.++.|+|
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~-~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQ-AISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhh-ccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 9999999987755443211 1111111100 01111111 12245689999999999999999999999
Q ss_pred cCCCCC
Q 014871 225 DSEYFW 230 (417)
Q Consensus 225 ~h~~f~ 230 (417)
+||||+
T Consensus 309 ~HPY~~ 314 (369)
T KOG0665|consen 309 RHPYIK 314 (369)
T ss_pred cCCeee
Confidence 999996
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.57 Aligned_cols=195 Identities=24% Similarity=0.417 Sum_probs=163.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++..+.+||||||+.+ +|...+.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 59 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 137 (318)
T cd05582 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 137 (318)
T ss_pred CcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcE
Confidence 688899999999999999999985 56555543 4469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+.....
T Consensus 138 kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~ 215 (318)
T cd05582 138 KLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL 215 (318)
T ss_pred EEeeccCCcccCCCC-CceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999987654321 22334568999999999876 5678999999999999999999999998887777666643110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
.+...++..+++||++||..||++|+| +.++++|+||..
T Consensus 216 ------------------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 216 ------------------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 011235678999999999999999999 788999999954
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=288.32 Aligned_cols=203 Identities=24% Similarity=0.356 Sum_probs=163.8
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+.+++.+...+++||||||+. ++|.+++.+....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 62 ~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~ 141 (332)
T cd05623 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI 141 (332)
T ss_pred CEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCE
Confidence 67888889999999999999997 57777776655679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
||+|||++..............++|+.|+|||++.. ...++.++|||||||+||||++|+.||...+..+.+.++.
T Consensus 142 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (332)
T cd05623 142 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (332)
T ss_pred EEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 999999997654333323334578999999999862 2457899999999999999999999999888777777664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~h~~f~~ 231 (417)
...... .+ ......++.++++||++||..++++ |++++++++|+||..
T Consensus 222 ~~~~~~---~~----------------------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 222 NHKERF---QF----------------------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCCccc---cC----------------------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 321100 00 0111236788999999999765554 689999999999954
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=288.08 Aligned_cols=197 Identities=24% Similarity=0.426 Sum_probs=157.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+|+.++++++..+++||||||+.+ +|...+.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 56 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~ 134 (327)
T cd05617 56 PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH 134 (327)
T ss_pred CCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC
Confidence 4789999999999999999999986 55554443 346999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh------HHH-H
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE------AEQ-L 154 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~------~~~-~ 154 (417)
+||+|||+++..... .......++|..|+|||++.+ ..++.++||||||||||||++|+.||..... .+. .
T Consensus 135 ~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 212 (327)
T cd05617 135 IKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212 (327)
T ss_pred EEEeccccceeccCC-CCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH
Confidence 999999998753221 222344678999999999976 5789999999999999999999999964221 111 1
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC------HHHHhcCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS------AKDALDSEY 228 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt------a~elL~h~~ 228 (417)
..+.. .+ ..+...++..+.+||++||..||++|++ +.++++|+|
T Consensus 213 ~~~~~---~~---------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 213 QVILE---KP---------------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred HHHHh---CC---------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence 11111 00 0112336778999999999999999998 579999999
Q ss_pred CCCC
Q 014871 229 FWTD 232 (417)
Q Consensus 229 f~~~ 232 (417)
|...
T Consensus 263 f~~~ 266 (327)
T cd05617 263 FRSI 266 (327)
T ss_pred CCCC
Confidence 9653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=286.83 Aligned_cols=195 Identities=27% Similarity=0.479 Sum_probs=161.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|++++++++..+.+||||||+.+ +|...+.+ ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 62 ~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~i 140 (323)
T cd05615 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI 140 (323)
T ss_pred chhheeeEEecCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE
Confidence 456788889999999999999986 55555543 4469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+.....
T Consensus 141 kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 218 (323)
T cd05615 141 KIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218 (323)
T ss_pred EEeccccccccCCCC-ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999987543221 12234568999999999876 5689999999999999999999999999888777776654211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
. ....++.++++||.+||..||++|++ ..++++|+||..
T Consensus 219 ~------------------------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 219 S------------------------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred C------------------------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 0 11235678999999999999999997 589999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=297.64 Aligned_cols=225 Identities=22% Similarity=0.302 Sum_probs=163.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||++++.+...+..|||||++.++|+.++......|++.+++.|+.||+.||+|||++||+||||||+||||+.++.+|
T Consensus 221 nIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vk 300 (461)
T PHA03211 221 AVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300 (461)
T ss_pred CCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEE
Confidence 78899999999999999999999999988876655799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCC------hHHHHH
Q 014871 84 LADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKN------EAEQLS 155 (417)
Q Consensus 84 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~p-f~~~~------~~~~~~ 155 (417)
|+|||+++........ .....++|..|+|||++.+ ..++.++||||||||||||++|..+ |.... ...++.
T Consensus 301 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~ 379 (461)
T PHA03211 301 LGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL 379 (461)
T ss_pred EcccCCceecccccccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH
Confidence 9999999865432221 1223568999999999986 5689999999999999999997754 33221 123333
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCC-------CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFK-------PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~ 228 (417)
+++......... ++..........+. ........+.. +..++.++.+||++||..||++|||+.|||+|+|
T Consensus 380 ~~i~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 380 RIIRQAQVHVDE-FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred HHHHhhcccccc-CCCCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 443332221111 11000000000000 00000001111 1246678999999999999999999999999999
Q ss_pred CCC
Q 014871 229 FWT 231 (417)
Q Consensus 229 f~~ 231 (417)
|..
T Consensus 458 f~~ 460 (461)
T PHA03211 458 FQS 460 (461)
T ss_pred cCC
Confidence 953
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=286.05 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=162.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+.++++++.++++||||||+.+ +|..++.+....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~ 141 (331)
T cd05597 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHI 141 (331)
T ss_pred CCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCE
Confidence 677888899999999999999975 7777776555679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
||+|||++..+...........++|+.|+|||++.. ...++.++|||||||++|||++|+.||.+.+..+.+..+.
T Consensus 142 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 142 RLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred EEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 999999997654333222233568999999999863 2457889999999999999999999999888777776664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~h~~f~~ 231 (417)
....... +......++..+++||++||..++++ |+++.++++|+||..
T Consensus 222 ~~~~~~~-------------------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 222 NHKEHFQ-------------------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred cCCCccc-------------------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 3211100 00011236778999999999765544 789999999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=275.71 Aligned_cols=225 Identities=47% Similarity=0.858 Sum_probs=185.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+...+.+|+||||+.++|.+++.+....+++.++..++.||+.+|+|||+++|+|+||+++||++++++.+
T Consensus 58 ~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~ 137 (282)
T cd07829 58 PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVL 137 (282)
T ss_pred CCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCE
Confidence 36777888888889999999999999888887764569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++....... .......+..|+|||++.....++.++|||||||+++||++|+.+|...+..+.+.++...++
T Consensus 138 ~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 216 (282)
T cd07829 138 KLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG 216 (282)
T ss_pred EEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhC
Confidence 9999999976543221 223344578899999987655789999999999999999999999999999999999999888
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+.+..|.....+..+..... ..........+..++..+++||++||..||++||++.++++|+||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 217 TPTEESWPGVTKLPDYKPTFP-KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CCcHHHHHhhccccccccccc-ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 888887776666542221111 111122234445568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.34 Aligned_cols=203 Identities=27% Similarity=0.357 Sum_probs=163.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+|||||||.+ +|..++.. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 103 p~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred CCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC
Confidence 3678889999999999999999985 56555543 35899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCC---CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++.............++|..|+|||++.... .++.++||||||||||||++|+.||.+.+.......|.
T Consensus 181 ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 260 (371)
T cd05622 181 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260 (371)
T ss_pred EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999876533333334567899999999987532 37899999999999999999999999988877777765
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTDP 233 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~h~~f~~~~ 233 (417)
....... ++. ...++..+++||.+||..++.+ |+++++|++|+||+...
T Consensus 261 ~~~~~~~---~~~-----------------------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 261 NHKNSLT---FPD-----------------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred cCCCccc---CCC-----------------------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 4211110 000 1236778999999999854443 78999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=289.98 Aligned_cols=201 Identities=24% Similarity=0.383 Sum_probs=161.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+|+++++.+..++++|||||||.+ +|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~ 139 (360)
T cd05627 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH 139 (360)
T ss_pred CCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC
Confidence 4688899999999999999999986 56555544 346999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC----------------------------------CcccccccccCCCCchhhcCCCCCCCccc
Q 014871 82 LKLADFGLARSFSYDHN----------------------------------NTLTNRVITLWYRPPELLLGATKYGPAVD 127 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~D 127 (417)
+||+|||+++.+..... ......++|..|+|||++.+ ..++.++|
T Consensus 140 vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~D 218 (360)
T cd05627 140 VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCD 218 (360)
T ss_pred EEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcce
Confidence 99999999875432110 01123478999999999986 57899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHH
Q 014871 128 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLE 207 (417)
Q Consensus 128 iwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~ 207 (417)
|||||||||||++|+.||...+..+.+.++........ .+ ....++.++++||.
T Consensus 219 iwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~---------~p-----------------~~~~~s~~~~~li~ 272 (360)
T cd05627 219 WWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLV---------FP-----------------PEVPISEKAKDLIL 272 (360)
T ss_pred eccccceeeecccCCCCCCCCCHHHHHHHHHcCCCcee---------cC-----------------CCCCCCHHHHHHHH
Confidence 99999999999999999999888777776643111000 00 00125778999999
Q ss_pred HhcccCCCCCC---CHHHHhcCCCCCCC
Q 014871 208 KMLMLDPSQRI---SAKDALDSEYFWTD 232 (417)
Q Consensus 208 ~~L~~dP~~Rp---ta~elL~h~~f~~~ 232 (417)
+|+. ||.+|+ ++.++++|+||...
T Consensus 273 ~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 273 RFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred Hhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 9874 999998 58999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=277.06 Aligned_cols=227 Identities=46% Similarity=0.836 Sum_probs=184.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~-~~ 80 (417)
.||+++++.+....++|+||||+++++...+.... ..+++..++.++.||+.||+|||+++|+|+||||+||+++. ++
T Consensus 61 ~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~ 140 (294)
T PLN00009 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140 (294)
T ss_pred CCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC
Confidence 57999999999999999999999988888775533 34788999999999999999999999999999999999985 45
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||++...... ........++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+.+++..
T Consensus 141 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~ 219 (294)
T PLN00009 141 ALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI 219 (294)
T ss_pred EEEEcccccccccCCC-ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 6999999999764322 122233456889999999876556889999999999999999999999999888888888888
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+.+....|.....++.+....... ...........++.++++||.+||..||++||++.++++|+||..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 220 LGTPNEETWPGVTSLPDYKSAFPKW-PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hCCCChhhccccccchhhhhhcccC-CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 8888888887666655543221110 011222334557889999999999999999999999999999954
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=289.65 Aligned_cols=226 Identities=23% Similarity=0.292 Sum_probs=162.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+...+..||||||+.++|+.++......+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 117 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~ 196 (357)
T PHA03209 117 PSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQV 196 (357)
T ss_pred CCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 47899999999999999999999999999888777789999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCh---------HH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNE---------AE 152 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~-~pf~~~~~---------~~ 152 (417)
||+|||+++..... .......+|..|+|||++.+ ..++.++||||||||+|||+++. .+|..... ..
T Consensus 197 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~ 273 (357)
T PHA03209 197 CIGDLGAAQFPVVA--PAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273 (357)
T ss_pred EEecCccccccccC--cccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHH
Confidence 99999999753321 12234567999999999876 57899999999999999999854 44443221 22
Q ss_pred HHHHHHHhcCCCCCCCCCCC-CC-CCccccCCCchh--hhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014871 153 QLSKIFELCGSPDETIWPGV-SK-MPAYNHFKPSRT--MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~ 228 (417)
.+..+....+.......... .. ...+..+..... ...........++.++.+||++||..||++|||+.|||+|+|
T Consensus 274 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred HHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 23333333332221111000 00 000000000000 000000001235678889999999999999999999999999
Q ss_pred CCC
Q 014871 229 FWT 231 (417)
Q Consensus 229 f~~ 231 (417)
|..
T Consensus 354 f~~ 356 (357)
T PHA03209 354 FAQ 356 (357)
T ss_pred hcc
Confidence 953
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=283.64 Aligned_cols=200 Identities=24% Similarity=0.407 Sum_probs=167.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||.+-..|+.++.+|+||..|.| ||.+.+.+.+ ..|++..++.|+.+|+.||++||..+||+|||||+|||||+.|+
T Consensus 246 FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 246 FIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH 325 (591)
T ss_pred cEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC
Confidence 467788999999999999999986 5555555443 35999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
|+|+|+|||..+.. ......++||..|||||++.+ ..|+...|.|||||+||||+.|+.||....+..-...+-.
T Consensus 326 vRISDLGLAvei~~--g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr-- 400 (591)
T KOG0986|consen 326 VRISDLGLAVEIPE--GKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR-- 400 (591)
T ss_pred eEeeccceEEecCC--CCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH--
Confidence 99999999998764 335566799999999999987 5599999999999999999999999986655433322211
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~~ 232 (417)
.......+....|++++++|.+.+|.+||++|. ++.++.+||||+..
T Consensus 401 ------------------------r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 401 ------------------------RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred ------------------------HHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 112223344567999999999999999999997 56899999999765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=287.42 Aligned_cols=197 Identities=26% Similarity=0.356 Sum_probs=153.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||++++.++.++.+|+|||||+++.+.. ...+.+..+..++.||+.||+|||+++|+|||||++||||++++.+|
T Consensus 133 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 208 (353)
T PLN00034 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVK 208 (353)
T ss_pred CcceeeeEeccCCeEEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEE
Confidence 78999999999999999999999754432 12467888999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
|+|||+++.+.... ......++|..|+|||++... ...+.++||||||||+|||++|+.||......+....+..
T Consensus 209 L~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 287 (353)
T PLN00034 209 IADFGVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA 287 (353)
T ss_pred Ecccccceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH
Confidence 99999998654221 223345789999999987431 2345689999999999999999999974433222222211
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
...... ......++.++++||++||..||++|+|+.|||+|+||..
T Consensus 288 ~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 288 ICMSQP--------------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HhccCC--------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 111000 0111236778999999999999999999999999999955
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=275.70 Aligned_cols=224 Identities=48% Similarity=0.899 Sum_probs=180.8
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
++++.++.+...+..||||||++++|..++.... ..+++.++..++.||+.+|+|||+++++|+||+|+|||++.++.+
T Consensus 59 ~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~ 138 (283)
T cd07835 59 NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGAL 138 (283)
T ss_pred CccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcE
Confidence 6788888888899999999999988887776543 368999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++...... .......++..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+.++.+...
T Consensus 139 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (283)
T cd07835 139 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG 217 (283)
T ss_pred EEeecccccccCCCc-cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999997653221 1223335588899999887655678899999999999999999999999988888888888877
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+....|+....++.+........ ..........++.++.+||.+||+.||++|||++|+++|+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 218 TPDEDVWPGVTSLPDYKPTFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CCChHHhhhhhhchhhhhhccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 777777766555443322111100 111223345677899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.33 Aligned_cols=228 Identities=26% Similarity=0.320 Sum_probs=165.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG----LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~----~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
.|||++++.++..+..|||+|++..+++.++.... ....+.+++.|+.||+.||+|||+++||||||||+||||+.
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 47899999999999999999999999888765432 23457788999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCC-CCC--CChHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPG--KNEAEQLS 155 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~p-f~~--~~~~~~~~ 155 (417)
++.+||+|||+++.+...........++|..|+|||++.+ ..++.++||||||||||||+++..+ |.. .+....+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999998765433333345678999999999986 5789999999999999999998754 432 23445555
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhh--hhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
++...+......+.+...++..+............+..++ ..++.++.+||.+||..||++|+|+.|+|.|+||..
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 5555444332221110000000000000000001111111 125678899999999999999999999999999954
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=275.70 Aligned_cols=226 Identities=32% Similarity=0.627 Sum_probs=174.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.++.++..||||||+.++++..+......+++.+++.++.||+.+|+|||+++|+|+||+|+||++++++.+
T Consensus 60 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~ 139 (286)
T cd07846 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVV 139 (286)
T ss_pred cchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcE
Confidence 36788899999999999999999988777666555569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++....... .......++..|+|||++.+...++.++|||||||++|||++|+++|......+.+..+.....
T Consensus 140 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07846 140 KLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218 (286)
T ss_pred EEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC
Confidence 999999987654322 2233456788999999987655678899999999999999999999998888777777766554
Q ss_pred CCCCCCCCCCCCCCcccc-CCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 163 SPDETIWPGVSKMPAYNH-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.............+.... .................++..+++||.+||..||++|||+.++++|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 432211100000000000 0000111122333445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=306.97 Aligned_cols=200 Identities=27% Similarity=0.392 Sum_probs=175.4
Q ss_pred EeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|+..+..|.+++++||||||+. |||+.++.+-+ +++++.++.|+..|+.||+-||+.|+|||||||+|||||..|+||
T Consensus 137 iv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHik 215 (1317)
T KOG0612|consen 137 IVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIK 215 (1317)
T ss_pred HHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEe
Confidence 4566788999999999999996 58999998877 799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
|+|||.|..+..+........|||+.|++||+|.. ...|+..+|.|||||++||||+|..||...+-.+++.+|++
T Consensus 216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 99999998888777777788899999999999852 25689999999999999999999999999999999999987
Q ss_pred hcC--CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 014871 160 LCG--SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWTDPL 234 (417)
Q Consensus 160 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~h~~f~~~~~ 234 (417)
.-. .+++. ..+|.++++||+++|. +++.|.. ++|+..||||....+
T Consensus 296 hk~~l~FP~~----------------------------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 296 HKESLSFPDE----------------------------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hhhhcCCCcc----------------------------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 521 11100 1278899999999876 7888988 999999999976544
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=280.31 Aligned_cols=226 Identities=39% Similarity=0.736 Sum_probs=173.4
Q ss_pred cEeecccCceec--CeEEEEEcCCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDHDLTGLADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g~l~~~~~~~----~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+... ..+||||||++++++.++... ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 63 ~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~ 142 (316)
T cd07842 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVM 142 (316)
T ss_pred CccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEc
Confidence 577778877777 789999999999888766432 23689999999999999999999999999999999999999
Q ss_pred C----CCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 78 N----EGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 78 ~----~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
. ++.+||+|||+++.+..... .......++..|+|||++.+...++.++|||||||++|+|++|+.||.+....
T Consensus 143 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 143 GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred CCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 9 88999999999986543222 11223456889999999876566889999999999999999999999866543
Q ss_pred ---------HHHHHHHHhcCCCCCCCCCCCCCCCccccCCC-------chhhhhhHHHhhhhhhHHHHHHHHHhcccCCC
Q 014871 152 ---------EQLSKIFELCGSPDETIWPGVSKMPAYNHFKP-------SRTMKRRVREVFRHFDRHALELLEKMLMLDPS 215 (417)
Q Consensus 152 ---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 215 (417)
..+..+++.+..+....|......+.+..... .........+.....+.++.+||.+||..||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 302 (316)
T cd07842 223 IKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPT 302 (316)
T ss_pred ccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcc
Confidence 35666777777666665554444444332100 00001111112235778999999999999999
Q ss_pred CCCCHHHHhcCCCC
Q 014871 216 QRISAKDALDSEYF 229 (417)
Q Consensus 216 ~Rpta~elL~h~~f 229 (417)
+|||+.++++|+||
T Consensus 303 ~Rps~~eil~~~~f 316 (316)
T cd07842 303 KRITAEEALEHPYF 316 (316)
T ss_pred cCcCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=276.89 Aligned_cols=200 Identities=22% Similarity=0.400 Sum_probs=168.4
Q ss_pred EeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||++|..|-.+..+|||||||+ |++.+.+..+++.|++.+|..+++..|.||+|||...-||||||..||||+.+|..|
T Consensus 90 VVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AK 169 (502)
T KOG0574|consen 90 VVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAK 169 (502)
T ss_pred hhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhh
Confidence 6888887777889999999998 678888877888999999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+|-.+... -....+.+||++||||||+.. ..|+.++||||||++..||.-|++|+..-.. ++.|+.+...
T Consensus 170 LADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~ 244 (502)
T KOG0574|consen 170 LADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTK 244 (502)
T ss_pred hhhccccchhhhh-HHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCC
Confidence 9999999776532 234556789999999999975 6789999999999999999999999964432 3445544444
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
|+..+. -...++.++.|||++||.++|++|-||.++++|+|++..+
T Consensus 245 PPPTF~------------------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 245 PPPTFK------------------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred CCCCCC------------------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 433221 1234678899999999999999999999999999997653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=291.35 Aligned_cols=201 Identities=22% Similarity=0.379 Sum_probs=167.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+||++++.|.+.+.+||++|||.|+-.+ .+..-+..|++++|..+++|+|.||.|||+++|||||||..|||+.-+|.|
T Consensus 90 ~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdi 169 (1187)
T KOG0579|consen 90 VIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDI 169 (1187)
T ss_pred HHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcE
Confidence 5789999999999999999999976544 444455679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+|+|||++.... .......+++||+.||||||+.+ ..+|+.++|||||||+|.||.-+.+|....+..-++-+|.
T Consensus 170 rLADFGVSAKn~-~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia 248 (1187)
T KOG0579|consen 170 RLADFGVSAKNK-STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 248 (1187)
T ss_pred eeecccccccch-hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh
Confidence 999999875432 12234456789999999999764 3579999999999999999999999998888877776664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.-- |+- .-...+++..+.|||++||.+||..||++.+||+|+||...
T Consensus 249 KSe--PPT-------------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 249 KSE--PPT-------------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred hcC--CCc-------------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 310 100 00123467789999999999999999999999999999754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=272.77 Aligned_cols=225 Identities=34% Similarity=0.611 Sum_probs=180.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.|++++++.+..++..|+||||+.+++.+.+.... ..+++.++..++.||+.+|.|||+++++|+|||++||+++.++.
T Consensus 58 ~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~ 137 (283)
T cd07830 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV 137 (283)
T ss_pred CCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC
Confidence 47888999999999999999999888888776654 46899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
++|+|||++....... ......++..|+|||++.....++.++|||||||+++||++|+.+|...+..+.+.++....
T Consensus 138 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 215 (283)
T cd07830 138 VKIADFGLAREIRSRP--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVL 215 (283)
T ss_pred EEEeecccceeccCCC--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhc
Confidence 9999999997654321 22345678899999988765568899999999999999999999999999999998888888
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+.+....|.....+.......................+.++++||++||..||++|||++|++.|+||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 216 GTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred CCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 77766555433321111111111111111233333447889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=270.19 Aligned_cols=208 Identities=25% Similarity=0.389 Sum_probs=163.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC-
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN- 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~- 81 (417)
|||++++.|+++.+.|||||-|.| .|+..+.+. +.|+|.++.+++++|..||+|||.+||.||||||+|||....+.
T Consensus 137 nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 137 NILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKV 215 (463)
T ss_pred cHHHHHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCc
Confidence 899999999999999999999985 677666543 46999999999999999999999999999999999999876554
Q ss_pred --EEEeeccCcccccCC------CCCcccccccccCCCCchhhc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 014871 82 --LKLADFGLARSFSYD------HNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKN 149 (417)
Q Consensus 82 --vkL~DFGla~~~~~~------~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 149 (417)
||||||.+...+... ....+.+.+|+..|||||++. ....|+.++|+||||+|||.||+|++||.+..
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 899999887543222 223456678899999999863 23578999999999999999999999997643
Q ss_pred h-----------HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC
Q 014871 150 E-----------AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218 (417)
Q Consensus 150 ~-----------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp 218 (417)
. ....+++++-+.. +...+ ..+-|..++.+++|||..+|..|+.+|.
T Consensus 296 g~dCGWdrGe~Cr~CQ~~LFesIQE-------GkYeF---------------PdkdWahIS~eakdlisnLlvrda~~rl 353 (463)
T KOG0607|consen 296 GADCGWDRGEVCRVCQNKLFESIQE-------GKYEF---------------PDKDWAHISSEAKDLISNLLVRDAKQRL 353 (463)
T ss_pred CCcCCccCCCccHHHHHHHHHHHhc-------cCCcC---------------ChhhhHHhhHHHHHHHHHHHhccHHhhh
Confidence 2 1122222221111 00000 1123567899999999999999999999
Q ss_pred CHHHHhcCCCCCCCCC
Q 014871 219 SAKDALDSEYFWTDPL 234 (417)
Q Consensus 219 ta~elL~h~~f~~~~~ 234 (417)
++.++++|||+.....
T Consensus 354 sa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 354 SAAQVLNHPWVQRCAP 369 (463)
T ss_pred hhhhccCCccccccch
Confidence 9999999999976543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=275.06 Aligned_cols=200 Identities=23% Similarity=0.395 Sum_probs=161.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+.+++.++..+++||||||+.+ +|...+... ...+++.++..++.||+.||+|||+++|+||||||+|||+++++
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 139 (285)
T cd05605 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG 139 (285)
T ss_pred CCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC
Confidence 4788999999999999999999985 565555432 34699999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.++|+|||+++...... .....+++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 140 ~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~ 216 (285)
T cd05605 140 HIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR 216 (285)
T ss_pred CEEEeeCCCceecCCCC--ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH
Confidence 99999999997654221 2234567999999999876 56899999999999999999999999887665544443321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
.... .......++..+.+||.+||..||++|+ +++++++|+||..
T Consensus 217 ~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 217 VKED--------------------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred hhhc--------------------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 1110 0111234677899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=273.87 Aligned_cols=192 Identities=26% Similarity=0.399 Sum_probs=165.6
Q ss_pred ccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeecc
Q 014871 9 TDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 88 (417)
Q Consensus 9 ~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFG 88 (417)
...|..++++|+||||+.|+.+++...+...|++...+.|-..|+.||.|||+++||+||||.+|+|||.||.+||+|||
T Consensus 234 KYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 234 KYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred hhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecc
Confidence 36788899999999999986666555555569999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 014871 89 LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 168 (417)
Q Consensus 89 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 168 (417)
+++..-.. .....+.|||+.|+||||+.. ..|+.++|.|-+|||+|||+||+.||...+...+...|...
T Consensus 314 LCKE~I~~-g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------- 383 (516)
T KOG0690|consen 314 LCKEEIKY-GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------- 383 (516)
T ss_pred cchhcccc-cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--------
Confidence 99875433 345567899999999999975 68999999999999999999999999988877777666431
Q ss_pred CCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 014871 169 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWTD 232 (417)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~~ 232 (417)
...+.+.++++++.||..+|.+||.+|. .++||.+|+||...
T Consensus 384 ----------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 384 ----------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred ----------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 1123456889999999999999999997 57999999999654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=295.00 Aligned_cols=198 Identities=24% Similarity=0.395 Sum_probs=164.7
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
|||++++.++..+++||||||+.+ +|.+.+.. ....|++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 126 niv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~ 205 (478)
T PTZ00267 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205 (478)
T ss_pred CEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC
Confidence 799999999999999999999975 66655432 33458999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+.+||+|||+++.+..... ......++|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.
T Consensus 206 ~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~ 284 (478)
T PTZ00267 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284 (478)
T ss_pred CcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999987643222 12334568999999999876 578999999999999999999999999888777776664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.....+ ....++.++++||.+||..||++|||+.++|.|+|+..
T Consensus 285 ~~~~~~-----------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 285 YGKYDP-----------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred hCCCCC-----------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 311100 01235678999999999999999999999999999843
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=281.90 Aligned_cols=203 Identities=24% Similarity=0.361 Sum_probs=162.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+.+++.++..+++||||||+.+ +|..++.+....+++..++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 62 ~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~ 141 (331)
T cd05624 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHI 141 (331)
T ss_pred CEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCE
Confidence 578888899999999999999975 6776776545579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
||+|||+++.............++|..|+|||++... ..++.++|||||||+||||++|+.||...+..+.+.++.
T Consensus 142 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05624 142 RLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred EEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence 9999999976653332223345689999999998642 357889999999999999999999999888777766664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~h~~f~~ 231 (417)
....... +......++.++++||.+||..++++ |.+++++++|+||..
T Consensus 222 ~~~~~~~-------------------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 222 NHEERFQ-------------------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred cCCCccc-------------------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 3211100 00111235778999999999976654 579999999999954
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=282.33 Aligned_cols=193 Identities=26% Similarity=0.392 Sum_probs=159.4
Q ss_pred cEeecccCceecC-eEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRG-STYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~-~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~g-ivHrDlkp~NILl~~~ 79 (417)
|||.++....... .++|||||+.+ +|..++.+ ....|+...+..|+.||+.|+.|||+++ |||||||++||||+.+
T Consensus 100 NIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~ 179 (362)
T KOG0192|consen 100 NIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLK 179 (362)
T ss_pred CeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCC
Confidence 8899998888777 79999999985 56666655 3567999999999999999999999999 9999999999999999
Q ss_pred C-CEEEeeccCcccccCCCCCcccccccccCCCCchhhcC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 80 G-NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 80 ~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
. ++||+|||+++...... ...+...||..|||||++.+ ...|+.++||||||||||||+||+.||...........+
T Consensus 180 ~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v 258 (362)
T KOG0192|consen 180 GKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV 258 (362)
T ss_pred CCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 7 99999999998755322 33444688999999999985 267999999999999999999999999999885555555
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
......+. +...++..+.+||++|+..||++||+..+|+.
T Consensus 259 ~~~~~Rp~----------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 259 VVGGLRPP----------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HhcCCCCC----------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 33211111 11226678999999999999999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=279.12 Aligned_cols=230 Identities=39% Similarity=0.669 Sum_probs=180.4
Q ss_pred cEeecccCceecC-----eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYRG-----STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~~-----~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
||+++++.+.... .+|+||||+..+|..++.+.. .+++..++.++.||+.||+|||++||+|+||||+|||++.
T Consensus 60 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~ 138 (330)
T cd07834 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS 138 (330)
T ss_pred chhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 4566666666654 789999999988877776544 7999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
++.++|+|||++........ .......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..
T Consensus 139 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~ 218 (330)
T cd07834 139 NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218 (330)
T ss_pred CCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 99999999999987654321 2234456789999999998744789999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
+....+.+....+............. ........+......++..+.+||++||..||++|||+.++++|+||.....
T Consensus 219 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 98888777655444221111000000 0111122334445567899999999999999999999999999999965433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=269.90 Aligned_cols=196 Identities=27% Similarity=0.433 Sum_probs=158.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++.+..+|+||||+.+ +|.+.+.+. ..+++..++.++.||+.||+|||+++|+|+||||+|||+++++++
T Consensus 65 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 688999999999999999999986 565555543 458999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcc--cccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++.......... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+...
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 222 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc
Confidence 9999999876542211111 23456789999999876 56899999999999999999999999876655544443221
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
... ..+...++..+.+||++||..||++|||+.++|+|+||
T Consensus 223 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 223 PTN----------------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCC----------------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 000 01122467789999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=277.65 Aligned_cols=231 Identities=35% Similarity=0.620 Sum_probs=176.3
Q ss_pred cEeecccCce----ecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNK----YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~----~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++++.++ ...++||||||+.++|..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 65 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~ 143 (334)
T cd07855 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED 143 (334)
T ss_pred CccCHHHhccccCCCCceEEEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 4566666554 33578999999998887777554 459999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCC---cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+.+||+|||++......... .....+++..|+|||++.....++.++|||||||++|||++|+.||.+.+...++..
T Consensus 144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~ 223 (334)
T cd07855 144 CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223 (334)
T ss_pred CcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH
Confidence 99999999999765432221 122346788999999987645689999999999999999999999999998888888
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccC-CCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHF-KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
+....+.+....+...........+ .........+..+...++.++++||++||..||++|||+.+++.|+||.....+
T Consensus 224 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 224 ILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 8887777655443322211000000 000001112233445678999999999999999999999999999999655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=276.27 Aligned_cols=229 Identities=40% Similarity=0.649 Sum_probs=175.1
Q ss_pred cEeecccCceec-----CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYR-----GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~-----~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
||+++++.+... .++||||||++++|.+.+.+. ..+++.+++.++.||+.||+|||+++++||||||+|||++.
T Consensus 65 ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~ 143 (337)
T cd07858 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143 (337)
T ss_pred CccchHHheecccccccCcEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 566666655433 358999999999888877654 46999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||+++...... .......++..|+|||++.....++.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 144 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 222 (337)
T cd07858 144 NCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT 222 (337)
T ss_pred CCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence 9999999999998654322 223345678899999998754568899999999999999999999999988888888888
Q ss_pred HhcCCCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
+..+.+....+............+ ...............++.++++||++||..||++|||+.++|+|+||.....
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 877766554432211100000000 0000011122334568899999999999999999999999999999966433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=280.23 Aligned_cols=221 Identities=32% Similarity=0.580 Sum_probs=166.6
Q ss_pred cEeecccCceec------CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYR------GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~------~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++++... .+.||||||+.+++...+... +++.++..++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~ 152 (353)
T cd07850 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 152 (353)
T ss_pred CCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 566666655433 357999999999988877543 89999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.++
T Consensus 153 ~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 153 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229 (353)
T ss_pred CCCCEEEccCccceeCCCC--CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999999999765422 12233456889999999986 57899999999999999999999999999888888888
Q ss_pred HHhcCCCCCCCCCCCCCC--------Cccc-----cCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 158 FELCGSPDETIWPGVSKM--------PAYN-----HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
.+.++.+........... +.+. ...................+..+++||++||..||++|+|+.|+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 230 IEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred HHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 777766544322221110 0000 000000000000001223467789999999999999999999999
Q ss_pred cCCCCC
Q 014871 225 DSEYFW 230 (417)
Q Consensus 225 ~h~~f~ 230 (417)
+|+||.
T Consensus 310 ~~~~~~ 315 (353)
T cd07850 310 QHPYIN 315 (353)
T ss_pred cChhHh
Confidence 999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=271.28 Aligned_cols=201 Identities=23% Similarity=0.354 Sum_probs=157.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+++++.++.+.++||||||+.+ +|..++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 53 p~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~ 132 (277)
T cd05607 53 PFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG 132 (277)
T ss_pred CcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC
Confidence 5789999999999999999999975 565555432 33589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||++...... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+...
T Consensus 133 ~~~l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~ 209 (277)
T cd05607 133 NCRLSDLGLAVELKDG--KTITQRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209 (277)
T ss_pred CEEEeeceeeeecCCC--ceeeccCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH
Confidence 9999999998765432 12233467899999999976 45899999999999999999999999765432211111110
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~h~~f~~ 231 (417)
.... ........++.++++||++||..||++|+|+ ++++.|+||..
T Consensus 210 ~~~~-------------------------~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 210 TLED-------------------------EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hhcc-------------------------ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 0000 0000112367789999999999999999999 77889999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=277.87 Aligned_cols=223 Identities=22% Similarity=0.350 Sum_probs=160.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~~~ 81 (417)
|||++++.+..++++||||||+.+ +|.+++.+ ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~ 142 (333)
T cd06650 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 142 (333)
T ss_pred cccceeEEEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC
Confidence 789999999999999999999975 66666654 34689999999999999999999985 7999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH-h
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE-L 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~-~ 160 (417)
+||+|||++...... ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.. .
T Consensus 143 ~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 218 (333)
T cd06650 143 IKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPV 218 (333)
T ss_pred EEEeeCCcchhhhhh---ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcc
Confidence 999999998765322 1223467899999999976 5688999999999999999999999987665443322211 0
Q ss_pred cCCCCCCCCCCCCC-----CCccc-cCCCchhhhhhHHHh---------hhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSK-----MPAYN-HFKPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+............ +..+. ..++........... ...++.++++||.+||.+||++|||+.||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 219 EGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 11111000000000 00000 000000000000000 0125788999999999999999999999999
Q ss_pred CCCCCC
Q 014871 226 SEYFWT 231 (417)
Q Consensus 226 h~~f~~ 231 (417)
|+||+.
T Consensus 299 h~~~~~ 304 (333)
T cd06650 299 HAFIKR 304 (333)
T ss_pred CHHHhc
Confidence 999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=276.62 Aligned_cols=227 Identities=37% Similarity=0.634 Sum_probs=169.9
Q ss_pred cEeecccCc-----eecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGN-----KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~-----~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
||+++++.+ ....++|+|+||+.+++...+.. ..|++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 64 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~ 141 (336)
T cd07849 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141 (336)
T ss_pred CcCchhheeecccccccceEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 455555433 33346899999999988877653 35999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
++.+||+|||+++........ .....++|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 142 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~ 221 (336)
T cd07849 142 NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221 (336)
T ss_pred CCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999765432211 122346789999999887655689999999999999999999999999888888777
Q ss_pred HHHhcCCCCCCCCCCCCCCCc--cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
+.+..+.+....+........ +..... ......+......++.++.+||.+||..||++|||+.++++|+||....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 222 ILGVLGTPSQEDLNCIISLRARNYIKSLP-FKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHcCCCCHHHHHHhhchhhhhHHhhcC-cCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 777766554433322111000 000000 0001112223345678899999999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=278.57 Aligned_cols=226 Identities=38% Similarity=0.652 Sum_probs=174.6
Q ss_pred cEeecccCceecC------eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~------~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
|++++.+.+.... ++|||+||++++|.+++.. ..|++.++..++.||+.+|+|||++||+|+||||+|||++
T Consensus 75 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07851 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152 (343)
T ss_pred CHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 3445555554444 4899999999888887765 3599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||++...... .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 153 ~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 153 EDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred CCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999999999765422 233466889999999876456789999999999999999999999999888888888
Q ss_pred HHhcCCCCCCCCCCCCCCCc--cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
.+.++.+.+..+........ +.... ...........+..++.++.+||++||..||++|||+.+|++|+||.....+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 229 MNLVGTPDEELLQKISSESARNYIQSL-PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHhcCCCCHHHHhhccchhHHHHHHhc-cccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 88777666554443322100 00000 0000112233344568899999999999999999999999999999765444
Q ss_pred C
Q 014871 236 C 236 (417)
Q Consensus 236 ~ 236 (417)
.
T Consensus 308 ~ 308 (343)
T cd07851 308 E 308 (343)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=283.18 Aligned_cols=222 Identities=30% Similarity=0.516 Sum_probs=178.6
Q ss_pred eecccCceecCeEEEEEcCCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-CE
Q 014871 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-NL 82 (417)
Q Consensus 6 v~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~-~v 82 (417)
|+++..|.+++|+|||||-+.-+|.+++.+-+ ..|....|+.|+.||+.||..|...||+|.||||+|||+++.. .+
T Consensus 497 lrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 67888999999999999999999999988744 4589999999999999999999999999999999999998764 58
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||||||.|.... ...++.+..+.+|+|||++++ ..|+...|+||+||.||||.||+-.|++.+...++..++++-|
T Consensus 577 KLCDfGSA~~~~---eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFAS---ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccc---cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999999997765 334566777999999999998 6899999999999999999999999999999999999988877
Q ss_pred CCCCCCCCCCCC----------C--------------CccccCCCchhhhhhHHHh---h---hhhhHHHHHHHHHhccc
Q 014871 163 SPDETIWPGVSK----------M--------------PAYNHFKPSRTMKRRVREV---F---RHFDRHALELLEKMLML 212 (417)
Q Consensus 163 ~~~~~~~~~~~~----------~--------------~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~Li~~~L~~ 212 (417)
.+.......-.. + -...+.++...+...+... . ..+-..+++||.+||.+
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 655432221110 0 0012233333333322221 1 12345789999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q 014871 213 DPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 213 dP~~Rpta~elL~h~~f~~ 231 (417)
||++|.|+.++|.||||..
T Consensus 733 dP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 733 DPEKRITVNQALKHPFITE 751 (752)
T ss_pred ChhhcCCHHHHhcCCcccC
Confidence 9999999999999999953
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=269.79 Aligned_cols=198 Identities=22% Similarity=0.341 Sum_probs=156.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
+|+++++.++..+.+|+||||+.++.+.........+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 58 ~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~k 137 (278)
T cd05606 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137 (278)
T ss_pred cEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEE
Confidence 67888899999999999999998654443333445699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||++..+... ......++..|+|||++.+...++.++|||||||++|||++|+.||..................
T Consensus 138 l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 214 (278)
T cd05606 138 ISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214 (278)
T ss_pred EccCcCccccCcc---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc
Confidence 9999998765422 1223467999999999875456889999999999999999999999765322211111000000
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
. ..+...++.++++||++||..||++|+ ++.++++|+||..
T Consensus 215 -~--------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 215 -A--------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred -C--------------------------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 0 011123567899999999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=269.79 Aligned_cols=196 Identities=24% Similarity=0.378 Sum_probs=154.7
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
+++.+++.+...+..|+||||+.++.+.........+++.++..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 58 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~ 137 (279)
T cd05633 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137 (279)
T ss_pred cEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEE
Confidence 57788888888899999999998644443333344699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhc
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE--QLSKIFELC 161 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~~~~i~~~~ 161 (417)
|+|||++....... .....+|..|+|||++.....++.++|||||||++|+|++|+.||....... .+.....
T Consensus 138 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-- 212 (279)
T cd05633 138 ISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-- 212 (279)
T ss_pred EccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--
Confidence 99999987654221 2234679999999988644568899999999999999999999997543221 1111110
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
.. ...+...++.++++||++||..||++|+ |+.++++|+||..
T Consensus 213 -~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 213 -TV--------------------------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred -cC--------------------------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 00 0011234677899999999999999999 6999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=264.82 Aligned_cols=220 Identities=40% Similarity=0.739 Sum_probs=174.1
Q ss_pred cEeecccCceecCe-----EEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRGS-----TYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~~-----~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+..... +|+||||+.+++..++.+.. ..+++.+++.++.||+.||+|||+++|+|+|||++|||++
T Consensus 62 ~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred CcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 67788888877776 99999999988887766533 3599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+++|...+..+.+.++
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~ 218 (287)
T cd07838 142 SDGQVKIADFGLARIYSFEM--ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218 (287)
T ss_pred cCCCEEEeccCcceeccCCc--ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence 99999999999997754322 2223356888999999976 56889999999999999999999999999999988888
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+....+....|+........ .+ ..............++..+.+||++||..||++||++.+++.|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 219 FDVIGLPSEEEWPRNVSLPRS-SF--PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHcCCCChHhcCCCcccchh-hc--ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 876665544444322210000 00 0011112234445677889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=283.68 Aligned_cols=199 Identities=29% Similarity=0.519 Sum_probs=163.0
Q ss_pred EeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||++|..|.+++++|+||||+. |++..++++.+. |.|..++.|+..|..|+++.|..|+|||||||+|||||.||.||
T Consensus 691 VVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 691 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred eEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCcee
Confidence 7999999999999999999997 588888888775 99999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCc-----------------------------------------ccccccccCCCCchhhcCCCCC
Q 014871 84 LADFGLARSFSYDHNNT-----------------------------------------LTNRVITLWYRPPELLLGATKY 122 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~-----------------------------------------~~~~~gt~~y~aPE~l~~~~~~ 122 (417)
|+|||||+-+.-.++.. .-..+||..|+||||+.. ..|
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~ 848 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGY 848 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCc
Confidence 99999997553111100 012478999999999986 679
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHH
Q 014871 123 GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHA 202 (417)
Q Consensus 123 ~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (417)
+..+|.||.|||||||+.|++||...+..+...++++ |.....++. -..++.++
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n---------w~~~l~~~~-----------------~~~ls~e~ 902 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN---------WRNFLHIPY-----------------QGNLSKEA 902 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee---------hhhcccccc-----------------ccccCHHH
Confidence 9999999999999999999999988887766555432 333322221 12478899
Q ss_pred HHHHHHhcccCCCCCC---CHHHHhcCCCCCCC
Q 014871 203 LELLEKMLMLDPSQRI---SAKDALDSEYFWTD 232 (417)
Q Consensus 203 ~~Li~~~L~~dP~~Rp---ta~elL~h~~f~~~ 232 (417)
++||.++. .++++|+ .++||..|+||+..
T Consensus 903 ~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 903 LDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred HHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 99998865 4778887 46779999999654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=265.64 Aligned_cols=200 Identities=23% Similarity=0.355 Sum_probs=160.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLT-GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~-~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+..|+||||+.++.+ .++.+....+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+
T Consensus 63 ~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~ 142 (282)
T cd06643 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDI 142 (282)
T ss_pred CeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCE
Confidence 788888889999999999999987544 4444445569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
||+|||++...... ........++..|+|||++.. ...++.++|||||||++|||++|+.||...+..+....+.
T Consensus 143 kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 221 (282)
T cd06643 143 KLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221 (282)
T ss_pred EEcccccccccccc-ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh
Confidence 99999998764322 122234467899999998742 2357789999999999999999999998877666555543
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..... .. .....++.++++||++||..||++|||+.++++|+||..
T Consensus 222 ~~~~~--~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 222 KSEPP--TL-------------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred hcCCC--CC-------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 21100 00 001235678999999999999999999999999999965
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.19 Aligned_cols=196 Identities=26% Similarity=0.371 Sum_probs=172.1
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKL 84 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL 84 (417)
||++|.-|++.+.+||+||-|-|+.+..+.+....|.+..++.|+..+++|++|||++|||+|||||+|+|||.+|-+||
T Consensus 482 IvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 482 IVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred HHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEE
Confidence 67888999999999999999976554555555557999999999999999999999999999999999999999999999
Q ss_pred eeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 014871 85 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 164 (417)
Q Consensus 85 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~ 164 (417)
.|||+|+.+... ....+.|||+.|.|||++++ +..+.++|.||||+++||||+|.+||.+.+...+++.|..-+
T Consensus 562 VDFGFAKki~~g--~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi--- 635 (732)
T KOG0614|consen 562 VDFGFAKKIGSG--RKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI--- 635 (732)
T ss_pred eehhhHHHhccC--CceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh---
Confidence 999999988744 34567899999999999997 678999999999999999999999999999999999886532
Q ss_pred CCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 165 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
+.-++++.++..+.+||+++...+|.+|.. +.||.+|.||..
T Consensus 636 -------------------------d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 636 -------------------------DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred -------------------------hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 122344668889999999999999999985 899999999943
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=269.27 Aligned_cols=200 Identities=23% Similarity=0.398 Sum_probs=158.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.+++.+++.+..++.+||||||+.+ +|.+++.. ....+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 60 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~ 139 (285)
T cd05630 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG 139 (285)
T ss_pred CCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC
Confidence 4688888888899999999999975 56555543 233599999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.++|+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...............
T Consensus 140 ~~~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~ 216 (285)
T cd05630 140 HIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 216 (285)
T ss_pred CEEEeeccceeecCCCc--cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh
Confidence 99999999987643221 2234568999999999976 56899999999999999999999999865432221111111
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
... ........++.++++||++||+.||++|+| ++|+++|+||..
T Consensus 217 ~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 217 VKE--------------------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred hhh--------------------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 000 001122346778999999999999999999 999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=273.88 Aligned_cols=229 Identities=37% Similarity=0.621 Sum_probs=173.0
Q ss_pred cEeecccCce----ecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNK----YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~----~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++++... ....+|+++||++++|...+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 63 ~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~ 141 (332)
T cd07857 63 NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD 141 (332)
T ss_pred ChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC
Confidence 5666665432 22468999999999888777543 469999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCC---CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+.+||+|||+++....... ......++|..|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..
T Consensus 142 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~ 221 (332)
T cd07857 142 CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221 (332)
T ss_pred CCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHH
Confidence 9999999999986543221 1123346789999999887655689999999999999999999999999998888888
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
++..++.++...+............. ........+......++..+++||.+||+.||++|+|+.+++.|+||....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 222 ILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 88887776654433222110000000 000001112223344678899999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=264.38 Aligned_cols=199 Identities=32% Similarity=0.459 Sum_probs=161.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+..+..+|+||||+.+ +|.+++. ....+++.++..++.||+.+|++||+++|+|+||||+|||+++++.
T Consensus 58 ~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~ 136 (260)
T PF00069_consen 58 PNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE 136 (260)
T ss_dssp TTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE
T ss_pred ccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3688889999999999999999998 7776666 3346899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
++|+|||++.... ..........++..|+|||++.....++.++||||||+++|+|++|..||...+..+....+.+..
T Consensus 137 ~~l~Dfg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~ 215 (260)
T PF00069_consen 137 VKLIDFGSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL 215 (260)
T ss_dssp EEESSGTTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence 9999999997541 223344456779999999998733678999999999999999999999998875444444443211
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhh---hhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF---RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.. ...... ......+.+||++||..||++|||+.++++|+||
T Consensus 216 ~~--------------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 216 KR--------------------------PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HT--------------------------HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cc--------------------------cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 10 011111 1123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=272.66 Aligned_cols=227 Identities=20% Similarity=0.245 Sum_probs=159.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-|||++++.+..++..||||||+.+ ++.+++... ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 59 pniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~ 138 (327)
T cd08227 59 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 138 (327)
T ss_pred CCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC
Confidence 3789999999999999999999985 566665432 33599999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCC------cccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 81 NLKLADFGLARSFSYDHNN------TLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
.++|+||+.+......... ......++..|+|||++.+. ..++.++||||||||+|||++|+.||........
T Consensus 139 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 9999999865443211110 01122457789999998753 3588999999999999999999999987655443
Q ss_pred HHHHHHhcCCCCCCC----CC------CCCC---CCccccCCC-----chhhhhhHHHhhhhhhHHHHHHHHHhcccCCC
Q 014871 154 LSKIFELCGSPDETI----WP------GVSK---MPAYNHFKP-----SRTMKRRVREVFRHFDRHALELLEKMLMLDPS 215 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~----~~------~~~~---~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 215 (417)
...... +...... .+ .... ...+..... ..............++..+++||++||..||+
T Consensus 219 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 296 (327)
T cd08227 219 LLEKLN--GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD 296 (327)
T ss_pred HHHHhc--CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCch
Confidence 333221 1110000 00 0000 000000000 00000111122345678999999999999999
Q ss_pred CCCCHHHHhcCCCCCC
Q 014871 216 QRISAKDALDSEYFWT 231 (417)
Q Consensus 216 ~Rpta~elL~h~~f~~ 231 (417)
+|||+.+||+|+||..
T Consensus 297 ~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 297 ARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcCCHHHHhcChhhhh
Confidence 9999999999999943
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=266.27 Aligned_cols=201 Identities=23% Similarity=0.362 Sum_probs=158.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLT-GLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~-~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+..++.+|+||||+.++.+ ..+.+....+++.++..++.||+.+|+|||+++|+||||||+|||++.++.
T Consensus 69 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 148 (292)
T cd06644 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD 148 (292)
T ss_pred CcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC
Confidence 3788999999999999999999997544 444444556999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+||+|||++...... ........++..|+|||++.. ...++.++|||||||++|||++|+.||...+....+.++
T Consensus 149 ~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 227 (292)
T cd06644 149 IKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227 (292)
T ss_pred EEEccCccceecccc-ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 999999998754321 112233456889999998852 245788999999999999999999999877665544444
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..... + .. .....++.++.+||++||..||++||+++++++|+||..
T Consensus 228 ~~~~~-~-~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 228 AKSEP-P-TL-------------------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred hcCCC-c-cC-------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 22100 0 00 001235567899999999999999999999999999954
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=268.48 Aligned_cols=203 Identities=24% Similarity=0.393 Sum_probs=162.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+...+..|+||||+.++.+..+... ..+++.++..++.||+.+|+|||+++|+||||||+||++++++.+
T Consensus 79 ~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~ 157 (292)
T cd06658 79 ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI 157 (292)
T ss_pred CcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCE
Confidence 5788888899999999999999987554444433 358999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++....... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+.....
T Consensus 158 kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~ 235 (292)
T cd06658 158 KLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP 235 (292)
T ss_pred EEccCcchhhccccc-ccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 999999987653222 12233567899999999875 5688999999999999999999999988776665554432111
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
... .....++..+.+||++||..||++|||++++++|+||.....+
T Consensus 236 ~~~---------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 236 PRV---------------------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred Ccc---------------------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 000 0011256688999999999999999999999999999765444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=275.95 Aligned_cols=191 Identities=25% Similarity=0.394 Sum_probs=163.9
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||+++.+.+..+.+|||||||. |+|++++.+ .+..+...+...|+.|||+|++||+++++|||||-+.||||+++..
T Consensus 262 ~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~ 341 (468)
T KOG0197|consen 262 KLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV 341 (468)
T ss_pred CeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce
Confidence 78999999999889999999997 689998886 5667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
|||+|||+|+.+.++.-.......-...|.|||++.- ..++.++|||||||+|+||+| |+.|+++.+..+++..+.+-
T Consensus 342 vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G 420 (468)
T KOG0197|consen 342 VKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG 420 (468)
T ss_pred EEEcccccccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence 9999999999654433333333333677999999975 689999999999999999998 99999999999999988654
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
...+.+ ..++.++-+|+..|+..+|++|||.+.+.
T Consensus 421 yRlp~P-----------------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 421 YRLPRP-----------------------------EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CcCCCC-----------------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 333322 34677899999999999999999998664
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.51 Aligned_cols=198 Identities=23% Similarity=0.352 Sum_probs=158.6
Q ss_pred cEeecccCceecC--------eEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014871 4 TFLETTDGNKYRG--------STYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71 (417)
Q Consensus 4 niv~~~~~~~~~~--------~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp 71 (417)
|+++.++.+.... .++|||||+.+ +|.+.+.. ....|++.++..++.||+.||+|||+++|+||||||
T Consensus 92 ~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP 171 (496)
T PTZ00283 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKS 171 (496)
T ss_pred cEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCH
Confidence 4666665554332 37899999985 67666543 234699999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeeccCcccccCCC-CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 014871 72 SNLLIDNEGNLKLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150 (417)
Q Consensus 72 ~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 150 (417)
+||||+.++.+||+|||+++...... .......++|..|+|||++.+ ..++.++||||||||||||++|+.||.+.+.
T Consensus 172 ~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred HHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999997654321 122334578999999999976 5689999999999999999999999998887
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
.+.+..+...... .+...++.++++||++||..||++|||+.++|+|+|+.
T Consensus 251 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~ 301 (496)
T PTZ00283 251 EEVMHKTLAGRYD-----------------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301 (496)
T ss_pred HHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHH
Confidence 7766665431110 01223667899999999999999999999999999985
Q ss_pred C
Q 014871 231 T 231 (417)
Q Consensus 231 ~ 231 (417)
.
T Consensus 302 ~ 302 (496)
T PTZ00283 302 L 302 (496)
T ss_pred H
Confidence 3
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=263.44 Aligned_cols=194 Identities=23% Similarity=0.409 Sum_probs=156.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
-||++.++.+...+.+||||||+.+ +|.+++.... .+++.+++.++.||+.||+|||+++|+||||||+||+++.++
T Consensus 69 ~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~ 147 (267)
T PHA03390 69 PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD 147 (267)
T ss_pred CCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC
Confidence 3789999999999999999999974 7777665543 799999999999999999999999999999999999999998
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-~~~i~~ 159 (417)
.++|+|||++...... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ...+..
T Consensus 148 ~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 221 (267)
T PHA03390 148 RIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221 (267)
T ss_pred eEEEecCccceecCCC-----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH
Confidence 8999999998765422 22356889999999976 5688999999999999999999999985543322 122211
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-AKDALDSEYFW 230 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-a~elL~h~~f~ 230 (417)
..... ....+.++..+++||.+||..||.+|++ +++||+|+||.
T Consensus 222 ~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 222 RQQKK---------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hhccc---------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 11000 0112247789999999999999999996 59999999995
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=273.93 Aligned_cols=229 Identities=38% Similarity=0.634 Sum_probs=172.4
Q ss_pred cEeecccCceec--CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+... ..+||||||+.++|...+... .+.+..++.++.||+.+|+|||+++|+||||||+||||+.++.
T Consensus 68 ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~ 145 (337)
T cd07852 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR 145 (337)
T ss_pred CccceeeeeccCCCceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc
Confidence 577777766543 368999999999888777654 6899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC----CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHN----NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+||+|||+++....... ......+++..|+|||++.+...++.++|||||||++|+|++|+.||.+....+...++
T Consensus 146 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 146 VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999986643322 12334567889999998876566889999999999999999999999998888888777
Q ss_pred HHhcCCCCCCCCCCCCCCCccccC-CCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHF-KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
....+.+....+...........+ ................++.++.+||.+||..||++|||+.++++|+||.....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 766554433222111000000000 00000111223334457889999999999999999999999999999965433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=261.65 Aligned_cols=199 Identities=22% Similarity=0.328 Sum_probs=155.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+|+||||+++ +|.+++... ..+++.+++.++.||+.+|+|||++||+|+||||+|||++.++.
T Consensus 66 ~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~ 144 (267)
T cd06645 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH 144 (267)
T ss_pred CCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC
Confidence 3788899999999999999999986 566655443 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||++...... ........++..|+|||++.. ...++.++|||||||++|+|++|..||........+..+..
T Consensus 145 ~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~ 223 (267)
T cd06645 145 VKLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK 223 (267)
T ss_pred EEECcceeeeEccCc-ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc
Confidence 999999998765422 222234567899999998742 24578899999999999999999999876554443332211
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~ 228 (417)
....+. .+. ....++..+.+||++||..||++|||+.+|++|+|
T Consensus 224 ~~~~~~--~~~-----------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 SNFQPP--KLK-----------------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cCCCCC--ccc-----------------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 100000 000 00124567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=257.75 Aligned_cols=196 Identities=24% Similarity=0.393 Sum_probs=157.3
Q ss_pred ccEeecccCcee-cCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNKY-RGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~~-~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.|++++++.+.. ++.+|+||||+.+ ++.+.+.. ....+++.+++.++.||+.+|++||+++|+|+||||+||+++.+
T Consensus 59 ~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred CCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 577888777653 4468999999985 66665554 23458999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.++|+|||++....... .......++..|+|||++.+ ..++.++|||||||++++|++|+.||...+.......+..
T Consensus 139 ~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~ 216 (257)
T cd08223 139 NIIKVGDLGIARVLENQC-DMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE 216 (257)
T ss_pred CcEEEecccceEEecccC-CccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 999999999997654322 22334567889999999876 5688999999999999999999999987776555544432
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
... . .....++..+.+||.+||..||++|||+.++++|+||
T Consensus 217 ~~~--~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 GKL--P---------------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCC--C---------------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 110 0 0112366789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=263.18 Aligned_cols=197 Identities=22% Similarity=0.377 Sum_probs=152.9
Q ss_pred cEeecccCcee------cCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 014871 4 TFLETTDGNKY------RGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75 (417)
Q Consensus 4 niv~~~~~~~~------~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NIL 75 (417)
||+++++.+.. ...+||||||+.+ +|..++... ...+++..++.++.||+.||+|||+++|+|+|||++||+
T Consensus 64 ~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nil 143 (272)
T cd06637 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 143 (272)
T ss_pred CeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEE
Confidence 67777766654 3468999999985 666666543 346899999999999999999999999999999999999
Q ss_pred EcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 76 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
++.++.+||+|||+++..... ........++..|+|||++.. ...++.++|||||||++|||++|+.||......
T Consensus 144 i~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~ 222 (272)
T cd06637 144 LTENAEVKLVDFGVSAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222 (272)
T ss_pred ECCCCCEEEccCCCceecccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 999999999999999765322 122334567889999999863 135788999999999999999999999765544
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.....+.. ..... .....++.++.+||.+||..||++|||+.++++|+||
T Consensus 223 ~~~~~~~~---~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 223 RALFLIPR---NPAPR-------------------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHhc---CCCCC-------------------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33332211 00000 0011256688999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=272.94 Aligned_cols=194 Identities=19% Similarity=0.364 Sum_probs=147.9
Q ss_pred ccEeecccCcee-cCeEEEEEcCCCC-CHHHHHhcCC-------------------------------------------
Q 014871 3 CTFLETTDGNKY-RGSTYMVFEYMDH-DLTGLADRPG------------------------------------------- 37 (417)
Q Consensus 3 cniv~~~~~~~~-~~~~yiV~Ey~~g-~l~~~~~~~~------------------------------------------- 37 (417)
-|||++++.+.. ++.+|||||||.+ +|.+++....
T Consensus 71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (338)
T cd05102 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQ 150 (338)
T ss_pred cceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccc
Confidence 378888876654 4468999999985 6666654321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCC
Q 014871 38 ------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN 99 (417)
Q Consensus 38 ------------------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 99 (417)
..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~ 230 (338)
T cd05102 151 PSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230 (338)
T ss_pred cccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch
Confidence 23788899999999999999999999999999999999999999999999999765322211
Q ss_pred -cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCc
Q 014871 100 -TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 177 (417)
Q Consensus 100 -~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 177 (417)
......++..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+.+..........
T Consensus 231 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 296 (338)
T cd05102 231 VRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM------------- 296 (338)
T ss_pred hcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-------------
Confidence 1122344678999999876 578999999999999999997 999998765444333322110000
Q ss_pred cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 178 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.....++.++.+||.+||..||++|||+.+|++
T Consensus 297 ---------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 ---------------RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001235668999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=256.97 Aligned_cols=195 Identities=27% Similarity=0.404 Sum_probs=161.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+..++..|+||||+.+ +|.+++... ...+++.++..++.||+.||.|||+++|+|+||||+||+++.++.
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~ 139 (256)
T cd08529 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN 139 (256)
T ss_pred CeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC
Confidence 678889999999999999999975 676666543 456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++....... ......++..|+|||++.. ..++.++|||||||++++|++|+.||...+..+...++....
T Consensus 140 ~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (256)
T cd08529 140 VKIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV 217 (256)
T ss_pred EEEcccccceeccCccc-hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876543221 2233457889999999876 568899999999999999999999998888766665553311
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.. .....++.+++++|++||+.+|++||++.++++|+|+
T Consensus 218 ~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 FP-----------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CC-----------------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 0111356789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=260.79 Aligned_cols=196 Identities=26% Similarity=0.518 Sum_probs=158.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+...+..|+||||+.+ +|..++.. ...+++.++..++.||+.||+|||+++++|+||||+|||+++++.
T Consensus 66 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~ 144 (267)
T cd06628 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG 144 (267)
T ss_pred CCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC
Confidence 4788999999999999999999986 55555544 346899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC-----CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 82 LKLADFGLARSFSYDHN-----NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 223 (267)
T cd06628 145 IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK 223 (267)
T ss_pred EEecccCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH
Confidence 99999999876642211 11122346788999999875 5678899999999999999999999987665544443
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+..... ..+...++..+++||++||..||++||++.+|++|+||
T Consensus 224 ~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 224 IGENAS-----------------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HhccCC-----------------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 322100 01112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=264.78 Aligned_cols=200 Identities=24% Similarity=0.408 Sum_probs=161.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.+|+.+++.+..++.+|+||||+.+ +|.+.+.. ....+++.++..++.||+.||.|||+++|+||||||+|||+++++
T Consensus 60 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~ 139 (285)
T cd05632 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG 139 (285)
T ss_pred cCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC
Confidence 4678888889999999999999986 55555543 234699999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||++...... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+...
T Consensus 140 ~~kl~Dfg~~~~~~~~--~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~ 216 (285)
T cd05632 140 HIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR 216 (285)
T ss_pred CEEEecCCcceecCCC--CcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999998764322 22234568999999999876 56899999999999999999999999887766555444332
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
...... .....++.++.+||.+||..||++|+| +.++++|+||..
T Consensus 217 ~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 217 VLETEE--------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred hhcccc--------------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 211111 112235678899999999999999999 899999999955
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=272.16 Aligned_cols=214 Identities=36% Similarity=0.659 Sum_probs=158.6
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCCEEEeeccCccccc
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFS 94 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~-~~~vkL~DFGla~~~~ 94 (417)
..+|+||||+.++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. +..+||+|||+++...
T Consensus 89 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~ 166 (342)
T cd07854 89 NSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166 (342)
T ss_pred ceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecC
Confidence 46899999999888776653 35999999999999999999999999999999999999975 4568999999997653
Q ss_pred CCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 014871 95 YDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 172 (417)
Q Consensus 95 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 172 (417)
.... .......++..|+|||++.....++.++|||||||++|+|++|+.||...+..+....+...........+...
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07854 167 PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNEL 246 (342)
T ss_pred CccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2111 11223356889999998876556888999999999999999999999998887777776654333222111111
Q ss_pred CC-CCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 173 SK-MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 173 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.. .+.... ............+...++.++++||++||..||++|+|+.++|+|+||...
T Consensus 247 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 247 LNVIPSFVR-NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhhhh-hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 000000 000011122333445688899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=262.25 Aligned_cols=201 Identities=24% Similarity=0.396 Sum_probs=161.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+..++.+||||||+++ +|..++.+....+++.+++.++.||+.+|.|||+++|+|+||||+||+++.++.
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~ 141 (280)
T cd06611 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD 141 (280)
T ss_pred CceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC
Confidence 3789999999999999999999986 565565555557999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
++|+|||++....... .......++..|++||++.. ...++.++|||||||++|+|++|+.||...+....+..+
T Consensus 142 ~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~ 220 (280)
T cd06611 142 VKLADFGVSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220 (280)
T ss_pred EEEccCccchhhcccc-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH
Confidence 9999999987643221 12233467889999998752 234678999999999999999999999877665555444
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
....... . .....++.++.+||.+||..||++|||+.++|+|+||..
T Consensus 221 ~~~~~~~-------~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 221 LKSEPPT-------L--------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred hcCCCCC-------c--------------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 2210000 0 001235668899999999999999999999999999954
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=269.64 Aligned_cols=194 Identities=26% Similarity=0.483 Sum_probs=167.3
Q ss_pred eecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEE
Q 014871 6 LETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKL 84 (417)
Q Consensus 6 v~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL 84 (417)
+.++.+|...+.+|+||||+.| +|...+.+- .+|.|..+..|+..|+.||-|||++|||+||||.+|||||.+|.|||
T Consensus 413 ~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 413 VQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred HHHHHHhhhhhheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEe
Confidence 4567899999999999999986 555555444 46999999999999999999999999999999999999999999999
Q ss_pred eeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 014871 85 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP 164 (417)
Q Consensus 85 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~ 164 (417)
+|||+++.--. ......+.+||+.|+|||++. ..+|+.++|.||+||+|||||.|++||.+.++.++.+.|.+..-.
T Consensus 492 ~DFGmcKEni~-~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs- 568 (683)
T KOG0696|consen 492 ADFGMCKENIF-DGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS- 568 (683)
T ss_pred eeccccccccc-CCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-
Confidence 99999986432 233455689999999999887 578999999999999999999999999999999999999763221
Q ss_pred CCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCC
Q 014871 165 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWTD 232 (417)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~h~~f~~~ 232 (417)
..+.+|.++.++.+.+|.+.|.+|... .||..|+||+..
T Consensus 569 -----------------------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 569 -----------------------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred -----------------------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 234688999999999999999999854 789999999543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=259.65 Aligned_cols=198 Identities=27% Similarity=0.448 Sum_probs=158.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++.+.+...+.+|+||||+.+ +|.+++.+ ...+++..+..++.||+.+|+|||+.+|+|+||||+||+++.++.
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~ 140 (265)
T cd06631 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI 140 (265)
T ss_pred CCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe
Confidence 4789999999999999999999986 55555544 346899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCC-----CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 82 LKLADFGLARSFSYDH-----NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+||+|||++....... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 219 (265)
T cd06631 141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219 (265)
T ss_pred EEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH
Confidence 9999999987643211 111223457889999999875 5688999999999999999999999987665544333
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+....... ..+...++.++++||++||..||++|||+.++|+|+||
T Consensus 220 ~~~~~~~~---------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 220 IGAHRGLM---------------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred hhhccCCC---------------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 32211110 01122367789999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=276.61 Aligned_cols=201 Identities=27% Similarity=0.465 Sum_probs=163.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-C
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRF--TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-E 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l--~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~-~ 79 (417)
|||++..++..++++-|+||-+.| +|..++...-..| +|..+..|.+|||+||.|||++.|||||||-+||||+. .
T Consensus 633 NIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS 712 (1226)
T KOG4279|consen 633 NIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS 712 (1226)
T ss_pred hHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc
Confidence 899999999999999999999985 6777777665667 89999999999999999999999999999999999975 6
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
|.+||+|||.++.+..- .....+..||+.|||||++.. ...|+.++|||||||++.||.||++||.......- .++
T Consensus 713 GvlKISDFGTsKRLAgi-nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMF 789 (1226)
T KOG4279|consen 713 GVLKISDFGTSKRLAGI-NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMF 789 (1226)
T ss_pred ceEEecccccchhhccC-CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhh
Confidence 78999999999876532 223345678999999999863 34699999999999999999999999975443221 111
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
++- .++ .-..+...++.+++.||.+|+..||.+|++|.++|.+||+...
T Consensus 790 kVG------------------myK-------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 790 KVG------------------MYK-------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hhc------------------cee-------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 110 000 0122345688999999999999999999999999999999654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=265.86 Aligned_cols=222 Identities=21% Similarity=0.281 Sum_probs=159.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+..++++||||||+.+ +|.+.+.+. ..+++..+..++.||+.||+|||+ .+++|+||||+|||++.++.
T Consensus 60 ~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~ 138 (308)
T cd06615 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE 138 (308)
T ss_pred CCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc
Confidence 789999999999999999999986 555555443 569999999999999999999997 59999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++...... .....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 139 ~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 214 (308)
T cd06615 139 IKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPV 214 (308)
T ss_pred EEEccCCCccccccc---ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcc
Confidence 999999998654322 2234567899999999875 568899999999999999999999998766443332221111
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHh---------hhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
................ ................ ...++.++++||.+||..||++|||+.+|++|+||..
T Consensus 215 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 215 SEGEAKESHRPVSGHP-PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred ccccccCCcccccCCC-CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 1000000000000000 0000000000000000 1136778999999999999999999999999999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=259.04 Aligned_cols=195 Identities=28% Similarity=0.429 Sum_probs=158.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|++++++.++.++.+||||||+.+ +|..++.. ...+++.++..++.||+.||.|||+++|+|+||+|+|||++.++.+
T Consensus 58 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~ 136 (260)
T cd05611 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHL 136 (260)
T ss_pred CeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcE
Confidence 789999999999999999999986 55555543 3468999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.... .....++..|++||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....
T Consensus 137 ~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 210 (260)
T cd05611 137 KLTDFGLSRNGLE-----NKKFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210 (260)
T ss_pred EEeecccceeccc-----cccCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 9999999876432 123356788999999876 4588999999999999999999999988877666555432111
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~h~~f~~ 231 (417)
... ......++..+.+||.+||..||++|+| ++|+|.|+||..
T Consensus 211 ~~~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 211 NWP--------------------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CCC--------------------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 000 0011246778999999999999999995 579999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=265.23 Aligned_cols=192 Identities=28% Similarity=0.471 Sum_probs=160.5
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+++|+||||+. ++|.+.+.+. ..+++.++..++.||+.+|+|||+++|+|+||||+||||+.++.+
T Consensus 62 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~ 140 (290)
T cd05580 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYI 140 (290)
T ss_pred CccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCE
Confidence 68889999999999999999995 5666665544 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+....
T Consensus 141 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~- 214 (290)
T cd05580 141 KITDFGFAKRVKGR----TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK- 214 (290)
T ss_pred EEeeCCCccccCCC----CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-
Confidence 99999999876433 233457889999998875 567899999999999999999999998877655555543210
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
. .+...++..+++||++||..||.+|+ +++|+++|+||..
T Consensus 215 -~----------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 215 -V----------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred -c----------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 0 01123567899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=263.17 Aligned_cols=198 Identities=22% Similarity=0.369 Sum_probs=153.6
Q ss_pred ccEeecccCce------ecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 3 CTFLETTDGNK------YRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 3 cniv~~~~~~~------~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
-||+++++.+. ....+||||||+.+ +|..++.. ....+++..+..++.||+.||+|||+++|+|+|||++||
T Consensus 73 ~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ni 152 (282)
T cd06636 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152 (282)
T ss_pred CcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 36778777764 35678999999986 66666654 234588999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 014871 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150 (417)
Q Consensus 75 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 150 (417)
+|++++.++|+|||++....... .......++..|+|||++.. ...++.++|||||||++|||++|+.||.....
T Consensus 153 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 153 LLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred EECCCCCEEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 99999999999999987653221 12234567889999998863 23578899999999999999999999976554
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
...+..+... ... ......++.++++||++||..||.+|||+.|||+|+||
T Consensus 232 ~~~~~~~~~~---~~~-------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 232 MRALFLIPRN---PPP-------------------------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HhhhhhHhhC---CCC-------------------------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 4333322110 000 00012366789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=256.63 Aligned_cols=198 Identities=23% Similarity=0.318 Sum_probs=165.6
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCCEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~~~vk 83 (417)
||+.+.+|-.+-.++|.||.|......++++-...++|..+-++...|+.||.||.++ +|||||+||+|||||+.|++|
T Consensus 153 IV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniK 232 (391)
T KOG0983|consen 153 IVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIK 232 (391)
T ss_pred eeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEE
Confidence 6788899999999999999999877777777666799999999999999999999965 999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHh
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFEL 160 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~-~~~~~~~~~i~~~ 160 (417)
|||||++-.+... ...+...|.+.|||||.+.- ...|+..+|||||||+|+||.||+.||.+ +.+.+++.+|.+.
T Consensus 233 lCDFGIsGrlvdS--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ 310 (391)
T KOG0983|consen 233 LCDFGISGRLVDS--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE 310 (391)
T ss_pred eecccccceeecc--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc
Confidence 9999999765432 22334567899999999853 24689999999999999999999999987 5678888888651
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.|+... --..|+..+++|++.||.+|+.+||...++|+|+|+..
T Consensus 311 --ePP~L~-------------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 311 --EPPLLP-------------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred --CCCCCC-------------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 111100 01238889999999999999999999999999999954
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=258.18 Aligned_cols=203 Identities=23% Similarity=0.373 Sum_probs=161.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~--~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.||+++++.+..++..||||||+.+ +|.+++... ...+++..++.++.||+.||+|||+++|+|+||||+||+++++
T Consensus 59 ~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~ 138 (267)
T cd06610 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED 138 (267)
T ss_pred CCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC
Confidence 4788888889999999999999986 555555442 2358999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCC---cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+.+||+|||++......... .....+++..|++||++.....++.++|+|||||++|+|++|+.||...+....+.+
T Consensus 139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 218 (267)
T cd06610 139 GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML 218 (267)
T ss_pred CCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH
Confidence 99999999998766543322 223345788999999987644689999999999999999999999987766555544
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+.... ... +. . ......++..+++||.+||..||++|||+.+|++|+||
T Consensus 219 ~~~~~---~~~-~~---~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 219 TLQND---PPS-LE---T-----------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HhcCC---CCC-cC---C-----------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 43210 000 00 0 00023467789999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=255.76 Aligned_cols=197 Identities=25% Similarity=0.410 Sum_probs=158.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+.....+|+|+||+.+ +|.+++......+++.+++.++.||+.+|.|||+.+|+|+||+|+||++++++.+
T Consensus 59 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~ 138 (256)
T cd06612 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQA 138 (256)
T ss_pred cEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcE
Confidence 788899999999999999999986 5666665555679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++........ ......++..|++||++.+ ..++.++||||||||+|+|++|+.||...........+...
T Consensus 139 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 214 (256)
T cd06612 139 KLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-- 214 (256)
T ss_pred EEcccccchhcccCcc-ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--
Confidence 9999999987543221 2223446888999999876 57889999999999999999999999876554433222110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.... ......++..+.+||.+||..||++|||+.|+|+|+||
T Consensus 215 -~~~~------------------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 -PPPT------------------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -CCCC------------------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000 00012356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=263.94 Aligned_cols=198 Identities=28% Similarity=0.475 Sum_probs=158.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+....+.|+||||+.+ +|.+++.. ..+++.++..++.||+.||+|||+++|+|+||||+|||++.++.
T Consensus 77 ~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~ 154 (296)
T cd06654 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 154 (296)
T ss_pred CCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC
Confidence 3788899999999999999999986 56655543 35899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+...
T Consensus 155 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~- 231 (296)
T cd06654 155 VKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN- 231 (296)
T ss_pred EEECccccchhccccc-cccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-
Confidence 9999999987643221 12233467889999998875 56789999999999999999999999877664443332110
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..+.. .....++..+++||.+||..||++|||+.+|++|+||..
T Consensus 232 ~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 232 GTPEL--------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred CCCCC--------------------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 00000 001235667899999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=264.11 Aligned_cols=201 Identities=25% Similarity=0.445 Sum_probs=161.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|++++++.+...+.+|+||||+.++.+..+... ..+++.++..++.||+.||+|||+++|+|+||||+|||++.++.+|
T Consensus 79 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~k 157 (297)
T cd06659 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157 (297)
T ss_pred chhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEE
Confidence 678888889999999999999986444434333 3589999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||++....... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+...
T Consensus 158 L~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 232 (297)
T cd06659 158 LSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS--- 232 (297)
T ss_pred EeechhHhhccccc-ccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---
Confidence 99999987554222 12233567899999999876 56899999999999999999999999877766655544221
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
.. ..+ .....++..+.+||++||..||++|||++++++|+||....+
T Consensus 233 ~~-~~~-----------------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 233 PP-PKL-----------------------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred CC-CCc-----------------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 00 000 001235668899999999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=263.68 Aligned_cols=198 Identities=26% Similarity=0.427 Sum_probs=159.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|+++.++.+.....+|+||||+.++.+..+.... .+++.++..++.||+.+|+|||+++++|+||||+||+++.++.+|
T Consensus 77 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~k 155 (296)
T cd06655 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVK 155 (296)
T ss_pred ceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 6888899999999999999999865444443332 589999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||++....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+....+..+.... .
T Consensus 156 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~ 232 (296)
T cd06655 156 LTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-T 232 (296)
T ss_pred EccCccchhccccc-ccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-C
Confidence 99999987654322 12233457889999998875 568899999999999999999999998887766554442211 0
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.. .....++..+++||++||..||++|+|+.+|++|+||..
T Consensus 233 ~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 233 PEL--------------------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ccc--------------------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 000 001235678999999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=260.98 Aligned_cols=200 Identities=25% Similarity=0.452 Sum_probs=161.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||++.++.+...+..|+|+||+.+ +|.+.+.. .++++.++..++.||+.+|+|||+++|+||||||+||+++.++.
T Consensus 76 ~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 153 (285)
T cd06648 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR 153 (285)
T ss_pred CChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc
Confidence 3678888888889999999999976 55555544 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 154 ~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~ 231 (285)
T cd06648 154 VKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL 231 (285)
T ss_pred EEEcccccchhhccCCc-ccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC
Confidence 99999998876543221 2223457889999999876 568899999999999999999999998877766666554321
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
. ... .....++..+.+||++||..||++|||+.++++|+||....
T Consensus 232 ~--~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 232 P--PKL-------------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred C--CCC-------------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0 000 00112556899999999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=264.77 Aligned_cols=200 Identities=26% Similarity=0.353 Sum_probs=158.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++.++++||||||+++ +|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~ 140 (305)
T cd05609 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHI 140 (305)
T ss_pred CeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCE
Confidence 688999999999999999999986 55555544 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC--------------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 014871 83 KLADFGLARSFSYDHNN--------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK 148 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~--------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 148 (417)
||+|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|..||.+.
T Consensus 141 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 141 KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred EEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998642111000 0112345788999999876 56899999999999999999999999887
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC---HHHHhc
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALD 225 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~ 225 (417)
+..+.+..+......... ....++..+++||++||..||++|+| +.++|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 220 TPEELFGQVISDDIEWPE---------------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CHHHHHHHHHhcccCCCC---------------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 776666555431100000 00135678999999999999999998 799999
Q ss_pred CCCCCCC
Q 014871 226 SEYFWTD 232 (417)
Q Consensus 226 h~~f~~~ 232 (417)
|+||...
T Consensus 273 ~~~~~~~ 279 (305)
T cd05609 273 HRFFLGL 279 (305)
T ss_pred CccccCC
Confidence 9999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=263.75 Aligned_cols=190 Identities=16% Similarity=0.130 Sum_probs=153.8
Q ss_pred ccEeecccCcee----cCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKY----RGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~----~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl 76 (417)
.|||++++.+.. ...+|||||||.++ |.+++. ....+++.....++.||+.||+|||+. +++||||||+|||+
T Consensus 78 ~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill 156 (283)
T PHA02988 78 NNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156 (283)
T ss_pred CCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh-hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE
Confidence 488999987766 45789999999965 555554 445799999999999999999999984 99999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
++++.+||+|||+++..... ....+++..|+|||++.+. ..++.++|||||||++|||++|+.||...+..+...
T Consensus 157 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~ 232 (283)
T PHA02988 157 TENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD 232 (283)
T ss_pred CCCCcEEEcccchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999999999765422 1234678899999998642 468999999999999999999999999888777766
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+......+. +...++..+++||++||+.||++|||+.+|++
T Consensus 233 ~i~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 233 LIINKNNSLK----------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCCCC----------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 6543211110 01135678999999999999999999999985
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=270.03 Aligned_cols=224 Identities=35% Similarity=0.614 Sum_probs=168.4
Q ss_pred cEeecccCceecC------eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~------~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++++.... .+||||||++.++..++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 75 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07880 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152 (343)
T ss_pred CccceeeeecCCccccccceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 5667776665543 4599999998787776653 3599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||++...... .....++..|++||++.+...++.++|||||||++|+|++|+.||...+....+..+
T Consensus 153 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 153 EDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228 (343)
T ss_pred CCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999765322 223456889999999876456889999999999999999999999988887777777
Q ss_pred HHhcCCCCCCCCCCCCCCCc--cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
...........+........ +....+ .........+...++..+++||.+||..||++|+|+.++++|+||.....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 229 MKVTGTPSKEFVQKLQSEDAKNYVKKLP-RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHhcCCCCHHHHHhhcchhHHHHHHhcc-ccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 66544433222211111000 000000 00011233444567889999999999999999999999999999976533
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=269.67 Aligned_cols=223 Identities=34% Similarity=0.609 Sum_probs=168.8
Q ss_pred cEeecccCceec------CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYR------GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~------~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++++... .++|+||||+..++.... +..+++.++..++.||+.||+|||+++|+||||||+|||++
T Consensus 75 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~ 151 (342)
T cd07879 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN 151 (342)
T ss_pred CccchhheecccccCCCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 566666666544 356999999987766554 23589999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... ......++..|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+
T Consensus 152 ~~~~~kL~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~ 227 (342)
T cd07879 152 EDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227 (342)
T ss_pred CCCCEEEeeCCCCcCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999876432 2223466889999999876456889999999999999999999999998888888888
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
....+.+....+............. ............+..++.++++||++||..||++|+|+.++|.|+||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 7766655433322221110000000 000011222333445778899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=266.70 Aligned_cols=201 Identities=26% Similarity=0.425 Sum_probs=161.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
+|+++++.++.....||||||+.+ +|.+++.+. +..|++..++.++.||+.+|+|||+++|+|+||||+||||+.++.
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 141 (316)
T cd05574 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH 141 (316)
T ss_pred CchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC
Confidence 678888889999999999999976 666666542 356999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC----------------------------CcccccccccCCCCchhhcCCCCCCCccchhhHHH
Q 014871 82 LKLADFGLARSFSYDHN----------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~ 133 (417)
++|+|||++........ ......++|..|+|||++.+ ..++.++|||||||
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ 220 (316)
T cd05574 142 IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGI 220 (316)
T ss_pred EEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHH
Confidence 99999999875432111 01112356888999999976 56889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccC
Q 014871 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 213 (417)
Q Consensus 134 il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 213 (417)
++|+|++|+.||.+.+....+..+..... .++. ...++..+++||++||..|
T Consensus 221 ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~-----------------------~~~~~~~~~~li~~~l~~~ 272 (316)
T cd05574 221 LLYEMLYGTTPFKGSNRDETFSNILKKEV-----TFPG-----------------------SPPVSSSARDLIRKLLVKD 272 (316)
T ss_pred HHHHHhhCCCCCCCCchHHHHHHHhcCCc-----cCCC-----------------------ccccCHHHHHHHHHHccCC
Confidence 99999999999988887766655532100 0000 0115678999999999999
Q ss_pred CCCCCC----HHHHhcCCCCCCCC
Q 014871 214 PSQRIS----AKDALDSEYFWTDP 233 (417)
Q Consensus 214 P~~Rpt----a~elL~h~~f~~~~ 233 (417)
|++|+| ++++|+|+||....
T Consensus 273 p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 273 PSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HhHCCCchhhHHHHHcCchhhcCC
Confidence 999999 99999999996543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=262.83 Aligned_cols=229 Identities=21% Similarity=0.279 Sum_probs=160.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+.+++++..++..|++|||+.+ ++.+++.+. ...+++..++.+++||+.||+|||+++|+||||||+||||+.++
T Consensus 59 ~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~ 138 (314)
T cd08216 59 PNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG 138 (314)
T ss_pred cchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC
Confidence 3788889999999999999999985 555555432 34589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCC------CcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 81 NLKLADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
.+||+||+.+........ .......++..|+|||++... ..++.++|||||||++|||++|+.||........
T Consensus 139 ~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~ 218 (314)
T cd08216 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218 (314)
T ss_pred ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999998875432211 111223457789999998653 3478899999999999999999999987665443
Q ss_pred HHHHHH-hcCC-CCCCCCCCCCC-CCcc-ccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 154 LSKIFE-LCGS-PDETIWPGVSK-MPAY-NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 154 ~~~i~~-~~~~-~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+..... .... .+...++.... ...- ...................++.++.+||++||..||++|||++++|+|+||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 219 LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred HHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 322111 1000 00000000000 0000 000000001111122234567899999999999999999999999999999
Q ss_pred CC
Q 014871 230 WT 231 (417)
Q Consensus 230 ~~ 231 (417)
..
T Consensus 299 ~~ 300 (314)
T cd08216 299 KQ 300 (314)
T ss_pred hh
Confidence 53
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=260.70 Aligned_cols=200 Identities=21% Similarity=0.352 Sum_probs=158.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~--~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~ 79 (417)
||+++++.+...+.+||||||+.+ +|..++... ...+++..++.++.||+.+|.|||+ .+|+|+||||+|||++.+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~ 139 (286)
T cd06622 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN 139 (286)
T ss_pred cHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC
Confidence 688889999999999999999987 554444432 2369999999999999999999997 599999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~ 154 (417)
+.+||+|||++..+... ......++..|+|||++.+.. .++.++|||||||++|+|++|+.||.........
T Consensus 140 ~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 216 (286)
T cd06622 140 GQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF 216 (286)
T ss_pred CCEEEeecCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH
Confidence 99999999998765321 222345688899999885422 3578999999999999999999999876655544
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
..+......... .+...++.++.+||.+||..||++||++.++++|+||...
T Consensus 217 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 217 AQLSAIVDGDPP--------------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHhhcCCC--------------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 443332211110 1122367789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=261.97 Aligned_cols=199 Identities=24% Similarity=0.342 Sum_probs=157.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~ 78 (417)
-||+++++.+..++.+|+||||++++|..++.. ....+++.++..++.||+.||+|||++ +++||||||+|||++.
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~ 139 (283)
T cd06617 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR 139 (283)
T ss_pred CCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC
Confidence 378999999999999999999999887766543 334699999999999999999999998 9999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC---CCCCCccchhhHHHHHHHHHhCCCCCCCC-ChHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQL 154 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~elltG~~pf~~~-~~~~~~ 154 (417)
++.+||+|||++...... .......++..|+|||++.+. ..++.++|||||||++|+|++|+.||... +..+.+
T Consensus 140 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 217 (283)
T cd06617 140 NGQVKLCDFGISGYLVDS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217 (283)
T ss_pred CCCEEEeecccccccccc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH
Confidence 999999999998765322 112234578899999988642 34688999999999999999999999643 223333
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..+... .... . ....++.++++||.+||..||++|||+.++++|+||..
T Consensus 218 ~~~~~~---~~~~-------~------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 218 KQVVEE---PSPQ-------L------------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHHHhc---CCCC-------C------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 332210 0000 0 00125678999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=258.73 Aligned_cols=196 Identities=27% Similarity=0.432 Sum_probs=158.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++....+||||||+.+ +|.+.+.+ ...+++.++..++.||+.||+|||+++++|+|||++||+++.++.+
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~ 132 (262)
T cd05572 54 FIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV 132 (262)
T ss_pred CEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCE
Confidence 688889999999999999999985 56555544 3459999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN--EAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~--~~~~~~~i~~~ 160 (417)
||+|||++....... ......++..|++||++.. ..++.++|+|||||++|+|++|..||.... ..+.+..+...
T Consensus 133 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 209 (262)
T cd05572 133 KLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209 (262)
T ss_pred EEeeCCcccccCccc--ccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc
Confidence 999999998765332 2223456889999999875 568899999999999999999999998766 44444444310
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
.... .....++.++++||++||..||++|+| ++|+++|+||..
T Consensus 210 ~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 210 NGKL----------------------------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred CCCC----------------------------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 0000 001123668999999999999999999 999999999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=256.97 Aligned_cols=199 Identities=24% Similarity=0.357 Sum_probs=157.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+.+||||||+.+ +|.+++......+++.++..++.||+.+|+|||+++|+|+||||+||++++++.+
T Consensus 61 ~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~ 140 (262)
T cd06613 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDV 140 (262)
T ss_pred ChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCE
Confidence 678888889999999999999986 5555555544679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||++..+.... .......++..|+|||++... ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 141 ~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd06613 141 KLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS 219 (262)
T ss_pred EECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 999999987654321 122334668889999988652 26788999999999999999999999877655554433221
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~ 228 (417)
...+.. ......++.++++||++||..||.+|||+.+|++|+|
T Consensus 220 ~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 220 NFPPPK-------------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred cCCCcc-------------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 000000 0011235668999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=258.60 Aligned_cols=199 Identities=23% Similarity=0.347 Sum_probs=153.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
+||+++++.+..++.+||||||+.+ +|.+++.+ ...+++.++..++.||+.+|+|||+++|+||||||+|||++.++.
T Consensus 66 ~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~ 144 (267)
T cd06646 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD 144 (267)
T ss_pred CCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC
Confidence 5889999999999999999999986 55555543 346899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||+++...... .......++..|+|||++.. ...++.++|||||||++|||++|+.||......+....+..
T Consensus 145 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~ 223 (267)
T cd06646 145 VKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223 (267)
T ss_pred EEECcCccceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec
Confidence 9999999997654221 12233457889999998752 23477899999999999999999999865543322211111
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~ 228 (417)
....+. .+ .....++..+.+||++||..||++|||+++||+|.|
T Consensus 224 ~~~~~~--~~-----------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 SNFQPP--KL-----------------------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCCCC--CC-----------------------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 00 001235678999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=261.48 Aligned_cols=199 Identities=25% Similarity=0.400 Sum_probs=158.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
+|++.++.++..+..||||||+.+ +|.+.+.+.. ..+++.++..++.||+.+|.|||+++++|+||||+|||+++++.
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~ 133 (277)
T cd05577 54 FIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN 133 (277)
T ss_pred CEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC
Confidence 678888899999999999999985 6666655433 35999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++..... ........++..|++||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 134 ~~l~dfg~~~~~~~--~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 210 (277)
T cd05577 134 VRISDLGLAVELKG--GKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT 210 (277)
T ss_pred EEEccCcchhhhcc--CCccccccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc
Confidence 99999999876543 222233456889999999876 458899999999999999999999997665422222221110
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
.. ........++..+++||++||..||++|+ ++.++++|+||+.
T Consensus 211 ~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 211 LE--------------------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred cc--------------------------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 00 00011234678899999999999999999 9999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=258.98 Aligned_cols=195 Identities=26% Similarity=0.411 Sum_probs=159.7
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++.+.+.....+|||+||+.+ +|.+.+... .+++.+++.++.||+.+|.|||+++|+|+||+|+||++++++.+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~ 137 (274)
T cd06609 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDV 137 (274)
T ss_pred CeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 688888888889999999999986 566555543 69999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
+|+|||+++...... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 138 ~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~- 214 (274)
T cd06609 138 KLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN- 214 (274)
T ss_pred EEcccccceeecccc-cccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-
Confidence 999999998765332 22234466888999999976 458999999999999999999999998776555444332210
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhh-hhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH-FDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.. .+... ++.++.+||.+||..||++|||++++++|+||..
T Consensus 215 -~~---------------------------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 215 -PP---------------------------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred -CC---------------------------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 00 00011 5668999999999999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=259.10 Aligned_cols=202 Identities=22% Similarity=0.316 Sum_probs=156.9
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLAD----RPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~----~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~ 78 (417)
|||++++.+...+..|++|||+..++..+.. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 64 ~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~ 143 (288)
T cd06616 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR 143 (288)
T ss_pred CEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc
Confidence 7899999888899999999999887655432 2335699999999999999999999975 9999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
++.+||+|||+++...... ......++..|+|||++... ..++.++|||||||++|+|++|+.||...+ .....
T Consensus 144 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~ 219 (288)
T cd06616 144 NGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQ 219 (288)
T ss_pred CCcEEEeecchhHHhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHH
Confidence 9999999999997654221 12233568889999998764 368899999999999999999999997654 22222
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.+.......... ......++.++.+||++||..||++|||+++|++|+||..
T Consensus 220 ~~~~~~~~~~~~~----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 220 LTQVVKGDPPILS----------------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred HhhhcCCCCCcCC----------------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 2222211110000 0011236778999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=260.59 Aligned_cols=196 Identities=21% Similarity=0.360 Sum_probs=154.0
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+...+..+|||||+.++.+.... .+++..+..++.||+.||+|||+++|+|+||||+|||++.++.+|
T Consensus 60 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~ 135 (279)
T cd06619 60 YIIGFYGAFFVENRISICTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVK 135 (279)
T ss_pred CeeeEEEEEEECCEEEEEEecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEE
Confidence 7899999999999999999999976555432 478999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHh
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ---LSKIFEL 160 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~---~~~i~~~ 160 (417)
|+|||++..+... .....++|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+. ...+...
T Consensus 136 l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 211 (279)
T cd06619 136 LCDFGVSTQLVNS---IAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211 (279)
T ss_pred EeeCCcceecccc---cccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH
Confidence 9999999765422 2233567899999999876 5689999999999999999999999865321110 0011111
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
........ .....++.++++||.+||..||++||+++|+++|+||..
T Consensus 212 ~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 212 IVDEDPPV------------------------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HhccCCCC------------------------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 10000000 001235678999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=275.53 Aligned_cols=193 Identities=20% Similarity=0.280 Sum_probs=161.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||++..+.+....+|||||||..+-+..+.+.+..++...+..|.++|+.|+.|||.+.|||||||.-||||..+..||
T Consensus 173 NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 173 NIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred ceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEE
Confidence 89999999999999999999999776676667777899999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||.++..... .....++||..|||||++.+ ..+++++|||||||||||||||.-||..-+...++.-+
T Consensus 253 IsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV------ 323 (904)
T KOG4721|consen 253 ISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV------ 323 (904)
T ss_pred eccccchHhhhhh--hhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEec------
Confidence 9999999887643 45567899999999999986 78999999999999999999999998654432221110
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 227 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~ 227 (417)
-.. ..-..+...+++-++-||+.||.-.|..||+..+||.|=
T Consensus 324 --------GsN--------------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 324 --------GSN--------------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred --------cCC--------------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 000 000012345677899999999999999999999999873
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=278.91 Aligned_cols=196 Identities=25% Similarity=0.415 Sum_probs=168.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||+++.+.+....+|+||||+.++.++....++.++.+.+++.+|.||+.||+|||+++|+|||||.+||||+.+.++|
T Consensus 116 nIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnik 195 (596)
T KOG0586|consen 116 NIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIK 195 (596)
T ss_pred ceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccccee
Confidence 78999999999999999999998765555555556789999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||++..+. ....+.+.++++.|.|||++.+..+.++.+|+||+|+|||.|++|..||++.+-.+.-.+.+.
T Consensus 196 IaDfgfS~~~~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---- 269 (596)
T KOG0586|consen 196 IADFGFSTFFD--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---- 269 (596)
T ss_pred eeccccceeec--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----
Confidence 99999998876 344667889999999999999988889999999999999999999999998876554332211
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
....+.-.++.++.+||+++|.++|.+|.+.+++++|.|...
T Consensus 270 --------------------------gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 270 --------------------------GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred --------------------------eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 011112236778999999999999999999999999999843
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=262.28 Aligned_cols=196 Identities=26% Similarity=0.368 Sum_probs=161.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++.+.+...+..||||||+.+++.+++......+++.++..++.||+.+|.|||+++|+|+||+|+||+++.++.+
T Consensus 75 ~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~ 154 (307)
T cd06607 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTV 154 (307)
T ss_pred CCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCE
Confidence 37888999999999999999999999888877655679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||++..... .....++..|+|||++.. ...++.++|||||||++|||++|+.||...+.......+...
T Consensus 155 kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~ 229 (307)
T cd06607 155 KLADFGSASLVSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (307)
T ss_pred EEeecCcceecCC-----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC
Confidence 9999999865432 123456788999998752 245788999999999999999999999877765554443210
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.... . ....++..+++||++||..||++|||+.+|+.|+||..
T Consensus 230 --~~~~--------------~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 230 --DSPT--------------L------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred --CCCC--------------C------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000 0 01125668999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=251.95 Aligned_cols=213 Identities=37% Similarity=0.656 Sum_probs=170.9
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCC
Q 014871 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 96 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 96 (417)
.+|+|+|+|..+|...+.... .|+.+.++-+++|||.||+|||+.+|+||||||.|+|++.+-.+||||||+|+....+
T Consensus 131 EiYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 131 ELYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 689999999999888777654 5999999999999999999999999999999999999999999999999999987766
Q ss_pred CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCC
Q 014871 97 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 176 (417)
Q Consensus 97 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 176 (417)
.....+..+.|..|+|||++++...|+.++||||+|||+.|||..+-.|...+..+++..|.++++.|..+...-...
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE-- 287 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE-- 287 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh--
Confidence 667777788899999999999999999999999999999999999999999999999999999999875432110000
Q ss_pred ccccCCCchhhh-hhHHHhh-----hhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 177 AYNHFKPSRTMK-RRVREVF-----RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 177 ~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
..++-......+ .....++ .+-..+..+++.+||..||++|++.++++.|++.-+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 000000000000 0000000 1233567899999999999999999999999997443
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=252.09 Aligned_cols=195 Identities=27% Similarity=0.451 Sum_probs=163.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+...+.+|+|||||.+ +|.+.+.+. ...+++.++..++.||+.+|+|||+.+++|+||||+||+++.++.
T Consensus 60 ~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~ 139 (256)
T cd08221 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL 139 (256)
T ss_pred CeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC
Confidence 789999999999999999999985 777776654 456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++........ ......++..|+|||++.+ ..++.++|||||||++|||++|..+|...+..+....+....
T Consensus 140 ~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08221 140 IKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN 217 (256)
T ss_pred EEECcCcceEEcccccc-cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999976543321 2334567899999999876 457889999999999999999999998887777666664210
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
... ....++.++++||.+||..||++|+|++++|+|+|+
T Consensus 218 --~~~---------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 218 --YTP---------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred --CCC---------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 000 012356789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=256.54 Aligned_cols=199 Identities=25% Similarity=0.410 Sum_probs=154.1
Q ss_pred ccEeecccCceecC------eEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 3 CTFLETTDGNKYRG------STYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 3 cniv~~~~~~~~~~------~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
-||+++++.+.... .+||||||+++ +|.+++.. .+..+++.+++.++.||+.||+|||+++|+|+||+|+
T Consensus 63 ~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ 142 (275)
T cd06608 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQ 142 (275)
T ss_pred CChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHH
Confidence 46778887776544 48999999986 55555433 2457999999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGK 148 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~ 148 (417)
||+++.++.+||+|||++...... ........++..|+|||++... ..++.++|||||||+||+|++|+.||...
T Consensus 143 ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 143 NILLTKNAEVKLVDFGVSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred HEEEccCCeEEECCCccceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 999999999999999998764322 2223345678899999987532 34678999999999999999999999866
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~ 228 (417)
+....+..+... .... . .....++..+++||++||..||++|||+.++++|+|
T Consensus 222 ~~~~~~~~~~~~---~~~~-------------~-----------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 222 HPMRALFKIPRN---PPPT-------------L-----------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred chHHHHHHhhcc---CCCC-------------C-----------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 555544443221 0000 0 001235678999999999999999999999999999
Q ss_pred C
Q 014871 229 F 229 (417)
Q Consensus 229 f 229 (417)
+
T Consensus 275 ~ 275 (275)
T cd06608 275 I 275 (275)
T ss_pred C
Confidence 6
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=256.48 Aligned_cols=187 Identities=21% Similarity=0.335 Sum_probs=150.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+.....+||||||+.+ +|.+.+.+. ..+++.++..++.||+.||+|||+++|+||||||+||+++.++.
T Consensus 45 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 123 (237)
T cd05576 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH 123 (237)
T ss_pred CceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC
Confidence 4789999999999999999999985 666665543 35999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
++|+|||++...... ......+..|+|||.+.. ..++.++||||+||++|||++|+.+|...... +..
T Consensus 124 ~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~-- 191 (237)
T cd05576 124 IQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT-- 191 (237)
T ss_pred EEEecccchhccccc----cccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc--
Confidence 999999988665422 122344678999998864 56789999999999999999999776432110 000
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~h~~f 229 (417)
. .. ..+...++..+++||++||+.||++|+|+ +++++|+||
T Consensus 192 ----------~------~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 ----------H------TT-----------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ----------c------cc-----------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0 00 01123367789999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=255.09 Aligned_cols=200 Identities=29% Similarity=0.513 Sum_probs=156.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-C
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-N 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~-~ 81 (417)
|++++++.+...+++++||||+.+. |.+++.+ ...+++..+..++.||+.||+|||++||+|+||||+||+++.++ .
T Consensus 64 ~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred ceehhhceeccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 7899999999999999999999864 5555443 44699999999999999999999999999999999999998775 5
Q ss_pred EEEeeccCcccccCCCCC---cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 221 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF 221 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH
Confidence 999999998765432111 1122356889999999875 568899999999999999999999997654433333332
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+...... ...+...++.++++||.+||..||++|+|+.++++|+||.
T Consensus 222 ~~~~~~~-------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 222 KIASATT-------------------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHhccCC-------------------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 2110000 0111234677899999999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=256.80 Aligned_cols=192 Identities=14% Similarity=0.207 Sum_probs=153.3
Q ss_pred cEeecccCceecCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...++.||||||+.++ |.+++.+....+++.++..++.||+.||+|||+++++||||||+||||+.++.+
T Consensus 67 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred CcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcE
Confidence 6788888889999999999999875 544555544579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||++...............++..|+|||++.. ..++.++|||||||++|||++ |+.||...+..+.+..+.+..
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~ 225 (266)
T cd05064 147 KISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF 225 (266)
T ss_pred EECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC
Confidence 999999876543221111112234678999999875 678999999999999999775 999999888777766654321
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..+ ....++..+.+||.+||..||++|||+++|++
T Consensus 226 ~~~-----------------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 RLP-----------------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 110 01235668899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=262.56 Aligned_cols=198 Identities=28% Similarity=0.479 Sum_probs=157.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...++.|+||||+.+ +|.+++.+ ..+++.++..++.||+.+|.|||+.+|+|+||||+|||++.++.+
T Consensus 77 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~ 154 (297)
T cd06656 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSV 154 (297)
T ss_pred CEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 688899999999999999999986 55555543 248999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.. .+
T Consensus 155 ~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~ 231 (297)
T cd06656 155 KLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG 231 (297)
T ss_pred EECcCccceEccCCc-cCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CC
Confidence 999999987653222 12233467889999999876 5688999999999999999999999977654333221110 00
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+. ......++..+++||.+||..||++|+|+.++++|+||...
T Consensus 232 ~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 232 TPE--------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred CCC--------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 000 00112356778999999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=253.68 Aligned_cols=193 Identities=18% Similarity=0.274 Sum_probs=154.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+..|+||||+.+ +|.+++......+++..+..++.||+.+|+|||+++|+||||||+|||+++++.+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~ 139 (256)
T cd05059 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVV 139 (256)
T ss_pred CEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcE
Confidence 678888888888999999999975 6777776555579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+++...............+..|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+....+....
T Consensus 140 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 218 (256)
T cd05059 140 KVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218 (256)
T ss_pred EECCcccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987654222111112223457999998875 578999999999999999998 899998877766655553211
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
... ....++.++.+||.+||..+|++|||+.|+++.
T Consensus 219 ~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 219 RLY-----------------------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred cCC-----------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 100 011256789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-34 Score=301.50 Aligned_cols=199 Identities=27% Similarity=0.407 Sum_probs=162.6
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|+|++|.+..++..+||+||||+++.+..+...+.-..|...+.|..|++.||+|||++||||||||++||||+..|.+|
T Consensus 1295 NlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1295 NLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred cccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEE
Confidence 78999999999999999999999655554444454578888999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCC---CCcccccccccCCCCchhhcCCC--CCCCccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHH
Q 014871 84 LADFGLARSFSYDH---NNTLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKI 157 (417)
Q Consensus 84 L~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~elltG~~pf~~-~~~~~~~~~i 157 (417)
+.|||.|+.+.... ...+....||+.|||||++.+.+ ....++||||||||+.||+||+.||.. +++..++.++
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH
Confidence 99999998776432 23445678999999999998753 356789999999999999999999864 3444444333
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
-.. ....++..++.+.+|||+.||.-||++|+++.+||+|.|-+.
T Consensus 1455 ~~g-----------------------------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1455 AAG-----------------------------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred hcc-----------------------------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 110 111223348889999999999999999999999999999754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=253.08 Aligned_cols=192 Identities=20% Similarity=0.319 Sum_probs=155.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++.++.+||||||+.+ +|.+.+......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+
T Consensus 60 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~ 139 (256)
T cd05114 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV 139 (256)
T ss_pred CceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeE
Confidence 788899999999999999999974 6776665444468999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+++...............+..|+|||++.. ..++.++|||||||++|||++ |+.||...+..+.+..+.+..
T Consensus 140 kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 218 (256)
T cd05114 140 KVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218 (256)
T ss_pred EECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 999999987654322222122234567999999875 578899999999999999999 899998888777777664421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... ....+..+.+||++||..||++|||+.+|++
T Consensus 219 ~~~~-----------------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 219 RLYR-----------------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCC-----------------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1000 0113457899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=253.55 Aligned_cols=194 Identities=24% Similarity=0.364 Sum_probs=156.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+.....+||||||+.+ +|.+++......+++.++..++.||+.||+|||+++|+|+||||+|||++.++.
T Consensus 59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~ 138 (256)
T cd05113 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC 138 (256)
T ss_pred CCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC
Confidence 3789999999988899999999975 676666554447999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............++..|++||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.+.
T Consensus 139 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05113 139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217 (256)
T ss_pred EEECCCccceecCCCceeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC
Confidence 9999999987654322211222234677999999875 568899999999999999998 99999887776666655332
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.... .....+..+++||.+||..||++|||+.+|+++
T Consensus 218 ~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 LRLY-----------------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 1110 011246788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=251.63 Aligned_cols=195 Identities=25% Similarity=0.462 Sum_probs=159.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.++..++.||||||+.+ +|...+... ...+++.++..++.||+.+|+|||+++++|+||+|+|||++.++.
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~ 139 (256)
T cd08218 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT 139 (256)
T ss_pred CeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 678889999999999999999975 676666543 335899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
++|+|||++....... .......++..|+|||++.+ ..++.++|||||||++++|++|+.||...+..+....+....
T Consensus 140 ~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08218 140 IKLGDFGIARVLNSTV-ELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217 (256)
T ss_pred EEEeeccceeecCcch-hhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC
Confidence 9999999997654321 11223356888999999876 567889999999999999999999998877766665553211
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.. .....++.++++||++||..+|++||++.++|+|+||
T Consensus 218 --~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 218 --YP---------------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred --CC---------------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 0112356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=254.29 Aligned_cols=201 Identities=22% Similarity=0.433 Sum_probs=156.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|++++++.++..+.+|+||||+.+ +|.+.+.+. ..+++.+++.++.||+.+|.|||+++++|+|||++||+++.++.+
T Consensus 69 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC 147 (272)
T ss_pred CcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeE
Confidence 577888888888999999999986 555555444 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC-CcccccccccCCCCchhhcCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++....... .......++..|+|||++.... .++.++|+||||||+|+|++|..||......+.+..+...
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc
Confidence 9999999876432211 1122345688999999987533 3788999999999999999999999765554443332211
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.... .. .......++.++++||.+||..||++|||++++|+|+||
T Consensus 228 ~~~~---~~---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 228 RSAP---PI---------------------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCC---cC---------------------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000 00 001122367799999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=262.86 Aligned_cols=227 Identities=28% Similarity=0.414 Sum_probs=172.5
Q ss_pred cEeecccCceecC----eEEEEEcCCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRG----STYMVFEYMDHDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~----~~yiV~Ey~~g~l~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~ 77 (417)
-||+++|.|++.+ |+|||+|+++.+||.++++.+. .|+...|+.|++|||.||.|||.+ ||||-||||+||||.
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 3799999999987 8999999999999999998664 499999999999999999999975 999999999999982
Q ss_pred CC------------------------------------------------------------------------------
Q 014871 78 NE------------------------------------------------------------------------------ 79 (417)
Q Consensus 78 ~~------------------------------------------------------------------------------ 79 (417)
.+
T Consensus 223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s 302 (590)
T KOG1290|consen 223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQES 302 (590)
T ss_pred ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccc
Confidence 00
Q ss_pred --------------------------------------------------------------------------------
Q 014871 80 -------------------------------------------------------------------------------- 79 (417)
Q Consensus 80 -------------------------------------------------------------------------------- 79 (417)
T Consensus 303 ~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p 382 (590)
T KOG1290|consen 303 YNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNP 382 (590)
T ss_pred cccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCC
Confidence
Q ss_pred --------CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC----
Q 014871 80 --------GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG---- 147 (417)
Q Consensus 80 --------~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~---- 147 (417)
-.|||+|||.|+.+. ...+.-+.|..|+||||+++ ..|+..+||||++|++|||+||..+|.-
T Consensus 383 ~~~~~~~di~vKIaDlGNACW~~----khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~ 457 (590)
T KOG1290|consen 383 DIPLPECDIRVKIADLGNACWVH----KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGE 457 (590)
T ss_pred CCCCCccceeEEEeeccchhhhh----hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence 015666777665432 23445567999999999998 6799999999999999999999988863
Q ss_pred --CChHHHHHHHHHhcCCCCCCCCCCCCCCCcc-c------c-----CCCchhhhhhHHHhhhhhhHHHHHHHHHhcccC
Q 014871 148 --KNEAEQLSKIFELCGSPDETIWPGVSKMPAY-N------H-----FKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 213 (417)
Q Consensus 148 --~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~------~-----~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 213 (417)
..+.+.++.|+++++..+....-.-.....| + + +.+........-++...-..++.+||.-||.++
T Consensus 458 ~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~ 537 (590)
T KOG1290|consen 458 NYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD 537 (590)
T ss_pred CCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence 3467789999999988654332211111111 1 0 111111111222222344577889999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCCCC
Q 014871 214 PSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 214 P~~Rpta~elL~h~~f~~~~~~ 235 (417)
|++|+||.++|+|||+.....+
T Consensus 538 PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 538 PEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ccccccHHHHhcCccccCCCCC
Confidence 9999999999999999876665
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=253.42 Aligned_cols=196 Identities=29% Similarity=0.469 Sum_probs=157.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+.....+|+||||+.+ +|..++.+ ...+++.++..++.||+.+|+|||+++|+|+||+|+||+++.++.
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~ 140 (258)
T cd06632 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV 140 (258)
T ss_pred CCchheeeeEecCCeEEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 3788889999999999999999986 56555544 346899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... ......++..|++||.+.....++.++|+|||||++|+|++|+.||......+....+....
T Consensus 141 ~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 218 (258)
T cd06632 141 VKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK 218 (258)
T ss_pred EEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc
Confidence 9999999987654322 22345578889999998753338899999999999999999999997766544443332110
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.. ..+...++.++++||++||..||++|||+.+++.|+|+
T Consensus 219 ~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 EL----------------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cC----------------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00 01122356789999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=256.25 Aligned_cols=199 Identities=26% Similarity=0.371 Sum_probs=152.8
Q ss_pred cEeecccCceec-----CeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 4 TFLETTDGNKYR-----GSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 4 niv~~~~~~~~~-----~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
|++++++.+... +.+|+||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+++|+|+||||+||
T Consensus 80 ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~ni 159 (291)
T cd06639 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNI 159 (291)
T ss_pred CeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 577777665533 468999999986 56555432 345699999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCC----CCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 014871 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT----KYGPAVDMWSVGCIFAELLNGKPILPGKNE 150 (417)
Q Consensus 75 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DiwSlG~il~elltG~~pf~~~~~ 150 (417)
+++.++.+||+|||++........ ......++..|+|||++.... .++.++||||||||+|||++|+.||...+.
T Consensus 160 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 160 LLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 999999999999999876542211 122345688999999875422 367899999999999999999999987766
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
...+..+.... .... .....++..+++||.+||..||++||++.+|++|+||.
T Consensus 239 ~~~~~~~~~~~---~~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 239 VKTLFKIPRNP---PPTL------------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHhcCC---CCCC------------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 55554442210 0000 00112445789999999999999999999999999983
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=254.90 Aligned_cols=198 Identities=31% Similarity=0.539 Sum_probs=159.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++..+..||||||+.+ +|..++.+.. .+++.++..++.||+.+|+|||+++++|+||+|+|||++.++.+
T Consensus 54 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~ 132 (265)
T cd05579 54 YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132 (265)
T ss_pred chhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCE
Confidence 577788888889999999999986 6666665444 69999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC-------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 83 KLADFGLARSFSYDHNN-------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
||+|||++......... ......++..|++||++.. ..++.++|||||||++|+|++|..||......+...
T Consensus 133 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 211 (265)
T cd05579 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ 211 (265)
T ss_pred EEEecccchhcccCcccccccccccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999998764432111 2233456788999999876 458889999999999999999999998887766665
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH---HHHhcCCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA---KDALDSEYFWT 231 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta---~elL~h~~f~~ 231 (417)
.+.... ..++.. ..++..+.+||++||..+|++|||+ .++|+|+||..
T Consensus 212 ~~~~~~-----~~~~~~-----------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 212 NILNGK-----IEWPED-----------------------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHhcCC-----cCCCcc-----------------------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 553310 001100 0146789999999999999999999 99999999953
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=255.62 Aligned_cols=196 Identities=27% Similarity=0.476 Sum_probs=151.4
Q ss_pred cEeecccCcee--cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKY--RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~--~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
||+.+++.+.. .+.+|+||||+.+ +|.+.+... ..+++.++..++.||+.+|+|||+++|+|+||||+||+++.++
T Consensus 65 ~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~ 143 (266)
T cd06651 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG 143 (266)
T ss_pred CeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC
Confidence 67777776654 3578999999986 566555543 4589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCC--CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDH--NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+++...... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||........+.++.
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~ 222 (266)
T cd06651 144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222 (266)
T ss_pred CEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 99999999987653211 111223456888999999876 568899999999999999999999998765544443332
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
. .... ..+...++..+++|| +||..||++|||++||++|+||.
T Consensus 223 ~---~~~~-------------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 223 T---QPTN-------------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred c---CCCC-------------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 1 1100 011123566788898 67778999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=256.84 Aligned_cols=193 Identities=22% Similarity=0.326 Sum_probs=155.7
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
||+++++.+...+..|++|||+.+ +|.+++.+.. ..+++.++..++.||+.||+|||+++|+|+
T Consensus 69 ~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~ 148 (283)
T cd05048 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHR 148 (283)
T ss_pred ccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 678888888888899999999985 6766665421 358899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPIL 145 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf 145 (417)
||||+|||+++++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 149 dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~ 227 (283)
T cd05048 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPY 227 (283)
T ss_pred ccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999976532221 12233455788999999875 568999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+..+....+..... ......++.++.+||.+||..||.+|||+.+|++
T Consensus 228 ~~~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 228 YGFSNQEVIEMIRSRQL-----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred CCCCHHHHHHHHHcCCc-----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 98887776665532110 0012246778999999999999999999999986
Q ss_pred C
Q 014871 226 S 226 (417)
Q Consensus 226 h 226 (417)
+
T Consensus 279 ~ 279 (283)
T cd05048 279 R 279 (283)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=272.50 Aligned_cols=196 Identities=25% Similarity=0.371 Sum_probs=168.2
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|+|.+..||--+-..|||||||-|+-.+++.-..+.|.+.+|..|+.+.|.||+|||+++.||||||..||||.+.|.||
T Consensus 87 ntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VK 166 (948)
T KOG0577|consen 87 NTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVK 166 (948)
T ss_pred CcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeee
Confidence 67888899988888999999999977776666566799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
|+|||.|.... ...+++||+.||||||++. ...|+-++|||||||+..||.-.++|+...|...-+..|....
T Consensus 167 LaDFGSAsi~~-----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe 241 (948)
T KOG0577|consen 167 LADFGSASIMA-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 241 (948)
T ss_pred eccccchhhcC-----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC
Confidence 99999987654 4456899999999999873 4579999999999999999999999998888888777775421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
...-. ...++..++.||..||.+-|.+|||.+++|.|+|+...
T Consensus 242 sPtLq----------------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 242 SPTLQ----------------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred CCCCC----------------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 11000 13467789999999999999999999999999999653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=268.44 Aligned_cols=193 Identities=20% Similarity=0.342 Sum_probs=150.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC----------------------------------------------
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---------------------------------------------- 36 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---------------------------------------------- 36 (417)
|||++++.+...+.+|||||||.+ +|.+++.+.
T Consensus 103 nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred ceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 789999999999999999999984 666655321
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccc
Q 014871 37 -----------------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93 (417)
Q Consensus 37 -----------------------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~ 93 (417)
...+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence 124788999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcc-cccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 014871 94 SYDHNNTL-TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPG 171 (417)
Q Consensus 94 ~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 171 (417)
........ ....++..|+|||++.. ..++.++|||||||++|||++ |+.||........+..+......+.
T Consensus 263 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~------ 335 (374)
T cd05106 263 MNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS------ 335 (374)
T ss_pred cCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc------
Confidence 43222111 12234567999999875 578999999999999999997 9999987655444333322110000
Q ss_pred CCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 172 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....++.++++||.+||..||++|||+.+|++
T Consensus 336 ----------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 ----------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01124678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=260.69 Aligned_cols=197 Identities=27% Similarity=0.381 Sum_probs=162.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.|++.+++.+......||||||+.++++.++......+++.++..++.||+.+|.|||++||+|+||||+||+++.++.+
T Consensus 81 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~ 160 (313)
T cd06633 81 PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQV 160 (313)
T ss_pred CCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCE
Confidence 47888888899999999999999999888887766679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||++.... ......++..|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+...
T Consensus 161 kL~dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~ 235 (313)
T cd06633 161 KLADFGSASKSS-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 235 (313)
T ss_pred EEeecCCCcccC-----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence 999999986432 1223467888999999742 245788999999999999999999999887766655554321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
. .+. .....++..+++||.+||..+|.+|||+.+++.|+||...
T Consensus 236 ~-~~~---------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 236 D-SPT---------------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred C-CCC---------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0 000 0012245678999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=256.93 Aligned_cols=197 Identities=24% Similarity=0.431 Sum_probs=157.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+..+...||||||+.+ +|.+++.. . .+++..+..++.||+.+|.|||+++|+|+||+|+||+++.++.+
T Consensus 63 ~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~ 140 (277)
T cd06917 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-G-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNV 140 (277)
T ss_pred CeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-c-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCE
Confidence 688888889999999999999986 55555443 3 68999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
+|+|||++....... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||...+.......+...
T Consensus 141 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-- 217 (277)
T cd06917 141 KLCDFGVAALLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-- 217 (277)
T ss_pred EEccCCceeecCCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--
Confidence 999999997765332 22233467889999999876556789999999999999999999999876543332221110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+.. + ....++.++.+||.+||..||++|+|+.++++|+||..
T Consensus 218 ~~~~--------~------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 218 KPPR--------L------------------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred CCCC--------C------------------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 0000 0 00125668999999999999999999999999999955
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=264.41 Aligned_cols=225 Identities=36% Similarity=0.604 Sum_probs=167.5
Q ss_pred cEeecccCce------ecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNK------YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~------~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+. ....+|+++|++.++|..++... .+++..++.++.||+.||+|||+++|+||||||+||+++
T Consensus 77 ~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~ 154 (345)
T cd07877 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 154 (345)
T ss_pred cccceeeeeeecccccccccEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc
Confidence 4566665543 33568999999988887766543 599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... ......++..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+
T Consensus 155 ~~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 155 EDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999876432 2233466889999999876556889999999999999999999999988887877777
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
......+....+........-.... ................+.++++||.+||..||.+|+|+.++|+|+||..-..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 7666554443332222100000000 0000000111222245788999999999999999999999999999975433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=256.04 Aligned_cols=195 Identities=27% Similarity=0.425 Sum_probs=156.5
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+...+.+||||||+. .+|.+++......+++..+..++.||+.+|+|||+ .+++|+||||+||++++++.
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~ 139 (265)
T cd06605 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ 139 (265)
T ss_pred chhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC
Confidence 67788888888899999999999 56776666544679999999999999999999999 99999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----hHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-----EAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-----~~~~~~~ 156 (417)
+||+|||++........ ....++..|++||.+.+ ..++.++|||||||++|+|++|+.||.... ..+.+..
T Consensus 140 ~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 215 (265)
T cd06605 140 IKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY 215 (265)
T ss_pred EEEeecccchhhHHHHh---hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH
Confidence 99999999876532211 12567889999999876 578999999999999999999999986542 2222222
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh-hhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.. .... .+.. .++..+++||.+||..||++|||+.+++.|+||..
T Consensus 216 ~~~---~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 216 IVN---EPPP--------------------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred Hhc---CCCC--------------------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 211 0000 0011 16778999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=255.54 Aligned_cols=198 Identities=27% Similarity=0.428 Sum_probs=151.6
Q ss_pred cEeecccCc-----eecCeEEEEEcCCCC-CHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 4 TFLETTDGN-----KYRGSTYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 4 niv~~~~~~-----~~~~~~yiV~Ey~~g-~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
||+++++.+ ...+.+|+||||+++ +|.+++. .....+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 76 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 155 (286)
T cd06638 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNI 155 (286)
T ss_pred CeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhE
Confidence 677777765 344678999999986 5555543 2344689999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 014871 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150 (417)
Q Consensus 75 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 150 (417)
+++.++.+||+|||+++...... .......++..|+|||++... ..++.++|||||||++|||++|+.||...+.
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred EECCCCCEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 99999999999999987654221 122334678999999987531 3478899999999999999999999987665
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
...+.++.... .... .....++..+++||.+||..||++|||+.||++|+||
T Consensus 235 ~~~~~~~~~~~--~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 235 MRALFKIPRNP--PPTL-------------------------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred hHHHhhccccC--CCcc-------------------------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 44333221100 0000 0011245679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=258.60 Aligned_cols=202 Identities=23% Similarity=0.386 Sum_probs=158.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+.++++++.++.+||||||+.+ +|.+.+... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 65 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~ 143 (290)
T cd05613 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH 143 (290)
T ss_pred CChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC
Confidence 4788888999999999999999985 566655543 46899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||++...............++..|+|||++... ..++.++||||||||+|+|++|+.||...+.......+.+.
T Consensus 144 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 223 (290)
T cd05613 144 VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223 (290)
T ss_pred EEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH
Confidence 99999999977644333333345678899999998642 24678999999999999999999999754433222222221
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
..... ......++..+.+||++||..||++|+ ++.++++|+||..
T Consensus 224 ~~~~~--------------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 224 ILKSE--------------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred hhccC--------------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 11000 001123567889999999999999997 8999999999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=249.34 Aligned_cols=193 Identities=22% Similarity=0.368 Sum_probs=157.9
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP--------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~--------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
+++++++.+.....+||||||+. ++|.+++... ...+++.++..++.||+.||+|||+++|+|+||||+||
T Consensus 57 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~ni 136 (262)
T cd00192 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC 136 (262)
T ss_pred ChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceE
Confidence 67788888888899999999995 5777776654 36799999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHH
Q 014871 75 LIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 152 (417)
Q Consensus 75 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~ 152 (417)
|++.++.+||+|||++........ .......++..|+|||++.. ..++.++|||||||++|+|++ |..||......+
T Consensus 137 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 215 (262)
T cd00192 137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215 (262)
T ss_pred EECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987653321 11223455788999998876 478999999999999999999 699999887777
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
....+...... .....++.++.+||++||..||++|||+.|++++
T Consensus 216 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 216 VLEYLRKGYRL-----------------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHcCCCC-----------------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 66666431000 0112346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=262.67 Aligned_cols=228 Identities=21% Similarity=0.234 Sum_probs=158.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-||+++++.+...+.+|+||||+.+ ++.+++.+. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 59 ~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~ 138 (328)
T cd08226 59 PNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG 138 (328)
T ss_pred CCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC
Confidence 3789999999999999999999985 666665543 23589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCc------ccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 81 NLKLADFGLARSFSYDHNNT------LTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
.+||+||+.+.......... .....++..|+|||++.+. ..++.++|||||||++|||++|+.||........
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 218 (328)
T cd08226 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM 218 (328)
T ss_pred cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH
Confidence 99999998654322111100 0011235679999998753 3478999999999999999999999987766554
Q ss_pred HHHHHHhcCC-CCC-CCCCCCCCCCccccCCC---------------chhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC
Q 014871 154 LSKIFELCGS-PDE-TIWPGVSKMPAYNHFKP---------------SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216 (417)
Q Consensus 154 ~~~i~~~~~~-~~~-~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 216 (417)
+..+...... +.. ..++............. ..............++..+++||++||..||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 298 (328)
T cd08226 219 LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298 (328)
T ss_pred HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence 4433321110 000 00000000000000000 000000001123457788999999999999999
Q ss_pred CCCHHHHhcCCCCC
Q 014871 217 RISAKDALDSEYFW 230 (417)
Q Consensus 217 Rpta~elL~h~~f~ 230 (417)
|||++++|+|+||.
T Consensus 299 Rpta~e~l~~~~~~ 312 (328)
T cd08226 299 RPSASSLLSHAFFK 312 (328)
T ss_pred CCCHHHHhhCHHHH
Confidence 99999999999994
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=251.38 Aligned_cols=192 Identities=19% Similarity=0.291 Sum_probs=153.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+..++.+|+||||+.+ +|.+++... ...+++..++.++.||+.+|+|||+++++||||||+|||+++++.
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~ 142 (263)
T cd05052 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 142 (263)
T ss_pred ChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc
Confidence 677888888888999999999974 676666543 335899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||++................+..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 143 ~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 221 (263)
T cd05052 143 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221 (263)
T ss_pred EEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 9999999997654322221122223567999998875 568899999999999999998 99999887766665555321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
... .....++.++.+||.+||..||++|||+.++++
T Consensus 222 ~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 222 YRM-----------------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCC-----------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 100 011235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=256.89 Aligned_cols=197 Identities=25% Similarity=0.354 Sum_probs=162.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.|++++++.+..+...||||||+.+++++.+......+++.++..++.||+.+|.|||+++|+|+||+|+||+++.++.+
T Consensus 85 ~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~ 164 (317)
T cd06635 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQV 164 (317)
T ss_pred CCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCE
Confidence 47899999999999999999999999888876656679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||++..... .....++..|+|||++.. ...++.++|||||||++|||++|+.||...+....+..+...
T Consensus 165 kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~ 239 (317)
T cd06635 165 KLADFGSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 239 (317)
T ss_pred EEecCCCccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 9999999865432 223456888999998742 245788999999999999999999999877666655555331
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
..... ....++..+++||++||..+|.+|||+.++++|+|+...
T Consensus 240 ~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 240 ESPTL----------------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred cCCCC----------------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 11000 011245678999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=255.46 Aligned_cols=194 Identities=29% Similarity=0.509 Sum_probs=160.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++.++.+||||||+. ++|.+++.+. ..+++.++..++.||+.+|+|||+++++|+||||+||+++.++++
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~ 141 (280)
T cd05581 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHI 141 (280)
T ss_pred CchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCE
Confidence 67888888999999999999995 5776666554 369999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC-------------------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCC
Q 014871 83 KLADFGLARSFSYDHN-------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143 (417)
Q Consensus 83 kL~DFGla~~~~~~~~-------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~ 143 (417)
+|+|||++........ .......++..|++||++.. ..++.++|||||||++++|++|+.
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~ 220 (280)
T cd05581 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKP 220 (280)
T ss_pred EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCC
Confidence 9999999876543221 11223356888999998875 568889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH---
Q 014871 144 ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA--- 220 (417)
Q Consensus 144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta--- 220 (417)
||...+....+..+...... +...++..+.+||++||..||++|||+
T Consensus 221 p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 270 (280)
T cd05581 221 PFRGSNEYLTFQKILKLEYS------------------------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEG 270 (280)
T ss_pred CCCCccHHHHHHHHHhcCCC------------------------------CCCccCHHHHHHHHHHhcCCHhhCCCcccC
Confidence 99988766655555321111 112346789999999999999999999
Q ss_pred -HHHhcCCCC
Q 014871 221 -KDALDSEYF 229 (417)
Q Consensus 221 -~elL~h~~f 229 (417)
+++|+|+||
T Consensus 271 ~~~ll~~~~~ 280 (280)
T cd05581 271 YDELKAHPFF 280 (280)
T ss_pred HHHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=250.58 Aligned_cols=199 Identities=27% Similarity=0.435 Sum_probs=152.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRF--TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l--~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~- 78 (417)
-||+++++.+...+.+|+||||+.+ +|...+......+ ++..+..++.||+.||+|||+++|+||||||+||+++.
T Consensus 65 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~ 144 (268)
T cd06624 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY 144 (268)
T ss_pred CCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 3788899999999999999999985 6666665443345 88899999999999999999999999999999999976
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
++.+||+|||++....... .......++..|+|||++... ..++.++|||||||++|+|++|+.||............
T Consensus 145 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~ 223 (268)
T cd06624 145 SGVVKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK 223 (268)
T ss_pred CCeEEEecchhheecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh
Confidence 5689999999987653221 122234568899999998642 24788999999999999999999998654322211110
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
..... ....+...++.++++||++||..+|++|||+.++++|+||
T Consensus 224 ~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 VGMFK---------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hhhhc---------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00000 0011123466789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=250.16 Aligned_cols=193 Identities=28% Similarity=0.433 Sum_probs=157.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+++++.++.++++|+||||+.+ ++.+++.. .+..+++..+..++.||+.||.|||+++|+|+||||+|||++.++
T Consensus 58 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~ 137 (255)
T cd08219 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137 (255)
T ss_pred CCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC
Confidence 5789999999999999999999975 67776654 344589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.++|+|||++....... .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 138 ~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~ 215 (255)
T cd08219 138 KVKLGDFGSARLLTSPG-AYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215 (255)
T ss_pred cEEEcccCcceeecccc-cccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC
Confidence 99999999997654322 12233567889999999875 56899999999999999999999999887766655554321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
... .+...++..+++||++||..||++|||+.+|+..
T Consensus 216 ~~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYK-----------------------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCC-----------------------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 100 0112356678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=284.16 Aligned_cols=199 Identities=29% Similarity=0.421 Sum_probs=154.3
Q ss_pred ccEeecccCcee--cCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCC
Q 014871 3 CTFLETTDGNKY--RGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-------QVLHRDI 69 (417)
Q Consensus 3 cniv~~~~~~~~--~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~-------givHrDl 69 (417)
.|||++++.|.. ...+|||||||.+ +|..++.. ....|++..++.|+.||+.||+|||+. +||||||
T Consensus 72 PNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDL 151 (1021)
T PTZ00266 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDL 151 (1021)
T ss_pred CCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccC
Confidence 478888887744 4578999999985 67666653 234699999999999999999999984 4999999
Q ss_pred CCCcEEEcC-----------------CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC-CCCCCccchhhH
Q 014871 70 KGSNLLIDN-----------------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSV 131 (417)
Q Consensus 70 kp~NILl~~-----------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSl 131 (417)
||+||||+. ...+||+|||++..+.... .....++|+.|+|||++... ..++.++|||||
T Consensus 152 KPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSL 229 (1021)
T PTZ00266 152 KPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229 (1021)
T ss_pred cHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHH
Confidence 999999964 2348999999997654322 22345689999999998642 357899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcc
Q 014871 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLM 211 (417)
Q Consensus 132 G~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~ 211 (417)
|||||||++|+.||...+....+..++... +.. ....++.++.+||..||.
T Consensus 230 G~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~l---------------------------pi~~~S~eL~dLI~~~L~ 280 (1021)
T PTZ00266 230 GCIIYELCSGKTPFHKANNFSQLISELKRG--PDL---------------------------PIKGKSKELNILIKNLLN 280 (1021)
T ss_pred HHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CCC---------------------------CcCCCCHHHHHHHHHHhc
Confidence 999999999999998766554443332211 000 011246689999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCC
Q 014871 212 LDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 212 ~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+|.+|||+.++|.|+||...
T Consensus 281 ~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 281 LSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CChhHCcCHHHHhccHHHhhc
Confidence 999999999999999999644
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=254.46 Aligned_cols=196 Identities=27% Similarity=0.418 Sum_probs=158.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+|+++++.+...+..||||||+.+ +|.+++.. ..+++.++..++.||+.+|+|||+++++|+||+|+||+++.++.
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~ 139 (277)
T cd06640 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD 139 (277)
T ss_pred CCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC
Confidence 4789999999999999999999986 56555543 35899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
++|+|||++....... .......++..|+|||++.+ ..++.++|+|||||++|||++|..||...+.......+...
T Consensus 140 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~- 216 (277)
T cd06640 140 VKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN- 216 (277)
T ss_pred EEEcccccceeccCCc-cccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-
Confidence 9999999997654322 12223456888999999875 56889999999999999999999999876655443322110
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+ ..+...++..+.+||.+||..||++|||+.+++.|+||..
T Consensus 217 -~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 217 -NP---------------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred -CC---------------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 00 0112235678999999999999999999999999999954
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=255.08 Aligned_cols=202 Identities=24% Similarity=0.401 Sum_probs=161.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||++.++.+...++.|+||||+.++.+..+... ..+++.+++.++.||+.+|+|||++|++|+||||+||+++.++.+
T Consensus 77 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~ 155 (292)
T cd06657 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155 (292)
T ss_pred cchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 3778888999999999999999987544444433 358999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
+|+|||++........ ......++..|++||++.. ..++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 156 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 233 (292)
T cd06657 156 KLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 233 (292)
T ss_pred EEcccccceecccccc-cccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Confidence 9999999876543221 2233456889999998865 5678999999999999999999999988776655554432110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
.. + .....++..+.+||.+||..||.+|+++.++|+|+||.....
T Consensus 234 ~~----~-----------------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 234 PK----L-----------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred cc----c-----------------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 00 0 001225667899999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=258.28 Aligned_cols=196 Identities=24% Similarity=0.367 Sum_probs=159.3
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|++++++++......||||||+.+++...+......+++.++..++.||+.+|.|||+++++|+||||+|||++.++.+|
T Consensus 76 ~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred CcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEE
Confidence 67788888888889999999999988887766556699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
|+|||++..... .....++..|+|||++.. ...++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 156 l~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 230 (308)
T cd06634 156 LGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230 (308)
T ss_pred ECCcccceeecC-----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC
Confidence 999999876432 123456889999999752 2457889999999999999999999987766555444332210
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
. +. .....++..+++||++||..+|++|||+.++++|+|+...
T Consensus 231 ~-~~---------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 231 S-PA---------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred C-CC---------------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0 00 0012356788999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=248.16 Aligned_cols=199 Identities=28% Similarity=0.453 Sum_probs=153.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+.+|+|+||+.+ +|.+.+. ....+++.+++.++.||+.+|+|||+++|+|+|||++||++++++.+
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~ 138 (264)
T cd06626 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVI 138 (264)
T ss_pred ChhheeeeEecCCEEEEEEecCCCCcHHHHHh-hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 567778888888899999999986 4555444 44458999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcc---cccccccCCCCchhhcCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTL---TNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
||+|||++........... ....++..|++||++.... .++.++|||||||++|+|++|+.||............
T Consensus 139 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~ 218 (264)
T cd06626 139 KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH 218 (264)
T ss_pred EEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH
Confidence 9999999877643322211 1345678999999987532 2788999999999999999999999765432222211
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
... ..... .+ ....++..+++||++||..||++|||+.|++.|+|+
T Consensus 219 ~~~-~~~~~--~~-----------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 219 VGA-GHKPP--IP-----------------------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred Hhc-CCCCC--CC-----------------------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111 10000 00 011246688999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=252.39 Aligned_cols=193 Identities=27% Similarity=0.443 Sum_probs=155.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++...+.|+||||+.+ +|...+.+. ..+++.++..++.||+++|.|||+++++|+||||+||++++++.+
T Consensus 61 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~ 139 (258)
T cd05578 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHV 139 (258)
T ss_pred ChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCE
Confidence 677888888999999999999986 555555444 569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA--EQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~--~~~~~i~~~ 160 (417)
+|+|||++....... ......++..|+|||++.. ..++.++|+|||||++|+|++|+.||...+.. +.+......
T Consensus 140 ~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 216 (258)
T cd05578 140 HITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET 216 (258)
T ss_pred EEeecccccccCCCc--cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc
Confidence 999999987654322 2233456888999999876 56899999999999999999999999876642 222111110
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA--KDALDSEYF 229 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta--~elL~h~~f 229 (417)
. .......++..+.+||.+||..||.+|+++ .|+++|+||
T Consensus 217 ---~--------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ---A--------------------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---c--------------------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0 001112355789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=255.89 Aligned_cols=199 Identities=19% Similarity=0.246 Sum_probs=151.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG------------------LRFTVPQIKCYMKQLLTGLHYCHVNQV 64 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~------------------~~l~~~~i~~i~~Qil~gL~~LH~~gi 64 (417)
||+++++.+...+..||||||+.+ +|.+++.... ..+++.++..++.||+.||+|||+++|
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 789999999999999999999975 6666554321 236788999999999999999999999
Q ss_pred eecCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh--C
Q 014871 65 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--G 141 (417)
Q Consensus 65 vHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt--G 141 (417)
+||||||+||||+.++.+||+|||+++........ ......++..|+|||++.. ..++.++|||||||++|||++ +
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999765432211 1122344778999999875 568999999999999999986 5
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHH
Q 014871 142 KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 221 (417)
Q Consensus 142 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~ 221 (417)
..||...+..+.+..+............ ......++..+.+||.+||..||++|||+.
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVY----------------------LFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhcccccc----------------------ccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 6778776666655544332111100000 000123567899999999999999999999
Q ss_pred HHhc
Q 014871 222 DALD 225 (417)
Q Consensus 222 elL~ 225 (417)
+|.+
T Consensus 297 ~i~~ 300 (304)
T cd05096 297 DIHA 300 (304)
T ss_pred HHHH
Confidence 9854
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=249.60 Aligned_cols=192 Identities=19% Similarity=0.343 Sum_probs=155.4
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+...+..||||||+. ++|.+++.+ ....+++.++..++.||+.||+|||+++++||||||+|||++.++.
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~ 141 (261)
T cd05072 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM 141 (261)
T ss_pred CeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc
Confidence 78888888899999999999997 477776654 3456899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05072 142 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220 (261)
T ss_pred EEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998754322222223344678999998875 568889999999999999998 99999888777666665332
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++.++.+||.+||..||++|||++++++
T Consensus 221 ~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 YRMP-----------------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCC-----------------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1100 01235668899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=247.65 Aligned_cols=194 Identities=26% Similarity=0.395 Sum_probs=157.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
||++.++.+..++.+||||||+.+ +|.+++... ...+++.+++.++.||+.+|+|||+++|+|+||||+||+++.++
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~ 139 (256)
T cd08220 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM 139 (256)
T ss_pred chhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 577888888889999999999986 676666543 34589999999999999999999999999999999999998654
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||++....... ......++..|+|||++.. ..++.++|||||||++|+|++|+.+|...+.......+...
T Consensus 140 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 140 VVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred EEEEccCCCceecCCCc--cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence 58999999998654322 2223467889999999875 56789999999999999999999999887766555444321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
... .+...++..+++||.+||..||++|||+.|+++||||
T Consensus 217 ~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 217 TFA-----------------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCC-----------------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 100 0112356789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=250.59 Aligned_cols=188 Identities=22% Similarity=0.242 Sum_probs=146.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+..+...||||||++++.+. ++.+....+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 64 p~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 64 KHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI 143 (262)
T ss_pred CCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCc
Confidence 37889999888888999999999975544 44444456999999999999999999999999999999999999987664
Q ss_pred -------EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHH-hCCCCCCCCChHHH
Q 014871 82 -------LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQ 153 (417)
Q Consensus 82 -------vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-tG~~pf~~~~~~~~ 153 (417)
+||+|||++..... .....++..|+|||++.....++.++|||||||++|||+ .|+.||......+.
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK 218 (262)
T ss_pred cCCCCceeEeCCCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence 89999999865432 123456788999998875467899999999999999998 48888876554333
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.. +..... ......+.++.+||.+||..||++||++.+|+++
T Consensus 219 ~~-~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 219 ER-FYEGQC------------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HH-HHhcCc------------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 22 111000 0001134578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=248.70 Aligned_cols=192 Identities=22% Similarity=0.350 Sum_probs=153.6
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+...+..|+||||+. ++|.+.+.... ..+++.++..++.||+.||.|||+++|+|+||||+|||++.++.
T Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (261)
T cd05068 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI 141 (261)
T ss_pred CccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC
Confidence 57888888888999999999995 67777765533 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++...............+..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+....+..+...
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 142 CKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred EEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998765222111111222457999998875 578999999999999999999 99999888776666655321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++..+.+||.+||..||++||++.+|++
T Consensus 221 ~~~~-----------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 YRMP-----------------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCC-----------------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1000 01124568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=255.48 Aligned_cols=201 Identities=24% Similarity=0.391 Sum_probs=154.7
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+++++.+..++.+||||||+.+ +|...+.+ ...+++.+++.++.||+.+|+|||+.+++|+||||.|||++.++.+
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~ 144 (288)
T cd05583 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHV 144 (288)
T ss_pred chhhhheeeecCCEEEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE
Confidence 577788889999999999999986 56555543 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+|+|||+++.+............++..|++||.+.+.. ..+.++||||||+++|||++|..||...........+.+..
T Consensus 145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 224 (288)
T cd05583 145 VLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI 224 (288)
T ss_pred EEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH
Confidence 99999998776543322233345788999999986532 36789999999999999999999996543322222221110
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS---AKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~h~~f~~ 231 (417)
... .......++..+.+||.+||..||++||| +.++|+|+||..
T Consensus 225 ~~~--------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 225 LKS--------------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred Hcc--------------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 000 00011235678899999999999999998 567899999965
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=251.08 Aligned_cols=195 Identities=27% Similarity=0.455 Sum_probs=151.9
Q ss_pred cEeecccCcee--cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKY--RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~--~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
||+++++++.. ...+|+||||+.+ +|.+.+.+. ..+++..+..++.||+.+|+|||+++|+|+||||+|||++.++
T Consensus 65 ~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~ 143 (265)
T cd06652 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG 143 (265)
T ss_pred CeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC
Confidence 67777777655 3468899999986 565555443 4589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........+..+.
T Consensus 144 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred CEEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence 999999999876532111 11223457889999999876 568899999999999999999999998665544443332
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
. .+.. ......++..+.++|++||. +|++|||++||++|+|+
T Consensus 223 ~---~~~~-------------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 223 T---QPTN-------------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred c---CCCC-------------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 1 1100 00123466788999999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=254.18 Aligned_cols=195 Identities=26% Similarity=0.396 Sum_probs=155.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+++|+||||+.+ +|.+.+. . ..+++.+++.++.||+.||.|||+++|+|+||+|+||++++++.
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~ 139 (277)
T cd06642 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-P-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD 139 (277)
T ss_pred CccHhhhcccccCCceEEEEEccCCCcHHHHhh-c-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC
Confidence 3788899999999999999999986 5555443 3 35899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 140 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 217 (277)
T cd06642 140 VKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS 217 (277)
T ss_pred EEEccccccccccCcc-hhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC
Confidence 9999999997654322 12223456888999999876 568899999999999999999999987655444333221100
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
.+ .+...++..+.+||.+||..+|++|||+.++++|+||.
T Consensus 218 -------~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 218 -------PP----------------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred -------CC----------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 00 01113566889999999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=243.85 Aligned_cols=195 Identities=29% Similarity=0.452 Sum_probs=157.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+.+++.+..++..|+|+||++ .+|.+++......+++.++..++.||+.+|++||+++++|+||+|+||+++.++.+
T Consensus 58 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~ 137 (253)
T cd05122 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEV 137 (253)
T ss_pred CEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeE
Confidence 57788888888899999999999 56666665554579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
+|+|||++........ .....++..|++||.+.. ..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 138 ~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~- 213 (253)
T cd05122 138 KLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG- 213 (253)
T ss_pred EEeecccccccccccc--ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-
Confidence 9999999977653321 234567889999999875 457889999999999999999999998775544443332210
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~ 228 (417)
.....+ ...++..+.+||++||..||++|||+.|+|+|+|
T Consensus 214 -~~~~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 214 -PPGLRN-------------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -CCCcCc-------------------------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000000 0013668999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=253.35 Aligned_cols=200 Identities=24% Similarity=0.346 Sum_probs=155.3
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+.+||||||+.++.+..+.+....+++..+..++.||+.+|.|||+ ++++|+||||+||++++++.+
T Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~ 143 (284)
T cd06620 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI 143 (284)
T ss_pred CcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcE
Confidence 6888899999999999999999875444444444569999999999999999999997 699999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH--------HH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE--------QL 154 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--------~~ 154 (417)
+|+|||++....... ....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ..
T Consensus 144 ~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~ 219 (284)
T cd06620 144 KLCDFGVSGELINSI---ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL 219 (284)
T ss_pred EEccCCcccchhhhc---cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH
Confidence 999999986543221 123467899999999876 578899999999999999999999998655421 11
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
..+........... ....++.++.+||.+||..||++|||+.|+++|+||...
T Consensus 220 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 220 DLLQQIVQEPPPRL-------------------------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHhhccCCCC-------------------------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11111100000000 001256689999999999999999999999999999553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=268.06 Aligned_cols=195 Identities=24% Similarity=0.364 Sum_probs=161.9
Q ss_pred cEeecccCceecCe--EEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEcC-
Q 014871 4 TFLETTDGNKYRGS--TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDN- 78 (417)
Q Consensus 4 niv~~~~~~~~~~~--~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--givHrDlkp~NILl~~- 78 (417)
|||++|+.|....+ +.+|+|++..+.+..++++.++++.+.++.|++|||+||.|||++ -|||||||.+||||+.
T Consensus 102 NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 102 NIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred ceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 89999999988877 889999998655555555566799999999999999999999998 5999999999999985
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCC-CCChHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP-GKNEAEQLSKI 157 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~-~~~~~~~~~~i 157 (417)
.|.|||.|+|||+...... ....+||+.|||||++. ..|++.+||||||..++||+|+..||. +.+...+++++
T Consensus 182 ~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV 256 (632)
T KOG0584|consen 182 LGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV 256 (632)
T ss_pred cCceeecchhHHHHhhccc---cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence 5889999999998865433 33468999999999886 579999999999999999999998885 56777777766
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
..-. .+ ..+.+--++++++||++||.. .++|+|+.|||+|+||..+
T Consensus 257 ~SGi--KP--------------------------~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 257 TSGI--KP--------------------------AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HcCC--CH--------------------------HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 4311 10 011112367899999999999 9999999999999999875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=280.66 Aligned_cols=193 Identities=22% Similarity=0.396 Sum_probs=149.3
Q ss_pred cEeecccC-ceec------CeEEEEEcCCC-CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCC
Q 014871 4 TFLETTDG-NKYR------GSTYMVFEYMD-HDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGS 72 (417)
Q Consensus 4 niv~~~~~-~~~~------~~~yiV~Ey~~-g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~ 72 (417)
|||.++|. .... -.++|+||||. ++|.+++..+ ..+|+|.+|.+||.|+|+||++||... |||||||-|
T Consensus 96 nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiE 175 (738)
T KOG1989|consen 96 NIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIE 175 (738)
T ss_pred ceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhh
Confidence 78888882 2111 24689999999 6899988642 335999999999999999999999997 999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCCC--------cccccccccCCCCchhhc--CCCCCCCccchhhHHHHHHHHHhCC
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHNN--------TLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGK 142 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~~--------~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~elltG~ 142 (417)
||||+.++++||||||.|+-....... ......-|+.|+|||++. .....++|+|||+|||+||.|++..
T Consensus 176 NvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t 255 (738)
T KOG1989|consen 176 NVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFT 255 (738)
T ss_pred heEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhC
Confidence 999999999999999998643322210 011224499999999863 2356899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHH
Q 014871 143 PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 222 (417)
Q Consensus 143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e 222 (417)
.||.......++..-+. +| .+..++..+++||+.||..||++||++.+
T Consensus 256 ~PFe~sg~laIlng~Y~---------------~P-----------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 256 TPFEESGKLAILNGNYS---------------FP-----------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred CCcCcCcceeEEecccc---------------CC-----------------CCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 99987755443322211 11 11357889999999999999999999999
Q ss_pred HhcCCC
Q 014871 223 ALDSEY 228 (417)
Q Consensus 223 lL~h~~ 228 (417)
++.+-+
T Consensus 304 v~~~~~ 309 (738)
T KOG1989|consen 304 VLEEIF 309 (738)
T ss_pred HHHHHH
Confidence 986543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=251.28 Aligned_cols=192 Identities=24% Similarity=0.381 Sum_probs=153.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-------------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDl 69 (417)
||+++++.+......||||||+.+ +|.+++...+ ..+++.++..++.||+.+|+|||+++++||||
T Consensus 69 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dl 148 (280)
T cd05049 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDL 148 (280)
T ss_pred CchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecccc
Confidence 678888888889999999999985 6666654322 34889999999999999999999999999999
Q ss_pred CCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 014871 70 KGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 147 (417)
Q Consensus 70 kp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~ 147 (417)
||+|||++.++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||..
T Consensus 149 kp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 149 ATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred ccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999975432211 11122344678999999876 568999999999999999998 9999988
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 148 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+..+....+...... .....++..+++||++||..||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 228 LSNEEVIECITQGRLL-----------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7777666655321100 001235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=264.87 Aligned_cols=193 Identities=21% Similarity=0.345 Sum_probs=150.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------------------------------------------
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG--------------------------------------------- 37 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~--------------------------------------------- 37 (417)
|||++++.+...+..|||||||.+ +|.+++....
T Consensus 100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 789999999999999999999984 6766664321
Q ss_pred -----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeecc
Q 014871 38 -----------------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 88 (417)
Q Consensus 38 -----------------------------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFG 88 (417)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG 259 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFG 259 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCc
Confidence 247888999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 014871 89 LARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDE 166 (417)
Q Consensus 89 la~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~ 166 (417)
+++......... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||........+.++......+.
T Consensus 260 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~- 337 (375)
T cd05104 260 LARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML- 337 (375)
T ss_pred cceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-
Confidence 998654322211 112234567999999976 578999999999999999998 8889987654443333322100000
Q ss_pred CCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 167 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.....+.++++||.+||..||++|||+.||++
T Consensus 338 ---------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 338 ---------------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred ---------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 01124568999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=268.56 Aligned_cols=196 Identities=23% Similarity=0.336 Sum_probs=166.2
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG--- 80 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~--- 80 (417)
||.+...|+....+|+|||-+.|+.++.+... ..+|++...+.++.|||.||.|||.++|+|+||||+||||....
T Consensus 625 iV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FP 704 (888)
T KOG4236|consen 625 IVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFP 704 (888)
T ss_pred eeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCC
Confidence 67788899999999999999999999987654 45799999999999999999999999999999999999997654
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||||||+|+.+.... ...+.+||+.|+|||++.+ +.|....|+||+|||+|--|+|..||.... ++-++|.+.
T Consensus 705 QvKlCDFGfARiIgEks--FRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNA 779 (888)
T KOG4236|consen 705 QVKLCDFGFARIIGEKS--FRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNA 779 (888)
T ss_pred ceeeccccceeecchhh--hhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhcc
Confidence 49999999999987443 4456789999999999986 679999999999999999999998886444 334445443
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
....+... |++++..+.|||..+|+..-++|.|++..|.|+|++.
T Consensus 780 aFMyPp~P--------------------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 780 AFMYPPNP--------------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ccccCCCc--------------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 33333333 4568889999999999999999999999999999954
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=247.39 Aligned_cols=193 Identities=20% Similarity=0.305 Sum_probs=151.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+...+.+||||||+.+ +|.+.+.+....+++.++..++.||+.||+|||+++|+|+||||+|||++.++.
T Consensus 53 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~ 132 (252)
T cd05084 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV 132 (252)
T ss_pred CCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc
Confidence 4788889999999999999999975 666666655556999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||++.......... ......+..|+|||.+.+ ..++.++||||||||+|||++ |..||...........+..
T Consensus 133 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~ 211 (252)
T cd05084 133 LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ 211 (252)
T ss_pred EEECccccCcccccccccccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 9999999987543211111 011122456999998875 568899999999999999997 8888877666554444422
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... .....++..+.+||++||..||++|||+.++++
T Consensus 212 ~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 GVRL-----------------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCCC-----------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1100 001134668999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=249.12 Aligned_cols=195 Identities=32% Similarity=0.462 Sum_probs=156.0
Q ss_pred cEeecccCce--ecCeEEEEEcCCCC-CHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCC
Q 014871 4 TFLETTDGNK--YRGSTYMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCH-----VNQVLHRDIKGS 72 (417)
Q Consensus 4 niv~~~~~~~--~~~~~yiV~Ey~~g-~l~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH-----~~givHrDlkp~ 72 (417)
||+++++.+. ....+|+||||+.+ +|..++.+. ...+++.++..++.||+.+|+||| +.+++|+||||+
T Consensus 60 ~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ 139 (265)
T cd08217 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139 (265)
T ss_pred ccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHH
Confidence 5777777554 34568999999975 666665432 456999999999999999999999 999999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 152 (417)
||++++++.+||+|||++........ ......++..|++||++.. ..++.++|||||||++++|++|+.||...+...
T Consensus 140 nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 217 (265)
T cd08217 140 NIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217 (265)
T ss_pred HEEEecCCCEEEecccccccccCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH
Confidence 99999999999999999987653321 1234567899999999876 568899999999999999999999998877555
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
....+.... . ..+...++..+.+||.+||..+|++|||+.+||+|||+
T Consensus 218 ~~~~~~~~~--~---------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 218 LASKIKEGK--F---------------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHhcCC--C---------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 444442210 0 01112356789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=272.32 Aligned_cols=211 Identities=25% Similarity=0.349 Sum_probs=143.3
Q ss_pred eecCeEEEEEcCCCC-CHHHHHhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 13 KYRGSTYMVFEYMDH-DLTGLADRPGLR-------------------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 13 ~~~~~~yiV~Ey~~g-~l~~~~~~~~~~-------------------l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
.....+||||||+.+ +|.+++...... ..+..+..++.||+.||+|||+++|+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 455679999999986 565655433211 123457789999999999999999999999999
Q ss_pred cEEEcC-CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCC---------------------CCCCccchhh
Q 014871 73 NLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT---------------------KYGPAVDMWS 130 (417)
Q Consensus 73 NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~DiwS 130 (417)
||||+. ++.+||+|||+|+.+...........++|+.|+|||.+.... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 578999999999865443333344567799999999764321 2345679999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhc
Q 014871 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKML 210 (417)
Q Consensus 131 lG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L 210 (417)
||||||||+++. |...+....+..++..++.... .|..... ...... .....+.+...+....+||++||
T Consensus 365 lGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~------~~~~~~-~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 365 AGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLV-AWRKLVE------PRASPD-LRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHH-HHHHhhc------cccchh-hhhhhhhccccchHHHHHHHHHc
Confidence 999999999865 4444444455444443322111 1110000 000000 01111222334456779999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 014871 211 MLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 211 ~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
.+||++|+|+.++|+||||....
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCC
Confidence 99999999999999999997643
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=253.34 Aligned_cols=192 Identities=22% Similarity=0.340 Sum_probs=153.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
||+++++.+...+..|+||||+.+ +|.+++... ...+++..+..++.||+.||+|||+++|+||
T Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 147 (291)
T cd05094 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR 147 (291)
T ss_pred CcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 678888888888999999999974 666666432 2348999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPIL 145 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf 145 (417)
||||+|||++.++.+||+|||+++....... .......++..|+|||++.+ ..++.++||||||||+|||++ |+.||
T Consensus 148 dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred ccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999976543221 11223345788999999876 568899999999999999998 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+..+.+..+...... .....++..+.+||.+||..||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 227 FQLSNTEVIECITQGRVL-----------------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCHHHHHHHHhCCCCC-----------------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 887776665554321100 001125668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=253.90 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=157.8
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+.....+|+||||+.+.+..++......+++.++..++.||+.+|+|||+ .+|+||||+|+|||+++++.+
T Consensus 75 ~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~ 154 (296)
T cd06618 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV 154 (296)
T ss_pred chHhhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCE
Confidence 7888889999999999999999988887777655579999999999999999999997 599999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA---TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-AEQLSKIF 158 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~~~~~~i~ 158 (417)
||+|||++..+..... .....++..|+|||++... ..++.++|||||||++|+|++|+.||..... .+.+..+.
T Consensus 155 kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 232 (296)
T cd06618 155 KLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232 (296)
T ss_pred EECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh
Confidence 9999999876543221 1223467889999998653 2378899999999999999999999975432 23333332
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
... ... ++. ...++.++++||.+||..||++|||+.++++|+||..
T Consensus 233 ~~~--~~~--~~~-----------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 233 QEE--PPS--LPP-----------------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred cCC--CCC--CCC-----------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 210 000 000 0125668999999999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=250.80 Aligned_cols=194 Identities=20% Similarity=0.331 Sum_probs=152.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NIL 75 (417)
.||+++++.+..++..||||||+.+ +|.+++.+.. ..+++.++..++.||+.+|+|||+++++||||||+|||
T Consensus 69 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil 148 (277)
T cd05036 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCL 148 (277)
T ss_pred CCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEE
Confidence 4789999988888999999999974 7776665432 25899999999999999999999999999999999999
Q ss_pred EcCCC---CEEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCh
Q 014871 76 IDNEG---NLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNE 150 (417)
Q Consensus 76 l~~~~---~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~ 150 (417)
++.++ .+||+|||+++......... ......+..|+|||++.+ ..++.++||||||||+|||++ |+.||...+.
T Consensus 149 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 149 LTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred EeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 98754 59999999998653221111 111223567999999975 568999999999999999997 9999988777
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.+....+.... .. .....++..+.+||++||..||++|||+.++++|
T Consensus 228 ~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 228 QEVMEFVTGGG-RL----------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHHHcCC-cC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66554442210 00 0012356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=258.21 Aligned_cols=223 Identities=37% Similarity=0.606 Sum_probs=170.6
Q ss_pred cEeecccCcee-cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKY-RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~-~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++.+.+.. ....|+||||+.++|..++.. ..+++..+..++.||+.||+|||+++|+||||||.|||++.++.+
T Consensus 70 niv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~ 147 (328)
T cd07856 70 NIISLSDIFISPLEDIYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDL 147 (328)
T ss_pred CeeeEeeeEecCCCcEEEEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCE
Confidence 67888887765 457899999998887766653 358999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++..... .....+++..|+|||++.....++.++|||||||++|+|++|+.+|...+.......+.+.++
T Consensus 148 ~l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 223 (328)
T cd07856 148 KICDFGLARIQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223 (328)
T ss_pred EeCccccccccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999875432 223345688899999886545689999999999999999999999998887777777777666
Q ss_pred CCCCCCCCCCCCC---CccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 163 SPDETIWPGVSKM---PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 163 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
.+.+..+...... ..+.... ........+....++.++++||++||..||++|+|+.+++.|+||.....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 224 TPPDDVINTICSENTLRFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred CCCHHHHHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 6544332221110 0000000 00011122333457789999999999999999999999999999965433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=247.84 Aligned_cols=187 Identities=18% Similarity=0.213 Sum_probs=147.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC-
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN- 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~- 81 (417)
|||++++.+....+.||||||+.+ +|..++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 60 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~ 139 (258)
T cd05078 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDR 139 (258)
T ss_pred ChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEeccccc
Confidence 678888888888999999999986 566666655556899999999999999999999999999999999999987765
Q ss_pred -------EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHH
Q 014871 82 -------LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQ 153 (417)
Q Consensus 82 -------vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~-~pf~~~~~~~~ 153 (417)
+||+|||++..... .....++..|+|||++.+...++.++|||||||++|||++|. .||...+....
T Consensus 140 ~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 140 KTGNPPFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred ccCCCceEEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 69999999865432 122456788999999976456789999999999999999984 66655554443
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
....... . .+....+.++.+||.+||+.||++|||+++|++.
T Consensus 215 ~~~~~~~-~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 215 LQFYEDR-H------------------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHcc-c------------------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3222110 0 0111234578999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=246.99 Aligned_cols=191 Identities=22% Similarity=0.347 Sum_probs=154.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+......|+||||+.+ +|.+++.+ .+..+++.++..++.||+.||+|||+++|+|+||||+||||++++.
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~ 142 (261)
T cd05148 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV 142 (261)
T ss_pred chhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce
Confidence 577788888888999999999985 77777765 3446899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||++........ .......+..|++||++.. ..++.++|||||||++|+|++ |+.||...+..+.+..+...
T Consensus 143 ~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05148 143 CKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220 (261)
T ss_pred EEEccccchhhcCCccc-cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC
Confidence 99999999976542211 1123334677999999875 578899999999999999998 89999888877776665431
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++..+.+||.+||..||++|||+.+|++
T Consensus 221 ~~~~-----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 221 YRMP-----------------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CcCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1100 01235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=252.33 Aligned_cols=193 Identities=22% Similarity=0.344 Sum_probs=153.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~------------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDl 69 (417)
-+|+++++.+...+.+|+||||+.+ +|.+++.... ..+++.++..++.||+.+|+|||+++++||||
T Consensus 67 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dl 146 (288)
T cd05093 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDL 146 (288)
T ss_pred CCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 3678888888889999999999985 6666654322 24899999999999999999999999999999
Q ss_pred CCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 014871 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 147 (417)
Q Consensus 70 kp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~ 147 (417)
||+|||+++++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 147 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 147 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred CcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999765322211 1122334678999999875 578999999999999999998 9999988
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 148 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+..+.+..+...... .....++.++.+||.+||..||.+|||+.++++
T Consensus 226 ~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 226 LSNNEVIECITQGRVL-----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8777766665331100 001235668999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=244.70 Aligned_cols=192 Identities=18% Similarity=0.304 Sum_probs=153.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+..|+||||+.+ +|...+......+++.++..++.||+.+|.|||+++++|+||||+||+++.++.+
T Consensus 53 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~ 132 (250)
T cd05085 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL 132 (250)
T ss_pred CcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeE
Confidence 678888888888999999999975 6766666555568999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||++................+..|+|||++.. ..++.++|||||||++|+|++ |..||...+.......+....
T Consensus 133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~ 211 (250)
T cd05085 133 KISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211 (250)
T ss_pred EECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987543221111112233567999998865 568899999999999999998 999998877666555443211
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.. .....++..+.+||.+||..+|++|||+.|+++
T Consensus 212 ~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 RM-----------------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CC-----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00 001235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=245.67 Aligned_cols=196 Identities=29% Similarity=0.467 Sum_probs=157.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-||+++++.+...+.+|||+||+.+ +|.+.+.+. ...+++..+..++.||+.+|+|||+++|+|+||||+||++++++
T Consensus 59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~ 138 (257)
T cd08225 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG 138 (257)
T ss_pred CChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC
Confidence 3788889999999999999999975 666666543 33589999999999999999999999999999999999999886
Q ss_pred C-EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 81 N-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~-vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
. +||+|||++....... .......++..|+|||++.. ..++.++|||||||+++||++|..||...+..+....+..
T Consensus 139 ~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (257)
T cd08225 139 MVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ 216 (257)
T ss_pred CeEEecccccchhccCCc-ccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 4 6999999997654322 22223457888999998875 4688999999999999999999999987766555444322
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
... ......++.+++++|.+||..+|++|||+.|+++|+||
T Consensus 217 ~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 GYF-----------------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccC-----------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 100 00112356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=252.01 Aligned_cols=194 Identities=24% Similarity=0.389 Sum_probs=153.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---------------~~~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
.||+++++.+..++.+||||||+.+ +|..++.. ....+++.++..++.||+.||+|||+++|+|
T Consensus 76 ~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH 155 (293)
T cd05053 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIH 155 (293)
T ss_pred CCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4788999999999999999999975 66666542 2346899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+|||++.++.+||+|||+++........ .......+..|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 156 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p 234 (293)
T cd05053 156 RDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP 234 (293)
T ss_pred cccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCC
Confidence 999999999999999999999999865432111 1112233567999998875 578999999999999999997 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|...+..+....+...... .....++.++.+||.+||..||++|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil 285 (293)
T cd05053 235 YPGIPVEELFKLLKEGYRM-----------------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285 (293)
T ss_pred CCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 9887766665554321100 00112456899999999999999999999998
Q ss_pred cC
Q 014871 225 DS 226 (417)
Q Consensus 225 ~h 226 (417)
++
T Consensus 286 ~~ 287 (293)
T cd05053 286 ED 287 (293)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=247.26 Aligned_cols=194 Identities=19% Similarity=0.311 Sum_probs=155.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+...+..||||||+.+ +|.+++......+++.++..++.||+.||+|||+++|+|+||||+||||+.++.
T Consensus 65 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~ 144 (266)
T cd05033 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV 144 (266)
T ss_pred CCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC
Confidence 4788888888889999999999985 676666665557999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||+++......... ......+..|+|||.+.. ..++.++|||||||++|+|++ |..||......+....+.+
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 223 (266)
T cd05033 145 CKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED 223 (266)
T ss_pred EEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc
Confidence 9999999998764211111 111233578999998875 568999999999999999997 9999987776666655533
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
....+. ...++..+.+||.+||..||++||++.+|+++
T Consensus 224 ~~~~~~-----------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 224 GYRLPP-----------------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCCCC-----------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 211110 11245678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=252.93 Aligned_cols=190 Identities=24% Similarity=0.322 Sum_probs=151.1
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
||+++++.+...+.+|+||||+. ++|.+++.... ..+++.++..++.||+.||+|||+++|+||
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~ 143 (297)
T cd05089 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHR 143 (297)
T ss_pred chhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 78888898998999999999997 46777664321 248899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILP 146 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~ 146 (417)
||||+||||+.++.+||+|||++....... .......+..|+|||++.. ..++.++|||||||++|||++ |..||.
T Consensus 144 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 144 DLAARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred cCCcceEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999986432111 1111122456999998875 568999999999999999997 999998
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 147 GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.....+....+...... .....++.++++||.+||..||.+|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 221 GMTCAELYEKLPQGYRM-----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred CCCHHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 88877766555321100 011235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=246.33 Aligned_cols=193 Identities=29% Similarity=0.508 Sum_probs=158.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+.+++.++.++.+|+||||+. ++|.+++... ..+++.++..++.||+.+|.|||+++++|+||||+||+++.++.+
T Consensus 54 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~ 132 (250)
T cd05123 54 FIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHI 132 (250)
T ss_pred cHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcE
Confidence 56777888899999999999995 5776666544 358999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
+|+|||++....... .......++..|++||.+.+ ...+.++|+|||||++|+|++|..||...+.......+....
T Consensus 133 ~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~- 209 (250)
T cd05123 133 KLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP- 209 (250)
T ss_pred EEeecCcceecccCC-CcccCCcCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-
Confidence 999999987654322 12334456888999999875 457889999999999999999999998777655555553310
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH---HHHhcCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA---KDALDSEYF 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta---~elL~h~~f 229 (417)
. .+...++..+++||++||..||++|+|+ +++++|+||
T Consensus 210 -~----------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 -L----------------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -C----------------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0 0111236688999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=253.55 Aligned_cols=198 Identities=28% Similarity=0.479 Sum_probs=157.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+..|+|+||+.+ +|.+++.+. .+++.++..++.||+.+|.|||+++++|+||||+||+++.++.+
T Consensus 77 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~ 154 (293)
T cd06647 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV 154 (293)
T ss_pred CeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCE
Confidence 688889999999999999999986 565555432 48999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++....... .......++..|++||++.. ..++.++|||||||++|+|++|+.||...+..+.+..+... .
T Consensus 155 kL~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~ 231 (293)
T cd06647 155 KLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G 231 (293)
T ss_pred EEccCcceecccccc-cccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-C
Confidence 999999987554322 12233457888999999875 56889999999999999999999999876654433222110 0
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+. ......++..+++||++||..||++|+++.+++.|+||...
T Consensus 232 ~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 232 TPE--------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred CCC--------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 000 00112356689999999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=249.69 Aligned_cols=193 Identities=18% Similarity=0.271 Sum_probs=151.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
||+++++.+.....+|+||||+.+ +|.+++.+.. ..+++..+..++.||+.||+|||+++++|+||||+|
T Consensus 70 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~N 149 (277)
T cd05062 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARN 149 (277)
T ss_pred CeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchhe
Confidence 688888888888999999999985 6666554321 235778899999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChH
Q 014871 74 LLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEA 151 (417)
Q Consensus 74 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~ 151 (417)
||++.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..
T Consensus 150 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~ 228 (277)
T cd05062 150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228 (277)
T ss_pred EEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999998754322111 1112344678999999875 568999999999999999998 78899888776
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
+.+..+.+... + .....++..+++||.+||..||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 229 QVLRFVMEGGL-L----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHcCCc-C----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66555432110 0 0011245688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=249.43 Aligned_cols=199 Identities=30% Similarity=0.516 Sum_probs=160.8
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+..|+|+||++ ++|.+++......+++.++..++.||+.+|+|||++||+|+||||+||+++.++.+
T Consensus 76 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~ 155 (286)
T cd06614 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSV 155 (286)
T ss_pred CeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCE
Confidence 68889999999999999999999 57777766554469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++........ ......++..|++||++.+ ..++.++||||||||+|+|++|+.||...+.......+.....
T Consensus 156 ~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06614 156 KLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI 233 (286)
T ss_pred EECccchhhhhccchh-hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999998865442211 1223346788999998875 5689999999999999999999999987766555444422100
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.. ......++..+++||++||..+|.+|||+.++++|+||..
T Consensus 234 -~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 234 -PP--------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -CC--------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 00 0001225678999999999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=244.30 Aligned_cols=195 Identities=30% Similarity=0.471 Sum_probs=159.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
|+++..+.+......||||||+++ +|...+.+. ...+++.++..++.||+.+|+|||+++++|+||+++||+++.+
T Consensus 60 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred ChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 567777778888899999999986 676666543 3679999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
++++|+|||++....... .......++..|+|||.+.. ..++.++||||||+++++|++|+.||...+..+....+..
T Consensus 140 ~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 217 (258)
T cd08215 140 GLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217 (258)
T ss_pred CcEEECCccceeecccCc-ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence 999999999997654332 12233467888999998875 5688999999999999999999999987776555554432
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.... .+...++..+.++|++||..||++|||+.++|+|+||
T Consensus 218 ~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 GQYP-----------------------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 1100 0111356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=245.87 Aligned_cols=192 Identities=21% Similarity=0.324 Sum_probs=154.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|++++.+.+...+..|+||||+.+ +|..++......+++.++..++.||+.||+|||+++++|+||||+|||++.++.+
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred CeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcE
Confidence 678888888999999999999986 5666665555679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccc--cccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~--~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||++............. ...+..|++||++.. ..++.++|||||||++|||++ |+.||...+..+....+.+
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~ 225 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND 225 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc
Confidence 999999997654322222111 122456999999875 568999999999999999997 9999988877776666643
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....+. ...++.++.+||.+||..||++||++.+|++
T Consensus 226 ~~~~~~-----------------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 226 GFRLPA-----------------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCCC-----------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 211110 0124567899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=247.57 Aligned_cols=202 Identities=24% Similarity=0.380 Sum_probs=151.6
Q ss_pred ccEeecccCcee--cCeEEEEEcCCCC-CHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKY--RGSTYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~--~~~~yiV~Ey~~g-~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
-||+++++.+.. .+.+||||||+++ +|.+++. .....+++..+..++.||+.+|+|||+.+++|+||+++||++
T Consensus 59 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~ 138 (287)
T cd06621 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL 138 (287)
T ss_pred CCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 367888776643 4478999999985 6655433 234468999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-----hH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-----EA 151 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-----~~ 151 (417)
+.++.++|+|||++....... .....++..|++||.+.+ ..++.++||||||||+|+|++|+.||.... ..
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (287)
T cd06621 139 TRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI 214 (287)
T ss_pred ecCCeEEEeeccccccccccc---cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH
Confidence 999999999999987543221 123346788999998875 578999999999999999999999997652 22
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+....+.... .+ .. .. ....-..++..+.+||.+||..||++|||+.|+++|+||..
T Consensus 215 ~~~~~~~~~~-~~--~~----~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 215 ELLSYIVNMP-NP--EL----KD----------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred HHHHHHhcCC-ch--hh----cc----------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 2222221100 00 00 00 00000124568899999999999999999999999999944
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=244.36 Aligned_cols=195 Identities=28% Similarity=0.449 Sum_probs=157.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.|++++++.+...+.+|+||||+++ +|.+++... ..+++..+..++.||+.+|.|||++||+|+||||+||+++.++.
T Consensus 59 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~ 137 (254)
T cd06627 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV 137 (254)
T ss_pred CCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC
Confidence 4678888888888999999999986 565555544 56999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++........ ......++..|++||.+.. ..++.++||||||+++|+|++|+.||...+......++..
T Consensus 138 ~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 213 (254)
T cd06627 138 VKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-- 213 (254)
T ss_pred EEEeccccceecCCCcc-cccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--
Confidence 99999999987653322 1233456888999998876 4588999999999999999999999987665444433321
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
... ..+...++..+++||.+||..+|++|||+.+++.|+||
T Consensus 214 -~~~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 214 -DDH--------------------------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -cCC--------------------------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 000 01112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=249.20 Aligned_cols=194 Identities=20% Similarity=0.283 Sum_probs=154.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
.|||++++.+.....+++++||+.+ +|..++... ...+++..+..++.||+.||+|||+++|+|
T Consensus 68 ~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H 147 (283)
T cd05091 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVH 147 (283)
T ss_pred CCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 4788999999999999999999985 555554311 234888999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+|||+++++.+||+|||+++....... ........+..|+|||++.. ..++.++|||||||++|||++ |..|
T Consensus 148 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p 226 (283)
T cd05091 148 KDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQP 226 (283)
T ss_pred cccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999876532221 11223345778999999875 568999999999999999998 8889
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+.+..+.+....+ ....++..+.+||.+||+.||++||++.+|+
T Consensus 227 ~~~~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~ 277 (283)
T cd05091 227 YCGYSNQDVIEMIRNRQVLP-----------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIH 277 (283)
T ss_pred CCCCCHHHHHHHHHcCCcCC-----------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 98887777666654321110 1123567889999999999999999999998
Q ss_pred cC
Q 014871 225 DS 226 (417)
Q Consensus 225 ~h 226 (417)
..
T Consensus 278 ~~ 279 (283)
T cd05091 278 SR 279 (283)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=248.00 Aligned_cols=187 Identities=21% Similarity=0.255 Sum_probs=146.8
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-- 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~-- 80 (417)
||+++++.+...+..||||||++++.++ .+.+....+++..+..++.||+.||+|||+++|+||||||+||||+.++
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 7899999999999999999999975544 4444455799999999999999999999999999999999999997643
Q ss_pred -----CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHH-hCCCCCCCCChHHHH
Q 014871 81 -----NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQL 154 (417)
Q Consensus 81 -----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-tG~~pf~~~~~~~~~ 154 (417)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|+.||......+..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3899999988653221 22356788999998876556899999999999999995 689999876654433
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
..+..... ........+.+||.+||..+|++|||+.+||++
T Consensus 232 ~~~~~~~~-------------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 RFYEKKHR-------------------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHhccC-------------------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 32211000 001133468899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=245.56 Aligned_cols=190 Identities=19% Similarity=0.245 Sum_probs=148.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++ ....||||||+.+ +|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||.|||++.++.+
T Consensus 57 ~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~ 134 (257)
T cd05116 57 YIVRMIGICE-AESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYA 134 (257)
T ss_pred CcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeE
Confidence 4566665544 4577999999986 46555544 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCc--ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||++.......... .....++..|+|||++.. ..++.++|||||||++|||++ |+.||...+..+....+.+
T Consensus 135 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~ 213 (257)
T cd05116 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213 (257)
T ss_pred EECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 999999997654332211 112233578999998864 568889999999999999997 9999988877776666532
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
... + .....++.++.+||.+||+.||++||++.+|.+
T Consensus 214 ~~~-~----------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 GER-M----------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCC-C----------------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 110 0 011236678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=244.29 Aligned_cols=194 Identities=22% Similarity=0.335 Sum_probs=154.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+|+++++.++.....|+||||+.+ +|.+.+......+++..+..++.||+.+|+|||+++++|+||||+||+++.++.
T Consensus 59 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~ 138 (256)
T cd05112 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV 138 (256)
T ss_pred CCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe
Confidence 5788899999989999999999986 555555544456899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++...............+..|+|||++.+ ..++.++|||||||++|||++ |+.||......+.+..+.+.
T Consensus 139 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05112 139 VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217 (256)
T ss_pred EEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC
Confidence 9999999987653222111122234568999998875 568899999999999999998 99999887776666665321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.... .....+..+.+|+++||..+|++|||+.++++.
T Consensus 218 ~~~~-----------------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 218 FRLY-----------------------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCC-----------------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 1000 011245689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=247.35 Aligned_cols=196 Identities=29% Similarity=0.461 Sum_probs=158.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~ 81 (417)
|++++++.+...+..|+||||+.+ +|.+.+.+. ..+++..+..++.||+.+|+|||+ ++++|+||+|+||+++.++.
T Consensus 60 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~ 138 (264)
T cd06623 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE 138 (264)
T ss_pred CeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC
Confidence 678888888889999999999995 666666544 569999999999999999999999 99999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~---~~~~~~~i~ 158 (417)
++|+|||++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.... ..+....+.
T Consensus 139 ~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 216 (264)
T cd06623 139 VKIADFGISKVLENTLD-QCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC 216 (264)
T ss_pred EEEccCccceecccCCC-cccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh
Confidence 99999999876643222 2224456889999999875 578899999999999999999999998774 233333332
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhh-hhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH-FDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
. .... ..... ++..+.+||.+||..+|++|||+.++++|+||..
T Consensus 217 ~---~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 217 D---GPPP--------------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred c---CCCC--------------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 1 1000 00112 6678999999999999999999999999999943
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=244.87 Aligned_cols=191 Identities=23% Similarity=0.360 Sum_probs=150.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
+|+++++.+. ...+|+||||+.+ +|.+++... ...+++.+++.++.||+.||+|||+++|+||||||+|||+++++.
T Consensus 62 ~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~ 140 (260)
T cd05070 62 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV 140 (260)
T ss_pred ceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce
Confidence 5677776554 5678999999985 677666543 345899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||++...............++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05070 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219 (260)
T ss_pred EEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999997654322222222334567999998875 568899999999999999999 89999887777666655321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
... .....++..+++||.+||..||++|||+.++++
T Consensus 220 ~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 220 YRM-----------------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCC-----------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 100 001235568999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=258.42 Aligned_cols=195 Identities=18% Similarity=0.343 Sum_probs=148.8
Q ss_pred ccEeecccCce-ecCeEEEEEcCCCC-CHHHHHhcC--------------------------------------------
Q 014871 3 CTFLETTDGNK-YRGSTYMVFEYMDH-DLTGLADRP-------------------------------------------- 36 (417)
Q Consensus 3 cniv~~~~~~~-~~~~~yiV~Ey~~g-~l~~~~~~~-------------------------------------------- 36 (417)
.||+++++.+. ....+|+||||+.+ +|..++...
T Consensus 71 ~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (337)
T cd05054 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIED 150 (337)
T ss_pred cchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccC
Confidence 47888887654 44578999999986 565554321
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-
Q 014871 37 ----------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN- 99 (417)
Q Consensus 37 ----------------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 99 (417)
...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~ 230 (337)
T cd05054 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230 (337)
T ss_pred cchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh
Confidence 125889999999999999999999999999999999999999999999999999875432221
Q ss_pred cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCcc
Q 014871 100 TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 178 (417)
Q Consensus 100 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 178 (417)
......++..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+.+.........+
T Consensus 231 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 295 (337)
T cd05054 231 RKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-------------- 295 (337)
T ss_pred hccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--------------
Confidence 1222344678999999876 578999999999999999997 999998765444433332210000
Q ss_pred ccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 179 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.....++.++.+|+.+||+.+|++|||+.+|++|
T Consensus 296 --------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 --------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred --------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012345689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=253.78 Aligned_cols=191 Identities=23% Similarity=0.326 Sum_probs=150.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
||+++++.+..++.+|+||||+.+ +|..++.+.. ..+++.+++.++.||+.||+|||++||+||
T Consensus 69 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~ 148 (303)
T cd05088 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 148 (303)
T ss_pred CcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 788899999999999999999974 6776664321 358999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILP 146 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~ 146 (417)
||||+||||+.++.+||+|||+++...... .......+..|+|||++.. ..++.++|||||||++|||++ |..||.
T Consensus 149 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 149 DLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred ccchheEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 999999999999999999999986432111 1111223567999998865 568899999999999999998 999998
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 147 GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
..+..+....+.... .+. ....++.++.+||.+||+.||++|||+.++|.+
T Consensus 226 ~~~~~~~~~~~~~~~------~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 226 GMTCAELYEKLPQGY------RLE-----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCChHHHHHHHhcCC------cCC-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777665554442110 000 011246688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=246.80 Aligned_cols=193 Identities=18% Similarity=0.284 Sum_probs=153.6
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP---------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~---------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
.||+++++.+...+..|+||||+. ++|.+++... ...+++.++..++.||+.||+|||+++|+||||||+
T Consensus 69 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~ 148 (277)
T cd05032 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAAR 148 (277)
T ss_pred CceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChh
Confidence 478999999999999999999997 4666665432 123788899999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCh
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNE 150 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~ 150 (417)
|||++.++.+||+|||+++.+..... .......++..|+|||++.. ..++.++|||||||++|||++ |..||...+.
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 149 NCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred eEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 99999999999999999876543221 11223345778999999875 568999999999999999998 9999988777
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+....+... ... .....++..+++||++||..+|++|||+.+|++
T Consensus 228 ~~~~~~~~~~-~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 228 EEVLKFVIDG-GHL----------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHHhcC-CCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6665554310 000 001124668999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=244.02 Aligned_cols=191 Identities=23% Similarity=0.365 Sum_probs=150.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|++.+++.+. .+..|+||||+.+ +|.+.+.+. ...+++..+..++.||+.||+|||+++|+|+||||+|||+++++.
T Consensus 62 ~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~ 140 (260)
T cd05069 62 KLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV 140 (260)
T ss_pred CeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe
Confidence 5677766654 4568999999985 777777543 345899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............++..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05069 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219 (260)
T ss_pred EEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999997654322222222344678999998875 568999999999999999999 89999888777666555331
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++..+++||++||.+||++|||+.++++
T Consensus 220 ~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 220 YRMP-----------------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCC-----------------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1000 01235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=250.72 Aligned_cols=192 Identities=22% Similarity=0.361 Sum_probs=153.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
||+++++.+...+.+||||||+.+ +|.+++.+. ...++..++..++.||+.||+|||++||+||
T Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred CchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 678888888889999999999985 676666542 2347888999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPIL 145 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf 145 (417)
||||+||||+.++.+||+|||+++......... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999998764322211 122334678999999876 568999999999999999998 88899
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+..+....+...... .....++..+++||.+||..+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 241 PGIPVEELFKLLKEGHRM-----------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred ccCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 887776666555321100 001235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=243.52 Aligned_cols=193 Identities=22% Similarity=0.342 Sum_probs=155.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-|++++++.+......|+||||+.+ +|.+.+.... ..+++.++..++.||+.||+|||+++|+|+||||+||+|+.++
T Consensus 61 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~ 140 (261)
T cd05034 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL 140 (261)
T ss_pred CCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC
Confidence 3688888888888899999999985 6777665533 4699999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||+++...............+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+..
T Consensus 141 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05034 141 VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219 (261)
T ss_pred CEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987654321111122233568999999875 568999999999999999998 9999988887777766643
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....+. ...++.+++++|.+||..||++|||++++++
T Consensus 220 ~~~~~~-----------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 220 GYRMPR-----------------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCC-----------------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 211110 0123567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=243.40 Aligned_cols=191 Identities=18% Similarity=0.236 Sum_probs=149.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.|||++++.++ ....|+||||+.+ +|.+++.+.. .+++..+..++.||+.+|+|||+++++|+||||+|||++.++.
T Consensus 56 ~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~ 133 (257)
T cd05060 56 PCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ 133 (257)
T ss_pred CCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc
Confidence 47788887655 4578999999975 6766665443 6999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCccc--ccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLT--NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++........... ...++..|+|||.+.. ..++.++|||||||++|+|++ |+.||...+..+....+.
T Consensus 134 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~ 212 (257)
T cd05060 134 AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212 (257)
T ss_pred EEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 999999999866433221111 1122467999998875 568999999999999999998 999998777665555543
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..... .....++..+++||.+||..||++|||+.++++
T Consensus 213 ~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 213 SGERL-----------------------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred cCCcC-----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 21100 011235668999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=248.06 Aligned_cols=198 Identities=17% Similarity=0.267 Sum_probs=154.4
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG---------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~---------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
+|+++++.+...+..|+||||+. ++|.+.+.+.. ..++...+..++.||+.||+|||+++|+||||||+|
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~n 149 (288)
T cd05061 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN 149 (288)
T ss_pred CeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChhe
Confidence 67888888888889999999997 46766665321 235678899999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChH
Q 014871 74 LLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEA 151 (417)
Q Consensus 74 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~ 151 (417)
||++.++.+||+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 150 ili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~ 228 (288)
T cd05061 150 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228 (288)
T ss_pred EEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998764322111 1122234678999999875 568999999999999999998 78899887766
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc------
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD------ 225 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~------ 225 (417)
+....+..... + .....++..+++||++||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~------~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 229 QVLKFVMDGGY------L-----------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHcCCC------C-----------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 65555432100 0 001124568999999999999999999999986
Q ss_pred CCCCCC
Q 014871 226 SEYFWT 231 (417)
Q Consensus 226 h~~f~~ 231 (417)
|+||..
T Consensus 280 ~~~~~~ 285 (288)
T cd05061 280 HPSFPE 285 (288)
T ss_pred CCCCCC
Confidence 788853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=248.37 Aligned_cols=193 Identities=24% Similarity=0.355 Sum_probs=152.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG--------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~--------------~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
.||+++++.+...+..|+||||+.+ +|.+++.... ..+++.++..++.||+.||+|||+++|+|+
T Consensus 67 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~ 146 (280)
T cd05092 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHR 146 (280)
T ss_pred CCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 4788888888888999999999985 6666654322 248899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPIL 145 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf 145 (417)
||||+|||+++++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++ |+.||
T Consensus 147 dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 147 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred cccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999875432211 11122234678999999876 568999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
......+.+..+...... .....++..+.+||.+||..||.+||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 226 YQLSNTEAIECITQGREL-----------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ccCCHHHHHHHHHcCccC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 887776666555321100 001235678899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=251.14 Aligned_cols=193 Identities=21% Similarity=0.354 Sum_probs=152.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
-||+++++.+..++.+||||||+.+ +|.+++... ...+++.++..++.||+.||+|||++||+|
T Consensus 78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 157 (314)
T cd05099 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH 157 (314)
T ss_pred CCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 3788999888888999999999975 666666432 234889999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+|||++.++.+||+|||+++....... ........+..|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p 236 (314)
T cd05099 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSP 236 (314)
T ss_pred ccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999976542211 11111223467999999876 578999999999999999999 8899
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+....+..... . .....++.++++||.+||..||++|||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 287 (314)
T cd05099 237 YPGIPVEELFKLLREGHR-M----------------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287 (314)
T ss_pred CCCCCHHHHHHHHHcCCC-C----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 988776666655532100 0 00123456889999999999999999999988
Q ss_pred c
Q 014871 225 D 225 (417)
Q Consensus 225 ~ 225 (417)
+
T Consensus 288 ~ 288 (314)
T cd05099 288 E 288 (314)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=243.33 Aligned_cols=191 Identities=19% Similarity=0.242 Sum_probs=149.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.++ ....|+||||+.+ +|.+++......+++.++..++.||+.||+|||+++++||||||+|||++.++.+
T Consensus 56 ~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~ 134 (257)
T cd05115 56 YIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA 134 (257)
T ss_pred CeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcE
Confidence 6777777665 4578999999975 6666665445579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCc--ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+++......... ......+..|+|||++.. ..++.++|||||||++|||++ |..||......+....+..
T Consensus 135 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 135 KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred EeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 999999997654322211 111222568999998875 568899999999999999996 9999988777666554432
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.. .+ ......+.++.+||.+||..||++||++.+|++
T Consensus 214 ~~-~~----------------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 GK-RL----------------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CC-CC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 00 001234678999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=247.66 Aligned_cols=193 Identities=19% Similarity=0.307 Sum_probs=152.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP----------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~----------------~~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
||+++++.+......||||||+.+ +|.+++... ...+++.++..++.||+.||+|||+++|+|
T Consensus 68 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H 147 (283)
T cd05090 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVH 147 (283)
T ss_pred CeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeeh
Confidence 788888888888999999999985 666665321 124788999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+|||++.++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p 226 (283)
T cd05090 148 KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQP 226 (283)
T ss_pred hccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999976532221 11223344677999999875 568999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+....+...... .....++..+++||.+||..||++||++.+|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 277 (283)
T cd05090 227 YYGFSNQEVIEMVRKRQLL-----------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277 (283)
T ss_pred CCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 9887766555554321100 01123567889999999999999999999998
Q ss_pred cC
Q 014871 225 DS 226 (417)
Q Consensus 225 ~h 226 (417)
++
T Consensus 278 ~~ 279 (283)
T cd05090 278 TR 279 (283)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=244.53 Aligned_cols=191 Identities=23% Similarity=0.357 Sum_probs=150.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+. ....|+||||+.+ +|.+++.+. ...+++.++..++.||+.||+|||+++|+||||||+|||+++++.
T Consensus 62 ~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~ 140 (262)
T cd05071 62 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 140 (262)
T ss_pred CcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc
Confidence 5666666553 4568999999985 777776542 345899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++.+............++..|+|||++.. ..++.++|||||||++|||++ |..||......+.+..+...
T Consensus 141 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd05071 141 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219 (262)
T ss_pred EEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC
Confidence 9999999997654332222223345678999998875 568999999999999999999 88899888777666655321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++..+.+||.+||..||++|||+.++++
T Consensus 220 ~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 220 YRMP-----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCC-----------------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1000 01135668899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=246.74 Aligned_cols=191 Identities=23% Similarity=0.311 Sum_probs=151.0
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
-||+++++.+..++.+||||||+. ++|.+++.... ..+++.++..++.||+.||+|||+++++|
T Consensus 56 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H 135 (270)
T cd05047 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 135 (270)
T ss_pred CCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 378999999999999999999997 57777665321 24889999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPIL 145 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf 145 (417)
|||||+|||++.++.+||+|||++....... .......+..|+|||++.. ..++.++|||||||++|||++ |..||
T Consensus 136 ~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 136 RDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred cccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999986432111 1111223567999998865 578999999999999999997 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+..+....+...... .....++.++.+||.+||..||.+|||+.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 213 CGMTCAELYEKLPQGYRL-----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cccCHHHHHHHHhCCCCC-----------------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 887766655554221000 001125568899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=241.26 Aligned_cols=193 Identities=21% Similarity=0.319 Sum_probs=152.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+....+.|+||||+.+ +|.+.+.+....+++..+..++.||+.+|+|||+++++||||||+||||+.++.
T Consensus 52 ~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~ 131 (251)
T cd05041 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV 131 (251)
T ss_pred CCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc
Confidence 3688888888999999999999975 676666555556899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcc-cccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTL-TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||+++.......... .....+..|+|||++.+ ..++.++|||||||++|||++ |..||...........+..
T Consensus 132 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~ 210 (251)
T cd05041 132 LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES 210 (251)
T ss_pred EEEeeccccccccCCcceeccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc
Confidence 99999999876432111111 11223567999998875 568999999999999999998 8889987776555544422
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..... ....++..+.+||.+||..+|++|||+.|+++
T Consensus 211 ~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 211 GYRMP-----------------------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCCCC-----------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 11000 01235668999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=251.16 Aligned_cols=193 Identities=22% Similarity=0.357 Sum_probs=152.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
.||+++++.+...+.+||||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||++|++|
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 163 (307)
T cd05098 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIH 163 (307)
T ss_pred CCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4788999999999999999999985 7777765421 24889999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+|||++.++.+||+|||+++......... ......+..|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 164 ~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred ccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999987653211111 111223567999999876 568999999999999999998 8899
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+....+.... .. .....++.++++||.+||..+|++|||+.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 293 (307)
T cd05098 243 YPGVPVEELFKLLKEGH-RM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293 (307)
T ss_pred CCcCCHHHHHHHHHcCC-CC----------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 98776655544442210 00 01123567899999999999999999999998
Q ss_pred c
Q 014871 225 D 225 (417)
Q Consensus 225 ~ 225 (417)
+
T Consensus 294 ~ 294 (307)
T cd05098 294 E 294 (307)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=246.93 Aligned_cols=195 Identities=26% Similarity=0.426 Sum_probs=157.6
Q ss_pred cEeecccCceecCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+..+.+.|+||||+.++ |...+. . ..+++.++..++.||+.+|.|||+++++|+||||+||++++++.+
T Consensus 63 ~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~-~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~ 140 (277)
T cd06641 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-P-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 140 (277)
T ss_pred CEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCE
Confidence 6889999999999999999999864 554443 3 358999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
+|+|||++..+.... .......++..|++||.+.. ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 141 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 217 (277)
T cd06641 141 KLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN- 217 (277)
T ss_pred EEeecccceecccch-hhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-
Confidence 999999987654321 12223456888999998875 567889999999999999999999998766555444432110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.. .+...++.++.+||.+||..||++||++.++++|+||..
T Consensus 218 -~~---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 218 -PP---------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred -CC---------------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 00 011235678999999999999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=247.99 Aligned_cols=200 Identities=17% Similarity=0.247 Sum_probs=154.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~----------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp 71 (417)
.||+++++.+..++..|+||||+.+ +|..++.+.. ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 5889999999998999999999985 6666654432 2589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh--CCCCCCCC
Q 014871 72 SNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGK 148 (417)
Q Consensus 72 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt--G~~pf~~~ 148 (417)
+|||+++++.+||+|||+++....... .......++..|+|||++.. ..++.++|||||||++|||++ +..||...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999999876432221 11223345678999999875 568999999999999999998 67888877
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+..+.+..+........... .......++.++++||.+||..||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQI----------------------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccc----------------------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 76666665543221111000 00011235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=242.26 Aligned_cols=198 Identities=30% Similarity=0.576 Sum_probs=156.2
Q ss_pred ccEeecccCceec--CeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNKYR--GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~~~--~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
-||+++++.+... ..+|+||||+.+ +|.+++.... .+++.++..++.||+.+|+|||+++++|+||+|+||+++.+
T Consensus 59 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred CCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 3678888888887 899999999965 6666555443 79999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+.+||+|||.+......... ......++..|++||.+.. ...+.++|||||||++|+|++|..||..... ....+.
T Consensus 138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~ 214 (260)
T cd06606 138 GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALY 214 (260)
T ss_pred CCEEEcccccEEecccccccccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHH
Confidence 99999999999876543221 1233466889999998875 4589999999999999999999999987662 222222
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
..... .....+...++..+++||.+||..||++|||+.|+++|+||
T Consensus 215 ~~~~~-------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 215 KIGSS-------------------------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hcccc-------------------------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 11100 00011122346789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=241.71 Aligned_cols=192 Identities=20% Similarity=0.364 Sum_probs=154.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~-l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
+|+++++.+...+..|+||||+.+ +|.+.+...... +++.++..++.||+.+|+|||+++++|+||||+||++++++.
T Consensus 62 ~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~ 141 (258)
T smart00219 62 NIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV 141 (258)
T ss_pred chheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe
Confidence 578888888888999999999975 676666554333 999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
++|+|||+++..............++..|++||.+.. ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (258)
T smart00219 142 VKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG 220 (258)
T ss_pred EEEcccCCceecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 9999999997765332211112235788999998854 678999999999999999998 88999887776666655331
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
... .....++.++.++|.+||..||++|||+.|+++
T Consensus 221 ~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 221 YRL-----------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCC-----------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 100 001125678999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=243.46 Aligned_cols=193 Identities=16% Similarity=0.241 Sum_probs=147.7
Q ss_pred cEeecccCceecC------eEEEEEcCCCC-CHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014871 4 TFLETTDGNKYRG------STYMVFEYMDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71 (417)
Q Consensus 4 niv~~~~~~~~~~------~~yiV~Ey~~g-~l~~~~~~-----~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp 71 (417)
||+++++.+.... ..|+||||+.+ +|...+.. ....+++..+..++.||+.||+|||+++|+||||||
T Consensus 62 ~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp 141 (273)
T cd05035 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAA 141 (273)
T ss_pred CeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 5667665544433 37999999985 55555432 223589999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 014871 72 SNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKN 149 (417)
Q Consensus 72 ~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~ 149 (417)
+|||+++++.+||+|||+++......... ......+..|+|||++.. ..++.++|||||||++|||++ |..||.+.+
T Consensus 142 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 142 RNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred heEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998654322111 111223667999998865 578999999999999999999 889998877
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
..+.+..+...... .....++..+.+||.+||..||++|||+.+++++
T Consensus 221 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 221 NHEIYDYLRHGNRL-----------------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHHcCCCC-----------------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76665554321000 0112356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=240.72 Aligned_cols=193 Identities=22% Similarity=0.355 Sum_probs=157.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++.+.+......|+||||+.+ +|...+.+ ....+++..+..++.||+.||+|||++|++|+||+++||+++.+
T Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred CchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 678888899999999999999975 66665544 23458999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||+++..... ......++..|++||.+.+ ..++.++|+||||+++++|++|+.||...+..+....+..
T Consensus 140 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 140 DLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred CcEEEeeccchhhhccC---CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 99999999999776433 2223456889999999876 5688899999999999999999999988776555444322
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
... ..+...++.+++++|.+||..+|++|||+.++++||++
T Consensus 216 ~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 GKY-----------------------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCC-----------------------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 100 01112356789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=249.44 Aligned_cols=194 Identities=21% Similarity=0.343 Sum_probs=153.3
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-||+++++.+...+.+||||||+. ++|.+++.+.. ..+++.++..++.||+.||+|||+++|+|+||||+|||++.++
T Consensus 99 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 178 (302)
T cd05055 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK 178 (302)
T ss_pred CCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC
Confidence 378888888999999999999997 56766665432 3489999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+++........ ......++..|+|||++.. ..++.++|||||||++|||++ |..||......+.+.++.
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~ 257 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI 257 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH
Confidence 9999999999765432211 1112344678999999876 568999999999999999998 999998777655544433
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....... ....++..+.+||.+||..+|++|||+.|+++
T Consensus 258 ~~~~~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 258 KEGYRMA----------------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HcCCcCC----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2110000 01124568999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=251.70 Aligned_cols=192 Identities=18% Similarity=0.246 Sum_probs=149.0
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+.. ...++|+||+. ++|.+.+......+++..+..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 70 niv~~~g~~~~-~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 70 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred CCCeEEEEEcC-CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcE
Confidence 67777766654 46789999997 57777777655569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++......... ......+..|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+....+ ..
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~ 226 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EK 226 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hC
Confidence 999999998765332211 112233667999999875 578999999999999999997 99999877655543322 21
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
...... ...++.++.+||.+||..||++|||+.+++.+
T Consensus 227 ~~~~~~----------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 GERLPQ----------------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCC----------------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100000 01244578899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=245.00 Aligned_cols=191 Identities=17% Similarity=0.228 Sum_probs=149.1
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+. ....++|+||+. ++|.+++......+++..+..++.||+.||+|||+++++||||||+|||++.++.+
T Consensus 70 ~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 70 YIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred CcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcE
Confidence 6777777654 456789999997 67887777656679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++.+...... ......++..|++||++.. ..++.++|||||||++|||++ |+.||.+.........+..
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~- 226 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK- 226 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-
Confidence 99999999765432221 1223345678999999875 568999999999999999998 9999987765554333321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+. ....++.++.+++.+||..||++|||+.|+++
T Consensus 227 ~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 GERLA----------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCcCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 10000 00113456789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=242.43 Aligned_cols=193 Identities=18% Similarity=0.293 Sum_probs=154.6
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+++++.+.. ...|+||||+. ++|.+.+.+.. ..+++..+..++.||+.||+|||+++++|+||||+|||++.++
T Consensus 56 ~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~ 134 (257)
T cd05040 56 ENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD 134 (257)
T ss_pred CCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC
Confidence 478888887777 88999999997 57777766544 4689999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 157 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i 157 (417)
.+||+|||+++.+...... ......++..|+|||.+.. ..++.++|||||||++|||++ |+.||...+..+.+..+
T Consensus 135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred EEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999876432211 1112345778999998875 568999999999999999998 99999888777766665
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...... +. ....++..+.+||.+||..+|++|||+.++++
T Consensus 214 ~~~~~~-----~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 214 DKEGER-----LE-----------------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HhcCCc-----CC-----------------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 431100 00 01124568999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=244.46 Aligned_cols=195 Identities=25% Similarity=0.428 Sum_probs=152.0
Q ss_pred cEeecccCceec--CeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
||+++++++... +.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++
T Consensus 65 ~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~ 143 (264)
T cd06653 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG 143 (264)
T ss_pred CcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 566777666543 468999999986 566665543 3589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCC--CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDH--NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.++|+|||+++...... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||..........++.
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 222 (264)
T cd06653 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222 (264)
T ss_pred CEEECccccccccccccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH
Confidence 99999999998653211 112223457889999999876 567899999999999999999999998766555444332
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
. .+.. ..+...+++.+.++|++||. ++.+|||+.++++|+|.
T Consensus 223 ~---~~~~-------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 223 T---QPTK-------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred c---CCCC-------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1 1100 01123467789999999999 56999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=243.71 Aligned_cols=192 Identities=21% Similarity=0.326 Sum_probs=154.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+..++..||||||+.+ +|.+.+.+....+++.++..++.||+.||+|||+++++||||||+|||++.++.+
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 145 (267)
T cd05066 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC 145 (267)
T ss_pred CcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeE
Confidence 688888888888999999999985 6766766655679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCccc--ccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLT--NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||++............ ....+..|++||++.. ..++.++|||||||++|||++ |..||...+..+....+.+
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~ 224 (267)
T cd05066 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224 (267)
T ss_pred EeCCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC
Confidence 99999999876432221111 1222567999999875 568999999999999999886 9999988776666655543
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....+. ...++..+.+||.+||..+|++|||+.++++
T Consensus 225 ~~~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 225 GYRLPA-----------------------------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCcCCC-----------------------------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 211000 1124568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=247.01 Aligned_cols=192 Identities=18% Similarity=0.315 Sum_probs=151.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-----------------------GLRFTVPQIKCYMKQLLTGLHYC 59 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-----------------------~~~l~~~~i~~i~~Qil~gL~~L 59 (417)
||+++++.+..++..|+||||+.+ +|.+++... ...+++..+..++.||+.+|+||
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L 143 (290)
T cd05045 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL 143 (290)
T ss_pred CEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH
Confidence 688889999999999999999985 565554321 12488999999999999999999
Q ss_pred HHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHH
Q 014871 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138 (417)
Q Consensus 60 H~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~el 138 (417)
|+++|+||||||+||||++++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||
T Consensus 144 H~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el 222 (290)
T cd05045 144 AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEI 222 (290)
T ss_pred HHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999765322211 1112234678999998875 5689999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCC
Q 014871 139 LN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217 (417)
Q Consensus 139 lt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R 217 (417)
++ |..||.+.........+....... ....++.++++||.+||..||++|
T Consensus 223 ~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~i~~cl~~~P~~R 273 (290)
T cd05045 223 VTLGGNPYPGIAPERLFNLLKTGYRME-----------------------------RPENCSEEMYNLMLTCWKQEPDKR 273 (290)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCCCCCC-----------------------------CCCCCCHHHHHHHHHHccCCcccC
Confidence 98 999998877666555442211000 012355689999999999999999
Q ss_pred CCHHHHhc
Q 014871 218 ISAKDALD 225 (417)
Q Consensus 218 pta~elL~ 225 (417)
|++.+|++
T Consensus 274 p~~~~i~~ 281 (290)
T cd05045 274 PTFADISK 281 (290)
T ss_pred CCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=241.71 Aligned_cols=193 Identities=22% Similarity=0.294 Sum_probs=147.7
Q ss_pred ccEeecccCc-eecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGN-KYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~-~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+++++.+ ..++..|+||||+. ++|.+++.+....+++..+..++.||+.||+|||+++++||||||+|||++.++
T Consensus 56 ~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~ 135 (262)
T cd05058 56 PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF 135 (262)
T ss_pred CCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC
Confidence 3677777743 45667899999998 477777765555678888999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCC---CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSK 156 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~ 156 (417)
.+||+|||+++....... .......++..|+|||++.. ..++.++|||||||++|||++ |.++|...+..+....
T Consensus 136 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 214 (262)
T cd05058 136 TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214 (262)
T ss_pred cEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999976532211 11112234678999998875 568999999999999999999 5677877666555444
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+.... .+. ....++..+.+||.+||..||++||++.|+++
T Consensus 215 ~~~~~-~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 215 LLQGR-RLL----------------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HhcCC-CCC----------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 42210 000 00124567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=244.72 Aligned_cols=191 Identities=19% Similarity=0.257 Sum_probs=146.9
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+. ....+++|||+. ++|.+++......+++.++..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 70 ~i~~~~~~~~-~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~ 148 (279)
T cd05109 70 YVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHV 148 (279)
T ss_pred CCceEEEEEc-CCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcE
Confidence 4455554443 346789999997 57877776655579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++........ .......+..|++||++.+ ..++.++|||||||++|||++ |..||...........+..
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~- 226 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK- 226 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-
Confidence 99999999876432211 1112233677999999875 568999999999999999998 8999977665554443322
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..... ....++.++.+||.+||..||++|||+.++++
T Consensus 227 ~~~~~----------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 GERLP----------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCcCC----------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11100 01124567899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.25 Aligned_cols=185 Identities=18% Similarity=0.200 Sum_probs=135.8
Q ss_pred cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC-------------
Q 014871 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN------------- 81 (417)
Q Consensus 15 ~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~------------- 81 (417)
...++++|||++.+|.+.+......|++.+++.|++||+.||+|||++||+||||||+||||+..+.
T Consensus 52 ~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 52 DDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred cchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3467889999999999988766666999999999999999999999999999999999999965444
Q ss_pred ------EEEeeccCcccccCCCC---------------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh
Q 014871 82 ------LKLADFGLARSFSYDHN---------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140 (417)
Q Consensus 82 ------vkL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt 140 (417)
+||+|||+++....... ......++|++|||||++.+ ..++.++||||||||||||++
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~ 210 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-SSSNCASDVYRLGVLLFELFC 210 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-CCCCchhhhhhHHHHHHHHhh
Confidence 55555565543211000 00112357889999999886 568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH
Q 014871 141 GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 220 (417)
Q Consensus 141 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta 220 (417)
+.++|.... ..+..+..... +. ... .....+.+++.+||..||.+|||+
T Consensus 211 ~~~~~~~~~--~~~~~~~~~~~-~~---------------------------~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 211 PVSSREEKS--RTMSSLRHRVL-PP---------------------------QIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred CCCchhhHH--HHHHHHHHhhc-Ch---------------------------hhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 988765322 12222211000 00 000 012345688999999999999999
Q ss_pred HHHhcCCCCCC
Q 014871 221 KDALDSEYFWT 231 (417)
Q Consensus 221 ~elL~h~~f~~ 231 (417)
.|||+|+||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999965
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.27 Aligned_cols=186 Identities=28% Similarity=0.419 Sum_probs=144.3
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCC-CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccccc
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRF-TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 94 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l-~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~ 94 (417)
-.+||-||||+..++..+++.+..+ ...++.++|++|++||+|+|+.|||||||||.||+|+.++.|||.|||+|+...
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~ 748 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK 748 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence 4689999999999999988877654 478899999999999999999999999999999999999999999999998611
Q ss_pred -----------------CCCCCcccccccccCCCCchhhcCCC--CCCCccchhhHHHHHHHHHhCCCCCCCC-ChHHHH
Q 014871 95 -----------------YDHNNTLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQL 154 (417)
Q Consensus 95 -----------------~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~-~~~~~~ 154 (417)
.......+..+||..|+|||++.+.. +|+.|+|||||||||+||+.- |... ....++
T Consensus 749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL 825 (1351)
T KOG1035|consen 749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSMERASIL 825 (1351)
T ss_pred hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHHHHHHH
Confidence 01112456779999999999998765 699999999999999999863 5432 223333
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
..+.+..-..+. .++..--..-..+|+.||+.||++||||.|+|++.||-
T Consensus 826 ~~LR~g~iP~~~--------------------------~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 826 TNLRKGSIPEPA--------------------------DFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HhcccCCCCCCc--------------------------ccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 333211110000 01111223557899999999999999999999999983
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=240.47 Aligned_cols=188 Identities=19% Similarity=0.329 Sum_probs=148.0
Q ss_pred cEeecccCc-eecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGN-KYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~-~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
++++.++.+ ..++.+|+||||+.+ +|.+++.+.. ..+++..+..++.||+.+|+|||+++|+||||||+|||+++++
T Consensus 60 ~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~ 139 (256)
T cd05082 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN 139 (256)
T ss_pred CeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC
Confidence 466666643 445678999999985 7777665433 3489999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||++....... .....+..|+|||++.. ..++.++|||||||++|||++ |+.||...+..+....+..
T Consensus 140 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~ 214 (256)
T cd05082 140 VAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214 (256)
T ss_pred cEEecCCccceeccccC----CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 99999999987643221 12233567999998875 568899999999999999997 9999987776665555432
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... .....++..+++||.+||..||++|||+.++++
T Consensus 215 ~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 GYKM-----------------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCC-----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1000 011235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=242.71 Aligned_cols=191 Identities=20% Similarity=0.303 Sum_probs=150.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++. ...||||||+.+ +|.+++.+....+++.++..++.||+.||+|||+++++|+||||+|||++.++.+
T Consensus 68 ~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~ 146 (270)
T cd05056 68 HIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCV 146 (270)
T ss_pred chhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCe
Confidence 56777776654 567899999974 6777776555569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+++...............+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+....
T Consensus 147 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 225 (270)
T cd05056 147 KLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225 (270)
T ss_pred EEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987654332111112223567999998865 568999999999999999986 999998888776665553211
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.. .....++..+.+||.+||..+|++|||+.++++
T Consensus 226 ~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 226 RL-----------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred cC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 011235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=245.45 Aligned_cols=198 Identities=17% Similarity=0.230 Sum_probs=149.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG----LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~----~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
.||+++++.+...+..||||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 55 ~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 134 (269)
T cd05042 55 PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT 134 (269)
T ss_pred CCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec
Confidence 5889999988889999999999985 6666665432 2256788999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcC------CCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 014871 78 NEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLG------ATKYGPAVDMWSVGCIFAELLN-GKPILPGKN 149 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~ 149 (417)
.++.+||+|||+++....... .......++..|+|||++.. ...++.++|||||||++|||++ |..||....
T Consensus 135 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 135 ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 999999999999865322111 11122334677999998742 2356889999999999999999 788898877
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..+.+..+.......... ......++..+.+++..|+ .||++|||+++|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 215 DEQVLKQVVREQDIKLPK------------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHhhccCccCCC------------------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 766665554321110000 0011235667888999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=245.48 Aligned_cols=195 Identities=19% Similarity=0.318 Sum_probs=154.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG--------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~--------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
.||+++++.+...+..||||||+.+ +|.+++.... ..+++.++..++.||+.+|+|||+++|+||||||+|
T Consensus 68 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~N 147 (275)
T cd05046 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARN 147 (275)
T ss_pred cceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccce
Confidence 4788888888888899999999985 6666665432 158999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHH
Q 014871 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 152 (417)
Q Consensus 74 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~ 152 (417)
||++.++.++|+|||++...............++..|++||.+.+ ..++.++|||||||++|+|++ |..||.......
T Consensus 148 ili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~ 226 (275)
T cd05046 148 CLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226 (275)
T ss_pred EEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence 999999999999999987543322222333455778999998875 467889999999999999998 788997766665
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.+..+.... ..|. ....++..+.+||.+||..||++|||+.++++.
T Consensus 227 ~~~~~~~~~-----~~~~-----------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 227 VLNRLQAGK-----LELP-----------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHcCC-----cCCC-----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 555543210 0010 012356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=235.41 Aligned_cols=220 Identities=30% Similarity=0.570 Sum_probs=165.3
Q ss_pred cEeecccCceecC--eEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYRG--STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~~--~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
|||+++|.-++.. ..-||+||++. +...+.. .|+...|+.++.+||.||.|||++||+|||+||.|++||...
T Consensus 94 NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~ 169 (338)
T KOG0668|consen 94 NIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL 169 (338)
T ss_pred CeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh
Confidence 7888887766543 45799999986 4333332 589999999999999999999999999999999999999764
Q ss_pred -CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCC-CCCCCCChHHHHHHHH
Q 014871 81 -NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 -~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~-~pf~~~~~~~~~~~i~ 158 (417)
.++|+|+|+|.+.. .......++.+..|.-||.+.....|+.+.|+|||||+|+.|+..+ +.|.+.+..+++.+|.
T Consensus 170 rkLrlIDWGLAEFYH--p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa 247 (338)
T KOG0668|consen 170 RKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA 247 (338)
T ss_pred ceeeeeecchHhhcC--CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence 49999999997654 2334455677889999999998888999999999999999999976 4567889999999998
Q ss_pred HhcCCCCCCCCCCCCC---CCccccCCCchhhhhhHHHhh-----hhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 159 ELCGSPDETIWPGVSK---MPAYNHFKPSRTMKRRVREVF-----RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
.++|.-+-...-.... .+.|.+..- +-.+..+..+. ...++++.|||.++|..|-.+|+||.|++.||||.
T Consensus 248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~-~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 248 KVLGTDELYAYLNKYQIDLDPQFEDILG-RHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HHhChHHHHHHHHHHccCCChhHhhHhh-ccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 8877643211111111 011111000 00111222222 22468999999999999999999999999999994
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=242.81 Aligned_cols=192 Identities=18% Similarity=0.253 Sum_probs=145.6
Q ss_pred cEeecccCce------ecCeEEEEEcCCCC-CHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014871 4 TFLETTDGNK------YRGSTYMVFEYMDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71 (417)
Q Consensus 4 niv~~~~~~~------~~~~~yiV~Ey~~g-~l~~~~~~-----~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp 71 (417)
||+++++.+. .....++||||+.+ +|...+.. ....+++..+..++.||+.||+|||+++|+||||||
T Consensus 61 ~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 140 (272)
T cd05075 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAA 140 (272)
T ss_pred CcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccch
Confidence 5666654321 22357899999984 66555432 223489999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 014871 72 SNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKN 149 (417)
Q Consensus 72 ~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~ 149 (417)
+|||++.++.+||+|||+++.+....... ......+..|++||++.. ..++.++|||||||++|||++ |+.||.+..
T Consensus 141 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 141 RNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred hheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999998754322111 112234678999998875 578999999999999999999 889998877
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..+....+.+.... .....++..+++||.+||..||++|||+.+|++
T Consensus 220 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 220 NSEIYDYLRQGNRL-----------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred HHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 66655554321000 001134567899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=243.39 Aligned_cols=194 Identities=29% Similarity=0.467 Sum_probs=154.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++++.+......|+||||+.+ +|..++.. ....+++.+++.++.||+.||.|||+++++|+||||+||++++
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~- 141 (260)
T cd08222 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN- 141 (260)
T ss_pred cHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-
Confidence 677888888888899999999986 55554432 3456999999999999999999999999999999999999976
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||++....... .......++..|++||.+.. ..++.++|+||||+++|+|++|..+|...+.......+..
T Consensus 142 ~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T cd08222 142 NLLKIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219 (260)
T ss_pred CCEeecccCceeecCCCc-ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 579999999987654322 12223456888999998865 5678899999999999999999999987766555544422
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
. ... .+...++.++.+||++||..||++||++.++++|+||
T Consensus 220 ~---~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 G---PTP--------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred C---CCC--------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 1 000 0112456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=239.82 Aligned_cols=191 Identities=20% Similarity=0.355 Sum_probs=150.7
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+ .++.+|+||||+. ++|.+.+.. .+..+++.++..++.||+.+|+|||+++++|+||||+||+++.++.
T Consensus 62 ~i~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~ 140 (260)
T cd05067 62 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC 140 (260)
T ss_pred CeeeEEEEE-ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC
Confidence 667777655 4567899999997 477776654 3446899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
++|+|||++...............++..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05067 141 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219 (260)
T ss_pred EEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Confidence 9999999997654222222223344678999998875 568899999999999999999 99999888776666555321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++.++.+||.+||..||++|||++++++
T Consensus 220 ~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 220 YRMP-----------------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCC-----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1100 01224568999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=241.15 Aligned_cols=192 Identities=27% Similarity=0.393 Sum_probs=150.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++++.+...+.+|+||||+.+ +|..++.. ....+++.++..++.||+.||+|||+++|+|+||||+|||++.+
T Consensus 63 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~ 142 (267)
T cd08228 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT 142 (267)
T ss_pred ceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC
Confidence 688899999999999999999986 56555432 33458999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKI 157 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~--~~~~~~i 157 (417)
+.++|+|||++....... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+
T Consensus 143 ~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T cd08228 143 GVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI 220 (267)
T ss_pred CCEEECccccceeccchh-HHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH
Confidence 999999999987654322 11223456888999999876 5678999999999999999999999865432 2222222
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.....+.. ....++..+.+||.+||..||++|||+.++++
T Consensus 221 -~~~~~~~~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 221 -EQCDYPPL---------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred -hcCCCCCC---------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 11111100 01235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=250.25 Aligned_cols=194 Identities=22% Similarity=0.357 Sum_probs=153.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
.||+++++.+...+.+||||||+.+ +|.+++.+. ...++..++..++.||+.||+|||+++|+|
T Consensus 78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred CCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4789999999999999999999975 666665432 224788899999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+||||+.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||+||||++ |..|
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999765432111 1112233567999999976 578899999999999999998 8899
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+....+...... .....++..+.+||.+||..+|++|||+.+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell 287 (334)
T cd05100 237 YPGIPVEELFKLLKEGHRM-----------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287 (334)
T ss_pred CCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 9888776666555321000 00113456889999999999999999999998
Q ss_pred cC
Q 014871 225 DS 226 (417)
Q Consensus 225 ~h 226 (417)
++
T Consensus 288 ~~ 289 (334)
T cd05100 288 ED 289 (334)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=239.59 Aligned_cols=193 Identities=22% Similarity=0.342 Sum_probs=152.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~------~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NIL 75 (417)
-||+++++.+...+..|+||||+.+ +|.+.+.+ ....+++.++..++.||+.+|+|||+++++|+||||+|||
T Consensus 59 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil 138 (269)
T cd05044 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCL 138 (269)
T ss_pred CCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEE
Confidence 3788899988999999999999974 67666643 2234889999999999999999999999999999999999
Q ss_pred EcCCC-----CEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 014871 76 IDNEG-----NLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGK 148 (417)
Q Consensus 76 l~~~~-----~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~ 148 (417)
++.++ .+||+|||++........ ........+..|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 139 ~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 139 VSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred EecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 99887 899999999876532211 11122344678999999875 568999999999999999998 99999887
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+..+....+.... . ......++..+.+||.+||..+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 218 NNQEVLQHVTAGG-R----------------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CHHHHHHHHhcCC-c----------------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7766555442110 0 0011235678899999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=239.18 Aligned_cols=189 Identities=21% Similarity=0.338 Sum_probs=152.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-||+++++.+......|+||||+.+ +|.+++..... .+++.++..++.||+.+|.|||+++++|+||||+|||++.++
T Consensus 60 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~ 139 (256)
T cd05039 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL 139 (256)
T ss_pred cceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC
Confidence 3788888888888999999999985 77776654432 589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||+++...... .....+..|+|||++.. ..++.++|||||||++|||++ |+.||...+..+....+..
T Consensus 140 ~~~l~d~g~~~~~~~~~----~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 214 (256)
T cd05039 140 VAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214 (256)
T ss_pred CEEEccccccccccccc----ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence 99999999998753221 12234667999998875 568889999999999999997 9999987776655544422
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.. .. .....++..+.+||++||..+|++|||++|+++
T Consensus 215 ~~-~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 GY-RM----------------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CC-CC----------------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 10 00 001235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=258.35 Aligned_cols=158 Identities=22% Similarity=0.354 Sum_probs=122.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhc
Q 014871 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLL 117 (417)
Q Consensus 39 ~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~ 117 (417)
.+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... .......++..|+|||++.
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 312 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc
Confidence 478888999999999999999999999999999999999999999999999976543221 1122334577899999987
Q ss_pred CCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh
Q 014871 118 GATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196 (417)
Q Consensus 118 ~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (417)
+ ..++.++|||||||++|||++ |..||......+.+.........+ ....
T Consensus 313 ~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~----------------------------~~~~ 363 (400)
T cd05105 313 D-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM----------------------------AKPD 363 (400)
T ss_pred C-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC----------------------------CCCc
Confidence 6 568999999999999999997 889998765443332222110000 0012
Q ss_pred hhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 197 HFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 197 ~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.++.++++||.+||..||++|||+.+|.+
T Consensus 364 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 364 HATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 35678999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=239.86 Aligned_cols=192 Identities=26% Similarity=0.366 Sum_probs=150.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++++.+..++.+|+||||+.+ +|..++.. ....+++..+..++.||+.+|+|||+++++|+||||+||+++.+
T Consensus 63 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~ 142 (267)
T cd08229 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 142 (267)
T ss_pred chhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 688899999999999999999985 66665542 33468999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH--HHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA--EQLSKI 157 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~--~~~~~i 157 (417)
+.++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.... +....+
T Consensus 143 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T cd08229 143 GVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 220 (267)
T ss_pred CCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh
Confidence 9999999999876543221 2223467889999999875 56889999999999999999999999754432 222222
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
... ..+. .....++..+++||.+||..||++|||+.+|++
T Consensus 221 ~~~-~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 221 EQC-DYPP---------------------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hcC-CCCC---------------------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 110 0000 001236778999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=239.02 Aligned_cols=191 Identities=18% Similarity=0.322 Sum_probs=150.9
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+.. ...|+||||+. ++|.+++.+ ....+++.++..++.||+.||+|||+++++|+||||+||+++.++.
T Consensus 62 ~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~ 140 (260)
T cd05073 62 KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV 140 (260)
T ss_pred CcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc
Confidence 56677766665 77899999997 477777754 3446889999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++.+............++..|+|||++.. ..++.++|||||||++|+|++ |+.||...+.......+...
T Consensus 141 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05073 141 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219 (260)
T ss_pred EEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 9999999997654322222222344677999999875 568889999999999999998 99999887776666555321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
... .....++.++.+||.+||..||++||++.++++
T Consensus 220 ~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 220 YRM-----------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCC-----------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 100 001235678999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=244.64 Aligned_cols=183 Identities=17% Similarity=0.211 Sum_probs=139.1
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCC
Q 014871 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 96 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 96 (417)
..|++||++..++...+... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~ 179 (294)
T PHA02882 101 YRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH 179 (294)
T ss_pred EEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccC
Confidence 34789999987777666543 34788999999999999999999999999999999999999999999999999876422
Q ss_pred CC------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHH-HhcCCCCCCC
Q 014871 97 HN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIF-ELCGSPDETI 168 (417)
Q Consensus 97 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-~~~i~-~~~~~~~~~~ 168 (417)
.. .......+|+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+.... ..... +......
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~--- 255 (294)
T PHA02882 180 GKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH--- 255 (294)
T ss_pred CcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh---
Confidence 11 11223468999999999876 5689999999999999999999999987743222 21111 0000000
Q ss_pred CCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 169 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.-.......+..+.++++.|+.+++++||+..+|++
T Consensus 256 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 256 ---------------------EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ---------------------hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000012235678999999999999999999999875
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=240.57 Aligned_cols=193 Identities=20% Similarity=0.321 Sum_probs=152.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+|+||||+.+ +|..++......+++.+++.++.||+.||+|||+++++|+||||+|||++.++.
T Consensus 65 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~ 144 (269)
T cd05065 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV 144 (269)
T ss_pred cCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc
Confidence 3778888888888899999999986 566666555557999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC-cccccc---cccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN-TLTNRV---ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~-~~~~~~---gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~ 156 (417)
+||+|||++......... ...... .+..|++||++.. ..++.++|||||||++|||++ |..||...+..+....
T Consensus 145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~ 223 (269)
T cd05065 145 CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA 223 (269)
T ss_pred EEECCCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999998755332211 111111 1457999999875 568999999999999999886 9999988777666665
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+......+. ...++..+.+||.+||..+|++||++.+|+.
T Consensus 224 i~~~~~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 224 IEQDYRLPP-----------------------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHcCCcCCC-----------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 532111000 1124567899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=241.18 Aligned_cols=194 Identities=25% Similarity=0.438 Sum_probs=159.0
Q ss_pred EeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
+|.++.||.....+++|.||+.| +|.+.+.+. .+|+++.++.|...|+.||.|||++|||+||||.+|||||.+|.+|
T Consensus 313 lvglhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 313 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred EEehhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCcee
Confidence 57788999999999999999986 565555544 4699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC-------CChHH-HHH
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-------KNEAE-QLS 155 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~-------~~~~~-~~~ 155 (417)
|+|+|+++.... .....++.+||+.|+|||++.+ ..|+.++|.|+|||+++||+.|+.||.- .|..+ +++
T Consensus 392 ltdygmcke~l~-~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq 469 (593)
T KOG0695|consen 392 LTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ 469 (593)
T ss_pred ecccchhhcCCC-CCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence 999999987543 3445677899999999999987 6899999999999999999999999962 11111 222
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC------CHHHHhcCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI------SAKDALDSEYF 229 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp------ta~elL~h~~f 229 (417)
.|.+ .-..+.+.++-.+..+|+..|++||.+|. ...|+..|+||
T Consensus 470 vile------------------------------kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ff 519 (593)
T KOG0695|consen 470 VILE------------------------------KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFF 519 (593)
T ss_pred HHhh------------------------------hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhh
Confidence 2221 01122344667788999999999999996 46899999999
Q ss_pred CC
Q 014871 230 WT 231 (417)
Q Consensus 230 ~~ 231 (417)
..
T Consensus 520 r~ 521 (593)
T KOG0695|consen 520 RS 521 (593)
T ss_pred hh
Confidence 64
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=244.39 Aligned_cols=200 Identities=18% Similarity=0.263 Sum_probs=152.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-----------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlk 70 (417)
.||+++++.+...+..||||||+.+ +|.+++.... ..+++.++..++.||+.||+|||+++++|+|||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 4678888888899999999999985 6666554321 137888999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh--CCCCCCC
Q 014871 71 GSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPG 147 (417)
Q Consensus 71 p~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt--G~~pf~~ 147 (417)
|+|||+++++.+||+|||++..+...... ......++..|+|||++.. ..++.++|||||||++|+|++ +..||..
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999765322211 1122334678999999876 568999999999999999988 6678887
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 148 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+..+.+..+.+.........+. .....++..+++||++||..||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYL----------------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccccccC----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 77666655543322111000000 001125678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=271.64 Aligned_cols=88 Identities=31% Similarity=0.497 Sum_probs=78.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.+||++++.+...+++||||||+.+ +|..++... ..+++..++.|+.||+.||+|||.++||||||||+||||+.++.
T Consensus 64 p~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~ 142 (669)
T cd05610 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH 142 (669)
T ss_pred CCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC
Confidence 3688888999999999999999975 666665543 46899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcc
Q 014871 82 LKLADFGLAR 91 (417)
Q Consensus 82 vkL~DFGla~ 91 (417)
+||+|||+++
T Consensus 143 vkL~DFGls~ 152 (669)
T cd05610 143 IKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCc
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=258.61 Aligned_cols=197 Identities=17% Similarity=0.239 Sum_probs=154.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||||-+-.++...+. -||+-+|+|+ |..++.....+|.+...+.|++||++|+.|||.++|||||||..||||.+++.
T Consensus 448 ~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 448 ENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred hhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc
Confidence 788888888887776 8999999985 54455445567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCC-CCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
|||.||||+..-... .........+...|||||++.. ..+|++.+||||||||+|||++|..||...+...++-.+=
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG 606 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG 606 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec
Confidence 999999999754322 2223344566788999999864 3468999999999999999999999998444433322111
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.-.. ..+..........++++|+..||.+++++||+..+||.
T Consensus 607 rG~l-------------------------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 607 RGYL-------------------------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cccc-------------------------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1000 12233344557779999999999999999999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=241.52 Aligned_cols=197 Identities=17% Similarity=0.281 Sum_probs=147.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++++.+.....+||||||+.+ +|..++.+. ...+.+..++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 56 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~ 135 (268)
T cd05086 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD 135 (268)
T ss_pred chhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC
Confidence 678888888888899999999985 666666542 2246778889999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCC-CCcccccccccCCCCchhhcCC------CCCCCccchhhHHHHHHHHHh-CCCCCCCCChH
Q 014871 80 GNLKLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGA------TKYGPAVDMWSVGCIFAELLN-GKPILPGKNEA 151 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~ 151 (417)
+.+||+|||++....... ........++..|+|||++... ..++.++|||||||++|||++ +..||...++.
T Consensus 136 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 215 (268)
T cd05086 136 LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215 (268)
T ss_pred ccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999986432111 1122334568899999987531 235789999999999999997 57788877776
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+.+..+...... . .+. ..+...++..+.+||+.|+ .+|++|||+.+|++
T Consensus 216 ~~~~~~~~~~~~--~-~~~---------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 216 EVLNHVIKDQQV--K-LFK---------------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHhhccc--c-cCC---------------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 666654321100 0 000 0011225667889999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=238.48 Aligned_cols=185 Identities=22% Similarity=0.282 Sum_probs=142.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-- 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~-- 80 (417)
||++++..+.. +..||||||+.+ +|..++.+....+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 62 ~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~ 140 (259)
T cd05037 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN 140 (259)
T ss_pred chhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc
Confidence 56777776666 678999999986 45555544443699999999999999999999999999999999999999887
Q ss_pred -----CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHH
Q 014871 81 -----NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQ 153 (417)
Q Consensus 81 -----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~ 153 (417)
.+||+|||++..... .....++..|+|||++... ..++.++|||||||++|||++ |..||...+..+.
T Consensus 141 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~ 215 (259)
T cd05037 141 EGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215 (259)
T ss_pred cCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence 799999999976542 2223456789999998763 368899999999999999999 5777766553333
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...... ... ++ ......+.+||.+||..||++|||+.+|++
T Consensus 216 ~~~~~~----~~~--~~-------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 216 ERFYQD----QHR--LP-------------------------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHhc----CCC--CC-------------------------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222210 000 00 001157889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=237.85 Aligned_cols=197 Identities=19% Similarity=0.221 Sum_probs=145.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~----~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
||++.++.+.....+||||||+.+ +|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 56 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~ 135 (269)
T cd05087 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA 135 (269)
T ss_pred CEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC
Confidence 788888888888899999999985 665555432 224677788899999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCC------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCh
Q 014871 79 EGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGA------TKYGPAVDMWSVGCIFAELLN-GKPILPGKNE 150 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~ 150 (417)
++++||+|||+++....... .......++..|+|||++.+. ..++.++|||||||++|||++ |+.||.....
T Consensus 136 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 136 DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred CCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 99999999999875432211 111223457789999988532 135789999999999999996 9999987766
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+............... ..+...++..+.+||++|+ .+|++|||++||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 216 EQVLTYTVREQQLKLPK------------------------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHHhhcccCCCCC------------------------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 55443332110000000 0001124567889999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-31 Score=240.47 Aligned_cols=202 Identities=22% Similarity=0.343 Sum_probs=159.2
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~ 78 (417)
|||++|.+.=.++..||.||+|+-++..+... ...+++|..+-.|..-++.||.||.+. .||||||||+||||+.
T Consensus 124 ~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 124 NIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR 203 (361)
T ss_pred HHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec
Confidence 67888988778899999999999988776543 344699999999999999999999965 8999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.|.|||||||++-.+.. ....+.-.|...|||||.+..... |+.++||||||++|||+.||+.|+..-+. ++.++
T Consensus 204 ~G~vKLCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql 279 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQL 279 (361)
T ss_pred CCCEeeecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHH
Confidence 99999999999865432 122334567889999999975544 99999999999999999999987764433 44444
Q ss_pred HHh-cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FEL-CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..+ .+.++....+.. --+++..++.||..||.+|-+.||...++++++|++.
T Consensus 280 ~~Vv~gdpp~l~~~~~----------------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 280 CQVVIGDPPILLFDKE----------------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred HHHHcCCCCeecCccc----------------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 332 233322211100 0136778999999999999999999999999999964
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=242.46 Aligned_cols=206 Identities=19% Similarity=0.333 Sum_probs=144.4
Q ss_pred cEeecccCceec--CeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
||+++.+.+... ..+||||||+.+ +|...+.+....+++.++..++.||+.+|+|||++||+||||||+|||++.++
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 146 (284)
T cd05079 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146 (284)
T ss_pred CeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC
Confidence 677777766654 568999999975 66666655444689999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++++.++..... ...
T Consensus 147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~--- 220 (284)
T cd05079 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--LFL--- 220 (284)
T ss_pred CEEECCCccccccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--hhh---
Confidence 9999999999865432221 1123445678999999876 5688999999999999999998765432111 000
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhh-hhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMK-RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+........ ... ..... .........++..+.+||.+||..||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 221 KMIGPTHGQMTV--------TRL--VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred hhcccccccccH--------HHH--HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000000000000 000 00000 0000112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=237.51 Aligned_cols=192 Identities=22% Similarity=0.380 Sum_probs=155.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~ 78 (417)
||+..++.+..++++|+||||+.+ +|.+++. .....+++..++.++.||+.+|.|||+ .+|+|+|||++|||++.
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~ 149 (269)
T cd08528 70 NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE 149 (269)
T ss_pred CeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC
Confidence 788888889999999999999985 5655542 344569999999999999999999996 68999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||++....... ......++..|++||++.+ ..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 150 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~ 226 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226 (269)
T ss_pred CCcEEEecccceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh
Confidence 9999999999997654332 3344567889999999976 568999999999999999999999998777666555543
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
+....+.. ...++.++.+||++||..||++|||+.|+..+
T Consensus 227 ~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 227 EAVYEPLP----------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred hccCCcCC----------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 31111000 01245689999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=240.98 Aligned_cols=200 Identities=18% Similarity=0.259 Sum_probs=150.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG----------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~----------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp 71 (417)
.||+++++.+...+.+|+||||+.+ +|.+++.+.. ..+++.++..++.||+.||+|||+++|+|+||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 4688888889999999999999975 6766665421 2377889999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh--CCCCCCCC
Q 014871 72 SNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN--GKPILPGK 148 (417)
Q Consensus 72 ~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt--G~~pf~~~ 148 (417)
+||||+.++.+||+|||+++.+....... ......+..|++||++.. ..++.++|||||||++|||++ +..||...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999997653222111 112233578999998875 568999999999999999998 67888776
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+..+.+....+......... .......++..+.+||.+||..||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQV----------------------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccc----------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555443322110000000 00001224568899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=236.58 Aligned_cols=192 Identities=25% Similarity=0.353 Sum_probs=150.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
+++++++.+..++..|+||||+.+ +|..++.+ .+..+++.++..++.||+.+|+|||++||+|+||||+||+++.+
T Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~ 142 (267)
T cd08224 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT 142 (267)
T ss_pred CeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC
Confidence 688889999999999999999985 67666543 23458999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE--AEQLSKI 157 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~--~~~~~~i 157 (417)
+.++|+|||++..+.... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+
T Consensus 143 ~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T cd08224 143 GVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 220 (267)
T ss_pred CcEEEeccceeeeccCCC-cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhh
Confidence 999999999987654322 12233457888999999875 5688999999999999999999999865432 1122221
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... ... .....++..+.+||.+||..+|++|||+.+|++
T Consensus 221 ~~~~--~~~--------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 221 EKCD--YPP--------------------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hcCC--CCC--------------------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1100 000 001245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=241.03 Aligned_cols=192 Identities=22% Similarity=0.333 Sum_probs=150.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---------------------GLRFTVPQIKCYMKQLLTGLHYCHV 61 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---------------------~~~l~~~~i~~i~~Qil~gL~~LH~ 61 (417)
||+++++.+.....+|+||||+.+ +|.+++... ...+++.++..++.||+.||+|||+
T Consensus 69 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~ 148 (288)
T cd05050 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE 148 (288)
T ss_pred chheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 577888888888899999999985 676666432 1247888999999999999999999
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt 140 (417)
++++||||||+|||++.++.+||+|||++........ ........+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 149 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 149 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred CCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999875432211 11112234567999999876 568999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC
Q 014871 141 -GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 219 (417)
Q Consensus 141 -G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt 219 (417)
|..||.+.+..+....+..... + .....++.++.+||.+||..||++|||
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~------~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt 278 (288)
T cd05050 228 YGMQPYYGMAHEEVIYYVRDGNV------L-----------------------SCPDNCPLELYNLMRLCWSKLPSDRPS 278 (288)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCC------C-----------------------CCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 8889987777666655532110 0 001124568999999999999999999
Q ss_pred HHHHhc
Q 014871 220 AKDALD 225 (417)
Q Consensus 220 a~elL~ 225 (417)
+.||++
T Consensus 279 ~~el~~ 284 (288)
T cd05050 279 FASINR 284 (288)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=237.89 Aligned_cols=191 Identities=19% Similarity=0.250 Sum_probs=149.4
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+.. ...|+||||+. ++|.+.+.+....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 70 ~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 70 HVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred CcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeE
Confidence 56666665555 78899999997 57777777655569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcc-cccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTL-TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++.......... .....+..|+|||.+.. ..++.++|||||||++|||++ |+.||.+....+....+...
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Confidence 9999999986543221111 11223567999998865 578899999999999999998 99999887766655544321
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++..+.++|.+||..||++|||+.++++
T Consensus 228 ~~~~-----------------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 228 ERLP-----------------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCC-----------------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 01124457889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=245.14 Aligned_cols=201 Identities=23% Similarity=0.384 Sum_probs=159.9
Q ss_pred ccEeecccCceecCe-EEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEcC-
Q 014871 3 CTFLETTDGNKYRGS-TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDN- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~-~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--givHrDlkp~NILl~~- 78 (417)
|-||+.||.|..+.+ .|-|+|||+|+.++++.+..+.+++++++.|+.||+.||.||.+. -|||-||||.||||.+
T Consensus 527 pRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 527 PRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred ceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC
Confidence 789999999998775 589999999988888888788899999999999999999999987 5999999999999854
Q ss_pred --CCCEEEeeccCcccccCCCCC------cccccccccCCCCchhhcC---CCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 014871 79 --EGNLKLADFGLARSFSYDHNN------TLTNRVITLWYRPPELLLG---ATKYGPAVDMWSVGCIFAELLNGKPILPG 147 (417)
Q Consensus 79 --~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~elltG~~pf~~ 147 (417)
.|.+||+||||++.+..+... ..+-..||.||++||.|.- ..+.+.++||||+|||||.+|+|+.||..
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 467999999999987654332 2233467999999998863 23578899999999999999999999975
Q ss_pred CChHHH-HH--HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 148 KNEAEQ-LS--KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 148 ~~~~~~-~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
.-.... +. .|++.. +.-++ ....++.++++||++||.+.-++|..+.+|.
T Consensus 687 nqsQQdILqeNTIlkAt----EVqFP-----------------------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 687 NQSQQDILQENTILKAT----EVQFP-----------------------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhHHHHHhhhchhcce----eccCC-----------------------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 443221 11 111100 00000 0123678999999999999999999999999
Q ss_pred cCCCCC
Q 014871 225 DSEYFW 230 (417)
Q Consensus 225 ~h~~f~ 230 (417)
.|+||.
T Consensus 740 ~dpyll 745 (775)
T KOG1151|consen 740 CDPYLL 745 (775)
T ss_pred cCcccc
Confidence 999994
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=238.85 Aligned_cols=204 Identities=17% Similarity=0.280 Sum_probs=143.5
Q ss_pred cEeecccCcee--cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKY--RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~--~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
||+++++.+.. ...+||||||+.+ +|.+++... .+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 67 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~ 144 (283)
T cd05080 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR 144 (283)
T ss_pred CEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC
Confidence 67777776544 3458999999986 555555432 499999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCc--ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+++......... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +..+.
T Consensus 145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~ 221 (283)
T cd05080 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMI 221 (283)
T ss_pred cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhh
Confidence 99999999997654322111 112234667999998875 56899999999999999999999887643321 11111
Q ss_pred HhcC-CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCG-SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... ......+. . ... ..........++.++.+||.+||..||++|||+++|++
T Consensus 222 ~~~~~~~~~~~~~---~-----~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 222 GPKQGQMTVVRLI---E-----LLE-----RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cccccccchhhhh---h-----hhh-----cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 00000000 0 000 00000112346678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=241.29 Aligned_cols=192 Identities=23% Similarity=0.368 Sum_probs=149.7
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+...+.++||||||. ++|.+.+... ...+++.++..|+.||+.||+|||+++|+|+||+++|||++.++.
T Consensus 62 ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~ 141 (259)
T PF07714_consen 62 NIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ 141 (259)
T ss_dssp TBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 78888888888888999999998 4777777765 567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||++........ ...........|+|||++.. ..++.++||||||+++|||++ |+.||...+..+...++.+
T Consensus 142 ~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~ 220 (259)
T PF07714_consen 142 VKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ 220 (259)
T ss_dssp EEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999987632211 11222345778999999875 458999999999999999999 7899988887777777643
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... .....++..+.+||.+||..||++|||+.+|++
T Consensus 221 ~~~~-----------------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 221 GQRL-----------------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TEET-----------------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccc-----------------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2111 112236678999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=229.36 Aligned_cols=185 Identities=25% Similarity=0.409 Sum_probs=137.6
Q ss_pred CeEEEEEcCCC-CCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCCEEEeeccC
Q 014871 16 GSTYMVFEYMD-HDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGL 89 (417)
Q Consensus 16 ~~~yiV~Ey~~-g~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~NILl~~~~~vkL~DFGl 89 (417)
..+||++.|.. |+|++.+.+ .+..++|.++..|+.+||.||++||+.. ++||||||.|||+.+++..+|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 35899999997 568887654 3446999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC--------cccccccccCCCCchhhcCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 90 ARSFSYDHNN--------TLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 90 a~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
++...-.-.. ......+|..|+|||.+.-.. ..++++|||||||+||+|++|..||.- +++
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~ 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQ 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hhh
Confidence 8754311110 112345699999999875432 367899999999999999999999952 222
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.-++..-.....-..+| . ...+++.+.+||+.||+.||.+||++.+++.+
T Consensus 247 ~GgSlaLAv~n~q~s~P-----~------------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIP-----N------------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCeEEEeeeccccccC-----C------------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11111110000000000 0 01278899999999999999999999999863
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=233.82 Aligned_cols=187 Identities=22% Similarity=0.354 Sum_probs=147.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+.. +..|+||||+.+ +|.+.+.... ..+++.++..++.||+.||.|||+++++||||||+|||++.++.
T Consensus 60 ~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~ 138 (254)
T cd05083 60 NLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV 138 (254)
T ss_pred CcCeEEEEEcC-CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc
Confidence 56777776654 457999999985 7777776543 35899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..... ......+..|+|||.+.+ ..++.++|||||||++|||++ |+.||...+..+....+...
T Consensus 139 ~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 213 (254)
T cd05083 139 AKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG 213 (254)
T ss_pred EEECCCccceecccc----CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC
Confidence 999999998754321 112233567999998875 568899999999999999997 99999887766555444221
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
. .+ .....++..+++||++||..+|++|||+.++++
T Consensus 214 ~-~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 214 Y-RM----------------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred C-CC----------------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00 001235678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=251.12 Aligned_cols=157 Identities=22% Similarity=0.324 Sum_probs=123.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcC
Q 014871 40 FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLG 118 (417)
Q Consensus 40 l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 118 (417)
|++..+..|+.||+.||+|||+++|+||||||+|||+++++.+||+|||+++....... .......++..|+|||++.+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 67788999999999999999999999999999999999999999999999976432221 11223355788999999876
Q ss_pred CCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhh
Q 014871 119 ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197 (417)
Q Consensus 119 ~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (417)
..++.++|||||||++|||++ |..||......+.+.........+ .....
T Consensus 316 -~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~----------------------------~~p~~ 366 (401)
T cd05107 316 -NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM----------------------------AKPAH 366 (401)
T ss_pred -CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC----------------------------CCCCC
Confidence 568899999999999999998 888998766555443332210000 00123
Q ss_pred hhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 198 FDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 198 ~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
++.++.+||.+||..||.+||++.||++
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=243.84 Aligned_cols=159 Identities=22% Similarity=0.404 Sum_probs=121.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhc
Q 014871 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLL 117 (417)
Q Consensus 39 ~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~ 117 (417)
.+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.
T Consensus 175 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 254 (343)
T cd05103 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 254 (343)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhc
Confidence 3678889999999999999999999999999999999999999999999999765322211 111223466799999987
Q ss_pred CCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh
Q 014871 118 GATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196 (417)
Q Consensus 118 ~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (417)
. ..++.++|||||||++|+|++ |..||........+........... ...
T Consensus 255 ~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~ 305 (343)
T cd05103 255 D-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR----------------------------APD 305 (343)
T ss_pred C-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC----------------------------CCC
Confidence 5 578999999999999999997 8999876543332222211000000 011
Q ss_pred hhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 197 HFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 197 ~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.++.++.+++.+||..||++|||+.+|++|
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 245678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=239.19 Aligned_cols=192 Identities=18% Similarity=0.220 Sum_probs=147.8
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+.. ...++|+||+. ++|.+.+......+++..+..++.||+.||+|||+++|+||||||+|||+++++.
T Consensus 69 ~niv~~~~~~~~-~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 69 PHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH 147 (303)
T ss_pred CCcccEEEEEcC-CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc
Confidence 367777776543 45789999998 5677777665556899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||+++........ ......++..|++||++.+ ..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 226 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 226 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 999999999865432221 1122334678999999875 568999999999999999997 8899987665444333321
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+. ....++..+.+||.+||..||++||++.++++
T Consensus 227 -~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 227 -GERLP----------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred -CCCCC----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 10000 00123457889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=257.91 Aligned_cols=201 Identities=23% Similarity=0.377 Sum_probs=161.0
Q ss_pred ccEeecccCceec-----CeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 014871 3 CTFLETTDGNKYR-----GSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75 (417)
Q Consensus 3 cniv~~~~~~~~~-----~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NIL 75 (417)
-|++++|.+|... +.+|||||||.+ +..+++.. .+.+|.|..|..|++.+|.||.+||.+.++|||||-.|||
T Consensus 76 pnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiL 155 (953)
T KOG0587|consen 76 PNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVL 155 (953)
T ss_pred CCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEE
Confidence 4677777666554 469999999985 66666653 3667999999999999999999999999999999999999
Q ss_pred EcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 76 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
++.++.|||+|||++..+.. ......+.+||+.||||||+... .-|+..+|+||||++..||.-|.+|+......
T Consensus 156 LT~e~~VKLvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 156 LTENAEVKLVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred EeccCcEEEeeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 99999999999999987653 34455677899999999999753 24678999999999999999999998765543
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
-.+-+| ...|... ...++..+.++.+||..||.+|..+||+..++|+|||++.
T Consensus 235 raLF~I---pRNPPPk------------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 235 RALFLI---PRNPPPK------------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hhhccC---CCCCCcc------------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 332222 2222111 1123457789999999999999999999999999999963
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=236.01 Aligned_cols=193 Identities=20% Similarity=0.272 Sum_probs=148.4
Q ss_pred ccEeecccCcee-cCeEEEEEcCCC-CCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 3 CTFLETTDGNKY-RGSTYMVFEYMD-HDLTGLADRPG-------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 3 cniv~~~~~~~~-~~~~yiV~Ey~~-g~l~~~~~~~~-------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
.||+++++.... ....++++||+. ++|.+++.... ..|++.++..++.||+.||+|||+++++||||||+|
T Consensus 68 ~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~n 147 (280)
T cd05043 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARN 147 (280)
T ss_pred CCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhh
Confidence 467777765443 567899999997 56666654321 358999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChH
Q 014871 74 LLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEA 151 (417)
Q Consensus 74 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~ 151 (417)
||+++++.+||+|||+++.+....... .....++..|+|||++.+ ..++.++|||||||++|||++ |+.||...+..
T Consensus 148 il~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 226 (280)
T cd05043 148 CVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF 226 (280)
T ss_pred EEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH
Confidence 999999999999999997653222111 112234677999999876 568999999999999999998 99999887766
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+....+.... .. . ....++.+++++|.+||..||++|||+.++++
T Consensus 227 ~~~~~~~~~~-~~-----~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 227 EMAAYLKDGY-RL-----A-----------------------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHHHHHcCC-CC-----C-----------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6544443210 00 0 01124567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=260.87 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=155.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCC--CCH-HHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLR--FTV-PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~--l~~-~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~- 78 (417)
.|||++|....+...+||.+|+|..+|.++++..... +.. -....++.|++.||++||+.+||||||||.||||+.
T Consensus 563 ~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~ 642 (903)
T KOG1027|consen 563 PNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVP 642 (903)
T ss_pred CceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEcc
Confidence 4899999999999999999999999999999874211 112 346788999999999999999999999999999976
Q ss_pred --CC--CEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChH
Q 014871 79 --EG--NLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEA 151 (417)
Q Consensus 79 --~~--~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG-~~pf~~~~~~ 151 (417)
++ +++|+|||+++....... ....+..||..|+|||++.. ..-+.++||||||||+|+.++| ..||...-+.
T Consensus 643 ~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 643 SADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred CCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 33 589999999998765433 23455678999999999986 4457799999999999999985 8899754433
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+ ..|...... +..+....+.+++|||.+||.+||..||+|.++|.|||||.
T Consensus 722 ~--~NIl~~~~~---------------------------L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 722 Q--ANILTGNYT---------------------------LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred h--hhhhcCccc---------------------------eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 2 122110000 00001111227899999999999999999999999999998
Q ss_pred C
Q 014871 232 D 232 (417)
Q Consensus 232 ~ 232 (417)
.
T Consensus 773 ~ 773 (903)
T KOG1027|consen 773 S 773 (903)
T ss_pred h
Confidence 5
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=264.56 Aligned_cols=195 Identities=22% Similarity=0.292 Sum_probs=148.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP----------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~----------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
||+++++.+...+..|+||||+++ +|.+++... ...++...+..++.||+.||+|||+++|+||||||+
T Consensus 63 NIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPe 142 (932)
T PRK13184 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPD 142 (932)
T ss_pred CcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchh
Confidence 788889999999999999999986 565555321 123667788999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCC-----------------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHH
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHN-----------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 135 (417)
|||++.++.+||+|||+++....... ......++|+.|+|||++.+ ..++.++||||||||+
T Consensus 143 NILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVIL 221 (932)
T PRK13184 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVIL 221 (932)
T ss_pred eEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHH
Confidence 99999999999999999986521110 01112468999999999876 5689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCC
Q 014871 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPS 215 (417)
Q Consensus 136 ~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 215 (417)
|||++|+.||............ ....+.. ......++..+.+++.+||..||+
T Consensus 222 yELLTG~~PF~~~~~~ki~~~~--~i~~P~~-------------------------~~p~~~iP~~L~~LI~rcL~~DP~ 274 (932)
T PRK13184 222 YQMLTLSFPYRRKKGRKISYRD--VILSPIE-------------------------VAPYREIPPFLSQIAMKALAVDPA 274 (932)
T ss_pred HHHHHCCCCCCCcchhhhhhhh--hccChhh-------------------------ccccccCCHHHHHHHHHHccCChh
Confidence 9999999999775543332211 0000000 001124667889999999999999
Q ss_pred CCCCHHHHhcC
Q 014871 216 QRISAKDALDS 226 (417)
Q Consensus 216 ~Rpta~elL~h 226 (417)
+|++..+.+.+
T Consensus 275 kR~ss~eeLl~ 285 (932)
T PRK13184 275 ERYSSVQELKQ 285 (932)
T ss_pred hCcCHHHHHHH
Confidence 99887665543
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=233.17 Aligned_cols=204 Identities=20% Similarity=0.296 Sum_probs=143.5
Q ss_pred ccEeecccCce--ecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNK--YRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~--~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.||+++++.+. ....+||||||+. ++|.+++.+....+++..+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 65 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~ 144 (284)
T cd05081 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE 144 (284)
T ss_pred CCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC
Confidence 36777766543 3346899999997 57777776555569999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcc--cccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+.+||+|||+++.......... .....+..|+|||++.+ ..++.++|||||||++|||+++..++..... .....+
T Consensus 145 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~ 222 (284)
T cd05081 145 NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMM 222 (284)
T ss_pred CeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhc
Confidence 9999999999986543222111 11123456999999875 5688999999999999999998765533221 111110
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhH-----HHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV-----REVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+...... .....+...+ ......++.++.+||.+||..||++|||+.+|++
T Consensus 223 ----~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 223 ----GNDKQGQ-------------MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ----ccccccc-------------cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000000 0000000000 0012346678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=224.82 Aligned_cols=195 Identities=39% Similarity=0.633 Sum_probs=154.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+++++.+......|+||||+.+ +|..++.... .+++..+..++.+|+.+|.+||+.+|+|+||++.||++++++.+
T Consensus 48 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~ 126 (244)
T smart00220 48 NIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHV 126 (244)
T ss_pred cHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcE
Confidence 566777777888899999999997 7776665443 38999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~-~~~~~~~~~i~~~~ 161 (417)
+|+|||++....... ......++..|++||.+.. ..++.++||||||+++++|++|..||.. .+.......+....
T Consensus 127 ~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~ 203 (244)
T smart00220 127 KLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK 203 (244)
T ss_pred EEccccceeeecccc--ccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence 999999997755322 2334556888999999875 5678899999999999999999999987 33333333332211
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
..... ....++.++.+||.+||..||++||++.++++|+||
T Consensus 204 ~~~~~---------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 204 PPFPP---------------------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCCcc---------------------------ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 11000 000155689999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=232.29 Aligned_cols=197 Identities=20% Similarity=0.328 Sum_probs=146.9
Q ss_pred ccEeecccCcee--cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNKY--RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~~--~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.||+++++.+.. ....|+||||+.+ +|.+++......+++.++..++.||+.||+|||+++++|+||||+|||++.+
T Consensus 66 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~ 145 (284)
T cd05038 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE 145 (284)
T ss_pred CChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC
Confidence 467777777666 5578999999974 7777776655569999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcc--cccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH----
Q 014871 80 GNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ---- 153 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~---- 153 (417)
+.+||+|||++........... .....+..|++||.+.. ..++.++|||||||+++||++|+.||........
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 224 (284)
T cd05038 146 DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG 224 (284)
T ss_pred CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccc
Confidence 9999999999987652221111 11234567999998875 5688999999999999999999988754322110
Q ss_pred -------HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 154 -------LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 154 -------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+.+.+..... ......++.++.+||.+||..||++|||+.||++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 225 IAQGQMIVTRLLELLKEGER-------------------------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cccccccHHHHHHHHHcCCc-------------------------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0111110000000 0001234568999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=254.29 Aligned_cols=191 Identities=24% Similarity=0.392 Sum_probs=162.3
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcC---------CCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP---------GLR----FTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~---------~~~----l~~~~i~~i~~Qil~gL~~LH~~givHrDl 69 (417)
|||+++.....++-+|||||||+ |||.++++.. +.. |+..+...|+.||+.|++||-++.+|||||
T Consensus 550 nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDL 629 (774)
T KOG1026|consen 550 NIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDL 629 (774)
T ss_pred CeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccch
Confidence 89999999999999999999998 6888877631 122 889999999999999999999999999999
Q ss_pred CCCcEEEcCCCCEEEeeccCcccccCCCCCccc-ccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 014871 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPG 147 (417)
Q Consensus 70 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~ 147 (417)
-..|+||.+.-.|||+|||+++.+-...--... .......||+||.++- .+|+.++||||+||||||+++ |+.|+.+
T Consensus 630 ATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 630 ATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred hhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccc
Confidence 999999999999999999999986533222222 3344778999999984 789999999999999999997 9999999
Q ss_pred CChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 148 KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 148 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
.+..++++.|.+ ..+....+.++.++.+|+..|++.+|++||+++||-
T Consensus 709 lSn~EVIe~i~~-----------------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 709 LSNQEVIECIRA-----------------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cchHHHHHHHHc-----------------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999988854 111223345778999999999999999999999984
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=235.83 Aligned_cols=225 Identities=30% Similarity=0.494 Sum_probs=162.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~-~~~ 81 (417)
-||++...+++.+++.+|||||++++-...+.. .++..+++.|++.++.||+++|.+|||||||||.|+|.+. .+.
T Consensus 95 ~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 95 DNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred hhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCC
Confidence 478999999999999999999999754444433 3789999999999999999999999999999999999975 456
Q ss_pred EEEeeccCcccccCC-------------------------------------------CCCcccccccccCCCCchhhcC
Q 014871 82 LKLADFGLARSFSYD-------------------------------------------HNNTLTNRVITLWYRPPELLLG 118 (417)
Q Consensus 82 vkL~DFGla~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~l~~ 118 (417)
-.|+|||+|...... ......++.||+.|+|||+++.
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 899999999621000 0011224578999999999998
Q ss_pred CCCCCCccchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCC---------CCC-CCCCCCC--CCCc----cccC
Q 014871 119 ATKYGPAVDMWSVGCIFAELLNGKPIL-PGKNEAEQLSKIFELCGS---------PDE-TIWPGVS--KMPA----YNHF 181 (417)
Q Consensus 119 ~~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~~~~i~~~~~~---------~~~-~~~~~~~--~~~~----~~~~ 181 (417)
...-+.++||||.|||+..+++++.|| ...++.+.+..|..+.+. +.. ..|.... .+++ |...
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 888899999999999999999998765 455555555554433321 111 1333211 1111 1111
Q ss_pred C-----CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 182 K-----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 182 ~-----~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
. ..+...-........++..+.|||++||..||.+|+||+|+|+|+||.
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 1 000000111222344667899999999999999999999999999995
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=228.26 Aligned_cols=192 Identities=17% Similarity=0.273 Sum_probs=143.3
Q ss_pred cEeecccCceecC------eEEEEEcCCCC-CHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 014871 4 TFLETTDGNKYRG------STYMVFEYMDH-DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71 (417)
Q Consensus 4 niv~~~~~~~~~~------~~yiV~Ey~~g-~l~~~~~~-----~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp 71 (417)
||+++++.+.... ..++++||+.+ ++..++.. ....+++..+..++.||+.||+|||+++|+||||||
T Consensus 62 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 141 (273)
T cd05074 62 NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA 141 (273)
T ss_pred CcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccch
Confidence 4566665443321 24788999974 55544432 112488999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 014871 72 SNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKN 149 (417)
Q Consensus 72 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~ 149 (417)
+|||++.++.+||+|||+++........ .......+..|++||.+.. ..++.++|||||||++|||++ |+.||.+.+
T Consensus 142 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred hhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999865322111 1122234577999998875 568889999999999999999 889998777
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..+....+....... ....++..+.+|+.+||..+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 221 NSEIYNYLIKGNRLK-----------------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred HHHHHHHHHcCCcCC-----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 666555443210000 00124568999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=215.36 Aligned_cols=165 Identities=19% Similarity=0.221 Sum_probs=127.3
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCCccccccc
Q 014871 27 HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 106 (417)
Q Consensus 27 g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g 106 (417)
|+|.+++.+.+..|++.+++.|+.||+.||+|||+++ ||+|||++.++.+|+ ||+++..... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCC
Confidence 4677777765667999999999999999999999998 999999999999999 9998765432 1257
Q ss_pred ccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCch
Q 014871 107 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSR 185 (417)
Q Consensus 107 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (417)
|..|||||++.+ ..++.++||||||||+|||++|+.||...... ..+..+..........
T Consensus 67 ~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------ 127 (176)
T smart00750 67 DPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR------------------ 127 (176)
T ss_pred cccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc------------------
Confidence 899999999986 57899999999999999999999999765442 2233332211110000
Q ss_pred hhhhhHHHhhhhhhH--HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 186 TMKRRVREVFRHFDR--HALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 186 ~~~~~~~~~~~~~~~--~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.......++. ++++||++||..||++|||+.++++|.|+
T Consensus 128 -----~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 128 -----DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred -----ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 0000112333 68999999999999999999999999987
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=245.82 Aligned_cols=199 Identities=24% Similarity=0.364 Sum_probs=135.1
Q ss_pred cCeEEEEEcCCCC-CHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 014871 15 RGSTYMVFEYMDH-DLTGLADRPG-----------------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70 (417)
Q Consensus 15 ~~~~yiV~Ey~~g-~l~~~~~~~~-----------------------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlk 70 (417)
++..||||||+.+ +|.+++.... ..+++..++.++.||+.+|+|||+++|+|||||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLK 336 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIK 336 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 4678999999985 5555543211 124567889999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCC-------------------CC--Cccchh
Q 014871 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-------------------YG--PAVDMW 129 (417)
Q Consensus 71 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-------------------~~--~~~Diw 129 (417)
|+|||++.++.+||+|||+++...............|+.|+|||++..... ++ .+.|||
T Consensus 337 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dvw 416 (507)
T PLN03224 337 PENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSY 416 (507)
T ss_pred hHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchh
Confidence 999999999999999999997654322212122234789999998863211 11 247999
Q ss_pred hHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHH
Q 014871 130 SVGCIFAELLNGKP-ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEK 208 (417)
Q Consensus 130 SlG~il~elltG~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~ 208 (417)
|+|||||+|+++.. +|..........+... .+...|..... .... ...+...+..++|||++
T Consensus 417 SlGvil~em~~~~l~p~~~~~~f~~~~~~~~----~~~~~~r~~~~------------~~~~-~~~~d~~s~~~~dLi~~ 479 (507)
T PLN03224 417 TAGVLLMQMCVPELRPVANIRLFNTELRQYD----NDLNRWRMYKG------------QKYD-FSLLDRNKEAGWDLACK 479 (507)
T ss_pred hHHHHHHHHHhCCCCCccchhhhhhHHhhcc----chHHHHHhhcc------------cCCC-cccccccChHHHHHHHH
Confidence 99999999999874 6643221111100000 00000110000 0000 11234567899999999
Q ss_pred hcccCC---CCCCCHHHHhcCCCCC
Q 014871 209 MLMLDP---SQRISAKDALDSEYFW 230 (417)
Q Consensus 209 ~L~~dP---~~Rpta~elL~h~~f~ 230 (417)
||..++ .+|+|++|+|+|+||.
T Consensus 480 LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 480 LITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred HhccCCCCcccCCCHHHHhCCCCcC
Confidence 999876 6899999999999995
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=257.44 Aligned_cols=192 Identities=21% Similarity=0.382 Sum_probs=162.0
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
|||+.+.+.-..+..+||+|||+ |||+.++++. ...|++.++..++.||+.|+.||+++++|||||...|+||
T Consensus 756 Niv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL 835 (1025)
T KOG1095|consen 756 NIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL 835 (1025)
T ss_pred ceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee
Confidence 78999988777899999999998 5888888876 5569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCccccc-ccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNR-VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 154 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~ 154 (417)
+....|||+|||+|+.+....-...... .-...|||||.+.. ..++.++|||||||+|||+++ |..||.+.+..+++
T Consensus 836 ~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~ 914 (1025)
T KOG1095|consen 836 DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL 914 (1025)
T ss_pred cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence 9999999999999996543332222222 23567999999986 689999999999999999998 99999999999988
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....+.- .. .....+++.+.+|+..|++.+|++||+..+|++
T Consensus 915 ~~~~~gg-RL----------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 915 LDVLEGG-RL----------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHhCC-cc----------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 7654422 11 112346778889999999999999999999986
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=238.04 Aligned_cols=204 Identities=24% Similarity=0.290 Sum_probs=148.3
Q ss_pred cEeecccCceecC-eEEEEEcCCC-CCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRG-STYMVFEYMD-HDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQ---VLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~-~~yiV~Ey~~-g~l~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~g---ivHrDlkp~NILl~ 77 (417)
|||+++.++...+ +.+||+|||. |+|.+.+..... .|++....+|+.+++.||+|||+.. |||||||++|||||
T Consensus 132 Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 132 NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 8899998888888 5999999998 577777766554 7999999999999999999999864 99999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCccccc-ccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---hHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNR-VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN---EAEQ 153 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~---~~~~ 153 (417)
.+.+.||+|||+|+..... .....+. .+|..|++||.+.. ...+.++|||||||||+||++|+.+..... +...
T Consensus 212 ~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 9999999999999665431 2222233 78999999998864 678999999999999999999997776432 1111
Q ss_pred HHHHHHhcCC--CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 154 LSKIFELCGS--PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 154 ~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.......+.. ..+..-+.... . ..... ..-..+..+..+|+..++++||++.++++
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~----~--------~~~~~----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKE----G--------EYPDE----KEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccC----C--------CCChH----HHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 2111111111 00000000000 0 00000 12234778999999999999999999754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=212.13 Aligned_cols=153 Identities=23% Similarity=0.326 Sum_probs=129.3
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCC
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~~ 80 (417)
+|++|......+.+||.||.|+-+|..+.. +.+..++|..+-+|+..+++||.|||++ .|||||+||+||||+.+|
T Consensus 107 ~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 107 TVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG 186 (282)
T ss_pred EEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC
Confidence 478888888899999999999988777654 4677899999999999999999999987 899999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcC---CCCCCCccchhhHHHHHHHHHhCCCCCC-CCChHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG---ATKYGPAVDMWSVGCIFAELLNGKPILP-GKNEAEQLSK 156 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~elltG~~pf~-~~~~~~~~~~ 156 (417)
.||+||||++-.+.+. ...+...|...|||||.+.. ...|+.++||||||++++||.+++.|++ +.++.+++.+
T Consensus 187 qVKiCDFGIsG~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred cEEEcccccceeehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 9999999998654322 12222456788999998753 2468999999999999999999999986 5678888888
Q ss_pred HHH
Q 014871 157 IFE 159 (417)
Q Consensus 157 i~~ 159 (417)
+++
T Consensus 265 vVe 267 (282)
T KOG0984|consen 265 VVE 267 (282)
T ss_pred Hhc
Confidence 865
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=240.51 Aligned_cols=191 Identities=20% Similarity=0.293 Sum_probs=159.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++|.+...+.-+|||||+|.+ +|.+++.+....++..+...++.+.+.||+|||++++|||||-..|+|++.++.+
T Consensus 222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeE
Confidence 899999999999999999999985 7877887776679999999999999999999999999999999999999999889
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH-h
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE-L 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~-~ 160 (417)
||+|||+++....... ..........|+|||++.. .-|+.++|||||||++||+++ |..||.+....++.++|.. .
T Consensus 302 KISDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~ 379 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG 379 (474)
T ss_pred EeCccccccCCcceee-ccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999976541111 1111134678999999975 589999999999999999998 8899999999999888843 1
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+. ....+.++..++.+|+..||++|+|+.++.+
T Consensus 380 ~r~~~-----------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 380 YRMPI-----------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ccCCC-----------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 11111 1135567889999999999999999998864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=236.57 Aligned_cols=142 Identities=27% Similarity=0.411 Sum_probs=122.0
Q ss_pred cEeecccCceecC------eEEEEEcCCCC-CHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 4 TFLETTDGNKYRG------STYMVFEYMDH-DLTGLADRP--GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 4 niv~~~~~~~~~~------~~yiV~Ey~~g-~l~~~~~~~--~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
|||+.+++.+.+. ...+|||||.+ +|...+.++ ...|++.++..++..|+.||.|||++||+||||||+||
T Consensus 72 NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NI 151 (732)
T KOG4250|consen 72 NIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNI 151 (732)
T ss_pred hhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcE
Confidence 7888888877765 45899999985 677777653 34599999999999999999999999999999999999
Q ss_pred EEc--CCC--CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 014871 75 LID--NEG--NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG 147 (417)
Q Consensus 75 Ll~--~~~--~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 147 (417)
++. .+| ..||+|||.|+.+..+. ...+.+||..|++||++....+|+..+|.|||||++|+++||..||..
T Consensus 152 vl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 152 VLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred EEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 874 333 37999999999877544 778889999999999997557899999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=241.65 Aligned_cols=205 Identities=29% Similarity=0.437 Sum_probs=160.7
Q ss_pred eecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEe
Q 014871 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLA 85 (417)
Q Consensus 6 v~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~ 85 (417)
++..+.......++-+||||..+|..++.+. .+|+..++.++++||+.||+|||+.||.|||||++|+|+...+.+||+
T Consensus 384 ~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 384 IETLDIVQEIDGILQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred hhhHHHHhhcccchhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEe
Confidence 4444444444455555999999776666654 469999999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCC---CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 86 DFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 86 DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
|||.+..+..... ......+|+..|+|||++.+........||||+|+|++.|++|+.||.-....+....
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------ 536 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------ 536 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------
Confidence 9999988766554 3455678899999999998866666789999999999999999988865443322110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+...............++..++...+.+|.+||+.||.+|.|+++|++.+||+..
T Consensus 537 ---------------~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 537 ---------------TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ---------------hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 0111111122334456667788899999999999999999999999999999654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=222.33 Aligned_cols=192 Identities=18% Similarity=0.275 Sum_probs=157.0
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~-l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|+|.+..+.+...-.|||+|||- |+|++++.+.+.. ++.-.+..++.||..|++||..+++|||||-..|+|+.++..
T Consensus 324 NLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi 403 (1157)
T KOG4278|consen 324 NLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI 403 (1157)
T ss_pred cHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce
Confidence 77888999999999999999996 7999988876543 666777888999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
|||+||||++.+..+.-+......-...|.|||.|. ...++.++|||+|||+|||+.| |-.||++-+...++..+.+-
T Consensus 404 VKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg 482 (1157)
T KOG4278|consen 404 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG 482 (1157)
T ss_pred EEeeccchhhhhcCCceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc
Confidence 999999999987644332222222256699999886 4678999999999999999987 88999998877666655331
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
... +-...+++.+.+|++.|++++|++||+..||-+
T Consensus 483 yRM-----------------------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 483 YRM-----------------------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ccc-----------------------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 111 112357789999999999999999999988754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-26 Score=233.10 Aligned_cols=192 Identities=20% Similarity=0.308 Sum_probs=168.6
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++...-+..+-+-||+|||+ |.|..++.+++..|+.-++.-+++-|..|++||-++++|||||-..|||++.+-.+
T Consensus 691 NIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvC 770 (996)
T KOG0196|consen 691 NIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVC 770 (996)
T ss_pred cEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEE
Confidence 88999998888889999999998 67877888888889999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCccccccc--ccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+++.+.++.....++.-| ...|.|||.+.- .+++.++||||+|||+||.++ |..|+-..++.++++.|.+
T Consensus 771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~ 849 (996)
T KOG0196|consen 771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ 849 (996)
T ss_pred EeccccceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence 999999999876665555454444 678999999974 789999999999999999885 9999999999999999987
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
-...|... +++..+-+|+..|+++|-.+||+..+|+.
T Consensus 850 gyRLPpPm-----------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 850 GYRLPPPM-----------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ccCCCCCC-----------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 66555432 25568889999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=225.20 Aligned_cols=191 Identities=21% Similarity=0.321 Sum_probs=156.1
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+||+++.+.+. .-+|||||++. |.|..++..+...|+...+..|+.||+.||+|||++++|||||-..|||+.....|
T Consensus 452 hIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 452 HIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCV 530 (974)
T ss_pred chhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCccee
Confidence 57777877764 47899999998 56767777776779999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+++-+.+..--..+......-|||||.+. ...++.++|||.|||.+||++. |..||.+-...+++-.|.+-.
T Consensus 531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe 609 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE 609 (974)
T ss_pred eecccchhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC
Confidence 99999999987654433333333366799999875 4689999999999999999986 999999988877766654322
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..| ....+++.+-.|+.+|+..||.+||+..+|..
T Consensus 610 RlP-----------------------------~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 610 RLP-----------------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCC-----------------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 211 12346778889999999999999999988763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=221.66 Aligned_cols=199 Identities=20% Similarity=0.257 Sum_probs=157.6
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~-l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++......++.+||||||++ |+|-.++.+.... +.-+....|+.||..|++||.+.++|||||.+.|+|++.+.+
T Consensus 596 NIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~ 675 (807)
T KOG1094|consen 596 NIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT 675 (807)
T ss_pred CeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc
Confidence 89999999999999999999998 6787777765332 344556679999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCccc-ccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHH--hCCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLT-NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL--NGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell--tG~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++.+-....-... ..+....|||+|.++. .+++.++|+|+||+++||++ |...||....+.++....-
T Consensus 676 iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 676 IKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred EEecCcccccccccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 999999999866433332222 2344788999999885 68999999999999999986 5778998887777666554
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
++........ +.....-++..+.+||.+|+..|-++|||.++|..
T Consensus 755 ~~~~~~~~~~----------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 755 EFFRDQGRQV----------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hhcCCCCcce----------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 4433322111 11122346778899999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=223.13 Aligned_cols=191 Identities=19% Similarity=0.301 Sum_probs=156.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
++|++|..-.. ..+-||||++. |+|++-+.+ ....|-...+..|+.||+.|+.||..+++|||||-..||||.....
T Consensus 172 hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt 250 (1039)
T KOG0199|consen 172 HLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT 250 (1039)
T ss_pred ceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce
Confidence 46777765554 67789999998 678876665 3445899999999999999999999999999999999999999889
Q ss_pred EEEeeccCcccccCCCCCcc--cccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
|||+||||.+.+........ ..+.....|+|||.|.. ..++.++|||++||+||||++ |..||.+.+...++.+|-
T Consensus 251 VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 251 VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID 329 (1039)
T ss_pred eeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence 99999999998765443221 12334678999999875 789999999999999999998 889999999999888873
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+- ......+.+++++.++++.|+..+|.+|||..+|.+
T Consensus 330 ~~-----------------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 330 AG-----------------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cc-----------------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 21 111123457889999999999999999999988853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=223.58 Aligned_cols=203 Identities=22% Similarity=0.298 Sum_probs=160.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||||.++..+-.+..+||.||||+++-++.+..-...|++.+|..+++..+.+|+|||+.|-+|||||-.|||+++.|.+
T Consensus 72 ~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDv 151 (829)
T KOG0576|consen 72 PNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDV 151 (829)
T ss_pred cChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCce
Confidence 78999999999999999999999988778887777789999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhc--CCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||.+-.+... .......+||+.|||||+-. ....|...+|||++|+...||---++|.........+..+..-
T Consensus 152 klaDfgvsaqitat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS 230 (829)
T KOG0576|consen 152 KLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS 230 (829)
T ss_pred eecccCchhhhhhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc
Confidence 99999998766532 23445678999999999853 2346899999999999999998766664433332222222111
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
...+. .. .. ....++.+-+|++.+|.++|++|||++.+|.|+|...
T Consensus 231 ~~qpp--~l----------------kD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 231 GFQPP--TL----------------KD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred CCCCC--cc----------------cC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11110 00 00 1124566789999999999999999999999999844
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=227.16 Aligned_cols=192 Identities=23% Similarity=0.392 Sum_probs=153.0
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
|||.+..+...++.+++|+|||. |+|+.++.+.. ..|+..++..+..||+.|++||+++.+|||
T Consensus 363 niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 363 NIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred chhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 67777777777899999999998 68888877654 238999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCCCcccccc--cccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRV--ITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
||-..||||..+..+||+|||+|+.......-...... ....|||||.+.. ..|+.++||||+||+||||++ |..|
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCC
Confidence 99999999999999999999999865433322212122 2455999999986 789999999999999999998 8899
Q ss_pred CCCCC-hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHH
Q 014871 145 LPGKN-EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223 (417)
Q Consensus 145 f~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el 223 (417)
+++-. ..+++..+.+.. ..+.+..++.++-+|++.|++.+|++||+..++
T Consensus 522 Yp~~~~~~~l~~~l~~G~-----------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 522 YPGIPPTEELLEFLKEGN-----------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred CCCCCcHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 98854 444444332211 011223467788999999999999999999998
Q ss_pred hc
Q 014871 224 LD 225 (417)
Q Consensus 224 L~ 225 (417)
.+
T Consensus 573 ~~ 574 (609)
T KOG0200|consen 573 VE 574 (609)
T ss_pred HH
Confidence 74
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=242.56 Aligned_cols=197 Identities=18% Similarity=0.283 Sum_probs=139.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH---~~givHrDlkp~NILl~~~ 79 (417)
|||++++++...+..||||||+++ +|.+++. .+++.++..++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 744 nIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~ 819 (968)
T PLN00113 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819 (968)
T ss_pred CcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC
Confidence 789999999999999999999985 5655553 3899999999999999999999 6699999999999999998
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA-EQLSKIF 158 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~-~~~~~i~ 158 (417)
...++. |+.+..... .....+|..|+|||++.. ..++.++||||||||+|||++|+.||...... ..+....
T Consensus 820 ~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~ 892 (968)
T PLN00113 820 DEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892 (968)
T ss_pred CceEEE-ecccccccc-----CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHH
Confidence 887775 665543221 122356899999999875 67899999999999999999999998532110 1111111
Q ss_pred Hhc-CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELC-GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
... .......|-. +. .... .........++.+|+.+||..||++|||+.|+++
T Consensus 893 ~~~~~~~~~~~~~~----~~---------~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 893 RYCYSDCHLDMWID----PS---------IRGD-VSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred HHhcCccchhheeC----cc---------ccCC-CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 100 0000000000 00 0000 0001112346789999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=202.22 Aligned_cols=198 Identities=25% Similarity=0.330 Sum_probs=142.6
Q ss_pred cEeecc-cCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--
Q 014871 4 TFLETT-DGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-- 79 (417)
Q Consensus 4 niv~~~-~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-- 79 (417)
+||..| -.|+..+.+++++||+. ++|..-+...+ +-|.-.++++.|++.||.|||++++||||||.+||||-+.
T Consensus 82 hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df 159 (378)
T KOG1345|consen 82 HIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF 159 (378)
T ss_pred hhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc
Confidence 344444 45778888899999998 67777766543 7899999999999999999999999999999999998533
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
.+|||||||+.+..... +....-+..|.+||++... -...+..|||.||||+|.+|+|++||......+.-.
T Consensus 160 ~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y 235 (378)
T KOG1345|consen 160 YRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY 235 (378)
T ss_pred cEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH
Confidence 36999999998764321 1112226779999987531 235778999999999999999999997433222111
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCC---CCHHHHhcCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR---ISAKDALDSEYF 229 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R---pta~elL~h~~f 229 (417)
.-+. .+.......+...++.|++.+..++++-|..++++| .++++.....|.
T Consensus 236 ~~~~----------------------~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 236 WEWE----------------------QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHH----------------------HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 1100 001111223455667799999999999999999999 445544444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=185.86 Aligned_cols=162 Identities=36% Similarity=0.574 Sum_probs=137.1
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-EGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~-~~~ 81 (417)
+|+++++.+......++||||+. .+|..++......+++..+..++.+|+.+|++||+++++|+||++.||+++. ++.
T Consensus 52 ~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~ 131 (215)
T cd00180 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK 131 (215)
T ss_pred CeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc
Confidence 57788888888889999999999 5777776654346899999999999999999999999999999999999999 889
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
++|+||+.+........ ..........|++||.+......+.+.|+|+||+++++|
T Consensus 132 ~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------- 187 (215)
T cd00180 132 VKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187 (215)
T ss_pred EEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------
Confidence 99999999976543321 123345678899999887533678899999999999999
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 227 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~ 227 (417)
..+.++|.+||..||++|+++.+++++.
T Consensus 188 --------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1577999999999999999999999863
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=208.99 Aligned_cols=208 Identities=21% Similarity=0.268 Sum_probs=140.9
Q ss_pred cEeecccCceecC----eEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCC
Q 014871 4 TFLETTDGNKYRG----STYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---------QVLHRDI 69 (417)
Q Consensus 4 niv~~~~~~~~~~----~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~---------givHrDl 69 (417)
|||+++...+... .++||+||-. |+|-++++.. .++..+..+++..|+.||+|||+. .|+||||
T Consensus 265 nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDl 342 (534)
T KOG3653|consen 265 NILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDL 342 (534)
T ss_pred hHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccc
Confidence 5667775555544 7999999998 5777777654 489999999999999999999953 5999999
Q ss_pred CCCcEEEcCCCCEEEeeccCcccccCC-CCCcccccccccCCCCchhhcCCCCCC-----CccchhhHHHHHHHHHhCCC
Q 014871 70 KGSNLLIDNEGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLGATKYG-----PAVDMWSVGCIFAELLNGKP 143 (417)
Q Consensus 70 kp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~-----~~~DiwSlG~il~elltG~~ 143 (417)
|..||||.+|.++.|+|||||..+... ........+||..|||||+|.+..++. ...||||+|.|||||++...
T Consensus 343 kSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 343 KSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred cccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999887532 223334479999999999998765555 36899999999999998754
Q ss_pred CCC-CCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh--hhhHHHHHHHHHhcccCCCCCCCH
Q 014871 144 ILP-GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISA 220 (417)
Q Consensus 144 pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~Li~~~L~~dP~~Rpta 220 (417)
.+. +....-++..- +.++..+ ....+ .......+.+..++..|. ..-..+++.|+.|+..|++.|+|+
T Consensus 423 ~~~~~~vp~Yqlpfe-~evG~hP-----t~e~m---q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 423 DADPGPVPEYQLPFE-AEVGNHP-----TLEEM---QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred cccCCCCCcccCchh-HHhcCCC-----CHHHH---HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 432 11111110000 0000000 00000 000001111111222221 134578999999999999999998
Q ss_pred HH
Q 014871 221 KD 222 (417)
Q Consensus 221 ~e 222 (417)
.=
T Consensus 494 ~C 495 (534)
T KOG3653|consen 494 GC 495 (534)
T ss_pred HH
Confidence 53
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-24 Score=212.19 Aligned_cols=139 Identities=27% Similarity=0.404 Sum_probs=124.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC--CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g--~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++++.|+.++++||+||--.. +|.++++.+ .+++|.+++.|++||..|+++||+.||||||||-+||+++.+|.
T Consensus 630 NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 630 NILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred chhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe
Confidence 899999999999999999999863 676666654 47999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP 146 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~ 146 (417)
+||+|||.|.-.. .......+||..|.|||++.+..+.+...|||+||++||.+++...||.
T Consensus 709 ~klidfgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 709 VKLIDFGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEeeccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999986543 3345567899999999999998888999999999999999999887774
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=197.44 Aligned_cols=195 Identities=22% Similarity=0.326 Sum_probs=136.9
Q ss_pred cEeecccC-ceecC---eEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCC
Q 014871 4 TFLETTDG-NKYRG---STYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDIK 70 (417)
Q Consensus 4 niv~~~~~-~~~~~---~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--------givHrDlk 70 (417)
||+.++.. .+.++ .+|||+||-+ |+|.+++.+. .++.....+++..++.||+|||.. .|.|||||
T Consensus 266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 56666632 23333 4799999998 6788877763 599999999999999999999943 49999999
Q ss_pred CCcEEEcCCCCEEEeeccCcccccCCCC---CcccccccccCCCCchhhcCCCCCC-----CccchhhHHHHHHHHHhC-
Q 014871 71 GSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYG-----PAVDMWSVGCIFAELLNG- 141 (417)
Q Consensus 71 p~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~-----~~~DiwSlG~il~elltG- 141 (417)
..|||+.+++.+.|+|||||.......+ .....++||..|||||+|....+.. ..+||||||.|+||+...
T Consensus 344 SKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 344 SKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred cccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999999987654432 3345689999999999986533221 258999999999999853
Q ss_pred ---------CCCCCCC----ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh--hhhHHHHHHH
Q 014871 142 ---------KPILPGK----NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR--HFDRHALELL 206 (417)
Q Consensus 142 ---------~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~Li 206 (417)
+.||.+. ...+.+++++ ..++....+...|. ..-..+..|+
T Consensus 424 ~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV------------------------Cv~~~RP~ipnrW~s~~~l~~m~klM 479 (513)
T KOG2052|consen 424 ESGGIVEEYQLPYYDVVPSDPSFEEMRKVV------------------------CVQKLRPNIPNRWKSDPALRVMAKLM 479 (513)
T ss_pred hcCCEehhhcCCcccCCCCCCCHHHHhcce------------------------eecccCCCCCcccccCHHHHHHHHHH
Confidence 2344321 1122222221 11111111111121 1224567899
Q ss_pred HHhcccCCCCCCCHHHHh
Q 014871 207 EKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 207 ~~~L~~dP~~Rpta~elL 224 (417)
+.|+..||.-|.||-.|.
T Consensus 480 keCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 480 KECWYANPAARLTALRIK 497 (513)
T ss_pred HHhhcCCchhhhHHHHHH
Confidence 999999999999997654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=180.54 Aligned_cols=154 Identities=34% Similarity=0.531 Sum_probs=125.7
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|++++++.+......|+|+||+.+ +|.+.+......+++..+..++.+++.+|.+||+++++|+||++.||+++.++.+
T Consensus 58 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~ 137 (225)
T smart00221 58 NIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLV 137 (225)
T ss_pred ChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 577778888888899999999997 7777666543228999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CChH-HHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEA-EQLSKI 157 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~-~~~~-~~~~~i 157 (417)
+|+|||++...............++..|++||.+.....++.++|||+||+++++|++|+.||.. .+.. .+.+.+
T Consensus 138 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 138 KLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred EEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 99999999876543211233456688899999884335677899999999999999999999977 3443 444544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-22 Score=201.33 Aligned_cols=188 Identities=23% Similarity=0.355 Sum_probs=158.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
..+|+...+|+.++.+|++++|..++.+.........+.+..++.+...++.+++++|+.+|+|||+|++||+++.+|.+
T Consensus 57 ~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi 136 (612)
T KOG0603|consen 57 PFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHI 136 (612)
T ss_pred CceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCcc
Confidence 35789999999999999999999986666666666678999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
|+.|||+++..-.... .|||..|||||++. ....++|.||||+++|||++|..||.. ++...|....
T Consensus 137 ~~tdfglske~v~~~~-----~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~- 203 (612)
T KOG0603|consen 137 KLTDFGLSKEAVKEKI-----ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE- 203 (612)
T ss_pred ccCCchhhhHhHhhhh-----cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-
Confidence 9999999987643222 28899999999886 357789999999999999999999987 5555554311
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~~ 232 (417)
..+...++..+.+++..++..+|.+|.- +.++++|+||+..
T Consensus 204 -----------------------------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 204 -----------------------------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred -----------------------------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 1223457788999999999999999974 4799999999653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-20 Score=176.53 Aligned_cols=206 Identities=30% Similarity=0.448 Sum_probs=156.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGL---RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~---~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
+++++.+.+...+..++++||+.+..+..+..... .+.+..+..++.||+.+|+|+|+.+++||||||+|||++..+
T Consensus 59 ~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~ 138 (384)
T COG0515 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG 138 (384)
T ss_pred ceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC
Confidence 47888888877778899999999654444443332 699999999999999999999999999999999999999988
Q ss_pred -CEEEeeccCcccccCCCCC-----cccccccccCCCCchhhcCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCh--
Q 014871 81 -NLKLADFGLARSFSYDHNN-----TLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-- 150 (417)
Q Consensus 81 -~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~-- 150 (417)
.++|+|||+++.+...... .....++|..|++||++... ..+....|+||+|+++++++++..||.....
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~ 218 (384)
T COG0515 139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218 (384)
T ss_pred CeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 6999999999755433221 34567889999999999863 4788899999999999999999999887764
Q ss_pred --HHHHHHHHHhcCCC-CCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014871 151 --AEQLSKIFELCGSP-DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 227 (417)
Q Consensus 151 --~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~ 227 (417)
......+.. .... ...... .... ......+.+++.+++..+|..|.+..+...+.
T Consensus 219 ~~~~~~~~~~~-~~~~~~~~~~~------------------~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~ 276 (384)
T COG0515 219 ATSQTLKIILE-LPTPSLASPLS------------------PSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276 (384)
T ss_pred cHHHHHHHHHh-cCCcccccccC------------------cccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhch
Confidence 333333322 2211 000000 0000 22345788999999999999999999998886
Q ss_pred CCCC
Q 014871 228 YFWT 231 (417)
Q Consensus 228 ~f~~ 231 (417)
|...
T Consensus 277 ~~~~ 280 (384)
T COG0515 277 LLAH 280 (384)
T ss_pred HhhC
Confidence 6543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=199.88 Aligned_cols=190 Identities=19% Similarity=0.260 Sum_probs=149.5
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|+|+++...... .+-||++|+. |.|++++......+-......|+.||++|+.|||+++++||||-..|||+..-..+
T Consensus 759 nl~RLLgvc~~s-~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hv 837 (1177)
T KOG1025|consen 759 NLLRLLGVCMLS-TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHV 837 (1177)
T ss_pred hHHHHhhhcccc-hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeE
Confidence 344555444433 2678999998 68999888777779999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccc-cccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTN-RVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~-~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
||.|||+|+............ ......|||=|.+.. ..|+.++|||||||++|||+| |..|+.+....++-+.+..
T Consensus 838 kitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~- 915 (1177)
T KOG1025|consen 838 KITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK- 915 (1177)
T ss_pred EEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-
Confidence 999999998776444332221 122566888898875 789999999999999999998 9999998887776555432
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
.+.. .-....+-++--++.+||..|+..||+++++.
T Consensus 916 ---geRL-------------------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 916 ---GERL-------------------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred ---cccC-------------------------CCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 1111 11233566788999999999999999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=172.31 Aligned_cols=181 Identities=21% Similarity=0.266 Sum_probs=140.9
Q ss_pred cCeEEEEEcCCC-CCHHHHHh-----cCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEee
Q 014871 15 RGSTYMVFEYMD-HDLTGLAD-----RPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLAD 86 (417)
Q Consensus 15 ~~~~yiV~Ey~~-g~l~~~~~-----~~~--~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~D 86 (417)
....++++.+++ ++|-.++. +.. ..++.-++..++.||..|++|||.++|||.||-..|.+||+.-.|||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 346678899998 56666555 211 2377778889999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCccc-ccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 014871 87 FGLARSFSYDHNNTLT-NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSP 164 (417)
Q Consensus 87 FGla~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~ 164 (417)
=.+++..-...-.-+. +.--...||++|.+.+ ..|+.++|+|||||+||||+| |+.|+..-+..++..-+.+-....
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla 518 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA 518 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence 9888765322111111 1122667999999986 689999999999999999998 999998888888877665421111
Q ss_pred CCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 165 DETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+-.+++++..++.-|+..+|++||+.+++..
T Consensus 519 -----------------------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 519 -----------------------------QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -----------------------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 01236778999999999999999999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.2e-19 Score=172.18 Aligned_cols=151 Identities=27% Similarity=0.313 Sum_probs=121.9
Q ss_pred EeecccCc-eecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---
Q 014871 5 FLETTDGN-KYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--- 79 (417)
Q Consensus 5 iv~~~~~~-~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~--- 79 (417)
|.++++.. ...+.-||||++++.+|.++..... .+|+...+.+++.|++.+|++||+.|++||||||+|+++...
T Consensus 82 ~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~ 161 (322)
T KOG1164|consen 82 FPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRS 161 (322)
T ss_pred CCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCc
Confidence 44555666 4667889999999999999886544 789999999999999999999999999999999999999764
Q ss_pred --CCEEEeeccCcc--cccCCCCC----c---ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 014871 80 --GNLKLADFGLAR--SFSYDHNN----T---LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK 148 (417)
Q Consensus 80 --~~vkL~DFGla~--~~~~~~~~----~---~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 148 (417)
..+.|+|||+|+ .+...... . .....||..|+++.+..+ ...+.+.|+||+..++.||+.|..||.+.
T Consensus 162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 359999999998 33222211 1 123458999999999887 57899999999999999999999998766
Q ss_pred ChHHHHHH
Q 014871 149 NEAEQLSK 156 (417)
Q Consensus 149 ~~~~~~~~ 156 (417)
.......+
T Consensus 241 ~~~~~~~~ 248 (322)
T KOG1164|consen 241 EMTDLKSK 248 (322)
T ss_pred cccchHHH
Confidence 64433333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=167.69 Aligned_cols=180 Identities=19% Similarity=0.253 Sum_probs=131.0
Q ss_pred ceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCC--CEEEeec
Q 014871 12 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEG--NLKLADF 87 (417)
Q Consensus 12 ~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~--~~~--~vkL~DF 87 (417)
.-....+|+||.....+|.+++..+. .+....+-++.|+|+|+.|||++||.|||+|.+||||. +|+ .+.|+||
T Consensus 312 ~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred cCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 34456899999999999999887654 67888889999999999999999999999999999984 333 3899999
Q ss_pred cCcccccCC--C---CCcccccccccCCCCchhhcCCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 88 GLARSFSYD--H---NNTLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 88 Gla~~~~~~--~---~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
|.+-..... . ........|.-..||||+..... -.-.++|.|++|.+.||++....||.+..+..+-..-
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 977432210 0 11122334566789999875311 0124789999999999999999999875543322211
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHH
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 221 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~ 221 (417)
++ ...+..+...++..+++|+..+|+.||++|+++.
T Consensus 470 Yq----------------------------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 470 YQ----------------------------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hh----------------------------hhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 11 1112223345778899999999999999999853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-19 Score=188.88 Aligned_cols=153 Identities=29% Similarity=0.482 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCCc--------------ccccccccCCCCchhh
Q 014871 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--------------LTNRVITLWYRPPELL 116 (417)
Q Consensus 51 Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~--------------~~~~~gt~~y~aPE~l 116 (417)
+++.+++|||..||+|||+|++|+||..-|.+||.|||+.+......... -.-.++|+.|+||||+
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 34789999999999999999999999999999999999987653221111 1123789999999999
Q ss_pred cCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh
Q 014871 117 LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196 (417)
Q Consensus 117 ~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (417)
+. ..|+..+|+|++|+|+||.+-|..||.+++..+++..++..... |+.-. .
T Consensus 231 lr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~-----wpE~d----------------------e 282 (1205)
T KOG0606|consen 231 LR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----WPEED----------------------E 282 (1205)
T ss_pred hh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc-----ccccC----------------------c
Confidence 86 57999999999999999999999999999999999887663322 22211 1
Q ss_pred hhhHHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCC
Q 014871 197 HFDRHALELLEKMLMLDPSQRI---SAKDALDSEYFWT 231 (417)
Q Consensus 197 ~~~~~~~~Li~~~L~~dP~~Rp---ta~elL~h~~f~~ 231 (417)
.+..++++||+++|..+|..|. .+-++.+|.||..
T Consensus 283 a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 283 ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 2567899999999999999995 5778899999954
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=180.03 Aligned_cols=180 Identities=27% Similarity=0.436 Sum_probs=131.7
Q ss_pred cCeEEEEEcCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 15 RGSTYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 15 ~~~~yiV~Ey~~g~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
+.++||.|++|..+.+...++ ....-+...++.+++||..+++| ++.+|||+||.||++..+..+||.|||+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 457899999999765555543 23347788999999999999999 999999999999999999899999999998
Q ss_pred cccCCC-----CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 014871 92 SFSYDH-----NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE 166 (417)
Q Consensus 92 ~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 166 (417)
...... ....+..++|.+||+||.+.+ ..|+.++||||||+||+||+.- |. ...+......+ ..+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~---f~--T~~er~~t~~d----~r~ 474 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQ---FS--TQFERIATLTD----IRD 474 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHH---hc--cHHHHHHhhhh----hhc
Confidence 766544 334566789999999999987 6899999999999999999972 11 11111111111 011
Q ss_pred CCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 167 TIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
..|+ ..+..-.+.-.+||..||.+.|.+||++.+.-.|.|.
T Consensus 475 g~ip----------------------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 475 GIIP----------------------PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCCC----------------------hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111 0000112344589999999999999987776666553
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-19 Score=188.12 Aligned_cols=184 Identities=29% Similarity=0.399 Sum_probs=131.5
Q ss_pred ceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 12 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 12 ~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.+.++-.|||-+|+..+|.+-+..+ .-|.+-|.+-|+.|||.||.-||..||+|+|||.|||||..=+-+.|+||..-+
T Consensus 90 ~~t~kAAylvRqyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 90 LVTDKAAYLVRQYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHhhHHHHHHHHHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC
Confidence 3445567899999999888766543 348889999999999999999999999999999999999999899999996543
Q ss_pred ccc--CCCCCccccc----ccccCCCCchhhcCCC----------CCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 014871 92 SFS--YDHNNTLTNR----VITLWYRPPELLLGAT----------KYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQL 154 (417)
Q Consensus 92 ~~~--~~~~~~~~~~----~gt~~y~aPE~l~~~~----------~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~ 154 (417)
..- .+.....+-. ..-..|+|||.+.... ..+++-||||+|||++||++ |+++|. +
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------L 241 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------L 241 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------H
Confidence 321 1111111111 1234699999986411 25778999999999999998 799984 1
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh-hhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.++++. +... ......+.+ .-+..++.||..|++.||++|.+|+|.|+.
T Consensus 242 SQL~aY------------------r~~~-----~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 242 SQLLAY------------------RSGN-----ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhH------------------hccC-----ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 222110 0000 001111111 124578999999999999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-19 Score=167.94 Aligned_cols=163 Identities=20% Similarity=0.278 Sum_probs=105.6
Q ss_pred eEEEEEcCCCCCHHHHHhc----CCCCCCH--HHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCc
Q 014871 17 STYMVFEYMDHDLTGLADR----PGLRFTV--PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 90 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~----~~~~l~~--~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla 90 (417)
+.+++|+-+.++|..++.- ....... .....+..|++..+++||..||+|+|||++|+|++.+|.++|.||+.+
T Consensus 113 n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 113 NRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp SEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 4578999999888776531 1111122 222345589999999999999999999999999999999999999877
Q ss_pred ccccCCCCCcccccccccCCCCchhhcCC-------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 91 RSFSYDHNNTLTNRVITLWYRPPELLLGA-------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 91 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
..... .......+..|.+||+.... ..++.+.|.|+||+++|.|+|++.||...........
T Consensus 193 ~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------- 261 (288)
T PF14531_consen 193 VRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------- 261 (288)
T ss_dssp EETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------
T ss_pred eecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------
Confidence 65432 11113446789999976431 3478899999999999999999999975443111000
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R 217 (417)
.+.... .+++.+++||+.+|..||.+|
T Consensus 262 --------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 --------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred --------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 111111 477899999999999999987
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=157.13 Aligned_cols=144 Identities=26% Similarity=0.391 Sum_probs=119.1
Q ss_pred eecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-----CCEEEeec
Q 014871 13 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-----GNLKLADF 87 (417)
Q Consensus 13 ~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-----~~vkL~DF 87 (417)
..-.+-.||||+++.+|.++++-.+.+|+.+.+..+++||+.-++++|++.+|+|||||+|+||..- ..|.|+||
T Consensus 94 qeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 94 QEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred cccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 3344557999999999999999889999999999999999999999999999999999999999643 35999999
Q ss_pred cCcccccCCCCC------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHH
Q 014871 88 GLARSFSYDHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSKI 157 (417)
Q Consensus 88 Gla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~---~~~~~~i 157 (417)
|+|+...+.... ......||..||+=-..++ ..-+...|+-|||.|+++.|.|..||.+... .+.+.+|
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 999987543221 2234568999999888887 4568889999999999999999999987543 4444444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=150.95 Aligned_cols=149 Identities=26% Similarity=0.324 Sum_probs=121.0
Q ss_pred cccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCCEEE
Q 014871 8 TTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EGNLKL 84 (417)
Q Consensus 8 ~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~---~~~vkL 84 (417)
+...++.+.+-.||||+++.+|.+++.-...+|+.+.+..++.|++.-|+|+|.+++|||||||+|+|+.- ...+.|
T Consensus 76 i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 76 IRHYGTEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred hhhhccccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEE
Confidence 34455666677999999999998888777778999999999999999999999999999999999999853 345999
Q ss_pred eeccCcccccCCCC------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 85 ADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 85 ~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+|||+|+.+.+... ....+..||..|.+=-...+ ..-+...|+-|+|.+|.++..|..||.+.......++.
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 99999987754322 12334578999998777765 44578899999999999999999999987665554444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-18 Score=181.50 Aligned_cols=203 Identities=29% Similarity=0.445 Sum_probs=163.7
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHh-cCCC-CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLAD-RPGL-RFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~-~~~~-~l~~~~i~~i~~Qil~gL~~LH-~~givHrDlkp~NILl~~~~ 80 (417)
|++++++........++++||.+++.+...+ ..+. .++...+..++.|+..+|.|+| ..++.||||||+|.+++..+
T Consensus 82 n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 82 NTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESG 161 (601)
T ss_pred cccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCC
Confidence 7899999999999999999999875544444 5554 6888999999999999999999 99999999999999999999
Q ss_pred -CEEEeeccCcccccC--CCCCccccccc-ccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 81 -NLKLADFGLARSFSY--DHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 81 -~vkL~DFGla~~~~~--~~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
.+|++|||+|..+.. .........++ +..|+|||.+.+........|+||+|+++..+++|..|+......+..
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-- 239 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-- 239 (601)
T ss_pred CcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--
Confidence 999999999998876 33445556788 999999999987567788999999999999999998887544432211
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
|..+.... .......+..++..+.+++.++|..+++.|.+.+++..++|+..
T Consensus 240 ---------------------~~~~~~~~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 ---------------------YSSWKSNK--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ---------------------ceeecccc--cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00000000 11122345567888999999999999999999999999999966
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.6e-16 Score=155.60 Aligned_cols=199 Identities=21% Similarity=0.297 Sum_probs=145.0
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV-LHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~gi-vHrDlkp~NILl~~~~~ 81 (417)
|+.+++...-.....++|.+||. |+|.+.+......++..-...++++|+.||+|||.--| .|+.|+..|.++|..-.
T Consensus 8 n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~ 87 (484)
T KOG1023|consen 8 NLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWV 87 (484)
T ss_pred hhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEE
Confidence 55677777777789999999998 67888887777788888999999999999999998765 89999999999999999
Q ss_pred EEEeeccCcccccCC-CCCcccccccccCCCCchhhcCCCC------CCCccchhhHHHHHHHHHhCCCCCCCCChH---
Q 014871 82 LKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLGATK------YGPAVDMWSVGCIFAELLNGKPILPGKNEA--- 151 (417)
Q Consensus 82 vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DiwSlG~il~elltG~~pf~~~~~~--- 151 (417)
+||+|||+....... .........-...|.|||.+..... .+.+.||||||++++|+++...||......
T Consensus 88 lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~ 167 (484)
T KOG1023|consen 88 LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP 167 (484)
T ss_pred EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh
Confidence 999999998654310 0011111112566899999876311 466799999999999999999999864332
Q ss_pred -HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 152 -EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 152 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+++..+.+ . ......+. +... ..+.+++..+++.|+..+|++||+++++-.
T Consensus 168 ~eii~~~~~-~--~~~~~rP~-------------------i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 168 DEIILRVKK-G--GSNPFRPS-------------------IELL-NELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHHHHHHHh-c--CCCCcCcc-------------------hhhh-hhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 33333332 0 00001110 0000 134558999999999999999999988754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.5e-16 Score=154.00 Aligned_cols=95 Identities=21% Similarity=0.245 Sum_probs=74.1
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEcCCCCEEEeeccCccccc
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI-KGSNLLIDNEGNLKLADFGLARSFS 94 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDl-kp~NILl~~~~~vkL~DFGla~~~~ 94 (417)
+..|||||||.+..+..+.. .. ...++.||+.+|+|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 46899999999765543321 11 2568899999999999999999999 9999999999999999999998765
Q ss_pred CCCCC-------cccccccccCCCCchhhc
Q 014871 95 YDHNN-------TLTNRVITLWYRPPELLL 117 (417)
Q Consensus 95 ~~~~~-------~~~~~~gt~~y~aPE~l~ 117 (417)
..... .+.+..++..|+|||.+.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 43211 123456688899999875
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.5e-16 Score=140.42 Aligned_cols=128 Identities=16% Similarity=0.088 Sum_probs=91.4
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEcCCCCEEEeeccCccccc
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI-KGSNLLIDNEGNLKLADFGLARSFS 94 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDl-kp~NILl~~~~~vkL~DFGla~~~~ 94 (417)
+..|++|||+.|..+.... ... ...++.||+.+|++||++||+|||| ||+|||++.++.++|+|||+|....
T Consensus 71 ~~~~lvmeyI~G~~L~~~~------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRP------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCEEEEEeeecCccHHhhh------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 3569999999986554322 111 2457899999999999999999999 7999999999999999999998654
Q ss_pred CCCCC----c---c-----cccccccCCCCchhhcCCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCh
Q 014871 95 YDHNN----T---L-----TNRVITLWYRPPELLLGATKYG-PAVDMWSVGCIFAELLNGKPILPGKNE 150 (417)
Q Consensus 95 ~~~~~----~---~-----~~~~gt~~y~aPE~l~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~ 150 (417)
..... . + .-...++.|++|+...-....+ ...+.++.|+-+|.++|++.++-++++
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 32210 0 0 0112367788887543222223 455777899999999999877765543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.2e-15 Score=136.66 Aligned_cols=75 Identities=16% Similarity=0.238 Sum_probs=63.0
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEcCCCCEEEeeccCcccc
Q 014871 18 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93 (417)
Q Consensus 18 ~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~L-H~~givHrDlkp~NILl~~~~~vkL~DFGla~~~ 93 (417)
.||||||++++.+.........+++.++..++.||+.+|++| |+.||+||||||+|||+++ +.++|+|||+|...
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GKLYIIDVSQSVEH 167 (190)
T ss_pred CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-CcEEEEEccccccC
Confidence 389999999754432222234699999999999999999999 7999999999999999984 68999999999653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.5e-15 Score=157.73 Aligned_cols=140 Identities=19% Similarity=0.265 Sum_probs=120.1
Q ss_pred CcccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-
Q 014871 1 MTCTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN- 78 (417)
Q Consensus 1 ~~cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~- 78 (417)
|+|-|+++..++.+.+..+||+||.+ |+|++++. ..+.+++..+..++.|||.-|+.||..+|||+||||+|+||..
T Consensus 752 ~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 752 MLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRRE 830 (974)
T ss_pred hhcchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecc
Confidence 56888999999999999999999999 67777776 5567999999999999999999999999999999999999853
Q ss_pred ------CCCEEEeeccCcccccCC-CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCC
Q 014871 79 ------EGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 142 (417)
Q Consensus 79 ------~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~ 142 (417)
.--++|+|||-+..+.-- ........+.|-.+-..|...+ ..++..+|.|.|+.+++-||.|+
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 223999999998765432 2235566677899999998887 78999999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.4e-15 Score=139.15 Aligned_cols=104 Identities=14% Similarity=0.240 Sum_probs=76.2
Q ss_pred ecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccc
Q 014871 14 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93 (417)
Q Consensus 14 ~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~ 93 (417)
..+..||||||++|..+..+. .+++ ..+.+|+.+|..||++||+||||||+|||++.++ ++|+|||..+..
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCT 184 (232)
T ss_pred ccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccc
Confidence 456789999999984333332 2333 3466999999999999999999999999999988 999999987654
Q ss_pred cCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh
Q 014871 94 SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140 (417)
Q Consensus 94 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt 140 (417)
....... ..++. ..|+.++|+|+||++|..+..
T Consensus 185 ~e~~a~d-------------~~vle-r~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 185 AQRKAKD-------------RIDLE-RHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred cchhhHH-------------HHHHH-hHhcccccccceeEeehHHHH
Confidence 2111000 02332 456789999999999876643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-14 Score=131.74 Aligned_cols=75 Identities=15% Similarity=0.255 Sum_probs=63.6
Q ss_pred EEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCCEEEeeccCccccc
Q 014871 18 TYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 94 (417)
Q Consensus 18 ~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~vkL~DFGla~~~~ 94 (417)
.||||||+++. +...... ...+++.++..++.||+.+|.+||+ +||+||||||+|||++ ++.++|+|||+|+...
T Consensus 92 ~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 38999999975 3333222 3458899999999999999999999 9999999999999999 7899999999997644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.2e-14 Score=129.62 Aligned_cols=185 Identities=16% Similarity=0.187 Sum_probs=135.1
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~NILl~~~ 79 (417)
||+-++.......++.+|..||. ++|..++... +.-+...++.+++.+|+.|++|||+.. |.--.|....|+||++
T Consensus 248 nilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided 327 (448)
T KOG0195|consen 248 NILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED 327 (448)
T ss_pred chhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch
Confidence 56667777778889999999998 4566555432 334677899999999999999999863 3344688889999998
Q ss_pred CCEEEe--eccCcccccCCCCCcccccccccCCCCchhhcCCCC--CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 80 GNLKLA--DFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 80 ~~vkL~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
-+.+|. |--++. ....+.-.+.||+||.+..... .-.++|+|||.++|+||.|...||......+.--
T Consensus 328 ltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm 399 (448)
T KOG0195|consen 328 LTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM 399 (448)
T ss_pred hhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh
Confidence 776654 322221 1112334789999999975322 2357999999999999999999998877766544
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
+|.- ......+...++..+..|+.-|+..||.+||....|+
T Consensus 400 kial----------------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 400 KIAL----------------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hhhh----------------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 4410 1111233456788999999999999999999876553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.1e-13 Score=127.95 Aligned_cols=76 Identities=13% Similarity=0.206 Sum_probs=63.3
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEcCCCCEEEeeccCcccc
Q 014871 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSF 93 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g-ivHrDlkp~NILl~~~~~vkL~DFGla~~~ 93 (417)
..||||||++++.+.........+.+.++..++.||+.+|++||++| |+||||||+|||++ ++.++|+|||+|...
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 45899999998654433323345677788999999999999999999 99999999999999 778999999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-13 Score=139.09 Aligned_cols=194 Identities=21% Similarity=0.218 Sum_probs=153.6
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLT----GLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~----gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
|.++.+..++..+..||-+|+|+.++..++.....-+++.++..++.+++. ||.++|...++|-|+|++||++..+
T Consensus 179 ~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 179 NPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSD 258 (524)
T ss_pred cccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccc
Confidence 345678899999999999999999999999888777999999999999999 9999999999999999999999988
Q ss_pred -CCEEEeeccCcccccCCCCCccc---cc-ccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC--ChHH
Q 014871 80 -GNLKLADFGLARSFSYDHNNTLT---NR-VITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK--NEAE 152 (417)
Q Consensus 80 -~~vkL~DFGla~~~~~~~~~~~~---~~-~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~--~~~~ 152 (417)
..+++.||++...+......... .+ .+...|++||++.+ -++.+.||++||.|+.+..++...+... +...
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 88999999999887654322111 11 45677999998864 5789999999999999999886554322 1111
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+++.. ..-.++....+.++..++..|+..++..|+++..++++.++.
T Consensus 337 ~~r~~-------------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 337 QLRQG-------------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred ccccc-------------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 11111 011233344566777799999999999999999999999985
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-13 Score=122.13 Aligned_cols=84 Identities=18% Similarity=0.177 Sum_probs=65.7
Q ss_pred ccEeecccCceecC---eEE-EEEcCCC---CCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCcE
Q 014871 3 CTFLETTDGNKYRG---STY-MVFEYMD---HDLTGLADRPGLRFTVPQIKCYMKQLLTGL-HYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 3 cniv~~~~~~~~~~---~~y-iV~Ey~~---g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL-~~LH~~givHrDlkp~NI 74 (417)
-||+++++.++.+. .+| +||||++ ++|.+++.+. .+++. ..++.|+|.++ +|||+++|+||||||+||
T Consensus 61 ~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NI 136 (210)
T PRK10345 61 SGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNI 136 (210)
T ss_pred cccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 47899999888873 545 7899954 4777777543 46666 46788888888 999999999999999999
Q ss_pred EEcCC----CCEEEeeccCc
Q 014871 75 LIDNE----GNLKLADFGLA 90 (417)
Q Consensus 75 Ll~~~----~~vkL~DFGla 90 (417)
|++.. ..++|+||+.+
T Consensus 137 Ll~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 137 LCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEeccCCCCCcEEEEECCCC
Confidence 99743 37999995443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.3e-13 Score=140.19 Aligned_cols=195 Identities=26% Similarity=0.394 Sum_probs=150.0
Q ss_pred CceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccC
Q 014871 11 GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 89 (417)
Q Consensus 11 ~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGl 89 (417)
-|......+||++|+.+ +|..++...+ ..+..-++.++..+..++++||...++|||+++.|+|+..++..++.||+.
T Consensus 872 s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 872 SFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccc
Confidence 35667789999999975 5544444433 578888889999999999999999999999999999999999999999984
Q ss_pred cccccCC----------------------CC--------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHH
Q 014871 90 ARSFSYD----------------------HN--------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 139 (417)
Q Consensus 90 a~~~~~~----------------------~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell 139 (417)
....... .. ......++|..|.+||.+++ .....++|+|++|++++|.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhh
Confidence 3221100 00 01122366999999999987 56788899999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC
Q 014871 140 NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 219 (417)
Q Consensus 140 tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt 219 (417)
+|.++|.......+...|... +..|+.. ....+..+.+++.++|..++.+|..
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~-----~~~~p~g----------------------~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNR-----DIPWPEG----------------------PEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred cCCCCCCCcchhhhhhccccC-----CCCCCCC----------------------ccccChhhhhhhhhhhccCchhccC
Confidence 999999988877766555331 2223222 1236678999999999999999998
Q ss_pred HH---HHhcCCCCCCCCC
Q 014871 220 AK---DALDSEYFWTDPL 234 (417)
Q Consensus 220 a~---elL~h~~f~~~~~ 234 (417)
+. ++..|+||.....
T Consensus 1083 a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1083 AKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred cccccccccCCccCCCCc
Confidence 87 8999999965543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.9e-12 Score=113.56 Aligned_cols=74 Identities=16% Similarity=0.231 Sum_probs=61.0
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccC
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 95 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 95 (417)
...||||||+++..+..+.. ...+..++.+|+.+|.+||+.+|+|+||||+||+|+.++.++|+|||++..+..
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 35689999999854433321 144677899999999999999999999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-11 Score=115.61 Aligned_cols=68 Identities=24% Similarity=0.361 Sum_probs=56.4
Q ss_pred EEEEcCCCC--CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 19 YMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 19 yiV~Ey~~g--~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
+|||||+++ +|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.++.
T Consensus 122 ~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 599999986 56555543 2455543 57899999999999999999999999999888999999998854
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-11 Score=112.47 Aligned_cols=75 Identities=23% Similarity=0.339 Sum_probs=61.9
Q ss_pred ceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCc
Q 014871 12 NKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 90 (417)
Q Consensus 12 ~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla 90 (417)
+......+|||||+++ +|.+++... .. ++..++.+|+.+|.+||+.+++|+|++|+|||++ ++.++|+|||++
T Consensus 68 ~~~~~~~~lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 68 FVDPENFIIVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred EEeCCCCEEEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 3345678999999987 555554422 22 8889999999999999999999999999999999 678999999988
Q ss_pred cc
Q 014871 91 RS 92 (417)
Q Consensus 91 ~~ 92 (417)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 54
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.2e-11 Score=113.36 Aligned_cols=195 Identities=16% Similarity=0.159 Sum_probs=127.2
Q ss_pred cEeecccCceecC-----eEEEEEcCCC-CCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCC
Q 014871 4 TFLETTDGNKYRG-----STYMVFEYMD-HDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGS 72 (417)
Q Consensus 4 niv~~~~~~~~~~-----~~yiV~Ey~~-g~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~--givHrDlkp~ 72 (417)
|+|+++.++.+++ .+.+++||+. +++..++++ ....+.....++|+.||+.||.|||+. -|+|.++..+
T Consensus 128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ 207 (458)
T KOG1266|consen 128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCD 207 (458)
T ss_pred HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchh
Confidence 5666665554443 4788999998 566555543 456689999999999999999999987 5999999999
Q ss_pred cEEEcCCCCEEEeeccCc--c-cccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCC-CCCC
Q 014871 73 NLLIDNEGNLKLADFGLA--R-SFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGK 148 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla--~-~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~p-f~~~ 148 (417)
-|++..++-+||.----. . .+............+-+.|.+||.=. ..+.+-++|||+||.-..||..+.-- -.+.
T Consensus 208 tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnse 286 (458)
T KOG1266|consen 208 TIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSE 286 (458)
T ss_pred heeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCc
Confidence 999998887776531110 0 00000001111123356788888544 35677899999999888898776421 1122
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~ 228 (417)
+..+....|.+.... .-+..-+++|.+||.-.|..|+++.++|.|+.
T Consensus 287 S~~~~ee~ia~~i~~---------------------------------len~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 287 SKVEVEENIANVIIG---------------------------------LENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred ceeehhhhhhhheee---------------------------------ccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 211111111111000 01112358899999999999999999999998
Q ss_pred CCCC
Q 014871 229 FWTD 232 (417)
Q Consensus 229 f~~~ 232 (417)
..+.
T Consensus 334 lfeV 337 (458)
T KOG1266|consen 334 LFEV 337 (458)
T ss_pred eeec
Confidence 7554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.7e-11 Score=109.24 Aligned_cols=70 Identities=21% Similarity=0.390 Sum_probs=57.2
Q ss_pred ecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 14 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 14 ~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
.....+|||||+++ ++.+++.... . .++.+|+.+|.+||+.+++|+|+||+|||++ ++.++|+|||++..
T Consensus 68 ~~~~~~lv~e~~~g~~l~~~~~~~~-------~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 68 DPDNKTIVMEYIEGKPLKDVIEEGN-------D-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCCCEEEEEEECCccHHHHHhhcH-------H-HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 34566899999986 4544443211 1 7899999999999999999999999999999 78999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.16 E-value=4e-11 Score=125.72 Aligned_cols=69 Identities=23% Similarity=0.389 Sum_probs=58.1
Q ss_pred ecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 14 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 14 ~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
.....||||||+++ +|.+++. ....++.+|+.+|.+||+++|+||||||+|||+ +++.++|+|||+++.
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 34567899999987 4544442 457789999999999999999999999999999 567899999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=6e-11 Score=106.65 Aligned_cols=74 Identities=19% Similarity=0.320 Sum_probs=58.5
Q ss_pred eEEEEEcCCCCC-HHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCCEEEeeccCcccc
Q 014871 17 STYMVFEYMDHD-LTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93 (417)
Q Consensus 17 ~~yiV~Ey~~g~-l~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~vkL~DFGla~~~ 93 (417)
..||||||+.++ +.. .+... .. ..++..++.+++.+|.+||. .+|+|+||||+||+++ ++.++|+|||.+...
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~--~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDV--RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhh--hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 458999999972 111 11110 01 16788999999999999999 9999999999999999 889999999998654
Q ss_pred c
Q 014871 94 S 94 (417)
Q Consensus 94 ~ 94 (417)
.
T Consensus 165 ~ 165 (187)
T cd05119 165 D 165 (187)
T ss_pred c
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.9e-10 Score=102.23 Aligned_cols=78 Identities=14% Similarity=0.219 Sum_probs=60.5
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEcCCCCEEEeeccCccccc
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYC-HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 94 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~L-H~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~ 94 (417)
...+|||||++++.+....-.+..+++.++..++.+++.+|..| |+.||||+||++.|||+++ +.+.|+||+.|....
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 35689999998742211111122466777888899999999998 8999999999999999974 579999999886643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.03 E-value=3e-10 Score=96.97 Aligned_cols=81 Identities=19% Similarity=0.257 Sum_probs=64.4
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEcCCCC
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---QVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~---givHrDlkp~NILl~~~~~ 81 (417)
+.+++..++..+..|+||||+.+..+..+ +......++.+++.+|++||.. +++|+|||++|||++..+.
T Consensus 55 ~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~ 127 (155)
T cd05120 55 VPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127 (155)
T ss_pred CCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE
Confidence 34444445555789999999987543322 5566778899999999999985 7999999999999999889
Q ss_pred EEEeeccCccc
Q 014871 82 LKLADFGLARS 92 (417)
Q Consensus 82 vkL~DFGla~~ 92 (417)
++|+||+++..
T Consensus 128 ~~l~Df~~~~~ 138 (155)
T cd05120 128 LGIIDWEYAGY 138 (155)
T ss_pred EEEEecccccC
Confidence 99999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.5e-10 Score=119.44 Aligned_cols=158 Identities=23% Similarity=0.306 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCCc--------ccccccccCCCCchhhcCC
Q 014871 49 MKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT--------LTNRVITLWYRPPELLLGA 119 (417)
Q Consensus 49 ~~Qil~gL~~LH~~-givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~l~~~ 119 (417)
+.+...||.|+|.. ++||+.|.|++|.++..+.+||+.|+++........-. -....-...|.|||++..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~- 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG- 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence 44555899999965 99999999999999999999999999886544311110 011123677999999987
Q ss_pred CCCCCccchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhh
Q 014871 120 TKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 198 (417)
Q Consensus 120 ~~~~~~~DiwSlG~il~ell-tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (417)
...+.++|+|||||++|.+. .|+..|...+.......-....... ....-..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~--------------------------~~~~s~~~ 237 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG--------------------------AFGYSNNL 237 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc--------------------------cccccccC
Confidence 67789999999999999998 5777776655433332221111000 00111457
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 199 DRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 199 ~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
+.++++-|.++|..|...|+++.+++..+||....
T Consensus 238 p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 238 PSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred cHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 78999999999999999999999999999996543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.2e-10 Score=118.34 Aligned_cols=189 Identities=21% Similarity=0.201 Sum_probs=136.6
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-~~v 82 (417)
+++..+..|....+.||-.|||++....+...--..+.+..++++..|++.++.++|++.++|+|+||+||++.++ +..
T Consensus 327 ~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 327 PSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred ccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhh
Confidence 4566677888888999999999876555554333348889999999999999999999999999999999999886 788
Q ss_pred EEeeccCcccccCCCCCcccccccccCCC-CchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYR-PPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
++.||+.++.+.... .....+-++. ..|++.....+..++|++||+..+.+.+++...-...+... .|..
T Consensus 407 ~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~-- 477 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRS-- 477 (524)
T ss_pred hccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeec--
Confidence 999999886532111 1112233444 36666666778899999999999999999864332221110 0100
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
..+.. ...+...+..+.+.++..|+..|+.+.++..|.-|
T Consensus 478 ---------------------------~~~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 478 ---------------------------GDTPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ---------------------------ccccC-CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00001 11223678899999999999999999999888765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.1e-09 Score=108.52 Aligned_cols=129 Identities=20% Similarity=0.349 Sum_probs=97.6
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH-~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++.++++|||+|.+.. |...+. .+....+..-+.||+.||.||| +.+++|++|.-+.|+++.+|++
T Consensus 70 ~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk----~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeW 144 (690)
T KOG1243|consen 70 NILSYLDTTEEEGTLYLVTERVRP-LETVLK----ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEW 144 (690)
T ss_pred hhhhhhhhhcccCceEEEeecccc-HHHHHH----HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcE
Confidence 578999999999999999999963 222333 2457788889999999999998 5689999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG 141 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG 141 (417)
||.+|.++........ ......---.|..|+.+-. -....|.|-|||+++|++.|
T Consensus 145 kLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 145 KLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred EEeeeEEEeccccCCc-ccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 9999998865443221 0011111223566664432 22567999999999999998
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.8e-08 Score=87.68 Aligned_cols=87 Identities=21% Similarity=0.252 Sum_probs=64.6
Q ss_pred cccEeecccCceecCeEEEEEcCCCC--CHHHHHhcCCCCCCHHHH-HHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 2 TCTFLETTDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQI-KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 2 ~cniv~~~~~~~~~~~~yiV~Ey~~g--~l~~~~~~~~~~l~~~~i-~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
.|..|-+.|.+ .-+|+|||+++ ++.+++......-.+++. ..+++.|=+.|.-||.++|||+||..+||+|..
T Consensus 73 ~~P~l~~~D~~----~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~ 148 (229)
T KOG3087|consen 73 PAPRLIFIDTY----GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRS 148 (229)
T ss_pred CCceEEEEecC----CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEec
Confidence 34444444433 34789999998 666666554333333444 788999999999999999999999999999987
Q ss_pred CCC---EEEeeccCccc
Q 014871 79 EGN---LKLADFGLARS 92 (417)
Q Consensus 79 ~~~---vkL~DFGla~~ 92 (417)
++. +.|+|||++..
T Consensus 149 ~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 149 DGNQITPILIDFGLSSV 165 (229)
T ss_pred CCCcCceEEEeecchhc
Confidence 664 58999999854
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-08 Score=104.41 Aligned_cols=77 Identities=19% Similarity=0.330 Sum_probs=55.6
Q ss_pred cCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 15 RGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLT-GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 15 ~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~-gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
....+|||||++|. +.+........+. ...++..++. .+..+|..|++|+|+||.||+++.++.++|+|||++..
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 34568999999874 3333321111122 3345555555 47789999999999999999999999999999999876
Q ss_pred cc
Q 014871 93 FS 94 (417)
Q Consensus 93 ~~ 94 (417)
+.
T Consensus 307 l~ 308 (437)
T TIGR01982 307 LS 308 (437)
T ss_pred CC
Confidence 54
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=3e-08 Score=94.63 Aligned_cols=75 Identities=16% Similarity=0.164 Sum_probs=61.9
Q ss_pred eEEEEEcCCCC--CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-------CCCEEEee
Q 014871 17 STYMVFEYMDH--DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-------EGNLKLAD 86 (417)
Q Consensus 17 ~~yiV~Ey~~g--~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~-------~~~vkL~D 86 (417)
..|||||++++ +|.+++... .......+...++.+|...+.-||++||+|+||++.||||+. +..+.|+|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 57899999997 466665421 234667788899999999999999999999999999999985 45799999
Q ss_pred ccCcc
Q 014871 87 FGLAR 91 (417)
Q Consensus 87 FGla~ 91 (417)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 98774
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=3e-08 Score=91.10 Aligned_cols=75 Identities=23% Similarity=0.336 Sum_probs=63.6
Q ss_pred eEEEEEcCCCC--CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---CEEEeeccCcc
Q 014871 17 STYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG---NLKLADFGLAR 91 (417)
Q Consensus 17 ~~yiV~Ey~~g--~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~---~vkL~DFGla~ 91 (417)
..|||||++++ +|.+++.... .++......++.+|...++-||++||+|+|+++.|||++.++ .+.|+||+.++
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 46899999987 5666655422 277888899999999999999999999999999999999887 79999998765
Q ss_pred c
Q 014871 92 S 92 (417)
Q Consensus 92 ~ 92 (417)
.
T Consensus 170 ~ 170 (206)
T PF06293_consen 170 F 170 (206)
T ss_pred e
Confidence 3
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.7e-08 Score=88.97 Aligned_cols=66 Identities=20% Similarity=0.258 Sum_probs=51.7
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV-----LHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~gi-----vHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
..++||||+++..+... ......++.+|+.+|+.||..++ +|+|+++.||+++ ++.++|+||+.+.
T Consensus 65 ~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 65 TGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 35899999998533211 11224567899999999999985 9999999999999 5689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-07 Score=93.28 Aligned_cols=168 Identities=15% Similarity=0.199 Sum_probs=122.3
Q ss_pred cEeecccCce----ecCeEEEEEcCCCC--CHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014871 4 TFLETTDGNK----YRGSTYMVFEYMDH--DLTGLADR--------------PGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63 (417)
Q Consensus 4 niv~~~~~~~----~~~~~yiV~Ey~~g--~l~~~~~~--------------~~~~l~~~~i~~i~~Qil~gL~~LH~~g 63 (417)
|||.+.++|. .+..+++|++|... +|.++... .+...+|..++.|+.||..||.++|+.|
T Consensus 334 NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG 413 (655)
T KOG3741|consen 334 NVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG 413 (655)
T ss_pred ceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC
Confidence 6788887777 34578999999975 67665432 2345788999999999999999999999
Q ss_pred ceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCC
Q 014871 64 VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143 (417)
Q Consensus 64 ivHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~ 143 (417)
+.-+-|.+.+||++.+.+++|...|+...+..+.. |.+.. -.+.|.-.||.|++.|.||..
T Consensus 414 LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 414 LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---------------EPLES----QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ceeecccHhHeEeeCcceEEEecccceeeecCCCC---------------cchhH----HhhhhHHHHHHHHHHHhhccc
Confidence 99999999999999988899988776644332220 11111 224688899999999999952
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHH
Q 014871 144 ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223 (417)
Q Consensus 144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el 223 (417)
- .++...........+...++.+++++|.-+...+.++ -++.++
T Consensus 475 n-----------------------------------s~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~l 518 (655)
T KOG3741|consen 475 N-----------------------------------SNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDL 518 (655)
T ss_pred c-----------------------------------cccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHH
Confidence 1 0011111123344555678889999999999988887 688888
Q ss_pred hcC
Q 014871 224 LDS 226 (417)
Q Consensus 224 L~h 226 (417)
+.+
T Consensus 519 lp~ 521 (655)
T KOG3741|consen 519 LPM 521 (655)
T ss_pred HHH
Confidence 765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.6e-08 Score=86.64 Aligned_cols=68 Identities=21% Similarity=0.332 Sum_probs=54.9
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
+..|+|||++|.++....... ...+++.|=.-+.-||.+||+|+||..+||++..++ +.++|||++..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 456999999998777444322 245667777778889999999999999999999874 99999999853
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.7e-08 Score=104.77 Aligned_cols=73 Identities=19% Similarity=0.364 Sum_probs=54.1
Q ss_pred cCeEEEEEcCCCC-CHHHH--HhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----CEEE
Q 014871 15 RGSTYMVFEYMDH-DLTGL--ADRPGL---RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----NLKL 84 (417)
Q Consensus 15 ~~~~yiV~Ey~~g-~l~~~--~~~~~~---~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~----~vkL 84 (417)
....+|||||++| .+.+. +...+. .+.+..+..++.||+ ..|++|+|+||.||+++.++ .+++
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~l 305 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIA 305 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence 3345699999997 44332 222221 255666667777765 58999999999999999988 8999
Q ss_pred eeccCccccc
Q 014871 85 ADFGLARSFS 94 (417)
Q Consensus 85 ~DFGla~~~~ 94 (417)
+|||++..++
T Consensus 306 lDFGivg~l~ 315 (537)
T PRK04750 306 LDFGIVGSLN 315 (537)
T ss_pred EecceEEECC
Confidence 9999987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.2e-07 Score=89.42 Aligned_cols=128 Identities=13% Similarity=0.132 Sum_probs=97.1
Q ss_pred EEEEEcCCCC--CHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCc
Q 014871 18 TYMVFEYMDH--DLTGLADR-----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 90 (417)
Q Consensus 18 ~yiV~Ey~~g--~l~~~~~~-----~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla 90 (417)
+-++|..+.+ .+..++.- .-..+...-+.++.+.|..+.+.||+.|.+-+|++++|||+.+++.|.|+|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 6788888875 33333321 2223777889999999999999999999999999999999999999999985322
Q ss_pred ccccCCCCCcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhC-CCCCCC
Q 014871 91 RSFSYDHNNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNG-KPILPG 147 (417)
Q Consensus 91 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG-~~pf~~ 147 (417)
. +. .........++...|.+||...-. -.-+...|.|-|++++|+||.| +.||.+
T Consensus 165 q-i~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 165 Q-IN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred e-ec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 1 11 233445566889999999975410 2246678999999999999986 899865
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.1e-08 Score=88.02 Aligned_cols=73 Identities=21% Similarity=0.323 Sum_probs=51.1
Q ss_pred EEEEEcCCC--CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCcEEEcCCCCEEEeeccCcccc
Q 014871 18 TYMVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHY-CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93 (417)
Q Consensus 18 ~yiV~Ey~~--g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~-LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~ 93 (417)
.+|||||++ +..+..+.... ++..+...++.+|+..+.. +|..||+|+||...|||++++ .+.|+|||.|...
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 369999999 64443333221 2355678888899886555 579999999999999999987 8999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.9e-06 Score=79.01 Aligned_cols=76 Identities=18% Similarity=0.228 Sum_probs=56.1
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV---------------------------------- 61 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~---------------------------------- 61 (417)
+..|+||||+++..+...... ..+++.+...++.+|+..|..||+
T Consensus 73 ~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 73 GTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 467999999998543332211 236777777777777777777773
Q ss_pred ----------------------CCceecCCCCCcEEEcC--CCCEEEeeccCccc
Q 014871 62 ----------------------NQVLHRDIKGSNLLIDN--EGNLKLADFGLARS 92 (417)
Q Consensus 62 ----------------------~givHrDlkp~NILl~~--~~~vkL~DFGla~~ 92 (417)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24689999999999998 56689999987743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.9e-06 Score=79.06 Aligned_cols=71 Identities=17% Similarity=0.287 Sum_probs=51.6
Q ss_pred ceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 12 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 12 ~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
+.+....+|||||++|-.+..+. .+.+ .+...|.++|.-||+.|++|+|++|.|++++++ .++++||+..+
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred ccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 34444667999999984332211 1232 244567778899999999999999999999976 49999997543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.4e-06 Score=75.75 Aligned_cols=76 Identities=13% Similarity=0.155 Sum_probs=63.1
Q ss_pred eEEEEEcCCCC--CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC--EEEeeccCcc
Q 014871 17 STYMVFEYMDH--DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN--LKLADFGLAR 91 (417)
Q Consensus 17 ~~yiV~Ey~~g--~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~--vkL~DFGla~ 91 (417)
..+||+|-+++ +|.+.+.... .+.++.+...++.+|...|+-||+.||.|+|+-+.|||++.++. |+++||.-++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 36899999984 7776665432 24678888999999999999999999999999999999987777 9999997654
Q ss_pred c
Q 014871 92 S 92 (417)
Q Consensus 92 ~ 92 (417)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.9e-06 Score=78.09 Aligned_cols=71 Identities=18% Similarity=0.301 Sum_probs=56.9
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
...+||||++|-.+..+ +++...+..++..||.-+.-+-..||||+|+..-|||+++||.+.|+||=-+..
T Consensus 181 RHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 181 RHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 45789999998544322 234666777788888888777799999999999999999999999999965543
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00056 Score=71.58 Aligned_cols=18 Identities=28% Similarity=0.246 Sum_probs=7.8
Q ss_pred HHHHHHHhc--ccCCCCCCC
Q 014871 202 ALELLEKML--MLDPSQRIS 219 (417)
Q Consensus 202 ~~~Li~~~L--~~dP~~Rpt 219 (417)
++++|+.+| .-|..-|+.
T Consensus 404 fLSILQhlllirnDy~~rpq 423 (1102)
T KOG1924|consen 404 FLSILQHLLLIRNDYYIRPQ 423 (1102)
T ss_pred HHHHHHHHHHHhhhhhhhHH
Confidence 344444433 234455553
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.66 E-value=9.6e-05 Score=68.80 Aligned_cols=76 Identities=13% Similarity=0.244 Sum_probs=57.3
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCCEEEeeccCccccc
Q 014871 18 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFS 94 (417)
Q Consensus 18 ~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~vkL~DFGla~~~~ 94 (417)
-.|||||++....-.=.-.+..+...++..+..++++.+.-|-. .++||.||+.-|||+. ++.+.|+||+-|....
T Consensus 141 nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 141 NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 36899999865111111122234555788889999999988887 8999999999999999 6789999999886543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.63 E-value=2.3e-05 Score=81.06 Aligned_cols=195 Identities=15% Similarity=0.090 Sum_probs=132.5
Q ss_pred EeecccCceecCeEEEEEcCCCCC--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~--l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.+..++.++.+...+|+++|++++ ...........|-+-++..+++.-+.+|++||+.--+||| |||..+ +..
T Consensus 296 ~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~ 370 (829)
T KOG0576|consen 296 VVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEV 370 (829)
T ss_pred cccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-ccc
Confidence 566778888888999999999864 3333333344466667777888888999999998778998 888776 479
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
|+.||+....+.... ...+..+|..+++||+... ..+..+.|+|++++-..+|.-|.+|-..
T Consensus 371 ~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~--------------- 432 (829)
T KOG0576|consen 371 KLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS--------------- 432 (829)
T ss_pred ccccccCCcccCccc--ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC---------------
Confidence 999999887665332 3445677999999998876 5688999999999877777777665433
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
.+......+... +...... + ..+... .-.++...||...|..|.+...++.|.+|...++
T Consensus 433 P~~~~~~~g~~p----~s~~L~~--~----~aw~~~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 433 PPAVLPMIGNGP----NSPMLTD--K----SAWSPV--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred CccccCCCCCCC----Cccccch--h----hhcCcc--cccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 000000000000 0000000 0 011000 0116788999999999999999999999976655
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00012 Score=75.89 Aligned_cols=78 Identities=17% Similarity=0.390 Sum_probs=53.8
Q ss_pred eecCeEEEEEcCCCC-CHHHH--HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccC
Q 014871 13 KYRGSTYMVFEYMDH-DLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 89 (417)
Q Consensus 13 ~~~~~~yiV~Ey~~g-~l~~~--~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGl 89 (417)
++.+.-+|+|||++| .+.+. +... .++.+.+...+.+++ +..+=..|++|.|.+|.||+++.++.+.+.|||+
T Consensus 236 e~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi 311 (517)
T COG0661 236 EYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGI 311 (517)
T ss_pred hccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcc
Confidence 455667899999998 33333 3332 355444443333332 2223348999999999999999999999999999
Q ss_pred ccccc
Q 014871 90 ARSFS 94 (417)
Q Consensus 90 a~~~~ 94 (417)
...+.
T Consensus 312 ~g~l~ 316 (517)
T COG0661 312 VGRLD 316 (517)
T ss_pred eecCC
Confidence 87654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00023 Score=78.27 Aligned_cols=169 Identities=20% Similarity=0.296 Sum_probs=109.2
Q ss_pred EEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC---cEEEcCCCCEEEe--eccCcccc
Q 014871 20 MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS---NLLIDNEGNLKLA--DFGLARSF 93 (417)
Q Consensus 20 iV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~---NILl~~~~~vkL~--DFGla~~~ 93 (417)
+..|||.. ++..++. .-..++...++.+..+++++|+++|+..+.|.-|... +..++.++.+.+. ||+..+..
T Consensus 263 v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l 341 (1351)
T KOG1035|consen 263 VLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPL 341 (1351)
T ss_pred HHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccC
Confidence 44566665 3333333 3345889999999999999999999996666655544 3334455556666 88877665
Q ss_pred cCCCCCcccccccccCCCCchhhcCCCCC--CCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCC
Q 014871 94 SYDHNNTLTNRVITLWYRPPELLLGATKY--GPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 171 (417)
Q Consensus 94 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~--~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 171 (417)
...... .....+..+.++|.+.. ..+ ....|+|++|.++..+..+...-.-. +.+
T Consensus 342 ~d~~~~--~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~------~~~-------------- 398 (1351)
T KOG1035|consen 342 PDNEKS--FSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQLSQGEDISEKS------AVP-------------- 398 (1351)
T ss_pred CCcccc--hhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhhhhcCcccccc------cch--------------
Confidence 433221 12233566777776653 223 33469999999999998875321100 000
Q ss_pred CCCCCccccCCCchhhhhhHHHhhh-hhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 172 VSKMPAYNHFKPSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
..+.. .+.....+++.+|+..|.++|+++.+++.|+|.+..
T Consensus 399 --------------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 399 --------------------VSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred --------------------hhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 00011 111257789999999999999999999999998543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00052 Score=71.15 Aligned_cols=76 Identities=20% Similarity=0.270 Sum_probs=52.8
Q ss_pred CeEEEEEcCCCC---CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC----CCCEEEeecc
Q 014871 16 GSTYMVFEYMDH---DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN----EGNLKLADFG 88 (417)
Q Consensus 16 ~~~yiV~Ey~~g---~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~----~~~vkL~DFG 88 (417)
..-+|+||||+| +-++.+.+.+ ++...+...+.++.. +-|=..|++|+|=+|.||+++. +..+.|.|||
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG 350 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG 350 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence 356899999997 3445555443 566655444443332 2233568999999999999983 5679999999
Q ss_pred CcccccC
Q 014871 89 LARSFSY 95 (417)
Q Consensus 89 la~~~~~ 95 (417)
+...+..
T Consensus 351 l~~~is~ 357 (538)
T KOG1235|consen 351 LYAVISH 357 (538)
T ss_pred ccccccH
Confidence 9876553
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00081 Score=68.47 Aligned_cols=91 Identities=25% Similarity=0.291 Sum_probs=70.4
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHH
Q 014871 124 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHAL 203 (417)
Q Consensus 124 ~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (417)
+++||||+|.|+.++..|...+....+.+.+..+.......... ........+...++..++
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~------------------~~~a~e~~~~~~~d~~~~ 171 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQEL------------------LSTAMEHLIQLLADKKRL 171 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhH------------------HHHHHHHHHHHhhhHhHH
Confidence 48999999999999999998888888888887776644332221 111222244556888999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 204 ELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 204 ~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+++++|+-..|..|+...+++++.-|...
T Consensus 172 ~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 172 PLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHhccCCccccccccchhHHhcCccHHHH
Confidence 99999999999999999999999988554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.001 Score=60.11 Aligned_cols=74 Identities=24% Similarity=0.214 Sum_probs=57.5
Q ss_pred EEEEcCCCC-CHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 19 YMVFEYMDH-DLTGLA--DRPGLRFTVPQIKCYMKQLLTGLHYCHV---NQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 19 yiV~Ey~~g-~l~~~~--~~~~~~l~~~~i~~i~~Qil~gL~~LH~---~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
++|+||+.. .+.... ...-..-++.+..+++.+|++.+++|+. ..+.-+|++++|+.+++++++|++|...+..
T Consensus 32 ~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 32 FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 458999985 343210 0011236889999999999999999997 4588899999999999999999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0015 Score=60.75 Aligned_cols=28 Identities=29% Similarity=0.381 Sum_probs=25.1
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.++|+|+++.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 578999999999999887 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0011 Score=62.11 Aligned_cols=29 Identities=24% Similarity=0.242 Sum_probs=25.6
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.++|+|+.+.|||++++..+.|+||+.|.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998778899998663
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0021 Score=62.25 Aligned_cols=72 Identities=15% Similarity=0.198 Sum_probs=51.4
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccc
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~ 93 (417)
+..|+|||++++--+..+.+ ...+..+...|+.-+.-|-.+|+||+|+.-=||+|++++.++++||=-....
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhhcc
Confidence 35689999998733222211 1223444555555566788999999999999999999999999999655443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0044 Score=60.88 Aligned_cols=70 Identities=24% Similarity=0.339 Sum_probs=55.2
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
..|++|++-...+... . .-..+++..|+.+.+.-|+-+..+ .+-|||+.-.||||+ +|+|.|+||-+++.
T Consensus 300 y~yl~~kdhgt~is~i-k----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDHGTPISII-K----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecCCceeeee-e----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4577888876654321 1 135678889999988888777766 788999999999999 89999999999974
|
|
| >KOG0921 consensus Dosage compensation complex, subunit MLE [Transcription] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.012 Score=63.29 Aligned_cols=21 Identities=29% Similarity=0.365 Sum_probs=10.2
Q ss_pred CCCCCCCCCCCCCCC-CCCCCC
Q 014871 374 RGPASGYGVGPQSYS-QSGQYG 394 (417)
Q Consensus 374 ~~~~~~~~~~~~~~~-~~~~~~ 394 (417)
|+-|+|++.+|++++ ++|++|
T Consensus 1236 rnnggGdyrnpgggyrgsGGfg 1257 (1282)
T KOG0921|consen 1236 RNNGGGDYRNPGGGYRGSGGFG 1257 (1282)
T ss_pred ccCCCCCCCCCCCCccCCCCcC
Confidence 333555555555433 444444
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.00043 Score=78.00 Aligned_cols=127 Identities=12% Similarity=0.037 Sum_probs=92.2
Q ss_pred eEEEEEcCCCC-CHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC-----CceecCCCCCcEEEcCCCCEEEeec
Q 014871 17 STYMVFEYMDH-DLTGLADRPGL---RFTVPQIKCYMKQLLTGLHYCHVN-----QVLHRDIKGSNLLIDNEGNLKLADF 87 (417)
Q Consensus 17 ~~yiV~Ey~~g-~l~~~~~~~~~---~l~~~~i~~i~~Qil~gL~~LH~~-----givHrDlkp~NILl~~~~~vkL~DF 87 (417)
..|++++||.. ++...+.+.-. .+.+.-+.+..++.+.+..-+|+. =.+|++||..|.+|+.+.++|+.++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 34788888874 55555554322 255556777777767777777754 2789999999999999999999999
Q ss_pred cCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 014871 88 GLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 145 (417)
Q Consensus 88 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf 145 (417)
|+.+.. ..........++++.|+.++..- ...++.++|+|..++.+|++..+..+|
T Consensus 1385 gLdKIk-np~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1385 GLDKIK-NPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccc-CchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 999832 22233344456678888888654 466788899999999999998876555
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.01 Score=65.69 Aligned_cols=31 Identities=19% Similarity=0.320 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEEcCC-C-CEEEeeccCcccc
Q 014871 63 QVLHRDIKGSNLLIDNE-G-NLKLADFGLARSF 93 (417)
Q Consensus 63 givHrDlkp~NILl~~~-~-~vkL~DFGla~~~ 93 (417)
.|||+|+++.|||++.+ . .+-|+||.+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 49999999999999853 2 3689999998653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.02 Score=55.89 Aligned_cols=81 Identities=21% Similarity=0.271 Sum_probs=46.4
Q ss_pred eecCeEEEEEcCCCCCHHHH----HhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCCCcEEEcCCC----
Q 014871 13 KYRGSTYMVFEYMDHDLTGL----ADRPGLRFTVPQIKCYMKQLLTGLHYCH----VNQVLHRDIKGSNLLIDNEG---- 80 (417)
Q Consensus 13 ~~~~~~yiV~Ey~~g~l~~~----~~~~~~~l~~~~i~~i~~Qil~gL~~LH----~~givHrDlkp~NILl~~~~---- 80 (417)
.++..-.||+.++..+-..+ ..+-+...-..-++.++.||+.-.--+- ...++|-||||+||||-++.
T Consensus 241 ~y~rGnIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~ 320 (434)
T PF05445_consen 241 SYDRGNIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIR 320 (434)
T ss_pred eeccCcEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceE
Confidence 34433448888876543221 1222222223345666666654331121 34799999999999985432
Q ss_pred --------------CEEEeeccCcccc
Q 014871 81 --------------NLKLADFGLARSF 93 (417)
Q Consensus 81 --------------~vkL~DFGla~~~ 93 (417)
.++|.||.+++..
T Consensus 321 I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 321 IKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred EEECCeEEEecccceeeecccCHHHhc
Confidence 3688888887653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.03 Score=54.24 Aligned_cols=28 Identities=21% Similarity=0.420 Sum_probs=24.9
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLA 90 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla 90 (417)
.+++|+|+++.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999988 57899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.013 Score=54.63 Aligned_cols=30 Identities=27% Similarity=0.381 Sum_probs=25.4
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
..++|+|+++.|||++++..+-|+||+.|.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999877556799998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.018 Score=53.51 Aligned_cols=29 Identities=21% Similarity=0.466 Sum_probs=25.7
Q ss_pred CceecCCCCCcEEEcC-CCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDN-EGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~-~~~vkL~DFGla~ 91 (417)
.++|+|+++.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 6999999999999998 5789999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.03 Score=54.40 Aligned_cols=30 Identities=30% Similarity=0.427 Sum_probs=26.7
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999988767899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.039 Score=53.86 Aligned_cols=30 Identities=27% Similarity=0.389 Sum_probs=25.9
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.+++|+|+++.|||++.+..+-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999977556899998774
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.039 Score=53.38 Aligned_cols=28 Identities=36% Similarity=0.515 Sum_probs=25.3
Q ss_pred CceecCCCCCcEEEcCC----CCEEEeeccCc
Q 014871 63 QVLHRDIKGSNLLIDNE----GNLKLADFGLA 90 (417)
Q Consensus 63 givHrDlkp~NILl~~~----~~vkL~DFGla 90 (417)
.++|+|+.+.|||++.+ +.++|+||..|
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 58999999999999984 78999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.04 Score=52.71 Aligned_cols=49 Identities=27% Similarity=0.377 Sum_probs=37.1
Q ss_pred HHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 43 PQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 43 ~~i~~i~~Qil~gL~~LH~~--givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
..+.+.+..+-..+.-++.. -++|+|+.++|+|+++++.++|+||..|.
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 33444555555555555554 58899999999999998899999998764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.019 Score=52.54 Aligned_cols=30 Identities=30% Similarity=0.612 Sum_probs=20.7
Q ss_pred CCceecCCCCCcEEEc-CCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLID-NEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~-~~~~vkL~DFGla~ 91 (417)
..++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3699999999999999 55667899998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.042 Score=54.10 Aligned_cols=28 Identities=29% Similarity=0.553 Sum_probs=25.4
Q ss_pred ceecCCCCCcEEEcCCCC-EEEeeccCcc
Q 014871 64 VLHRDIKGSNLLIDNEGN-LKLADFGLAR 91 (417)
Q Consensus 64 ivHrDlkp~NILl~~~~~-vkL~DFGla~ 91 (417)
+||+|+.++|||++.+.. +.++||+.|.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999874 8999998763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.049 Score=52.44 Aligned_cols=30 Identities=30% Similarity=0.411 Sum_probs=26.3
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.+++|+|+++.|||+++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998767899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.93 E-value=0.087 Score=51.28 Aligned_cols=29 Identities=21% Similarity=0.265 Sum_probs=26.8
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
+++|+|+.+.|||++.++.+.|+||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999899999998774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.93 E-value=0.063 Score=53.28 Aligned_cols=29 Identities=24% Similarity=0.495 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEEcC-CCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDN-EGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~-~~~vkL~DFGla~ 91 (417)
.++|+|+++.|||+++ ++.++|+||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4679999998763
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.84 E-value=0.049 Score=49.04 Aligned_cols=28 Identities=36% Similarity=0.582 Sum_probs=24.6
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
-.+|+|+.|+||++.+++ ++|+||+.|.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 368999999999998876 9999999874
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.12 Score=46.96 Aligned_cols=31 Identities=26% Similarity=0.507 Sum_probs=25.4
Q ss_pred HCCceecCCCCCcEEEcCCC-----CEEEeeccCcc
Q 014871 61 VNQVLHRDIKGSNLLIDNEG-----NLKLADFGLAR 91 (417)
Q Consensus 61 ~~givHrDlkp~NILl~~~~-----~vkL~DFGla~ 91 (417)
.+.++|+|+.+.||++..++ .+.|+||..++
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 34689999999999998553 58999998763
|
subfamily of choline kinases |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.15 Score=47.10 Aligned_cols=37 Identities=32% Similarity=0.398 Sum_probs=31.9
Q ss_pred HHHHHHHHHC--CceecCCCCCcEEEcCCCCEEEeeccC
Q 014871 53 LTGLHYCHVN--QVLHRDIKGSNLLIDNEGNLKLADFGL 89 (417)
Q Consensus 53 l~gL~~LH~~--givHrDlkp~NILl~~~~~vkL~DFGl 89 (417)
+.+|.-.|+. +.+|+|..|+||+-|..|.+||.|=+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 5677788843 799999999999999999999999653
|
The function of this family is unknown. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=93.51 E-value=0.28 Score=44.65 Aligned_cols=76 Identities=14% Similarity=0.127 Sum_probs=49.8
Q ss_pred EeecccCceecCeEEEEEcCCC---C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 5 FLETTDGNKYRGSTYMVFEYMD---H----DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~---g----~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
|-+++...+.+--+-+|+|.+. | +|.+++.+. .+++ ++...+ -+-.++|-++.|+.+||+|.||++.
T Consensus 79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHH---HHHHHHHHHcCCeecCCCcccEEEE
Confidence 3455555666666778888874 2 355555333 3555 343333 3445678899999999999999996
Q ss_pred CCC----CEEEee
Q 014871 78 NEG----NLKLAD 86 (417)
Q Consensus 78 ~~~----~vkL~D 86 (417)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 478887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.13 Score=46.91 Aligned_cols=38 Identities=32% Similarity=0.395 Sum_probs=31.8
Q ss_pred HHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCc
Q 014871 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 90 (417)
Q Consensus 48 i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla 90 (417)
-+.+|+.-|..||..||+-+|+|+.|.. .=||+|||.+
T Consensus 169 ~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 3556777888899999999999999987 3499999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.26 E-value=0.16 Score=50.44 Aligned_cols=75 Identities=16% Similarity=0.237 Sum_probs=56.5
Q ss_pred eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 17 STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH-~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
+.+|||++|+.+-+-.=.-.+..|+...+..+-.|++.-+.-|- ..++||.||.--|+|+-+ |.|.|+|.+-+..
T Consensus 238 ~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 238 NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYIIDVSQSVE 313 (520)
T ss_pred cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEEEEcccccc
Confidence 44699999986543332333455888888888888877777665 459999999999999865 5899999887654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.23 E-value=0.11 Score=47.40 Aligned_cols=29 Identities=38% Similarity=0.676 Sum_probs=20.3
Q ss_pred CceecCCCCCcEEE-cCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLI-DNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl-~~~~~vkL~DFGla~ 91 (417)
-+.|+||.+.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58899999999999 777899999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.11 Score=50.56 Aligned_cols=65 Identities=22% Similarity=0.216 Sum_probs=38.4
Q ss_pred cCeEEEEEcCCCCCHHH----HHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCCCcEEEcCC
Q 014871 15 RGSTYMVFEYMDHDLTG----LADRPGLRFTVPQIKCYMKQLLTGLHYCH----VNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 15 ~~~~yiV~Ey~~g~l~~----~~~~~~~~l~~~~i~~i~~Qil~gL~~LH----~~givHrDlkp~NILl~~~ 79 (417)
+..-.||+.++.++-.+ .+.+-+..--..-++.++.||+.-.-.+- ...++|-||||+||||-++
T Consensus 247 drGnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 247 DRGNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred cCCcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 33445788887653222 22222222223446777788766543442 3469999999999998544
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.04 E-value=0.35 Score=46.92 Aligned_cols=26 Identities=19% Similarity=0.342 Sum_probs=21.0
Q ss_pred CceecCCCCCcEEEcCC-CC-EEEeecc
Q 014871 63 QVLHRDIKGSNLLIDNE-GN-LKLADFG 88 (417)
Q Consensus 63 givHrDlkp~NILl~~~-~~-vkL~DFG 88 (417)
.++|+|+++.||+++.+ +. +.|+|..
T Consensus 194 sLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 194 VLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred eeEeCCCCcccEEECCCCCceEEEECch
Confidence 58999999999999865 33 6788864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.01 E-value=0.067 Score=50.45 Aligned_cols=28 Identities=39% Similarity=0.637 Sum_probs=24.9
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.++|+|+.+.|||++.++ ++|+||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 589999999999999876 8999998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.15 E-value=0.18 Score=49.51 Aligned_cols=28 Identities=29% Similarity=0.327 Sum_probs=23.8
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3789999999999995 4 58899998763
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.03 E-value=0.26 Score=55.94 Aligned_cols=31 Identities=39% Similarity=0.641 Sum_probs=26.0
Q ss_pred CCceecCCCCCcEEEcCCC--CEE-EeeccCccc
Q 014871 62 NQVLHRDIKGSNLLIDNEG--NLK-LADFGLARS 92 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~--~vk-L~DFGla~~ 92 (417)
.+|||.|++++|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 454 999998743
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.83 E-value=0.18 Score=48.43 Aligned_cols=30 Identities=27% Similarity=0.494 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEEcCCCC-EEEeeccCccc
Q 014871 63 QVLHRDIKGSNLLIDNEGN-LKLADFGLARS 92 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~-vkL~DFGla~~ 92 (417)
.++|+|+++.|||+++++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 57999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.78 E-value=0.27 Score=55.68 Aligned_cols=31 Identities=26% Similarity=0.294 Sum_probs=25.7
Q ss_pred HCCceecCCCCCcEEEcCCC--C---EEEeeccCcc
Q 014871 61 VNQVLHRDIKGSNLLIDNEG--N---LKLADFGLAR 91 (417)
Q Consensus 61 ~~givHrDlkp~NILl~~~~--~---vkL~DFGla~ 91 (417)
..++||.|++.+|||++.+. . .-|+|||.+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 35899999999999998652 3 4899999874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=89.96 E-value=0.42 Score=47.09 Aligned_cols=27 Identities=33% Similarity=0.660 Sum_probs=23.8
Q ss_pred ceecCCCCCcEEEcC-CCCEEEeeccCc
Q 014871 64 VLHRDIKGSNLLIDN-EGNLKLADFGLA 90 (417)
Q Consensus 64 ivHrDlkp~NILl~~-~~~vkL~DFGla 90 (417)
+.|.|+.+.|||+++ ++.++|+||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 789999999999974 467999999876
|
|
| >KOG0921 consensus Dosage compensation complex, subunit MLE [Transcription] | Back alignment and domain information |
|---|
Probab=89.72 E-value=1.5 Score=48.00 Aligned_cols=18 Identities=44% Similarity=0.796 Sum_probs=9.6
Q ss_pred CCCCCCCCCCCCCCCCCC
Q 014871 340 PNRGGQGGGYSNAPYPPQ 357 (417)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~ 357 (417)
.++||+|+||+|++|=--
T Consensus 1189 ysgGGYGggys~gGygsG 1206 (1282)
T KOG0921|consen 1189 YSGGGYGGGYSGGGYGSG 1206 (1282)
T ss_pred CCCCCcCCCCCCCCcCCC
Confidence 445666665555544333
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=89.59 E-value=0.59 Score=45.73 Aligned_cols=97 Identities=12% Similarity=0.135 Sum_probs=0.0
Q ss_pred CcccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCC
Q 014871 1 MTCTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 1 ~~cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~ 79 (417)
+-|.-|-... ..+|||-|++.+-+-.-.-.+.+|+..+.++.-.|++..+.-|-.. -+||-||.--|||+...
T Consensus 347 lpcP~vV~lk------khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g 420 (531)
T KOG2269|consen 347 LPCPQVVKLK------KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG 420 (531)
T ss_pred CCCCceeeee------cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecCC
Q ss_pred CCEEEeeccCcccccCCCCCccccc
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNR 104 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~ 104 (417)
.|.++|..-+.............+
T Consensus 421 -Kvw~IDVsQsvep~HP~~LeFL~R 444 (531)
T KOG2269|consen 421 -KVWVIDVSQSVEPSHPRSLEFLTR 444 (531)
T ss_pred -ceEEEechhccCCCCcchhHHHHH
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 417 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-63 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-63 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-63 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-62 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-51 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-51 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-51 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-51 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-51 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-51 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-51 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-51 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-51 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-51 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-51 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-51 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-51 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-51 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-51 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-51 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-51 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-51 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-51 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-51 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-51 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-51 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-51 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-51 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-51 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-51 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-51 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-51 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-51 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-51 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-51 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-51 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-51 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-51 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-51 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-51 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-51 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-50 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-49 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-49 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-48 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-46 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-46 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-44 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-44 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-43 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-41 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-41 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-40 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-40 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-40 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-40 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-39 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-38 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-38 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-36 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-36 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-36 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-36 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-36 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-36 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-36 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-36 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-36 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-36 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-36 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-36 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-36 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-36 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-36 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-36 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-36 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-36 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-36 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-36 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-36 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-36 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-36 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-35 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-35 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-35 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-35 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-35 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-35 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-35 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-35 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-35 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-35 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-35 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-35 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-35 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-35 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-35 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-35 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-35 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-35 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-35 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-35 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-35 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-35 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-35 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-35 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-35 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-35 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-35 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-35 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-35 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-35 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-35 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-35 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-35 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-35 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-35 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-35 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-35 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-35 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-35 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-35 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-35 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-35 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-35 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-35 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-35 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-35 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-35 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-35 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-35 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-35 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-35 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-35 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-35 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-35 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-35 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-35 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-34 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-34 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-34 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-34 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-34 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-34 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-34 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-34 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-33 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-33 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-33 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-32 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-32 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-30 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-30 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-30 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-29 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-29 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-28 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-27 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-27 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-27 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-27 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-27 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-27 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-27 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-27 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-27 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-27 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-27 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-27 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-26 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-26 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-26 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-26 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-26 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-26 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-26 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-26 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-26 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-26 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-26 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-26 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-26 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-26 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-26 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-26 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-26 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-26 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-26 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-26 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-26 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-26 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-26 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-26 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-26 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-26 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-26 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-26 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-26 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-26 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-26 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-25 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-25 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-25 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-25 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-25 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-25 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-25 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-25 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-25 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-25 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-25 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-25 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-24 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-24 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-23 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-23 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-22 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-22 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-22 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-22 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-22 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-22 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-22 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-22 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-22 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-22 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-22 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-22 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-22 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-22 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-19 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-19 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-19 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-19 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-19 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-19 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-19 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-19 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-19 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 4e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 8e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 2e-04 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 2e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-04 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 450 bits (1161), Expect = e-159
Identities = 117/263 (44%), Positives = 168/263 (63%), Gaps = 7/263 (2%)
Query: 7 ETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
+ + N+ +GS Y+VF++ +HDL GL ++FT+ +IK M+ LL GL+Y H N++LH
Sbjct: 88 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 147
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSY---DHNNTLTNRVITLWYRPPELLLGATKYG 123
RD+K +N+LI +G LKLADFGLAR+FS N TNRV+TLWYRPPELLLG YG
Sbjct: 148 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 207
Query: 124 PAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKP 183
P +D+W GCI AE+ PI+ G E QL+ I +LCGS +WP V Y +
Sbjct: 208 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 267
Query: 184 SRTMKRRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 241
+ KR+V++ + + D +AL+L++K+L+LDP+QRI + DAL+ ++FW+DP+P D K +
Sbjct: 268 VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGM 327
Query: 242 PKYE--SSHEYQTKKRRQQQRQH 262
S EY RR+ H
Sbjct: 328 LSTHLTSMFEYLAPPRRKHHHHH 350
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-146
Identities = 105/268 (39%), Positives = 146/268 (54%), Gaps = 9/268 (3%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+ + +VF++M+ DL + L T IK YM L GL Y H + +LHRD+K +NL
Sbjct: 84 KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
L+D G LKLADFGLA+SF N T++V+T WYR PELL GA YG VDMW+VGCI
Sbjct: 144 LLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 202
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
AELL P LPG ++ +QL++IFE G+P E WP + +P Y FK + +
Sbjct: 203 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--GIPLHHI 260
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKK 254
F L+L++ + + +P RI+A AL +YF P P LP+ E
Sbjct: 261 FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNCPVE----- 315
Query: 255 RRQQQRQHEEATKRQKLHHPQPHGRLPP 282
++Q A KR++ + G LP
Sbjct: 316 TLKEQSNPALAIKRKRTEALE-QGGLPK 342
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-139
Identities = 100/263 (38%), Positives = 136/263 (51%), Gaps = 10/263 (3%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
S +VFEY+D DL D G + +K ++ QLL GL YCH +VLHRD+K NL
Sbjct: 72 EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
LI+ G LKLADFGLAR+ S T N V+TLWYRPP++LLG+T Y +DMW VGCI
Sbjct: 132 LINERGELKLADFGLARAKS-IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 190
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
F E+ G+P+ PG EQL IF + G+P E WPG+ + + + +
Sbjct: 191 FYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH 250
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKK 254
D +LL K+L + RISA+DA+ +F + LP S K+
Sbjct: 251 APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK--LPDTTSIFA--LKE 306
Query: 255 RRQQQRQHEEATKRQKLHHPQPH 277
+ Q+ + HH H
Sbjct: 307 IQLQKE-----ASLRSAHHHHHH 324
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-133
Identities = 93/248 (37%), Positives = 132/248 (53%), Gaps = 9/248 (3%)
Query: 8 TTDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
T +VFE++D DLT D+ P IK M QLL GL + H ++V+H
Sbjct: 84 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH 143
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
RD+K N+L+ + G +KLADFGLAR +S LT+ V+TLWYR PE+LL ++ Y V
Sbjct: 144 RDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLLQSS-YATPV 200
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
D+WSVGCIFAE+ KP+ G ++ +QL KI ++ G P E WP +P S
Sbjct: 201 DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS-- 258
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD--PKSLPKY 244
+ + + D +LL K L +P++RISA AL YF + LP
Sbjct: 259 -AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPS 317
Query: 245 ESSHEYQT 252
+++ E T
Sbjct: 318 QNTSELNT 325
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-131
Identities = 93/218 (42%), Positives = 127/218 (58%), Gaps = 3/218 (1%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+VFE+ D DL D +K ++ QLL GL +CH VLHRD+K NLLI+
Sbjct: 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
G LKLA+FGLAR+F + V+TLWYRPP++L GA Y ++DMWS GCIFAEL
Sbjct: 137 NGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 139 LN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
N G+P+ PG + +QL +IF L G+P E WP ++K+P Y + P + V
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY-PMYPATTSLVNVVPK 254
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235
+ +LL+ +L +P QRISA++AL YF P
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-131
Identities = 95/245 (38%), Positives = 141/245 (57%), Gaps = 12/245 (4%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLR-----FTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
+VFE+MD+DL D + + +K + QLL GL +CH N++LHRD+
Sbjct: 75 ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
K NLLI+ G LKL DFGLAR+F NT ++ V+TLWYR P++L+G+ Y ++D+W
Sbjct: 135 KPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIW 193
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
S GCI AE++ GKP+ PG N+ EQL IF++ G+P+E++WP V+K+P YN R R
Sbjct: 194 SCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP-PR 252
Query: 190 RVREVFRH-----FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKY 244
+R+V + D + ++ L +L L+P R+SAK AL +F +
Sbjct: 253 DLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGGSRSH 312
Query: 245 ESSHE 249
H
Sbjct: 313 HHHHH 317
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 374 bits (964), Expect = e-129
Identities = 92/219 (42%), Positives = 138/219 (63%), Gaps = 1/219 (0%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+VFE+M+ DL + D QIK Y+ QLL G+ +CH +++LHRD+K NL
Sbjct: 91 ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
LI+++G LKLADFGLAR+F + T+ V+TLWYR P++L+G+ KY +VD+WS+GCI
Sbjct: 151 LINSDGALKLADFGLARAFG-IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCI 209
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
FAE++ GKP+ PG + +QL KIF + G+P+ WP V ++P + K+ +
Sbjct: 210 FAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSI 269
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233
F + ++LL ML DP++RISA+DA++ YF
Sbjct: 270 IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-128
Identities = 95/211 (45%), Positives = 134/211 (63%), Gaps = 2/211 (0%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+VFE++D DL L D K ++ QLL G+ YCH +VLHRD+K NLLI+
Sbjct: 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
EG LK+ADFGLAR+F T+ ++TLWYR P++L+G+ KY +D+WSVGCIFAE+
Sbjct: 136 EGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 198
+NG P+ PG +EA+QL +IF + G+P+ WP V+++P Y+ +
Sbjct: 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE-PLPWESFLKGL 253
Query: 199 DRHALELLEKMLMLDPSQRISAKDALDSEYF 229
D ++LL KML LDP+QRI+AK AL+ YF
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 369 bits (950), Expect = e-127
Identities = 95/233 (40%), Positives = 125/233 (53%), Gaps = 9/233 (3%)
Query: 8 TTDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
T +VFE++D DL D P IK M+Q L GL + H N ++H
Sbjct: 84 ATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVH 143
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
RD+K N+L+ + G +KLADFGLAR +S + LT V+TLWYR PE+LL +T Y V
Sbjct: 144 RDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVVTLWYRAPEVLLQST-YATPV 200
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
DMWSVGCIFAE+ KP+ G +EA+QL KIF+L G P E WP +P
Sbjct: 201 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP- 259
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 239
R V+ V + +LL +ML +P +RISA AL Y D P+
Sbjct: 260 --RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN--PE 308
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 364 bits (938), Expect = e-126
Identities = 77/238 (32%), Positives = 119/238 (50%), Gaps = 2/238 (0%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+ ++VFEY DH + DR +K Q L +++CH + +HRD+K N+
Sbjct: 74 KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
LI +KL DFG AR + ++ + V T WYR PELL+G T+YGP VD+W++GC+
Sbjct: 134 LITKHSVIKLCDFGFARLLT-GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCV 192
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRVRE 193
FAELL+G P+ PGK++ +QL I + G S ++ K P +
Sbjct: 193 FAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL 252
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQ 251
F + AL LL+ L +DP++R++ + L YF D + + Y
Sbjct: 253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAENLYF 310
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-125
Identities = 92/226 (40%), Positives = 135/226 (59%), Gaps = 7/226 (3%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+++FEY ++DL D+ ++ IK ++ QL+ G+++CH + LHRD+K NL
Sbjct: 105 NHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163
Query: 75 LID-----NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
L+ LK+ DFGLAR+F T+ +ITLWYRPPE+LLG+ Y +VD+W
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIW 222
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
S+ CI+AE+L P+ PG +E +QL KIFE+ G PD+T WPGV+ +P + P K
Sbjct: 223 SIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKT 282
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235
R + D L+LL ML +DP +RISAK+AL+ YF +
Sbjct: 283 LKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 361 bits (930), Expect = e-124
Identities = 67/238 (28%), Positives = 118/238 (49%), Gaps = 2/238 (0%)
Query: 13 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
K + Y+VFE++DH + + ++ Y+ Q++ G+ +CH + ++HRDIK
Sbjct: 94 KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPE 153
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N+L+ G +KL DFG AR+ + + V T WYR PELL+G KYG AVD+W++G
Sbjct: 154 NILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIG 212
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSRTMKRRV 191
C+ E+ G+P+ PG ++ +QL I G+ +K P + + P + +
Sbjct: 213 CLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPL 272
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
+ ++L +K L +DP +R + L ++F D + + +
Sbjct: 273 ERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-124
Identities = 93/312 (29%), Positives = 152/312 (48%), Gaps = 45/312 (14%)
Query: 17 STYMVFEYMDHDLTGL--------ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68
+++F+Y +HDL + A++ ++ +K + Q+L G+HY H N VLHRD
Sbjct: 94 KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153
Query: 69 IKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTN---RVITLWYRPPELLLGATK 121
+K +N+L+ G +K+AD G AR F+ L + V+T WYR PELLLGA
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRAPELLLGARH 212
Query: 122 YGPAVDMWSVGCIFAELLNGKPILPGKNE---------AEQLSKIFELCGSPDETIWPGV 172
Y A+D+W++GCIFAELL +PI + E +QL +IF + G P + W +
Sbjct: 213 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDI 272
Query: 173 SKMPAYNHFKP--------SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
KMP ++ + ++ + + + D A LL+K+L +DP +RI+++ A+
Sbjct: 273 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332
Query: 225 DSEYFWTDPLPCDPKSLP------------KYESSHEYQTKKRRQQQRQHEEATKRQKLH 272
YF DPLP + E + K ++QQQ + +
Sbjct: 333 QDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGN 392
Query: 273 HPQPHGRLPPIQ 284
H + PP++
Sbjct: 393 QDSSHTQGPPLK 404
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 1e-84
Identities = 83/302 (27%), Positives = 128/302 (42%), Gaps = 23/302 (7%)
Query: 19 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+V +Y+ + +A R V +K YM QL L Y H + HRDIK NLL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 76 ID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
+D + LKL DFG A+ + + + +YR PEL+ GAT Y ++D+WS GC+
Sbjct: 189 LDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
AELL G+PI PG + +QL +I ++ G+P ++ P Y FK + +V
Sbjct: 247 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKV 304
Query: 195 FR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP---LPCDPKSLPKYE-SS 247
FR A+ L ++L P+ R++ +A +F DP LP + + ++
Sbjct: 305 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTT 364
Query: 248 HEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVP 307
E + A + P S +G NNA
Sbjct: 365 QELSSNPPLATILIPPHARIQAAASTPTN--------ATAASDANTGDRGQTNNAASASA 416
Query: 308 GG 309
Sbjct: 417 SN 418
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 2e-84
Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 15/274 (5%)
Query: 19 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+V EY+ + + + + IK YM QLL L Y H + HRDIK NLL
Sbjct: 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173
Query: 76 ID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
+D G LKL DFG A+ + + + +YR PEL+ GAT Y +D+WS GC+
Sbjct: 174 LDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCV 231
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
AEL+ G+P+ PG++ +QL +I ++ G+P ++ P Y K + +V
Sbjct: 232 MAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN--PNYMEHKFPQIRPHPFSKV 289
Query: 195 FR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP---LPCDPKSLPKYE-SS 247
FR A++L+ ++L PS R++A +AL +F +P + P + +
Sbjct: 290 FRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTK 349
Query: 248 HEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLP 281
E + + + A H P
Sbjct: 350 EELSVRPDLISRLVPQHAEAELLSRGIDVHNFQP 383
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 6e-79
Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 16/221 (7%)
Query: 19 YMVFEY-MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+VFE+ + D L T I+ YM ++L L YCH ++HRD+K N++ID
Sbjct: 109 ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164
Query: 78 NE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+E L+L D+GLA Y RV + +++ PELL+ Y ++DMWS+GC+ A
Sbjct: 165 HEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 137 ELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS--RTMKRRVRE 193
++ K P G + +QL +I ++ G+ D + + F R ++R
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 282
Query: 194 VFRHFDRH-----ALELLEKMLMLDPSQRISAKDALDSEYF 229
++H AL+ L+K+L D R++A++A++ YF
Sbjct: 283 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 3e-78
Identities = 69/235 (29%), Positives = 120/235 (51%), Gaps = 12/235 (5%)
Query: 19 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
++ EY+ L + R G + I Y+ QL + + H + HRDIK NLL
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 76 ID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
++ + LKL DFG A+ + + + +YR PEL+LGAT+Y P++D+WS+GC+
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSV--AYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
F EL+ GKP+ G+ +QL +I ++ G+P + ++ P Y + + R++
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKI 289
Query: 195 FRHF-DRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 248
A++LLE++L +P RI+ +A+ +F D L + +S+
Sbjct: 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF--DHLR-NSYESEVKNNSN 341
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 4e-78
Identities = 74/219 (33%), Positives = 109/219 (49%), Gaps = 6/219 (2%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E M DL + + + I+ +M +L GLH H V+HRD+ N+L+ +
Sbjct: 110 YLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
++ + DF LAR + D N T+ V WYR PEL++ + VDMWS GC+ AE+
Sbjct: 170 NNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV--REVFR 196
N K + G QL+KI E+ G+P S A ++ + S + V
Sbjct: 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 233
D AL+L+ KML +P +RIS + AL YF DP
Sbjct: 288 TADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-77
Identities = 72/236 (30%), Positives = 107/236 (45%), Gaps = 16/236 (6%)
Query: 19 YMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSN 73
+V EY+ L R + IK ++ QL+ + H+ V HRDIK N
Sbjct: 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN 161
Query: 74 LLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
+L++ G LKL DFG A+ S N + + +YR PEL+ G Y AVD+WSVG
Sbjct: 162 VLVNEADGTLKLCDFGSAKKLSPSEPNV--AYICSRYYRAPELIFGNQHYTTAVDIWSVG 219
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK----PSRTMK 188
CIFAE++ G+PI G N A QL +I + G P + ++ P++
Sbjct: 220 CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN--PSHTDVDLYNSKGIPWS 277
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLP 242
+ + A +LL +L P +R+ +AL YF DP P +
Sbjct: 278 NVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKD 333
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-75
Identities = 88/236 (37%), Positives = 132/236 (55%), Gaps = 8/236 (3%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V + M+ DL L L + I ++ Q+L GL Y H VLHRD+K SNLL++
Sbjct: 106 YIVQDLMETDLYKLLKTQHL--SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163
Query: 79 EGNLKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+LK+ DFGLAR DH++T LT V T WYR PE++L + Y ++D+WSVGCI A
Sbjct: 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVF 195
E+L+ +PI PGK+ +QL+ I + GSP + + + A N+ + +F
Sbjct: 224 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 283
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKYESSHE 249
+ D AL+LL+KML +P +RI + AL Y + DP +P + ++ E
Sbjct: 284 PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP-SDEPIAEAPFKFDME 338
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-75
Identities = 81/221 (36%), Positives = 119/221 (53%), Gaps = 9/221 (4%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V EYM+ DL + ++ L + +M QLL GL Y H VLHRD+K +NL I+
Sbjct: 98 YIVQEYMETDLANVLEQGPL--LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155
Query: 79 EG-NLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
E LK+ DFGLAR Y H L+ ++T WYR P LLL Y A+DMW+ GCIF
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSP-DETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
AE+L GK + G +E EQ+ I E +E +S +P Y + + + ++
Sbjct: 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQL 274
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 233
R A++ LE++L P R++A++AL Y ++ P
Sbjct: 275 LPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-75
Identities = 80/250 (32%), Positives = 128/250 (51%), Gaps = 20/250 (8%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y++ E M DL + L + I+ ++ Q L + H + V+HRD+K SNLLI++
Sbjct: 90 YIIQELMQTDLHRVISTQML--SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS 147
Query: 79 EGNLKLADFGLARSFS---------YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
+LK+ DFGLAR + + V T WYR PE++L + KY A+D+W
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP--DETIWPGVSKMPAYNHFKPSRTM 187
S GCI AEL +PI PG++ QL IF + G+P D + + A + K
Sbjct: 208 SCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR-CIESPRAREYIKSLPMY 266
Query: 188 KRR-VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPL---PCDPKSL 241
+ ++F + ++LL++ML+ DP++RI+AK+AL+ Y + DP +P
Sbjct: 267 PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPP 326
Query: 242 PKYESSHEYQ 251
+E H +
Sbjct: 327 SFFEFDHYKE 336
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 4e-75
Identities = 79/236 (33%), Positives = 128/236 (54%), Gaps = 11/236 (4%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V +M DL + F+ +I+ + Q+L GL Y H V+HRD+K NL ++
Sbjct: 105 YLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR + +T V+T WYR PE++L Y VD+WSVGCI AE+
Sbjct: 162 DCELKILDFGLARHA----DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFRH 197
L GK + GK+ +QL++I ++ G P ++ A ++ + R+ ++F
Sbjct: 218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 277
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKYESSHEYQ 251
A +LLEKML LD +R++A AL +F + DP + ++ ++ S E++
Sbjct: 278 ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP-EEETEAQQPFDDSLEHE 332
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-74
Identities = 87/328 (26%), Positives = 132/328 (40%), Gaps = 70/328 (21%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E D D L R + T IK + LL G+ Y H +LHRD+K +N L++
Sbjct: 133 YVVLEIADSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191
Query: 79 EGNLKLADFGLARSFSYDHNN--------------------------TLTNRVITLWYRP 112
+ ++K+ DFGLAR+ Y N LT V+T WYR
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 113 PELLLGATKYGPAVDMWSVGCIFAELLN-----------GKPILPGKN------------ 149
PEL+L Y A+D+WS+GCIFAELLN P+ PG +
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGN 311
Query: 150 --------EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFRHFDR 200
+QL+ IF + G+P E + K A + + + + E F
Sbjct: 312 DFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371
Query: 201 HALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKYESSHEYQTKKRRQQ 258
A+ LL++ML+ +P++RI+ + L +F + + K Q
Sbjct: 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA-EVETNATEKVRLPFNDWMNMDEPQ 430
Query: 259 QRQ--HEEATKRQKLHHPQPHGRLPPIQ 284
R +E + P +LP
Sbjct: 431 LRYAFVKEIQRY------HPEIQLPRRS 452
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 3e-74
Identities = 78/267 (29%), Positives = 126/267 (47%), Gaps = 26/267 (9%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V +M DL L L +I+ + Q+L GL Y H ++HRD+K NL ++
Sbjct: 106 YLVMPFMGTDLGKLMKHEKL--GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 163
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR + +T V+T WYR PE++L +Y VD+WSVGCI AE+
Sbjct: 164 DCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFRH 197
+ GK + G + +QL +I ++ G+P + A N+ K ++++ + +
Sbjct: 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 279
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPL---PCDP-------KSLPK-- 243
A+ LLEKML+LD QR++A +AL YF D
Sbjct: 280 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDE 339
Query: 244 -----YESSHEYQTKKRRQQQRQHEEA 265
Y+ ++ ++ + E
Sbjct: 340 WKRVTYKEVLSFKPPRQLGARVSKETP 366
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 9e-73
Identities = 90/262 (34%), Positives = 132/262 (50%), Gaps = 16/262 (6%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V M DL + L T ++ + Q+L GL Y H ++HRD+K SNL ++
Sbjct: 110 YLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR + + +T V T WYR PE++L Y VD+WSVGCI AEL
Sbjct: 168 DCELKILDFGLARHTA----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFRH 197
L G+ + PG + +QL I L G+P + +S A N+ + M + VF
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 283
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKYESSHEYQTKKR 255
+ A++LLEKML+LD +RI+A AL YF + DP D Y+ S E +
Sbjct: 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVADPYDQSLESRDLLI 341
Query: 256 RQ-QQRQHEEATKRQKLHHPQP 276
+ + ++E P P
Sbjct: 342 DEWKSLTYDEVIS----FVPPP 359
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 6e-70
Identities = 90/300 (30%), Positives = 139/300 (46%), Gaps = 44/300 (14%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+VF+YM+ DL + L + + QL+ + Y H +LHRD+K SN+L++
Sbjct: 87 YLVFDYMETDLHAVIRANIL--EPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA 144
Query: 79 EGNLKLADFGLARSFSY--------------------DHNNTLTNRVITLWYRPPELLLG 118
E ++K+ADFGL+RSF D LT+ V T WYR PE+LLG
Sbjct: 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204
Query: 119 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSP-DETIW-------- 169
+TKY +DMWS+GCI E+L GKPI PG + QL +I + P +E +
Sbjct: 205 STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAK 264
Query: 170 ------PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRH--ALELLEKMLMLDPSQRISAK 221
++ N K + ++ D + AL+LL+K+L +P++RISA
Sbjct: 265 TMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324
Query: 222 DALDSEYF--WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQ--HEEATKRQKLHHPQPH 277
DAL + + +P +P K R + E ++R++ H
Sbjct: 325 DALKHPFVSIFHNP-NEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKRELISNKH 383
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-68
Identities = 82/309 (26%), Positives = 142/309 (45%), Gaps = 24/309 (7%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E MD +L + ++ + Q+L G+ + H ++HRD+K SN+++ +
Sbjct: 143 YLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR+ + +T V+T +YR PE++LG Y VD+WSVGCI E+
Sbjct: 200 DCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 256
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDE----TIWPGVSKMPAYNHFKPSRTMKRR---- 190
+ K + PG++ +Q +K+ E G+P + P V T +
Sbjct: 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 316
Query: 191 ----VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKY 244
E + A +LL KML++DP++RIS DAL Y W DP + Y
Sbjct: 317 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 376
Query: 245 ESSHEYQTKKRRQQQRQ--HEEATK-RQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNN 301
+ + + + ++ ++ ++E +K + G+ P A S P+ +N+
Sbjct: 377 DKQLD-EREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVND 435
Query: 302 APPPVPGGP 310
Sbjct: 436 ISSMSTDQT 444
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-68
Identities = 84/333 (25%), Positives = 138/333 (41%), Gaps = 62/333 (18%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E D DL L + + T IK + LL G ++ H + ++HRD+K +N L++
Sbjct: 106 YIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ 164
Query: 79 EGNLKLADFGLARSFSYDHNNT---------------------LTNRVITLWYRPPELLL 117
+ ++K+ DFGLAR+ + + + LT+ V+T WYR PEL+L
Sbjct: 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224
Query: 118 GATKYGPAVDMWSVGCIFAELLNG-----------KPILPG-----------------KN 149
Y ++D+WS GCIFAELLN P+ PG K+
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284
Query: 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFRHFDRHALELLEK 208
+QL+ IF + G+P E ++K + K K +++ + + LLE
Sbjct: 285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344
Query: 209 MLMLDPSQRISAKDALDSEYF--WTDP---LPCDPKSLPKYESSHEYQTKKRRQQQRQHE 263
ML +P++RI+ ALD Y K + ++ + R +
Sbjct: 345 MLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLR--YIFLK 402
Query: 264 EATKRQKLHHPQPHGRLPPIQHAGQSHHWSGPN 296
E HP+ H ++ P+
Sbjct: 403 EVQS----FHPELVIPSVFTIHENNFYNNEKPS 431
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-67
Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V E MD +L + ++ + Q+L G+ + H ++HRD+K SN+++ +
Sbjct: 106 YIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR+ + +T V+T +YR PE++LG Y VD+WSVGCI E+
Sbjct: 163 DCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 219
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS--------KMPAYNHFKPSR----T 186
+ G + PG + +Q +K+ E G+P + P Y + +
Sbjct: 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 279
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPL---PCDPKSL 241
+ E + A +LL KML++D S+RIS +AL Y W DP P
Sbjct: 280 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPP--- 336
Query: 242 PKYESSHEYQTKKRRQQQRQ--HEEATKRQKLHHPQ 275
+ + + + ++ ++ ++E + HH
Sbjct: 337 KIPDKQLD-EREHTIEEWKELIYKEVMDLEHHHHHH 371
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-47
Identities = 50/225 (22%), Positives = 86/225 (38%), Gaps = 42/225 (18%)
Query: 19 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++ EY + L L L + +Q+L L Y H ++HRD+K N+ ID
Sbjct: 91 FIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150
Query: 78 NEGNLKLADFGLARSFS-------------YDHNNTLTNRVITLWYRPPELLLGATKYGP 124
N+K+ DFGLA++ ++ LT+ + T Y E+L G Y
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE 210
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 184
+DM+S+G IF E++ P G L K+ + K
Sbjct: 211 KIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMK---------- 258
Query: 185 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+++ ++ DP++R A+ L+S +
Sbjct: 259 ----------------VEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-47
Identities = 60/239 (25%), Positives = 92/239 (38%), Gaps = 42/239 (17%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
YMV E + DL + + K Y K +L +H H + ++H D+K +N LI +
Sbjct: 104 YMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD 162
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGA----------TKYGPAVD 127
G LKL DFG+A D + + + + T+ Y PPE + +K P D
Sbjct: 163 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 128 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE-TIWPGVSKMPAYNHFKPSRT 186
+WS+GCI + GK P + Q+SK+ + E K
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEFPDIPEKD----------- 268
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 245
++L+ L DP QRIS + L Y P + + E
Sbjct: 269 ---------------LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 312
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 4e-46
Identities = 61/269 (22%), Positives = 97/269 (36%), Gaps = 43/269 (15%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
YMV E + DL + + K Y K +L +H H + ++H D+K +N LI +
Sbjct: 85 YMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD 143
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG----------ATKYGPAVD 127
G LKL DFG+A D + + + + T+ Y PPE + +K P D
Sbjct: 144 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 202
Query: 128 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE-TIWPGVSKMPAYNHFKPSRT 186
+WS+GCI + GK P + Q+SK+ + E K
Sbjct: 203 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEFPDIPEK------------ 248
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYES 246
++L+ L DP QRIS + L Y P +
Sbjct: 249 --------------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP-VNQMAKGTTE 293
Query: 247 SHEYQTKKRRQQQRQHEEATKRQKLHHPQ 275
+Y + + + L+
Sbjct: 294 EMKYVLGQLVGLNSPNSILKAAKTLYEHY 322
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 38/254 (14%)
Query: 14 YRGSTYMVFEYMDHDL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+R M FE + +L + F++P ++ + +L L H N+++H D+K
Sbjct: 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229
Query: 73 NLLIDNEG--NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
N+L+ +G +K+ DFG S Y+H + + + +YR PE++LGA +YG +DMWS
Sbjct: 230 NILLKQQGRSGIKVIDFG---SSCYEHQ-RVYTYIQSRFYRAPEVILGA-RYGMPIDMWS 284
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDE----------------------TI 168
+GCI AELL G P+LPG++E +QL+ + EL G P + T+
Sbjct: 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344
Query: 169 WPGVSKMPAYNHFKPSRTMK------RRVREVFRHFDRHAL-ELLEKMLMLDPSQRISAK 221
N + R R + D + L++ L DP+ R++
Sbjct: 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404
Query: 222 DALDSEYFWTDPLP 235
AL + LP
Sbjct: 405 QALRHPWL-RRRLP 417
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-44
Identities = 60/268 (22%), Positives = 99/268 (36%), Gaps = 41/268 (15%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
YMV E + DL + + K Y K +L +H H + ++H D+K +N LI +
Sbjct: 132 YMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD 190
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGA----------TKYGPAVD 127
G LKL DFG+A D + + + + + Y PPE + +K P D
Sbjct: 191 -GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 128 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 187
+WS+GCI + GK P + Q+SK+ + E +P
Sbjct: 250 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEFP----------------- 290
Query: 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESS 247
++ ++L+ L DP QRIS + L Y P +
Sbjct: 291 --------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP-VNQMAKGTTEE 341
Query: 248 HEYQTKKRRQQQRQHEEATKRQKLHHPQ 275
+Y + + + L+
Sbjct: 342 MKYVLGQLVGLNSPNSILKAAKTLYEHY 369
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 64/258 (24%), Positives = 103/258 (39%), Gaps = 38/258 (14%)
Query: 20 MVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLID 77
MVFE + +L L + + +K KQLL GL Y H ++H DIK N+L++
Sbjct: 107 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166
Query: 78 NE------GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
+K+AD G A + + TN + T YR PE+LLGA +G D+WS
Sbjct: 167 IVDSPENLIQIKIADLGNA---CWYDEH-YTNSIQTREYRSPEVLLGA-PWGCGADIWST 221
Query: 132 GCIFAELLNGKPILPGK------NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF---- 181
C+ EL+ G + + + +++I EL G + + F
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL---LRNGKYTRTFFNSR 278
Query: 182 ---KPSRTMKRRVRE--------VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230
+ +K E + + + L ML LDP +R A ++ +
Sbjct: 279 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL- 337
Query: 231 TDPLPCDPKSLPKYESSH 248
D L + +P E
Sbjct: 338 KDTLGMEEIRVPDRELYG 355
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-42
Identities = 66/255 (25%), Positives = 106/255 (41%), Gaps = 44/255 (17%)
Query: 14 YRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIK 70
+R +VFE + ++L L R ++ + + +Q+ T L + ++H D+K
Sbjct: 127 FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLK 186
Query: 71 GSNLLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 128
N+L+ N +K+ DFG S + + + +YR PE+LLG Y A+DM
Sbjct: 187 PENILLCNPKRSAIKIVDFG---SSCQLGQ-RIYQYIQSRFYRSPEVLLGM-PYDLAIDM 241
Query: 129 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD----------------------- 165
WS+GCI E+ G+P+ G NE +Q++KI E+ G P
Sbjct: 242 WSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWN 301
Query: 166 ---------ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHA--LELLEKMLMLDP 214
E PG K+ + RR E + +L+ +ML DP
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361
Query: 215 SQRISAKDALDSEYF 229
RI AL +F
Sbjct: 362 KTRIQPYYALQHSFF 376
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 56/252 (22%), Positives = 99/252 (39%), Gaps = 43/252 (17%)
Query: 14 YRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+ G +VFE + G F + I+ Q+ +++ H N++ H D+K
Sbjct: 88 HHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPE 147
Query: 73 NLLIDNEGN-------------------LKLADFGLARSFSYDHNNTLTNRVITLWYRPP 113
N+L +K+ DFG S +YD + + V T YR P
Sbjct: 148 NILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDEH-HSTLVSTRHYRAP 203
Query: 114 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI----- 168
E++L + D+WS+GCI E G + P + E L+ + + G + +
Sbjct: 204 EVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTR 262
Query: 169 -----------WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217
W S Y + + +K + +L++KML DP++R
Sbjct: 263 KRKYFHHDRLDWDEHSSAGRY-VSRACKPLKEFML-SQDVEHERLFDLIQKMLEYDPAKR 320
Query: 218 ISAKDALDSEYF 229
I+ ++AL +F
Sbjct: 321 ITLREALKHPFF 332
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 46/271 (16%)
Query: 14 YRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+ G + FE + + + + +P ++ QL L + H NQ+ H D+K
Sbjct: 93 FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPE 152
Query: 73 N-LLIDNEG------------------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 113
N L +++E ++++ADFG S ++DH + T V T YRPP
Sbjct: 153 NILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEH-HTTIVATRHYRPP 208
Query: 114 ELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVS 173
E++L + D+WS+GCI E G + E L + ++ G + +
Sbjct: 209 EVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM---IH 264
Query: 174 KMPAYNHF--------------KPSRTMKRRVREVFRH---FDRHALELLEKMLMLDPSQ 216
+ +F + + + ++ +L+ +ML DP+Q
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324
Query: 217 RISAKDALDSEYFWTDPLPCDPKSLPKYESS 247
RI+ +AL +F P + S
Sbjct: 325 RITLAEALLHPFF-AGLTPEERSFHTSRNPS 354
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 57/241 (23%), Positives = 94/241 (39%), Gaps = 32/241 (13%)
Query: 19 YMVFEYMD--------HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDI 69
Y+++EYM+ L + IKC +K +L Y H + HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY-GPAVDM 128
K SN+L+D G +KL+DFG + + + T + PPE + Y G VD+
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYMV---DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 129 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET---IWPGVSKMPAYNHFKPSR 185
WS+G + +P F L S E I + P +
Sbjct: 236 WSLGICLYVMFYNV--VP-----------FSLKISLVELFNNIRTKNIEYPLDRNHFLYP 282
Query: 186 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF---WTDPLPCDPKSLP 242
++ ++ L+ L +P++RI+++DAL E+ + L K L
Sbjct: 283 LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELY 342
Query: 243 K 243
K
Sbjct: 343 K 343
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 48/223 (21%), Positives = 86/223 (38%), Gaps = 37/223 (16%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+ E L ++ + ++Q +GL + H ++HRD+K N+LI
Sbjct: 94 YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153
Query: 79 EGN-----LKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATK--YGPAVDMW 129
++DFGL + + + + + T + PE+L K VD++
Sbjct: 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIF 213
Query: 130 SVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 188
S GC+F ++ G + + + + + P
Sbjct: 214 SAGCVFYYVISEGSHPFGKSLQRQANILL----------------GACSLDCLHPE---- 253
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231
+H D A EL+EKM+ +DP +R SAK L +FW+
Sbjct: 254 -------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 51/258 (19%), Positives = 92/258 (35%), Gaps = 47/258 (18%)
Query: 14 YRGSTYMVFEYMDHDLTGLADRPGLR-FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
Y ++FE + L + R F + IK Y ++L L+Y + H D+K
Sbjct: 107 YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE 166
Query: 73 N-LLIDNEG------------------------NLKLADFGLARSFSYDHNNTLTNRVIT 107
N LL D +KL DFG ++ + + + T
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CATFKSDY-HGSIINT 222
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET 167
YR PE++L + + DMWS GC+ AEL G + E L+ + + +
Sbjct: 223 RQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKN 281
Query: 168 IWPGVSKMPAYNHFK---------PSRTMKRRVREVFRHF-------DRHALELLEKMLM 211
+ +K + + + ++ V + + L +L
Sbjct: 282 MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341
Query: 212 LDPSQRISAKDALDSEYF 229
+DP+ R S + L ++
Sbjct: 342 IDPTLRPSPAELLKHKFL 359
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 46/214 (21%), Positives = 84/214 (39%), Gaps = 39/214 (18%)
Query: 19 YMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
++ E+ D L + R G + +Q+ G+ Y H ++++RD+K SN+ +
Sbjct: 96 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ +K+ DFGL S ++ T TL Y PE + YG VD++++G I A
Sbjct: 156 VDTKQVKIGDFGLVTSLK--NDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILA 212
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
ELL+ ++ + + + +
Sbjct: 213 ELLHVCD--TAFETSKFFTDLRD-------------GIISD------------------- 238
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230
FD+ LL+K+L P R + + L + W
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 8e-40
Identities = 30/233 (12%), Positives = 60/233 (25%), Gaps = 36/233 (15%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADR------PGLRFTVPQIKCYMKQLLTGLHYC 59
L + + ++ DL L + + QL+
Sbjct: 151 LSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG- 118
++H NL I +G L L D + + Y P E L
Sbjct: 211 QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK----VGTRGPASSVPVTYAPREFLNAS 266
Query: 119 ATKYGPAVDMWSVGCIFAELLNGKP--ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMP 176
+ A++ W +G + L + D + + +P
Sbjct: 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP 326
Query: 177 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ L+ + L D +R+ +A+++ F
Sbjct: 327 DF-----------------------VKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-40
Identities = 47/212 (22%), Positives = 71/212 (33%), Gaps = 37/212 (17%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+ E L + G Q+ Y++ L L + H ++H D+K +N+ +
Sbjct: 133 YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP 192
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
G KL DFGL Y PELL G YG A D++S+G E
Sbjct: 193 RGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILE 247
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
+ LP + E ++ + G G+S
Sbjct: 248 VACNME-LP--HGGEGWQQLRQ--GYLPPEFTAGLSS----------------------- 279
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+L ML DP R +A+ L
Sbjct: 280 ---ELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 58/278 (20%), Positives = 100/278 (35%), Gaps = 41/278 (14%)
Query: 15 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
GS Y+V +Y + DL + + G+ F QI + Q+ L + H ++LHRDIK
Sbjct: 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N+ + +G ++L DFG+AR + + T +Y PE+ Y D+W++G
Sbjct: 155 NIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICEN-KPYNNKSDIWALG 212
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
C+ EL K + + KI +
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKI-----------------------------ISGSFP 243
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY-------FWTDPLPCDPKSLPKYE 245
V H+ L+ ++ +P R S L+ + F + L + L +
Sbjct: 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFS 303
Query: 246 SSHEYQTKKRRQQQRQH-EEATKRQKLHHPQPHGRLPP 282
+R Q+ QK+ P +P
Sbjct: 304 KFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPL 341
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 45/216 (20%)
Query: 19 YMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y+V E G L D R F +KQ+L+G+ Y H + ++HRD+K NL
Sbjct: 112 YLVMEC----YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167
Query: 75 LIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
L+++ + +K+ DFGL+ F ++ + R+ T +Y PE+L KY D+WS+
Sbjct: 168 LLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSI 223
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMKR 189
G I LL G P G+ + E L K+ G W VS+
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFDSPEWKNVSE--------------- 266
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A +L+++ML D +RISA+ AL+
Sbjct: 267 -----------GAKDLIKQMLQFDSQRRISAQQALE 291
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 44/249 (17%), Positives = 90/249 (36%), Gaps = 48/249 (19%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
M+FE++ +G + +R +I Y+ Q+ L + H + + H DI+ N
Sbjct: 77 VMIFEFI----SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 74 LLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
++ + +K+ +FG AR + Y PE+ A DMWS+
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSL 189
Query: 132 GCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTM 187
G + LL+G P + + + I + E + +S
Sbjct: 190 GTLVYVLLSGIN--PFLAETNQQIIENI--MNAEYTFDEEAFKEISI------------- 232
Query: 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESS 247
A++ ++++L+ + R++A +AL + K + +
Sbjct: 233 -------------EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR 279
Query: 248 HEYQTKKRR 256
Y T ++
Sbjct: 280 RYYHTLIKK 288
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 47/221 (21%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V E+ G L ++ +F MKQ+L+G+ Y H + ++HRDIK N
Sbjct: 122 YLVTEF----YEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 74 LLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
+L++N N+K+ DFGL+ F + L +R+ T +Y PE+L KY D+WS
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWS 232
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMK 188
G I LL G P G+N+ + + K+ G W +S
Sbjct: 233 CGVIMYILLCGYPPFGGQNDQDIIKKV--EKGKYYFDFNDWKNISD-------------- 276
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A EL++ ML D ++R +A++AL+S +
Sbjct: 277 ------------EAKELIKLMLTYDYNKRCTAEEALNSRWI 305
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 48/245 (19%), Positives = 87/245 (35%), Gaps = 58/245 (23%)
Query: 19 YMVFEYMDHDL------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
Y+ E + +L ++D ++Q+ +G+ + H +++HRD+K
Sbjct: 85 YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 73 NLLIDNEG-------------NLKLADFGLARSFSYDH---NNTLTNRVITLWYRPPELL 116
N+L+ + ++DFGL + L N T +R PELL
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204
Query: 117 LGAT------KYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQ--LSKIFELCGSPDET 167
+ + ++D++S+GC+F +L GK K E + IF L
Sbjct: 205 EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL-DEMKCL 263
Query: 168 IWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 227
+ A +L+ +M+ DP +R +A L
Sbjct: 264 HDRSLIA--------------------------EATDLISQMIDHDPLKRPTAMKVLRHP 297
Query: 228 YFWTD 232
FW
Sbjct: 298 LFWPK 302
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 45/220 (20%)
Query: 19 YMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y+V E TG L D R F+ ++Q+L+G+ Y H N+++HRD+K NL
Sbjct: 102 YLVGEV----YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 157
Query: 75 LIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
L+++ + N+++ DFGL+ F + + + +++ T +Y PE+L G Y D+WS
Sbjct: 158 LLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWST 213
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMKR 189
G I LL+G P G NE + L K+ G W VS+
Sbjct: 214 GVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSE--------------- 256
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A +L+ KML PS RISA+DALD E+
Sbjct: 257 -----------SAKDLIRKMLTYVPSMRISARDALDHEWI 285
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 47/221 (21%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V E TG L D RF+ +KQ+ +G+ Y H + ++HRD+K N
Sbjct: 97 YIVGEL----YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151
Query: 74 LLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
+L+++ + ++K+ DFGL+ F N + +R+ T +Y PE+L G Y D+WS
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWS 207
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMK 188
G I LL+G P GKNE + L ++ G W +S
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRTISD-------------- 251
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A +L+ KML PS RI+A L+ +
Sbjct: 252 ------------DAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 51/251 (20%), Positives = 98/251 (39%), Gaps = 43/251 (17%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
++ E++ +G L DR + + ++ YM+Q GL + H + ++H DIK N
Sbjct: 124 VLILEFL----SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179
Query: 74 LLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
++ + + +K+ DFGLA + + + T + PE++ G DMW++
Sbjct: 180 IMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAI 236
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G + LL+G G+++ E L + DE + VS
Sbjct: 237 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP----------------- 279
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW-TDPLPCDPKSLPKYESSHEY 250
A + ++ +L +P +R++ DAL+ W +P +
Sbjct: 280 ---------EAKDFIKNLLQKEPRKRLTVHDALEHP--WLKGDHSNLTSRIPSSRYNKIR 328
Query: 251 QTKKRRQQQRQ 261
Q K +
Sbjct: 329 QKIKEKYADWP 339
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 52/204 (25%), Positives = 80/204 (39%), Gaps = 36/204 (17%)
Query: 30 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI--DNEGNLKLADF 87
G + I M+Q+ + LHY H + HRDIK N L + +KL DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 88 GLARSF---SYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFAELLNGKP 143
GL++ F + +T + T ++ PE+L + YGP D WS G + LL G
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 144 ILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRH 201
PG N+A+ +S++ L + +S
Sbjct: 275 PFPGVNDADTISQV--LNKKLCFENPNYNVLSP--------------------------L 306
Query: 202 ALELLEKMLMLDPSQRISAKDALD 225
A +LL +L + +R A AL
Sbjct: 307 ARDLLSNLLNRNVDERFDAMRALQ 330
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 47/225 (20%)
Query: 19 YMVFEY------MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
Y+V E + L +R F+ + + +M Q++TG+ Y H + +LHRD+ S
Sbjct: 87 YLVLEMCHNGEMNRY----LKNRVK-PFSENEARHFMHQIITGMLYLHSHGILHRDLTLS 141
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
NLL+ N+K+ADFGLA H TL T Y PE+ + +G D+WS
Sbjct: 142 NLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG---TPNYISPEIATR-SAHGLESDVWS 197
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+GC+F LL G+P L+K+ +MP
Sbjct: 198 LGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------ADYEMP-------------- 232
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235
A +L+ ++L +P+ R+S LD + +
Sbjct: 233 -----SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 64/272 (23%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V E M G L D+ R K Y Q+L + Y H N ++HRD+K N
Sbjct: 90 YIVLELM----EGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 74 LLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK--YGPAVDM 128
+L+ ++ +K+ DFG ++ + + T Y PE+L+ Y AVD
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 129 WSVGCIFAELLNGKPILP---GKNEAEQLSKI----FELCGSPDETIWPGVSKMPAYNHF 181
WS+G I L+G P P + + +I + +W VS+
Sbjct: 203 WSLGVILFICLSGYP--PFSEHRTQVSLKDQITSGKYNF----IPEVWAEVSE------- 249
Query: 182 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 241
AL+L++K+L++DP R + ++AL + + + + L
Sbjct: 250 -------------------KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290
Query: 242 PKYESSH--------EYQTKKRRQQQRQHEEA 265
E+ + T ++R ++ + E A
Sbjct: 291 LSEENESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-37
Identities = 64/217 (29%), Positives = 87/217 (40%), Gaps = 47/217 (21%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V E TG L +R F MK +L+ + YCH V HRD+K N
Sbjct: 82 YLVMELC----TGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPEN 136
Query: 74 LLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
L + LKL DFGLA F + +V T +Y P++L G YGP D WS
Sbjct: 137 FLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWS 192
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMK 188
G + LL G P ++E + KI G+ E W VS
Sbjct: 193 AGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLNVSP-------------- 236
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A L+ ++L P QRI++ AL+
Sbjct: 237 ------------QAESLIRRLLTKSPKQRITSLQALE 261
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 40/220 (18%)
Query: 19 YMVFEYMDH-DLTGL---ADRPGLRFTVPQIKCYMKQLLTGLHYCH-----VNQVLHRDI 69
Y+V EY + DL + + + M QL L CH + VLHRD+
Sbjct: 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
K +N+ +D + N+KL DFGLAR ++D + T V T +Y PE + Y D+W
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNRM-SYNEKSDIW 200
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
S+GC+ EL P ++ E KI +
Sbjct: 201 SLGCLLYELCALMPPFTAFSQKELAGKI-----------------------------REG 231
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ R + + E++ +ML L R S ++ L++
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 51/232 (21%)
Query: 19 YMVFEY------MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
++V E ++ R T P+ + Y++Q++ G Y H N+V+HRD+K
Sbjct: 91 FVVLELCRRRSLLEL----HKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 144
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWS 130
NL ++ + +K+ DFGLA YD + T Y PE+L + VD+WS
Sbjct: 145 NLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK-KGHSFEVDVWS 200
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+GCI LL GKP E +I + +P
Sbjct: 201 IGCIMYTLLVGKPPFETSCLKETYLRIKK-----------NEYSIP-------------- 235
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 242
+H + A L++KML DP+ R + + L+ E+F + + P LP
Sbjct: 236 -----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI---PARLP 279
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 47/219 (21%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
++VF+ M L D + + + M+ LL + H ++HRD+K N
Sbjct: 100 FLVFDLM----KKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-----TKYGPAVDM 128
+L+D++ N+KL DFG + D L T Y PE++ + YG VDM
Sbjct: 155 ILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 129 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRT 186
WS G I LL G P + + L I + G+ W S
Sbjct: 213 WSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGNYQFGSPEWDDYSD------------ 258
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+L+ + L++ P +R +A++AL
Sbjct: 259 --------------TVKDLVSRFLVVQPQKRYTAEEALA 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 47/217 (21%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V E TG L D RF+ +KQ+ +G+ Y H + ++HRD+K N
Sbjct: 97 YIVGELY----TGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151
Query: 74 LLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
+L++++ ++K+ DFGL+ F N + +R+ T +Y PE+L G Y D+WS
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWS 207
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMK 188
G I LL+G P GKNE + L ++ G W +S
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRTISD-------------- 251
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A +L+ KML PS RI+A L+
Sbjct: 252 ------------DAKDLIRKMLTFHPSLRITATQCLE 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 42/238 (17%), Positives = 75/238 (31%), Gaps = 46/238 (19%)
Query: 12 NKYRGSTYMVFEYMDH-DLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68
+ + Y+ + +L Q+ + + H ++HRD
Sbjct: 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRD 143
Query: 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHN-----------NTLTNRVITLWYRPPELLL 117
+K SN+ + +K+ DFGL + D T +V T Y PE +
Sbjct: 144 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203
Query: 118 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 177
G Y VD++S+G I ELL P L+ +
Sbjct: 204 G-NSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV-------------------- 240
Query: 178 YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235
+ +F +++ ML P +R A + +++ F P
Sbjct: 241 ---------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 42/243 (17%), Positives = 76/243 (31%), Gaps = 37/243 (15%)
Query: 5 FLETTDGNKYRGSTYMVFEYMDHDLTG--LADR-----PGLRFTVPQIKCYMKQLLTGLH 57
E T ++ E+ L + ++ ++ G++
Sbjct: 75 IEEETTTRHK----VLIMEFC----PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 58 YCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 113
+ N ++HR+IK N++ D + KL DFG AR + + + T Y P
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHP 184
Query: 114 ELLLGAT-------KYGPAVDMWSVGCIFAELLNGKP----ILPGKNEAEQLSKIFELCG 162
++ A KYG VD+WS+G F G + E + KI + G
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI--ITG 242
Query: 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 222
P I + + + + +L +L D +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ---VLLTPVLANILEADQEKCWGFDQ 299
Query: 223 ALD 225
Sbjct: 300 FFA 302
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 48/222 (21%)
Query: 15 RGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
Y+VF+ + TG L + R ++ ++Q+L + YCH N ++HR++K
Sbjct: 77 ESFHYLVFDLV----TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 71 GSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 127
NLL+ ++ +KLADFGLA + + T Y PE+L Y VD
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVD 189
Query: 128 MWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKP 183
+W+ G I LL G P P +++ ++I G+ D W V+
Sbjct: 190 IWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTP--------- 236
Query: 184 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A L++ ML ++P +RI+A AL
Sbjct: 237 -----------------EAKSLIDSMLTVNPKKRITADQALK 261
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 4e-36
Identities = 53/317 (16%), Positives = 97/317 (30%), Gaps = 31/317 (9%)
Query: 5 FLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHV 61
+ + EY + DL ++ + I+ + + + L Y H
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 62 NQVLHRDIKGSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG 118
N+++HRD+K N+++ K+ D G A+ D T V TL Y PELL
Sbjct: 140 NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQ 197
Query: 119 ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 178
KY VD WS G + E + G + Q + ++ ++ +
Sbjct: 198 -KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256
Query: 179 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--------- 229
+ P+ + L+ MLM QR + + F
Sbjct: 257 SSVLPTPNHLSGILAGKLE------RWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310
Query: 230 ------WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPI 283
+ + E+ ++ ++ EE Q + P
Sbjct: 311 KLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLA-LNSAQPLT 369
Query: 284 QHAGQSHHWSGPNHPMN 300
Q+ G +
Sbjct: 370 QYVIDCTVIDGRQGEGD 386
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-36
Identities = 53/229 (23%), Positives = 86/229 (37%), Gaps = 47/229 (20%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
+ + + ++ E M G + +R FT + M+ + T + + H +
Sbjct: 93 NMHHGKRCLLIIMECM----EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148
Query: 64 VLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 120
+ HRD+K NLL ++ LKL DFG A+ N L T +Y PE+L G
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPCYTPYYVAPEVL-GPE 204
Query: 121 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIWPGVSKMP 176
KY + DMWS+G I LL G P + G W VS+
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE-- 262
Query: 177 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A +L+ +L DP++R++ ++
Sbjct: 263 ------------------------DAKQLIRLLLKTDPTERLTITQFMN 287
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 54/219 (24%), Positives = 80/219 (36%), Gaps = 48/219 (21%)
Query: 19 YMVFEYMDHDLTG--LADR------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
Y+V E G L +R G + + MKQ++ L Y H V+H+D+K
Sbjct: 96 YIVMETC----EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK 151
Query: 71 GSNLLIDN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 127
N+L + +K+ DFGLA F + TN T Y PE+ D
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPEVFKR--DVTFKCD 207
Query: 128 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD-ETIWPGVSKMPAYNHFKPSRT 186
+WS G + LL G G + E K P+ ++
Sbjct: 208 IWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRPLTP------------ 253
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A++LL++ML DP +R SA L
Sbjct: 254 --------------QAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 36/212 (16%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y++ EY + + +F + Y+ +L L YCH +V+HRDIK NLL+
Sbjct: 85 YLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 143
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+ G LK+ADFG + L TL Y PPE++ G + VD+WS+G + E
Sbjct: 144 SAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEGRM-HDEKVDLWSLGVLCYE 199
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
L GKP E +I P
Sbjct: 200 FLVGKPPFEANTYQETYKRISR-----------VEFTFP-------------------DF 229
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A +L+ ++L +PSQR ++ L+ +
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-36
Identities = 42/225 (18%), Positives = 75/225 (33%), Gaps = 46/225 (20%)
Query: 19 YMVFEYMDH-DLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
Y+ + +L +R Q+ + + H ++HRD+K SN+
Sbjct: 137 YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIF 196
Query: 76 IDNEGNLKLADFGLARSFSYD-----------HNNTLTNRVITLWYRPPELLLGATKYGP 124
+ +K+ DFGL + D T T +V T Y PE + G Y
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSH 255
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 184
VD++S+G I ELL ++ +
Sbjct: 256 KVDIFSLGLILFELLY--SFSTQMERVRIITDV--------------------------- 286
Query: 185 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ +F +++ ML P++R A D +++ F
Sbjct: 287 --RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-36
Identities = 53/252 (21%), Positives = 101/252 (40%), Gaps = 47/252 (18%)
Query: 19 YMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
++ E + +G L D + + ++KQ+L G++Y H ++ H D+K N+
Sbjct: 91 VLILELV----SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 75 LI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
++ ++KL DFGLA + N T + PE++ G DMWS
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWS 203
Query: 131 VGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 188
+G I LL+G P G + E L+ I + DE + S+
Sbjct: 204 IGVITYILLSGAS--PFLGDTKQETLANITSVSYDFDEEFFSHTSE-------------- 247
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 248
A + + K+L+ + +R++ ++AL W P+ + + +
Sbjct: 248 ------------LAKDFIRKLLVKETRKRLTIQEALRHP--WITPVDNQQAMVRRESVVN 293
Query: 249 EYQTKKRRQQQR 260
+K+ ++R
Sbjct: 294 LENFRKQYVRRR 305
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 55/261 (21%)
Query: 19 YMVFEY------MDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
++V E ++ R T P+ + Y++Q++ G Y H N+V+HRD+K
Sbjct: 117 FVVLELCRRRSLLEL----HKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
NL ++ + +K+ DFGLA YD L T Y PE+L + VD+WS
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG---TPNYIAPEVLSK-KGHSFEVDVWS 226
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+GCI LL GKP E +I + +P
Sbjct: 227 IGCIMYTLLVGKPPFETSCLKETYLRIKK-----------NEYSIP-------------- 261
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEY 250
+H + A L++KML DP+ R + + L+ E+F + + P LP
Sbjct: 262 -----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI---PARLP----ITCL 309
Query: 251 QTKKRRQQQRQHEEATKRQKL 271
R + + R+ L
Sbjct: 310 TIPPRFSIAPSSLDPSNRKPL 330
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 53/255 (20%), Positives = 93/255 (36%), Gaps = 50/255 (19%)
Query: 19 YMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
++ EY G + + +KQ+L G++Y H N ++H D+K
Sbjct: 105 ILILEYA----AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQ 160
Query: 73 NLLIDNE---GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
N+L+ + G++K+ DFG++R H L + T Y PE+L A DMW
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNY-DPITTATDMW 217
Query: 130 SVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSR 185
++G I LL P G++ E I + D E + VS+
Sbjct: 218 NIGIIAYMLLTHTS--PFVGEDNQETYLNI--SQVNVDYSEETFSSVSQ----------- 262
Query: 186 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 245
A + ++ +L+ +P +R +A+ L +
Sbjct: 263 ---------------LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSS 307
Query: 246 SSHEYQTKKRRQQQR 260
SS R + +
Sbjct: 308 SSQTQDHSVRSSEDK 322
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 56/224 (25%)
Query: 19 YMVFEYMDHDLTG--LADR------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
YMVFE+M G L G ++ YM+Q+L L YCH N ++HRD+K
Sbjct: 102 YMVFEFM----DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK 157
Query: 71 GSNLLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 127
+L+ +N +KL FG+A + RV T + PE++ YG VD
Sbjct: 158 PHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVD 215
Query: 128 MWSVGCIFAELLNGKPILP--GKNEAEQLSKIFE--LCGSPD--ETIWPGVSKMPAYNHF 181
+W G I LL+G P G E ++FE + G W +S+
Sbjct: 216 VWGCGVILFILLSGCL--PFYGTKE-----RLFEGIIKGKYKMNPRQWSHISE------- 261
Query: 182 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A +L+ +MLMLDP++RI+ +AL+
Sbjct: 262 -------------------SAKDLVRRMLMLDPAERITVYEALN 286
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 54/251 (21%), Positives = 98/251 (39%), Gaps = 44/251 (17%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
M++E+M +G L ++ + + + YM+Q+ GL + H N +H D+K N
Sbjct: 230 VMIYEFM----SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285
Query: 74 LLIDN--EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
++ LKL DFGL D ++ T + PE+ G G DMWSV
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSV 342
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRTMKR 189
G + LL+G G+N+ E L + + ++ + G+S+
Sbjct: 343 GVLSYILLSGLSPFGGENDDETLRNV--KSCDWNMDDSAFSGISE--------------- 385
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHE 249
+ + K+L+ DP+ R++ AL+ + P +P +
Sbjct: 386 -----------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434
Query: 250 YQTKKRRQQQR 260
+ K +
Sbjct: 435 RDSIKTKYDAW 445
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 15 RGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
Y+VF+ + TG L + R ++ ++Q+L + YCH N ++HR++K
Sbjct: 100 ESFHYLVFDLV----TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155
Query: 71 GSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 127
NLL+ ++ +KLADFGLA + + T Y PE+L Y VD
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVD 212
Query: 128 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSR 185
+W+ G I LL G P +++ ++I G+ D W V+
Sbjct: 213 IWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTP----------- 259
Query: 186 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A L++ ML ++P +RI+A AL
Sbjct: 260 ---------------EAKSLIDSMLTVNPKKRITADQALK 284
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 45/217 (20%)
Query: 19 YMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
++ E + G L D T + ++KQ+L G++Y H Q+ H D+K N+
Sbjct: 90 ILILELV----AGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145
Query: 75 LIDNE----GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
++ + +K+ DFGLA D N N T + PE++ G DMWS
Sbjct: 146 MLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWS 202
Query: 131 VGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 188
+G I LL+G P G + E L+ + + ++ + S
Sbjct: 203 IGVITYILLSGAS--PFLGDTKQETLANVSAVNYEFEDEYFSNTSA-------------- 246
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A + + ++L+ DP +R++ +D+L
Sbjct: 247 ------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 54/252 (21%), Positives = 101/252 (40%), Gaps = 47/252 (18%)
Query: 19 YMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
++ E + +G L D + + ++KQ+L G++Y H ++ H D+K N+
Sbjct: 91 VLILELV----SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 75 LI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
++ ++KL DFGLA + N T + PE++ G DMWS
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWS 203
Query: 131 VGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 188
+G I LL+G P G + E L+ I + DE + S+
Sbjct: 204 IGVITYILLSGAS--PFLGDTKQETLANITAVSYDFDEEFFSQTSE-------------- 247
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 248
A + + K+L+ + +R++ ++AL W P+ + + +
Sbjct: 248 ------------LAKDFIRKLLVKETRKRLTIQEALRHP--WITPVDTQQAMVRRESVVN 293
Query: 249 EYQTKKRRQQQR 260
KK+ ++R
Sbjct: 294 LENFKKQYVRRR 305
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 49/219 (22%)
Query: 19 YMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
++ E + +G L D T + ++KQ+L G+HY H ++ H D+K N+
Sbjct: 84 VLILELV----SGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139
Query: 75 LIDNE----GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
++ ++ +KL DFG+A + N N T + PE++ G DMWS
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWS 196
Query: 131 VGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPSRT 186
+G I LL+G P G+ + E L+ I + D E + S+
Sbjct: 197 IGVITYILLSGAS--PFLGETKQETLTNI--SAVNYDFDEEYFSNTSE------------ 240
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A + + ++L+ DP +R++ +L+
Sbjct: 241 --------------LAKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 36/229 (15%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y++ E+ +L + G RF + +M++L LHYCH +V+HRDIK NLL+
Sbjct: 90 YLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG 148
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+G LK+ADFG + T+ TL Y PPE++ G + VD+W G + E
Sbjct: 149 YKGELKIADFGWSVHAPSLRRRTMCG---TLDYLPPEMIEG-KTHDEKVDLWCAGVLCYE 204
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
L G P + E +I K P
Sbjct: 205 FLVGMPPFDSPSHTETHRRIVN-----------VDLKFP-------------------PF 234
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYES 246
+ +L+ K+L P QR+ K ++ + + P +S
Sbjct: 235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQS 283
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 58/226 (25%), Positives = 87/226 (38%), Gaps = 51/226 (22%)
Query: 15 RGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
Y+V E M G L D+ + F+ + + + + Y H V+HRD+K
Sbjct: 88 GKYVYVVTELM----KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLK 143
Query: 71 GSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
SN+L N ++++ DFG A+ N L T + PE+L Y A
Sbjct: 144 PSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTANFVAPEVLER-QGYDAAC 201
Query: 127 DMWSVGCIFAELLNGKP---ILPGKNEAEQLSKI----FELCGSPDETIWPGVSKMPAYN 179
D+WS+G + +L G P E L++I F L G W VS
Sbjct: 202 DIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY----WNSVSD----- 252
Query: 180 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A +L+ KML +DP QR++A L
Sbjct: 253 ---------------------TAKDLVSKMLHVDPHQRLTAALVLR 277
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 62/245 (25%), Positives = 94/245 (38%), Gaps = 40/245 (16%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
+V EY+ G L DR T +MKQ+ G+ + H +LH D+K N
Sbjct: 162 VLVMEYV----DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN 217
Query: 74 LLIDN--EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
+L N +K+ DFGLAR + L T + PE++ DMWSV
Sbjct: 218 ILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSV 274
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G I LL+G G N+AE L+ I ++ + +S+
Sbjct: 275 GVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE----------------- 317
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQ 251
A E + K+L+ + S RISA +AL + L + K + Q
Sbjct: 318 ---------EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQ 368
Query: 252 TKKRR 256
+
Sbjct: 369 DFVTK 373
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 55/221 (24%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V + + +G L DR G +T ++Q+L+ + Y H N ++HRD+K N
Sbjct: 82 YLVMQLV----SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 74 LLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
LL + + + DFGL++ + N ++ T Y PE+L Y AVD WS
Sbjct: 137 LLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWS 192
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKI------FELCGSPDETIWPGVSKMPAYNHFKPS 184
+G I LL G P + E++ KI FE SP W +S+
Sbjct: 193 IGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE---SPF---WDDISE---------- 236
Query: 185 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A + + +L DP++R + + AL
Sbjct: 237 ----------------SAKDFICHLLEKDPNERYTCEKALS 261
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 47/222 (21%)
Query: 15 RGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
G Y++F+ + TG L + R ++ ++Q+L + +CH V+HR++K
Sbjct: 82 EGHHYLIFDLV----TGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLK 137
Query: 71 GSNLLIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 127
NLL+ ++ +KLADFGLA + T Y PE+L YG VD
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVLRK-DPYGKPVD 195
Query: 128 MWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKP 183
+W+ G I LL G P P +++ +I G+ D W V+
Sbjct: 196 LWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTP--------- 242
Query: 184 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A +L+ KML ++PS+RI+A +AL
Sbjct: 243 -----------------EAKDLINKMLTINPSKRITAAEALK 267
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 52/222 (23%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+V E M G L D+ R K Y Q+L + Y H N ++HRD+K N
Sbjct: 215 YIVLELM----EGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269
Query: 74 LLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK--YGPAVDM 128
+L+ + + +K+ DFG ++ + + T Y PE+L+ Y AVD
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 327
Query: 129 WSVGCIFAELLNGKPILP---GKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKP 183
WS+G I L+G P P + + +I G + +W VS+
Sbjct: 328 WSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGKYNFIPEVWAEVSE--------- 374
Query: 184 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
AL+L++K+L++DP R + ++AL
Sbjct: 375 -----------------KALDLVKKLLVVDPKARFTTEEALR 399
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 56/229 (24%), Positives = 87/229 (37%), Gaps = 46/229 (20%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
+ R +V E + G + DR FT + MK + + Y H
Sbjct: 126 NLYAGRKCLLIVMECL----DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 64 VLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 120
+ HRD+K NLL ++ LKL DFG A+ +N+LT T +Y PE+L G
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPYYVAPEVL-GPE 238
Query: 121 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIWPGVSKMP 176
KY + DMWS+G I LL G P + + G + W VS+
Sbjct: 239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-- 296
Query: 177 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
L+ +L +P+QR++ + ++
Sbjct: 297 ------------------------EVKMLIRNLLKTEPTQRMTITEFMN 321
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 50/295 (16%), Positives = 90/295 (30%), Gaps = 43/295 (14%)
Query: 5 FLETTDGNKYRGSTYMVFEYMDHDLTG--LADR-----PGLRFTVPQIKCYMKQLLTGLH 57
E T ++ E+ L + ++ ++ G++
Sbjct: 75 IEEETTTRHK----VLIMEFC----PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 58 YCHVNQVLHRDIKGSNLLI----DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPP 113
+ N ++HR+IK N++ D + KL DFG AR + + + T Y P
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHP 184
Query: 114 ELLLGAT-------KYGPAVDMWSVGCIFAELLNGKP----ILPGKNEAEQLSKIFELCG 162
++ A KYG VD+WS+G F G + E + KI
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 222
S + P + + R +L +L D +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS-----LSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 223 ALDSEYFWTDPLPCDPKSLPKYES----SHEYQTKKRRQQ--QRQHEEATKRQKL 271
+ SL + + H Y T + +Q + + Q+L
Sbjct: 300 FFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQEL 354
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-34
Identities = 55/248 (22%), Positives = 90/248 (36%), Gaps = 45/248 (18%)
Query: 13 KYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
KY S +V E D + + + Y QL + L + H
Sbjct: 96 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATK 121
+V+HRDIK +N+ I G +KL D GL R FS T + ++ T +Y PE +
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHE-NG 212
Query: 122 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG-VSKMPAYNH 180
Y D+WS+GC+ E+ + P + L + + I +P+ +H
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCKK-------IEQCDYPPLPS-DH 262
Query: 181 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 240
+ S ++ +L+ + DP +R D C S
Sbjct: 263 Y--SEELR---------------QLVNMCINPDPEKRPDVTYVYDVAKRMH---ACTASS 302
Query: 241 LPKYESSH 248
L + H
Sbjct: 303 LEHHHHHH 310
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-34
Identities = 59/262 (22%), Positives = 101/262 (38%), Gaps = 51/262 (19%)
Query: 15 RGSTYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
+ T++V E + G L +R + F+ + M++L++ + + H V+HRD+K
Sbjct: 78 QLHTFLVMELL----NGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 71 GSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVD 127
NLL +E +K+ DFG AR N L TL Y PE LL Y + D
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCFTLHYAAPE-LLNQNGYDESCD 191
Query: 128 MWSVGCIFAELLNGKPILPGKNEAEQLS---KIFE--LCGSPD--ETIWPGVSKMPAYNH 180
+WS+G I +L+G+ + + + +I + G W VS+
Sbjct: 192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ------ 245
Query: 181 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW---TDPLPCD 237
A +L++ +L +DP++R+ +E W L +
Sbjct: 246 --------------------EAKDLIQGLLTVDPNKRLKMSGLRYNE--WLQDGSQLSSN 283
Query: 238 PKSLPKYESSHEYQTKKRRQQQ 259
P P S +
Sbjct: 284 PLMTPDILGSSGAAVHTCVKAT 305
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 52/221 (23%), Positives = 87/221 (39%), Gaps = 51/221 (23%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
++VF+ M L D + + + M+ LL + + H N ++HRD+K N
Sbjct: 176 FLVFDLM----RKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-----TKYGPAVDM 128
+L+D+ ++L+DFG + + L T Y PE+L + YG VD+
Sbjct: 231 ILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288
Query: 129 WSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD--ETIWPGVSKMPAYNHFKPS 184
W+ G I LL G P P + + L I + G W S
Sbjct: 289 WACGVILFTLLAGSP--PFWHRRQILMLRMI--MEGQYQFSSPEWDDRSS---------- 334
Query: 185 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+L+ ++L +DP R++A+ AL
Sbjct: 335 ----------------TVKDLISRLLQVDPEARLTAEQALQ 359
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 40/217 (18%)
Query: 19 YMVFEYMDHDLTG-LADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
YMVFE ++ G + + P L + Q + Y + L+ G+ Y H +++HRDIK SNLL+
Sbjct: 114 YMVFELVNQ---GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-Y-GPAVDMWSVGCI 134
+G++K+ADFG++ F + L+N V T + PE L K + G A+D+W++G
Sbjct: 171 GEDGHIKIADFGVSNEFK-GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
Query: 135 FAELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
+ G+ P + SKI + P
Sbjct: 230 LYCFVFGQ--CPFMDERIMCLHSKIKS-----------QALEFPDQPDIAED-------- 268
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+L+ +ML +P RI + +
Sbjct: 269 ---------LKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 38/237 (16%)
Query: 19 YMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
YMV EY + + D P RF V Q Y QL+ GL Y H ++H+DIK NLL+
Sbjct: 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143
Query: 78 NEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKY-GPAVDMWSVGCIF 135
G LK++ G+A + + ++T + ++PPE+ G + G VD+WS G
Sbjct: 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 136 AELLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
+ G P G N + I + G +P
Sbjct: 204 YNITTGL--YPFEGDNIYKLFENIGK-----------GSYAIP----------------- 233
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PLPCDPKSLPKYESSHE 249
+LL+ ML +P++R S + +F P P +P + +
Sbjct: 234 --GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 31/255 (12%), Positives = 70/255 (27%), Gaps = 56/255 (21%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLAD------RPGLRFTVPQIKCYMKQLLTGLHYC 59
+ + + + S + ++ M +L + Q++ L
Sbjct: 163 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222
Query: 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL--- 116
H ++H ++ ++++D G + L F + ++ + PPEL
Sbjct: 223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARR 277
Query: 117 -------LGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 169
T + D W++G + + + IF C
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC-------- 329
Query: 170 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
++ + LLE L R+ A+++ +
Sbjct: 330 --------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 230 WTDPLPCDPKSLPKY 244
+LP Y
Sbjct: 364 -EQLRTELSAALPLY 377
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 48/229 (20%), Positives = 74/229 (32%), Gaps = 67/229 (29%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTG------LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
+ R +V E + G + DR FT + MK + + Y H
Sbjct: 82 NLYAGRKCLLIVMECL----DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 64 VLHRDIKGSNLLIDNEG---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 120
+ HRD+K NLL ++ LKL DFG A E
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KETT--GE 173
Query: 121 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIWPGVSKMP 176
KY + DMWS+G I LL G P + + G + W VS+
Sbjct: 174 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-- 231
Query: 177 AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
L+ +L +P+QR++ + ++
Sbjct: 232 ------------------------EVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 65/219 (29%), Positives = 93/219 (42%), Gaps = 49/219 (22%)
Query: 19 YMVFEYMDHDLTG--LADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
+V E + TG L DR G ++ +KQ+L + Y H N ++HRD+K N
Sbjct: 124 SLVLELV----TGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 74 LLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
LL + LK+ADFGL++ +H + T Y PE+L G YGP VDMWS
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWS 235
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFE--LCGSPD--ETIWPGVSKMPAYNHFKPSRT 186
VG I LL G P +E +F L W VS
Sbjct: 236 VGIITYILLCGFE--PFYDERGD-QFMFRRILNCEYYFISPWWDEVSL------------ 280
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+A +L+ K+++LDP +R++ AL
Sbjct: 281 --------------NAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 44/232 (18%), Positives = 76/232 (32%), Gaps = 55/232 (23%)
Query: 13 KYRGST------YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
G+ + E ++ L + + Y+ Q L GL Y H
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 63 QVLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLL 117
++LH D+K N+L+ ++G+ L DFG A D + + PE+++
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 118 GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA 177
G VD+WS C+ +LNG P W + P
Sbjct: 230 G-KPCDAKVDIWSSCCMMLHMLNGCH--P----------------------WTQYFRGPL 264
Query: 178 Y----NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+ P R + + +++ L +P R SA +
Sbjct: 265 CLKIASEPPPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRR 309
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 41/223 (18%), Positives = 72/223 (32%), Gaps = 47/223 (21%)
Query: 19 YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+++ + + G T QI + + GL H HRD+K +N+
Sbjct: 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNI 165
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI--------TLWYRPPELLLGA--TKYGP 124
L+ +EG L D G + + T+ YR PEL
Sbjct: 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE 225
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDET---IWPGVSKMPAYNHF 181
D+WS+GC+ ++ G+ P +++ ++ +P
Sbjct: 226 RTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKGDSVALAVQNQLSIPQSPRH 272
Query: 182 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
S + +LL M+ +DP QR L
Sbjct: 273 --SSALW---------------QLLNSMMTVDPHQRPHIPLLL 298
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 50/241 (20%), Positives = 84/241 (34%), Gaps = 62/241 (25%)
Query: 17 STYMVFEYMDHDLTG--LADRPGLR--FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
Y+VFE M G + R F + ++ + + L + H + HRD+K
Sbjct: 85 RFYLVFEKM----RGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 73 NLLIDNEGN---LKLADFGLARSFSYDH------NNTLTNRVITLWYRPPELLLG----A 119
N+L ++ +K+ DF L + L + Y PE++ A
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 120 TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI----------- 168
+ Y D+WS+G I LL+G P G+ ++ E C + +
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF 260
Query: 169 ----WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
W +S A +L+ K+L+ D QR+SA L
Sbjct: 261 PDKDWAHISC--------------------------AAKDLISKLLVRDAKQRLSAAQVL 294
Query: 225 D 225
Sbjct: 295 Q 295
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 41/233 (17%), Positives = 71/233 (30%), Gaps = 60/233 (25%)
Query: 19 YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+ EY + D R F ++K + Q+ GL Y H ++H DIK SN+
Sbjct: 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNI 146
Query: 75 LIDNEGNL-------------------KLADFGLARSFSYDHNNTLTNRVITLWYRPPEL 115
I K+ D G S + E+
Sbjct: 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--SPQVEEG---DSRFLANEV 201
Query: 116 LLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 175
L + P D++++ +P LP +Q +I + ++
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQWHEIRQ-------------GRL 245
Query: 176 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228
P + + + ELL+ M+ DP +R SA +
Sbjct: 246 P----------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 68/227 (29%), Positives = 98/227 (43%), Gaps = 45/227 (19%)
Query: 13 KYRGST------YMVFEYMD----HDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHV 61
+Y GS + E + L L + G L+ I Y KQ+L GL Y H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSAL--LRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 62 NQVLHRDIKGSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGA 119
NQ++HRDIKG N+LI+ G LK++DFG ++ + N T TL Y PE++
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEIIDKG 198
Query: 120 TK-YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 178
+ YG A D+WS+GC E+ GKP P E + +F++ G+ K+
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAMFKV----------GMFKVH-- 244
Query: 179 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
P E+ A + K DP +R A D L
Sbjct: 245 ----P---------EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 42/225 (18%), Positives = 78/225 (34%), Gaps = 37/225 (16%)
Query: 9 TDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VL 65
K + +V E M L R + ++ + +Q+L GL + H ++
Sbjct: 95 ESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 66 HRDIKGSNLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 124
HRD+K N+ I G++K+ D GLA + + T + PE+ KY
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEM--YEEKYDE 208
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 184
+VD+++ G E+ + A Q+ + G +
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKVAI----------- 256
Query: 185 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ +E + + +R S KD L+ +F
Sbjct: 257 --------PEVKEI-------IEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 38/233 (16%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y++ EY ++ G R + + +Q+++ + YCH +++HRD+K NLL+D
Sbjct: 90 YLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+ N+K+ADFG + F+ L Y PEL G GP VD+WS+G I
Sbjct: 149 ADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYT 206
Query: 138 LLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
L++G LP G+N E ++ G ++P
Sbjct: 207 LVSGS--LPFDGQNLKELRERVLR-----------GKYRIP------------------- 234
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSH 248
+ LL++ L+L+P +R + + + + + K + E
Sbjct: 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDI 287
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 68/235 (28%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 19 YMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y+ EY +G L DR P + P + + QL+ G+ Y H + HRDIK NL
Sbjct: 81 YLFLEYC----SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGC 133
L+D NLK++DFGLA F Y++ L N++ TL Y PELL + VD+WS G
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 134 IFAELLNGKPILP---GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+ +L G+ LP + ++ S E P
Sbjct: 197 VLTAMLAGE--LPWDQPSDSCQEYSDWKE----------KKTYLNP-------------- 230
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYE 245
++ D L LL K+L+ +PS RI+ D ++ K L K
Sbjct: 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY--------NKPLKKGA 273
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 38/234 (16%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
MV EY +L R T + + + +Q++ + YCH ++++HRD+K NLL+D+
Sbjct: 85 VMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD 143
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
N+K+ADFGL+ + + L + Y PE++ G GP VD+WS G + +
Sbjct: 144 NLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVM 201
Query: 139 LNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
L G+ LP + K+ V MP
Sbjct: 202 LVGR--LPFDDEFIPNLFKKVNS-----------CVYVMP-------------------D 229
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PLPCDPKSLPKYESSHE 249
A L+ +M++ DP QRI+ ++ +F + P P + +
Sbjct: 230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADS 283
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 44/243 (18%), Positives = 79/243 (32%), Gaps = 42/243 (17%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
R P +QL++ + Y + ++HRDIK N++I + +KL DFG A
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK- 184
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
T+ Y PE+L+G GP ++MWS+G L+ + P +L +
Sbjct: 185 -LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE--NP----FCELEETV 237
Query: 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218
E P + + L+ +L P +R
Sbjct: 238 E-----------AAIHPP-------------------YLVSKELMSLVSGLLQPVPERRT 267
Query: 219 SAKDALDSEYFWTD----PLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHP 274
+ + + + + S R + + Q+L
Sbjct: 268 TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGG 327
Query: 275 QPH 277
+ H
Sbjct: 328 EGH 330
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 72/278 (25%), Positives = 108/278 (38%), Gaps = 54/278 (19%)
Query: 19 YMVFEYMDHDLTG--LADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y+ EY +G L DR P + P + + QL+ G+ Y H + HRDIK NL
Sbjct: 81 YLFLEYC----SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGC 133
L+D NLK++DFGLA F Y++ L N++ TL Y PELL + VD+WS G
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 134 IFAELLNGKPILP---GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+ +L G+ LP + ++ S E P
Sbjct: 197 VLTAMLAGE--LPWDQPSDSCQEYSDWKE----------KKTYLNP-------------- 230
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEY 250
++ D L LL K+L+ +PS RI+ D ++ PL K
Sbjct: 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLKKGAKRPRVTSGGVSE 285
Query: 251 QTKKRRQQQRQHEEATK-----------RQKLHHPQPH 277
+ + + + + K HH H
Sbjct: 286 SPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH 323
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 54/281 (19%), Positives = 91/281 (32%), Gaps = 78/281 (27%)
Query: 20 MVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLID 77
MVFE + H L + +P +K ++Q+L GL Y H +++H DIK N+L+
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181
Query: 78 NE-------------------------------------------------GNLKLADFG 88
+K+AD G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241
Query: 89 LARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK 148
A + T YR E+L+G+ Y D+WS C+ EL G +
Sbjct: 242 NACWVHKHFTEDIQ----TRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 149 N------EAEQLSKIFELCGSPDETIWPGVSKMPAY----------NHFKPSRTMKRRVR 192
+ + + ++ I EL G + + KP + V
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 193 EVFRHFDRH----ALELLEKMLMLDPSQRISAKDALDSEYF 229
+ + + + L ML L P +R +A + L +
Sbjct: 357 K--YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 51/214 (23%), Positives = 80/214 (37%), Gaps = 33/214 (15%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EY DL L + G R + Y+ +++ + H +HRDIK N+L+D
Sbjct: 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD 196
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG------ATKYGPAVDMWSV 131
G+++LADFG D V T Y PE+L YGP D W++
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G E+ G+ + AE KI + +P +
Sbjct: 257 GVFAYEMFYGQTPFYADSTAETYGKIVH---------YKEHLSLPLVD------------ 295
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
A + +++ L+ P R+ A D
Sbjct: 296 ----EGVPEEARDFIQR-LLCPPETRLGRGGAGD 324
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 53/220 (24%), Positives = 82/220 (37%), Gaps = 43/220 (19%)
Query: 19 YMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
++ E + DL G + + Q+L + +CH VLHRDIK N+LI
Sbjct: 124 VLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 182
Query: 77 D-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
D N G LKL DFG + + T+ T Y PPE + +G + +WS+G +
Sbjct: 183 DLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
+++ G +P FE DE I G
Sbjct: 240 YDMVCGD--IP-----------FEH----DEEIIRGQVFFR------------------- 263
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235
+ L+ L L PS R + ++ + + LP
Sbjct: 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y Y + +L + G F + Y ++++ L Y H ++HRD+K N+L++
Sbjct: 106 YFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 164
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNR-VITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ ++++ DFG A+ S + N V T Y PELL + D+W++GCI
Sbjct: 165 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIY 223
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
+L+ G P NE KI + E +P
Sbjct: 224 QLVAGLPPFRAGNEYLIFQKIIK-----LEYDFP-------------------------E 253
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALDSE 227
F A +L+EK+L+LD ++R+ ++
Sbjct: 254 KFFPKARDLVEKLLVLDATKRLGCEEMEGYG 284
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 66/308 (21%), Positives = 104/308 (33%), Gaps = 59/308 (19%)
Query: 48 YMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVIT 107
+Q+L+G+ YCH + V+HRD+K N+L+D N K+ADFGL+ S L +
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGS 178
Query: 108 LWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQLSKIFELCGSPD 165
Y PE++ G GP VD+WS G I LL G LP + KI +
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD------ 230
Query: 166 ETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
G+ P ++ + + LL+ ML +DP +R + KD +
Sbjct: 231 -----GIFYTP-------------------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
Query: 226 SEYFWTDPLPCDPKSLPKYESSH----------------EYQTKKRRQQQRQHEEAT--- 266
E+F D P Y S+ E + + +
Sbjct: 267 HEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAY 326
Query: 267 ----KRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPP 322
+++ + L P V P H P
Sbjct: 327 HLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQ 386
Query: 323 GGANRYPS 330
++
Sbjct: 387 KSKHQGVR 394
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 50/242 (20%), Positives = 83/242 (34%), Gaps = 48/242 (19%)
Query: 35 RPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEGNLKLADFGLARS 92
+ + Q + + H + ++HRD+K NLL+ N+G +KL DFG A +
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
Query: 93 FSYDHNNTLT-----------NRVITLWYRPPEL--LLGATKYGPAVDMWSVGCIFAELL 139
S+ + + + R T YR PE+ L G D+W++GCI L
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 140 NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFD 199
+ P FE I G +P ++
Sbjct: 248 FRQH--P-----------FE--DGAKLRIVNGKYSIPPHDTQ--YTVFHS---------- 280
Query: 200 RHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQQQ 259
L+ ML ++P +R+S + + +PKS P E +
Sbjct: 281 -----LIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS-PITELLEQNGGYGSATLS 334
Query: 260 RQ 261
R
Sbjct: 335 RG 336
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+MV EY+ +L + G R + + +Q+L+ + YCH + V+HRD+K N+L+D
Sbjct: 87 FMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
N K+ADFGL S L + Y PE++ G GP VD+WS G I
Sbjct: 146 AHMNAKIADFGL--SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203
Query: 138 LLNGKPILP--GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
LL G LP ++ KI GV +P
Sbjct: 204 LLCGT--LPFDDEHVPTLFKKIRG-----------GVFYIP------------------- 231
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ +R LL ML +DP +R + KD + E+F
Sbjct: 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 31/254 (12%), Positives = 66/254 (25%), Gaps = 45/254 (17%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLAD------RPGLRFTVPQIKCYMKQLLTGLHYC 59
+ + + + S + ++ M +L + Q++ L
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227
Query: 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA 119
H ++H ++ ++++D G + L F + + +L
Sbjct: 228 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFG 287
Query: 120 ----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 175
T A D W++G + IF C +
Sbjct: 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC-----------KNI 336
Query: 176 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235
P LLE L R+ A+++ +
Sbjct: 337 PQP-----------------------VRALLEGFLRYPKEDRLLPLQAMETP-EYEQLRT 372
Query: 236 CDPKSLPKYESSHE 249
+LP Y++ E
Sbjct: 373 ELSAALPLYQTDGE 386
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 52/236 (22%), Positives = 83/236 (35%), Gaps = 45/236 (19%)
Query: 19 YMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
+V E DL G +C+ Q++ + +CH V+HRDIK N+LI
Sbjct: 114 MLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI 172
Query: 77 DNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
D G KL DFG + H+ T+ T Y PPE + + +WS+G +
Sbjct: 173 DLRRGCAKLIDFGSG---ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
+++ G +P FE D+ I P
Sbjct: 230 YDMVCGD--IP-----------FER----DQEILEAELHFP------------------- 253
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDPLPCDPKSLPKYESSHE 249
H L+ + L PS R S ++ L + + +P +P +
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 45/211 (21%), Positives = 91/211 (43%), Gaps = 38/211 (18%)
Query: 19 YMVFEYMD------HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+V M+ H + + + F P+ Y Q+++GL + H +++RD+K
Sbjct: 261 CLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE 318
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N+L+D++GN++++D GLA T T + PELLLG +Y +VD +++G
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLG-EEYDFSVDYFALG 376
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
E++ + + E + ++ + R +++ V
Sbjct: 377 VTLYEMIAARGPFRARGEKVENKELKQ-------------------------RVLEQAVT 411
Query: 193 EVF-RHFDRHALELLEKMLMLDPSQRISAKD 222
+ F + + E +L DP +R+ +D
Sbjct: 412 --YPDKFSPASKDFCEALLQKDPEKRLGFRD 440
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 50/195 (25%), Positives = 76/195 (38%), Gaps = 32/195 (16%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEGNLKLADFGLARSFSYD 96
RF+ + + + +QLL+G+ YCH Q+ HRD+K N L+D LK+ DFG ++S
Sbjct: 112 RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 97 HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP--GKNEAEQL 154
+ V T Y PE+LL G D+WS G +L G P E
Sbjct: 172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEEPRDY 227
Query: 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDP 214
K + I +P P L+ ++ + DP
Sbjct: 228 RKTI-------QRILSVKYSIPDDIRISPE-----------------CCHLISRIFVADP 263
Query: 215 SQRISAKDALDSEYF 229
+ RIS + +F
Sbjct: 264 ATRISIPEIKTHSWF 278
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 50/212 (23%), Positives = 80/212 (37%), Gaps = 31/212 (14%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V +Y DL L + R + Y+ +++ + H +HRDIK N+L+D
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGC 133
G+++LADFG D + V T Y PE+L G +YGP D WS+G
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
E+L G+ ++ E KI + P
Sbjct: 270 CMYEMLYGETPFYAESLVETYGKIMN---------HKERFQFPTQ--------------- 305
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+A +L+ + L+ R+ D
Sbjct: 306 -VTDVSENAKDLIRR-LICSREHRLGQNGIED 335
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 53/295 (17%), Positives = 84/295 (28%), Gaps = 37/295 (12%)
Query: 13 KYRGS------TYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
YR + ++V +M DL + I ++ +L L Y H
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRP----PELL 116
+HR +K S++LI +G + L+ S + + PE+L
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 117 L-GATKYGPAVDMWSVGCIFAELLNGKP-------------IL---PGKNEAEQLSKIFE 159
Y D++SVG EL NG L E
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267
Query: 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 219
L SP ++ R F H +E+ L +P R S
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
Query: 220 AKDALDSEYFWTDPLPCDPKSLPKY-ESSHEYQTKKRRQQQRQHEEATKRQKLHH 273
A L+ +F ++LP+ + Q Q L
Sbjct: 328 ASTLLNHSFF-KQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEE 381
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 35/231 (15%), Positives = 84/231 (36%), Gaps = 26/231 (11%)
Query: 14 YRGSTYMVFEYMDHD-----LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68
++ + +V E + + + P + + ++L + H +++H D
Sbjct: 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGD 197
Query: 69 IKGSNLLI-----------DNEGNLKLADFGLARSFS-YDHNNTLTNRVITLWYRPPELL 116
IK N ++ D L L D G + + T + T ++ E+L
Sbjct: 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML 257
Query: 117 LGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELCGSPDETIWPGVSK- 174
+ +D + V +L G + + + + +F P +W
Sbjct: 258 SN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR--RLPHLDMWNEFFHV 314
Query: 175 ---MPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAK 221
+P +H +++++++VF +H+ L ++++L + S K
Sbjct: 315 MLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 365
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 33/204 (16%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+MV + + DL + F +K ++ +L+ L Y +++HRD+K N+L+D
Sbjct: 91 FMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD 149
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIF 135
G++ + DF +A + +T T Y PE+ Y AVD WS+G
Sbjct: 150 EHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
ELL G+ ++ + +I V P
Sbjct: 208 YELLRGRRPYHIRS-STSSKEIVHT-------FETTVVTYP------------------- 240
Query: 196 RHFDRHALELLEKMLMLDPSQRIS 219
+ + + LL+K+L +P QR S
Sbjct: 241 SAWSQEMVSLLKKLLEPNPDQRFS 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-24
Identities = 63/264 (23%), Positives = 105/264 (39%), Gaps = 54/264 (20%)
Query: 13 KYRGSTY------MVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
KY GS + +V EY D+ L ++ T +I ++ L GL Y H
Sbjct: 88 KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLHFM 144
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 119
+ +HRDIK N+L++ EG+ KLADFG + +T+ R + T ++ PE++
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 120 TKYGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAY 178
Y D+WS+G I A E+ GKP + + I P
Sbjct: 201 G-YNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMI---------------PTNPP- 242
Query: 179 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 238
P+ + F F +++ L+ P QR +A L + +
Sbjct: 243 ----PTFRKPELWSDNFTDF-------VKQCLVKSPEQRATATQLLQHPFVRS---AKGV 288
Query: 239 KSL-PKYESSHEYQTKKRRQQQRQ 261
L + + + K++ QQR+
Sbjct: 289 SILRDLINEAMDVKLKRQESQQRE 312
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 41/202 (20%), Positives = 83/202 (41%), Gaps = 33/202 (16%)
Query: 19 YMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
+V M+ DL + F + Y ++ GL H ++++RD+K N+L+
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
D+ G+++++D GLA T+ RV T+ Y PE++ +Y + D W++GC+
Sbjct: 320 DDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLY 376
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF- 195
E++ G+ + + + ++ + +
Sbjct: 377 EMIAGQSPFQQRKKKIKREEVER-------------------------LVKEVPEE--YS 409
Query: 196 RHFDRHALELLEKMLMLDPSQR 217
F A L ++L DP++R
Sbjct: 410 ERFSPQARSLCSQLLCKDPAER 431
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 47/203 (23%), Positives = 81/203 (39%), Gaps = 38/203 (18%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+ + M+ DL + G F+ ++ Y +++ GL + H V++RD+K +N+L+D
Sbjct: 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
G+++++D GLA FS + V T Y PE+L Y + D +S+GC+ +
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 383
Query: 138 LLNGKP---ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
LL G K++ E P
Sbjct: 384 LLRGHSPFRQHKTKDKHEIDRMTLT-----MAVELP------------------------ 414
Query: 195 FRHFDRHALELLEKMLMLDPSQR 217
F LLE +L D ++R
Sbjct: 415 -DSFSPELRSLLEGLLQRDVNRR 436
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 50/225 (22%)
Query: 13 KYRGSTY------MVFEYMDHDLTG--LAD--RPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
Y S +V EY+ G L D QI ++ L L + H N
Sbjct: 81 NYLDSYLVGDELWVVMEYLA----GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGAT 120
QV+HRDIK N+L+ +G++KL DFG + + + +T+ V T ++ PE++
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTR-K 191
Query: 121 KYGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN 179
YGP VD+WS+G I A E++ G+P P NE L ++ + +
Sbjct: 192 AYGPKVDIWSLG-IMAIEMIEGEP--PYLNE-NPLRALYLIATNG--------------- 232
Query: 180 HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
P ++ +FR F L + L +D +R SAK+ L
Sbjct: 233 --TPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELL 268
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 47/143 (32%), Positives = 61/143 (42%), Gaps = 6/143 (4%)
Query: 19 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
YMV EYM DL L + Y +++ L H +HRD+K N+L+D
Sbjct: 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVGCI 134
G+LKLADFG + + V T Y PE+L G YG D WSVG
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 135 FAELLNGKPILPGKNEAEQLSKI 157
E+L G + SKI
Sbjct: 263 LYEMLVGDTPFYADSLVGTYSKI 285
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 27/233 (11%)
Query: 16 GSTYMVFEYMDHDLTG-LAD--RPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKG 71
G + E+MD G L + R + ++ GL Y +++HRD+K
Sbjct: 104 GEISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160
Query: 72 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWS 130
SN+L+++ G +KL DFG++ +++ N + T Y PE L G T Y D+WS
Sbjct: 161 SNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG-THYSVQSDIWS 215
Query: 131 VGCIFAELLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
+G E+ G+ PI P + +L ++ G ET + N F
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275
Query: 190 RVREVFRH-------------FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ E+ + F + + K L+ +P++R K + +
Sbjct: 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 53/230 (23%)
Query: 13 KYRGSTY------MVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
K G+ Y ++ E+ + DR T PQI+ +Q+L L++ H
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK 136
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 119
+++HRD+K N+L+ EG+++LADFG S + TL R + T ++ PE+++
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 120 TK----YGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 174
T Y D+WS+G I E+ +P N L KI +K
Sbjct: 193 TMKDTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRVLLKI---------------AK 236
Query: 175 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
P+ + FR F L+ L +P R SA L
Sbjct: 237 SDP-----PTLLTPSKWSVEFRDF-------LKIALDKNPETRPSAAQLL 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 13 KYRGSTY------MVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
+ S ++ E++ LT + + +R QI + +L L Y H V+
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVI 163
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYG 123
HRDIK ++L+ +G +KL+DFG S D +L V T ++ PE++ + Y
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISR-SLYA 219
Query: 124 PAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK 182
VD+WS+G I E+++G+P P ++ + + L SP
Sbjct: 220 TEVDIWSLG-IMVIEMVDGEP--PYFSD-SPVQAMKRLRDSP-----------------P 258
Query: 183 PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
P +V V R F LE+ML+ DP +R +A++ L
Sbjct: 259 PKLKNSHKVSPVLRDF-------LERMLVRDPQERATAQELL 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 57/265 (21%), Positives = 95/265 (35%), Gaps = 53/265 (20%)
Query: 13 KYRGSTY------MVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
+YRG +V EY + L + +I L GL Y H + ++H
Sbjct: 118 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGATK-- 121
RD+K N+L+ G +KL DFG A + + V T ++ PE++L +
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMDEGQ 229
Query: 122 YGPAVDMWSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 180
Y VD+WS+G I EL KP L N L I ++
Sbjct: 230 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI---------------AQNE---- 269
Query: 181 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKS 240
E FR+F ++ L P R +++ L + P
Sbjct: 270 --SPALQSGHWSEYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR---ERPPTV 317
Query: 241 L-PKYESSHEYQTKKRRQQQRQHEE 264
+ + + + + Q R+ ++
Sbjct: 318 IMDLIQRTKDAVRELDNLQYRKMKK 342
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+++ +Y++ +L + RFT +++ Y+ +++ L + H +++RDIK N+L+D
Sbjct: 135 HLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 193
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMWSVGCIFA 136
+ G++ L DFGL++ F D + T+ Y P+++ G + AVD WS+G +
Sbjct: 194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253
Query: 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
ELL G E ++I I P +
Sbjct: 254 ELLTGASPFTVDGEKNSQAEISRR-------ILKSEPPYP-------------------Q 287
Query: 197 HFDRHALELLEKMLMLDPSQR 217
A +L++++LM DP +R
Sbjct: 288 EMSALAKDLIQRLLMKDPKKR 308
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 19 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
YMV EY+ ++ R G RF+ P + Y Q++ Y H +++RD+K NLLID
Sbjct: 117 YMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+G +++ DFG A+ TL T PE++L Y AVD W++G + E
Sbjct: 176 QQGYIQVTDFGFAKRVK-GRTWTLCG---TPEALAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
+ G P P A+Q +I+E I G + P H
Sbjct: 231 MAAGYP--P--FFADQPIQIYEK-------IVSGKVRFP-------------------SH 260
Query: 198 FDRHALELLEKMLMLDPSQRI 218
F +LL +L +D ++R
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRF 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-22
Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 16 GSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y+V EY++ L+ + G +V + Q+L G+ + H +++HRDIK N+
Sbjct: 84 DCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGC 133
LID+ LK+ DFG+A++ S + + T TN V+ T+ Y PE G D++S+G
Sbjct: 143 LIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGI 200
Query: 134 IFAELLNGKP 143
+ E+L G+P
Sbjct: 201 VLYEMLVGEP 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 34/130 (26%), Positives = 58/130 (44%), Gaps = 5/130 (3%)
Query: 16 GSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
G Y+ ++ DL + R G P+ ++Q+ + L H HRD+K N+
Sbjct: 107 GQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGC 133
L+ + L DFG+A + + D T + TL+Y PE + D++++ C
Sbjct: 166 LVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTC 223
Query: 134 IFAELLNGKP 143
+ E L G P
Sbjct: 224 VLYECLTGSP 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 40/212 (18%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
V EY + +L R FT + + Y ++++ L Y H V++RDIK NL++D
Sbjct: 81 CFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIF 135
+G++K+ DFGL + D T T Y PE+L YG AVD W +G +
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVM 195
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
E++ G+ ++ I +E +P
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILM-----EEIRFP------------------------- 225
Query: 196 RHFDRHALELLEKMLMLDPSQRI--SAKDALD 225
R A LL +L DP QR+ DA +
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+ V EY++ DL +F + + Y +++ GL + H +++RD+K N+L+D
Sbjct: 94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+G++K+ADFG+ + T T T Y PE+LLG KY +VD WS G + E
Sbjct: 153 KDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYE 210
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
+L G+ G++E E I D +P R
Sbjct: 211 MLIGQSPFHGQDEEELFHSIRM-----DNPFYP-------------------------RW 240
Query: 198 FDRHALELLEKMLMLDPSQRISAKD 222
++ A +LL K+ + +P +R+ +
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRG 265
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 38/235 (16%)
Query: 13 KYRGS------TYMVFEYMD----HDLTGLADRPGLR----FTVPQIKCYMKQLLTGLHY 58
Y S ++V + + D+ G I ++++L GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP----PE 114
H N +HRD+K N+L+ +G++++ADFG++ + + T T P PE
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 115 LLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 174
++ Y D+WS G EL G + L + + ++ GV
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---NDPPSLETGVQD 253
Query: 175 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ S FR + L DP +R +A + L ++F
Sbjct: 254 KEMLKKYGKS----------FRKM-------ISLCLQKDPEKRPTAAELLRHKFF 291
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 46/218 (21%), Positives = 75/218 (34%), Gaps = 39/218 (17%)
Query: 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNL 74
++ E M L R + ++ L+Y + V+HRD+K SN+
Sbjct: 97 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPE----LLLGATKYGPAVDM 128
L+D G +KL DFG++ + Y PE Y D+
Sbjct: 157 LLDERGQIKLCDFGISGRLV----DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADV 212
Query: 129 WSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 187
WS+G EL G+ K + E L+K+ + P P +P + F
Sbjct: 213 WSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP-----P---LLPGHMGFSGD--- 259
Query: 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
F+ F ++ L D +R L+
Sbjct: 260 -------FQSF-------VKDCLTKDHRKRPKYNKLLE 283
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-21
Identities = 46/191 (24%), Positives = 87/191 (45%), Gaps = 38/191 (19%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
F Y+ ++ L + H +++RD+K N++++++G++KL DFGL + +D
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
Query: 99 NTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156
T T T+ Y PE+L+ + + AVD WS+G + ++L G P G+N + + K
Sbjct: 177 VTHT---FCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232
Query: 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216
I + + P + + A +LL+K+L + +
Sbjct: 233 ILK-----CKLNLP-------------------------PYLTQEARDLLKKLLKRNAAS 262
Query: 217 RISA--KDALD 225
R+ A DA +
Sbjct: 263 RLGAGPGDAGE 273
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 44/181 (24%), Positives = 73/181 (40%), Gaps = 36/181 (19%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
FT +K Y+ +L L + H +++RD+K N+L+D EG++KL DFGL++
Sbjct: 122 MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 99 NTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156
+ T+ Y PE++ + + D WS G + E+L G GK+ E ++
Sbjct: 182 KAYS---FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237
Query: 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216
I L MP + A LL + +P+
Sbjct: 238 I--LKAKL---------GMP-------------------QFLSPEAQSLLRMLFKRNPAN 267
Query: 217 R 217
R
Sbjct: 268 R 268
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y V EY++ DL + G RF P Y ++ GL + +++RD+K N+++D
Sbjct: 97 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIF 135
+EG++K+ADFG+ + +D T T T Y PE++ YG +VD W+ G +
Sbjct: 156 SEGHIKIADFGMCKENIWDGVTTKT---FCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLL 211
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
E+L G+ G++E E I E +P
Sbjct: 212 YEMLAGQAPFEGEDEDELFQSIME-----HNVAYP------------------------- 241
Query: 196 RHFDRHALELLEKMLMLDPSQRI--SAKDALD 225
+ + A+ + + ++ P +R+ + D
Sbjct: 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 37/200 (18%)
Query: 19 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+M+ +Y++ +L L + RF P K Y ++ L Y H +++RD+K N+L+D
Sbjct: 82 FMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 140
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
G++K+ DFG A+ D TL T Y PE++ Y ++D WS G + E
Sbjct: 141 KNGHIKITDFGFAKYVP-DVTYTLCG---TPDYIAPEVVST-KPYNKSIDWWSFGILIYE 195
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
+L G N + KI E +P
Sbjct: 196 MLAGYTPFYDSNTMKTYEKILN-----AELRFP-------------------------PF 225
Query: 198 FDRHALELLEKMLMLDPSQR 217
F+ +LL +++ D SQR
Sbjct: 226 FNEDVKDLLSRLITRDLSQR 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 38/202 (18%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+ V E+++ DL + RF + + Y ++++ L + H +++RD+K N+L+D
Sbjct: 100 FFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIF 135
+EG+ KLADFG+ + + T T T Y PE+L YGPAVD W++G +
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTAT---FCGTPDYIAPEILQE-MLYGPAVDWWAMGVLL 214
Query: 136 AELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
E+L G +NE + I DE ++P
Sbjct: 215 YEMLCGHAPFEAENEDDLFEAILN-----DEVVYP------------------------- 244
Query: 196 RHFDRHALELLEKMLMLDPSQR 217
A +L+ + +P+ R
Sbjct: 245 TWLHEDATGILKSFMTKNPTMR 266
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 55/257 (21%), Positives = 101/257 (39%), Gaps = 48/257 (18%)
Query: 20 MVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+V E+ DL + + G I +++L GL + H ++V+HRDIKG N+L
Sbjct: 104 LVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGATK----YGPAVDM 128
+ +KL DFG++ T+ R + T ++ PE++ Y D+
Sbjct: 162 LTENAEVKLVDFGVSAQLD----RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 217
Query: 129 WSVGCIFA-ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 187
WS+G I A E+ G P L + L I + P R
Sbjct: 218 WSLG-ITAIEMAEGAPPLCDMHPMRALFLI---------------PRNP------APRLK 255
Query: 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESS 247
++ + F+ F +E L+ + SQR + + + + P + K +
Sbjct: 256 SKKWSKKFQSF-------IESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK-DHI 307
Query: 248 HEYQTKKRRQQQRQHEE 264
+ K+ + + ++E
Sbjct: 308 DRTKKKRGEKDETEYEY 324
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 41/128 (32%), Positives = 67/128 (52%), Gaps = 5/128 (3%)
Query: 19 YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y+V EY+D L + G T + + L++ H N ++HRD+K +N++I
Sbjct: 92 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 78 NEGNLKLADFGLARSFSYDHNN-TLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGCIF 135
+K+ DFG+AR+ + N+ T T VI T Y PE G + D++S+GC+
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVL 209
Query: 136 AELLNGKP 143
E+L G+P
Sbjct: 210 YEVLTGEP 217
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 35/190 (18%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDH 97
F+ + + Y ++++ L Y H + V++RD+K NL++D +G++K+ DFGL + D
Sbjct: 244 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303
Query: 98 NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157
T T Y PE+L YG AVD W +G + E++ G+ ++ + I
Sbjct: 304 ATMKT-FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361
Query: 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217
+E +P R A LL +L DP QR
Sbjct: 362 LM-----EEIRFP-------------------------RTLGPEAKSLLSGLLKKDPKQR 391
Query: 218 I--SAKDALD 225
+ ++DA +
Sbjct: 392 LGGGSEDAKE 401
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 49/145 (33%), Positives = 73/145 (50%), Gaps = 25/145 (17%)
Query: 13 KYRGSTY------MVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
KY GS ++ EY+ DL PG QI ++++L GL Y H
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPG-PLDETQIATILREILKGLDYLHSE 138
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGA 119
+ +HRDIK +N+L+ G +KLADFG+A + +T R V T ++ PE++ +
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKRNTFVGTPFWMAPEVIKQS 194
Query: 120 TKYGPAVDMWSVGCIFA-ELLNGKP 143
Y D+WS+G I A EL G+P
Sbjct: 195 A-YDSKADIWSLG-ITAIELARGEP 217
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 46/229 (20%), Positives = 78/229 (34%), Gaps = 52/229 (22%)
Query: 16 GSTYMVFEYMDHDLTGLAD------RPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRD 68
G ++ E MD T L G + ++ L + H V+HRD
Sbjct: 79 GDVWICMELMD---TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRD 135
Query: 69 IKGSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITLWYRPPELLLG---ATK 121
+K SN+LI+ G +K+ DFG L + D + Y PE +
Sbjct: 136 VKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGCKPYMAPERINPELNQKG 189
Query: 122 YGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 180
Y D+WS+G EL + +QL ++ + P ++PA +
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPS-----P---QLPA-DK 238
Query: 181 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
F F F + L + +R + + + +F
Sbjct: 239 FSAE----------FVDF-------TSQCLKKNSKERPTYPELMQHPFF 270
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 32/138 (23%), Positives = 54/138 (39%), Gaps = 16/138 (11%)
Query: 9 TDGNKYRGSTYMVFEYMDHDLTG--LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
Y+V EY+ G L G + V + Y+ ++L L Y H +++
Sbjct: 150 HTDRHGDPVGYIVMEYVG----GQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVY 205
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPA 125
D+K N+++ E LKL D G + T ++ PE++ A
Sbjct: 206 NDLKPENIMLTEEQ-LKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVRTGP--TVA 256
Query: 126 VDMWSVGCIFAELLNGKP 143
D+++VG A L P
Sbjct: 257 TDIYTVGRTLAALTLDLP 274
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 36/186 (19%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
F P+ + Y ++ + L Y H +++RD+K N+L+D++G++ L DFGL + ++
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194
Query: 99 NTLTNRVI--TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156
T T T Y PE+L Y VD W +G + E+L G P +N AE
Sbjct: 195 TTST---FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 250
Query: 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216
I + A LLE +L D ++
Sbjct: 251 ILN-----KPLQLK-------------------------PNITNSARHLLEGLLQKDRTK 280
Query: 217 RISAKD 222
R+ AKD
Sbjct: 281 RLGAKD 286
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 38/155 (24%), Positives = 62/155 (40%), Gaps = 19/155 (12%)
Query: 16 GSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIK 70
G ++ E M + + + L++ N +++HRDIK
Sbjct: 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 71 GSNLLIDNEGNLKLADFG----LARSFSYDHNNTLTNRVITLWYRPPELLLGATK---YG 123
SN+L+D GN+KL DFG L S + T Y PE + + Y
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIA------KTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 124 PAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKI 157
D+WS+G EL G+ P + +QL+++
Sbjct: 208 VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 34/200 (17%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
Y V EY++ DL + G RF P Y ++ GL + +++RD+K N+++D
Sbjct: 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+EG++K+ADFG+ + +D T T T Y PE++ YG +VD W+ G + E
Sbjct: 477 SEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYE 534
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
+L G+ G++E E I E +P +
Sbjct: 535 MLAGQAPFEGEDEDELFQSIME-----HNVAYP-------------------------KS 564
Query: 198 FDRHALELLEKMLMLDPSQR 217
+ A+ + + ++ P +R
Sbjct: 565 MSKEAVAICKGLMTKHPGKR 584
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 88.0 bits (217), Expect = 2e-19
Identities = 33/222 (14%), Positives = 59/222 (26%), Gaps = 36/222 (16%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLID 77
++V E+ L ++ K + QL L + + HRD+ N+L+
Sbjct: 138 FIVLEFEFGG-IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
KL +S + L + Y + +F +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCG---------------LQVSIIDYTLSRLERDGIVVFCD 241
Query: 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF----------KPSRTM 187
+ + + G + + I+ L + W P N K
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYH--PYSNVLWLHYLTDKMLKQMTFK 297
Query: 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ + R E ML SA D L
Sbjct: 298 TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 29/139 (20%), Positives = 62/139 (44%), Gaps = 4/139 (2%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+V ++ + L +F + ++ +Q G+ Y H ++HRD+K +N+ +
Sbjct: 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH 154
Query: 78 NEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCI 134
+ +K+ DFGLA S + ++ + PE++ + Y D+++ G +
Sbjct: 155 EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214
Query: 135 FAELLNGKPILPGKNEAEQ 153
EL+ G+ N +Q
Sbjct: 215 LYELMTGQLPYSNINNRDQ 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 43/193 (22%), Positives = 73/193 (37%), Gaps = 51/193 (26%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
+ + Y ++ L+Y H +++RD+K N+L+D+EG++KL D+G+ + +
Sbjct: 106 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
Query: 99 NTLT-----NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP---------I 144
T T N Y PE+L G YG +VD W++G + E++ G+
Sbjct: 166 TTSTFCGTPN------YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
Query: 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE 204
E I E + P R A
Sbjct: 219 PDQNTEDYLFQVILE-----KQIRIP-------------------------RSLSVKAAS 248
Query: 205 LLEKMLMLDPSQR 217
+L+ L DP +R
Sbjct: 249 VLKSFLNKDPKER 261
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 56/265 (21%), Positives = 95/265 (35%), Gaps = 40/265 (15%)
Query: 19 YMVFEYMDH-DLTGL--ADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQVLHRDIKGS 72
+V EY + L + P +T + Q G+ Y H ++HRD+K
Sbjct: 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 73 NLLIDNEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
NLL+ G LK+ DFG A D +TN + + PE+ G + Y D++S
Sbjct: 135 NLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSW 189
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G I E++ + P F+ G P I V +N +P
Sbjct: 190 GIILWEVITRR--KP-----------FDEIGGPAFRIMWAV-----HNGTRP-------- 223
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDS-EYFWTDPLPCDPKSLPKYESSHEY 250
+ ++ + L+ + DPSQR S ++ + + D + S
Sbjct: 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPP 282
Query: 251 QTKKRRQQQRQHEEATKRQKLHHPQ 275
R + E + + H +
Sbjct: 283 GEDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 43/193 (22%), Positives = 73/193 (37%), Gaps = 51/193 (26%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
+ + Y ++ L+Y H +++RD+K N+L+D+EG++KL D+G+ + +
Sbjct: 149 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
Query: 99 NTLT-----NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP---------I 144
T T N Y PE+L G YG +VD W++G + E++ G+
Sbjct: 209 TTSTFCGTPN------YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
Query: 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALE 204
E I E + P R A
Sbjct: 262 PDQNTEDYLFQVILE-----KQIRIP-------------------------RSLSVKAAS 291
Query: 205 LLEKMLMLDPSQR 217
+L+ L DP +R
Sbjct: 292 VLKSFLNKDPKER 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 15/115 (13%)
Query: 55 GLHYCHVNQ----------VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNR 104
GL Y H + + HRDIK N+L+ N +ADFGLA F + T+
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 105 VI-TLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154
+ T Y PE+L GA +DM+++G + EL + G + L
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 48/238 (20%), Positives = 79/238 (33%), Gaps = 33/238 (13%)
Query: 9 TDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ- 63
G Y++ +Y + +D L + ++GL + H
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDY--LKSTT---LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 64 -------VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPP 113
+ HRD+K N+L+ G +AD GLA F D N RV T Y PP
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 114 ELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 168
E+L + + DM+S G I E+ E + E +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 169 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226
V +PS + E R +L+ + +P+ R++A +
Sbjct: 276 REIV----CIKKLRPSFPNRWSSDECLRQM----GKLMTECWAHNPASRLTALRVKKT 325
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 32/180 (17%), Positives = 67/180 (37%), Gaps = 34/180 (18%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++ L + + V + + ++++ G+ Y H +LH+D+K N+ D
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD 164
Query: 78 NEGNLKLADFGLAR----SFSYDHNNTLTNRVITLWYRPPELLLGATK--------YGPA 125
N G + + DFGL + + L + L + PE++ + +
Sbjct: 165 N-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223
Query: 126 VDMWSVGCIFAELL--------------------NGKPILPGKNEAEQLSKIFELCGSPD 165
D++++G I+ EL KP L +++S I C + +
Sbjct: 224 SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFE 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 34/143 (23%), Positives = 58/143 (40%), Gaps = 15/143 (10%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+ EY+ L G+ ++ Q + K + +G+ Y H ++HRD+ N L+
Sbjct: 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR 142
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRP-------------PELLLGATKYGP 124
N+ +ADFGLAR + R + R PE++ G Y
Sbjct: 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDE 201
Query: 125 AVDMWSVGCIFAELLNGKPILPG 147
VD++S G + E++ P
Sbjct: 202 KVDVFSFGIVLCEIIGRVNADPD 224
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 26/133 (19%), Positives = 51/133 (38%), Gaps = 13/133 (9%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHRDIKGSNLL 75
MV E++ DL M + G+ Y ++HRD++ N+
Sbjct: 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 76 IDNEG-----NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK-YGPAVDMW 129
+ + K+ADFGL++ ++++ + + PE + + Y D +
Sbjct: 157 LQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 130 SVGCIFAELLNGK 142
S I +L G+
Sbjct: 213 SFAMILYTILTGE 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-16
Identities = 19/132 (14%), Positives = 46/132 (34%), Gaps = 16/132 (12%)
Query: 19 YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV--NQVLHRDIKGS 72
++ +M +++ L + Q + + G+ + H + +
Sbjct: 85 TLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSR 142
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWS 130
+++ID + +++ + SF R+ + PE L + DMWS
Sbjct: 143 SVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWS 196
Query: 131 VGCIFAELLNGK 142
+ EL+ +
Sbjct: 197 FAVLLWELVTRE 208
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 41/219 (18%), Positives = 86/219 (39%), Gaps = 27/219 (12%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--------VLHRDI 69
++V +Y +H L +R + TV + +GL + H+ + HRD+
Sbjct: 116 WLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLLGAT-----K 121
K N+L+ G +AD GLA + +RV T Y PE+L + +
Sbjct: 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233
Query: 122 YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 181
D++++G +F E+ I + + + D ++ + K+
Sbjct: 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP---YYDLVPSDPSVEE-MRKVVCEQKL 289
Query: 182 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 220
+P+ + + E R +++ + + + R++A
Sbjct: 290 RPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTA 324
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 41/237 (17%), Positives = 77/237 (32%), Gaps = 33/237 (13%)
Query: 9 TDGNKYRGSTYMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ- 63
+++ Y + +D L + + +GL + H+
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDY--LQLTT---LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 64 -------VLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPP 113
+ HRD+K N+L+ G +AD GLA S N RV T Y P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 114 ELLLGAT-----KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 168
E+L VD+W+ G + E+ + + F D +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP---FYDVVPNDPSF 243
Query: 169 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+ K+ + +P+ + +L+++ +PS R++A
Sbjct: 244 ED-MRKVVCVDQQRPNIPNRWFSDPTLTSL----AKLMKECWYQNPSARLTALRIKK 295
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 45/226 (19%), Positives = 74/226 (32%), Gaps = 31/226 (13%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---------VNQVLHRD 68
+V EY + L + GL Y H + HRD
Sbjct: 88 LLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRD 145
Query: 69 IKGSNLLIDNEGNLKLADFGLARSFSYDH-------NNTLTNRVITLWYRPPELLLGA-- 119
+ N+L+ N+G ++DFGL+ + + +N + V T+ Y PE+L GA
Sbjct: 146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205
Query: 120 ----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 175
VDM+++G I+ E+ L + F+ P M
Sbjct: 206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNH----PTFEDM 261
Query: 176 PAYNHFKPSR-TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA 220
+ R +E E +E D R++A
Sbjct: 262 QVLVSREKQRPKFPEAWKENSLAVRSLK-ETIEDCWDQDAEARLTA 306
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 7/129 (5%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVP--QIKCYMKQLLTGLHYCHVN--QVLHRDIKGSN 73
+V EY+ L L + G R + + + G++Y H ++HR++K N
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
LL+D + +K+ DFGL+R + + T + PE+L D++S G
Sbjct: 170 LLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGV 227
Query: 134 IFAELLNGK 142
I EL +
Sbjct: 228 ILWELATLQ 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 36/139 (25%), Positives = 63/139 (45%), Gaps = 24/139 (17%)
Query: 19 YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH---VNQVLHRDIKG 71
+V E+ + + L+ + R + + Q+ G++Y H + ++HRD+K
Sbjct: 82 CLVMEFARGGPLNRV--LSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136
Query: 72 SNLLIDNEG--------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYG 123
SN+LI + LK+ DFGLAR H T + + PE++ + +
Sbjct: 137 SNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWMAPEVIRA-SMFS 192
Query: 124 PAVDMWSVGCIFAELLNGK 142
D+WS G + ELL G+
Sbjct: 193 KGSDVWSYGVLLWELLTGE 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-15
Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 3/90 (3%)
Query: 55 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPP 113
G+++ H N +HRDIK +N+L+D K++DFGLAR+ +T+R++ T Y P
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204
Query: 114 ELLLGATKYGPAVDMWSVGCIFAELLNGKP 143
E L G + P D++S G + E++ G P
Sbjct: 205 EALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 77/423 (18%), Positives = 123/423 (29%), Gaps = 80/423 (18%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+V + + L L + + ++ + Q++ + + H LHRDIK N L+
Sbjct: 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138
Query: 79 EGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY-----------GP 124
+ + DFGLA+ + D + T++ I YR + L G +Y
Sbjct: 139 GRRANQVYIIDFGLAKKY-RDTS---THQHIP--YRENKNLTGTARYASVNTHLGIEQSR 192
Query: 125 AVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE---------LC-GSPDETIW 169
D+ S+G + L G LP + ++ KI E LC G P E
Sbjct: 193 RDDLESLGYVLMYFLRGS--LPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTE--- 247
Query: 170 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
F + + L D D Y
Sbjct: 248 -------------------------FASYFHYCRSL-------------RFDDKPDYSYL 269
Query: 230 WTDPLPCDPKSLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQS 289
L D ++ + + + QQ Q A R H P G PP +
Sbjct: 270 KR--LFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQ 327
Query: 290 HHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGY 349
++ P G S ++ + N G+ G
Sbjct: 328 SGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGS 387
Query: 350 SNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSR 409
S P R P+ AS S Q NSA + + S
Sbjct: 388 SRRPAVSSSRDVMPIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSS 447
Query: 410 NQQ 412
N +
Sbjct: 448 NVK 450
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 29/173 (16%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
L +G YR +M+ + DL + + RF+ + ++L L Y H ++ +
Sbjct: 118 LHDKNGKSYR---FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYV 174
Query: 66 HRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY- 122
H DIK SNLL++ N + L D+GLA + ++ P G ++
Sbjct: 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRY-CPEG---VHKAYA--ADPKRCHDGTIEFT 228
Query: 123 ------GPAV----DMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFEL 160
G A D+ +G + L G LP + + SKI
Sbjct: 229 SIDAHNGVAPSRRGDLEILGYCMIQWLTGH--LPWEDNLKDPKYVRDSKIRYR 279
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 6/143 (4%)
Query: 19 YMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V EYM L L G +PQ+ Q+ +G+ Y +HRD++ +N+L+
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 313
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSVGCIF 135
K+ADFGLAR + + W P L G ++ D+WS G +
Sbjct: 314 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILL 371
Query: 136 AELLN-GKPILPGKNEAEQLSKI 157
EL G+ PG E L ++
Sbjct: 372 TELTTKGRVPYPGMVNREVLDQV 394
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 55 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPP 113
GLHY H ++HRD+K N+L+D K+ DFG+++ + L+ V TL Y P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210
Query: 114 E 114
E
Sbjct: 211 E 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 41/163 (25%), Positives = 64/163 (39%), Gaps = 29/163 (17%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
MV E + L L D F++ + QL++ + Y H +++RD+K N LI
Sbjct: 81 AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR 140
Query: 79 EGNLK-----LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY----------- 122
GN + DF LA+ + D T + I YR + L G +Y
Sbjct: 141 PGNKTQQVIHIIDFALAKEY-IDPE---TKKHIP--YREHKSLTGTARYMSINTHLGKEQ 194
Query: 123 GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFEL 160
D+ ++G +F L G LP E+ KI +
Sbjct: 195 SRRDDLEALGHMFMYFLRGS--LPWQGLKADTLKERYQKIGDT 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 23/143 (16%), Positives = 38/143 (26%), Gaps = 33/143 (23%)
Query: 14 YRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
R +V E++ L +AD + M+ L H V S
Sbjct: 102 TRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAHRAGVALSIDHPS 158
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
+ + +G++ LA P P D+ +G
Sbjct: 159 RVRVSIDGDVVLAYPA---------------------TMPDA--------NPQDDIRGIG 189
Query: 133 CIFAELLNGKPILPGKNEAEQLS 155
LL + LP L+
Sbjct: 190 ASLYALLVNRWPLPEAGVRSGLA 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 39/179 (21%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+V + + L L D G +F+V + KQ+L + H +++RDIK N LI
Sbjct: 82 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 141
Query: 79 EGNLK-----LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY----------- 122
+ + DFG+ + + + +T + I YR + L G +Y
Sbjct: 142 PNSKNANMIYVVDFGMVKFYR----DPVTKQHIP--YREKKNLSGTARYMSINTHLGREQ 195
Query: 123 GPAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE---------LC-GSPDE 166
D+ ++G +F L G LP ++ +I E LC G P+E
Sbjct: 196 SRRDDLEALGHVFMYFLRGS--LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 252
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 29/171 (16%), Positives = 58/171 (33%), Gaps = 30/171 (17%)
Query: 9 TDGNKYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67
+KYR ++V + L D P + + +LL L + H N+ +H
Sbjct: 127 VHQDKYR---FLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHG 183
Query: 68 DIKGSNLLI--DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY--- 122
++ N+ + +++ + LA +G A + + + + G ++
Sbjct: 184 NVTAENIFVDPEDQSQVTLAGYGFAFRY------CPSGKHVAYVEGSRSPHEGDLEFISM 237
Query: 123 ----GPAV----DMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFEL 160
G D+ S+G + L G LP E K +
Sbjct: 238 DLHKGCGPSRRSDLQSLGYCMLKWLYGF--LPWTNCLPNTEDIMKQKQKFV 286
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 40/154 (25%), Positives = 64/154 (41%), Gaps = 25/154 (16%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
L G YR +MV E + DL ++ + G F + ++L L Y H N+ +
Sbjct: 118 LTEFKGRSYR---FMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYV 173
Query: 66 HRDIKGSNLLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY- 122
H DIK +NLL+ N + LAD+GL+ + ++ P + G ++
Sbjct: 174 HGDIKAANLLLGYKNPDQVYLADYGLSYRYC----PNGNHKQYQ--ENPRKGHNGTIEFT 227
Query: 123 ------GPAV----DMWSVGCIFAELLNGKPILP 146
G A+ D+ +G L GK LP
Sbjct: 228 SLDAHKGVALSRRSDVEILGYCMLRWLCGK--LP 259
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 6/143 (4%)
Query: 19 YMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V EYM L L G +PQ+ Q+ +G+ Y +HRD++ +N+L+
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 396
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSVGCIF 135
K+ADFGLAR + + W P L G ++ D+WS G +
Sbjct: 397 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILL 454
Query: 136 AELLN-GKPILPGKNEAEQLSKI 157
EL G+ PG E L ++
Sbjct: 455 TELTTKGRVPYPGMVNREVLDQV 477
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 37/178 (20%)
Query: 18 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI- 76
MV E + L L + +F++ + Q+++ + Y H +HRD+K N L+
Sbjct: 80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139
Query: 77 --DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKY-----------G 123
+ + DFGLA+ + + T++ I YR + L G +Y
Sbjct: 140 LGKKGNLVYIIDFGLAKKYR----DARTHQHIP--YRENKNLTGTARYASINTHLGIEQS 193
Query: 124 PAVDMWSVGCIFAELLNGKPILP-----GKNEAEQLSKIFE---------LC-GSPDE 166
D+ S+G + G LP + ++ +I E LC G P E
Sbjct: 194 RRDDLESLGYVLMYFNLGS--LPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 249
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 5/124 (4%)
Query: 19 YMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y++ E+M + +L L + + + Q+ + + Y +HR++ N L+
Sbjct: 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV 351
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSVGCIF 135
+K+ADFGL+R + D + W P L K+ D+W+ G +
Sbjct: 352 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLL 409
Query: 136 AELL 139
E+
Sbjct: 410 WEIA 413
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 11/112 (9%)
Query: 55 GLHYCHVN---QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVI-TLW 109
GL Y H + +++HRD+K +N+L+D E + DFGLA+ D+ +T +T V T+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDTHVTTAVRGTIG 200
Query: 110 YRPPE-LLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFE 159
+ PE L G K D++ G + EL+ G + + + + +
Sbjct: 201 HIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
R + ++ EY+ + L + R ++ Y Q+ G+ Y + +HRD+ N
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 175
Query: 74 LLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYGPAVDMWS 130
+L++NE +K+ DFGL + D + WY PE L +K+ A D+WS
Sbjct: 176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLT-ESKFSVASDVWS 233
Query: 131 VGCIFAELL 139
G + EL
Sbjct: 234 FGVVLYELF 242
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
R + ++ EY+ + L + R ++ Y Q+ G+ Y + +HRD+ N
Sbjct: 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 144
Query: 74 LLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYGPAVDMWS 130
+L++NE +K+ DFGL + D + WY PE L +K+ A D+WS
Sbjct: 145 ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLT-ESKFSVASDVWS 202
Query: 131 VGCIFAELL 139
G + EL
Sbjct: 203 FGVVLYELF 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 7/122 (5%)
Query: 13 KYRGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
+ +G Y+V EYM L L R + + + + Y N +HRD+
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
N+L+ + K++DFGL + S + ++ W PE L K+ D+WS
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWT-APEALR-EKKFSTKSDVWS 199
Query: 131 VG 132
G
Sbjct: 200 FG 201
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 29/118 (24%), Positives = 49/118 (41%), Gaps = 6/118 (5%)
Query: 18 TYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+++ E +L L R + + Y QL T L Y + +HRDI N+L
Sbjct: 465 VWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 523
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITL-WYRPPELLLGATKYGPAVDMWSVG 132
+ + +KL DFGL+R + + + W P + ++ A D+W G
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFG 579
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 29/121 (23%), Positives = 50/121 (41%), Gaps = 11/121 (9%)
Query: 18 TYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
Y++ E+M + +L L + + + Q+ + + Y +HRD+ N L
Sbjct: 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSV 131
+ +K+ADFGL+R +T T W PE L K+ D+W+
Sbjct: 144 VGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWT-APESLA-YNKFSIKSDVWAF 198
Query: 132 G 132
G
Sbjct: 199 G 199
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 30/119 (25%), Positives = 48/119 (40%), Gaps = 7/119 (5%)
Query: 18 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V E + D G R V + + G+ Y +HRD+ N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVDMWSVG 132
+ LK++DFG++R D + + + W PE L +Y D+WS G
Sbjct: 247 TEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWT-APEALN-YGRYSSESDVWSFG 302
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 33/121 (27%), Positives = 58/121 (47%), Gaps = 11/121 (9%)
Query: 18 TYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
Y++ EYM++ L L G++ T+ ++ Q+ G+ + +HRD++ +N+L
Sbjct: 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSV 131
+ + + K+ADFGLAR +N T R W PE + + D+WS
Sbjct: 142 VSDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWT-APEAIN-YGTFTIKSDVWSF 196
Query: 132 G 132
G
Sbjct: 197 G 197
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 29/120 (24%), Positives = 49/120 (40%), Gaps = 11/120 (9%)
Query: 19 YMVFEYMDHDLTG-LAD--RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+V E + G L + I + Q+ G+ Y + +HRD+ N+L
Sbjct: 93 MLVMEMAEL---GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 149
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVDMWSVG 132
+ + K++DFGL+++ D N WY PE + K+ D+WS G
Sbjct: 150 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECIN-YYKFSSKSDVWSFG 207
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 32/120 (26%), Positives = 54/120 (45%), Gaps = 11/120 (9%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y++ E+M L L G + +P++ + Q+ G+ + +HRD++ +N+L+
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 317
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSVG 132
K+ADFGLAR +N T R W P + G + D+WS G
Sbjct: 318 SASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFG 372
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 6/118 (5%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++ E++ L + + + Q Y Q+ G+ Y Q +HRD+ N+L++
Sbjct: 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 160
Query: 78 NEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYGPAVDMWSVG 132
+E +K+ DFGL ++ D +R + WY PE L+ +K+ A D+WS G
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-APECLM-QSKFYIASDVWSFG 216
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 30/120 (25%), Positives = 49/120 (40%), Gaps = 7/120 (5%)
Query: 15 RGSTYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+G Y+V EYM L L R + + + + Y N +HRD+
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N+L+ + K++DFGL + S + ++ W P L K+ D+WS G
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTAPEALREK--KFSTKSDVWSFG 373
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 28/119 (23%), Positives = 47/119 (39%), Gaps = 8/119 (6%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+V E L V + + Q+ G+ Y +HRD+ N+L+
Sbjct: 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 144
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSVG 132
N K++DFGL+++ ++ T R WY P + K+ D+WS G
Sbjct: 145 NRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYG 200
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 35/145 (24%), Positives = 65/145 (44%), Gaps = 9/145 (6%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+V EYM++ L + +FTV Q+ ++ + +G+ Y +HRD+ N+LI+
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSVGC 133
+ K++DFGL R D W PE + K+ A D+WS G
Sbjct: 182 SNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWT-SPEAIA-YRKFTSASDVWSYGI 238
Query: 134 IFAELLN-GKPILPGKNEAEQLSKI 157
+ E+++ G+ + + + +
Sbjct: 239 VLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 37/129 (28%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
R S +V EY+ L R R ++ Y Q+ G+ Y + +HRD+ N
Sbjct: 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN 157
Query: 74 LLIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYGPAVDMWS 130
+L+++E ++K+ADFGLA+ D + + WY PE L + D+WS
Sbjct: 158 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLS-DNIFSRQSDVWS 215
Query: 131 VGCIFAELL 139
G + EL
Sbjct: 216 FGVVLYELF 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 31/120 (25%), Positives = 54/120 (45%), Gaps = 12/120 (10%)
Query: 19 YMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
+V E+M+H L+ L + G F + + G+ Y V+HRD+ N L+
Sbjct: 79 CLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSVG 132
+K++DFG+ R + ++ T+ T W PE+ ++Y D+WS G
Sbjct: 138 GENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWA-SPEVFS-FSRYSSKSDVWSFG 192
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 8/119 (6%)
Query: 19 YMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
+V EYM++ L L G +FT+ Q+ ++ + G+ Y +HRD+ N+L+
Sbjct: 126 MIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVDMWSVG 132
D+ K++DFGL+R D + T + W PE + + A D+WS G
Sbjct: 185 DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEAIA-FRTFSSASDVWSFG 241
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 6/118 (5%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
MV E L + F + + Y Q+ G+ Y + +HRD+ NLL+
Sbjct: 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA 155
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVDMWSVG 132
+K+ DFGL R+ + ++ + + W PE L + A D W G
Sbjct: 156 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APESLK-TRTFSHASDTWMFG 211
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 3e-09
Identities = 21/134 (15%), Positives = 30/134 (22%), Gaps = 4/134 (2%)
Query: 272 HHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSG 331
HH + R+ P Q Q + P PP YG+ PP GA
Sbjct: 3 HHKK---RVYP-QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQ 58
Query: 332 NQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSG 391
Q Q + + P G + Q +
Sbjct: 59 QQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAA 118
Query: 392 QYGNSAAGRGPNQM 405
+ M
Sbjct: 119 PAYGQPSAAMGQNM 132
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 7e-07
Identities = 11/148 (7%), Positives = 20/148 (13%)
Query: 267 KRQKLHHPQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGAN 326
K++ Q + + G P
Sbjct: 5 KKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTP 64
Query: 327 RYPSGNQSGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQS 386
+Q + P P + Q
Sbjct: 65 AQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQP 124
Query: 387 YSQSGQYGNSAAGRGPNQMGGSRNQQYG 414
+ GQ P +
Sbjct: 125 SAAMGQNMRPMNQLYPIDLLTELPPPIT 152
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 49.8 bits (118), Expect = 1e-06
Identities = 14/123 (11%), Positives = 20/123 (16%), Gaps = 3/123 (2%)
Query: 295 PNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQSGGYNNPNRGGQGGGYSNAPY 354
P + P + P+ P Y P+ G Q
Sbjct: 10 PQAQLQYGQNATPLQQP-AQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQ 68
Query: 355 PPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQYGNSAAGRGPNQMGGSRNQQYG 414
Q A M Q G + + Q
Sbjct: 69 LHQ--QIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSA 126
Query: 415 WQQ 417
Sbjct: 127 AMG 129
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 34/119 (28%), Positives = 60/119 (50%), Gaps = 10/119 (8%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+++ EYM + L RF Q+ K + + Y Q LHRD+ N L++
Sbjct: 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSVG 132
++G +K++DFGL+R ++ T+ V + W PPE+L+ +K+ D+W+ G
Sbjct: 155 DQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWS-PPEVLM-YSKFSSKSDIWAFG 208
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 7e-09
Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 13 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71
+ GS +V YM H DL TV + + Q+ G+ Y + +HRD+
Sbjct: 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAA 156
Query: 72 SNLLIDNEGNLKLADFGLAR 91
N ++D + +K+ADFGLAR
Sbjct: 157 RNCMLDEKFTVKVADFGLAR 176
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 7e-09
Identities = 31/120 (25%), Positives = 53/120 (44%), Gaps = 10/120 (8%)
Query: 18 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V EY+ + L G Q+ + G+ + +Q +HRD+ N L+
Sbjct: 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSVG 132
D + +K++DFG+ R Y ++ + V T W PE+ KY D+W+ G
Sbjct: 138 DRDLCVKVSDFGMTR---YVLDDQYVSSVGTKFPVKWS-APEVFH-YFKYSSKSDVWAFG 192
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 8e-09
Identities = 30/119 (25%), Positives = 50/119 (42%), Gaps = 8/119 (6%)
Query: 18 TYMVFEYMDH-DLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75
+++ E +L L R + + Y QL T L Y + +HRDI N+L
Sbjct: 90 VWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148
Query: 76 IDNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVG 132
+ + +KL DFGL+R D + ++ W P + ++ A D+W G
Sbjct: 149 VSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFG 204
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 36/121 (29%), Positives = 57/121 (47%), Gaps = 10/121 (8%)
Query: 17 STYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
S +V EY+ L L + Q+ + +Q+ G+ Y H +HRD+ N+
Sbjct: 109 SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV 165
Query: 75 LIDNEGNLKLADFGLARSFSYDHN--NTLTNRVITL-WYRPPELLLGATKYGPAVDMWSV 131
L+DN+ +K+ DFGLA++ H + + WY PE L K+ A D+WS
Sbjct: 166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLK-EYKFYYASDVWSF 223
Query: 132 G 132
G
Sbjct: 224 G 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 6/118 (5%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+V E L V + + Q+ G+ Y +HR++ N+L+
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV 470
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITL---WYRPPELLLGATKYGPAVDMWSVG 132
N K++DFGL+++ D + WY P + K+ D+WS G
Sbjct: 471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYG 526
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 25/117 (21%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++ + M L + + Q+ G++Y +++HRD+ N+L+
Sbjct: 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 151
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVG 132
++K+ DFGLA+ + +V W E +L Y D+WS G
Sbjct: 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESIL-HRIYTHQSDVWSYG 206
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 16/90 (17%), Positives = 37/90 (41%), Gaps = 6/90 (6%)
Query: 8 TTDGNKYRGSTYMVFEYMDH-DL-----TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 61
++ ++ +M + DL + + + +M + G+ Y
Sbjct: 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN 165
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
LHRD+ N ++ ++ + +ADFGL++
Sbjct: 166 RNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 21/75 (28%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 18 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
T+++ E + +L +R V + Y Q+ + Y +HRDI N+L+
Sbjct: 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV 146
Query: 77 DNEGNLKLADFGLAR 91
+ +KL DFGL+R
Sbjct: 147 ASPECVKLGDFGLSR 161
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 13 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71
+ GS +V YM H DL TV + + Q+ G+ + + +HRD+
Sbjct: 161 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 220
Query: 72 SNLLIDNEGNLKLADFGLAR 91
N ++D + +K+ADFGLAR
Sbjct: 221 RNCMLDEKFTVKVADFGLAR 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 25/123 (20%), Positives = 46/123 (37%), Gaps = 14/123 (11%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+V E++ L + + KQL +H+ N ++H ++ N+L+
Sbjct: 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI 147
Query: 78 NEGNL--------KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
E + KL+D G++ + + + W PPE + A D W
Sbjct: 148 REEDRKTGNPPFIKLSDPGISITV-LPKDIL---QERIPWV-PPECIENPKNLNLATDKW 202
Query: 130 SVG 132
S G
Sbjct: 203 SFG 205
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 31/127 (24%), Positives = 56/127 (44%), Gaps = 8/127 (6%)
Query: 18 TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
++ EYM++ L F+V Q+ ++ + G+ Y +HRD+ N+L+
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 180
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITL----WYRPPELLLGATKYGPAVDMWSVG 132
++ K++DFGL+R D W PE + K+ A D+WS G
Sbjct: 181 NSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT-APEAIS-YRKFTSASDVWSFG 237
Query: 133 CIFAELL 139
+ E++
Sbjct: 238 IVMWEVM 244
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 16 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
G +++ YM H DL P TV + + Q+ G+ Y + +HRD+ N
Sbjct: 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNC 155
Query: 75 LIDNEGNLKLADFGLAR 91
++D +K+ADFGLAR
Sbjct: 156 MLDESFTVKVADFGLAR 172
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 6/88 (6%)
Query: 10 DGNKYRGSTYMVFEYMDH-DL-----TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
++ +M H DL + + +M + G+ Y
Sbjct: 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN 157
Query: 64 VLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+HRD+ N ++ + + +ADFGL+R
Sbjct: 158 FIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 26/118 (22%), Positives = 51/118 (43%), Gaps = 7/118 (5%)
Query: 19 YMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
+V +Y+ L + G + + Q+ G++Y + ++HR++ N+L+
Sbjct: 90 QLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL 148
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVG 132
+ +++ADFG+A D L + + W E + KY D+WS G
Sbjct: 149 KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIH-FGKYTHQSDVWSYG 204
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 25/117 (21%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++ + M L + + Q+ G++Y +++HRD+ N+L+
Sbjct: 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK 151
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTN--RVITLWYRPPELLLGATKYGPAVDMWSVG 132
++K+ DFGLA+ + +V W E +L Y D+WS G
Sbjct: 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESIL-HRIYTHQSDVWSYG 206
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 10/86 (11%)
Query: 16 GSTYMVFEYMDH-DL---------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
T ++ E M DL + ++ ++ ++ G+ Y + N+ +
Sbjct: 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLAR 91
HRD+ N ++ + +K+ DFG+ R
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 16/97 (16%)
Query: 15 RGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLLTGLHY 58
RG Y+ EY H +L +A+ + Q+ + + G+ Y
Sbjct: 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157
Query: 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSY 95
Q +HRD+ N+L+ K+ADFGL+R
Sbjct: 158 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 16/90 (17%)
Query: 18 TYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 61
++ E+ +L D T+ + CY Q+ G+ +
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ +HRD+ N+L+ + +K+ DFGLAR
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 22/93 (23%), Positives = 39/93 (41%), Gaps = 16/93 (17%)
Query: 15 RGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLLTGLHY 58
G Y++ EY +L + P + + + Q+ G+ Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ +HRD+ N+L+ + +K+ADFGLAR
Sbjct: 207 LASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 16/93 (17%)
Query: 15 RGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLLTGLHY 58
G Y++ EY +L + P + T + QL G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ +HRD+ N+L+ +K+ADFGLAR
Sbjct: 173 LASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 21/95 (22%), Positives = 38/95 (40%), Gaps = 18/95 (18%)
Query: 15 RGSTYMVFEYMDH-DL-----------------TGLADRPGLRFTVPQIKCYMKQLLTGL 56
G T ++ EY + DL + + L + + + Q+ G+
Sbjct: 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 57 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ +HRD+ N+L+ + K+ DFGLAR
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 16/93 (17%)
Query: 15 RGSTYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLLTGLHY 58
G Y++ EY +L + P + T + QL G+ Y
Sbjct: 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ +HRD+ N+L+ +K+ADFGLAR
Sbjct: 219 LASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 24/90 (26%), Positives = 37/90 (41%), Gaps = 16/90 (17%)
Query: 18 TYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 61
MVFEYM H DL G + + Q+ Q+ +G+ Y
Sbjct: 92 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+HRD+ N L+ +K+ DFG++R
Sbjct: 152 QHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 20/90 (22%), Positives = 34/90 (37%), Gaps = 14/90 (15%)
Query: 16 GSTYMVFEYMDH-DL-------------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 61
G ++ EY + DL + + + Q+ G+ +
Sbjct: 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+HRD+ N+L+ N K+ DFGLAR
Sbjct: 183 KNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 25/89 (28%), Positives = 36/89 (40%), Gaps = 15/89 (16%)
Query: 18 TYMVFEYMDH-DL--------------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
MVFEYM H DL G D + Q+ Q+ G+ Y
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+HRD+ N L+ +K+ DFG++R
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 22/90 (24%), Positives = 37/90 (41%), Gaps = 16/90 (17%)
Query: 18 TYMVFEYMDH-DL---------------TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV 61
M+F Y H DL T P + Q+ G+ Y
Sbjct: 87 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146
Query: 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ V+H+D+ N+L+ ++ N+K++D GL R
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 20/93 (21%), Positives = 39/93 (41%)
Query: 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65
+ ++ + G + D T+ + CY Q+ G+ + + +
Sbjct: 156 ITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 215
Query: 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
HRD+ N+L+ + +K+ DFGLAR D +
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 20/101 (19%), Positives = 39/101 (38%), Gaps = 24/101 (23%)
Query: 15 RGSTYMVFEYMDH-DL-----------------------TGLADRPGLRFTVPQIKCYMK 50
G ++ EY + L + L T+ + +
Sbjct: 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW 157
Query: 51 QLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
Q+ G+ Y +++HRD+ N+L+ +K++DFGL+R
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 22/84 (26%), Positives = 33/84 (39%), Gaps = 10/84 (11%)
Query: 18 TYMVFEYMDH-DLTG--LADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
+++ E M DL RP + + + + G Y N +HRDI
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167
Query: 71 GSNLLIDNEGN---LKLADFGLAR 91
N L+ G K+ DFG+AR
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 22/84 (26%), Positives = 33/84 (39%), Gaps = 10/84 (11%)
Query: 18 TYMVFEYMDH-DLTG--LADRP----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70
+++ E M DL RP + + + + G Y N +HRDI
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208
Query: 71 GSNLLIDNEGN---LKLADFGLAR 91
N L+ G K+ DFG+AR
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 23/100 (23%)
Query: 15 RGSTYMVFEYMDH-DL----------------------TGLADRPGLRFTVPQIKCYMKQ 51
G Y++FEY + DL + T + C+ Q
Sbjct: 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 52 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ G+ + +HRD+ N+L+ + +K+ DFGLAR
Sbjct: 181 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 24/100 (24%)
Query: 16 GSTYMVFEYMDH-DL-----------------------TGLADRPGLRFTVPQIKCYMKQ 51
++FEYM + DL ++ + + C +Q
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 52 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91
+ G+ Y + +HRD+ N L+ +K+ADFGL+R
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 2e-04
Identities = 31/143 (21%), Positives = 44/143 (30%), Gaps = 3/143 (2%)
Query: 274 PQPHGRLPPIQHAGQSHHWSGPNHPMNNAPPPVPGGPGHHHYGKPRGPPGGANRYPSGNQ 333
+ + + G S + + N PP GG G H G P GG P G
Sbjct: 2 SKKRPKPGGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHG-- 59
Query: 334 SGGYNNPNRGGQGGGYSNAPYPPQGRGPPYAGAGMPANGPRGPASGYGVGPQSYSQSGQY 393
GG+ P+ GG G + + G + P + A G G
Sbjct: 60 -GGWGQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYM 118
Query: 394 GNSAAGRGPNQMGGSRNQQYGWQ 416
SA R G +Y +
Sbjct: 119 LGSAMSRPLIHFGSDYEDRYYRE 141
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.98 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.98 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.98 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.75 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.59 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.38 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.08 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.58 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.44 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.33 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.41 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.64 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.4 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.81 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 92.7 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 91.62 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.89 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 89.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 88.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.23 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.74 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=385.08 Aligned_cols=199 Identities=25% Similarity=0.446 Sum_probs=172.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||+++++|+.++++|||||||++ +|.+++.+ .+|++.+++.|++||+.||+|||++|||||||||+||||+.+++|
T Consensus 132 nIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~v 209 (346)
T 4fih_A 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRV 209 (346)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE
T ss_pred CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCE
Confidence 899999999999999999999996 56555544 359999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+.+... .....+.+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++..|.+...
T Consensus 210 Kl~DFGla~~~~~~-~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~ 287 (346)
T 4fih_A 210 KLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 287 (346)
T ss_dssp EECCCTTCEECCSS-SCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred EEecCcCceecCCC-CCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 99999999876533 234556789999999999876 6799999999999999999999999999999998888865321
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
... ..+..+++++++||++||.+||++|+|+.|||+|+||....
T Consensus 288 ~~~---------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 288 PRL---------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp CCC---------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCC---------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 100 01235788999999999999999999999999999997654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=376.17 Aligned_cols=195 Identities=26% Similarity=0.480 Sum_probs=163.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||+++++++.++++|||||||+++|++.+.+.+ .|++.+++.|++||+.||+|||++||+||||||+||||+.++++|
T Consensus 74 nIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 74 HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEE
T ss_pred CCCeEEEEEEECCEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEE
Confidence 7999999999999999999999999998887654 699999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+|+.... .....+.+||+.|||||++.+..+++.++||||||||||||++|+.||.+.+..+++..|.+....
T Consensus 153 l~DFGla~~~~~--~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~ 230 (275)
T 3hyh_A 153 IADFGLSNIMTD--GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT 230 (275)
T ss_dssp ECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EeecCCCeecCC--CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999986543 223456789999999999987555678999999999999999999999999988888877552211
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+...+++++++||++||..||++|+|++|+|+|+||+.
T Consensus 231 ------------------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 231 ------------------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11236789999999999999999999999999999964
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=387.63 Aligned_cols=231 Identities=36% Similarity=0.609 Sum_probs=187.6
Q ss_pred cEeecccCce------ecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNK------YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~------~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
|||+++++++ ..+++|||||||+++|.+++.+. ..|++.+++.|++||+.||+|||++|||||||||+||||+
T Consensus 114 nIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~ 192 (398)
T 4b99_A 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN 192 (398)
T ss_dssp TBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC
Confidence 7788887654 45789999999999988887664 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCC---CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 014871 78 NEGNLKLADFGLARSFSYD---HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~ 154 (417)
.++.+||+|||+|+.+... ......+.+||+.|||||++.+..+++.++||||||||||||++|++||.+.+..+++
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l 272 (398)
T 4b99_A 193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 272 (398)
T ss_dssp TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999999876432 2234556789999999999988677899999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccC-CCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHF-KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
..|+...+.+....|............ .........+..++..++.+++|||++||.+||++|+|+.|+|+||||+...
T Consensus 273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999887776654332211000 0000112234556677899999999999999999999999999999998754
Q ss_pred CC
Q 014871 234 LP 235 (417)
Q Consensus 234 ~~ 235 (417)
.+
T Consensus 353 ~p 354 (398)
T 4b99_A 353 DP 354 (398)
T ss_dssp CG
T ss_pred CC
Confidence 43
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=387.59 Aligned_cols=199 Identities=25% Similarity=0.447 Sum_probs=172.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||+++++|+.++++|||||||++ +|.+++.. .+|++.+++.|++|||.||+|||++|||||||||+||||+.++.|
T Consensus 209 nIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~v 286 (423)
T 4fie_A 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRV 286 (423)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCE
T ss_pred CCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCE
Confidence 899999999999999999999996 55555543 359999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+.+... .....+.+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++..|.+...
T Consensus 287 Kl~DFGla~~~~~~-~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~ 364 (423)
T 4fie_A 287 KLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 364 (423)
T ss_dssp EECCCTTCEECCSS-CCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred EEecCccceECCCC-CccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 99999999876533 234556789999999999976 6799999999999999999999999999999998888865321
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
.. .. .+..++.++++||++||.+||++|+|+.|||+|+||....
T Consensus 365 ~~-~~--------------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 365 PR-LK--------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp CC-CS--------------------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CC-Cc--------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 10 00 1224678999999999999999999999999999997643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=379.14 Aligned_cols=197 Identities=25% Similarity=0.432 Sum_probs=171.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.|+.++++|||||||++ +|.+++.+. ..|++.+++.|++||+.||+|||+++||||||||+||||+.++.+
T Consensus 93 nIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~v 171 (311)
T 4aw0_A 93 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI 171 (311)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCE
Confidence 799999999999999999999986 777776654 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCC-CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+|+.+.... .....+.+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|.+..
T Consensus 172 Kl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 250 (311)
T 4aw0_A 172 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250 (311)
T ss_dssp EECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred EEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998775433 334556789999999999986 578999999999999999999999999999999988886532
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD------ALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e------lL~h~~f~~~ 232 (417)
-. +...+++++++||++||.+||++|+|++| |++||||...
T Consensus 251 ~~------------------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 251 YD------------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp CC------------------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CC------------------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 11 11236778999999999999999999987 5899999653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=373.09 Aligned_cols=195 Identities=24% Similarity=0.420 Sum_probs=168.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.++.++++|||||||++ +|.+++.+. ..|++.+++.|++||+.||+|||++||+||||||+||||+.++.+
T Consensus 87 nIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 87 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp TEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCE
T ss_pred CCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCE
Confidence 899999999999999999999985 666666554 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+..... .....+.+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|.+..-
T Consensus 166 Kl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 243 (304)
T 3ubd_A 166 KLTDFGLSKESIDH-EKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243 (304)
T ss_dssp EEESSEEEEC------CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EecccccceeccCC-CccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence 99999999865432 234456789999999999986 6789999999999999999999999999999999888865221
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
. ++..+++++++||++||.+||++|+| ++||++|+||..
T Consensus 244 ~------------------------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 244 G------------------------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred C------------------------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 1 11246789999999999999999998 589999999964
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=379.16 Aligned_cols=197 Identities=25% Similarity=0.447 Sum_probs=171.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++++.++.++++|||||||++ +|.+++.. ....+++.+++.|++||+.||+|||++|||||||||+||||+.+++
T Consensus 84 nIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~ 163 (350)
T 4b9d_A 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT 163 (350)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC
T ss_pred CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC
Confidence 799999999999999999999985 78777754 3456899999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
|||+|||+|+.+... .......+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|.+..
T Consensus 164 vKl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 241 (350)
T 4b9d_A 164 VQLGDFGIARVLNST-VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS 241 (350)
T ss_dssp EEECSTTEESCCCHH-HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred EEEcccccceeecCC-cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 999999999875421 122345689999999999986 679999999999999999999999999999999988886532
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..+ ....++.++++||++||.+||++|+|+.|||+|+||..
T Consensus 242 ~~~-----------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 242 FPP-----------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred CCC-----------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 111 11246789999999999999999999999999999954
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=374.88 Aligned_cols=224 Identities=25% Similarity=0.434 Sum_probs=169.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-GN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-~~ 81 (417)
|||+++++|+.++++|||||||++ +|.+++. .|++.+++.|++||+.||+|||++||+||||||+||||+.+ +.
T Consensus 81 nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~ 156 (361)
T 4f9c_A 81 NVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKK 156 (361)
T ss_dssp TBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE
T ss_pred CCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCe
Confidence 899999999999999999999985 6766653 49999999999999999999999999999999999999876 78
Q ss_pred EEEeeccCcccccCCC---------------------------CCcccccccccCCCCchhhcCCCCCCCccchhhHHHH
Q 014871 82 LKLADFGLARSFSYDH---------------------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134 (417)
Q Consensus 82 vkL~DFGla~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i 134 (417)
+||+|||+|+...... .....+.+||+.|||||++.+...|+.++||||+|||
T Consensus 157 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~i 236 (361)
T 4f9c_A 157 YALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236 (361)
T ss_dssp EEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred EEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHH
Confidence 9999999997643221 1123456899999999999876679999999999999
Q ss_pred HHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCCCCCCCCC--------CCCcc------------c----cCCCchhhhh
Q 014871 135 FAELLNGKPIL-PGKNEAEQLSKIFELCGSPDETIWPGVS--------KMPAY------------N----HFKPSRTMKR 189 (417)
Q Consensus 135 l~elltG~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~--------~~~~~------------~----~~~~~~~~~~ 189 (417)
||||++|+.|| .+.++.+++..|...++.++...+.... ..+.. . ..........
T Consensus 237 l~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 316 (361)
T 4f9c_A 237 FLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHA 316 (361)
T ss_dssp HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------------
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccc
Confidence 99999999877 5677888999998877653221111000 00000 0 0000000011
Q ss_pred hHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 190 ~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
...+.+..++++++|||++||.+||++|+|++|+|+||||++
T Consensus 317 ~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 317 TNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp -----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 112334568899999999999999999999999999999965
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=368.44 Aligned_cols=201 Identities=23% Similarity=0.285 Sum_probs=166.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-C
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-N 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~-~ 81 (417)
|||++++.++.++++|||||||++ +|.+++.+. ..|++.+++.|+.||+.||+|||+++||||||||+||||+.++ .
T Consensus 111 nIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~ 189 (336)
T 4g3f_A 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSR 189 (336)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCC
T ss_pred CCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCE
Confidence 899999999999999999999985 677666554 4699999999999999999999999999999999999999987 5
Q ss_pred EEEeeccCcccccCCCCC----cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN----TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+||+|||+|+.+...... .....+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|
T Consensus 190 vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i 268 (336)
T 4g3f_A 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268 (336)
T ss_dssp EEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH
T ss_pred EEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 999999999876533211 1233579999999999987 67999999999999999999999999988877777776
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHH-------------h
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA-------------L 224 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el-------------L 224 (417)
.... ....+++..+++.+++||++||.+||++|+|+.|| |
T Consensus 269 ~~~~---------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l 321 (336)
T 4g3f_A 269 ASEP---------------------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321 (336)
T ss_dssp HHSC---------------------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred HcCC---------------------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence 5421 01122344578899999999999999999999997 6
Q ss_pred cCCCCCCCC
Q 014871 225 DSEYFWTDP 233 (417)
Q Consensus 225 ~h~~f~~~~ 233 (417)
+|||+....
T Consensus 322 ~hPw~~~~~ 330 (336)
T 4g3f_A 322 KSPWKGEYK 330 (336)
T ss_dssp CSCSSSSCC
T ss_pred cCCCcCCCC
Confidence 799986543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=358.94 Aligned_cols=195 Identities=22% Similarity=0.334 Sum_probs=158.6
Q ss_pred cEeecccCcee----cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEE
Q 014871 4 TFLETTDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLI 76 (417)
Q Consensus 4 niv~~~~~~~~----~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~NILl 76 (417)
|||+++++|+. ++.+|||||||++ +|.+++.+ ...+++.+++.|++||+.||+|||+++ ||||||||+||||
T Consensus 86 nIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl 164 (290)
T 3fpq_A 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164 (290)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE
T ss_pred CCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE
Confidence 78999998865 4568999999985 66666654 446999999999999999999999998 9999999999999
Q ss_pred cC-CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 77 DN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 77 ~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
+. ++.+||+|||+|+... .....+.+||+.|||||++.+ .|+.++||||||||||||+||+.||.+.+....+.
T Consensus 165 ~~~~g~vKl~DFGla~~~~---~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~ 239 (290)
T 3fpq_A 165 TGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239 (290)
T ss_dssp SSTTSCEEECCTTGGGGCC---TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred ECCCCCEEEEeCcCCEeCC---CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH
Confidence 85 7899999999997543 234456789999999998864 59999999999999999999999998766555443
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
........+ ..+...+++++++||.+||..||++|||+.|||+||||+.
T Consensus 240 ~~i~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 240 RRVTSGVKP---------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHTTTCCC---------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHcCCCC---------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 332211000 0112345678999999999999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=372.00 Aligned_cols=205 Identities=25% Similarity=0.420 Sum_probs=178.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--C
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--G 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~--~ 80 (417)
|||++++.|+.++++|||||||++ +|++++.+....|++.+++.|++|||.||+|||+++|+||||||+||||+.+ +
T Consensus 215 nIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~ 294 (573)
T 3uto_A 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 294 (573)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC
T ss_pred CCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCC
Confidence 789999999999999999999985 7877777666679999999999999999999999999999999999999864 7
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||+|+.+.. .......+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++..|...
T Consensus 295 ~vKl~DFG~a~~~~~--~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~ 371 (573)
T 3uto_A 295 ELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 371 (573)
T ss_dssp CEEECCCSSCEECCT--TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred CEEEeeccceeEccC--CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC
Confidence 899999999987653 334556789999999999987 67899999999999999999999999999999999888764
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 237 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~ 237 (417)
...+... .+..++.++++||++||..||++|+|+.|||+|+||+....+..
T Consensus 372 ~~~~~~~--------------------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 372 DWNMDDS--------------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp CCCCCSG--------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred CCCCCcc--------------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 4333222 23357789999999999999999999999999999986555443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=371.36 Aligned_cols=194 Identities=25% Similarity=0.402 Sum_probs=164.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.|+.++++|||||||.| +|..++.+. ..|++.+++.|++||+.||+|||++|||||||||+||||+.+|.|
T Consensus 253 ~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~v 331 (689)
T 3v5w_A 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 331 (689)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCE
T ss_pred CEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCE
Confidence 799999999999999999999985 676666554 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~---~~~~~i~~ 159 (417)
||+|||+|+.+... ...+.+||+.|||||++.....|+.++||||||||||||++|++||.+.+.. ++...+..
T Consensus 332 KL~DFGlA~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~ 408 (689)
T 3v5w_A 332 RISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408 (689)
T ss_dssp EECCCTTCEECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH
T ss_pred EecccceeeecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC
Confidence 99999999876532 3345789999999999975467999999999999999999999999865432 33333322
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
.. ..++..++.++++||++||.+||++|++ ++||++|+||..
T Consensus 409 ~~------------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 409 MA------------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp CC------------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred CC------------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 11 0112347889999999999999999998 799999999965
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=338.10 Aligned_cols=228 Identities=41% Similarity=0.782 Sum_probs=195.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+...+++|||||||++++.+.+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 79 p~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~ 158 (311)
T 3niz_A 79 PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGAL 158 (311)
T ss_dssp TTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred CCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCE
Confidence 37899999999999999999999999999988877779999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++
T Consensus 159 kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 237 (311)
T 3niz_A 159 KLADFGLARAFGIP-VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237 (311)
T ss_dssp EECCCTTCEETTSC-CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHC
T ss_pred EEccCcCceecCCC-cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHC
Confidence 99999999875432 22344557799999999998756789999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+....|+.....+.+............+......++.++++||++||..||++|||++|+|+|+||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp CCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred CCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 988888887666544333222222233445566778899999999999999999999999999999965
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=337.79 Aligned_cols=197 Identities=20% Similarity=0.318 Sum_probs=146.7
Q ss_pred cEeecccCceecC------------eEEEEEcCCCC-CHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 014871 4 TFLETTDGNKYRG------------STYMVFEYMDH-DLTGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68 (417)
Q Consensus 4 niv~~~~~~~~~~------------~~yiV~Ey~~g-~l~~~~~~~~~--~l~~~~i~~i~~Qil~gL~~LH~~givHrD 68 (417)
|||+++++|...+ ++|||||||.+ +|.+++..... ...+..++.|+.||+.||+|||++||||||
T Consensus 64 nIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRD 143 (299)
T 4g31_A 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRD 143 (299)
T ss_dssp TBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCcccc
Confidence 7899998887655 37999999985 67666655432 245677899999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeeccCcccccCCCCC-----------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHH
Q 014871 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHNN-----------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137 (417)
Q Consensus 69 lkp~NILl~~~~~vkL~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 137 (417)
|||+||||+.++.+||+|||+|+.+...... ..+..+||+.|||||++.+ ..|+.++|||||||||||
T Consensus 144 lKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilye 222 (299)
T 4g31_A 144 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFE 222 (299)
T ss_dssp CCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHH
T ss_pred CcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999876533221 2234689999999999986 679999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCC
Q 014871 138 LLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217 (417)
Q Consensus 138 lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R 217 (417)
|++ ||... .+....+...... .....+...++.+++||++||..||++|
T Consensus 223 ll~---Pf~~~--~~~~~~~~~~~~~--------------------------~~p~~~~~~~~~~~~li~~~L~~dP~~R 271 (299)
T 4g31_A 223 LLY---PFSTQ--MERVRTLTDVRNL--------------------------KFPPLFTQKYPCEYVMVQDMLSPSPMER 271 (299)
T ss_dssp HHS---CCSSH--HHHHHHHHHHHTT--------------------------CCCHHHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred Hcc---CCCCc--cHHHHHHHHHhcC--------------------------CCCCCCcccCHHHHHHHHHHcCCChhHC
Confidence 996 66543 2333333221110 0112234456678899999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 014871 218 ISAKDALDSEYFWTD 232 (417)
Q Consensus 218 pta~elL~h~~f~~~ 232 (417)
||+.|||+|+||...
T Consensus 272 ps~~eil~h~~~~~~ 286 (299)
T 4g31_A 272 PEAINIIENAVFEDL 286 (299)
T ss_dssp CCHHHHHTSGGGCCC
T ss_pred cCHHHHhcCHhhCCC
Confidence 999999999999653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.22 Aligned_cols=196 Identities=19% Similarity=0.287 Sum_probs=155.3
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++++. ++++|||||||+ ++|.+++......|++.++..|+.||+.||+|||+++||||||||+||||++++++
T Consensus 93 NIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~ 171 (307)
T 3omv_A 93 NILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTV 171 (307)
T ss_dssp TBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEE
T ss_pred CEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcE
Confidence 7888888654 568999999998 57777776666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCC-CCcccccccccCCCCchhhcCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+|+...... .......+||+.|||||++... ..|+.++||||||||||||+||+.||.+.+....+..+..
T Consensus 172 Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~ 251 (307)
T 3omv_A 172 KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG 251 (307)
T ss_dssp EECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred EEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 999999998764322 2334556899999999999742 3589999999999999999999999998777666655543
Q ss_pred hc-CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LC-GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.. ..++. ......++.++.+||.+||..||++|||+.||++
T Consensus 252 ~~~~~p~~-------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 252 RGYASPDL-------------------------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TTCCCCCS-------------------------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cCCCCCCc-------------------------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 21 11110 1122346778999999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=333.43 Aligned_cols=229 Identities=41% Similarity=0.749 Sum_probs=189.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+...+.+||||||++++|.+++......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~ 139 (324)
T 3mtl_A 60 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGEL 139 (324)
T ss_dssp TTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCE
T ss_pred CCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCE
Confidence 37889999999999999999999999999988877779999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+++..+...++
T Consensus 140 kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 218 (324)
T 3mtl_A 140 KLADFGLARAKSIP-TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG 218 (324)
T ss_dssp EECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEccCcccccccCC-ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999999765422 22334457799999999998766789999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+....|+.......+..+................++.++++||++||..||++|||++|||+|+||...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 9988888766543332222222222223344556788999999999999999999999999999999654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.42 Aligned_cols=227 Identities=40% Similarity=0.728 Sum_probs=192.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+..++++|||||||+++++..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 61 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~ 140 (292)
T 3o0g_A 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140 (292)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred CCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 37899999999999999999999999999888777789999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~p-f~~~~~~~~~~~i~~~~ 161 (417)
||+|||+++..... .......++|..|+|||++.+...++.++||||||||+|||++|..| |.+.+..+.+..+.+..
T Consensus 141 kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 141 KLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp EECCCTTCEECCSC-CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred EEeecccceecCCc-cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 99999999876432 23344567799999999998755689999999999999999987655 78888899999999999
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.+....|+.....+.+..+.... ...........++.++++||++||..||++|+|++|+|+|+||..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 220 GTPTEEQWPSMTKLPDYKPYPMYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCCChhhhhhhccccccccccccc-CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 999988888777666554332211 112223344568899999999999999999999999999999965
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=330.85 Aligned_cols=192 Identities=22% Similarity=0.306 Sum_probs=162.6
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~------------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlk 70 (417)
|||++++++..++.+|||||||+ |+|.+++.+. ...|++.++..|+.||+.||+|||+++|||||||
T Consensus 76 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlK 155 (299)
T 4asz_A 76 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 155 (299)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccC
Confidence 89999999999999999999998 5777777543 2469999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 014871 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGK 148 (417)
Q Consensus 71 p~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~ 148 (417)
|+||||+.++++||+|||+|+......... ....++|+.|||||++.+ ..|+.++||||||||||||+| |+.||.+.
T Consensus 156 p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 156 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred HhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999998754332222 233468999999999986 679999999999999999998 89999999
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+..+++..+.+....+ ....++.++.+||.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~i~~~~~~~-----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 235 SNNEVIECITQGRVLQ-----------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp CHHHHHHHHHHTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCCC-----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9888888776522110 11246778999999999999999999999853
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=324.36 Aligned_cols=227 Identities=42% Similarity=0.786 Sum_probs=188.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+...+++||||||++++|.+++......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 139 (288)
T 1ob3_A 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139 (288)
T ss_dssp TTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred CCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCE
Confidence 37899999999999999999999999999888766679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+...++.++|||||||++|||++|+.||.+.+..+.+..++...+
T Consensus 140 kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 218 (288)
T 1ob3_A 140 KIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218 (288)
T ss_dssp EECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEeECccccccCcc-ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHC
Confidence 99999999865422 22334457799999999997656689999999999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+....|+.....+.+....... ....+......++.++++||++||..||++|||+.|+|+|+||..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 219 TPNSKNWPNVTELPKYDPNFTVY-EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCC-CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCChhhchhhhcccccccccccc-cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 88888887665544432211100 011233445568899999999999999999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=330.69 Aligned_cols=234 Identities=47% Similarity=0.909 Sum_probs=193.9
Q ss_pred cEeecccCcee--------cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 014871 4 TFLETTDGNKY--------RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75 (417)
Q Consensus 4 niv~~~~~~~~--------~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NIL 75 (417)
||+++++.+.. .+.+|||||||+++++..+......+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 77 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 156 (351)
T 3mi9_A 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 156 (351)
T ss_dssp TBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEE
Confidence 67777777666 5579999999999999998887778999999999999999999999999999999999999
Q ss_pred EcCCCCEEEeeccCcccccCC---CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 014871 76 IDNEGNLKLADFGLARSFSYD---HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152 (417)
Q Consensus 76 l~~~~~vkL~DFGla~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 152 (417)
|+.++.+||+|||+|+.+... ........++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+
T Consensus 157 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 236 (351)
T 3mi9_A 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236 (351)
T ss_dssp ECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999999875422 22233456789999999999876678999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh--hhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
++..+...++.+....|+.......+.................. ..+..+++||++||..||++|+|+.|+|+|+||+
T Consensus 237 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 99999999999988888877665544443322222222222222 2477899999999999999999999999999998
Q ss_pred CCCCCCC
Q 014871 231 TDPLPCD 237 (417)
Q Consensus 231 ~~~~~~~ 237 (417)
..+.+..
T Consensus 317 ~~~~~~~ 323 (351)
T 3mi9_A 317 SDPMPSD 323 (351)
T ss_dssp SSSCCCC
T ss_pred CCCCccc
Confidence 8776654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=331.73 Aligned_cols=192 Identities=23% Similarity=0.328 Sum_probs=155.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG--------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~--------------~~l~~~~i~~i~~Qil~gL~~LH~~givHrD 68 (417)
|||++++++...+.+|||||||++ +|.+++.+.. ..|++.++..|+.||+.||+|||+++|||||
T Consensus 104 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 183 (329)
T 4aoj_A 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183 (329)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccc
Confidence 899999999999999999999985 6777665432 3599999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 014871 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILP 146 (417)
Q Consensus 69 lkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~ 146 (417)
|||+||||+.++++||+|||+|+....... ......++|+.|||||++.+ ..|+.++||||||||||||+| |+.||.
T Consensus 184 LKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp CCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred ccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCC
Confidence 999999999999999999999987643322 22334578999999999986 679999999999999999998 899999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 147 GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+.+..+.+..+.+....+ ....+++++.+||.+||..||++|||+.||++
T Consensus 263 ~~~~~~~~~~i~~g~~~~-----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 263 QLSNTEAIDCITQGRELE-----------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp SSCHHHHHHHHHHTCCCC-----------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCC-----------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999888887775521110 11236778999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=329.87 Aligned_cols=232 Identities=41% Similarity=0.757 Sum_probs=200.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+...+++||||||++++|...+......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 72 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 72 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp TTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred CCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCE
Confidence 37889999999999999999999999988888777779999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.+... .......++|..|+|||++.+...++.++||||||||+|||++|.+||.+.+..+.+..+++..+
T Consensus 152 kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~ 230 (346)
T 1ua2_A 152 KLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230 (346)
T ss_dssp EECCCGGGSTTTSC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEEecccceeccCC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999999876432 22344567899999999997655689999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 237 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~ 237 (417)
.+....|+.....+.+..+.... ......++..++.++++||++||..||++|||+.|+|+|+||...+.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred CCChhhhhhhccCcccccccccC--CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 99888888877766554333211 12244556778899999999999999999999999999999987765544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=326.92 Aligned_cols=227 Identities=41% Similarity=0.804 Sum_probs=189.9
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRP-----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~-----~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
|||++++.+..++.+||||||++++|.+++... ...+++.+++.++.||+.||+|||++||+||||||+||||+.
T Consensus 64 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 143 (317)
T 2pmi_A 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK 143 (317)
T ss_dssp TBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC
Confidence 789999999999999999999999988877542 235999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||+++..... .......++|..|+|||++.+...++.++||||||||+|||++|+.||.+.+..+++..++
T Consensus 144 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 144 RGQLKLGDFGLARAFGIP-VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp TCCEEECCCSSCEETTSC-CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEECcCccceecCCC-cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999999876432 2233456789999999999865678999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCc---hhhhhhH-HHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPS---RTMKRRV-REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.++.+....|+...+.+.+...... ......+ ......++.++++||++||..||++|||+.|+|+|+||..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp HHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 99999988888877766554322111 1111111 1122357889999999999999999999999999999965
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=327.73 Aligned_cols=228 Identities=41% Similarity=0.764 Sum_probs=186.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-----
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID----- 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~----- 77 (417)
-|||++++.++.++.+||||||++++|.+++.+.. .+++.+++.++.||+.||+|||+++|+||||||+||||+
T Consensus 93 ~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~ 171 (329)
T 3gbz_A 93 RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDAS 171 (329)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC----
T ss_pred CCcceEEEEEecCCEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCC
Confidence 37899999999999999999999999888887654 599999999999999999999999999999999999995
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... .......++|..|+|||++.+...++.++||||||||+|||++|+.||.+.+..+.+..+
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 250 (329)
T 3gbz_A 172 ETPVLKIGDFGLARAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250 (329)
T ss_dssp -CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccceEEECcCCCccccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH
Confidence 4445999999999875432 223345577999999999987566899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
++..+.++...|+.....+.+...............+...++.++++||++||..||++|+|+.|+|+|+||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred HHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 999999988888877665554433322222222233445588999999999999999999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.93 Aligned_cols=223 Identities=41% Similarity=0.691 Sum_probs=188.0
Q ss_pred ccEeecccCceecC-----eEEEEEcCCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKYRG-----STYMVFEYMDHDLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~~~-----~~yiV~Ey~~g~l~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
-||+++++.+.... .+||||||++++|.+++..... .+++.+++.++.||+.||+|||+++|+||||||+||||
T Consensus 74 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~ 153 (308)
T 3g33_A 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 153 (308)
T ss_dssp TTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE
T ss_pred CCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 37888888877665 5899999999999888876543 49999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+.++.+||+|||+++.... .......++|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+.+
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 230 (308)
T 3g33_A 154 TSGGTVKLADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230 (308)
T ss_dssp CTTSCEEECSCSCTTTSTT--CCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEeeCccccccCC--CcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999986543 223455678999999999986 5689999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+++..+.+....|+.....+..... .............++.++++||++||..||++|+|+.|+|+|+||..
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFP---PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSC---CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred HHHHhCCCChhhccchhhccccccC---CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 9999999888888766554432111 11123345566778999999999999999999999999999999965
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=326.35 Aligned_cols=193 Identities=21% Similarity=0.297 Sum_probs=163.6
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
|||++++++..++.+|||||||+ |+|.+++.... ..|++.++..|+.||+.||+|||+++||||
T Consensus 90 NIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR 169 (308)
T 4gt4_A 90 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHK 169 (308)
T ss_dssp TBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 89999999999999999999998 57777775421 348999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPIL 145 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf 145 (417)
||||+||||++++++||+|||+|+....... ......++|+.|||||++.+ ..|+.++||||||||||||+| |+.||
T Consensus 170 DLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf 248 (308)
T 4gt4_A 170 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY 248 (308)
T ss_dssp CCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987643322 23445678999999999986 679999999999999999998 89999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+..+++..+.+....+ ....++..+.+||.+||..||++|||+.||++
T Consensus 249 ~~~~~~~~~~~i~~~~~~~-----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 249 CGYSNQDVVEMIRNRQVLP-----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp TTCCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCC-----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999888887775421111 11236678999999999999999999999986
Q ss_pred C
Q 014871 226 S 226 (417)
Q Consensus 226 h 226 (417)
+
T Consensus 300 ~ 300 (308)
T 4gt4_A 300 R 300 (308)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=341.65 Aligned_cols=230 Identities=36% Similarity=0.640 Sum_probs=175.4
Q ss_pred ccEeecccCc-----eecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 3 CTFLETTDGN-----KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~-----~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
-|||++++++ +....+||||||++++|..++... ..|++.+++.|+.||+.||+|||+++||||||||+||||+
T Consensus 112 ~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~ 190 (458)
T 3rp9_A 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190 (458)
T ss_dssp TTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCCceEEEEecCCcccCceEEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC
Confidence 3678888777 344679999999999988888754 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCC--------------------------CcccccccccCCCCchhhcCCCCCCCccchhhH
Q 014871 78 NEGNLKLADFGLARSFSYDHN--------------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl 131 (417)
.++.+||+|||+|+....... ......++|++|+|||+++....++.++|||||
T Consensus 191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 999999999999987643211 134456789999999988665779999999999
Q ss_pred HHHHHHHHh-----------CCCCCCCCC--------------------hHHHHHHHHHhcCCCCCCCCCCCCCCCc--c
Q 014871 132 GCIFAELLN-----------GKPILPGKN--------------------EAEQLSKIFELCGSPDETIWPGVSKMPA--Y 178 (417)
Q Consensus 132 G~il~ellt-----------G~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~ 178 (417)
|||||||++ ++++|.+.+ ..+++..|++.++.+....+........ +
T Consensus 271 G~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 350 (458)
T 3rp9_A 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350 (458)
T ss_dssp HHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHH
T ss_pred HHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHH
Confidence 999999998 788887765 3678888999888887655443322100 0
Q ss_pred ccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 179 NHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
.... .......+.+.+..++.++++||++||..||++|+|++|+|+|+||.....
T Consensus 351 ~~~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 351 IRIF-PKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HTTS-CCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHhc-CCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 0000 000112233445567899999999999999999999999999999976544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=329.76 Aligned_cols=228 Identities=35% Similarity=0.590 Sum_probs=177.3
Q ss_pred ccEeecccCceecC--eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRG--STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~--~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-|||++++.+...+ ++|||||||+++|..++... .+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 69 ~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 146 (388)
T 3oz6_A 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC 146 (388)
T ss_dssp TTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred CCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC
Confidence 47888888887554 78999999999988887753 599999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCC--------------------CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYD--------------------HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~--------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt 140 (417)
.+||+|||+|+.+... ........++|++|+|||++.+...++.++||||||||||||++
T Consensus 147 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 226 (388)
T 3oz6_A 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226 (388)
T ss_dssp CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh
Confidence 9999999999865321 11223456889999999999876679999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCcccc-----------CCCchhhhhhHHHh------hhhhhHHHH
Q 014871 141 GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH-----------FKPSRTMKRRVREV------FRHFDRHAL 203 (417)
Q Consensus 141 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~------~~~~~~~~~ 203 (417)
|++||.+.+..+++..|...++.+....+........... ..........+... ...++.+++
T Consensus 227 g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (388)
T 3oz6_A 227 GKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306 (388)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHH
Confidence 9999999999999999999888876554432221100000 00000000001111 124678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 204 ELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 204 ~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+||++||..||++|+|++|+|+|+||...
T Consensus 307 dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 307 DLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 99999999999999999999999999653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=332.43 Aligned_cols=194 Identities=20% Similarity=0.355 Sum_probs=157.4
Q ss_pred cEeecccCcee-cCeEEEEEcCCCC-CHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 4 TFLETTDGNKY-RGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 4 niv~~~~~~~~-~~~~yiV~Ey~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
|||++++.+.. .+.+|||||||++ +|.+++.+. ...|++.++..|+.||+.||+|||+++|||
T Consensus 129 nIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiH 208 (353)
T 4ase_A 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 208 (353)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred cEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeec
Confidence 79999987755 4578999999985 777776532 234899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+||||++++++||+|||+|+.+...... .....++|+.|||||++.+ ..|+.++||||||||||||+| |+.|
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCC
Confidence 999999999999999999999999876543332 2344578999999999986 679999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+.+.+++.....+. ....+++++.+||.+||..||++|||+.||+
T Consensus 288 f~~~~~~~~~~~~i~~g~~~~----------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil 339 (353)
T 4ase_A 288 YPGVKIDEEFCRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELV 339 (353)
T ss_dssp STTCCCSHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 998775554444333211110 1123567899999999999999999999999
Q ss_pred cC
Q 014871 225 DS 226 (417)
Q Consensus 225 ~h 226 (417)
+|
T Consensus 340 ~~ 341 (353)
T 4ase_A 340 EH 341 (353)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=330.95 Aligned_cols=235 Identities=36% Similarity=0.697 Sum_probs=179.1
Q ss_pred ccEeecccCce--ecCeEEEEEcCCCCCHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 3 CTFLETTDGNK--YRGSTYMVFEYMDHDLTGLADR--------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 3 cniv~~~~~~~--~~~~~yiV~Ey~~g~l~~~~~~--------~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
.|||++++++. ....+||||||++++|+.++.. ....+++.+++.|+.||+.||+|||+++|+||||||+
T Consensus 78 pniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~ 157 (405)
T 3rgf_A 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA 157 (405)
T ss_dssp TTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred CCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHH
Confidence 47888888884 4778999999999998887652 1224999999999999999999999999999999999
Q ss_pred cEEE----cCCCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 014871 73 NLLI----DNEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILP 146 (417)
Q Consensus 73 NILl----~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~ 146 (417)
|||| +.++.+||+|||+|+.+..... ......++|..|+|||++.+...++.++||||||||||||++|+.||.
T Consensus 158 NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 158 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp GEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999 6778999999999987643211 233456789999999999875668999999999999999999999998
Q ss_pred CCCh---------HHHHHHHHHhcCCCCCCCCCCCCCCCccccC----CCch----hhhhhHHHhhhhhhHHHHHHHHHh
Q 014871 147 GKNE---------AEQLSKIFELCGSPDETIWPGVSKMPAYNHF----KPSR----TMKRRVREVFRHFDRHALELLEKM 209 (417)
Q Consensus 147 ~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~~~~~Li~~~ 209 (417)
+.++ .+++..+++.++.+....|.....++.+... .... .............+..+++||++|
T Consensus 238 ~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~ 317 (405)
T 3rgf_A 238 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317 (405)
T ss_dssp CCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHH
T ss_pred CccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHH
Confidence 7665 4788999999999999888877665543211 0000 000111111122377899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014871 210 LMLDPSQRISAKDALDSEYFWTDPLPCD 237 (417)
Q Consensus 210 L~~dP~~Rpta~elL~h~~f~~~~~~~~ 237 (417)
|..||++|+|++|||+|+||...+.+..
T Consensus 318 L~~dP~~R~ta~e~L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 318 LTMDPIKRITSEQAMQDPYFLEDPLPTS 345 (405)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTSSSCCCS
T ss_pred ccCCcccCCCHHHHhcChhhccCCCCcc
Confidence 9999999999999999999988776643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.91 Aligned_cols=222 Identities=31% Similarity=0.546 Sum_probs=171.9
Q ss_pred cEeecccCceec------CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYR------GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~------~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
|||++++++... .++|||||||+++++..+.. .+++.+++.++.||+.||+|||++||+||||||+||||+
T Consensus 122 nIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp TBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 788888877544 46799999999998887754 499999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+|+.... .......++|+.|+|||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|
T Consensus 199 ~~~~~kl~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i 275 (464)
T 3ttj_A 199 SDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275 (464)
T ss_dssp TTSCEEECCCCCC-------CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEEEEEeeeecCC--CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999987543 233455788999999999987 57999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCC--------CCccccCCCchhh----hhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSK--------MPAYNHFKPSRTM----KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
++.++.+....+..... .+.+......... .....+.....+.++++||++||..||++|+|++|+|+
T Consensus 276 ~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 276 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998876655443321 0000000000000 00001112234788999999999999999999999999
Q ss_pred CCCCCC
Q 014871 226 SEYFWT 231 (417)
Q Consensus 226 h~~f~~ 231 (417)
|+||..
T Consensus 356 Hp~~~~ 361 (464)
T 3ttj_A 356 HPYINV 361 (464)
T ss_dssp STTTGG
T ss_pred Chhhhh
Confidence 999964
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.17 Aligned_cols=198 Identities=24% Similarity=0.437 Sum_probs=169.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++..+.+||||||+++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.+++
T Consensus 74 pnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~ 152 (328)
T 3fe3_A 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN 152 (328)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred CCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC
Confidence 4789999999999999999999975 666666544 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++..... ......++|+.|+|||++.+....+.++||||||||+|+|++|+.||.+.+..+....+....
T Consensus 153 ~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 230 (328)
T 3fe3_A 153 IKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230 (328)
T ss_dssp EEECSTTCCGGGSSS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEeeccCceecCCC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 999999999865432 344567889999999999875545689999999999999999999999999888887775521
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
... ...++.++.+||++||..||++|||++|||+|+||....
T Consensus 231 ~~~------------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 231 YRI------------------------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp CCC------------------------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCC------------------------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 111 113567899999999999999999999999999997543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=333.60 Aligned_cols=232 Identities=33% Similarity=0.589 Sum_probs=178.7
Q ss_pred ccEeecccCceec-----CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNKYR-----GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~~~-----~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
-|||++++.+... +.+||||||++++|..++... ..|++.+++.++.||+.||+|||++||+||||||+||||+
T Consensus 85 ~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 163 (432)
T 3n9x_A 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163 (432)
T ss_dssp TTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC
Confidence 3678888777666 679999999999988887654 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCC---------------------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHN---------------------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~---------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 136 (417)
.++.+||+|||+|+....... ......++|++|+|||+++....++.++||||||||||
T Consensus 164 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ 243 (432)
T 3n9x_A 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243 (432)
T ss_dssp TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHH
Confidence 999999999999987643321 12456788999999999866677999999999999999
Q ss_pred HHHh-----------CCCCCCCCC-----------------hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCC-Cchhh
Q 014871 137 ELLN-----------GKPILPGKN-----------------EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-PSRTM 187 (417)
Q Consensus 137 ellt-----------G~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 187 (417)
||++ ++++|.+.+ ..+++..|++.++.+....+............. .....
T Consensus 244 ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 323 (432)
T 3n9x_A 244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323 (432)
T ss_dssp HHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred HHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCC
Confidence 9997 566776655 477888999999988765544332211000000 00001
Q ss_pred hhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 188 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
...+...+..++.++++||++||..||++|+|++|+|+|+||.....+
T Consensus 324 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred CCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 122344456789999999999999999999999999999999765443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.21 Aligned_cols=223 Identities=28% Similarity=0.562 Sum_probs=179.7
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC-
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN- 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~- 81 (417)
||+++++.+...+++||||||++++|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+||||+.++.
T Consensus 160 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~ 239 (429)
T 3kvw_A 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS 239 (429)
T ss_dssp CBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSC
T ss_pred CEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCc
Confidence 8999999999999999999999999998887654 35999999999999999999999999999999999999999887
Q ss_pred -EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 82 -LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+|+.... .....++|+.|+|||++.+ ..++.++||||||||||||++|++||.+.++.+++..+.+.
T Consensus 240 ~vkL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQ----RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp CEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ceEEeecccceecCC----cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999976432 2345678999999999987 56899999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCCCCCCCcccc------C------C----------------CchhhhhhH-HHhhhhhhHHHHHHHHHhcc
Q 014871 161 CGSPDETIWPGVSKMPAYNH------F------K----------------PSRTMKRRV-REVFRHFDRHALELLEKMLM 211 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~------~------~----------------~~~~~~~~~-~~~~~~~~~~~~~Li~~~L~ 211 (417)
++.+....+........+.. + . ........+ ..+....+..+++||++||.
T Consensus 315 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~ 394 (429)
T 3kvw_A 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394 (429)
T ss_dssp HCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTC
T ss_pred cCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCC
Confidence 88776554332211100000 0 0 000001111 12223357889999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 014871 212 LDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 212 ~dP~~Rpta~elL~h~~f~~ 231 (417)
.||++|+|+.|||+|+||+.
T Consensus 395 ~dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 395 WDPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp SSTTTSCCHHHHHTSTTTC-
T ss_pred CChhhCCCHHHHhCChhhcc
Confidence 99999999999999999965
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=316.76 Aligned_cols=199 Identities=24% Similarity=0.414 Sum_probs=170.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
-|||++++.++..+.+|||||||.+ +|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 75 pnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~ 153 (361)
T 2yab_A 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153 (361)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS
T ss_pred cCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCC
Confidence 3789999999999999999999975 66666554 45699999999999999999999999999999999999998877
Q ss_pred ---CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 81 ---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 81 ---~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.+||+|||+++..... ......++|+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..|
T Consensus 154 ~~~~vkl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 154 PIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp SSCCEEECCCSSCEECCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CccCEEEEecCCceEcCCC--CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7999999999876532 23445678999999999976 57899999999999999999999999999998888887
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
......++ ...+..++..+++||++||..||++|||+.|+|+|+||..
T Consensus 231 ~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 231 TAVSYDFD--------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HTTCCCCC--------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred HhcCCCCC--------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 65322211 2334567889999999999999999999999999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.13 Aligned_cols=226 Identities=34% Similarity=0.581 Sum_probs=181.0
Q ss_pred ccEeecccCceecC------eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~~~------~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
-||+++++++...+ .+||||||++++|..++.. ..+++.+++.++.||+.||+|||++||+||||||+||||
T Consensus 84 pnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll 161 (367)
T 1cm8_A 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 161 (367)
T ss_dssp TTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred cCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE
Confidence 37788888776653 4699999998888887765 359999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+.++.+||+|||+++.... .....++|.+|+|||++.+...++.++||||||||+|||++|+.||.+.+..+++..
T Consensus 162 ~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~ 237 (367)
T 1cm8_A 162 NEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237 (367)
T ss_dssp CTTCCEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCCCCEEEEeeeccccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999987542 234567899999999998756799999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCc--cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
|.+..+.+....+........ +....+ ......+...+..++..+++||++||..||++|+|+.|+|+|+||.....
T Consensus 238 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 238 IMKVTGTPPAEFVQRLQSDEAKNYMKGLP-ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHSC-CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhCC-CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 999988876655433321000 000000 00011223444567899999999999999999999999999999976544
Q ss_pred C
Q 014871 235 P 235 (417)
Q Consensus 235 ~ 235 (417)
+
T Consensus 317 ~ 317 (367)
T 1cm8_A 317 T 317 (367)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=325.07 Aligned_cols=196 Identities=25% Similarity=0.408 Sum_probs=164.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++++...+++|||||||.+ +|..++.+. ..|++.+++.|+.||+.||+|||++||+||||||+||||+.++.
T Consensus 84 p~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC
T ss_pred CceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC
Confidence 3789999999999999999999986 566555543 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+|+..... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+++..|....
T Consensus 163 ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 240 (353)
T 3txo_A 163 CKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240 (353)
T ss_dssp EEECCCTTCBCSCC----------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEccccceeecccC-CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 999999999764322 233445688999999999976 568999999999999999999999999999999888886522
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta------~elL~h~~f~~ 231 (417)
... ...++.++++||++||..||++|+++ .||++|+||..
T Consensus 241 ~~~------------------------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 241 VVY------------------------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp CCC------------------------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred CCC------------------------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 111 12366789999999999999999998 99999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=315.10 Aligned_cols=201 Identities=20% Similarity=0.386 Sum_probs=173.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--C
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--E 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~--~ 79 (417)
-||+++++.++..+.+|||||||++ +|.+.+......+++.++..++.||+.||+|||++||+||||||+|||++. +
T Consensus 61 pnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~ 140 (321)
T 1tki_A 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS 140 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC
T ss_pred CCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCC
Confidence 3789999999999999999999986 777777666667999999999999999999999999999999999999987 7
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||+++..... ......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+..
T Consensus 141 ~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 217 (321)
T 1tki_A 141 STIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217 (321)
T ss_dssp CCEEECCCTTCEECCTT--CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCEEEEECCCCeECCCC--CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc
Confidence 88999999999876432 23445678999999999976 5689999999999999999999999999999888888765
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
....+. ...+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 218 ~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 218 AEYTFD--------------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TCCCCC--------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCCC--------------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 332211 12344578899999999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=316.27 Aligned_cols=195 Identities=28% Similarity=0.436 Sum_probs=166.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+++||||||+.+ +|...+.+ ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 66 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~v 144 (337)
T 1o6l_A 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE
T ss_pred cCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCE
Confidence 688899999999999999999986 56555544 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+..... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+....+.....
T Consensus 145 kL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~ 222 (337)
T 1o6l_A 145 KITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222 (337)
T ss_dssp EECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEeeccchhhcccC-CCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999999864322 223455688999999999976 5789999999999999999999999999888887777754211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
. +...++.++++||++||..||++|+ +++||++|+||..
T Consensus 223 ~------------------------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 223 R------------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred C------------------------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 0 1124678999999999999999999 9999999999964
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=311.41 Aligned_cols=229 Identities=33% Similarity=0.560 Sum_probs=175.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.||+++++.+...+.+|||||||+++++..+.+....+++.++..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 141 (311)
T 4agu_A 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVI 141 (311)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred CCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCE
Confidence 47899999999999999999999988777776666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+
T Consensus 142 kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 220 (311)
T 4agu_A 142 KLCDFGFARLLTGP-SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG 220 (311)
T ss_dssp EECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEeeCCCchhccCc-ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhc
Confidence 99999999875432 22334557899999999998766789999999999999999999999999999998888877665
Q ss_pred CCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
......+........+.... ............+..++..+++||++||..||++|||++|||+|+||+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp SCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 43321111000000000000 00001112233345688899999999999999999999999999999653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=315.55 Aligned_cols=231 Identities=30% Similarity=0.478 Sum_probs=178.4
Q ss_pred ccEeecccCceecCe-------EEEEEcCCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCC
Q 014871 3 CTFLETTDGNKYRGS-------TYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCH--VNQVLHRDIK 70 (417)
Q Consensus 3 cniv~~~~~~~~~~~-------~yiV~Ey~~g~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH--~~givHrDlk 70 (417)
.|||++++++...+. +||||||++++++..+. .....+++..++.++.||+.||.||| +++|+|||||
T Consensus 79 ~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlk 158 (360)
T 3e3p_A 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIK 158 (360)
T ss_dssp TTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCC
T ss_pred CCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCC
Confidence 377888887765544 89999999998776554 35557999999999999999999999 9999999999
Q ss_pred CCcEEEcC-CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 014871 71 GSNLLIDN-EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN 149 (417)
Q Consensus 71 p~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 149 (417)
|+||||+. ++.+||+|||+++...... .....++|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+
T Consensus 159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 159 PHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp GGGEEEETTTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEEeCCCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999996 8899999999998765322 33445779999999999775668999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCc-cccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPA-YNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 227 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~ 227 (417)
..+.+..+.+..+.+....+........ +.... ...............++.++++||.+||..||++|||+.|||+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 237 SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 9999999988877765544332211000 00000 000001111111223678999999999999999999999999999
Q ss_pred CCCCCCCC
Q 014871 228 YFWTDPLP 235 (417)
Q Consensus 228 ~f~~~~~~ 235 (417)
||.....+
T Consensus 317 ~f~~~~~~ 324 (360)
T 3e3p_A 317 YFDELHDP 324 (360)
T ss_dssp GGGGGGCT
T ss_pred cccccCCc
Confidence 99765443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=325.33 Aligned_cols=226 Identities=31% Similarity=0.529 Sum_probs=175.9
Q ss_pred ccEeecccCceec------CeEEEEEcCCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 3 CTFLETTDGNKYR------GSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 3 cniv~~~~~~~~~------~~~yiV~Ey~~g~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
+|||++++.+... ..+||||||+.++++.++. +....+++..++.|+.||+.||+|||+++|+||||||+|
T Consensus 107 pniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 186 (420)
T 1j1b_A 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186 (420)
T ss_dssp TTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred CCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence 5788887776432 2478999999998776654 345579999999999999999999999999999999999
Q ss_pred EEEcCC-CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 014871 74 LLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152 (417)
Q Consensus 74 ILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 152 (417)
|||+.+ +.+||+|||+|+..... ......++|+.|+|||++.+...++.++||||||||||||++|+.||.+.+..+
T Consensus 187 ILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~ 264 (420)
T 1j1b_A 187 LLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264 (420)
T ss_dssp EEEETTTTEEEECCCTTCEECCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEeCCCCeEEeccchhhhhcccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999965 56899999999875432 223456789999999999875679999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHH-hhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
++.++++.++.+....|.... +.+..+.........+.. +...++.++++||++||..||++|+|+.|+|+|+||..
T Consensus 265 ~l~~i~~~lg~p~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 265 QLVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHHHHHHCSCCHHHHHHHC--SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHHHHHhCCCCHHHHHhhC--hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 999999888876543332111 111111111111111222 22457889999999999999999999999999999965
Q ss_pred C
Q 014871 232 D 232 (417)
Q Consensus 232 ~ 232 (417)
.
T Consensus 343 ~ 343 (420)
T 1j1b_A 343 L 343 (420)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.74 Aligned_cols=198 Identities=27% Similarity=0.441 Sum_probs=167.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+|||||||++ +|.+++.+. .+++.+++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 77 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~ 154 (297)
T 3fxz_A 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 154 (297)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC
T ss_pred CCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC
Confidence 3789999999999999999999975 666666543 5999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... ......++|..|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..+....
T Consensus 155 ~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 232 (297)
T 3fxz_A 155 VKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (297)
T ss_dssp EEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred EEEeeCCCceecCCcc-cccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999998765332 23445678999999999986 578999999999999999999999999988877776664422
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.... .....++..+++||++||..||++|||+.|+|+|+||..
T Consensus 233 ~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 233 TPEL---------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp SCCC---------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCC---------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 1110 012346778999999999999999999999999999965
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=322.73 Aligned_cols=226 Identities=31% Similarity=0.516 Sum_probs=177.8
Q ss_pred ccEeecccCceecCe------EEEEEcCCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 3 CTFLETTDGNKYRGS------TYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 3 cniv~~~~~~~~~~~------~yiV~Ey~~g~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
.|||++++.+...+. +|||||||.++++..+. .....+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 92 ~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 171 (394)
T 4e7w_A 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171 (394)
T ss_dssp TTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHH
Confidence 478888887755544 89999999998776554 234569999999999999999999999999999999999
Q ss_pred EEEc-CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 014871 74 LLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152 (417)
Q Consensus 74 ILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 152 (417)
|||+ .++.+||+|||+|+..... ......++|+.|+|||++.+...++.++||||||||||||++|+.||.+.+..+
T Consensus 172 ill~~~~~~~kL~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 249 (394)
T 4e7w_A 172 LLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249 (394)
T ss_dssp EEEETTTTEEEECCCTTCEECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEcCCCCcEEEeeCCCcccccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999 7889999999999876432 233456789999999999876679999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHH-hhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE-VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
++..+.+.++.+....+..... .+............+.. +...++.++++||++||..||++|+|+.|+|+|+||..
T Consensus 250 ~l~~i~~~~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 250 QLVEIIKVLGTPSREQIKTMNP--NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCG--GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred HHHHHHHHhCCCCHHHHHhhCh--hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 9999998888765433221110 01000000000111222 23447889999999999999999999999999999975
Q ss_pred C
Q 014871 232 D 232 (417)
Q Consensus 232 ~ 232 (417)
.
T Consensus 328 ~ 328 (394)
T 4e7w_A 328 L 328 (394)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=320.56 Aligned_cols=225 Identities=36% Similarity=0.619 Sum_probs=169.5
Q ss_pred cEeecccCceec------CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYR------GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~------~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+... ..+||||||++++|..++.. ..+++.+++.++.||+.||+|||++||+||||||+||||+
T Consensus 89 nIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 166 (367)
T 2fst_X 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 166 (367)
T ss_dssp TBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC
Confidence 677777766543 67899999998888777654 3699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... .....++|..|+|||++.+...++.++||||||||+|||++|+.||.+.+..+++..|
T Consensus 167 ~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i 242 (367)
T 2fst_X 167 EDCELKILDFGLARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242 (367)
T ss_dssp TTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEeeccccccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999976542 2345678999999999987567899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCc--cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
.+.++.+....+........ +.... .......+...+..++..+++||++||..||++|+|+.|+|+|+||.....+
T Consensus 243 ~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 243 LRLVGTPGAELLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHHCSCCHHHHTTCCCHHHHHHHHTS-CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHHhcc-CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 99999887665544332100 00000 0001123345556678999999999999999999999999999999765443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=320.66 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=170.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---C
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID---N 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~---~ 78 (417)
-|||++++.++.++.+|||||||.+ +|.+.+... ..+++.++..++.||+.||+|||++||+||||||+||||+ .
T Consensus 70 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~ 148 (444)
T 3soa_A 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK 148 (444)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSST
T ss_pred cCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCC
Confidence 3789999999999999999999986 666666654 4599999999999999999999999999999999999998 4
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||+|+..... .......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+.
T Consensus 149 ~~~vkL~DFG~a~~~~~~-~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 226 (444)
T 3soa_A 149 GAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226 (444)
T ss_dssp TCCEEECCCSSCBCCCTT-CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCcEEEccCceeEEecCC-CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 578999999999776533 223345678999999999976 578999999999999999999999999999988888887
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..........| ..++.++++||++||..||++|||+.|+|+|+||..
T Consensus 227 ~~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 227 AGAYDFPSPEW--------------------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HTCCCCCTTTT--------------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred hCCCCCCcccc--------------------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 64433332222 246778999999999999999999999999999953
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.43 Aligned_cols=192 Identities=25% Similarity=0.440 Sum_probs=166.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.+...+.+|||||||.+ +|.+++.+. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 67 ~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~ 145 (318)
T 1fot_A 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHI 145 (318)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCE
T ss_pred CCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCE
Confidence 788999999999999999999986 666666543 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.... .....++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+.+.++.+...
T Consensus 146 kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 220 (318)
T 1fot_A 146 KITDFGFAKYVPD----VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220 (318)
T ss_dssp EECCCSSCEECSS----CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC
T ss_pred EEeecCcceecCC----ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999999986542 2334678999999999976 6789999999999999999999999999998888888765211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
. +...++.++++||++||..||++|+ +++||++|+||..
T Consensus 221 ~------------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 221 R------------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred C------------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 1 1123677899999999999999999 9999999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=324.14 Aligned_cols=205 Identities=23% Similarity=0.350 Sum_probs=172.4
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+++|||||||. ++|.+++.+....|++.+++.|+.||+.||+|||+++||||||||+||||+.++.
T Consensus 134 p~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred CCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC
Confidence 368889999999999999999996 5777777765667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+||+|||+|+.............+||+.|+|||++. +...++.++||||||||||||++|+.||.+.+..+++.+|
T Consensus 214 vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 999999999876544443444568999999999986 2356899999999999999999999999999999988888
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~h~~f~~~ 232 (417)
........ +......++.++++||++||..++++ |++++||++|+||...
T Consensus 294 ~~~~~~~~-------------------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 294 MNHKERFQ-------------------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HTHHHHCC-------------------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred hhcccccc-------------------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 64221100 00011236789999999999998888 9999999999999653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.98 Aligned_cols=223 Identities=23% Similarity=0.355 Sum_probs=174.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~--- 78 (417)
-|||++++.+...+++||||||+.++|.+++.+.. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 96 ~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 96 NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 48999999999999999999999889988887654 35999999999999999999999999999999999999975
Q ss_pred ----------------------CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHH
Q 014871 79 ----------------------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136 (417)
Q Consensus 79 ----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 136 (417)
++.+||+|||+|+.... .....++|..|+|||++.+ ..++.++||||||||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHH
Confidence 77899999999986442 2234578999999999986 57899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCc------------cccCCCchhhhhh----HHHhhhhhhH
Q 014871 137 ELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPA------------YNHFKPSRTMKRR----VREVFRHFDR 200 (417)
Q Consensus 137 elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~----~~~~~~~~~~ 200 (417)
+|++|+.||...+..+.+..+...........+........ +............ ........+.
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 99999999999999999988888776554322111110000 0000000000000 1111122357
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 201 HALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 201 ~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
.+++||++||..||++|||+.|||+|+||+
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 889999999999999999999999999994
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=317.57 Aligned_cols=196 Identities=27% Similarity=0.462 Sum_probs=167.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+++|||||||.+ +|..++.+. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 79 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~v 157 (345)
T 1xjd_A 79 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI 157 (345)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE
T ss_pred CCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCE
Confidence 688999999999999999999975 666666543 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+..... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+++..|.....
T Consensus 158 kL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~ 235 (345)
T 1xjd_A 158 KIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235 (345)
T ss_dssp EECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEeEChhhhhcccC-CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999999764322 223455688999999999986 5789999999999999999999999999998888887754211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~-elL~h~~f~~~ 232 (417)
. +...++.++++||++||..||++|+++. +|++|+||...
T Consensus 236 ~------------------------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 236 F------------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred C------------------------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 0 0123677899999999999999999998 99999999653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.94 Aligned_cols=221 Identities=28% Similarity=0.511 Sum_probs=175.1
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEc--C
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCH--VNQVLHRDIKGSNLLID--N 78 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH--~~givHrDlkp~NILl~--~ 78 (417)
+|+++++.+...+++||||||++++|.+++.... ..+++.+++.++.||+.||+||| +++|+||||||+||||+ .
T Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp GBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred eEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence 5888899999999999999999999999887654 45999999999999999999999 57999999999999995 4
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||+|+.... .....++|+.|+|||++.+ ..++.++||||||||||||++|+.||.+.+..+++..+.
T Consensus 197 ~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQ----RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp SCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEEeccCceeccc----ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 67899999999987642 2344678999999999986 578999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCCCcc------------------ccCCCchhhhhhHHHhh------------------hhhhHHH
Q 014871 159 ELCGSPDETIWPGVSKMPAY------------------NHFKPSRTMKRRVREVF------------------RHFDRHA 202 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~------------------~~~~~~~ 202 (417)
+..+.+....++.......+ ..+.. .....+...+ ...+.++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKP--PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKF 349 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCC--TTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCC--cchhhHHHHhhccccCCCccccccccccchhhHHH
Confidence 88777655443322110000 00000 0000011111 1123578
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 203 LELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 203 ~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
++||++||..||++|||+.|+|+|+||..
T Consensus 350 ~dli~~mL~~dP~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 350 KDLILRMLDYDPKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHhcCCChhhCCCHHHHhcCccccc
Confidence 99999999999999999999999999965
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.99 Aligned_cols=196 Identities=24% Similarity=0.411 Sum_probs=161.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++++...+.+|||||||.+ +|..++.+ ...|++.+++.|+.||+.||+|||++||+||||||+||||+.++.
T Consensus 113 p~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ 191 (396)
T 4dc2_A 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH 191 (396)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC
T ss_pred CCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC
Confidence 3789999999999999999999986 56555554 346999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh---------HH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---------AE 152 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~---------~~ 152 (417)
+||+|||+|+.... ........++|+.|+|||++.+ ..++.++||||||||||||++|+.||..... ..
T Consensus 192 ikL~DFGla~~~~~-~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~ 269 (396)
T 4dc2_A 192 IKLTDYGMCKEGLR-PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269 (396)
T ss_dssp EEECCCTTCBCCCC-TTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred EEEeecceeeeccc-CCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence 99999999986332 2234456789999999999986 6789999999999999999999999964321 22
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH------HHHhcC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDS 226 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta------~elL~h 226 (417)
....+.... ..+...++.++++||++||..||++|+++ .||++|
T Consensus 270 ~~~~i~~~~------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 270 LFQVILEKQ------------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHHCC------------------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHHhccc------------------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 223332210 01123467899999999999999999985 899999
Q ss_pred CCCCC
Q 014871 227 EYFWT 231 (417)
Q Consensus 227 ~~f~~ 231 (417)
+||..
T Consensus 320 pff~~ 324 (396)
T 4dc2_A 320 PFFRN 324 (396)
T ss_dssp TTTTT
T ss_pred ccccC
Confidence 99965
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.34 Aligned_cols=195 Identities=25% Similarity=0.466 Sum_probs=167.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|++++++++..+++|||||||.+ +|..++.+. ..|++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 82 ~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~v 160 (353)
T 2i0e_A 82 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI 160 (353)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE
T ss_pred EEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcE
Confidence 678888999999999999999986 666666543 369999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+..... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+++..|.....
T Consensus 161 kL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 238 (353)
T 2i0e_A 161 KIADFGMCKENIWD-GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238 (353)
T ss_dssp EECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEEeCCcccccccC-CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999999864322 223445688999999999976 5789999999999999999999999999999888888865211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
. +...++.++++||++||..||++|+ ++.+|++|+||..
T Consensus 239 ~------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 239 A------------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred C------------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 1 1124678999999999999999999 4799999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=305.81 Aligned_cols=199 Identities=24% Similarity=0.412 Sum_probs=169.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
-||+++++.+...+.+|||||||.+ +|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++
T Consensus 74 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS
T ss_pred CCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCC
Confidence 3789999999999999999999975 66666544 45699999999999999999999999999999999999999887
Q ss_pred ---CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 81 ---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 81 ---~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.+||+|||+++..... ......++|+.|+|||++.. ..++.++||||||||+|+|++|+.||.+.+..+.+..+
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp SSCCEEECCCTTCEECCTT--SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCEEEEECCCCeECCCC--CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 7999999999876432 23345678999999999875 57899999999999999999999999999888888777
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
........ ...+..++..+++||++||..||++|||+.|+|+|+||..
T Consensus 230 ~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 230 SAVNYEFE--------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHTCCCCC--------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HhcCCCcC--------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 55321111 1234457789999999999999999999999999999954
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=313.59 Aligned_cols=228 Identities=29% Similarity=0.596 Sum_probs=175.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.++..+.+||||||++++++..+......+++.++..++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 84 ~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~ 163 (331)
T 4aaa_A 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVV 163 (331)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred CCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcE
Confidence 47899999999999999999999998888776655679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++...... .......+|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+....+
T Consensus 164 kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 242 (331)
T 4aaa_A 164 KLCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG 242 (331)
T ss_dssp EECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEeCCCceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 999999997654322 2334457899999999998755789999999999999999999999999999998888877665
Q ss_pred CCCCCCCCCCCCCCccccCC-CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFK-PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
......+......+.+.... ...............++..+++||++||..||++|||+.|||+|+||..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp SCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred CCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 54322111100001000000 0001112233444568899999999999999999999999999999953
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=312.24 Aligned_cols=198 Identities=26% Similarity=0.414 Sum_probs=167.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-- 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~-- 80 (417)
|||++++.+...+.+|||||||.+ +|.+.+... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++
T Consensus 89 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~ 167 (362)
T 2bdw_A 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKG 167 (362)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTT
T ss_pred CCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCC
Confidence 789999999999999999999986 666666543 4699999999999999999999999999999999999998654
Q ss_pred -CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 81 -NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 -~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||+++..... ......++|+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+..
T Consensus 168 ~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~ 244 (362)
T 2bdw_A 168 AAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244 (362)
T ss_dssp CCEEECCCTTCBCCTTC--CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCEEEeecCcceEecCC--cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 5999999999876532 23345678999999999976 5789999999999999999999999999998888877765
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
........ .+..++.++++||++||..||++|+|+.++|+|+||..
T Consensus 245 ~~~~~~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 245 GAYDYPSP--------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp TCCCCCTT--------------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCCCCcc--------------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 33222111 12356789999999999999999999999999999964
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.44 Aligned_cols=203 Identities=26% Similarity=0.375 Sum_probs=169.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+++++.+...+++|||||||. ++|..++.+.+..+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 122 ~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~v 201 (412)
T 2vd5_A 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI 201 (412)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred CeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCE
Confidence 68889999999999999999996 57777777655579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC------CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
||+|||+|+.............++|+.|+|||++.. ...++.++||||||||+|||++|+.||.+.+..+++.+
T Consensus 202 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~ 281 (412)
T 2vd5_A 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK 281 (412)
T ss_dssp EECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999998765433333345688999999999872 24689999999999999999999999999999888888
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR---ISAKDALDSEYFWTD 232 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R---pta~elL~h~~f~~~ 232 (417)
|........ .......++.++++||++||. +|++| ++++||++|+||...
T Consensus 282 i~~~~~~~~-------------------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 282 IVHYKEHLS-------------------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHTHHHHCC-------------------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred HHhcccCcC-------------------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 764210000 001123478899999999999 99998 599999999999654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=314.80 Aligned_cols=227 Identities=37% Similarity=0.636 Sum_probs=181.4
Q ss_pred cEeecccCceec-----CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYR-----GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~-----~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
||+++++.+... ..+||||||++++|.+++... .+++.+++.++.||+.||+|||++||+||||||+||||+.
T Consensus 86 niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 163 (364)
T 3qyz_A 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163 (364)
T ss_dssp TBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCccceeEEecCCccccceEEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC
Confidence 677777766544 478999999999998887654 5999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
++.+||+|||+++....... ......++|+.|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..
T Consensus 164 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 243 (364)
T 3qyz_A 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 243 (364)
T ss_dssp TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH
T ss_pred CCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 99999999999987643222 1234567899999999987766789999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCcccc-CCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNH-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
+...++.+....+........... ..........+...+..++.++++||++||..||++|+|+.|||+|+||...
T Consensus 244 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 998888876554433221100000 0000001122344556688999999999999999999999999999999765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.28 Aligned_cols=213 Identities=31% Similarity=0.584 Sum_probs=168.0
Q ss_pred ecCeEEEEEcCCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCCEEEeeccC
Q 014871 14 YRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGL 89 (417)
Q Consensus 14 ~~~~~yiV~Ey~~g~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~-~~~~vkL~DFGl 89 (417)
....+|||||||+++|.+.+. ..+..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+
T Consensus 109 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~ 188 (383)
T 3eb0_A 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188 (383)
T ss_dssp -CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCC
Confidence 344589999999998666554 4556799999999999999999999999999999999999998 578899999999
Q ss_pred cccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 014871 90 ARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 169 (417)
Q Consensus 90 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 169 (417)
|+..... ......++|..|+|||++.+...++.++||||||||+|||++|+.||.+.+..+++..+.+.++.+....+
T Consensus 189 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 266 (383)
T 3eb0_A 189 AKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266 (383)
T ss_dssp CEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 9875432 23345677999999999987667999999999999999999999999999999999999988887754332
Q ss_pred CCCCCCCccccCCCchhhhhhHH-HhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 170 PGVSKMPAYNHFKPSRTMKRRVR-EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
..... .+............+. .+...++.++++||++||..||++|+|+.|+|+|+||.
T Consensus 267 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 267 IRMNP--HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp HHHCT--TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGH
T ss_pred HHhCc--ccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHH
Confidence 21110 0111110000111122 23345788999999999999999999999999999994
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.00 Aligned_cols=194 Identities=23% Similarity=0.278 Sum_probs=161.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+...+.+||||||++++|...+...+..+++.+++.++.||+.||+|||+++|+||||||+||||+.++++
T Consensus 117 ~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCE
T ss_pred CcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCE
Confidence 37889999999999999999999999999888777779999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......+|..|+|||++.+ .++.++||||||||+|||++|..+|...... ..+...
T Consensus 197 kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~-- 267 (311)
T 3p1a_A 197 KLGDFGLLVELGTA--GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQG-- 267 (311)
T ss_dssp EECCCTTCEECC--------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTT--
T ss_pred EEccceeeeecccC--CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhcc--
Confidence 99999999776432 22334568999999999875 6899999999999999999997776544322 222110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.....+...++.++++||++||..||++|||+.|||+|+||+.
T Consensus 268 --------------------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 --------------------------YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --------------------------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0011234567889999999999999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.15 Aligned_cols=223 Identities=39% Similarity=0.674 Sum_probs=183.9
Q ss_pred cEeecccCce-----ecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNK-----YRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~-----~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+. ....+||||||++++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||||+
T Consensus 75 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~ 154 (326)
T 1blx_A 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 154 (326)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc
Confidence 6778877776 567899999999999988876543 3599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..+
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 231 (326)
T 1blx_A 155 SSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231 (326)
T ss_dssp TTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEecCcccccccCC--CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 9999999999999765422 23344577999999999976 57899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+..+.+....|+.....+....... .......+...++..+++||++||..||++|||+.|+|+|+||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 232 LDVIGLPGEEDWPRDVALPRQAFHSK---SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCC---CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHcCCCCcccCccccccchhhhccc---CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 99888887777765444332111100 0112334456688999999999999999999999999999999653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.27 Aligned_cols=195 Identities=27% Similarity=0.417 Sum_probs=167.0
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.+...+++|||||||.+ +|..++.+ ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 100 ~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred CCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCE
Confidence 688889999999999999999986 56665554 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+++..|....-
T Consensus 179 kL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 256 (373)
T 2r5t_A 179 VLTDFGLCKENIEH-NSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 256 (373)
T ss_dssp EECCCCBCGGGBCC-CCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC
T ss_pred EEeeCccccccccC-CCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc
Confidence 99999999864322 223455688999999999986 6789999999999999999999999999999888888865211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA----KDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~h~~f~~ 231 (417)
. +...++..+++||++||..||++|+++ .+|++|+||..
T Consensus 257 ~------------------------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 257 Q------------------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp C------------------------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred C------------------------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 1 112367789999999999999999986 69999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=312.41 Aligned_cols=201 Identities=23% Similarity=0.412 Sum_probs=171.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--C
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--E 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~--~ 79 (417)
.|||++++.++..+.+|||||||.+ +|.+.+......+++.++..++.||+.||+|||++||+||||||+||||+. +
T Consensus 108 pnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~ 187 (387)
T 1kob_A 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA 187 (387)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC
T ss_pred cCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCC
Confidence 4789999999999999999999975 777777666667999999999999999999999999999999999999974 4
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||+++..... ......++|..|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+.+..+..
T Consensus 188 ~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~ 264 (387)
T 1kob_A 188 SSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264 (387)
T ss_dssp CCEEECCCTTCEECCTT--SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CceEEEecccceecCCC--cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 67999999999876432 23344578999999999976 5789999999999999999999999999998888887765
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.....+.. .+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 265 ~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 265 CDWEFDED--------------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp CCCCCCSS--------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCCCCCcc--------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 33222211 123467789999999999999999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=312.41 Aligned_cols=228 Identities=32% Similarity=0.492 Sum_probs=173.7
Q ss_pred ccEeecccCce-----ecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNK-----YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~-----~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
.||+++++.+. ....+||||||++++|++.+......+++.+++.++.||+.||+|||+++|+||||||+||||+
T Consensus 89 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168 (362)
T ss_dssp TTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred cCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc
Confidence 36788887773 3446899999999999999988777899999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... .......+|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999754322 23344577999999999986567899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCC--ccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMP--AYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+..+.+....+....... .+............+......++..+++||++||..||++|||+.|+|+|+||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 8887776543221111000 00000000011122344556678899999999999999999999999999999765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=311.84 Aligned_cols=196 Identities=25% Similarity=0.415 Sum_probs=160.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++++...+++|||||||.+ +|...+.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 70 p~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~ 148 (345)
T 3a8x_A 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH 148 (345)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC
T ss_pred CccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC
Confidence 3689999999999999999999986 666665543 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC---------ChHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK---------NEAE 152 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~---------~~~~ 152 (417)
+||+|||+|+..... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||... +...
T Consensus 149 ~kL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 226 (345)
T 3a8x_A 149 IKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226 (345)
T ss_dssp EEECCGGGCBCSCCT-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred EEEEeccccccccCC-CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence 999999999764322 223455688999999999986 57899999999999999999999999752 2222
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH------HHHhcC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA------KDALDS 226 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta------~elL~h 226 (417)
....+..... .+...++.++++||++||..||++|+++ .||++|
T Consensus 227 ~~~~i~~~~~------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 227 LFQVILEKQI------------------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHHHCCC------------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHHcCCC------------------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 3333322100 0123467889999999999999999995 899999
Q ss_pred CCCCC
Q 014871 227 EYFWT 231 (417)
Q Consensus 227 ~~f~~ 231 (417)
+||..
T Consensus 277 p~f~~ 281 (345)
T 3a8x_A 277 PFFRN 281 (345)
T ss_dssp GGGTT
T ss_pred CccCC
Confidence 99964
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=305.81 Aligned_cols=203 Identities=28% Similarity=0.423 Sum_probs=163.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-|||++++.++..+..|||||||+++.+..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 65 pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~ 144 (323)
T 3tki_A 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNL 144 (323)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred CCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCE
Confidence 37899999999999999999999874444444445569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCC-CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+++.+.... .......++|+.|+|||++.+...++.++||||||||||+|++|+.||...+............
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 224 (323)
T 3tki_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224 (323)
T ss_dssp EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT
T ss_pred EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc
Confidence 999999998654322 2233456789999999999875555789999999999999999999998766543322221110
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.. ....+..++..+++||++||..||++|+|+.|||+|+||...
T Consensus 225 ~~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 225 KT---------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp CT---------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cc---------------------------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 00 001124577889999999999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=318.27 Aligned_cols=202 Identities=27% Similarity=0.336 Sum_probs=169.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++++...+++|||||||.+ +|.+++.+. .+++..++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 129 p~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred CCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC
Confidence 4789999999999999999999975 676666543 5999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCC---CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT---KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+|+.............++|+.|+|||++.... .++.++||||||||||||++|+.||.+.+..+++.+|.
T Consensus 207 ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp EEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred EEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence 999999999876543333344678999999999998632 27889999999999999999999999999988888886
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ--RISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~h~~f~~~ 232 (417)
+....... + ....++.++++||++||..++.+ |++++||++|+||...
T Consensus 287 ~~~~~~~~---p-----------------------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 287 NHKNSLTF---P-----------------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp THHHHCCC---C-----------------------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred hccccccC---C-----------------------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 52111000 0 01236789999999999999988 9999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=319.96 Aligned_cols=223 Identities=30% Similarity=0.536 Sum_probs=164.7
Q ss_pred cEeecccCceecC------eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~------~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+...+ .+|||||||+++|.+.+.. .+++.+++.++.||+.||+|||++||+||||||+||||+
T Consensus 85 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp TBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CccceEEeeccccccccccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 6777777776554 7899999999998888763 489999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... ......++|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+++..+
T Consensus 162 ~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 238 (371)
T 2xrw_A 162 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238 (371)
T ss_dssp TTSCEEECCCCC------------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEEEeecccccccc--cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999765422 23345678999999999986 57899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCC--------CCccccCCCchh----hhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSK--------MPAYNHFKPSRT----MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.++.+....+..... .+.+........ ......+.....+.++++||++||..||++|+|++|+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 88777665443332211 000000000000 000001122335788999999999999999999999999
Q ss_pred CCCCCCC
Q 014871 226 SEYFWTD 232 (417)
Q Consensus 226 h~~f~~~ 232 (417)
|+||...
T Consensus 319 hp~~~~~ 325 (371)
T 2xrw_A 319 HPYINVW 325 (371)
T ss_dssp SHHHHTT
T ss_pred Ccchhhh
Confidence 9999643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=311.76 Aligned_cols=192 Identities=27% Similarity=0.426 Sum_probs=166.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+++||||||+.+ +|.+++.+. ..|++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 102 ~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~ 180 (350)
T 1rdq_E 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred CCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCE
Confidence 688899999999999999999975 676666553 369999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++.... .....++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+++..|.....
T Consensus 181 kL~DFg~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~ 255 (350)
T 1rdq_E 181 QVTDFGFAKRVKG----RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255 (350)
T ss_dssp EECCCTTCEECSS----CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEcccccceeccC----CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999987543 2334678999999999986 5789999999999999999999999999998888888765211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~ 231 (417)
. +...++.++++||++||..||++|++ ++||++|+||..
T Consensus 256 ~------------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 256 R------------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp C------------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred C------------------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 1 11236778999999999999999998 999999999954
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=318.02 Aligned_cols=197 Identities=27% Similarity=0.450 Sum_probs=162.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.++..+.+||||||++++|++.+.... .+++.+++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 69 pnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~ 147 (336)
T 3h4j_B 69 PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNV 147 (336)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCE
T ss_pred CCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCE
Confidence 37899999999999999999999989988876543 59999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++...... ......++|+.|+|||++.+....+.++||||||||+|+|++|+.||...+..+....+
T Consensus 148 kl~DFG~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----- 220 (336)
T 3h4j_B 148 KIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----- 220 (336)
T ss_dssp EECCSSCTBTTTTS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-----
T ss_pred EEEEeccceeccCC--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-----
Confidence 99999999765432 23445678999999999987544578999999999999999999999765432211110
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.. ....+...++..+++||++||..||++|||+.||++|+||...
T Consensus 221 ----------~~---------------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 ----------NS---------------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ----------CS---------------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ----------Hc---------------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00 0001123467889999999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=306.67 Aligned_cols=198 Identities=21% Similarity=0.299 Sum_probs=144.7
Q ss_pred cEeecccCceecC----eEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCC
Q 014871 4 TFLETTDGNKYRG----STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDIK 70 (417)
Q Consensus 4 niv~~~~~~~~~~----~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--------givHrDlk 70 (417)
|||++++++..++ .+|||||||++ +|.+++.+. .+++.++.+++.||+.||+|||++ +|||||||
T Consensus 58 NIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlK 135 (303)
T 3hmm_A 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 135 (303)
T ss_dssp TBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCC
T ss_pred CCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCC
Confidence 7899998887765 58999999985 677666543 589999999999999999999987 99999999
Q ss_pred CCcEEEcCCCCEEEeeccCcccccCCCCC---cccccccccCCCCchhhcCCC-----CCCCccchhhHHHHHHHHHhCC
Q 014871 71 GSNLLIDNEGNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNGK 142 (417)
Q Consensus 71 p~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~elltG~ 142 (417)
|+||||+.++++||+|||+|+........ .....+||+.|||||++.+.. .++.++||||||||||||+||+
T Consensus 136 p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~ 215 (303)
T 3hmm_A 136 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215 (303)
T ss_dssp GGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTB
T ss_pred cccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCC
Confidence 99999999999999999999876543321 223467999999999997532 3567899999999999999998
Q ss_pred CCCCCCCh--------------HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHH
Q 014871 143 PILPGKNE--------------AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEK 208 (417)
Q Consensus 143 ~pf~~~~~--------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~ 208 (417)
+||...+. .+.+.+... .. ..++... . ..........+.+||.+
T Consensus 216 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~--~~----------------~~rp~~p--~--~~~~~~~~~~l~~li~~ 273 (303)
T 3hmm_A 216 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC--EQ----------------KLRPNIP--N--RWQSCEALRVMAKIMRE 273 (303)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT--TS----------------CCCCCCC--G--GGGSSHHHHHHHHHHHT
T ss_pred CCCCccccccccchhcccccchHHHHHHHHh--cc----------------cCCCCCC--c--cccchHHHHHHHHHHHH
Confidence 77643321 111111110 00 0000000 0 00011245678899999
Q ss_pred hcccCCCCCCCHHHHhc
Q 014871 209 MLMLDPSQRISAKDALD 225 (417)
Q Consensus 209 ~L~~dP~~Rpta~elL~ 225 (417)
||..||++|||+.||++
T Consensus 274 cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 274 CWYANGAARLTALRIKK 290 (303)
T ss_dssp TCCSSGGGSCCHHHHHH
T ss_pred HcccCHhHCcCHHHHHH
Confidence 99999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=319.77 Aligned_cols=196 Identities=27% Similarity=0.411 Sum_probs=165.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~ 80 (417)
.||+++++.+...+.+|||||||++ +|...+.+ ...|++.+++.++.||+.||+|||+ +||+||||||+||||+.++
T Consensus 208 ~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~ 286 (446)
T 4ejn_A 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 286 (446)
T ss_dssp TTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS
T ss_pred CeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC
Confidence 3788899999999999999999986 55555544 3469999999999999999999998 9999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||+|+..... .......++|+.|+|||++.+ ..++.++||||||||||||++|+.||.+.+..+....+...
T Consensus 287 ~~kl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 364 (446)
T 4ejn_A 287 HIKITDFGLCKEGIKD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364 (446)
T ss_dssp CEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CEEEccCCCceeccCC-CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 9999999999764322 233455788999999999986 57899999999999999999999999999888887777542
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
... +...++.++++||.+||..||++|+ |++|||+|+||..
T Consensus 365 ~~~------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 365 EIR------------------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp CCC------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCC------------------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 111 1123677899999999999999999 9999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.74 Aligned_cols=222 Identities=26% Similarity=0.405 Sum_probs=170.7
Q ss_pred cEeecccCce----ecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEc
Q 014871 4 TFLETTDGNK----YRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~----~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~ 77 (417)
||+++++.+. ...++||||||++++++..+.+.. ..+++.+++.++.||+.||+|||++ ||+||||||+||||+
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~ 181 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred eeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence 4888888887 456899999999999998877654 5699999999999999999999999 999999999999998
Q ss_pred CCC-------------------------------------------------CEEEeeccCcccccCCCCCccccccccc
Q 014871 78 NEG-------------------------------------------------NLKLADFGLARSFSYDHNNTLTNRVITL 108 (417)
Q Consensus 78 ~~~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~ 108 (417)
.++ .+||+|||+|+.... .....++|.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----~~~~~~gt~ 257 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTR 257 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----CSCSCCSCG
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----cCccCCCCC
Confidence 775 799999999987543 234457899
Q ss_pred CCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCCCCCC----------CCC
Q 014871 109 WYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN------EAEQLSKIFELCGSPDETIW----------PGV 172 (417)
Q Consensus 109 ~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~------~~~~~~~i~~~~~~~~~~~~----------~~~ 172 (417)
.|+|||++.+ ..++.++||||||||||||++|+.||...+ ..+.+..+.+..+.+....+ ...
T Consensus 258 ~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 258 QYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred cccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 9999999987 568999999999999999999999998655 55667777777766543221 111
Q ss_pred CCCCccccCCCchhh--hhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 173 SKMPAYNHFKPSRTM--KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 173 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
............... ..........++..+++||++||..||++|||+.|||+|+||.
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 111111111111000 0001112245678899999999999999999999999999995
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=301.97 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=155.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~--- 78 (417)
-||+++++.++..+.+||||||+.+ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 108 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~ 186 (349)
T 2w4o_A 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAP 186 (349)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSST
T ss_pred CCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCC
Confidence 3788999999999999999999985 666666543 46999999999999999999999999999999999999975
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH-HHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSKI 157 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~~~~i 157 (417)
++.+||+|||+++..... ......++|+.|+|||++.+ ..++.++||||||||||||++|+.||......+ .+..+
T Consensus 187 ~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i 263 (349)
T 2w4o_A 187 DAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263 (349)
T ss_dssp TCCEEECCCC------------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH
T ss_pred CCCEEEccCccccccCcc--cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH
Confidence 788999999999865432 22344678999999999986 578999999999999999999999998766554 44555
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.+........ .+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 264 ~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 264 LNCEYYFISP--------------------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HTTCCCCCTT--------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HhCCCccCCc--------------------------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 4322111111 123467789999999999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.10 Aligned_cols=223 Identities=24% Similarity=0.428 Sum_probs=174.9
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC----
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---- 78 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~---- 78 (417)
+++++++.++..+++||||||++++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 78 RCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEE
T ss_pred eeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccc
Confidence 4788899999999999999999989998887654 35899999999999999999999999999999999999987
Q ss_pred ---------------CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCC
Q 014871 79 ---------------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKP 143 (417)
Q Consensus 79 ---------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~ 143 (417)
++.+||+|||+++.... .....++|..|+|||++.+ ..++.++||||||||+|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCC
Confidence 56799999999976432 2234578999999999986 578999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccc----cCCCchhhhhhHHH----------hhhhhhHHHHHHHHHh
Q 014871 144 ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN----HFKPSRTMKRRVRE----------VFRHFDRHALELLEKM 209 (417)
Q Consensus 144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~----------~~~~~~~~~~~Li~~~ 209 (417)
||...+..+.+..+....+......+........+. .+............ .....+.++.+||++|
T Consensus 233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 999999988888887777655443322111110000 01100011111111 1123567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 014871 210 LMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 210 L~~dP~~Rpta~elL~h~~f~~ 231 (417)
|..||++|||+.|||+|+||+.
T Consensus 313 L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 313 LEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGG
T ss_pred hCcCcccccCHHHHhcCHHHHH
Confidence 9999999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=306.93 Aligned_cols=196 Identities=24% Similarity=0.423 Sum_probs=163.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+++|||||||.+ +|.+.+.+. ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 81 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 159 (327)
T 3a62_A 81 PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH 159 (327)
T ss_dssp TTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC
T ss_pred CCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc
Confidence 3788999999999999999999985 666666543 45999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++..... .......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+.+..+....
T Consensus 160 ~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 237 (327)
T 3a62_A 160 VKLTDFGLCKESIHD-GTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237 (327)
T ss_dssp EEECCCSCC-----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred EEEEeCCcccccccC-CccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 999999999764322 122344578999999999976 578999999999999999999999999999888888776532
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
... ...++.++++||++||..||++|+ ++.++++|+||..
T Consensus 238 ~~~------------------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 238 LNL------------------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp CCC------------------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred CCC------------------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 111 123677899999999999999999 8999999999964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=312.73 Aligned_cols=200 Identities=29% Similarity=0.416 Sum_probs=170.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE--cCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI--DNE 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl--~~~ 79 (417)
-|||++++.++..+.+|||||||++ +|.+.+......+++.++..++.||+.||+|||+++|+||||||+|||| +.+
T Consensus 146 pnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 225 (373)
T 2x4f_A 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA 225 (373)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTT
T ss_pred CCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCC
Confidence 3789999999999999999999985 6777776665679999999999999999999999999999999999999 556
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||+++..... ......++|+.|+|||++.. ..++.++||||||||||||++|+.||.+.+..+.+..+..
T Consensus 226 ~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 302 (373)
T 2x4f_A 226 KQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302 (373)
T ss_dssp TEEEECCCSSCEECCTT--CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CcEEEEeCCCceecCCc--cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 78999999999876432 23344578999999999875 5789999999999999999999999999999988888876
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
....... ..+..++.++++||++||..||++|||+.|+|+|+||..
T Consensus 303 ~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 303 CRWDLED--------------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TCCCSCS--------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ccCCCCh--------------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 4322221 112346789999999999999999999999999999954
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=314.85 Aligned_cols=201 Identities=26% Similarity=0.395 Sum_probs=155.5
Q ss_pred ccEeecccCcee----cCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKY----RGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~----~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
-||+++++.++. .+++|||||||++ +|.+++.... ..|++.+++.|+.||+.||+|||+++|+||||||+||||
T Consensus 115 p~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill 194 (400)
T 1nxk_A 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194 (400)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEE
Confidence 378888888776 6789999999986 7777776543 459999999999999999999999999999999999999
Q ss_pred cC---CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH-
Q 014871 77 DN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE- 152 (417)
Q Consensus 77 ~~---~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~- 152 (417)
+. ++.+||+|||+++..... ......++|+.|+|||++.+ ..++.++||||||||||||++|+.||.+.+...
T Consensus 195 ~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 271 (400)
T 1nxk_A 195 TSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_dssp SSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred ecCCCCccEEEEecccccccCCC--CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 97 788999999999865422 23445678999999999875 678999999999999999999999998765432
Q ss_pred ---HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 153 ---QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 153 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
....+......... ..+..++.++++||++||..||++|+|+.|||+|+||
T Consensus 272 ~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 272 SPGMKTRIRMGQYEFPN--------------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp CCSHHHHHHHTCCCCCT--------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred cHHHHHHHHcCcccCCC--------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 22333221111110 0123467899999999999999999999999999999
Q ss_pred CCC
Q 014871 230 WTD 232 (417)
Q Consensus 230 ~~~ 232 (417)
+..
T Consensus 326 ~~~ 328 (400)
T 1nxk_A 326 MQS 328 (400)
T ss_dssp HTT
T ss_pred cCC
Confidence 754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=311.69 Aligned_cols=222 Identities=35% Similarity=0.609 Sum_probs=175.4
Q ss_pred cEeecccCceecCeE------EEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRGST------YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~~~------yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++++...+.. ||||||+.++|...+. ..+++.+++.++.||+.||+|||++||+||||||+||||+
T Consensus 102 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 178 (371)
T 4exu_A 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 178 (371)
T ss_dssp TBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CchhhhhheeccCCcccceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC
Confidence 788888888877765 9999999998877764 3499999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... .....++|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+
T Consensus 179 ~~~~~kL~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 254 (371)
T 4exu_A 179 EDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254 (371)
T ss_dssp TTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEEecCccccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 999999999999976542 2334577999999999987567899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCccccC-CCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHF-KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
....+.+....+............ .........+...+..++..+++||++||..||++|+|+.|+|+|+||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 988887765544333210000000 000000122334455678999999999999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=308.34 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=162.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-C
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-G 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-~ 80 (417)
-||+++++.++..+.+|||||||.+ +|.+.+.+. ..|++.+++.++.||+.||+|||++||+||||||+|||+.++ +
T Consensus 76 p~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~ 154 (342)
T 2qr7_A 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG 154 (342)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSC
T ss_pred CCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCC
Confidence 3789999999999999999999985 676666554 469999999999999999999999999999999999998543 2
Q ss_pred ---CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC---CChHHHH
Q 014871 81 ---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG---KNEAEQL 154 (417)
Q Consensus 81 ---~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~---~~~~~~~ 154 (417)
.+||+|||+++...... ......++|+.|+|||++.+ ..++.++||||||||+|||++|+.||.. .+..+++
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 232 (342)
T 2qr7_A 155 NPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232 (342)
T ss_dssp SGGGEEECCCTTCEECBCTT-CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH
T ss_pred CcCeEEEEECCCcccCcCCC-CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH
Confidence 49999999998765332 23445678999999999875 4588899999999999999999999986 3445555
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..+.......... .+..++.++++||++||..||++|+|+.++|+|+||..
T Consensus 233 ~~i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 233 ARIGSGKFSLSGG--------------------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHCCCCCCST--------------------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHccCCcccCcc--------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 5554422111111 12346789999999999999999999999999999954
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=334.32 Aligned_cols=196 Identities=25% Similarity=0.458 Sum_probs=168.7
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
+|+.++++++..+++||||||+.+ +|..++.+. ..|++.+++.|+.||+.||+|||+++||||||||+||||+.++.+
T Consensus 403 ~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~i 481 (674)
T 3pfq_A 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI 481 (674)
T ss_dssp TBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCE
T ss_pred eEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcE
Confidence 577888999999999999999986 666665543 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+..... .......++|+.|+|||++.+ ..|+.++||||||||||||++|+.||.+.+..+++..|.+...
T Consensus 482 kL~DFGla~~~~~~-~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 559 (674)
T 3pfq_A 482 KIADFGMCKENIWD-GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 559 (674)
T ss_dssp EECCCTTCEECCCT-TCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC
T ss_pred EEeecceeeccccC-CcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999999864322 233456789999999999976 6789999999999999999999999999999999888865211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISA-----KDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~h~~f~~~ 232 (417)
. +...++.++++||++||..||++|+++ +||++|+||...
T Consensus 560 ~------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 560 A------------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred C------------------------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 1 112467899999999999999999997 999999999653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=303.33 Aligned_cols=222 Identities=25% Similarity=0.421 Sum_probs=173.6
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-------
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI------- 76 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl------- 76 (417)
++.+++.+...+++||||||+++++++.+.... ..+++.+++.++.||+.||+|||+++|+||||||+||||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred EEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 677788899999999999999999998877654 469999999999999999999999999999999999999
Q ss_pred ------------cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCC
Q 014871 77 ------------DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI 144 (417)
Q Consensus 77 ------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~p 144 (417)
+.++.+||+|||+++.... .....++|..|+|||++.+ ..++.++||||||||||||++|+.|
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCC
Confidence 5678899999999976432 2234578999999999986 5789999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccc----cCCCchhhhhhHHH----------hhhhhhHHHHHHHHHhc
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYN----HFKPSRTMKRRVRE----------VFRHFDRHALELLEKML 210 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~----------~~~~~~~~~~~Li~~~L 210 (417)
|...+..+.+..+....+......+........+. .+............ .....+.++++||++||
T Consensus 239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 99999998888888877765543322211110000 00000000000110 01224668999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCC
Q 014871 211 MLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 211 ~~dP~~Rpta~elL~h~~f~~ 231 (417)
..||++|||+.|+|+|+||..
T Consensus 319 ~~dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 319 EFDPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp CSSTTTSCCHHHHTTSGGGGG
T ss_pred cCChhhCcCHHHHhcChhhcC
Confidence 999999999999999999954
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.57 Aligned_cols=196 Identities=30% Similarity=0.473 Sum_probs=167.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++..+.+|||||||.+ +|.+++.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++++
T Consensus 77 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~v 155 (476)
T 2y94_A 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA 155 (476)
T ss_dssp TBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCE
T ss_pred CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCe
Confidence 789999999999999999999975 66665544 4569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+++..... ......++|+.|+|||++.+....+.++||||||||+|+|++|+.||.+.+....+.++.....
T Consensus 156 kL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 233 (476)
T 2y94_A 156 KIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF 233 (476)
T ss_dssp EECCCSSCEECCTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC
T ss_pred EEEeccchhhcccc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc
Confidence 99999999876432 2344567899999999998754557899999999999999999999999888888777754221
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.. ...++.++++||++||..||++|||+.||++|+||+..
T Consensus 234 ~~------------------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 YT------------------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CC------------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CC------------------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 10 12356789999999999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=304.34 Aligned_cols=200 Identities=31% Similarity=0.510 Sum_probs=163.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
-|||++++.++.++.+|||||||++ +|.+.+.+ .+..+++.+++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 86 pnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~ 165 (351)
T 3c0i_A 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLAS 165 (351)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECS
T ss_pred CCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEec
Confidence 3789999999999999999999985 66655543 3345999999999999999999999999999999999999987
Q ss_pred CCC---EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 79 EGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 79 ~~~---vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
++. +||+|||+++..... .......++|+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.+ .+.+.
T Consensus 166 ~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~ 242 (351)
T 3c0i_A 166 KENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFE 242 (351)
T ss_dssp SSTTCCEEECCCTTCEECCTT-SCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHH
T ss_pred CCCCCcEEEecCcceeEecCC-CeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHH
Confidence 655 999999999876532 223345678999999999976 578999999999999999999999998754 34444
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+....... ....+..++.++++||++||..||++|+|+.++|+|+||..
T Consensus 243 ~i~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 243 GIIKGKYKM--------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHHTCCCC--------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHcCCCCC--------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 443311110 01223457889999999999999999999999999999964
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=299.27 Aligned_cols=198 Identities=25% Similarity=0.368 Sum_probs=160.5
Q ss_pred ccEeecccCcee--cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKY--RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~--~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-||+++++.+.. .+++||||||++++.+..+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 174 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG 174 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC
Confidence 378888888776 668999999998654443333 34699999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCC--CCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATK--YGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+++...... ......++|..|+|||++.+... ++.++||||||||+|+|++|+.||...+.......+.
T Consensus 175 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 253 (298)
T 2zv2_A 175 HIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK 253 (298)
T ss_dssp CEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHh
Confidence 99999999998765322 23345678999999999875332 4778999999999999999999999888777666664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
........ ...++.++++||++||..||++|||+.|||+|+||.
T Consensus 254 ~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 254 SQALEFPD----------------------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HCCCCCCS----------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred cccCCCCC----------------------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 42111100 123567899999999999999999999999999984
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=298.13 Aligned_cols=200 Identities=25% Similarity=0.450 Sum_probs=166.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+.+ +|.+++. . ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-Q-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-T-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-h-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc
Confidence 3788999999999999999999986 4555444 3 36999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... ......++|..|+|||++.+ ..++.++||||||||+|||++|+.||...+..+.+..+....
T Consensus 180 ~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 257 (321)
T 2c30_A 180 VKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP 257 (321)
T ss_dssp EEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred EEEeeeeeeeecccCc-cccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999998765322 22345678999999999976 578999999999999999999999999988877776665421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
.... .....++..+++||++||..||++|||+.++|+|+||....
T Consensus 258 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 258 PPKL---------------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp CCCC---------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred CCCc---------------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 1000 00124677899999999999999999999999999997543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.69 Aligned_cols=201 Identities=26% Similarity=0.432 Sum_probs=145.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
-||+++++.++..+++|||||||++ +|.+.+.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++
T Consensus 66 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~ 144 (325)
T 3kn6_A 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEND 144 (325)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC---
T ss_pred CCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCC
Confidence 4789999999999999999999986 666666554 4699999999999999999999999999999999999998766
Q ss_pred --CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh-------H
Q 014871 81 --NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE-------A 151 (417)
Q Consensus 81 --~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-------~ 151 (417)
.+||+|||+++..... .......++|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+. .
T Consensus 145 ~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 222 (325)
T 3kn6_A 145 NLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222 (325)
T ss_dssp -CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH
T ss_pred cccEEEeccccceecCCC-CCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH
Confidence 7999999999865432 223445677999999999876 5789999999999999999999999986543 2
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.+..+....... ....+..++.++++||++||..||++|||+.|+++|+||..
T Consensus 223 ~~~~~i~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 223 EIMKKIKKGDFSF--------------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp HHHHHHTTTCCCC--------------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred HHHHHHHcCCCCC--------------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 3333332211100 01223457889999999999999999999999999999976
Q ss_pred C
Q 014871 232 D 232 (417)
Q Consensus 232 ~ 232 (417)
.
T Consensus 277 ~ 277 (325)
T 3kn6_A 277 G 277 (325)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=309.39 Aligned_cols=230 Identities=20% Similarity=0.233 Sum_probs=162.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-|||++++.+...+.+|||||||++ +|.+++... ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++
T Consensus 86 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~ 165 (389)
T 3gni_B 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 165 (389)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred CCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 4789999999999999999999985 666666543 34699999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCC------CCcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 81 NLKLADFGLARSFSYDH------NNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
.+||+|||++....... .......++|..|+|||++.+. ..++.++||||||||+|||++|+.||.+.+..+.
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 245 (389)
T 3gni_B 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245 (389)
T ss_dssp CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH
T ss_pred CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99999999986543211 1112234678999999999763 4689999999999999999999999998776665
Q ss_pred HHHHHHhcCC--------CCCCCCCCCCCCCcc----ccCC----CchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCC
Q 014871 154 LSKIFELCGS--------PDETIWPGVSKMPAY----NHFK----PSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217 (417)
Q Consensus 154 ~~~i~~~~~~--------~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R 217 (417)
+..+...... +.............. .... ...............++..+++||++||..||++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 325 (389)
T 3gni_B 246 LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325 (389)
T ss_dssp HHHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTS
T ss_pred HHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence 5443321100 000000000000000 0000 00000111122445688999999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 014871 218 ISAKDALDSEYFWTD 232 (417)
Q Consensus 218 pta~elL~h~~f~~~ 232 (417)
||+.|||+|+||...
T Consensus 326 pta~ell~hp~f~~~ 340 (389)
T 3gni_B 326 PSASTLLNHSFFKQI 340 (389)
T ss_dssp CCHHHHTTSGGGGGC
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=302.91 Aligned_cols=230 Identities=32% Similarity=0.573 Sum_probs=176.0
Q ss_pred cEeecccCcee-----cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKY-----RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~-----~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
||+++++.+.. ...+||||||++++|..++... .+++.+++.++.||+.||+|||++||+||||||+||||+.
T Consensus 70 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~ 147 (353)
T 2b9h_A 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS 147 (353)
T ss_dssp TBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CcCCeeeeecccccCccceEEEEEeccCccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC
Confidence 56666654443 3789999999999988887753 5999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCC---------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 014871 79 EGNLKLADFGLARSFSYDHNN---------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN 149 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 149 (417)
++.+||+|||+++........ .....++|..|+|||++.....++.++||||||||+|+|++|+.||.+.+
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999875432111 12234679999999998765678999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccC--CCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHF--KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 227 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~ 227 (417)
..+.+..+....+.+................+ .............+..++.++++||++||..||++|||+.|||+|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 99999999888877653221111100000000 0000001123344567889999999999999999999999999999
Q ss_pred CCCCCCCC
Q 014871 228 YFWTDPLP 235 (417)
Q Consensus 228 ~f~~~~~~ 235 (417)
||.....+
T Consensus 308 ~~~~~~~~ 315 (353)
T 2b9h_A 308 YLQTYHDP 315 (353)
T ss_dssp GGTTTCCT
T ss_pred cccccCCc
Confidence 99765443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=299.73 Aligned_cols=203 Identities=23% Similarity=0.366 Sum_probs=167.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN-- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~-- 78 (417)
-||+++++.++..+.+|||||||.+ +|.+++... ...+++.+++.++.||+.||+|||++||+||||||+||||+.
T Consensus 89 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT
T ss_pred CCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC
Confidence 4789999999999999999999987 566655432 356999999999999999999999999999999999999987
Q ss_pred -CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 79 -EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 79 -~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
++.+||+|||+++..... ......++|+.|+|||++.. ..++.++||||||||+|+|++|+.||.+.+..+.+..+
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 245 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245 (327)
T ss_dssp TBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcEEEeeCccccccCCc--cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 789999999999876432 22344578999999999975 57899999999999999999999999999988888777
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
........... +..++..+++||++||..||++|||+++||+|+||.....
T Consensus 246 ~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 246 SQVNVDYSEET--------------------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHTCCCCCTTT--------------------------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HhcccccCchh--------------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 66443322211 2346778999999999999999999999999999976433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.48 Aligned_cols=196 Identities=24% Similarity=0.373 Sum_probs=161.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+...+.+|||||||.+ +|..++. ....|++.+++.|+.||+.||+|||++||+||||||+||||+.++.
T Consensus 75 p~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ 153 (384)
T 4fr4_A 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH 153 (384)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred CCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC
Confidence 3788999999999999999999986 5555554 4557999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~---~~~~~~ 156 (417)
+||+|||+|+.... .......++|+.|+|||++... ..++.++||||||||||||++|+.||...+. .+.+..
T Consensus 154 vkL~DFG~a~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~ 231 (384)
T 4fr4_A 154 VHITDFNIAAMLPR--ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231 (384)
T ss_dssp EEECCCTTCEECCT--TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH
T ss_pred EEEeccceeeeccC--CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH
Confidence 99999999987543 2344567889999999998642 3589999999999999999999999975433 233333
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-AKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-a~elL~h~~f~~ 231 (417)
+..... .....++..+++||++||..||++|++ +.+|++|+||..
T Consensus 232 ~~~~~~------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 232 FETTVV------------------------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHCCC------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred Hhhccc------------------------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 322110 111236778999999999999999998 999999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=304.26 Aligned_cols=197 Identities=24% Similarity=0.349 Sum_probs=168.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-|||++++++...+.+|||||||.+++.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 114 pniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 193 (348)
T 1u5q_A 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 193 (348)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEE
T ss_pred CCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCE
Confidence 37899999999999999999999999988887656679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++.... ....++|+.|+|||++.. ...++.++||||||||+|||++|+.||...+..+.+..+...
T Consensus 194 kL~DfG~a~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 268 (348)
T 1u5q_A 194 KLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 268 (348)
T ss_dssp EECCCTTCBSSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EEeeccCceecCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence 9999999976542 234578999999999853 356899999999999999999999999988887777666542
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
..... ....++..+++||++||..||++|||+.+||+|+||...
T Consensus 269 ~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 269 ESPAL----------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp CCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCC----------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 11000 012356789999999999999999999999999999653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=296.66 Aligned_cols=199 Identities=25% Similarity=0.424 Sum_probs=168.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
.||+++++.+...+.+||||||+.+ +|.+++.. ...+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 75 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS
T ss_pred CCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCC
Confidence 4788999999999999999999975 67666654 44699999999999999999999999999999999999999887
Q ss_pred ---CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 81 ---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 81 ---~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.+||+|||+++..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 230 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (321)
T ss_dssp SSCCEEECCCTTCEECCTT--CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CcCCEEEccCccceecCcc--ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 7999999999876532 22345578999999999876 57899999999999999999999999999888888777
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.......+ ...+..++..+++||++||..||++|||+.|+|+|+||..
T Consensus 231 ~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 231 TSVSYDFD--------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HTTCCCCC--------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HhcccccC--------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 54321111 1234557789999999999999999999999999999954
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.89 Aligned_cols=203 Identities=25% Similarity=0.374 Sum_probs=148.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++++...+++|||||||.+ +|...+.+. .++++.+++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 76 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~ 154 (361)
T 3uc3_A 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA 154 (361)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSS
T ss_pred CCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC
Confidence 3789999999999999999999975 666666543 36999999999999999999999999999999999999987765
Q ss_pred --EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 82 --LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 --vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||+++.... .......++|+.|+|||++.+....+.++||||||||+|+|++|+.||.+.+....+..+..
T Consensus 155 ~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~ 232 (361)
T 3uc3_A 155 PRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232 (361)
T ss_dssp CCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH
T ss_pred ceEEEeecCccccccc--cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence 99999999975332 22234457899999999998744444558999999999999999999987655333322222
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
....... ..+ ....++..+++||++||..||++|||+.|||+|+||...
T Consensus 233 ~~~~~~~-~~~-----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 233 RILSVKY-SIP-----------------------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHTTCC-CCC-----------------------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHhcCCC-CCC-----------------------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 1100000 000 001356789999999999999999999999999999653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=307.72 Aligned_cols=198 Identities=25% Similarity=0.423 Sum_probs=159.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++++...+.+|||||||++ +|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 119 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 197 (355)
T 1vzo_A 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH 197 (355)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred CceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc
Confidence 4788899999999999999999986 666666543 36999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChH----HHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEA----EQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~----~~~~~ 156 (417)
+||+|||+++.+...........++|..|+|||++.+. ..++.++||||||||||||++|+.||...+.. .+...
T Consensus 198 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 277 (355)
T 1vzo_A 198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277 (355)
T ss_dssp EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH
T ss_pred EEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH
Confidence 99999999987654333344456789999999999752 35789999999999999999999999754432 22222
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
+..... .....++..+++||++||..||++|+ |+.+|++|+||..
T Consensus 278 ~~~~~~------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 278 ILKSEP------------------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HhccCC------------------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 221100 01123667899999999999999999 9999999999954
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=315.47 Aligned_cols=199 Identities=32% Similarity=0.511 Sum_probs=169.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl---~~ 78 (417)
-|||++++.++..+.+|||||||.+ +|.+.+... ..+++.+++.++.||+.||+|||+++|+||||||+|||| +.
T Consensus 86 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 164 (484)
T 3nyv_A 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSK 164 (484)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSST
T ss_pred CCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCC
Confidence 4789999999999999999999985 666666544 469999999999999999999999999999999999999 45
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||+|+.+... ......++|+.|+|||++.+ .++.++||||||||+|+|++|+.||.+.+..+++..+.
T Consensus 165 ~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 240 (484)
T 3nyv_A 165 DANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240 (484)
T ss_dssp TCCEEECCTTHHHHBCCC--CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEEeeeeeEEcccc--cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 678999999999876432 23455678999999999975 58999999999999999999999999999999888886
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
........ ..+..++..+++||++||..||++|||+.++|+|+||...
T Consensus 241 ~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 241 KGKYTFEL--------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HCCCCCCS--------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred cCCCCCCC--------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 53322211 1134577899999999999999999999999999999653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=301.71 Aligned_cols=220 Identities=35% Similarity=0.627 Sum_probs=165.5
Q ss_pred eecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCCEEEeeccCcc
Q 014871 13 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NEGNLKLADFGLAR 91 (417)
Q Consensus 13 ~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~-~~~~vkL~DFGla~ 91 (417)
...+.+||||||++++|.+++.+ ..+++.+++.++.||+.||+|||++||+||||||+|||++ +++.+||+|||+++
T Consensus 92 ~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 92 TELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp CSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred cccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 45578999999999988887754 3599999999999999999999999999999999999997 45689999999998
Q ss_pred cccCCC--CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 014871 92 SFSYDH--NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 169 (417)
Q Consensus 92 ~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 169 (417)
...... ........+|..|+|||++.....++.++|||||||++|||++|+.||.+.+..+.+..+...........+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (320)
T 2i6l_A 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249 (320)
T ss_dssp CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHH
T ss_pred ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhh
Confidence 654221 122334566999999999876567899999999999999999999999999998888888765543322211
Q ss_pred CCCCC-CCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 170 PGVSK-MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 170 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
..... ++.+..... .............++.++++||++||..||++|||+.|+|+|+||.....+
T Consensus 250 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 250 QELLSVIPVYIRNDM-TEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHTTSCHHHHHHT-TSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhcCcccccccc-cCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 11000 000000000 000111234445688999999999999999999999999999999765444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=302.93 Aligned_cols=199 Identities=25% Similarity=0.449 Sum_probs=166.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++..+..||||||+++ +|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.
T Consensus 160 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp TTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred CCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 3788889999999999999999986 66666554 346999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+||+|||++..+... ......++|+.|+|||++.+ ...++.++||||||||+|+|++|+.||...+....+..
T Consensus 239 ikl~DfG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp EEECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEEecCcccccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 999999999876532 23345678999999999863 23578899999999999999999999999888877777
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+........ ...+..++..+++||++||..||++|||+.++|+|+||.
T Consensus 317 i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 317 IMEGQYQFS--------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHTCCCCC--------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHhCCCCCC--------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 654221111 112334677899999999999999999999999999995
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=296.46 Aligned_cols=202 Identities=24% Similarity=0.360 Sum_probs=155.0
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||++ ++|.+++.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 71 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~ 149 (316)
T 2ac3_A 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ 149 (316)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS
T ss_pred CCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC
Confidence 378999999999999999999998 5777766553 46999999999999999999999999999999999999998776
Q ss_pred ---EEEeeccCcccccCCC------CCcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 014871 82 ---LKLADFGLARSFSYDH------NNTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGKPILPGK 148 (417)
Q Consensus 82 ---vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~ 148 (417)
+||+|||++....... .......++|..|+|||++... ..++.++||||||||+|||++|+.||.+.
T Consensus 150 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 150 VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 9999999987653221 1122345689999999998631 34788999999999999999999999876
Q ss_pred ChH---------------HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccC
Q 014871 149 NEA---------------EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 213 (417)
Q Consensus 149 ~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 213 (417)
+.. .....+....... ....+..++..+++||++||..|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~L~~d 283 (316)
T 2ac3_A 230 CGSDCGWDRGEACPACQNMLFESIQEGKYEF--------------------------PDKDWAHISCAAKDLISKLLVRD 283 (316)
T ss_dssp CCSCSCC----CCHHHHHHHHHHHHHCCCCC--------------------------CHHHHTTSCHHHHHHHHHHSCSS
T ss_pred ccccccccccccchhHHHHHHHHHhccCccc--------------------------CchhcccCCHHHHHHHHHHhhCC
Confidence 431 1222222210000 01123457889999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q 014871 214 PSQRISAKDALDSEYFWT 231 (417)
Q Consensus 214 P~~Rpta~elL~h~~f~~ 231 (417)
|++|||+.|+|+|+||..
T Consensus 284 P~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 284 AKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp TTTSCCHHHHHHSTTCC-
T ss_pred hhhCCCHHHHhcChhhcC
Confidence 999999999999999964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.30 Aligned_cols=197 Identities=30% Similarity=0.467 Sum_probs=166.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl---~~ 78 (417)
.||+++++.+...+.+||||||+++ +|.+.+... ..+++.++..++.||+.||+|||+++|+||||||+|||| +.
T Consensus 66 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 144 (277)
T 3f3z_A 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144 (277)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSST
T ss_pred CCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCC
Confidence 4789999999999999999999986 666655543 459999999999999999999999999999999999999 77
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||++...... .......+|..|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 145 ~~~~~l~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 220 (277)
T 3f3z_A 145 DSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR 220 (277)
T ss_dssp TCCEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEEecccceeccCc--cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 889999999999775432 23345678999999999865 48999999999999999999999999999888887776
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+...... ...+..++..+++||++||..||++|||+.++|+|+||.
T Consensus 221 ~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 221 EGTFTFP--------------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp HCCCCCC--------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred hCCCCCC--------------------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 5322111 112234678999999999999999999999999999994
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=304.28 Aligned_cols=222 Identities=36% Similarity=0.622 Sum_probs=172.4
Q ss_pred cEeecccCceecCe------EEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRGS------TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~~------~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
||+++++.+...+. +||||||+.++|...+.. .+++.+++.++.||+.||+|||++||+||||||+||||+
T Consensus 84 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~ 160 (353)
T 3coi_A 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160 (353)
T ss_dssp TBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred CcccHhheEecccccccceeEEEEeccccCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC
Confidence 67888887776654 499999999887766542 499999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... .....++|..|+|||++.+...++.++||||||||+|+|++|+.||.+.+..+.+..+
T Consensus 161 ~~~~~kl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i 236 (353)
T 3coi_A 161 EDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236 (353)
T ss_dssp TTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH
T ss_pred CCCcEEEeecccccCCCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999976442 2334577999999999986567899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCc--cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPA--YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~ 233 (417)
....+.+...++........ +..... ......+...+..++.++++||++||..||++|||+.++|+|+||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLP-QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHCBCCHHHHTTCSCHHHHHHHHTSC-BCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhCCCCHHHHHHHhhHHHHHHHHhCc-CCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 88877765544333221000 000000 0001112223345788999999999999999999999999999997543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=289.98 Aligned_cols=198 Identities=28% Similarity=0.378 Sum_probs=158.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID- 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~- 77 (417)
.||+++++.+...+.+||||||+++ +|.+.+.. .+..+++.+++.++.||+.||+|||+++|+||||||+||||+
T Consensus 80 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~ 159 (285)
T 3is5_A 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159 (285)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESS
T ss_pred chHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEec
Confidence 4789999999999999999999986 77776643 235699999999999999999999999999999999999994
Q ss_pred --CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 78 --NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 78 --~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
.++.+||+|||+++..... .......+|..|+|||++.+ .++.++||||||||+|||++|+.||.+.+..+...
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 160 TSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235 (285)
T ss_dssp SSTTCCEEECCCCCCCC------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCCCEEEEeeecceecCCc--ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence 4578999999999765432 22345578999999998863 68899999999999999999999999988777766
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+......... ....++..+++||++||..||++|||+.|||+|+||+.
T Consensus 236 ~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 236 KATYKEPNYAV---------------------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHCCCCCCC-----------------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred hhccCCccccc---------------------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 65432111110 01125678999999999999999999999999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=288.65 Aligned_cols=200 Identities=26% Similarity=0.404 Sum_probs=167.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+..|+||||+.+ +|.+.+... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 65 ~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~ 143 (284)
T 3kk8_A 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK 143 (284)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSST
T ss_pred CCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCC
Confidence 3788999999999999999999986 666665544 45999999999999999999999999999999999999987655
Q ss_pred ---EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 82 ---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 ---vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 144 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 220 (284)
T 3kk8_A 144 GAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 220 (284)
T ss_dssp TCCEEECCCTTCEECCSS--CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEeeceeeEEcccC--ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH
Confidence 999999999765432 23344678999999999976 578999999999999999999999999998888887776
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.......... +..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 221 ~~~~~~~~~~--------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 221 AGAYDYPSPE--------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HTCCCCCTTT--------------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred hccccCCchh--------------------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 5332222111 12466789999999999999999999999999999653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=293.86 Aligned_cols=222 Identities=30% Similarity=0.543 Sum_probs=162.6
Q ss_pred cEeecccCcee--cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKY--RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~--~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
||+++++.+.. ....||||||+.+ +|..++. .+++.+++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 92 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~ 167 (330)
T 3nsz_A 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167 (330)
T ss_dssp TBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred CEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC
Confidence 78888888887 6789999999986 4544443 389999999999999999999999999999999999999777
Q ss_pred -CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHH
Q 014871 81 -NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL-PGKNEAEQLSKIF 158 (417)
Q Consensus 81 -~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~~~~i~ 158 (417)
.+||+|||+|+...... .....++|..|+|||++.+...++.++||||||||||+|++|+.|| .+.+..+.+..+.
T Consensus 168 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~ 245 (330)
T 3nsz_A 168 RKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245 (330)
T ss_dssp TEEEECCCTTCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred CEEEEEeCCCceEcCCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH
Confidence 79999999998654322 3345678999999999987567899999999999999999999888 4556666666655
Q ss_pred HhcCCCCCCCCCC---CCCCCccc----cCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPG---VSKMPAYN----HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..++......+-. ....+.+. ..................++.++++||++||..||++|||++|||+|+||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 5443211000000 00000000 0000000000001112347889999999999999999999999999999965
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=290.14 Aligned_cols=195 Identities=28% Similarity=0.447 Sum_probs=162.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+.+.+. ..+++.++..++.||+.||+|||++||+||||||+||||+.++.
T Consensus 69 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~ 147 (279)
T 3fdn_A 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE 147 (279)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC
T ss_pred CCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC
Confidence 3788999999999999999999986 566655543 45999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++...... ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 148 ~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (279)
T 3fdn_A 148 LKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223 (279)
T ss_dssp EEECSCCEESCC-----------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred EEEEeccccccCCcc---cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC
Confidence 999999998654322 2344578999999999876 578999999999999999999999999988888877775532
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
... ...++..+++||++||..||++|||+.|||+|+||...
T Consensus 224 ~~~------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 224 FTF------------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp CCC------------------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCC------------------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 211 12356789999999999999999999999999999643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=291.82 Aligned_cols=198 Identities=21% Similarity=0.287 Sum_probs=152.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~ 79 (417)
||+++++.+...+.+||||||++++|.+++.. ....+++.+++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 67 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~ 146 (290)
T 3fme_A 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL 146 (290)
T ss_dssp TBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT
T ss_pred eEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC
Confidence 68889999999999999999999988666543 556799999999999999999999998 99999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhh---cCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CChHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL---LGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLS 155 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~~DiwSlG~il~elltG~~pf~~-~~~~~~~~ 155 (417)
+.+||+|||+++..... .......+|..|+|||++ .....++.++||||||||+|+|++|+.||.. ......+.
T Consensus 147 ~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 224 (290)
T 3fme_A 147 GQVKMCDFGISGYLVDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 224 (290)
T ss_dssp CCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH
T ss_pred CCEEEeecCCccccccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH
Confidence 99999999999765432 222334689999999997 3335688999999999999999999999986 34444444
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+........ ....++.++++||.+||..||++|||+.|+|+|+||..
T Consensus 225 ~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 225 QVVEEPSPQL----------------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHSCCCCC----------------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHhccCCCCc----------------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 4433211100 01236678999999999999999999999999999953
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.97 Aligned_cols=198 Identities=29% Similarity=0.499 Sum_probs=168.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-- 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-- 79 (417)
-|||++++.++..+.+|||||||.+ +|.+.+.+. ..+++.+++.+++||+.||+|||++||+||||||+||||+..
T Consensus 96 pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 174 (494)
T 3lij_A 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174 (494)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSST
T ss_pred CCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCC
Confidence 3789999999999999999999986 666666544 459999999999999999999999999999999999999764
Q ss_pred -CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 80 -GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 80 -~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+.+||+|||+|+..... ......++|+.|+|||++.+ .++.++||||||||+|+|++|+.||.+.+..+++..+.
T Consensus 175 ~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (494)
T 3lij_A 175 DALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250 (494)
T ss_dssp TCCEEECCCTTCEECBTT--BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEEECCCCeECCCC--ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45999999999876532 23455678999999998863 68999999999999999999999999999999888887
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.......... +..++..+++||++||..||++|||+.++|+|+||..
T Consensus 251 ~~~~~~~~~~--------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 251 KGKYTFDSPE--------------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HTCCCCCSGG--------------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred hCCCCCCchh--------------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 6433332221 2346778999999999999999999999999999954
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=297.22 Aligned_cols=224 Identities=27% Similarity=0.441 Sum_probs=168.5
Q ss_pred cEeecccCceecC----eEEEEEcCCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRG----STYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~----~~yiV~Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~ 77 (417)
||+++++.+...+ ++||||||++++|.+++.+. ...+++.+++.++.||+.||+|||++ ||+||||||+||||+
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 6888888888765 89999999988898887753 34599999999999999999999998 999999999999995
Q ss_pred C------CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--
Q 014871 78 N------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-- 149 (417)
Q Consensus 78 ~------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-- 149 (417)
. .+.+||+|||+++.... .....++|..|+|||++.+ ..++.++||||||||||||++|+.||...+
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccCCCcCcceEEEcccccccccCC----CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 3 34799999999986543 2334578999999999986 568999999999999999999999998654
Q ss_pred ----hHHHHHHHHHhcCCCCCCCCCCCCC----------CCcccc--CCCchhhhhhHHHhhhhhhHHHHHHHHHhcccC
Q 014871 150 ----EAEQLSKIFELCGSPDETIWPGVSK----------MPAYNH--FKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 213 (417)
Q Consensus 150 ----~~~~~~~i~~~~~~~~~~~~~~~~~----------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 213 (417)
..+.+..+.+.++......+..... ...... .............+...++.++++||++||..|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence 5566777777776654322111000 000000 001111111111233567889999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 014871 214 PSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 214 P~~Rpta~elL~h~~f~~~ 232 (417)
|++|||+.|||+|+||...
T Consensus 322 P~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 322 PRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp TTTCBCHHHHHTCGGGTTC
T ss_pred ccccCCHHHHhhChhhhcc
Confidence 9999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=299.85 Aligned_cols=199 Identities=30% Similarity=0.460 Sum_probs=167.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++.+ ...+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 101 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 179 (335)
T 2owb_A 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE 179 (335)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred CCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC
Confidence 3789999999999999999999985 56665544 346999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+....
T Consensus 180 ~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 257 (335)
T 2owb_A 180 VKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257 (335)
T ss_dssp EEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred EEEeeccCceecccCc-ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC
Confidence 9999999998764322 22344578999999999986 568999999999999999999999999888777766664421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
.. +...++..+.+||++||..||++|||+.|||+|+||.....
T Consensus 258 ~~------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 258 YS------------------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp CC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CC------------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 11 11235678999999999999999999999999999976543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.34 Aligned_cols=199 Identities=30% Similarity=0.494 Sum_probs=166.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---C
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID---N 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~---~ 78 (417)
-|||++++.++..+.+|||||||.+ +|.+.+... ..+++.+++.++.||+.||+|||++||+||||||+||||+ .
T Consensus 81 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~ 159 (486)
T 3mwu_A 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159 (486)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSST
T ss_pred CCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC
Confidence 3789999999999999999999985 666666543 4699999999999999999999999999999999999995 4
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
++.+||+|||+++..... ......++|+.|+|||++.+ .++.++||||||||+|+|++|+.||.+.+..+++..+.
T Consensus 160 ~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 235 (486)
T 3mwu_A 160 DCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (486)
T ss_dssp TCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCEEEEECCcCeECCCC--CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 557999999999865432 23445678999999999975 58999999999999999999999999999998888886
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
......... .+..++.++++||++||..||++|||+.++|+|+||...
T Consensus 236 ~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 236 TGKYAFDLP--------------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HTCCCSCSG--------------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred hCCCCCCCc--------------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 533222111 134577899999999999999999999999999999653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.10 Aligned_cols=200 Identities=30% Similarity=0.468 Sum_probs=161.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+..||||||+++ +|.+.+ .....+++.++..++.||+.||+|||++||+|+||||+|||++.++.
T Consensus 65 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 143 (276)
T 2yex_A 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 143 (276)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred CCceeeeeEEEcCCEEEEEEEecCCCcHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC
Confidence 3788899999999999999999987 555554 44456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHH
Q 014871 82 LKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ-LSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-~~~i~~ 159 (417)
+||+|||++........ .......+|..|+|||++.+...++.++|||||||++|+|++|+.||...+.... +..+..
T Consensus 144 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (276)
T 2yex_A 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223 (276)
T ss_dssp EEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT
T ss_pred EEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh
Confidence 99999999976543221 2234456799999999998644457889999999999999999999987665322 222221
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
... ....+..++..+++||++||..||++|||+.||++|+||..
T Consensus 224 ~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 224 KKT----------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp TCT----------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ccc----------------------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 100 00112356788999999999999999999999999999965
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.88 Aligned_cols=204 Identities=26% Similarity=0.392 Sum_probs=163.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc---------------------------------------CCCCCCH
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---------------------------------------PGLRFTV 42 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---------------------------------------~~~~l~~ 42 (417)
.|||++++.+...+.+|||||||++ +|.+++.. ....+++
T Consensus 88 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (345)
T 3hko_A 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167 (345)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHH
T ss_pred CCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccH
Confidence 4789999999999999999999975 66665531 0112467
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--CEEEeeccCcccccCCCC---CcccccccccCCCCchhhc
Q 014871 43 PQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG--NLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLL 117 (417)
Q Consensus 43 ~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~ 117 (417)
..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++.+..... .......+|+.|+|||++.
T Consensus 168 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence 88999999999999999999999999999999998776 799999999986543221 1234567899999999986
Q ss_pred CC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh
Q 014871 118 GA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196 (417)
Q Consensus 118 ~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (417)
+. ..++.++||||||||||||++|+.||.+.+..+.+..+......... ..+.
T Consensus 248 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~ 301 (345)
T 3hko_A 248 TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN--------------------------PNYN 301 (345)
T ss_dssp CSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS--------------------------GGGG
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC--------------------------cccc
Confidence 42 56899999999999999999999999999988888777653222111 1123
Q ss_pred hhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 197 HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 197 ~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.++..+++||++||..||++|||+.++|+|+||...
T Consensus 302 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 302 VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 467899999999999999999999999999999653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=303.95 Aligned_cols=201 Identities=28% Similarity=0.409 Sum_probs=158.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-|||++++++...+.+|||||+..++|.+++.+.. .+++.+++.++.||+.||+|||+++|+||||||+||||+ ++.+
T Consensus 116 ~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~ 193 (390)
T 2zmd_A 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 193 (390)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCE
T ss_pred CeEEEEEEEEecCCEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeE
Confidence 47899999999999999999987788888877654 699999999999999999999999999999999999996 5789
Q ss_pred EEeeccCcccccCCCCC-cccccccccCCCCchhhcCC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCh-
Q 014871 83 KLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNE- 150 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~elltG~~pf~~~~~- 150 (417)
||+|||+++.+...... .....++|+.|+|||++.+. ..++.++||||||||||||++|+.||.....
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 273 (390)
T 2zmd_A 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273 (390)
T ss_dssp EECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred EEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence 99999999876433221 23456789999999998641 3588899999999999999999999987543
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
...+..+.... ....+ ....+.++++||++||..||++|||+.|||+|+||.
T Consensus 274 ~~~~~~~~~~~---~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 274 ISKLHAIIDPN---HEIEF-------------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp HHHHHHHHCTT---SCCCC-------------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHHHHhCcc---ccCCC-------------------------CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 33444433211 10000 011356789999999999999999999999999997
Q ss_pred CCC
Q 014871 231 TDP 233 (417)
Q Consensus 231 ~~~ 233 (417)
...
T Consensus 326 ~~~ 328 (390)
T 2zmd_A 326 IQT 328 (390)
T ss_dssp SCC
T ss_pred ccC
Confidence 543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=290.31 Aligned_cols=197 Identities=28% Similarity=0.474 Sum_probs=141.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 71 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~ 150 (278)
T 3cok_A 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN 150 (278)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC
T ss_pred CCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC
Confidence 3788999999999999999999975 677777666567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++........ ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus 151 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~- 227 (278)
T 3cok_A 151 IKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA- 227 (278)
T ss_dssp EEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-
T ss_pred EEEEeecceeeccCCCC-cceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-
Confidence 99999999987543222 2234567999999999876 56899999999999999999999999876654433322100
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.. .....++.++++||++||..||++|||+.++|+|+||..
T Consensus 228 ------------------~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 228 ------------------DY-----------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp ------------------CC-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ------------------cc-----------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 00 011236778999999999999999999999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=300.78 Aligned_cols=201 Identities=28% Similarity=0.417 Sum_probs=155.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-||+++++.+...+.+||||||..++|.+++.+. ..+++.+++.++.||+.||+|||+++|+||||||+||||+ ++.+
T Consensus 69 ~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 69 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEE
T ss_pred CceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcE
Confidence 3789999999999999999998888888888764 4699999999999999999999999999999999999997 5689
Q ss_pred EEeeccCcccccCCCCC-cccccccccCCCCchhhcC----------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCh-
Q 014871 83 KLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLG----------ATKYGPAVDMWSVGCIFAELLNGKPILPGKNE- 150 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~----------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~- 150 (417)
||+|||+++........ .....++|+.|+|||++.+ ...++.++||||||||||||++|+.||.....
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 99999999876433222 2335678999999999853 24678899999999999999999999986443
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
...+..+.. ......+ ....+.++.+||++||..||++|||+.|+|+|+||.
T Consensus 227 ~~~~~~~~~---~~~~~~~-------------------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 227 ISKLHAIID---PNHEIEF-------------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp HHHHHHHHC---TTSCCCC-------------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHHHHhc---CCcccCC-------------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 233333322 1111111 112346789999999999999999999999999997
Q ss_pred CCC
Q 014871 231 TDP 233 (417)
Q Consensus 231 ~~~ 233 (417)
...
T Consensus 279 ~~~ 281 (343)
T 3dbq_A 279 IQT 281 (343)
T ss_dssp SCC
T ss_pred ccC
Confidence 543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=288.64 Aligned_cols=194 Identities=28% Similarity=0.466 Sum_probs=165.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+.+||||||+++ +|.+.+.+. ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 75 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 153 (284)
T 2vgo_A 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGEL 153 (284)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCE
T ss_pred CEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCE
Confidence 788899999999999999999986 777766554 359999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++...... ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 154 kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 229 (284)
T 2vgo_A 154 KIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229 (284)
T ss_dssp EECCCTTCEECSSS---CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred EEecccccccCccc---ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc
Confidence 99999998765422 2234567999999999986 5789999999999999999999999999888777776654211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
. +...++..+++||++||..||++|||+.++++|+||+..
T Consensus 230 ~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 K------------------------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred C------------------------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1 012356789999999999999999999999999999653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.72 Aligned_cols=200 Identities=31% Similarity=0.470 Sum_probs=167.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++.+ ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 75 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 153 (294)
T 2rku_A 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE 153 (294)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred CCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC
Confidence 3788999999999999999999985 56555544 346999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 154 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 231 (294)
T 2rku_A 154 VKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231 (294)
T ss_dssp EEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred EEEEeccCceecccCc-cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc
Confidence 9999999998764322 22344568999999999876 568999999999999999999999999888777766654311
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
.. +...++..+.+||++||..||++|||+.|+|+|+||.....+
T Consensus 232 ~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 232 YS------------------------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp CC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred CC------------------------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 10 112356789999999999999999999999999999765443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.88 Aligned_cols=190 Identities=24% Similarity=0.380 Sum_probs=157.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC--CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g--~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+++++.+...+.+||||||+.. +|..++.+ ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++
T Consensus 89 ~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred CCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC
Confidence 4789999999999999999999964 56665554 44699999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||+++..... ......++|..|+|||++.+...++.++||||||||+|+|++|+.||...... ..
T Consensus 168 ~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~- 238 (335)
T 3dls_A 168 TIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE- 238 (335)
T ss_dssp CEEECCCTTCEECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-
T ss_pred cEEEeecccceECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-
Confidence 9999999999876432 23345678999999999987544588999999999999999999999652210 00
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
. .. .....++.++++||++||..||++|||+.+||+|+||+.
T Consensus 239 --~--------~~-------------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 239 --A--------AI-------------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp --T--------CC-------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred --h--------cc-------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0 00 001126778999999999999999999999999999965
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=287.31 Aligned_cols=200 Identities=25% Similarity=0.431 Sum_probs=167.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++.++.+||||||+++ +|.+++... ..+++.++..++.||+.||+|||++||+|+||||+|||++.++.
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN 162 (298)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred CCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc
Confidence 4788999999999999999999985 676666543 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhc-----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL-----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+||+|||++...... .......+|..|+|||++. ....++.++|||||||++|+|++|+.||...+..+....
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 240 (298)
T 1phk_A 163 IKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240 (298)
T ss_dssp EEECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEecccchhhcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence 999999999876432 2334457899999999985 234678999999999999999999999999888887777
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+......... ..+..++..+++||.+||..||++|||+.++|+|+||..
T Consensus 241 ~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 241 IMSGNYQFGS--------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp HHHTCCCCCT--------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HhcCCcccCc--------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 7553222111 012346778999999999999999999999999999965
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=318.63 Aligned_cols=196 Identities=24% Similarity=0.430 Sum_probs=162.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-|||++++.+..++++|||||||.+ +|..++.... ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++
T Consensus 244 p~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g 323 (576)
T 2acx_A 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323 (576)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred CCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC
Confidence 3788999999999999999999975 6666665543 3499999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh----HHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE----AEQLSK 156 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~----~~~~~~ 156 (417)
.+||+|||+|+..... ......++|+.|+|||++.+ ..++.++||||||||||||++|+.||...+. .++...
T Consensus 324 ~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~ 400 (576)
T 2acx_A 324 HIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400 (576)
T ss_dssp CEEECCCTTCEECCTT--CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH
T ss_pred CeEEEecccceecccC--ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH
Confidence 9999999999876432 23345689999999999986 5789999999999999999999999987643 233333
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
+..... .+...++.++++||++||..||++|+ ++.||++|+||..
T Consensus 401 i~~~~~------------------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 401 VKEVPE------------------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred hhcccc------------------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 322100 01134678999999999999999999 8999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.04 Aligned_cols=199 Identities=32% Similarity=0.483 Sum_probs=169.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
.|||++++.++..+++|||||||.+ +|.+.+... ..+++.+++.+++||+.||+|||+++|+||||||+||||+.++
T Consensus 106 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC
T ss_pred CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC
Confidence 4789999999999999999999986 666666544 4699999999999999999999999999999999999999876
Q ss_pred --CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 --NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 --~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+|+..... ......++|+.|+|||++.+ .++.++||||||||+|+|++|+.||.+.+..+++..+.
T Consensus 185 ~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp CSSEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CccEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6999999999876532 23455678999999999864 68999999999999999999999999999988888886
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
....... ...+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 261 ~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 261 KGKYYFD--------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HCCCCCC--------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred cCCCCCC--------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 5321111 12245578899999999999999999999999999999653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=289.82 Aligned_cols=198 Identities=25% Similarity=0.378 Sum_probs=166.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl---~~~ 79 (417)
||+++++.+...+.+||||||+++ +|.+.+... ..+++.++..++.||+.||+|||+++|+||||||+|||+ +.+
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~ 145 (304)
T 2jam_A 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN 145 (304)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT
T ss_pred CeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC
Confidence 688889999999999999999975 676666543 359999999999999999999999999999999999999 678
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||+++.... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.+
T Consensus 146 ~~~kl~Dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (304)
T 2jam_A 146 SKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221 (304)
T ss_dssp CCEEBCSCSTTCCCCC---BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CCEEEccCCcceecCC---CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 8999999999875432 22344568999999999875 5789999999999999999999999999988888877765
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
........ .+..++.++++||.+||..||++|||+.++|+|+||...
T Consensus 222 ~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 222 GYYEFESP--------------------------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CCCCCCTT--------------------------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCCCCCcc--------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 33222111 123467789999999999999999999999999999653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=312.34 Aligned_cols=197 Identities=22% Similarity=0.376 Sum_probs=162.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
-||+++++.+...+++|||||||.+ +|...+.+. ...|++.+++.|+.||+.||+|||++||+||||||+||||+.
T Consensus 245 p~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~ 324 (543)
T 3c4z_A 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD 324 (543)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC
Confidence 3688899999999999999999985 666665543 346999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh----HHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE----AEQL 154 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~----~~~~ 154 (417)
++.+||+|||+++.+.... ......++|+.|+|||++.+ ..++.++||||||||||||++|+.||.+.+. .++.
T Consensus 325 ~g~vkL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~ 402 (543)
T 3c4z_A 325 DGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402 (543)
T ss_dssp TSCEEECCCTTCEECCTTC-CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH
T ss_pred CCCEEEeecceeeeccCCC-cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH
Confidence 9999999999998765322 22334588999999999986 6789999999999999999999999987642 3444
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYF 229 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f 229 (417)
..+..... .+...++..+++||++||..||++|++ +.+|++|+||
T Consensus 403 ~~i~~~~~------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 403 QRVLEQAV------------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp HHHHHCCC------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred HHHhhccc------------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 44433110 011346789999999999999999995 5899999999
Q ss_pred CC
Q 014871 230 WT 231 (417)
Q Consensus 230 ~~ 231 (417)
..
T Consensus 453 ~~ 454 (543)
T 3c4z_A 453 RD 454 (543)
T ss_dssp TT
T ss_pred cC
Confidence 65
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.43 Aligned_cols=196 Identities=30% Similarity=0.444 Sum_probs=156.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+.+||||||+.+ +|.+++.+. ..+++.++..++.||+.||+|||+++|+|+||||+|||++.++.+
T Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 150 (276)
T 2h6d_A 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA 150 (276)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCE
T ss_pred CEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCE
Confidence 788899999999999999999975 777666543 359999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||++...... .......+|..|+|||++.+....+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 151 ~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 228 (276)
T 2h6d_A 151 KIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF 228 (276)
T ss_dssp EECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEeecccccccCCC--cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 99999999775432 2233456799999999998644456899999999999999999999998887777766644211
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
. +...++..+.+||.+||..||++|||+.||++|+||+..
T Consensus 229 ~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 Y------------------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp C------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred c------------------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 1 012356789999999999999999999999999999653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=285.99 Aligned_cols=201 Identities=22% Similarity=0.341 Sum_probs=160.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|..++......+++.++..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 76 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 155 (302)
T 2j7t_A 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD 155 (302)
T ss_dssp TTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC
T ss_pred CCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC
Confidence 3788899999999999999999986 555555554556999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL----GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+||+|||++....... .......+|..|+|||++. ....++.++||||||||+|+|++|+.||...+....+..+
T Consensus 156 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 234 (302)
T 2j7t_A 156 IRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 234 (302)
T ss_dssp EEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred EEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 9999999875432110 1122346799999999984 3356889999999999999999999999988887776665
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
........ .....++..+.+||++||..||++|||+.+|++|+||..
T Consensus 235 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 235 AKSDPPTL---------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp HHSCCCCC---------------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred hccCCccc---------------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 44211100 011235678999999999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=303.68 Aligned_cols=202 Identities=24% Similarity=0.340 Sum_probs=155.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE--- 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~--- 79 (417)
-|||++++.+...+.+|||||||.++|.+++......+.+.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 78 pnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~ 157 (432)
T 3p23_A 78 PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAH 157 (432)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTT
T ss_pred CCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCC
Confidence 47899999999999999999999999999998877667777888999999999999999999999999999999532
Q ss_pred --CCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHH
Q 014871 80 --GNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAE 152 (417)
Q Consensus 80 --~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~ 152 (417)
..+||+|||+|+....... ......++|+.|+|||++.+ ...++.++||||||||+|||++ |..||.......
T Consensus 158 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp TBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred CceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 3588999999987643221 23345678999999999874 2457789999999999999999 899996554433
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.. .+.. ....... ......+..+++||++||..||++|||+.+||+|+||+.
T Consensus 238 ~~-~~~~---~~~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 238 AN-ILLG---ACSLDCL-----------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HH-HHTT---CCCCTTS-----------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HH-HHhc---cCCcccc-----------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 22 2211 1000000 001234667899999999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=286.03 Aligned_cols=209 Identities=20% Similarity=0.343 Sum_probs=160.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-------~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
-||+++++.+...+.+||||||+.+ +|.+++.. ....+++.++..++.||+.||+|||+++|+||||||+||
T Consensus 73 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni 152 (303)
T 2vwi_A 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNI 152 (303)
T ss_dssp TTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred CCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhE
Confidence 3788999999999999999999975 67666653 344599999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccCcccccCCCC----CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 014871 75 LIDNEGNLKLADFGLARSFSYDHN----NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150 (417)
Q Consensus 75 Ll~~~~~vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 150 (417)
|++.++.+||+|||++........ .......+|..|+|||++.....++.++||||||||+|+|++|+.||.....
T Consensus 153 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 153 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp EECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred EEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 999999999999999876543211 1223456799999999986534689999999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
...+............. ..........++.++++||++||..||++|||+.+|++|+||.
T Consensus 233 ~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 292 (303)
T 2vwi_A 233 MKVLMLTLQNDPPSLET--------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292 (303)
T ss_dssp GGHHHHHHTSSCCCTTC-------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred hhHHHHHhccCCCcccc--------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence 66554443211100000 0001122345677899999999999999999999999999995
Q ss_pred C
Q 014871 231 T 231 (417)
Q Consensus 231 ~ 231 (417)
.
T Consensus 293 ~ 293 (303)
T 2vwi_A 293 K 293 (303)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=301.40 Aligned_cols=198 Identities=27% Similarity=0.446 Sum_probs=150.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-- 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~-- 80 (417)
|||++++.+. .+.+|||||||.+ +|.+.+. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++
T Consensus 201 niv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 201 CIIKIKNFFD-AEDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp TBCCCCEEEE-SSEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSS
T ss_pred CEeeEEEEEe-cCceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCc
Confidence 6788888765 5568999999986 5555544 445799999999999999999999999999999999999997544
Q ss_pred -CEEEeeccCcccccCCCCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH-HH
Q 014871 81 -NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL-SK 156 (417)
Q Consensus 81 -~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~-~~ 156 (417)
.+||+|||+|+..... ......++|+.|+|||++.+ ...++.++||||||||||+|++|+.||........+ ..
T Consensus 279 ~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~ 356 (419)
T 3i6u_A 279 CLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 356 (419)
T ss_dssp CCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH
T ss_pred ceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH
Confidence 4999999999876432 23345678999999999853 346788999999999999999999999865543322 22
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+..... ......+..++..+++||++||..||++|||+.|+|+|+||..
T Consensus 357 i~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 357 ITSGKY--------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHTTCC--------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HhcCCC--------------------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 221100 0112344567889999999999999999999999999999953
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=289.63 Aligned_cols=201 Identities=22% Similarity=0.356 Sum_probs=166.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++......+++.++..++.||+.||+|||++||+|+||||+|||++.++.
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 163 (314)
T 3com_A 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH 163 (314)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC
T ss_pred CCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC
Confidence 3788999999999999999999986 677766645567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 164 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 241 (314)
T 3com_A 164 AKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP 241 (314)
T ss_dssp EEECCCTTCEECBTTB-SCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred EEEeecccchhhhhhc-cccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence 9999999997654322 22334567999999999876 568999999999999999999999999887766555443211
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.... .....++..+.+||++||..||++|||+.++|+|+||...
T Consensus 242 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 242 PPTF---------------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp CCCC---------------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred Cccc---------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0000 0122357789999999999999999999999999999653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=284.12 Aligned_cols=196 Identities=22% Similarity=0.324 Sum_probs=155.9
Q ss_pred ccEeecccCcee----cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEE
Q 014871 3 CTFLETTDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLL 75 (417)
Q Consensus 3 cniv~~~~~~~~----~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~NIL 75 (417)
-||+++++.+.. +..+||||||+++ +|.+++.+. ..+++.+++.++.||+.||+|||+++ |+||||||+|||
T Consensus 85 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil 163 (290)
T 1t4h_A 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp TTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred CCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEE
Confidence 367888877665 4568999999976 666666543 46999999999999999999999999 999999999999
Q ss_pred Ec-CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 014871 76 ID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154 (417)
Q Consensus 76 l~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~ 154 (417)
|+ .++.+||+|||++..... .......+|..|+|||++.+ .++.++|||||||++|+|++|+.||........+
T Consensus 164 ~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 238 (290)
T 1t4h_A 164 ITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238 (290)
T ss_dssp ESSTTSCEEECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred EECCCCCEEEeeCCCcccccc---cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH
Confidence 98 788999999999975432 23344568999999998864 5899999999999999999999999886555444
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.........+ ..+...++.++.+||++||..||++|||+.|||+|+||..
T Consensus 239 ~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 239 YRRVTSGVKP---------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHTTTCCC---------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHhccCCc---------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 3332211000 1112335578999999999999999999999999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=287.77 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=162.6
Q ss_pred ccEeecccCc--eecCeEEEEEcCCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGN--KYRGSTYMVFEYMDHDLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~--~~~~~~yiV~Ey~~g~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.||+++++.+ ...+.+||||||+++++.+++.. ....+++.++..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 66 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~ 145 (305)
T 2wtk_C 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG 145 (305)
T ss_dssp TTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC
Confidence 4788888877 55668999999999887776654 34569999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCC-CCcccccccccCCCCchhhcCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+.+||+|||++....... ........+|..|+|||++.+.. .++.++|||||||++|||++|+.||.+.+..+....+
T Consensus 146 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i 225 (305)
T 2wtk_C 146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225 (305)
T ss_dssp CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH
Confidence 999999999998754322 22334456799999999987532 2477899999999999999999999998887777766
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
...... +...++..+.+||++||..||++|||+.|+++|+||...
T Consensus 226 ~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 226 GKGSYA------------------------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHCCCC------------------------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred hcCCCC------------------------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 542110 112356788999999999999999999999999999654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=286.00 Aligned_cols=195 Identities=21% Similarity=0.245 Sum_probs=157.9
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC--
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-- 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~-- 81 (417)
||+++++.+...+..||||||+.++|.+++......|++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 66 ~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~ 145 (330)
T 2izr_A 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKT 145 (330)
T ss_dssp TSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTC
T ss_pred CCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCC
Confidence 678888899999999999999988898888876667999999999999999999999999999999999999998887
Q ss_pred ---EEEeeccCcccccCCCCC------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH-
Q 014871 82 ---LKLADFGLARSFSYDHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA- 151 (417)
Q Consensus 82 ---vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~- 151 (417)
+||+|||+|+.+...... .....++|..|+|||++.+ ..++.++||||||||||||++|+.||.+.+..
T Consensus 146 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 146 QQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp TTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred CceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 999999999876433221 1245678999999999986 67899999999999999999999999875433
Q ss_pred --HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 152 --EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 152 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+.+..+.... ...........++ ++.+||+.||..||.+||++.+|++
T Consensus 225 ~~~~~~~i~~~~-------------------------~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 225 LKERYQKIGDTK-------------------------RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHHH-------------------------HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhh-------------------------ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3333332210 0011122223355 8999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=287.50 Aligned_cols=200 Identities=22% Similarity=0.356 Sum_probs=155.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++..+.+||||||+++ +|.+++.+. ..+++.++..++.||+.||+|||++||+||||||+||||+.++.
T Consensus 71 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~ 149 (294)
T 4eqm_A 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT 149 (294)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred CCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 3788999999999999999999986 666666544 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+++.............++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 228 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS 228 (294)
T ss_dssp EEECCCSSSTTC-------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC
T ss_pred EEEEeCCCccccccccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc
Confidence 9999999998765444344445678999999999986 578999999999999999999999999988777655543210
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
. ..........++..+.+||.+||..||++|++..+.+.+.|.
T Consensus 229 ~-------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 229 V-------------------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp C-------------------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred C-------------------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 0 011123334578899999999999999999955555544443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=283.58 Aligned_cols=198 Identities=24% Similarity=0.409 Sum_probs=163.2
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
-||+++++.+...+.+||||||+. ++|.+++.+ ...+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 68 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSS
T ss_pred CCeeehhheecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCC
Confidence 378889999999999999999997 467666654 34699999999999999999999999999999999999998877
Q ss_pred ---CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 81 ---NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 81 ---~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.+||+|||+++...... ......+|..|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 223 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223 (283)
T ss_dssp SSCCEEECCCTTCEECC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred CCCceEEEecccceeccCCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence 79999999998754322 2334568999999999875 57899999999999999999999999998888777766
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
....... ....+..++..+++||++||..||++|||+.++|+|+||.
T Consensus 224 ~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 224 SAVNYDF--------------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp HTTCCCC--------------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred HhcccCC--------------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 4421111 1223345778899999999999999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=297.02 Aligned_cols=224 Identities=22% Similarity=0.301 Sum_probs=160.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~~ 80 (417)
-||+++++.+...+.+||||||+++ +|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++
T Consensus 91 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~ 169 (360)
T 3eqc_A 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 169 (360)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC
T ss_pred CCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC
Confidence 3789999999999999999999986 676666543 3699999999999999999999996 999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||++...... ......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..+....+...
T Consensus 170 ~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 245 (360)
T 3eqc_A 170 EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245 (360)
T ss_dssp CEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--
T ss_pred CEEEEECCCCcccccc---cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccc
Confidence 9999999999765322 2234578999999999986 57899999999999999999999999987766654433211
Q ss_pred c-CCCCCCCCCCCCCCCccccCCCc----hhhhhhHHHh---------hhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 C-GSPDETIWPGVSKMPAYNHFKPS----RTMKRRVREV---------FRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
. +......+........+..+... .......... ...++.++++||++||..||++|||+.|+|+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1 11111111000000000000000 0000000100 12367899999999999999999999999999
Q ss_pred CCCCC
Q 014871 227 EYFWT 231 (417)
Q Consensus 227 ~~f~~ 231 (417)
+||..
T Consensus 326 p~~~~ 330 (360)
T 3eqc_A 326 AFIKR 330 (360)
T ss_dssp HHHHH
T ss_pred hHhhc
Confidence 99943
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=285.09 Aligned_cols=192 Identities=19% Similarity=0.208 Sum_probs=153.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
-||+++++.+..++.+||||||+++ +|.+++.+. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.
T Consensus 71 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~ 150 (289)
T 1x8b_A 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISR 150 (289)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-
T ss_pred CCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcC
Confidence 4789999999999999999999976 777776543 245999999999999999999999999999999999999984
Q ss_pred C-------------------CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHH
Q 014871 79 E-------------------GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 139 (417)
Q Consensus 79 ~-------------------~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell 139 (417)
+ ..+||+|||++...... ....+|..|+|||++.+...++.++|||||||++|+|+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (289)
T 1x8b_A 151 TSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225 (289)
T ss_dssp -------------------CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT
T ss_pred CCCCcccccccccccccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh
Confidence 4 47999999999876532 22457999999999986556778999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC
Q 014871 140 NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS 219 (417)
Q Consensus 140 tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt 219 (417)
+|.+++..... ...+..... ..+...++..+++||++||..||++|||
T Consensus 226 ~~~~~~~~~~~---~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps 273 (289)
T 1x8b_A 226 GAEPLPRNGDQ---WHEIRQGRL-----------------------------PRIPQVLSQEFTELLKVMIHPDPERRPS 273 (289)
T ss_dssp TCCCCCSSSHH---HHHHHTTCC-----------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCCCCcchhH---HHHHHcCCC-----------------------------CCCCcccCHHHHHHHHHHhCCCcccCCC
Confidence 99987754432 222221100 0011236778999999999999999999
Q ss_pred HHHHhcCCCCCC
Q 014871 220 AKDALDSEYFWT 231 (417)
Q Consensus 220 a~elL~h~~f~~ 231 (417)
+.|+|+|+||..
T Consensus 274 ~~~ll~h~~~~~ 285 (289)
T 1x8b_A 274 AMALVKHSVLLS 285 (289)
T ss_dssp HHHHHTCTTC--
T ss_pred HHHHhhChHhhh
Confidence 999999999964
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=280.63 Aligned_cols=196 Identities=19% Similarity=0.216 Sum_probs=160.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC--
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN-- 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~-- 81 (417)
+++++++.+......||||||+.++|.+++...+..+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 146 (298)
T 1csn_A 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKN 146 (298)
T ss_dssp TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTT
T ss_pred CCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCC
Confidence 577788888899999999999988899888876667999999999999999999999999999999999999987776
Q ss_pred ---EEEeeccCcccccCCCC------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC---
Q 014871 82 ---LKLADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN--- 149 (417)
Q Consensus 82 ---vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~--- 149 (417)
+||+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+|||++|+.||.+.+
T Consensus 147 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 225 (298)
T 1csn_A 147 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 225 (298)
T ss_dssp TTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred CCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccc
Confidence 99999999987654322 12345578999999999876 568999999999999999999999998743
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..+.+..+.... ...........++.++.+||.+||..||++|||+.+|++
T Consensus 226 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 226 NKQKYERIGEKK-------------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHHHHH-------------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cHHHHHHHHhhc-------------------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 333333332210 111223344567889999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=304.47 Aligned_cols=190 Identities=15% Similarity=0.164 Sum_probs=143.8
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccC
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQI------KCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 89 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i------~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGl 89 (417)
.++|||||||+++|.+++...+..+.+..+ ..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 161 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~ 240 (371)
T 3q60_A 161 ANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240 (371)
T ss_dssp EEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecce
Confidence 458999999999999888764444555555 56779999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 014871 90 ARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETI 168 (417)
Q Consensus 90 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 168 (417)
|+.... ......+|..|+|||++.+. ..++.++||||||||||||++|+.||........ ..
T Consensus 241 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------------~~ 303 (371)
T 3q60_A 241 LWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK-------------GS 303 (371)
T ss_dssp EEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT-------------TC
T ss_pred eeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc-------------cc
Confidence 986542 22245667999999999641 4689999999999999999999999986643210 00
Q ss_pred CCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 169 WPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+........ .... ........++..+++||++||..||++|||+.++|+|+||.
T Consensus 304 ~~~~~~~~~-~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 304 WKRPSLRVP-GTDS-------LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp CCBCCTTSC-CCCS-------CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred hhhhhhhhc-cccc-------cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 000000000 0000 00001235788999999999999999999999999999993
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.62 Aligned_cols=200 Identities=22% Similarity=0.361 Sum_probs=156.5
Q ss_pred ccEeecccCceecCe----EEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNKYRGS----TYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~----~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
-||+++++.+..... .||||||+++ +|.+++... ..+++.++..++.||+.||+|||+++|+||||||+||||+
T Consensus 72 p~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 150 (311)
T 3ork_A 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150 (311)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred CCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 368888888776654 3999999985 666666543 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
.++.+||+|||+++.+..... ......++|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...
T Consensus 151 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~ 229 (311)
T 3ork_A 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229 (311)
T ss_dssp TTSCEEECCCSCC------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 999999999999986543222 22234568999999999986 578999999999999999999999999988877766
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
.+......+ .......++.++.+||.+||..||++|+++.++|.|+|+.
T Consensus 230 ~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 230 QHVREDPIP--------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHCCCCC--------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhcCCCCC--------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 654421111 1222345788999999999999999999999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=306.05 Aligned_cols=172 Identities=16% Similarity=0.224 Sum_probs=139.0
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCC-------HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCc
Q 014871 18 TYMVFEYMDHDLTGLADRPGLRFT-------VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLA 90 (417)
Q Consensus 18 ~yiV~Ey~~g~l~~~~~~~~~~l~-------~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla 90 (417)
.||||||++++|.+++.+.. .++ +..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus 175 ~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a 253 (377)
T 3byv_A 175 RFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253 (377)
T ss_dssp EEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhh
Confidence 89999999989888876532 244 4888899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCchhhcCC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 91 RSFSYDHNNTLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 91 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
+... ......++ ..|+|||++.+. ..++.++||||||||||||++|+.||.+.+....+..+.
T Consensus 254 ~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-- 326 (377)
T 3byv_A 254 VRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-- 326 (377)
T ss_dssp EETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG--
T ss_pred eecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh--
Confidence 8633 23345566 999999999863 168999999999999999999999997654322211110
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.....++.++++||++||..||++|||+.++|+|+||
T Consensus 327 --------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 327 --------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp --------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred --------------------------------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 0113467899999999999999999999999999999
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=280.65 Aligned_cols=194 Identities=20% Similarity=0.314 Sum_probs=162.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 65 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~ 144 (269)
T 4hcu_A 65 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV 144 (269)
T ss_dssp TTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred CCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC
Confidence 3788999999999999999999986 677777666667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 145 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~ 223 (269)
T 4hcu_A 145 IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 223 (269)
T ss_dssp EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred EEeccccccccccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Confidence 9999999998654332223334455778999999975 578999999999999999999 99999999888887777543
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
..... ...++..+.+||++||..||++|||+.+++++
T Consensus 224 ~~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 224 FRLYK-----------------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCC-----------------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 21111 12256789999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=286.73 Aligned_cols=198 Identities=27% Similarity=0.452 Sum_probs=156.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC-
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN- 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~- 81 (417)
||+++++.+..+ .+||||||+.+ +|.+.+.. ...+++.+++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 76 ~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 76 CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp TBCCEEEEEESS-SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSS
T ss_pred CCceEeeEEcCC-ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCC
Confidence 677877777654 48999999986 66665554 456999999999999999999999999999999999999987664
Q ss_pred --EEEeeccCcccccCCCCCcccccccccCCCCchhhc--CCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH-HHHH
Q 014871 82 --LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE-QLSK 156 (417)
Q Consensus 82 --vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~~~~ 156 (417)
+||+|||+++.... ........+|..|+|||++. ....++.++||||||||+|+|++|+.||....... ....
T Consensus 154 ~~~kl~Dfg~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 231 (322)
T 2ycf_A 154 CLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231 (322)
T ss_dssp CCEEECCCTTCEECCC--CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH
T ss_pred CeEEEccCccceeccc--ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH
Confidence 99999999986542 12233456799999999974 23568899999999999999999999997655432 2222
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+...... .....+..++..+++||++||..||++|||+.++|+|+||..
T Consensus 232 ~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 232 ITSGKYN--------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHTCCC--------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHhCccc--------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 3221000 012334567889999999999999999999999999999953
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.34 Aligned_cols=204 Identities=25% Similarity=0.388 Sum_probs=151.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLR------FTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~------l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
-|||++++.+...+.+|||||||+++|.+++...... .++.++..++.||+.||+|||+++|+||||||+||||
T Consensus 69 pnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl 148 (434)
T 2rio_A 69 PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 148 (434)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence 3789999999999999999999999988888754321 1333567899999999999999999999999999999
Q ss_pred cCC-------------CCEEEeeccCcccccCCCCC---cccccccccCCCCchhhcC------CCCCCCccchhhHHHH
Q 014871 77 DNE-------------GNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLG------ATKYGPAVDMWSVGCI 134 (417)
Q Consensus 77 ~~~-------------~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~i 134 (417)
+.+ ..+||+|||+|+........ .....++|+.|+|||++.+ ...++.++||||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~i 228 (434)
T 2rio_A 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228 (434)
T ss_dssp ECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHH
T ss_pred ecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHH
Confidence 754 37999999999876543221 2234578999999999864 2468999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccC
Q 014871 135 FAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 213 (417)
Q Consensus 135 l~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 213 (417)
+|||++ |+.||......+ ..+.......... .. . ....++.++++||++||..|
T Consensus 229 l~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~-----~~------~------------~~~~~~~~~~~li~~~L~~d 283 (434)
T 2rio_A 229 FYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM-----KC------L------------HDRSLIAEATDLISQMIDHD 283 (434)
T ss_dssp HHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC-----TT------C------------CCHHHHHHHHHHHHHHTCSS
T ss_pred HHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc-----cc------c------------ccccchHHHHHHHHHHhhCC
Confidence 999999 999997665443 2232211111100 00 0 01246778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q 014871 214 PSQRISAKDALDSEYFWT 231 (417)
Q Consensus 214 P~~Rpta~elL~h~~f~~ 231 (417)
|++|||+.+||+|+|||.
T Consensus 284 P~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 284 PLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp GGGSCCHHHHHTSGGGSC
T ss_pred hhhCCCHHHHHhCCccCC
Confidence 999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=287.38 Aligned_cols=183 Identities=23% Similarity=0.354 Sum_probs=141.4
Q ss_pred eEEEEEcCCCC-CHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccc
Q 014871 17 STYMVFEYMDH-DLTGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93 (417)
Q Consensus 17 ~~yiV~Ey~~g-~l~~~~~~~~~--~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~ 93 (417)
.+|||||||++ +|.+++.+... ...+..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence 48999999986 67666665332 2566779999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-----------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 94 SYDHN-----------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 94 ~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
..... ......++|..|+|||++.+ ..++.++||||||||+|||++|..++.. ....+..+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--- 288 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--- 288 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT---
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc---
Confidence 54321 12234578999999999986 5789999999999999999998655421 1111111111
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
......+...+..+++||++||..||++|||+.|+|+|+||..
T Consensus 289 --------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 289 --------------------------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp --------------------------TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred --------------------------cCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 0011223445678899999999999999999999999999953
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=285.01 Aligned_cols=199 Identities=22% Similarity=0.346 Sum_probs=155.3
Q ss_pred cEeecccCcee------cCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 014871 4 TFLETTDGNKY------RGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75 (417)
Q Consensus 4 niv~~~~~~~~------~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NIL 75 (417)
||+++++.+.. .+.+||||||+++ +|.+++... ...+++..++.++.||+.||+|||++||+|+||||+|||
T Consensus 82 ~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl 161 (326)
T 2x7f_A 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161 (326)
T ss_dssp TBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEE
Confidence 67788877766 5689999999986 777776653 246999999999999999999999999999999999999
Q ss_pred EcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 76 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
|+.++.+||+|||++....... .......+|..|+|||++.. ...++.++||||||||+|+|++|+.||...+..
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 162 LTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp ECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred EcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 9999999999999997654221 22334568999999999862 246889999999999999999999999988877
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..+..+........ ....++..+++||++||..||++|||+.+||+|+||+.
T Consensus 241 ~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 241 RALFLIPRNPAPRL----------------------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHHHHHHSCCCCC----------------------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred HHHHHhhcCccccC----------------------------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 76655543211000 01235678999999999999999999999999999965
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=291.36 Aligned_cols=193 Identities=23% Similarity=0.365 Sum_probs=159.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
-|||++++.+...+.+||||||+.+ +|.+++.... ..+++.++..++.||+.||+|||+++|+|
T Consensus 147 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 226 (370)
T 2psq_A 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 226 (370)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3789999999999999999999986 7777766432 35899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+||||+.++.+||+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+|||++ |+.|
T Consensus 227 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 227 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp SCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999986643222 22233456789999999986 578999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+....+...... .....++..+.+||++||..||++|||+.||+
T Consensus 306 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 356 (370)
T 2psq_A 306 YPGIPVEELFKLLKEGHRM-----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356 (370)
T ss_dssp STTCCGGGHHHHHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCHHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9988877776665432110 01123567899999999999999999999998
Q ss_pred c
Q 014871 225 D 225 (417)
Q Consensus 225 ~ 225 (417)
+
T Consensus 357 ~ 357 (370)
T 2psq_A 357 E 357 (370)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=287.73 Aligned_cols=215 Identities=23% Similarity=0.380 Sum_probs=164.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCc
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGL------ADRP-GLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSN 73 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~------~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~N 73 (417)
.||+++++.+...+.+||||||+++ +|.++ +... ...+++.+++.++.||+.||+|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 4788999999999999999999987 66665 3332 4569999999999999999999999 999999999999
Q ss_pred EEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCC-ccchhhHHHHHHHHHhCCCCCCCCCh-H
Q 014871 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP-AVDMWSVGCIFAELLNGKPILPGKNE-A 151 (417)
Q Consensus 74 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~~DiwSlG~il~elltG~~pf~~~~~-~ 151 (417)
|||+.++.+||+|||++...... ......+|..|+|||++.+...++. ++||||||||+|||++|+.||...+. .
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999999875432 3445678999999999986435555 99999999999999999999998777 5
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.+..+.......... +.... ... ...........++.++.+||++||..||++|||+.|+|+|+||..
T Consensus 260 ~~~~~i~~~~~~~~~~-~~~~~-----~~~-----~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLD-RNHFL-----YPL-----TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHTSCCCCCCCS-SSSST-----TTT-----CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHhccCcCCccc-hhhhh-----ccc-----cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 5555553321111100 00000 000 011112223557889999999999999999999999999999954
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=281.10 Aligned_cols=194 Identities=21% Similarity=0.313 Sum_probs=162.0
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+...+.+||||||++ ++|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~ 158 (283)
T 3gen_A 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV 158 (283)
T ss_dssp TTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC
T ss_pred CCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC
Confidence 478899999999999999999997 4777777665567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 237 (283)
T 3gen_A 159 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237 (283)
T ss_dssp EEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred EEEccccccccccccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc
Confidence 9999999998654322222333445788999999985 568999999999999999998 99999998888877777543
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
..... ...++..+.+||++||..||++|||+.++++|
T Consensus 238 ~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 238 LRLYR-----------------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCCCC-----------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-----------------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 22111 11245689999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=280.82 Aligned_cols=197 Identities=25% Similarity=0.395 Sum_probs=164.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++.. ..+++.++..++.||+.||+|||++||+|+||||+||||+.++.
T Consensus 80 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 157 (303)
T 3a7i_A 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE 157 (303)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred CCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC
Confidence 3688899999999999999999987 56655543 36999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++....... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+.......+....
T Consensus 158 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (303)
T 3a7i_A 158 VKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 235 (303)
T ss_dssp EEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred EEEeecccceecCccc-cccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC
Confidence 9999999997764322 22344577999999999976 578999999999999999999999999888777665554321
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.. .+...++..+.+||++||..||++|||+.+||+|+||...
T Consensus 236 ~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 236 PP-----------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CC-----------------------------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CC-----------------------------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 10 0112356789999999999999999999999999999653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=283.28 Aligned_cols=199 Identities=22% Similarity=0.307 Sum_probs=153.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||++..+..+.......+++.++..++.||+.||+|||++ ||+||||||+|||++.++.
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~ 163 (318)
T 2dyl_A 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ 163 (318)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC
T ss_pred CceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC
Confidence 378999999999999999999996666666655456799999999999999999999995 9999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCC-CChHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~-~~~~~~~~~ 156 (417)
+||+|||++....... ......+|..|+|||++.. ...++.++||||||||+|+|++|+.||.. .+..+.+..
T Consensus 164 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 241 (318)
T 2dyl_A 164 IKLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241 (318)
T ss_dssp EEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred EEEEECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence 9999999997654322 2334567999999999852 34688999999999999999999999987 444555555
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+........ +. ...++.++.+||++||..||.+|||+.+||+|+||.
T Consensus 242 ~~~~~~~~~----~~-----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 242 VLQEEPPLL----PG-----------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp HHHSCCCCC----CS-----------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred HhccCCCCC----Cc-----------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 543211100 00 013567899999999999999999999999999994
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=286.45 Aligned_cols=193 Identities=22% Similarity=0.300 Sum_probs=160.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++.+...+.+||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 110 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (325)
T 3kul_A 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV 189 (325)
T ss_dssp TTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred CCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC
Confidence 4789999999999999999999975 777777666667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCc--ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++......... .....+|..|+|||++.+ ..++.++||||||||+|||++ |+.||...+..+....+.
T Consensus 190 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred EEECCCCcccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 9999999998765432222 222344778999999975 578999999999999999999 999999999888887775
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.....+. ...++..+.+||++||..||++|||+.+|++
T Consensus 269 ~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 269 EGYRLPA-----------------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCC-----------------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 4322111 1236678999999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=278.48 Aligned_cols=194 Identities=19% Similarity=0.253 Sum_probs=161.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 63 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~ 142 (268)
T 3sxs_A 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC 142 (268)
T ss_dssp TTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC
T ss_pred CCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC
Confidence 3788999999999999999999975 677777665556999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 143 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 221 (268)
T 3sxs_A 143 VKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221 (268)
T ss_dssp EEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred EEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC
Confidence 9999999998765433333334455778999999875 568999999999999999999 99999998888777766442
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
..... ...++..+.+||++||..||++|||+.+++++
T Consensus 222 ~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 222 HRLYR-----------------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CCCCC-----------------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCC-----------------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21111 11245689999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=289.95 Aligned_cols=197 Identities=17% Similarity=0.225 Sum_probs=155.0
Q ss_pred ccEeecccCceec----CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-
Q 014871 3 CTFLETTDGNKYR----GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID- 77 (417)
Q Consensus 3 cniv~~~~~~~~~----~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~- 77 (417)
-||+++++.+... .++|||||||.++|.+++......|++.+++.|+.||+.||+|||+++|+||||||+||||+
T Consensus 108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 108 LGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 3678888777664 56899999997788888877767799999999999999999999999999999999999999
Q ss_pred -CCCCEEEeeccCcccccCCCCC------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh
Q 014871 78 -NEGNLKLADFGLARSFSYDHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE 150 (417)
Q Consensus 78 -~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 150 (417)
.++.+||+|||+|+.+...... .....++|..|+|||++.+ ..++.++||||||||||||++|+.||.+...
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8889999999999765432211 1233458999999999986 5689999999999999999999999986433
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhh------hhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF------RHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
.......... .....+..+. ..++.++.+||+.||..||++|||+.+|+
T Consensus 267 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~ 321 (364)
T 3op5_A 267 DPKYVRDSKI-------------------------RYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR 321 (364)
T ss_dssp CHHHHHHHHH-------------------------HHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred CHHHHHHHHH-------------------------HhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHH
Confidence 3322221110 0001111111 34588999999999999999999999887
Q ss_pred c
Q 014871 225 D 225 (417)
Q Consensus 225 ~ 225 (417)
+
T Consensus 322 ~ 322 (364)
T 3op5_A 322 D 322 (364)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=279.48 Aligned_cols=190 Identities=25% Similarity=0.415 Sum_probs=143.2
Q ss_pred eecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 13 KYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 13 ~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
...+.+||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 346789999999975 8888887666678999999999999999999999999999999999999999999999999997
Q ss_pred cccCCC-------------CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHH
Q 014871 92 SFSYDH-------------NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-KNEAEQLSKI 157 (417)
Q Consensus 92 ~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~-~~~~~~~~~i 157 (417)
...... ........+|..|+|||++.+...++.++|||||||++|+|++ ||.. .+..+.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~ 241 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhc
Confidence 654221 1223345679999999999865578999999999999999998 4443 2333333443
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
......... .+....+..+++||++||..||++|||+.++|+|+||..
T Consensus 242 ~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 242 RSVSIEFPP--------------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HSTTCCCCT--------------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred cccccccCc--------------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 321111110 011235567899999999999999999999999999953
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=291.88 Aligned_cols=204 Identities=24% Similarity=0.368 Sum_probs=136.8
Q ss_pred ccEeecccCcee----cCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKY----RGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~----~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
.||+++++.+.. +..+|||||||++ +|.+++.+.. ..+++.+++.++.||+.||+|||+++|+||||||+||||
T Consensus 82 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll 161 (336)
T 3fhr_A 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY 161 (336)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 467778877776 5568999999986 7877776543 469999999999999999999999999999999999999
Q ss_pred cCC---CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 77 DNE---GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 77 ~~~---~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
+.+ +.+||+|||+++.... ......++|..|+|||++.. ..++.++|||||||++|+|++|+.||........
T Consensus 162 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 162 TSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp SCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred EecCCCceEEEeccccceeccc---cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 864 4599999999976542 22334567999999999865 5688999999999999999999999977665443
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
...+......... . .....+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 238 ~~~~~~~~~~~~~-------~---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 238 SPGMKRRIRLGQY-------G---------------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp --------------------C---------------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhhHHHhhhcccc-------c---------------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 2222111000000 0 0001123467899999999999999999999999999999754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=284.91 Aligned_cols=193 Identities=21% Similarity=0.288 Sum_probs=152.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~--~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~NILl~ 77 (417)
.||+++++.+...+.+||||||+++ +|.+++.+... .+++.++..++.||+.||+|||+++ |+||||||+||||+
T Consensus 94 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~ 173 (309)
T 3p86_A 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173 (309)
T ss_dssp TTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC
T ss_pred CCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe
Confidence 4789999999999999999999986 67776665432 3999999999999999999999999 99999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... ........+|..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+
T Consensus 174 ~~~~~kL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 174 KKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp TTCCEEECCCC------------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred CCCcEEECCCCCCcccccc-ccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999754322 222344678999999999986 56899999999999999999999999998887777666
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
........ +...++..+.+||++||..||++|||+.+|++
T Consensus 252 ~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 252 GFKCKRLE----------------------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHSCCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCC----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 43221111 11246778999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=278.67 Aligned_cols=193 Identities=19% Similarity=0.233 Sum_probs=153.9
Q ss_pred ecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCCEE
Q 014871 7 ETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLK 83 (417)
Q Consensus 7 ~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl---~~~~~vk 83 (417)
.+..++...+..||||||+.++|.+++......+++.++..++.||+.||+|||+++|+||||||+|||| +.++.+|
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 69 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp CEEEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEE
T ss_pred eeeeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEE
Confidence 3345557778889999999889988887666679999999999999999999999999999999999999 7888999
Q ss_pred EeeccCcccccCCCC------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH---HHH
Q 014871 84 LADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQL 154 (417)
Q Consensus 84 L~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~---~~~ 154 (417)
|+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+.. ..+
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 999999987654322 12234578999999999986 56899999999999999999999999764432 122
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..+... ............++.++.+||++||..||++|||+.+|++
T Consensus 228 ~~~~~~-------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 228 ERISEK-------------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHH-------------------------HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhcc-------------------------cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 222110 0111123333557889999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=279.25 Aligned_cols=192 Identities=20% Similarity=0.318 Sum_probs=147.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+. ++.+||||||+.+ +|.+++......+++.++..++.||+.||+|||++||+||||||+||||+.++.
T Consensus 76 ~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 154 (281)
T 1mp8_A 76 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 154 (281)
T ss_dssp TTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE
T ss_pred CccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC
Confidence 36788887764 5678999999986 777777766667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............+|..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~ 233 (281)
T 1mp8_A 155 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233 (281)
T ss_dssp EEECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEECccccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC
Confidence 9999999998765433323334455788999999875 578999999999999999996 99999988887777766432
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++..+.+||++||..||++|||+.++++
T Consensus 234 ~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 234 ERLP-----------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-----------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1110 11246778999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.97 Aligned_cols=194 Identities=22% Similarity=0.359 Sum_probs=161.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
-|||++++.+...+.+||||||+++ +|.+++.... ..+++.+++.++.||+.||+|||+++|+|
T Consensus 135 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 214 (382)
T 3tt0_A 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 214 (382)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred chhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 4789999999999999999999985 7777776543 35999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+||||+.++.+||+|||+|+....... .......+|..|+|||++.+ ..++.++||||||||+|||++ |+.|
T Consensus 215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986643222 22334456889999999986 678999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+....+........ ...++.++.+||++||..||++|||+.+|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 294 YPGVPVEELFKLLKEGHRMDK-----------------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp STTCCHHHHHHHHHTTCCCCC-----------------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCC-----------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 999888777776654221110 123567899999999999999999999998
Q ss_pred cC
Q 014871 225 DS 226 (417)
Q Consensus 225 ~h 226 (417)
++
T Consensus 345 ~~ 346 (382)
T 3tt0_A 345 ED 346 (382)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=288.08 Aligned_cols=217 Identities=20% Similarity=0.284 Sum_probs=158.0
Q ss_pred ccEeecccCceecC--eEEEEEcCCCC-CHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-
Q 014871 3 CTFLETTDGNKYRG--STYMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI- 76 (417)
Q Consensus 3 cniv~~~~~~~~~~--~~yiV~Ey~~g-~l~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl- 76 (417)
-||+++++.+...+ ++||||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||
T Consensus 67 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 146 (319)
T 4euu_A 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146 (319)
T ss_dssp TTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred CCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEe
Confidence 36788888777655 78999999974 6777666533 239999999999999999999999999999999999999
Q ss_pred ---cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcC-------CCCCCCccchhhHHHHHHHHHhCCCCCC
Q 014871 77 ---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-------ATKYGPAVDMWSVGCIFAELLNGKPILP 146 (417)
Q Consensus 77 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~elltG~~pf~ 146 (417)
+.++.+||+|||+++...... .....++|..|+|||++.. ...++.++||||||||+|||++|+.||.
T Consensus 147 ~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 147 IGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp ECTTSCEEEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred ccCCCCceEEEccCCCceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 777789999999998765332 3345678999999999862 2578999999999999999999999997
Q ss_pred CCCh----HHHHHHHHHhcCCCCCCCCCCCCCCCc-cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHH
Q 014871 147 GKNE----AEQLSKIFELCGSPDETIWPGVSKMPA-YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 221 (417)
Q Consensus 147 ~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~ 221 (417)
.... .+.+.++... .....+........ ...+... . .....+...++..+.+||++||..||++|+|+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (319)
T 4euu_A 225 PFEGPRRNKEVMYKIITG---KPSGAISGVQKAENGPIDWSGD--M-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (319)
T ss_dssp CTTCGGGCHHHHHHHHHH---CCTTCCEEEECSTTCCEEEESS--C-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred CCCccchhHHHHHHHhcC---CCcccchhhhcccCCccccCcc--C-CcccccchhHHHHhHHHHHHhccCChhhhccHH
Confidence 4332 3344444332 11112221111100 0000000 0 000122355778899999999999999999999
Q ss_pred HHhcCC
Q 014871 222 DALDSE 227 (417)
Q Consensus 222 elL~h~ 227 (417)
|+|+|+
T Consensus 299 ell~h~ 304 (319)
T 4euu_A 299 QFFAET 304 (319)
T ss_dssp HHHHHH
T ss_pred Hhhhcc
Confidence 999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=278.56 Aligned_cols=198 Identities=30% Similarity=0.498 Sum_probs=163.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-- 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-- 79 (417)
-||+++++.+...+.+||||||+.+ +|.+.+... ..+++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 81 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~ 159 (287)
T 2wei_A 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK 159 (287)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred CCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCC
Confidence 3688899999999999999999975 666666543 369999999999999999999999999999999999999764
Q ss_pred -CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 80 -GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 80 -~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
..+||+|||++...... .......+|..|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 160 ~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (287)
T 2wei_A 160 DCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (287)
T ss_dssp TCCEEECSTTGGGTBCCC--SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccEEEeccCcceeecCC--CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 36999999999765432 22334567999999999875 48999999999999999999999999998888777765
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
......+. ..+..++.++++||++||..||++|||+.++|+|+||..
T Consensus 236 ~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 236 TGKYAFDL--------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HCCCCCCS--------------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred cCCCCCCc--------------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 52211111 012346778999999999999999999999999999953
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=274.69 Aligned_cols=192 Identities=18% Similarity=0.231 Sum_probs=152.8
Q ss_pred cccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCCEEE
Q 014871 8 TTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLKL 84 (417)
Q Consensus 8 ~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl---~~~~~vkL 84 (417)
+..++...+..||||||+.++|.+++......+++.++..++.||+.||+|||+++|+||||||+|||| +.++.+||
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl 149 (296)
T 3uzp_A 70 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp EEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred cccccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEE
Confidence 334556777889999999888988887666679999999999999999999999999999999999999 47889999
Q ss_pred eeccCcccccCCCCC------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCh---HHHHH
Q 014871 85 ADFGLARSFSYDHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNE---AEQLS 155 (417)
Q Consensus 85 ~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~---~~~~~ 155 (417)
+|||+++........ ......+|..|+|||++.+ ..++.++||||||||+|||++|+.||...+. .+.+.
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred eeCCCcccccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 999999876543221 1244578999999999986 5689999999999999999999999986432 22222
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+... ........+...++.++.+||++||..||++|||+.+|++
T Consensus 229 ~~~~~-------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 229 RISEK-------------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHH-------------------------HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhccc-------------------------ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 22210 0111122333567889999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=276.79 Aligned_cols=201 Identities=29% Similarity=0.435 Sum_probs=157.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~- 78 (417)
-||+++++.+...+.+||||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+++|+|+||||+||||+.
T Consensus 79 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~ 158 (295)
T 2clq_A 79 KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY 158 (295)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred CCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC
Confidence 3788999999999999999999974 6777665542 34779999999999999999999999999999999999987
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
++.+||+|||+++...... .......+|..|+|||++.+. ..++.++|||||||++|+|++|+.||............
T Consensus 159 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 237 (295)
T 2clq_A 159 SGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK 237 (295)
T ss_dssp TCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH
T ss_pred CCCEEEeecccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh
Confidence 8899999999998754321 223345679999999998642 23788999999999999999999999765443322111
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
........ .+...++.++.+||++||..||++|||+.++|+|+||..
T Consensus 238 ~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 238 VGMFKVHP---------------------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp HHHHCCCC---------------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred hccccccc---------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 11111000 112246778999999999999999999999999999964
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=277.60 Aligned_cols=195 Identities=21% Similarity=0.291 Sum_probs=154.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+..++.+||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 67 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~ 146 (310)
T 3s95_A 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN 146 (310)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC
T ss_pred cCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC
Confidence 3789999999999999999999986 777777776677999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC-------------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 014871 82 LKLADFGLARSFSYDHNN-------------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK 148 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~-------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 148 (417)
+||+|||+++........ .....++|..|+|||++.+ ..++.++|||||||++|||++|..+|...
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 999999999875432221 1114578999999999986 67899999999999999999999888643
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..... ... ..............++..+.+||.+||..||++|||+.+|++
T Consensus 226 ~~~~~--------------------------~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 226 LPRTM--------------------------DFG-LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp SCBCT--------------------------TSS-BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhHH--------------------------HHh-hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 21100 000 000001111123456778999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=286.71 Aligned_cols=189 Identities=25% Similarity=0.343 Sum_probs=156.8
Q ss_pred ccEeecccCceecCeEEEEEcCCC--CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NE 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~--g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~-~~ 79 (417)
-||+++++.+...+.+|+||||+. ++|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+||||+ ++
T Consensus 108 ~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp CSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred CCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence 478899999999999999999997 5777776653 4699999999999999999999999999999999999999 77
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||+++..... ......+|..|+|||++.+...++.++||||||||+|||++|+.||...+. +..
T Consensus 187 ~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~ 257 (320)
T 3a99_A 187 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR 257 (320)
T ss_dssp TEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH
T ss_pred CCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc
Confidence 89999999999876532 233456899999999987644457889999999999999999999965321 111
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.. . .....++.++.+||++||..||++|||+.+|++|+||..
T Consensus 258 ~~--~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 258 GQ--V----------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp CC--C----------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred cc--c----------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 00 0 001235678999999999999999999999999999965
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=285.25 Aligned_cols=197 Identities=19% Similarity=0.197 Sum_probs=153.4
Q ss_pred cEeecccCcee----cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKY----RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~----~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++++.+.. .+.+|||||||.++|.+++.... .+++.+++.++.||+.||+|||+++|+||||||+||||+.+
T Consensus 109 ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 109 GIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp CCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred CcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence 67788887777 77899999999667777766544 79999999999999999999999999999999999999988
Q ss_pred C--CEEEeeccCcccccCCCC------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC--C
Q 014871 80 G--NLKLADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK--N 149 (417)
Q Consensus 80 ~--~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~--~ 149 (417)
+ .+||+|||+|+.+..... .......+|..|+|||++.+ ..++.++||||||||||||++|+.||... +
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 7 999999999987643211 12244578999999999986 57899999999999999999999999653 2
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhh--hhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR--HFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
............... ...+..... .++.++++||++||..||++|||+.+|++
T Consensus 267 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 267 PVAVQTAKTNLLDEL-----------------------PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHHHTT-----------------------THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHHHHHhhcccc-----------------------cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 222222221111000 111111111 57789999999999999999999999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=288.84 Aligned_cols=197 Identities=18% Similarity=0.293 Sum_probs=161.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLL 75 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NIL 75 (417)
-|||++++.+...+..|||||||.+ +|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||
T Consensus 134 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 213 (367)
T 3l9p_A 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 213 (367)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence 3788999999999999999999975 7777776432 35999999999999999999999999999999999999
Q ss_pred EcCCC---CEEEeeccCcccccCCC-CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCh
Q 014871 76 IDNEG---NLKLADFGLARSFSYDH-NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNE 150 (417)
Q Consensus 76 l~~~~---~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~ 150 (417)
|+.++ .+||+|||+|+...... ........+|..|+|||++.+ ..++.++||||||||||||++ |+.||...+.
T Consensus 214 l~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 214 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp ESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99555 49999999997653221 223334567899999999976 578999999999999999998 9999999998
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.+.+..+........ ...++..+.+||++||..||++|||+.+|+++-++
T Consensus 293 ~~~~~~i~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 293 QEVLEFVTSGGRMDP-----------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HHHHHHHHTTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCC-----------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 888777654221110 12356789999999999999999999999987655
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=278.67 Aligned_cols=200 Identities=28% Similarity=0.401 Sum_probs=154.0
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
||+++++.+...+.+|||||+..++|.+++.+.. .+++.+++.++.||+.||+|||+++|+||||||+||||++ +.+|
T Consensus 89 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 89 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp TBCCEEEEEECSSEEEEEECCCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEE
T ss_pred ceEEEEEEeecCCEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEE
Confidence 6889999999999999999988888888887653 6999999999999999999999999999999999999965 7899
Q ss_pred EeeccCcccccCCCCC-cccccccccCCCCchhhcCC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCh-H
Q 014871 84 LADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGA----------TKYGPAVDMWSVGCIFAELLNGKPILPGKNE-A 151 (417)
Q Consensus 84 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~ 151 (417)
|+|||+++........ ......+|..|+|||++.+. ..++.++|||||||++|+|++|+.||..... .
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 9999999875432221 22345679999999998641 3578899999999999999999999976543 2
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
..+..+....... . +....+.++.+||++||..||++|||+.|+|+|+||..
T Consensus 247 ~~~~~~~~~~~~~---~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 247 SKLHAIIDPNHEI---E-------------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHHHHHCTTSCC---C-------------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHHHHHhccccc---C-------------------------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 3333332211000 0 01123568899999999999999999999999999965
Q ss_pred CC
Q 014871 232 DP 233 (417)
Q Consensus 232 ~~ 233 (417)
..
T Consensus 299 ~~ 300 (313)
T 3cek_A 299 QT 300 (313)
T ss_dssp C-
T ss_pred CC
Confidence 43
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=275.77 Aligned_cols=198 Identities=28% Similarity=0.419 Sum_probs=160.3
Q ss_pred ccEeecccCc--eecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCC
Q 014871 3 CTFLETTDGN--KYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-----VLHRDIKG 71 (417)
Q Consensus 3 cniv~~~~~~--~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~g-----ivHrDlkp 71 (417)
-||+++++.+ +..+.+||||||+++ +|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||
T Consensus 65 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p 144 (279)
T 2w5a_A 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 144 (279)
T ss_dssp TTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSG
T ss_pred CCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccch
Confidence 3678888766 346789999999986 77776654 2345999999999999999999999999 99999999
Q ss_pred CcEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 72 SNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 72 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
+|||++.++.+||+|||+++...... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||...+..
T Consensus 145 ~NIl~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 222 (279)
T 2w5a_A 145 ANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222 (279)
T ss_dssp GGEEECSSSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhEEEcCCCCEEEecCchheeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHH
Confidence 99999999999999999997654221 12234567999999999986 56899999999999999999999999998887
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+....+.+.... .+...++.++.+||++||..||++|||+.|||+|+|+..
T Consensus 223 ~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 223 ELAGKIREGKFR-----------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp HHHHHHHHTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred HHHHHHhhcccc-----------------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 777666542110 011236778999999999999999999999999999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=282.40 Aligned_cols=193 Identities=18% Similarity=0.221 Sum_probs=155.6
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++ .+..|+||||+. ++|.+++......+++.++..++.||+.||+|||++||+||||||+||||+.++.
T Consensus 75 ~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~ 153 (325)
T 3kex_A 75 AHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ 153 (325)
T ss_dssp TTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC
T ss_pred CCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe
Confidence 36788888765 567999999998 5787777766567999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||+++........ ......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||.+.+..+....+..
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 232 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 999999999876543322 2334556789999999975 568999999999999999999 9999998887777666643
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
...... ...++.++.+||.+||..||++|||+.+++++
T Consensus 233 ~~~~~~-----------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 233 GERLAQ-----------------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TCBCCC-----------------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCCCC-----------------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 211110 01234567899999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.24 Aligned_cols=192 Identities=20% Similarity=0.307 Sum_probs=159.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+...+.+||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~ 143 (267)
T 3t9t_A 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 143 (267)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCE
T ss_pred CEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCE
Confidence 688888989989999999999975 7777777666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+++..............+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+....
T Consensus 144 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~ 222 (267)
T 3t9t_A 144 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222 (267)
T ss_dssp EECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred EEcccccccccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Confidence 999999997654322222233455788999999975 568999999999999999999 899999988887777765421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... ...++..+.+||++||..||++|||+.++++
T Consensus 223 ~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 223 RLYK-----------------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp CCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCC-----------------------------CccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1100 1125678999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=279.84 Aligned_cols=199 Identities=18% Similarity=0.274 Sum_probs=148.5
Q ss_pred ccEeecccCceecCeE------EEEEcCCCC-CHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 014871 3 CTFLETTDGNKYRGST------YMVFEYMDH-DLTGLADRP-----GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIK 70 (417)
Q Consensus 3 cniv~~~~~~~~~~~~------yiV~Ey~~g-~l~~~~~~~-----~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlk 70 (417)
-||+++++.+...... |+||||+.+ +|.+++... ...+++.++..++.||+.||+|||++||+|||||
T Consensus 85 ~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dik 164 (323)
T 3qup_A 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLA 164 (323)
T ss_dssp TTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Confidence 3678888887776665 999999986 666665432 2259999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 014871 71 GSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGK 148 (417)
Q Consensus 71 p~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~ 148 (417)
|+||||+.++.+||+|||+++....... .......++..|+|||++.+ ..++.++||||||||+|||++ |+.||.+.
T Consensus 165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp GGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999986543222 12223345788999999976 578999999999999999999 99999998
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-------HH
Q 014871 149 NEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-------AK 221 (417)
Q Consensus 149 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-------a~ 221 (417)
+..+....+....... ....++.++.+||++||..||++||| ++
T Consensus 244 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 244 ENAEIYNYLIGGNRLK-----------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp CGGGHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ChHHHHHHHhcCCCCC-----------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 8888777765422111 01235678999999999999999999 78
Q ss_pred HHhcCCCCCC
Q 014871 222 DALDSEYFWT 231 (417)
Q Consensus 222 elL~h~~f~~ 231 (417)
++++|+|+..
T Consensus 295 ~~l~~~~~~~ 304 (323)
T 3qup_A 295 NILGHLSVLS 304 (323)
T ss_dssp HHHHC-----
T ss_pred HHHHHhhhcC
Confidence 8899999955
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=291.86 Aligned_cols=193 Identities=18% Similarity=0.235 Sum_probs=155.9
Q ss_pred ecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCCEE
Q 014871 7 ETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI---DNEGNLK 83 (417)
Q Consensus 7 ~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl---~~~~~vk 83 (417)
.+..++...+..||||||+.++|.+++......|++.+++.|+.||+.||+|||+++||||||||+|||| +.++.+|
T Consensus 67 ~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 67 NVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp CEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred eEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEE
Confidence 3444556677889999999889999888766679999999999999999999999999999999999999 6888999
Q ss_pred EeeccCcccccCCCCC------cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH---HHH
Q 014871 84 LADFGLARSFSYDHNN------TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA---EQL 154 (417)
Q Consensus 84 L~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~---~~~ 154 (417)
|+|||+++.+...... .....++|..|+|||++.+ ..++.++||||||||||||++|+.||.+.... +.+
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 225 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH
Confidence 9999999876543221 1225678999999999986 57899999999999999999999999875543 333
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.++... .....+..+...++.++.+||.+||..||++||++.+|++
T Consensus 226 ~~i~~~-------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 226 EKISEK-------------------------KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHH-------------------------HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhhc-------------------------cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 333220 1122233445667899999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=286.42 Aligned_cols=194 Identities=20% Similarity=0.355 Sum_probs=155.2
Q ss_pred cEeecccCceecCe-EEEEEcCCCC-CHHHHHhcCCC-------------------------------------------
Q 014871 4 TFLETTDGNKYRGS-TYMVFEYMDH-DLTGLADRPGL------------------------------------------- 38 (417)
Q Consensus 4 niv~~~~~~~~~~~-~yiV~Ey~~g-~l~~~~~~~~~------------------------------------------- 38 (417)
|||++++.+...+. +|||||||.+ +|.+++.....
T Consensus 87 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred ceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 78999988777555 8999999986 77777654321
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCC
Q 014871 39 ----------------------RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYD 96 (417)
Q Consensus 39 ----------------------~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 96 (417)
.+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 1899999999999999999999999999999999999999999999999999865432
Q ss_pred CC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCC
Q 014871 97 HN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 174 (417)
Q Consensus 97 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 174 (417)
.. .......+|..|+|||++.+ ..++.++||||||||+|||++ |+.||.+.+..+.+...........
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 316 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--------- 316 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------
T ss_pred ccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC---------
Confidence 22 22334567889999999976 678999999999999999998 9999988776555444433211110
Q ss_pred CCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 175 MPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
....++.++.+||.+||..||++|||+.||++|
T Consensus 317 -------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 -------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 012356789999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=280.69 Aligned_cols=193 Identities=20% Similarity=0.300 Sum_probs=158.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHH
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-----------------------LRFTVPQIKCYMKQLLTGLHY 58 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-----------------------~~l~~~~i~~i~~Qil~gL~~ 58 (417)
-||+++++.+...+.+||||||+++ +|.+++.... ..+++.++..++.||+.||+|
T Consensus 110 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 189 (343)
T 1luf_A 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 189 (343)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 3788999999999999999999986 7777766532 469999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHH
Q 014871 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137 (417)
Q Consensus 59 LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 137 (417)
||+++|+||||||+||||+.++.+||+|||+++....... .......+|..|+|||++.+ ..++.++|||||||++||
T Consensus 190 LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~e 268 (343)
T 1luf_A 190 LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWE 268 (343)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHH
T ss_pred HHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHH
Confidence 9999999999999999999999999999999976543221 22234466889999999875 568999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC
Q 014871 138 LLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216 (417)
Q Consensus 138 llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 216 (417)
|++ |+.||.+.+..+....+.+.... .....++..+.+||++||..||++
T Consensus 269 l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~ 319 (343)
T 1luf_A 269 IFSYGLQPYYGMAHEEVIYYVRDGNIL-----------------------------ACPENCPLELYNLMRLCWSKLPAD 319 (343)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHhcCCCcCCCCChHHHHHHHhCCCcC-----------------------------CCCCCCCHHHHHHHHHHcccCccc
Confidence 999 99999998887777666442110 011235678999999999999999
Q ss_pred CCCHHHHhc
Q 014871 217 RISAKDALD 225 (417)
Q Consensus 217 Rpta~elL~ 225 (417)
|||+.++++
T Consensus 320 Rps~~~~~~ 328 (343)
T 1luf_A 320 RPSFCSIHR 328 (343)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=275.45 Aligned_cols=198 Identities=18% Similarity=0.300 Sum_probs=146.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+.+++ +...+.+||||||+++ +|.+.+......+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 80 ~~iv~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~ 158 (289)
T 3og7_A 80 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT 158 (289)
T ss_dssp TTBCCEEE-EECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred CcEEEEEe-eccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence 36777776 4566788999999985 677777666667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCC-CCCcccccccccCCCCchhhcC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLG--ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++..... .........+|..|+|||++.. ...++.++|||||||++|+|++|+.||...+..+.+..+.
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 999999999765432 1223344568999999999862 2467889999999999999999999998877666655554
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
........ ...+...++..+++||++||..||++|||+.++++
T Consensus 239 ~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 239 GRGSLSPD------------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHTSCCCC------------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccCcc------------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 32211110 01112246678999999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=272.75 Aligned_cols=192 Identities=19% Similarity=0.243 Sum_probs=153.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++. +..|+||||+.+ +|.+++.+....+++.++..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 73 ~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 151 (281)
T 3cc6_A 73 PHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC 151 (281)
T ss_dssp TTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE
T ss_pred CCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc
Confidence 367788877664 567999999985 777777665566999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||++...............+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 152 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~ 230 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230 (281)
T ss_dssp EEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT
T ss_pred EEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC
Confidence 9999999998765433333334456788999999875 578999999999999999998 99999887777766665442
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+. ...++..+.+||++||..||++|||+.|+++
T Consensus 231 ~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 231 DRLPK-----------------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp CCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-----------------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 21110 1235678999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=277.70 Aligned_cols=193 Identities=20% Similarity=0.315 Sum_probs=154.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++......+++.++..++.||+.||+|||++||+||||||+||||+.++.
T Consensus 106 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~ 185 (333)
T 1mqb_A 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV 185 (333)
T ss_dssp TTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred CCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc
Confidence 3788899999999999999999986 777777766667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCc--ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++......... .....+|..|+|||++.. ..++.++||||||||+|||++ |+.||...+..+.+..+.
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 264 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 9999999998765332211 122344778999999975 578999999999999999998 999999888877777664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+....+. ...++..+.+||++||..||++|||+.++++
T Consensus 265 ~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 265 DGFRLPT-----------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp TTCCCCC-----------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCcCCC-----------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4211110 1135678999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=279.76 Aligned_cols=195 Identities=22% Similarity=0.346 Sum_probs=158.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHH
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGL----------------------RFTVPQIKCYMKQLLTGLHYC 59 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~----------------------~l~~~~i~~i~~Qil~gL~~L 59 (417)
-||+++++.+...+.+||||||+++ +|.+++..... .+++.++..++.||+.||+||
T Consensus 109 p~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 188 (344)
T 1rjb_A 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188 (344)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred CCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3788999999999999999999975 78777765432 379999999999999999999
Q ss_pred HHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHH
Q 014871 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138 (417)
Q Consensus 60 H~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~el 138 (417)
|++||+||||||+||||+.++.+||+|||+++........ ......+|..|+|||++.+ ..++.++||||||||||+|
T Consensus 189 H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el 267 (344)
T 1rjb_A 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEI 267 (344)
T ss_dssp HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred HhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHH
Confidence 9999999999999999999999999999999876533222 2233456888999999876 5789999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCC
Q 014871 139 LN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQR 217 (417)
Q Consensus 139 lt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R 217 (417)
++ |+.||.+......+..+......+. ....++..+.+||.+||..||++|
T Consensus 268 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~R 319 (344)
T 1rjb_A 268 FSLGVNPYPGIPVDANFYKLIQNGFKMD----------------------------QPFYATEEIYIIMQSCWAFDSRKR 319 (344)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HcCCCCCcccCCcHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCchhC
Confidence 98 9999988776555554443211110 011356789999999999999999
Q ss_pred CCHHHHhcC
Q 014871 218 ISAKDALDS 226 (417)
Q Consensus 218 pta~elL~h 226 (417)
||+.+|+++
T Consensus 320 ps~~~l~~~ 328 (344)
T 1rjb_A 320 PSFPNLTSF 328 (344)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=275.38 Aligned_cols=188 Identities=17% Similarity=0.212 Sum_probs=151.8
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+..||||||++ ++|.+++.+....+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 72 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 151 (289)
T 4fvq_A 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREED 151 (289)
T ss_dssp TTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCB
T ss_pred CCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCc
Confidence 378899999999999999999998 5787777766556999999999999999999999999999999999999998887
Q ss_pred --------EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChHH
Q 014871 82 --------LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAE 152 (417)
Q Consensus 82 --------vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG-~~pf~~~~~~~ 152 (417)
+||+|||++.... ......+|..|+|||++.+...++.++|||||||++|||++| .++|...+...
T Consensus 152 ~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~ 226 (289)
T 4fvq_A 152 RKTGNPPFIKLSDPGISITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226 (289)
T ss_dssp GGGTBCCEEEECCCCSCTTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred ccccccceeeeccCccccccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence 9999999986543 123345788999999998656789999999999999999995 45555555444
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
......... .. ...++.++.+||++||..||++|||+.+++++
T Consensus 227 ~~~~~~~~~-~~------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 227 KLQFYEDRH-QL------------------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHTTC-CC------------------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHhhccC-CC------------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 433332111 00 01134467899999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=283.91 Aligned_cols=193 Identities=21% Similarity=0.319 Sum_probs=149.8
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+...+.+|||||||+ ++|.+++.+.+..+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 106 ~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 185 (373)
T 2qol_A 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185 (373)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred CCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC
Confidence 378899999999999999999997 5787777776667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCccc--ccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLT--NRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++........... ...+|..|+|||++.. ..++.++||||||||||||++ |+.||...+..+....+.
T Consensus 186 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~ 264 (373)
T 2qol_A 186 CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264 (373)
T ss_dssp EEECCC----------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred EEECcCccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999876533222211 2234678999999975 578999999999999999997 999999888877776664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.....+. ...++..+.+||.+||..||++|||+.+|++
T Consensus 265 ~~~~~~~-----------------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 265 EGYRLPP-----------------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TTEECCC-----------------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCC-----------------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 4221111 1135678999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=281.46 Aligned_cols=189 Identities=25% Similarity=0.364 Sum_probs=151.1
Q ss_pred ccEeecccCceecCeEEEEEcC-CC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEY-MD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID-NE 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey-~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~-~~ 79 (417)
.||+++++.+...+..|+|||| +. ++|.+++.+. ..+++.++..++.||+.||+|||+++|+||||||+|||++ .+
T Consensus 98 ~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp SSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTT
T ss_pred CCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCC
Confidence 4789999999999999999999 55 5777776653 3599999999999999999999999999999999999999 78
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||+++..... ......+|..|+|||++.+....+.++||||||||+|+|++|+.||..... +..
T Consensus 177 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~ 247 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE 247 (312)
T ss_dssp TEEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH
T ss_pred CeEEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh
Confidence 89999999999876532 234556899999999987644445689999999999999999999965321 111
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
... .+...++..+++||++||..||++|||+.|+|+|+||..
T Consensus 248 ~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 248 AEL------------------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp TCC------------------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred hcc------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 000 011236678999999999999999999999999999965
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=280.03 Aligned_cols=202 Identities=22% Similarity=0.301 Sum_probs=140.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVN-QVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~-givHrDlkp~NILl~ 77 (417)
-||+++++.+...+.+||||||++++|..++.. ....+++..+..++.||+.||.|||++ +|+||||||+||||+
T Consensus 81 ~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~ 160 (327)
T 3aln_A 81 PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD 160 (327)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE
T ss_pred CcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc
Confidence 378999999999999999999999988776653 245699999999999999999999999 999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhc---CCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLL---GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~ 154 (417)
.++.+||+|||+++...... ......+|..|+|||++. ....++.++||||||||+|+|++|+.||...+...
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 236 (327)
T 3aln_A 161 RSGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-- 236 (327)
T ss_dssp TTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred CCCCEEEccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--
Confidence 99999999999997654322 223346899999999983 22468899999999999999999999997654321
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
..+........ +.+. ......++..+++||++||..||++|||+.+|++|+||.
T Consensus 237 ~~~~~~~~~~~----------~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 237 DQLTQVVKGDP----------PQLS------------NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp ---CCCCCSCC----------CCCC------------CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHHHHhcCCC----------CCCC------------CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 11111000000 0000 001123677899999999999999999999999999994
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=272.45 Aligned_cols=193 Identities=19% Similarity=0.283 Sum_probs=161.0
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-||+++++.+...+.+||||||++ ++|.+++... ...+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 69 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~ 148 (288)
T 3kfa_A 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH 148 (288)
T ss_dssp TTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG
T ss_pred CCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC
Confidence 378889999999999999999998 4777777653 34599999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||++...............+|..|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+..
T Consensus 149 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~ 227 (288)
T 3kfa_A 149 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227 (288)
T ss_dssp CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred CEEEccCccceeccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 99999999998765444334444556888999999975 578999999999999999999 9999998887776666543
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..... ....++..+.+||++||..||++|||+.++++
T Consensus 228 ~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 228 DYRME-----------------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCC-----------------------------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 21110 01235678999999999999999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=276.88 Aligned_cols=194 Identities=19% Similarity=0.313 Sum_probs=158.8
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHH
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG-----------------------LRFTVPQIKCYMKQLLTGLHY 58 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~-----------------------~~l~~~~i~~i~~Qil~gL~~ 58 (417)
-||+++++.+...+.+||||||+. ++|.+++.... ..+++.++..++.||+.||+|
T Consensus 86 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 165 (314)
T 2ivs_A 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165 (314)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHH
T ss_pred CceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999998 57777765432 238999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHH
Q 014871 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137 (417)
Q Consensus 59 LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 137 (417)
||+++|+||||||+||||+.++.+||+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+||
T Consensus 166 lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e 244 (314)
T 2ivs_A 166 LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWE 244 (314)
T ss_dssp HHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHH
T ss_pred HHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHH
Confidence 9999999999999999999999999999999986543222 12223455788999999976 568999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC
Q 014871 138 LLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216 (417)
Q Consensus 138 llt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 216 (417)
|++ |+.||.+.+.......+....... ....++..+.+||.+||..||++
T Consensus 245 l~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~dp~~ 295 (314)
T 2ivs_A 245 IVTLGGNPYPGIPPERLFNLLKTGHRME-----------------------------RPDNCSEEMYRLMLQCWKQEPDK 295 (314)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHhCCCCCCCCCCHHHHHHHhhcCCcCC-----------------------------CCccCCHHHHHHHHHHccCChhh
Confidence 999 999999888777666554321100 11236778999999999999999
Q ss_pred CCCHHHHhcC
Q 014871 217 RISAKDALDS 226 (417)
Q Consensus 217 Rpta~elL~h 226 (417)
|||+.+|+++
T Consensus 296 Rps~~~l~~~ 305 (314)
T 2ivs_A 296 RPVFADISKD 305 (314)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=277.43 Aligned_cols=192 Identities=23% Similarity=0.326 Sum_probs=156.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
-||+++++.++..+.+||||||+++ +|.+++.+.. ..+++.+++.++.||+.||+|||+++|+|
T Consensus 86 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 165 (327)
T 1fvr_A 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 165 (327)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 3789999999999999999999975 7877776543 36999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPIL 145 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf 145 (417)
|||||+||||+.++.+||+|||+++...... ......++..|+|||++.+ ..++.++||||||||+|||++ |+.||
T Consensus 166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf 242 (327)
T 1fvr_A 166 RDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPY 242 (327)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCccceEEEcCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999997533211 1223345788999999875 568899999999999999998 99999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+..+....+...... .....++..+.+||++||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 243 CGMTCAELYEKLPQGYRL-----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293 (327)
T ss_dssp TTCCHHHHHHHGGGTCCC-----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcHHHHHHHhhcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 998887766655331100 001235678999999999999999999999986
Q ss_pred C
Q 014871 226 S 226 (417)
Q Consensus 226 h 226 (417)
+
T Consensus 294 ~ 294 (327)
T 1fvr_A 294 S 294 (327)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=280.00 Aligned_cols=204 Identities=22% Similarity=0.267 Sum_probs=154.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
||+++++.+...+.+||||||+++ +|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 96 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175 (321)
T ss_dssp TBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT
T ss_pred CEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC
Confidence 788899999999999999999985 6666654432 359999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH-
Q 014871 80 GNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI- 157 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i- 157 (417)
+.+||+|||+++....... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+
T Consensus 176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~ 254 (321)
T 2qkw_B 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254 (321)
T ss_dssp CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred CCEEEeecccccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence 9999999999986543222 22334567999999999875 57899999999999999999999999765432221111
Q ss_pred --HH--hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 158 --FE--LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 158 --~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.. ..........+. ........++..+.+||.+||..||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 255 WAVESHNNGQLEQIVDPN------------------LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HTHHHHTTTCCCSSSSSS------------------CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhhccccccHHHhcChh------------------hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 000000000000 0011123467789999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=273.66 Aligned_cols=194 Identities=22% Similarity=0.340 Sum_probs=158.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGL-----------------RFTVPQIKCYMKQLLTGLHYCHVNQV 64 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~-----------------~l~~~~i~~i~~Qil~gL~~LH~~gi 64 (417)
-||+++++.+...+..||||||+++ +|.+++..... .+++.++..++.||+.||+|||+++|
T Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 166 (313)
T 1t46_A 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (313)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3789999999999999999999986 78777765432 48999999999999999999999999
Q ss_pred eecCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CC
Q 014871 65 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GK 142 (417)
Q Consensus 65 vHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~ 142 (417)
+||||||+||||+.++.+||+|||+++........ ......+|..|+|||++.+ ..++.++||||||||+|+|++ |+
T Consensus 167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999876543322 1223456788999999876 578999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHH
Q 014871 143 PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 222 (417)
Q Consensus 143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e 222 (417)
.||.+......+..+........ ....++..+.+||++||..||++|||+.+
T Consensus 246 ~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 297 (313)
T 1t46_A 246 SPYPGMPVDSKFYKMIKEGFRML----------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (313)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCcccchhHHHHHhccCCCCC----------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 99988776555554433211110 01235678999999999999999999999
Q ss_pred Hhc
Q 014871 223 ALD 225 (417)
Q Consensus 223 lL~ 225 (417)
+++
T Consensus 298 ll~ 300 (313)
T 1t46_A 298 IVQ 300 (313)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=271.46 Aligned_cols=191 Identities=23% Similarity=0.306 Sum_probs=147.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEcC-
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ---VLHRDIKGSNLLIDN- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g---ivHrDlkp~NILl~~- 78 (417)
-||+++++.+...+.+||||||++++.+..+.+ ...+++.++..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 66 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~ 144 (271)
T 3dtc_A 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144 (271)
T ss_dssp TTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSC
T ss_pred CCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecc
Confidence 378889999999999999999998654444443 346999999999999999999999999 899999999999986
Q ss_pred -------CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 79 -------EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 79 -------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
++.+||+|||+++..... ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 145 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 145 VENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp CSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred cccccccCcceEEccCCcccccccc---cccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 677999999999765432 2234568999999999876 57899999999999999999999999988877
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.....+........ ....++..+.+||++||..||++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 221 AVAYGVAMNKLALP----------------------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHTSCCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhhcCCCCCC----------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 76665543111100 112356789999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=271.26 Aligned_cols=193 Identities=23% Similarity=0.316 Sum_probs=156.0
Q ss_pred ccEeecccC-ceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDG-NKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~-~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
.||+++++. +..++..||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 86 ~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~ 165 (298)
T 3f66_A 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF 165 (298)
T ss_dssp TTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred CCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC
Confidence 478888886 5667789999999986 78888877667799999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCC---CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSK 156 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~ 156 (417)
.+||+|||+++....... .......+|..|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....
T Consensus 166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3f66_A 166 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244 (298)
T ss_dssp CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred CEEECcccccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 999999999976543221 12233456788999999976 578999999999999999999 6778888777766666
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+........ ...++..+.+||++||..||++|||+.++++
T Consensus 245 ~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 245 LLQGRRLLQ-----------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHTTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCC-----------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 544221111 1225668999999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=274.93 Aligned_cols=194 Identities=21% Similarity=0.313 Sum_probs=146.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+..++.+||||||+++ +|.+++.+. ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 94 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~ 172 (309)
T 2h34_A 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF 172 (309)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred CCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC
Confidence 3788999999999999999999986 676666543 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||++...............+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (309)
T 2h34_A 173 AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI 251 (309)
T ss_dssp EEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC
T ss_pred EEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC
Confidence 9999999998765443334445678999999999876 578999999999999999999999998876654333332110
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-SAKDALD 225 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-ta~elL~ 225 (417)
.. .......++..+.+||++||..||++|| |++++++
T Consensus 252 -~~--------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 252 -PR--------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -CC--------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -CC--------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 00 0112234677899999999999999999 8888775
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=285.09 Aligned_cols=192 Identities=20% Similarity=0.322 Sum_probs=157.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.+..++.+|||||||+ ++|.+++...+..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 173 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~ 252 (377)
T 3cbl_A 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252 (377)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred CEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcE
Confidence 78899999999999999999997 57887777655569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCc-ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNNT-LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++......... .....++..|+|||++.. ..++.++|||||||+||||++ |..||.+.+..+....+...
T Consensus 253 kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 331 (377)
T 3cbl_A 253 KISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331 (377)
T ss_dssp EECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred EECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997643221111 112234678999999875 568999999999999999998 99999988877766655432
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++..+.+||++||..||++|||+.+|++
T Consensus 332 ~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 GRLP-----------------------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1111 01235678999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=269.87 Aligned_cols=192 Identities=18% Similarity=0.223 Sum_probs=157.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+ ..+.+||||||+.+ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 71 ~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 71 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp TBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE
T ss_pred CEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCE
Confidence 678888877 45679999999986 6777776666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+++........ ......+|..|+|||++.+ ..++.++||||||||+|||++ |+.||...+..+....+..
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 99999999876433221 1223345788999999875 568999999999999999998 9999998888777766643
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.... .....++..+.+||++||..||++|||+.+++++
T Consensus 229 ~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 229 GKRM-----------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp TCCC-----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCcC-----------------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2100 0112467789999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=279.48 Aligned_cols=198 Identities=14% Similarity=0.162 Sum_probs=151.6
Q ss_pred eecccCcee-cCeEEEEEcCCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--C
Q 014871 6 LETTDGNKY-RGSTYMVFEYMDHDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG--N 81 (417)
Q Consensus 6 v~~~~~~~~-~~~~yiV~Ey~~g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~--~ 81 (417)
+++++.+.. ++.+||||||+.++|.+++... ...+++.++..++.||+.||+|||+++|+||||||+||||+.++ .
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEE
T ss_pred cchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCce
Confidence 334555555 6788999999977888887754 35699999999999999999999999999999999999999988 8
Q ss_pred EEEeeccCcccccCCCC------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--hHHH
Q 014871 82 LKLADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN--EAEQ 153 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~--~~~~ 153 (417)
+||+|||+++.+..... .......+|..|+|||++.+ ..++.++||||||||||||++|+.||.... ....
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 278 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence 99999999976543221 12234478999999999976 578999999999999999999999998764 3333
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+......+...... ...+..++..+.+||++||..||++|||+.+|++
T Consensus 279 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 279 MKQKQKFVDKPGPFVGP---------------------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHSCCCEECT---------------------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhccCChhhhhhh---------------------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 33332222111110000 0001235789999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=275.21 Aligned_cols=208 Identities=18% Similarity=0.227 Sum_probs=157.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---LRFTVPQIKCYMKQLLTGLHYCHVN---QVLHRDIKGSNLL 75 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---~~l~~~~i~~i~~Qil~gL~~LH~~---givHrDlkp~NIL 75 (417)
-||+++++.+...+..||||||+.+ +|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||
T Consensus 87 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp TTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred CCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 4789999999999999999999986 6766665432 2499999999999999999999999 9999999999999
Q ss_pred EcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCC-----CCh
Q 014871 76 IDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPG-----KNE 150 (417)
Q Consensus 76 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~-----~~~ 150 (417)
|+.++.+||+|||+++..............+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.. ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 167 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp ECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred ECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence 9999999999999998765544444555668999999999875 5689999999999999999999999952 111
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSE 227 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~ 227 (417)
......+...... ........ . ..........+..+.+||.+||..||++|||+.||++|-
T Consensus 246 ~~~~~~~~~~~~~---~~~~~~~~------~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 246 VMLLDWVKGLLKE---KKLEALVD------V-------DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SBHHHHHTTTTSS---CCSTTSSC------T-------TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhHHHHHHHHhhc---hhhhhhcC------h-------hhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 1111111111100 00000000 0 000112234567899999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=267.40 Aligned_cols=193 Identities=20% Similarity=0.266 Sum_probs=155.8
Q ss_pred ccEeecccCceecCeE-EEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGST-YMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~-yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-||+++++.+...+.. |+||||+. ++|.+++......+++.++..++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~ 161 (298)
T 3pls_A 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF 161 (298)
T ss_dssp TTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred CCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 3788888888766665 99999996 578888877677799999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCC---CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014871 81 NLKLADFGLARSFSYDH---NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSK 156 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~ 156 (417)
.+||+|||+++...... ........+|..|+|||++.+ ..++.++|||||||++|+|++ +.++|...+..+....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~ 240 (298)
T 3pls_A 162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240 (298)
T ss_dssp CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH
T ss_pred cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH
Confidence 99999999997653221 122233456889999999976 578999999999999999999 5566766666666555
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+......+. ...++..+.+||++||..||++|||+.++++
T Consensus 241 ~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 241 LAQGRRLPQ-----------------------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHTTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCCCCCC-----------------------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 543221111 1235678999999999999999999999885
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.49 Aligned_cols=193 Identities=18% Similarity=0.233 Sum_probs=155.7
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||+++++++... ..++|+||+. ++|.+++.+....+++.++..|+.||+.||+|||+++|+||||||+||||+.+++
T Consensus 77 ~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp TTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE
T ss_pred CCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC
Confidence 3678888877764 5778888887 5788888776677999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
+||+|||+|+........ ......+|..|+|||++.+ ..++.++||||||||+|||++ |+.||.+.+..+....+..
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 234 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc
Confidence 999999999876533222 2223445789999999986 678999999999999999999 9999998887766655543
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
....+. ...++.++.+||.+||..||++|||+.+++++
T Consensus 235 ~~~~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 235 GERLPQ-----------------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TCCCCC-----------------------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCCCC-----------------------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 211110 12356689999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.57 Aligned_cols=193 Identities=18% Similarity=0.268 Sum_probs=158.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
||+++++.+...+.+||||||+.+ +|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|
T Consensus 89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 168 (322)
T 1p4o_A 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168 (322)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccce
Confidence 688888999999999999999985 7777665321 357999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChH
Q 014871 74 LLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEA 151 (417)
Q Consensus 74 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~ 151 (417)
|||+.++.+||+|||+++....... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 9999999999999999976543221 12223456889999999875 568999999999999999999 89999988887
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
+....+.+..... ....++..+.+||++||..||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 248 QVLRFVMEGGLLD-----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCcCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7776664321100 012366789999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.95 Aligned_cols=193 Identities=23% Similarity=0.359 Sum_probs=158.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG---------------LRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~---------------~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
-||+++++.+..++.+||||||+++ +|.+++.... ..+++.++..++.||+.||+|||+++|+|
T Consensus 101 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (334)
T 2pvf_A 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 180 (334)
T ss_dssp TTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 3788999999999999999999985 7777776532 24899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+||||+.++.+||+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+|||++ |+.|
T Consensus 181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986543221 11223345788999999875 568999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+....+....... ....++..+.+||++||..||++|||+.+|+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 260 YPGIPVEELFKLLKEGHRMD-----------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp STTCCHHHHHHHHHHTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCcCCHHHHHHHHhcCCCCC-----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99988877776665422110 0123567899999999999999999999998
Q ss_pred c
Q 014871 225 D 225 (417)
Q Consensus 225 ~ 225 (417)
+
T Consensus 311 ~ 311 (334)
T 2pvf_A 311 E 311 (334)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.10 Aligned_cols=192 Identities=23% Similarity=0.313 Sum_probs=147.3
Q ss_pred cEeecccC-ceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDG-NKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~-~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++++. +..++..||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 151 nIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 230 (373)
T 3c1x_A 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 230 (373)
T ss_dssp TBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred CcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC
Confidence 78888876 4556788999999985 788888776667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC---cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i 157 (417)
+||+|||+++........ ......+|..|+|||++.+ ..++.++||||||||+|||++ |.+||...+..+....+
T Consensus 231 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~ 309 (373)
T 3c1x_A 231 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309 (373)
T ss_dssp EEECCC---------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH
T ss_pred EEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH
Confidence 999999999865432211 1223455788999999975 578999999999999999999 78889887766665555
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....... ....++..+.+||.+||..||++|||+.++++
T Consensus 310 ~~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 310 LQGRRLL-----------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp HTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3321100 01235678999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.39 Aligned_cols=193 Identities=18% Similarity=0.278 Sum_probs=159.5
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-|||++++.+...+.+|||||||. ++|.+++.+. ...+++.++..++.||+.||+|||+++|+||||||+||||+.++
T Consensus 276 pniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 355 (495)
T 1opk_A 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH 355 (495)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred CCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC
Confidence 378999999999999999999998 5788777653 34599999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||+++..............++..|+|||++.. ..++.++||||||||||||++ |+.||.+.+..++...+..
T Consensus 356 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 434 (495)
T 1opk_A 356 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434 (495)
T ss_dssp CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999998764332222233445778999999875 568999999999999999999 9999998887776665543
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..... ....++..+.+||++||..||++|||+.+|++
T Consensus 435 ~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 435 DYRME-----------------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-----------------------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 21110 11236678999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=269.80 Aligned_cols=194 Identities=14% Similarity=0.193 Sum_probs=154.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.+...+.+||||||+++ +|.+++......+++.++..++.||+.||+|||+++|+||||||+|||++ ++.
T Consensus 89 ~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp TTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C
T ss_pred CCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC
Confidence 3789999999999999999999985 67777766666799999999999999999999999999999999999998 578
Q ss_pred EEEeeccCcccccCC----CCCcccccccccCCCCchhhcC--------CCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 014871 82 LKLADFGLARSFSYD----HNNTLTNRVITLWYRPPELLLG--------ATKYGPAVDMWSVGCIFAELLNGKPILPGKN 149 (417)
Q Consensus 82 vkL~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 149 (417)
+||+|||+++..... .........+|..|+|||++.. ...++.++||||||||+|||++|+.||...+
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998754321 1122334467999999999874 2357889999999999999999999999888
Q ss_pred hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 150 EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 150 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.......+......... ...++.++.+||.+||..||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 248 AEAIIWQMGTGMKPNLS----------------------------QIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHHHHTTCCCCCC----------------------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCCCCCCC----------------------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 87776665432111000 0124557899999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=266.82 Aligned_cols=191 Identities=19% Similarity=0.349 Sum_probs=154.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
||+++++.+. .+.+||||||+.+ +|.+++.... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 69 ~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~ 147 (279)
T 1qpc_A 69 RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147 (279)
T ss_dssp TBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC
T ss_pred CcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC
Confidence 6777777665 5578999999975 6766665432 25999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............++..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 226 (279)
T 1qpc_A 148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (279)
T ss_dssp EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred EEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc
Confidence 9999999998765433223334455788999999875 568899999999999999999 99999998887777666432
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... ....++..+.+||++||..||++|||+.+|++
T Consensus 227 ~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 YRMV-----------------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCC-----------------------------CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1110 01235678999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=274.55 Aligned_cols=214 Identities=22% Similarity=0.248 Sum_probs=149.3
Q ss_pred ccEeecccCceecC----eEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------Cceec
Q 014871 3 CTFLETTDGNKYRG----STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN----------QVLHR 67 (417)
Q Consensus 3 cniv~~~~~~~~~~----~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~----------givHr 67 (417)
-|||++++.+.... ++|||||||++ +|.+++... .+++.++..++.||+.||+|||++ +|+||
T Consensus 78 pniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~ 155 (322)
T 3soc_A 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR 155 (322)
T ss_dssp TTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECS
T ss_pred CCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeC
Confidence 37888888887754 47999999986 777777653 499999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCC----CCCCCccchhhHHHHHHHHHhCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGA----TKYGPAVDMWSVGCIFAELLNGK 142 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DiwSlG~il~elltG~ 142 (417)
||||+||||+.++.+||+|||+|+....... ......++|..|+|||++.+. ..++.++||||||||+|||++|+
T Consensus 156 Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 235 (322)
T 3soc_A 156 DIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235 (322)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred CCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence 9999999999999999999999987654322 223345789999999999753 23456789999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHH
Q 014871 143 PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 222 (417)
Q Consensus 143 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e 222 (417)
.||.+................+....+..... .....+. ....+ .....+.++.+||++||..||++|||+.+
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (322)
T 3soc_A 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV---HKKKRPV--LRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGC 308 (322)
T ss_dssp TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT---TSCCCCC--CCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCcchhccchhhhhccCCchhhhhhhhh---cccCCCC--ccccc--cccchHHHHHHHHHHHccCChhhCcCHHH
Confidence 99976543211100000000000000000000 0000000 00000 01124567999999999999999999999
Q ss_pred Hhc
Q 014871 223 ALD 225 (417)
Q Consensus 223 lL~ 225 (417)
|++
T Consensus 309 ll~ 311 (322)
T 3soc_A 309 VGE 311 (322)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=287.71 Aligned_cols=192 Identities=18% Similarity=0.331 Sum_probs=156.5
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-|||++++++. .+.+|||||||.+ +|.+++.+.. ..+++.++..++.||+.||+|||+++|+||||||+||||+.++
T Consensus 243 ~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~ 321 (454)
T 1qcf_A 243 DKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL 321 (454)
T ss_dssp TTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC
T ss_pred CCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC
Confidence 36788887766 6689999999975 7777776432 3589999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||+++..............+|..|+|||++.. ..++.++||||||||||||++ |+.||.+.+..+++..+..
T Consensus 322 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~ 400 (454)
T 1qcf_A 322 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400 (454)
T ss_dssp CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH
T ss_pred cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999998754321112223345778999999975 578999999999999999999 9999999988888777754
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....+. ...++.++.+||.+||..||++|||+.+|++
T Consensus 401 ~~~~~~-----------------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 401 GYRMPR-----------------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCC-----------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 321111 1235678999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=277.25 Aligned_cols=191 Identities=21% Similarity=0.339 Sum_probs=131.3
Q ss_pred cEeecccCc--------eecCeEEEEEcCCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCC
Q 014871 4 TFLETTDGN--------KYRGSTYMVFEYMDHDLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKG 71 (417)
Q Consensus 4 niv~~~~~~--------~~~~~~yiV~Ey~~g~l~~~~~~--~~~~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp 71 (417)
||+++++++ .....+||||||++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||
T Consensus 87 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp 166 (337)
T 3ll6_A 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166 (337)
T ss_dssp TBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCG
T ss_pred ChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCc
Confidence 566766655 44556899999999999887754 3446999999999999999999999999 99999999
Q ss_pred CcEEEcCCCCEEEeeccCcccccCCCCC-----------cccccccccCCCCchhhc--CCCCCCCccchhhHHHHHHHH
Q 014871 72 SNLLIDNEGNLKLADFGLARSFSYDHNN-----------TLTNRVITLWYRPPELLL--GATKYGPAVDMWSVGCIFAEL 138 (417)
Q Consensus 72 ~NILl~~~~~vkL~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~--~~~~~~~~~DiwSlG~il~el 138 (417)
+||||+.++.+||+|||+++........ ......+|..|+|||++. ....++.++||||||||+|+|
T Consensus 167 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el 246 (337)
T 3ll6_A 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246 (337)
T ss_dssp GGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred ccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence 9999999999999999999876533221 112446799999999983 234678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC
Q 014871 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218 (417)
Q Consensus 139 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp 218 (417)
++|+.||........+..... .+. ....+..+.+||++||..||++||
T Consensus 247 ~~g~~p~~~~~~~~~~~~~~~---~~~-----------------------------~~~~~~~~~~li~~~l~~~p~~Rp 294 (337)
T 3ll6_A 247 CFRQHPFEDGAKLRIVNGKYS---IPP-----------------------------HDTQYTVFHSLIRAMLQVNPEERL 294 (337)
T ss_dssp HHSSCCC------------CC---CCT-----------------------------TCCSSGGGHHHHHHHSCSSGGGSC
T ss_pred HhCCCCCcchhHHHhhcCccc---CCc-----------------------------ccccchHHHHHHHHHccCChhhCc
Confidence 999999976554333222110 000 011334578999999999999999
Q ss_pred CHHHHhcC
Q 014871 219 SAKDALDS 226 (417)
Q Consensus 219 ta~elL~h 226 (417)
|+.|++++
T Consensus 295 s~~e~l~~ 302 (337)
T 3ll6_A 295 SIAEVVHQ 302 (337)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=274.89 Aligned_cols=194 Identities=20% Similarity=0.355 Sum_probs=154.1
Q ss_pred cEeecccCceecC-eEEEEEcCCCC-CHHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 4 TFLETTDGNKYRG-STYMVFEYMDH-DLTGLADRPGL---------------RFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 4 niv~~~~~~~~~~-~~yiV~Ey~~g-~l~~~~~~~~~---------------~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
||+++++.+...+ .+||||||+.+ +|.+++..... .+++.++..++.||+.||+|||+++|+|
T Consensus 92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H 171 (316)
T 2xir_A 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 171 (316)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 7888888776654 48999999986 77777765432 2899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~p 144 (417)
|||||+||||+.++.+||+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.|
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986543322 22234456889999999976 578999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+.+........... ....++..+.+||.+||..||++|||+.+|+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 302 (316)
T 2xir_A 251 YPGVKIDEEFCRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302 (316)
T ss_dssp STTCCCSHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcccchhHHHHHHhccCccCC----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 987765444433322111100 0123567899999999999999999999998
Q ss_pred cC
Q 014871 225 DS 226 (417)
Q Consensus 225 ~h 226 (417)
+|
T Consensus 303 ~~ 304 (316)
T 2xir_A 303 EH 304 (316)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=272.41 Aligned_cols=191 Identities=18% Similarity=0.240 Sum_probs=150.5
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+... ..++||||+. ++|.+++......+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 78 ~iv~~~~~~~~~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~ 156 (327)
T 3lzb_A 78 HVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp TBCCCCEEEESS-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE
T ss_pred CeeEEEEEEecC-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCE
Confidence 678888887765 4788888887 57888887766679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+|||++ |+.||.+.+..+....+...
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999987643222 12223445788999999986 678999999999999999999 99999988877766655432
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+. ...++.++.+||++||..||++|||+.||++
T Consensus 236 ~~~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 236 ERLPQ-----------------------------PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CCCCC-----------------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-----------------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21111 1235678999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=274.76 Aligned_cols=194 Identities=20% Similarity=0.329 Sum_probs=157.1
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-------------~~~l~~~~i~~i~~Qil~gL~~LH~~givHrD 68 (417)
-||+++++.+...+.+||||||+.+ +|.+++... ...+++.++..++.||+.||+|||+++|+|||
T Consensus 110 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 189 (333)
T 2i1m_A 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189 (333)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred CCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCC
Confidence 3788999999999999999999986 777766532 33589999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 014871 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILP 146 (417)
Q Consensus 69 lkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~ 146 (417)
|||+||||+.++.+||+|||+++........ ......+|..|+|||++.+ ..++.++||||||||+|||++ |..||.
T Consensus 190 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp CSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999999999865433222 2233456788999999876 578999999999999999998 999998
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 147 GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+......+..+......... ...++..+.+||.+||..||++|||+.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 269 GILVNSKFYKLVKDGYQMAQ----------------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp TCCSSHHHHHHHHHTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHHHHhcCCCCCC----------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 87766655554432211100 1124568899999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=267.85 Aligned_cols=190 Identities=19% Similarity=0.231 Sum_probs=153.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+ ..+.+||||||+.+ +|.+++... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 79 ~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~ 156 (291)
T 1xbb_A 79 YIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 156 (291)
T ss_dssp TBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred CEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcE
Confidence 678888877 56789999999985 666666553 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCc--ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+++......... .....+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 235 (291)
T 1xbb_A 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235 (291)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred EEccCCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999998764332211 122344688999999875 568889999999999999999 9999999888777666543
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.... .....++..+.+||++||..||++|||+.++++
T Consensus 236 ~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 GERM-----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2100 011246778999999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=269.53 Aligned_cols=204 Identities=19% Similarity=0.272 Sum_probs=146.0
Q ss_pred ccEeecccCcee--cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNKY--RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~~--~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
-||+++++.+.. ..++||||||+.+ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 71 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~ 150 (295)
T 3ugc_A 71 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 150 (295)
T ss_dssp TTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET
T ss_pred CCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC
Confidence 367777776643 4568999999975 7888877666669999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|||++|..+|....... ...+
T Consensus 151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~ 228 (295)
T 3ugc_A 151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-MRMI 228 (295)
T ss_dssp TEEEECCCCSCC-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH-HHHH
T ss_pred CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHHH-Hhhh
Confidence 9999999999987643322 12223445778999999986 578999999999999999999998876432211 1100
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhh-----HHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-----VREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
........ ........ .......++.++.+||++||..||++|||+.||++
T Consensus 229 ----~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 229 ----GNDKQGQM-------------IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp ----CTTCCTHH-------------HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----cCccccch-------------hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000000 00000000 00112346788999999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=263.60 Aligned_cols=188 Identities=15% Similarity=0.186 Sum_probs=154.8
Q ss_pred ccEeecccCceec--CeEEEEEcCCCC-CHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKYR--GSTYMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~~--~~~yiV~Ey~~g-~l~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~NILl 76 (417)
-||+++++.+... +.+||||||+++ +|.+++.+... .+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 67 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~ 146 (271)
T 3kmu_A 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI 146 (271)
T ss_dssp TTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE
T ss_pred CchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE
Confidence 3788999888776 788999999985 78777766443 4999999999999999999999999 9999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCC---ccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP---AVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~---~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
+.++.++|+||+++.... .....+|..|+|||++.+. .++. ++|||||||++|||++|+.||...+..+.
T Consensus 147 ~~~~~~~l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 219 (271)
T 3kmu_A 147 DEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKK-PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219 (271)
T ss_dssp CTTSCEEEEGGGSCCTTS------CTTCBSCGGGSCHHHHHSC-GGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred cCCcceeEEeccceeeec------ccCccCCccccChhhhccC-CCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence 999999999999875432 2235679999999999863 3333 79999999999999999999999888777
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+......+. ....++..+.+||++||..||++|||+.++++
T Consensus 220 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 220 GMKVALEGLRPT----------------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHSCCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 666644221110 11236778999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.78 Aligned_cols=184 Identities=24% Similarity=0.400 Sum_probs=141.9
Q ss_pred ccEeecccCcee----cCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKY----RGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~----~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
-||+++++.+.. .+.+||||||+++ +|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||||
T Consensus 71 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 150 (299)
T 3m2w_A 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 150 (299)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 377888888877 7789999999985 7877776543 469999999999999999999999999999999999999
Q ss_pred cC---CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 77 DN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 77 ~~---~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
+. ++.+||+|||++.... ...++.++|||||||++|||++|+.||...+....
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 151 TSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp SSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred ecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 98 7889999999986432 13467889999999999999999999976654332
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
...+.. ... .... ......+..++.++++||++||..||++|||+.|+|+|+||...
T Consensus 207 ~~~~~~-------~~~--------~~~~-------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 207 SPGMKT-------RIR--------MGQY-------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp -CCSCC-------SSC--------TTCC-------SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred hHHHHH-------HHh--------hccc-------cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 111100 000 0000 00112234578899999999999999999999999999999654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.07 Aligned_cols=175 Identities=15% Similarity=0.191 Sum_probs=143.8
Q ss_pred CeEEEEEcCCCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccC
Q 014871 16 GSTYMVFEYMDHDLTGLAD------RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 89 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~------~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGl 89 (417)
..+|++|+++.++|.+++. ..+..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 178 ~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~ 257 (413)
T 3dzo_A 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257 (413)
T ss_dssp CSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred cceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence 3578999999999888773 2344588889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCchhhc---------CCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 90 ARSFSYDHNNTLTNRVITLWYRPPELLL---------GATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 90 a~~~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
++..... ....++ ..|+|||++. ....++.++||||||||||||++|+.||...+..+....++.
T Consensus 258 a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~- 331 (413)
T 3dzo_A 258 LVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR- 331 (413)
T ss_dssp CEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS-
T ss_pred eeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh-
Confidence 9765432 344566 9999999983 334578899999999999999999999976654322111100
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
....++..+++||++||..||++|||+.++|+|+||
T Consensus 332 ---------------------------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~ 367 (413)
T 3dzo_A 332 ---------------------------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 367 (413)
T ss_dssp ---------------------------------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred ---------------------------------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 012356789999999999999999999999999999
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=263.36 Aligned_cols=188 Identities=18% Similarity=0.227 Sum_probs=150.5
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~NILl~~~~ 80 (417)
||+++++.+.... ||||||+. ++|.+.+.+....+++.++..++.||+.||+|||+++ |+||||||+||||+.++
T Consensus 84 ~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 84 NIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp TBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCC
T ss_pred CchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccC
Confidence 6777777765544 79999998 5787888777778999999999999999999999999 99999999999998877
Q ss_pred C-----EEEeeccCcccccCCCCCcccccccccCCCCchhhcC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH-
Q 014871 81 N-----LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ- 153 (417)
Q Consensus 81 ~-----vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~- 153 (417)
. +||+|||+++.... ......+|..|+|||++.. ...++.++|||||||++|||++|+.||...+....
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 237 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH
T ss_pred CCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH
Confidence 6 99999999975432 3445678999999999843 24578899999999999999999999987654433
Q ss_pred -HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 154 -LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 154 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+......+ .+...++..+.+||++||..||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 238 FINMIREEGLRP----------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHSCCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCC----------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33332211000 011246778999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.21 Aligned_cols=196 Identities=18% Similarity=0.285 Sum_probs=159.1
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPG------LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~------~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
||+++++.+...+..||||||++ ++|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+||||
T Consensus 94 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli 173 (327)
T 2yfx_A 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 173 (327)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEE
Confidence 78889999999999999999996 47777776543 349999999999999999999999999999999999999
Q ss_pred cCC---CCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChH
Q 014871 77 DNE---GNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEA 151 (417)
Q Consensus 77 ~~~---~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~ 151 (417)
+.+ ..+||+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||...+..
T Consensus 174 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 252 (327)
T 2yfx_A 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252 (327)
T ss_dssp SCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence 844 4599999999976533221 22234466889999999875 578999999999999999998 99999988887
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+.+..+....... ....++..+.+||++||..||++|||+.+|+++.|+
T Consensus 253 ~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 253 EVLEFVTSGGRMD-----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhcCCCCC-----------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 7776664321110 012356789999999999999999999999998766
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=267.76 Aligned_cols=199 Identities=22% Similarity=0.274 Sum_probs=147.0
Q ss_pred ccEeecccCceec----CeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCC
Q 014871 3 CTFLETTDGNKYR----GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--------QVLHRDI 69 (417)
Q Consensus 3 cniv~~~~~~~~~----~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~--------givHrDl 69 (417)
-||+++++.+... ..+|||||||++ +|.+++... .+++.++..++.||+.||+|||++ +|+||||
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Di 168 (337)
T 3mdy_A 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168 (337)
T ss_dssp TTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCC
T ss_pred CCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEeccc
Confidence 3778888877776 789999999986 777777544 599999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCCEEEeeccCcccccCCCCCc---ccccccccCCCCchhhcCCCCCCCc------cchhhHHHHHHHHHh
Q 014871 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLLGATKYGPA------VDMWSVGCIFAELLN 140 (417)
Q Consensus 70 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~------~DiwSlG~il~ellt 140 (417)
||+||||+.++.+||+|||+|+......... ....++|..|+|||++.+ ..+... +||||||||+|||++
T Consensus 169 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~t 247 (337)
T 3mdy_A 169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVAR 247 (337)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHh
Confidence 9999999999999999999997654332211 224578999999999976 344444 899999999999999
Q ss_pred C----------CCCCCCCC----hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHH
Q 014871 141 G----------KPILPGKN----EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELL 206 (417)
Q Consensus 141 G----------~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li 206 (417)
| ..||.... ....+..+......... .........++.++.+||
T Consensus 248 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~li 305 (337)
T 3mdy_A 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPS----------------------FPNRWSSDECLRQMGKLM 305 (337)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC----------------------CCGGGGGSHHHHHHHHHH
T ss_pred ccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcc----------------------ccccchhhHHHHHHHHHH
Confidence 9 55554321 12222222111100000 000001124677899999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 014871 207 EKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 207 ~~~L~~dP~~Rpta~elL~h 226 (417)
++||..||++|||+.+|+++
T Consensus 306 ~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 306 TECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHSCSSGGGSCCHHHHHHH
T ss_pred HHhhhhChhhCCCHHHHHHH
Confidence 99999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=265.35 Aligned_cols=198 Identities=21% Similarity=0.259 Sum_probs=146.9
Q ss_pred cEeecccCcee----cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCC
Q 014871 4 TFLETTDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH--------VNQVLHRDIK 70 (417)
Q Consensus 4 niv~~~~~~~~----~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH--------~~givHrDlk 70 (417)
||+++++.+.. ...+||||||+++ +|.+++.. ..+++.++..++.||+.||+||| +++|+|||||
T Consensus 63 niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk 140 (301)
T 3q4u_A 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140 (301)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCC
T ss_pred CeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCC
Confidence 66777765333 4568999999986 67776643 36999999999999999999999 9999999999
Q ss_pred CCcEEEcCCCCEEEeeccCcccccCCCCCc---ccccccccCCCCchhhcCCC-----CCCCccchhhHHHHHHHHHhC-
Q 014871 71 GSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNG- 141 (417)
Q Consensus 71 p~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~elltG- 141 (417)
|+||||+.++.+||+|||+|+......... ....++|..|+|||++.+.. .++.++|||||||++|||++|
T Consensus 141 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~ 220 (301)
T 3q4u_A 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220 (301)
T ss_dssp GGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhh
Confidence 999999999999999999997654332211 23347899999999997632 234689999999999999999
Q ss_pred ---------CCCCCCCC----hHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHH
Q 014871 142 ---------KPILPGKN----EAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEK 208 (417)
Q Consensus 142 ---------~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~ 208 (417)
+.||.... ....+..+.......... ........++..+.+||++
T Consensus 221 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~ 278 (301)
T 3q4u_A 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI----------------------PNRWFSDPTLTSLAKLMKE 278 (301)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC----------------------CGGGGGSHHHHHHHHHHHH
T ss_pred cCccccccccccccccCCCCcchhhhhHHHhccCCCCCC----------------------ChhhccCccHHHHHHHHHH
Confidence 77875432 222333322111110000 0011123466789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 014871 209 MLMLDPSQRISAKDALD 225 (417)
Q Consensus 209 ~L~~dP~~Rpta~elL~ 225 (417)
||..||++|||+.+|++
T Consensus 279 cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 279 CWYQNPSARLTALRIKK 295 (301)
T ss_dssp HCCSSGGGSCCHHHHHH
T ss_pred HhhcChhhCCCHHHHHH
Confidence 99999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=284.85 Aligned_cols=191 Identities=23% Similarity=0.346 Sum_probs=151.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++++.+.. +.+|||||||.+ +|.+++... +..+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 240 ~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~ 318 (452)
T 1fmk_A 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 318 (452)
T ss_dssp TBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC
Confidence 67888877665 789999999985 777776542 345999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............++..|+|||++.. ..++.++|||||||+||||++ |+.||.+.+..+.+..+...
T Consensus 319 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 397 (452)
T 1fmk_A 319 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397 (452)
T ss_dssp EEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred EEECCCccceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998765332222333455788999999875 578999999999999999999 99999999888877776442
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+. ...++..+.+||.+||..||++|||+.+|++
T Consensus 398 ~~~~~-----------------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 398 YRMPC-----------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-----------------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11110 1235678999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=269.99 Aligned_cols=203 Identities=20% Similarity=0.343 Sum_probs=150.8
Q ss_pred ccEeecccCceec--CeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNKYR--GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~~~--~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.||+++++.+... ..+||||||+++ +|.+++.+....+++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 83 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~ 162 (302)
T 4e5w_A 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE 162 (302)
T ss_dssp TTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC
Confidence 4778888888776 678999999975 7877776655679999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
+.+||+|||+++....... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|+.... ......
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~ 239 (302)
T 4e5w_A 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM--ALFLKM 239 (302)
T ss_dssp TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHHHHH
T ss_pred CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh--hHHhhc
Confidence 9999999999987654332 22334566888999999976 568899999999999999999988753221 111111
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhH-----HHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV-----REVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
........ ........+ ......++..+.+||++||..||++|||+.++++
T Consensus 240 ---~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 240 ---IGPTHGQM--------------TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp ---HCSCCGGG--------------HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ---cCCccccc--------------CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000000 000000000 0012346789999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=278.20 Aligned_cols=188 Identities=17% Similarity=0.235 Sum_probs=148.2
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADR----PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~----~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
.||+++++.+...+..|||||||+ ++|.+++.. ....|++.+++.|+.||+.||+|||+++|+||||||+||||+
T Consensus 127 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp GGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred hhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 578899999999999999999998 577777653 345699999999999999999999999999999999999999
Q ss_pred C-----------CCCEEEeeccCcccccCC-CCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 014871 78 N-----------EGNLKLADFGLARSFSYD-HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPIL 145 (417)
Q Consensus 78 ~-----------~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf 145 (417)
. ++.+||+|||+|+.+... ........++|..|+|||++.+ ..++.++||||||||||||++|+.||
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcc
Confidence 8 889999999999765422 2334455678999999999987 56899999999999999999999998
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....... +.... .+. .. ..++.+.+||.+||..+|.+|++..+.|.
T Consensus 286 ~~~~~~~----------------~~~~~------~~~----------~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 286 VKNEGGE----------------CKPEG------LFR----------RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp EEEETTE----------------EEECS------CCT----------TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ccCCCCc----------------eeech------hcc----------cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 5432200 00000 000 00 13557789999999999999965544443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=267.33 Aligned_cols=192 Identities=16% Similarity=0.210 Sum_probs=147.9
Q ss_pred cEeecccCceecC-----eEEEEEcCCCC-CHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 4 TFLETTDGNKYRG-----STYMVFEYMDH-DLTGLAD-----RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 4 niv~~~~~~~~~~-----~~yiV~Ey~~g-~l~~~~~-----~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
||+++++.+...+ ..|+||||+.+ +|..++. .....+++.++..++.||+.||+|||+++|+||||||+
T Consensus 97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~ 176 (313)
T 3brb_A 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176 (313)
T ss_dssp TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGG
T ss_pred CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcc
Confidence 6778887776654 35999999985 6666653 23356999999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCh
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNE 150 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~ 150 (417)
||||+.++.+||+|||+++....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+.
T Consensus 177 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp GEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 99999999999999999976543221 12223455788999999986 678999999999999999999 8999998888
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+....+....... ....++..+.+||.+||..||++|||+.+|++
T Consensus 256 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 256 HEMYDYLLHGHRLK-----------------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp GGHHHHHHTTCCCC-----------------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCC-----------------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77776664421110 11235678999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=267.13 Aligned_cols=192 Identities=20% Similarity=0.289 Sum_probs=155.3
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.+... ..|+||||+. ++|.+.+......+++.++..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 82 ~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~ 160 (291)
T 1u46_A 82 NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV 160 (291)
T ss_dssp TBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred CcccEEEEEccC-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCE
Confidence 678888877765 4899999998 57887776655569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||++......... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+..
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence 99999999876533221 1223455778999999875 567899999999999999999 9999999988887776644
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...... ....++..+.+||++||..||++|||+.++++
T Consensus 240 ~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 240 EGERLP----------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp SCCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCC----------------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 211110 01236678999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=291.51 Aligned_cols=192 Identities=17% Similarity=0.210 Sum_probs=154.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+.. +.+|||||||.+ +|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 396 pniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~ 474 (613)
T 2ozo_A 396 PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY 474 (613)
T ss_dssp TTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE
T ss_pred CCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc
Confidence 378888888765 679999999986 677777666667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++........ ......+|..|+|||++.. ..++.++||||||||||||++ |+.||.+.+..+++..+.
T Consensus 475 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 553 (613)
T 2ozo_A 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553 (613)
T ss_dssp EEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 999999999876432221 1122234688999999975 578999999999999999998 999999988888777765
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...... ....++.++.+||.+||..||++|||+.+|++
T Consensus 554 ~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 554 QGKRME-----------------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TTCCCC-----------------------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred cCCCCC-----------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 421110 11236778999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=294.95 Aligned_cols=191 Identities=19% Similarity=0.240 Sum_probs=153.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.++ .+.+|||||||.+ +|.+++.. ...+++.++..|+.||+.||+|||+++||||||||+||||+.++.
T Consensus 430 pnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~ 507 (635)
T 4fl3_A 430 PYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY 507 (635)
T ss_dssp TTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE
T ss_pred CCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC
Confidence 37888888776 4578999999986 56666544 456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+|+.+..... .......+|..|+|||++.. ..++.++||||||||||||++ |+.||.+.+..++...+.
T Consensus 508 ~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 508 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp EEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred EEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999987653322 12223345788999999975 578999999999999999998 999999999888777765
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...... ....++.++.+||++||..||++|||+.+|++
T Consensus 587 ~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 587 KGERMG-----------------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 422110 11236678999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-33 Score=291.53 Aligned_cols=195 Identities=23% Similarity=0.369 Sum_probs=157.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++++.+.. +.+|||||||.+ +|.+++... +..+++.++..|+.||+.||+|||+++|+||||||+||||+.++.
T Consensus 323 niv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~ 401 (535)
T 2h8h_A 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 401 (535)
T ss_dssp TBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc
Confidence 67888877665 789999999986 777777542 345999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............++..|+|||++.. ..++.++||||||||||||++ |+.||.+....+++..+...
T Consensus 402 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~ 480 (535)
T 2h8h_A 402 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480 (535)
T ss_dssp EEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT
T ss_pred EEEcccccceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998654221112223345788999999875 578999999999999999999 99999999888887776542
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC--CCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS--EYF 229 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h--~~f 229 (417)
...+ ....++..+.+||++||..||++|||+.+|++. .+|
T Consensus 481 ~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 481 YRMP-----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCC-----------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111 012356789999999999999999999999863 444
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=280.99 Aligned_cols=189 Identities=18% Similarity=0.287 Sum_probs=153.5
Q ss_pred ccEeecccCceecC-eEEEEEcCCCC-CHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNKYRG-STYMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~~~~-~~yiV~Ey~~g-~l~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.|||++++.+.... .+|||||||.+ +|.+++.+.+. .+++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 246 ~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~ 325 (450)
T 1k9a_A 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 325 (450)
T ss_dssp TTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC
Confidence 47888888765554 79999999985 78777765443 37999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+.+||+|||+++..... .....++..|+|||++.. ..++.++|||||||+||||++ |+.||...+..+.+..+.
T Consensus 326 ~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~ 400 (450)
T 1k9a_A 326 NVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400 (450)
T ss_dssp SCEEECCCTTCEECC----------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH
T ss_pred CCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999999864322 122356889999999986 578999999999999999998 999999887777766664
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...... ....++..+.+||++||..||++|||+.+|++
T Consensus 401 ~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 401 KGYKMD-----------------------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCC-----------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 321110 11236778999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-33 Score=269.55 Aligned_cols=205 Identities=22% Similarity=0.299 Sum_probs=155.4
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADR--PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~--~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
||+++++.+...+.+||||||+. ++|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+||||+.++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF 170 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC
Confidence 68888999999999999999997 577776653 234599999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||+++........ ......+|..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.+
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH
Confidence 9999999999865432222 2233567999999998865 478999999999999999999999987655443333322
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
........... + ............+..+.+||.+||..||++|||+.+|++
T Consensus 249 ~~~~~~~~~~~----------~-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 249 EIEDEEKTIED----------Y-----IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp HHHTTSCCHHH----------H-----SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred Hhhhhhhhhhh----------h-----ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11110000000 0 000001112345678999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-33 Score=262.63 Aligned_cols=180 Identities=26% Similarity=0.441 Sum_probs=144.8
Q ss_pred cCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 15 RGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 15 ~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
...+||||||+++ +|.+++... ...+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||++..
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 171 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhee
Confidence 5568999999996 777776543 34699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCCC
Q 014871 93 FSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGV 172 (417)
Q Consensus 93 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 172 (417)
..... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..+|... ......+...
T Consensus 172 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~------------ 234 (284)
T 2a19_B 172 LKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG------------ 234 (284)
T ss_dssp SSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT------------
T ss_pred ccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc------------
Confidence 65332 2334568999999999986 57899999999999999999998776421 1111111110
Q ss_pred CCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 173 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+...++..+++||++||..||++|||+.|++++.+.+.
T Consensus 235 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 --------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011235678999999999999999999999999877643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-33 Score=271.28 Aligned_cols=197 Identities=21% Similarity=0.302 Sum_probs=150.1
Q ss_pred ccEeecccCce--ecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNK--YRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~--~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
-||+++++.+. .++.+||||||++ ++|.+++......+++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 84 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~ 163 (327)
T 3lxl_A 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE 163 (327)
T ss_dssp TTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC
Confidence 36777776654 5567999999996 57777776545569999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH--
Q 014871 80 GNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS-- 155 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~-- 155 (417)
+.+||+|||+++........ ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 164 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~ 242 (327)
T 3lxl_A 164 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242 (327)
T ss_dssp TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC
T ss_pred CCEEEcccccceecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc
Confidence 99999999999876433221 2233456888999999876 568999999999999999999999986543321110
Q ss_pred ---------HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 156 ---------KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 156 ---------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+..... ........++..+.+||++||..||++|||+.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 243 CERDVPALSRLLELLEEG-------------------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp ----CCHHHHHHHHHHTT-------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccccHHHHHHHhhcc-------------------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000000 000112346789999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=262.37 Aligned_cols=193 Identities=25% Similarity=0.355 Sum_probs=143.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
-||+++++.+...+.+||||||+++ +|.+++.. ....+++.++..++.||+.||+|||+++|+||||||+||||+.
T Consensus 92 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~ 171 (310)
T 2wqm_A 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA 171 (310)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred CCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcC
Confidence 3788999999999999999999986 66666543 3456999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN--EAEQLSK 156 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~--~~~~~~~ 156 (417)
++.+||+|||+++...... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.. .......
T Consensus 172 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 249 (310)
T 2wqm_A 172 TGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249 (310)
T ss_dssp TSCEEECCC-------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH
T ss_pred CCCEEEEeccceeeecCCC-ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH
Confidence 9999999999997654322 22334567999999999876 578999999999999999999999997643 2233333
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+... ..+.. ....++.++.+||++||..||++|||+.+|++
T Consensus 250 ~~~~-~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 250 IEQC-DYPPL---------------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHTT-CSCCC---------------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcc-cCCCC---------------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3221 10000 01236678999999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-33 Score=262.62 Aligned_cols=189 Identities=20% Similarity=0.317 Sum_probs=146.1
Q ss_pred ccEeecccCc-eecCeEEEEEcCCCC-CHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGN-KYRGSTYMVFEYMDH-DLTGLADRPGL-RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~-~~~~~~yiV~Ey~~g-~l~~~~~~~~~-~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.||+++++.+ ..++.+||||||+++ +|.+++.+... .+++.++..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 74 ~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 153 (278)
T 1byg_A 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 153 (278)
T ss_dssp TTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC
Confidence 3677777764 444578999999986 77777764332 28999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.
T Consensus 154 ~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 228 (278)
T 1byg_A 154 NVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228 (278)
T ss_dssp SCEEECCCCC----------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred CcEEEeecccccccccc----ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 99999999999765422 123356888999999875 578999999999999999998 999998887766665553
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..... .....++..+.+||++||..||++|||+.++++
T Consensus 229 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 229 KGYKM-----------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCC-----------------------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 21100 011236678999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-33 Score=273.87 Aligned_cols=178 Identities=16% Similarity=0.127 Sum_probs=138.7
Q ss_pred cCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCC------------
Q 014871 15 RGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEG------------ 80 (417)
Q Consensus 15 ~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH-~~givHrDlkp~NILl~~~~------------ 80 (417)
.+.+|||||||.++ +++.+.+ ..+++.+++.|+.||+.||+||| +++|+||||||+||||+.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~ 211 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEE
T ss_pred cCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCcc
Confidence 78999999999764 6666654 45899999999999999999999 99999999999999999887
Q ss_pred --------CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHH-HHHHHhCCCCCCCCCh-
Q 014871 81 --------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI-FAELLNGKPILPGKNE- 150 (417)
Q Consensus 81 --------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i-l~elltG~~pf~~~~~- 150 (417)
.+||+|||+|+.... ...++|+.|+|||++.+. . +.++|||||+++ ++++++|..||.....
T Consensus 212 ~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~ 283 (336)
T 2vuw_A 212 STIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL 283 (336)
T ss_dssp EEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH
T ss_pred ccccCCCceEEEeeccccEecCC------CcEEEeecccChhhhcCC-C-ccceehhhhhCCCCcccccccCCCcchhhh
Confidence 899999999987642 234789999999999863 3 889999998777 7788899988853221
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh-cCCCC
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL-DSEYF 229 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL-~h~~f 229 (417)
......+........ ......+..++.++++||++||..| |+.|+| +||||
T Consensus 284 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f 335 (336)
T 2vuw_A 284 HYLTDKMLKQMTFKT-----------------------KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLF 335 (336)
T ss_dssp HHHHHHHHHTCCCSS-----------------------CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGG
T ss_pred hHHHHhhhhhhccCc-----------------------ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCc
Confidence 112223322111000 0011234568899999999999987 999999 99999
Q ss_pred C
Q 014871 230 W 230 (417)
Q Consensus 230 ~ 230 (417)
+
T Consensus 336 ~ 336 (336)
T 2vuw_A 336 K 336 (336)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=268.69 Aligned_cols=199 Identities=25% Similarity=0.340 Sum_probs=140.2
Q ss_pred cEeeccc-----CceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecC
Q 014871 4 TFLETTD-----GNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN---------QVLHRD 68 (417)
Q Consensus 4 niv~~~~-----~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~---------givHrD 68 (417)
||+++++ .+.....+|||||||++ +|.+++... .+++.++..++.||+.||+|||++ +|+|||
T Consensus 68 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~D 145 (336)
T 3g2f_A 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRD 145 (336)
T ss_dssp TBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSS
T ss_pred chhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecc
Confidence 5566654 33334467999999975 777777654 369999999999999999999999 999999
Q ss_pred CCCCcEEEcCCCCEEEeeccCcccccCCC-------CCcccccccccCCCCchhhcCC------CCCCCccchhhHHHHH
Q 014871 69 IKGSNLLIDNEGNLKLADFGLARSFSYDH-------NNTLTNRVITLWYRPPELLLGA------TKYGPAVDMWSVGCIF 135 (417)
Q Consensus 69 lkp~NILl~~~~~vkL~DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il 135 (417)
|||+||||+.++.+||+|||+++.+.... .......++|..|+|||++.+. ..++.++||||||||+
T Consensus 146 ikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il 225 (336)
T 3g2f_A 146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225 (336)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHH
Confidence 99999999999999999999998764321 1222345789999999998752 2355789999999999
Q ss_pred HHHHhCCCCC-CCCChHH----------------HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhh
Q 014871 136 AELLNGKPIL-PGKNEAE----------------QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 198 (417)
Q Consensus 136 ~elltG~~pf-~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (417)
|||++|..|| .+....+ .+..+....... + .++. .+ .....+
T Consensus 226 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~--~~-----------~~~~~~ 284 (336)
T 3g2f_A 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR-----P---KFPE--AW-----------KENSLA 284 (336)
T ss_dssp HHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC-----C---CCCT--TC-----------CCCSHH
T ss_pred HHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccC-----C---CCCc--cc-----------ccccch
Confidence 9999996554 3322111 111111000000 0 0000 00 001235
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 199 DRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 199 ~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+.++.+||++||..||++|||+.||++
T Consensus 285 ~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 285 VRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 668999999999999999999999964
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-33 Score=282.12 Aligned_cols=215 Identities=21% Similarity=0.324 Sum_probs=154.1
Q ss_pred ccEeecccCceecC--eEEEEEcCCCC-CHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-
Q 014871 3 CTFLETTDGNKYRG--STYMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI- 76 (417)
Q Consensus 3 cniv~~~~~~~~~~--~~yiV~Ey~~g-~l~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl- 76 (417)
-||+++++.+...+ +.|||||||++ +|.+++.+.. ..+++.+++.++.||+.||+|||+++|+||||||+||||
T Consensus 67 pnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 146 (396)
T 4eut_A 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146 (396)
T ss_dssp TTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred CCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEe
Confidence 37888888877655 78999999985 6766665432 239999999999999999999999999999999999999
Q ss_pred ---cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCC-------CCCCCccchhhHHHHHHHHHhCCCCCC
Q 014871 77 ---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA-------TKYGPAVDMWSVGCIFAELLNGKPILP 146 (417)
Q Consensus 77 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~elltG~~pf~ 146 (417)
+.++.+||+|||+++..... ......++|..|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus 147 ~~~~~~~~~kL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 147 IGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp ECTTSCEEEEECCGGGCEECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred ecCCCceeEEEecCCCceEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 77777999999999875432 233456789999999998631 346789999999999999999999996
Q ss_pred CC----ChHHHHHHHHHhcCCCCCCCCCCCCCCCc-cccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHH
Q 014871 147 GK----NEAEQLSKIFELCGSPDETIWPGVSKMPA-YNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK 221 (417)
Q Consensus 147 ~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~ 221 (417)
.. ...+.+.++.. +.+ ...+........ ...+... . .....+...++..+.+||++||..||++|+|+.
T Consensus 225 ~~~~~~~~~~~~~~~~~--~~p-~~~~~~~~~~~~~~~~~~~~--~-~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (396)
T 4eut_A 225 PFEGPRRNKEVMYKIIT--GKP-SGAISGVQKAENGPIDWSGD--M-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (396)
T ss_dssp CTTCTTTCHHHHHHHHH--SCC-TTCCEEEECSTTCCEEEESS--C-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred CCCcccchHHHHHHHhc--CCC-cccchhheeccCCCcccCcc--C-CcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence 42 33344444433 122 222211111000 0000000 0 001122345778899999999999999999999
Q ss_pred HHhc
Q 014871 222 DALD 225 (417)
Q Consensus 222 elL~ 225 (417)
++++
T Consensus 299 e~l~ 302 (396)
T 4eut_A 299 QFFA 302 (396)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8854
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=261.16 Aligned_cols=186 Identities=23% Similarity=0.379 Sum_probs=141.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGL--RFTVPQIKCYMKQLLTGLHYCHV---NQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~--~l~~~~i~~i~~Qil~gL~~LH~---~givHrDlkp~NILl~ 77 (417)
||+++++.+. +..||||||+++ +|.+++..... .+++.++..++.||+.||+|||+ ++|+||||||+||||+
T Consensus 62 ~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~ 139 (307)
T 2eva_A 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 139 (307)
T ss_dssp TBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE
T ss_pred CcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe
Confidence 6778877666 458999999975 77777665432 48899999999999999999999 8999999999999999
Q ss_pred CCCC-EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH--HH
Q 014871 78 NEGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE--QL 154 (417)
Q Consensus 78 ~~~~-vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~~ 154 (417)
.++. +||+|||++..... ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 140 ~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 214 (307)
T 2eva_A 140 AGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214 (307)
T ss_dssp TTTTEEEECCCCC----------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH
T ss_pred CCCCEEEEccccccccccc----ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH
Confidence 8886 79999999976542 2233468999999999976 578999999999999999999999997643322 22
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
..+.. .... .....++..+.+||.+||..||++|||+.++++
T Consensus 215 ~~~~~--~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 215 WAVHN--GTRP---------------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHT--TCCC---------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhc--CCCC---------------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22211 0000 012246678999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=265.58 Aligned_cols=195 Identities=22% Similarity=0.316 Sum_probs=149.3
Q ss_pred ccEeecccCceec--CeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGNKYR--GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~~~~--~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
.||+++++++... ..+||||||+++ +|.+++.+. .+++.++..++.||+.||+|||+++|+||||||+||||+.+
T Consensus 93 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~ 170 (318)
T 3lxp_A 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170 (318)
T ss_dssp TTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred cchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC
Confidence 4788888888874 678999999985 676666544 49999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH----
Q 014871 80 GNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ---- 153 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~---- 153 (417)
+.+||+|||+++....... .......+|..|+|||++.+ ..++.++||||||||+|+|++|+.||........
T Consensus 171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~ 249 (318)
T 3lxp_A 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249 (318)
T ss_dssp CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred CCEEECCccccccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc
Confidence 9999999999987653322 12233456888999999976 5688999999999999999999999865332110
Q ss_pred -------HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 154 -------LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 154 -------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+.+...... .......++.++.+||++||..||++|||+.+|++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 250 IAQGQMTVLRLTELLERGE-------------------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp SCCHHHHHHHHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccchhHHHHHHHHhccc-------------------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001111000000 00011346788999999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=289.55 Aligned_cols=192 Identities=20% Similarity=0.323 Sum_probs=155.9
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+. ++.+||||||+. ++|.+++......+++..+..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 451 pnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~ 529 (656)
T 2j0j_A 451 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 529 (656)
T ss_dssp TTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE
T ss_pred CCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC
Confidence 37888888774 567899999998 5777777766667999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+++..............+|..|+|||++.. ..++.++||||||||+|||++ |..||.+.+..+.+..+...
T Consensus 530 vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~ 608 (656)
T 2j0j_A 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 608 (656)
T ss_dssp EEECCCCCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT
T ss_pred EEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998765433333334456789999999975 578999999999999999997 99999999888887777542
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
...+ ....++..+.+||.+||..||++|||+.+|++
T Consensus 609 ~~~~-----------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 609 ERLP-----------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-----------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2111 11235678999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=265.82 Aligned_cols=195 Identities=21% Similarity=0.297 Sum_probs=147.3
Q ss_pred ccEeecccCce----ecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 3 CTFLETTDGNK----YRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 3 cniv~~~~~~~----~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
-||+++++.+. ....+||||||+.+ +|.+++.+ .+..+++.++..++.||+.||+|||+++|+||||||+||
T Consensus 86 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NI 165 (317)
T 2buj_A 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNI 165 (317)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 36788887776 34578999999986 77766654 455799999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeeccCcccccCCCCC--------cccccccccCCCCchhhcCCC--CCCCccchhhHHHHHHHHHhCCCC
Q 014871 75 LIDNEGNLKLADFGLARSFSYDHNN--------TLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVGCIFAELLNGKPI 144 (417)
Q Consensus 75 Ll~~~~~vkL~DFGla~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~elltG~~p 144 (417)
||+.++.+||+|||++......... ......+|..|+|||++.... .++.++||||||||+|+|++|+.|
T Consensus 166 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 245 (317)
T 2buj_A 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245 (317)
T ss_dssp EECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred EEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999998764321111 012335689999999987532 268899999999999999999999
Q ss_pred CCCCCh--HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHH
Q 014871 145 LPGKNE--AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD 222 (417)
Q Consensus 145 f~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e 222 (417)
|..... ......+...... .....++..+.+||++||..||++|||+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 296 (317)
T 2buj_A 246 YDMVFQKGDSVALAVQNQLSI-----------------------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPL 296 (317)
T ss_dssp THHHHHTTSCHHHHHHCC--C-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhhhhcccchhhHHhhccCCC-----------------------------CccccCCHHHHHHHHHHhhcChhhCCCHHH
Confidence 953111 0111111110000 001236678999999999999999999999
Q ss_pred HhcC
Q 014871 223 ALDS 226 (417)
Q Consensus 223 lL~h 226 (417)
|+++
T Consensus 297 ll~~ 300 (317)
T 2buj_A 297 LLSQ 300 (317)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=288.60 Aligned_cols=218 Identities=20% Similarity=0.275 Sum_probs=155.4
Q ss_pred cEeecccCcee------cCeEEEEEcCCCC-CHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 014871 4 TFLETTDGNKY------RGSTYMVFEYMDH-DLTGLADRPG--LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74 (417)
Q Consensus 4 niv~~~~~~~~------~~~~yiV~Ey~~g-~l~~~~~~~~--~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NI 74 (417)
||+++++.+.. .+..|||||||++ +|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 73 nIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NI 152 (676)
T 3qa8_A 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152 (676)
T ss_dssp TBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTE
T ss_pred CCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 56666665544 7788999999965 7777776533 2599999999999999999999999999999999999
Q ss_pred EEcCCCC---EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 75 LIDNEGN---LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 75 Ll~~~~~---vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
||+.++. +||+|||+++..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 153 Ll~~~g~~~~vKL~DFG~a~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 153 VLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp EEECCSSSCEEEECSCCCCCBTTSC--CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred EeecCCCceeEEEcccccccccccc--cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence 9997765 999999999876432 23345678999999999876 67899999999999999999999999876544
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 152 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
..+..............+........+.... .....+...++..+.+||++||..||++|||+.++|+|+||.
T Consensus 230 ~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~l------p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 230 VQWHGKVREKSNEHIVVYDDLTGAVKFSSVL------PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp HHSSTTCC------CCSCCCCSSSCCCCSSS------CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred hhhhhhhhcccchhhhhhhhhcccccccccc------CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 3321111100000000011000000000000 001123345788999999999999999999999999999994
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=263.02 Aligned_cols=200 Identities=21% Similarity=0.257 Sum_probs=149.4
Q ss_pred ccEeecccCceecC----eEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCC
Q 014871 3 CTFLETTDGNKYRG----STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH--------VNQVLHRDI 69 (417)
Q Consensus 3 cniv~~~~~~~~~~----~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH--------~~givHrDl 69 (417)
-||+++++.+.... .+||||||+.+ +|.+++.+. .+++.++..++.||+.||+||| +++|+||||
T Consensus 96 ~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp TTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred CcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 36788888877776 89999999986 777777653 5999999999999999999999 899999999
Q ss_pred CCCcEEEcCCCCEEEeeccCcccccCCCCC---cccccccccCCCCchhhcCCCC-----CCCccchhhHHHHHHHHHhC
Q 014871 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGATK-----YGPAVDMWSVGCIFAELLNG 141 (417)
Q Consensus 70 kp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DiwSlG~il~elltG 141 (417)
||+||||+.++.+||+|||+++........ ......+|..|+|||++.+... ++.++||||||||+|||++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 999999999999999999999876543321 2234578999999999876322 22689999999999999999
Q ss_pred ----------CCCCCCCCh----HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHH
Q 014871 142 ----------KPILPGKNE----AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLE 207 (417)
Q Consensus 142 ----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~ 207 (417)
..||..... .+.+........ .... .+ .. .....+...+.+||+
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~-------~~------------~~--~~~~~~~~~l~~li~ 311 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK-LRPN-------IP------------NR--WQSCEALRVMAKIMR 311 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-CCCC-------CC------------GG--GGTSHHHHHHHHHHH
T ss_pred cCcCCcccccccCccccCcCcccHHHHHHHHHHHH-hCCC-------Cc------------cc--ccchhHHHHHHHHHH
Confidence 677765421 222222211000 0000 00 00 011235668999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q 014871 208 KMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 208 ~~L~~dP~~Rpta~elL~h 226 (417)
+||..||++|||+.+|+++
T Consensus 312 ~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 312 ECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHCCSSGGGSCCHHHHHHH
T ss_pred HHhccChhhCCCHHHHHHH
Confidence 9999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=262.48 Aligned_cols=203 Identities=18% Similarity=0.278 Sum_probs=147.6
Q ss_pred cEeecccCceec--CeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
||+++++.+... ..+||||||+++ +|.+++.+....+++.++..++.||+.||+|||+++|+||||||+||||+.++
T Consensus 103 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 182 (326)
T 2w1i_A 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182 (326)
T ss_dssp TBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT
T ss_pred CeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC
Confidence 677777665544 378999999975 88888877666799999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+++........ ......++..|+|||++.+ ..++.++||||||||+|||++|..+|..... ...
T Consensus 183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~--- 256 (326)
T 2w1i_A 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFM--- 256 (326)
T ss_dssp EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHH---
T ss_pred cEEEecCcchhhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHH---
Confidence 9999999999876533221 1223345778999999876 5688999999999999999999988753211 100
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhH-----HHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV-----REVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+..+......+. ...+...+ ......++.++.+||++||..||++|||+.+|++
T Consensus 257 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 257 RMIGNDKQGQMI-------------VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHCTTCCTHHH-------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Hhhccccchhhh-------------HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000000000 00000000 0012346788999999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-31 Score=280.76 Aligned_cols=181 Identities=20% Similarity=0.303 Sum_probs=143.7
Q ss_pred ccEeecccCceecCe-----EEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNKYRGS-----TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~-----~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
-|||++++.+...+. .|||||||++..+..+... .+++.+++.|+.||+.+|+|||++|||||||||+||||+
T Consensus 139 p~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~ 216 (681)
T 2pzi_A 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216 (681)
T ss_dssp TTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe
Confidence 378899998888776 7999999987444433332 699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.+ .+||+|||+++..... ...++|+.|+|||++.+ .++.++||||||||||+|++|..+|.+....
T Consensus 217 ~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------ 282 (681)
T 2pzi_A 217 EE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD------ 282 (681)
T ss_dssp SS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS------
T ss_pred CC-cEEEEecccchhcccC-----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc------
Confidence 86 8999999999875432 34578999999999875 3488999999999999999998887542100
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
.++ . . ......+..+.+||.+||..||++|++..+++.|.|+
T Consensus 283 ----------------~~~-------~---~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 283 ----------------GLP-------E---D----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ----------------SCC-------T---T----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----------------ccc-------c---c----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 000 0 0 0111245688999999999999999998888887765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=243.25 Aligned_cols=167 Identities=18% Similarity=0.125 Sum_probs=131.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++.++.+||||||+++ +|.+++. .+ ....++..++.||+.||+|||++||+||||||+||||+.++.
T Consensus 91 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~ 167 (286)
T 3uqc_A 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD 167 (286)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT-TC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC
T ss_pred CCcceeeEEEEECCcEEEEEEecCCCCHHHHHh-cC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC
Confidence 3789999999999999999999985 6666653 32 567789999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||++++. ++ .++.++|||||||+||||++|+.||.+.+..+.+...
T Consensus 168 ~kl~~~~~---------------------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---- 214 (286)
T 3uqc_A 168 VVLAYPAT---------------------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---- 214 (286)
T ss_dssp EEECSCCC---------------------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----
T ss_pred EEEEeccc---------------------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----
Confidence 99986542 22 3688899999999999999999999876542211000
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+.... ............++.++.+||.+||..||++| |+.|+++
T Consensus 215 ----------------~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 215 ----------------ERDTA---GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ----------------CBCTT---SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ----------------HHHhc---cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00000 00112234455688899999999999999999 9999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-29 Score=264.13 Aligned_cols=133 Identities=18% Similarity=0.115 Sum_probs=97.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-||+++++.++.++.+|||||||+| +|.+++. .+..+++. .|++|||.||+|||++|||||||||+||||+.+++
T Consensus 302 ~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~ 377 (569)
T 4azs_A 302 FDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH 377 (569)
T ss_dssp CCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC
T ss_pred CCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC
Confidence 3789999999999999999999997 4555554 44567765 47899999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCC
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK 142 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~ 142 (417)
|||+|||+|+...... ....+.+||+.|||||++.+ .+..++|+||+|+++++|+++.
T Consensus 378 vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 378 ARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp EEECCCTTEESCC----CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred EEEeecccCeeCCCCC-ccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence 9999999998765332 34456789999999999975 4677899999999998887663
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=7.4e-20 Score=190.25 Aligned_cols=132 Identities=15% Similarity=0.175 Sum_probs=102.1
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.||++....+...++.|||||||+ ++|.+++.+ +..++.||+.+|+|||+++|+||||||+||||+. +
T Consensus 399 ~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~ 467 (540)
T 3en9_A 399 FGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D 467 (540)
T ss_dssp GTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S
T ss_pred CCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e
Confidence 356643433446677899999998 467666653 6689999999999999999999999999999999 9
Q ss_pred EEEeeccCcccccCCCCCc------ccccccccCCCCchhhcCC-CCCCCccchhhHHHHHHHHHhCCCCC
Q 014871 82 LKLADFGLARSFSYDHNNT------LTNRVITLWYRPPELLLGA-TKYGPAVDMWSVGCIFAELLNGKPIL 145 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~elltG~~pf 145 (417)
+||+|||+|+......... ....++|+.|||||++... ..|+..+|+|+..+-..+.+..+..+
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999999998765321111 2356789999999998641 24677889999988888877665444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.7e-16 Score=150.06 Aligned_cols=88 Identities=17% Similarity=0.185 Sum_probs=70.6
Q ss_pred eecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEE
Q 014871 6 LETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKL 84 (417)
Q Consensus 6 v~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL 84 (417)
+++.+.+.. +.+|||||||++ +|.+ +. ..++..++.||+.||+|||++||+||||||+||||+ ++.+||
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence 455555543 567999999987 5554 32 134567999999999999999999999999999999 899999
Q ss_pred eeccCcccccCCCCCcccccccccCCCCchhhc
Q 014871 85 ADFGLARSFSYDHNNTLTNRVITLWYRPPELLL 117 (417)
Q Consensus 85 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 117 (417)
+|||+|+. +..++|||++.
T Consensus 234 ~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE--------------TTSTTHHHHHH
T ss_pred EECCCCeE--------------CCCCCHHHHHH
Confidence 99999864 34578898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=2.5e-13 Score=127.61 Aligned_cols=71 Identities=13% Similarity=0.316 Sum_probs=58.9
Q ss_pred eEEEEEcCCCC------CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCCCEEEeeccC
Q 014871 17 STYMVFEYMDH------DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSNLLIDNEGNLKLADFGL 89 (417)
Q Consensus 17 ~~yiV~Ey~~g------~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH-~~givHrDlkp~NILl~~~~~vkL~DFGl 89 (417)
..||||||+++ .|.+.... +++.++..++.||+.+|.||| ++||+||||||+|||++. .++|+|||+
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~ 215 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQ 215 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTT
T ss_pred CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcc
Confidence 56899999952 34443321 345678899999999999999 999999999999999998 899999999
Q ss_pred cccc
Q 014871 90 ARSF 93 (417)
Q Consensus 90 a~~~ 93 (417)
|...
T Consensus 216 a~~~ 219 (258)
T 1zth_A 216 AVTL 219 (258)
T ss_dssp CEET
T ss_pred cccC
Confidence 9654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.08 E-value=7.7e-11 Score=116.65 Aligned_cols=70 Identities=19% Similarity=0.216 Sum_probs=56.4
Q ss_pred EEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----------CEEEeec
Q 014871 18 TYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG----------NLKLADF 87 (417)
Q Consensus 18 ~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~----------~vkL~DF 87 (417)
.||||||+++..+..+. ....+..++.||+.+|.+||++|||||||||.||||++++ .+.|+||
T Consensus 186 ~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~ 259 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXF 259 (397)
T ss_dssp TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCC
T ss_pred ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEe
Confidence 37999999975443222 2234677899999999999999999999999999998876 3899999
Q ss_pred cCcccc
Q 014871 88 GLARSF 93 (417)
Q Consensus 88 Gla~~~ 93 (417)
+-+...
T Consensus 260 ~Q~V~~ 265 (397)
T 4gyi_A 260 PQMVSM 265 (397)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=3e-08 Score=92.41 Aligned_cols=82 Identities=12% Similarity=0.090 Sum_probs=62.1
Q ss_pred EeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------
Q 014871 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV----------------------- 61 (417)
Q Consensus 5 iv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~----------------------- 61 (417)
+.++++..+..+..||||||++|..+.... .+......++.++..+|+.||+
T Consensus 72 vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred CCeEEEEEecCCceEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 345566667778899999999985444331 1223345788899999999998
Q ss_pred ------------------------------------CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 ------------------------------------NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ------------------------------------~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
..++|+|+++.|||++++..+.|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.46 E-value=1.2e-07 Score=92.73 Aligned_cols=75 Identities=13% Similarity=0.232 Sum_probs=60.5
Q ss_pred CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 014871 16 GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV---------------------------------- 61 (417)
Q Consensus 16 ~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~---------------------------------- 61 (417)
+..|+||||++|..+... .-..++..+...++.++...|+.||+
T Consensus 114 g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 568999999998543211 11247888999999999999999997
Q ss_pred ------------------------CCceecCCCCCcEEEcCCCC--EEEeeccCccc
Q 014871 62 ------------------------NQVLHRDIKGSNLLIDNEGN--LKLADFGLARS 92 (417)
Q Consensus 62 ------------------------~givHrDlkp~NILl~~~~~--vkL~DFGla~~ 92 (417)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997753 69999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.44 E-value=1.1e-07 Score=87.88 Aligned_cols=78 Identities=13% Similarity=0.100 Sum_probs=56.4
Q ss_pred eecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------
Q 014871 6 LETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ---------------------- 63 (417)
Q Consensus 6 v~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g---------------------- 63 (417)
.+++......+..|+||||++|..+. .. ... ...++.+|...|..||+..
T Consensus 78 P~~~~~~~~~~~~~~v~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (264)
T 1nd4_A 78 AAVLDVVTEAGRDWLLLGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRME 149 (264)
T ss_dssp CCEEEEEECSSCEEEEEECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHH
T ss_pred CeEEEeccCCCCCEEEEEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence 34555556667789999999985443 11 122 2356677777777777643
Q ss_pred ------------------------------------ceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 64 ------------------------------------VLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 64 ------------------------------------ivHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
++|+|+++.|||++++..++|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 150 AGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.33 E-value=1.6e-07 Score=89.69 Aligned_cols=121 Identities=19% Similarity=0.128 Sum_probs=78.9
Q ss_pred eEEEEEcCCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 014871 17 STYMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHV---------------------------------- 61 (417)
Q Consensus 17 ~~yiV~Ey~~g~l~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~---------------------------------- 61 (417)
..|+|||+++|..+. ... ..++..+...++.++...|+.||+
T Consensus 90 ~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp CSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred cceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 348999999984332 222 137888888899999998888886
Q ss_pred ------------------------CCceecCCCCCcEEEcC--CCCEEEeeccCcccccCCCCCcccccccccCC---CC
Q 014871 62 ------------------------NQVLHRDIKGSNLLIDN--EGNLKLADFGLARSFSYDHNNTLTNRVITLWY---RP 112 (417)
Q Consensus 62 ------------------------~givHrDlkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y---~a 112 (417)
..++|+|+++.|||++. ...+.|+||+.+...... ........+ ..
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-----~Dl~~~~~~~~~~~ 241 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-----NDFISLMEDDEEYG 241 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-----HHHHTTCCTTTSCC
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-----HHHHHHHhhccccC
Confidence 23799999999999998 456899999988653211 000001111 22
Q ss_pred chhh---cC-CC---------CCCCccchhhHHHHHHHHHhCCCCC
Q 014871 113 PELL---LG-AT---------KYGPAVDMWSVGCIFAELLNGKPIL 145 (417)
Q Consensus 113 PE~l---~~-~~---------~~~~~~DiwSlG~il~elltG~~pf 145 (417)
++.+ +. .. ......++|+++.+++.+.+|..+|
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2211 11 00 0112258999999999999997554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00013 Score=69.58 Aligned_cols=76 Identities=14% Similarity=0.192 Sum_probs=51.9
Q ss_pred cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------
Q 014871 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN-------------------------------- 62 (417)
Q Consensus 15 ~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~-------------------------------- 62 (417)
.+..|+||||++|..+....-. .++..+...++.+|...|+.||+.
T Consensus 85 ~g~~~~v~e~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~ 162 (306)
T 3tdw_A 85 DGNPFVGYRKVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP 162 (306)
T ss_dssp TSCEEEEEECCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred CCceEEEEeccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence 4567899999998543321111 245556666666666666666532
Q ss_pred ----------------------------CceecCCCCCcEEEcC---CCC-EEEeeccCccc
Q 014871 63 ----------------------------QVLHRDIKGSNLLIDN---EGN-LKLADFGLARS 92 (417)
Q Consensus 63 ----------------------------givHrDlkp~NILl~~---~~~-vkL~DFGla~~ 92 (417)
.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 455 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00011 Score=68.24 Aligned_cols=28 Identities=29% Similarity=0.347 Sum_probs=24.8
Q ss_pred ceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 64 VLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 64 ivHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
++|+|+++.|||++.++.+-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 7899999999999987767799998774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0011 Score=59.79 Aligned_cols=97 Identities=15% Similarity=0.020 Sum_probs=64.8
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCCccccccc
Q 014871 28 DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI 106 (417)
Q Consensus 28 ~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g 106 (417)
+|.+.+...+..|+|.+++.++.|.+..|.-+-. +.-..+=+.+..|+|..+|+|.+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 5777777777789999999999999999877632 1212334457899999999988875 1110 01
Q ss_pred ccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh
Q 014871 107 TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN 140 (417)
Q Consensus 107 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt 140 (417)
...+.+||.+. ...+.+.-|||||++||.-+-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 23456788653 345677889999999998874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00026 Score=68.52 Aligned_cols=31 Identities=16% Similarity=0.217 Sum_probs=25.9
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
..++|+|+++.|||++++..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4689999999999999644579999988743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0022 Score=61.17 Aligned_cols=30 Identities=17% Similarity=0.297 Sum_probs=26.8
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999877889999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0092 Score=56.19 Aligned_cols=28 Identities=21% Similarity=0.286 Sum_probs=23.9
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.++|+|+.+.||| ..++.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 4899999999999 555679999998774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0076 Score=59.78 Aligned_cols=32 Identities=9% Similarity=0.313 Sum_probs=27.9
Q ss_pred HHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 60 HVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 60 H~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
+...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356899999999999998876 99999998854
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.42 E-value=0.027 Score=53.42 Aligned_cols=28 Identities=29% Similarity=0.337 Sum_probs=24.5
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999999 4 89999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.40 E-value=0.016 Score=55.25 Aligned_cols=31 Identities=32% Similarity=0.397 Sum_probs=27.0
Q ss_pred CCceecCCCCCcEEEcCC----CCEEEeeccCccc
Q 014871 62 NQVLHRDIKGSNLLIDNE----GNLKLADFGLARS 92 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~----~~vkL~DFGla~~ 92 (417)
..++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999874 6799999998854
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.17 E-value=0.018 Score=54.54 Aligned_cols=30 Identities=27% Similarity=0.310 Sum_probs=25.6
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.+++|+|+++.|||++.+..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999987556899998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.81 E-value=0.057 Score=51.82 Aligned_cols=31 Identities=26% Similarity=0.415 Sum_probs=27.2
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999877899999987754
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
Probab=92.70 E-value=0.021 Score=56.59 Aligned_cols=6 Identities=33% Similarity=0.672 Sum_probs=2.7
Q ss_pred CCcEEE
Q 014871 71 GSNLLI 76 (417)
Q Consensus 71 p~NILl 76 (417)
+.|++|
T Consensus 68 ~~~~ll 73 (448)
T 2z73_A 68 PANMFI 73 (448)
T ss_dssp TTHHHH
T ss_pred ccchHH
Confidence 445444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.60 E-value=0.095 Score=50.63 Aligned_cols=28 Identities=29% Similarity=0.515 Sum_probs=23.9
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.++|+|+++.|||++++ .+.|+||..|.
T Consensus 213 ~l~HgDl~~~Nil~~~~-~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK-CLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC--CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCC-cEEEEEecCCC
Confidence 58999999999999865 49999998774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.26 E-value=0.086 Score=52.99 Aligned_cols=15 Identities=27% Similarity=0.383 Sum_probs=14.1
Q ss_pred CceecCCCCCcEEEc
Q 014871 63 QVLHRDIKGSNLLID 77 (417)
Q Consensus 63 givHrDlkp~NILl~ 77 (417)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=91.62 E-value=0.12 Score=50.35 Aligned_cols=30 Identities=17% Similarity=0.333 Sum_probs=25.6
Q ss_pred HCCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 61 VNQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 61 ~~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
...++|+|+++.|||++.+ .++|+||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 3579999999999999876 59999997763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.73 E-value=0.076 Score=52.81 Aligned_cols=29 Identities=31% Similarity=0.510 Sum_probs=23.7
Q ss_pred CceecCCCCCcEEEcCC----------------------------CCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNE----------------------------GNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~----------------------------~~vkL~DFGla~ 91 (417)
.++|+|+++.|||++.+ +.+.|+||..|.
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~ 306 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 306 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence 58999999999999875 578899998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=88.78 E-value=0.19 Score=49.18 Aligned_cols=29 Identities=34% Similarity=0.536 Sum_probs=25.7
Q ss_pred CceecCCCCCcEEEcCC----CCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNE----GNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~----~~vkL~DFGla~ 91 (417)
.++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 58999999999999876 689999998774
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.23 E-value=0.27 Score=48.26 Aligned_cols=28 Identities=29% Similarity=0.513 Sum_probs=23.9
Q ss_pred ceecCCCCCcEEE------cCCCCEEEeeccCcc
Q 014871 64 VLHRDIKGSNLLI------DNEGNLKLADFGLAR 91 (417)
Q Consensus 64 ivHrDlkp~NILl------~~~~~vkL~DFGla~ 91 (417)
++|+|+.+.|||+ +++..|+|+||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 345679999998874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.74 E-value=0.51 Score=46.80 Aligned_cols=28 Identities=25% Similarity=0.583 Sum_probs=24.9
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.++|+|+++.||| +.++.+.|+||..|.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 4899999999999 777889999998774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 417 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-71 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-66 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-57 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-56 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-56 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-53 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-53 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-47 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-46 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-18 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 1e-71
Identities = 111/233 (47%), Positives = 158/233 (67%), Gaps = 5/233 (2%)
Query: 12 NKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKG 71
N+ +GS Y+VF++ +HDL GL ++FT+ +IK M+ LL GL+Y H N++LHRD+K
Sbjct: 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 145
Query: 72 SNLLIDNEGNLKLADFGLARSFS---YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 128
+N+LI +G LKLADFGLAR+FS N TNRV+TLWYRPPELLLG YGP +D+
Sbjct: 146 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 205
Query: 129 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 188
W GCI AE+ PI+ G E QL+ I +LCGS +WP V Y + + K
Sbjct: 206 WGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 265
Query: 189 RRVREVFRHF--DRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 239
R+V++ + + D +AL+L++K+L+LDP+QRI + DAL+ ++FW+DP+P D K
Sbjct: 266 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK 318
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 8e-66
Identities = 97/234 (41%), Positives = 135/234 (57%), Gaps = 3/234 (1%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
D ++ + +VF++M+ DL + L T IK YM L GL Y H + +LHRD+
Sbjct: 67 DAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
K +NLL+D G LKLADFGLA+SF + T++V+T WYR PELL GA YG VDMW
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMW 185
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
+VGCI AELL P LPG ++ +QL++IFE G+P E WP + +P Y FK
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--GI 243
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 243
+ +F L+L++ + + +P RI+A AL +YF P P LP+
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-57
Identities = 103/229 (44%), Positives = 139/229 (60%), Gaps = 5/229 (2%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68
D Y+VFE++ DL D +P IK Y+ QLL GL +CH ++VLHRD
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDM 128
+K NLLI+ EG +KLADFGLAR+F T+ V+TLWYR PE+LLG Y AVD+
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 129 WSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMK 188
WS+GCIFAE++ + + PG +E +QL +IF G+PDE +WPGV+ MP Y P + +
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP-KWAR 245
Query: 189 RRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW--TDPLP 235
+ +V D LL +ML DP++RISAK AL +F T P+P
Sbjct: 246 QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-56
Identities = 91/269 (33%), Positives = 136/269 (50%), Gaps = 7/269 (2%)
Query: 9 TDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68
+ Y+V M DL L + I ++ Q+L GL Y H VLHRD
Sbjct: 77 APTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRD 134
Query: 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAV 126
+K SNLL++ +LK+ DFGLAR DH++ LT V T WYR PE++L + Y ++
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH-FKPSR 185
D+WSVGCI AE+L+ +PI PGK+ +QL+ I + GSP + + + A N+
Sbjct: 195 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254
Query: 186 TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD-PKSLPKY 244
K +F + D AL+LL+KML +P +RI + AL Y P D P + +
Sbjct: 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPF 314
Query: 245 ESSHEYQT-KKRRQQQRQHEEATKRQKLH 272
+ E K + ++ EE + Q +
Sbjct: 315 KFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 185 bits (469), Expect = 3e-56
Identities = 95/211 (45%), Positives = 135/211 (63%), Gaps = 2/211 (0%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+VFE++D DL L D K ++ QLL G+ YCH +VLHRD+K NLLI+
Sbjct: 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
EG LK+ADFGLAR+F T+ ++TLWYR P++L+G+ KY +D+WSVGCIFAE+
Sbjct: 136 EGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHF 198
+NG P+ PG +EA+QL +IF + G+P+ WP V+++P Y+ + +
Sbjct: 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD-PNFTVYEPLPWESFLKGL 253
Query: 199 DRHALELLEKMLMLDPSQRISAKDALDSEYF 229
D ++LL KML LDP+QRI+AK AL+ YF
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-53
Identities = 81/281 (28%), Positives = 126/281 (44%), Gaps = 16/281 (5%)
Query: 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHV 61
F ++ K +V +Y+ + +A R V +K YM QL L Y H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 62 NQVLHRDIKGSNLLIDNEGNL-KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT 120
+ HRDIK NLL+D + + KL DFG A+ + + + +YR PEL+ GAT
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGAT 198
Query: 121 KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 180
Y ++D+WS GC+ AELL G+PI PG + +QL +I ++ G+P ++ P Y
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN--PNYTE 256
Query: 181 FKPSRTMKRRVREVFR-HFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPK 239
FK + +VFR A+ L ++L P+ R++ +A +F D L
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRDPNV 314
Query: 240 SLPKYESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRL 280
LP + ++ AT PH R+
Sbjct: 315 KLPNGRDTPALFNFTTQELSSNPPLATILI-----PPHARI 350
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-53
Identities = 79/243 (32%), Positives = 130/243 (53%), Gaps = 7/243 (2%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
Y+V +M DL L + +I+ + Q+L GL Y H ++HRD+K NL ++
Sbjct: 99 YLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 156
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
+ LK+ DFGLAR ++ +T V+T WYR PE++L +Y VD+WSVGCI AE+
Sbjct: 157 DCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212
Query: 139 LNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR-VREVFRH 197
+ GK + G + +QL +I ++ G+P + A N+ K ++++ + +
Sbjct: 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 272
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQTKKRRQ 257
A+ LLEKML+LD QR++A +AL YF + D + KY+ S + + +
Sbjct: 273 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDE 332
Query: 258 QQR 260
+R
Sbjct: 333 WKR 335
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-52
Identities = 92/218 (42%), Positives = 126/218 (57%), Gaps = 5/218 (2%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+VFE+ D DL D +K ++ QLL GL +CH VLHRD+K NLLI+
Sbjct: 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAEL 138
G LKLA+FGLAR+F + V+TLWYRPP++L GA Y ++DMWS GCIFAEL
Sbjct: 137 NGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 139 LNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRH 197
N P+ PG + +QL +IF L G+P E WP ++K+P Y + P + V
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY-PMYPATTSLVNVVPK 254
Query: 198 FDRHALELLEKMLMLDPSQRISAKDALDSEYF--WTDP 233
+ +LL+ +L +P QRISA++AL YF + P
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (443), Expect = 1e-51
Identities = 56/282 (19%), Positives = 108/282 (38%), Gaps = 33/282 (11%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
M++E+M +L + + + YM+Q+ GL + H N +H D+K N
Sbjct: 95 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154
Query: 74 LLIDNE--GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
++ + LKL DFGL D ++ T + PE+ G G DMWSV
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSV 211
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G + LL+G G+N+ E L + + D++ + G+S+
Sbjct: 212 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE----------------- 254
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQ 251
+ + K+L+ DP+ R++ AL+ + P +P + +
Sbjct: 255 ---------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS-SRYTKIR 304
Query: 252 TKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQHAGQSHHWS 293
+ + E ++ + + P +++ + W
Sbjct: 305 DSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWD 346
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-51
Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 19/230 (8%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-VNQVLHRDIKGSN 73
G + E+MD + R + ++ GL Y ++++HRD+K SN
Sbjct: 76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
+L+++ G +KL DFG++ ++ + V T Y PE L G T Y D+WS+G
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGL 191
Query: 134 IFAELLNGKPILPGKNEAE-QLSKIFELCGSPDET----IWPGVSKMPAYNHFKPSRTMK 188
E+ G+ +P + E +L ++ G ET PG +P +
Sbjct: 192 SLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIF 251
Query: 189 RRVREVFRH---------FDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ + F + + K L+ +P++R K + +
Sbjct: 252 ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-51
Identities = 87/223 (39%), Positives = 121/223 (54%), Gaps = 7/223 (3%)
Query: 8 TTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66
T +VFE++D D T L P IK M QLL GL + H ++V+H
Sbjct: 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH 139
Query: 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
RD+K N+L+ + G +KLADFGLAR +S+ T + V+TLWYR PE+LL + Y V
Sbjct: 140 RDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVTLWYRAPEVLLQ-SSYATPV 196
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
D+WSVGCIFAE+ KP+ G ++ +QL KI ++ G P E WP +P S
Sbjct: 197 DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS-- 254
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ + + D +LL K L +P++RISA AL YF
Sbjct: 255 -AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-50
Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 14 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
Y+ EY P + P + + QL+ G+ Y H + HRDIK N
Sbjct: 74 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 133
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVG 132
LL+D NLK++DFGLA F Y++ L N++ TL Y PELL + VD+WS G
Sbjct: 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
+ +L G+ +++ Q + K+
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDW---------------------------KEKKTYL 226
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235
++ D L LL K+L+ +PS RI+ D ++ PL
Sbjct: 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPLK 268
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 9e-50
Identities = 87/273 (31%), Positives = 128/273 (46%), Gaps = 10/273 (3%)
Query: 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 64
+ Y+V M DL + + T ++ + Q+L GL Y H +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 65 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 124
+HRD+K SNL ++ + LK+ DFGLAR + T V T WYR PE++L Y
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQ 198
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFK-P 183
VD+WSVGCI AELL G+ + PG + +QL I L G+P + +S A N+ +
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 184 SRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 243
++ K VF + A++LLEKML+LD +RI+A AL YF P D
Sbjct: 259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 318
Query: 244 YESSHEYQTKKRRQQQRQHEEATKRQKLHHPQP 276
Y+ S E + + + + P P
Sbjct: 319 YDQSFESRDLLIDEWKSLTYDEVIS---FVPPP 348
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-48
Identities = 45/246 (18%), Positives = 89/246 (36%), Gaps = 32/246 (13%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
M+FE++ D+ + +I Y+ Q+ L + H + + H DI+ N
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 74 LLIDNEGN--LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
++ + +K+ +FG AR N L Y PE+ A DMWS+
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQH-DVVSTATDMWSL 189
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G + LL+G + + + I + DE + +S
Sbjct: 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI----------------- 232
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQ 251
A++ ++++L+ + R++A +AL + K + + Y
Sbjct: 233 ---------EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYH 283
Query: 252 TKKRRQ 257
T ++
Sbjct: 284 TLIKKD 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (411), Expect = 9e-48
Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 35/217 (16%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++VF+ M +L + + + M+ LL + H ++HRD+K N+L+D
Sbjct: 86 FLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD 144
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVG 132
++ N+KL DFG + D L T Y PE++ + YG VDMWS G
Sbjct: 145 DDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
I LL G P + + L I W S
Sbjct: 203 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD------------------ 244
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+L+ + L++ P +R +A++AL +F
Sbjct: 245 --------TVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-47
Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 36/234 (15%)
Query: 10 DGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRD 68
D Y + +++ E+ + + T QI+ KQ L L+Y H N+++HRD
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRD 135
Query: 69 IKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT----KYGP 124
+K N+L +G++KLADFG++ + + + T ++ PE+++ T Y
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 184
D+WS+G E+ +P N L KI + P S
Sbjct: 195 KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSRWSS---------- 243
Query: 185 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF---WTDPLP 235
+ + L+K L + R + L + P+
Sbjct: 244 ----------------NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (413), Expect = 3e-47
Identities = 48/260 (18%), Positives = 104/260 (40%), Gaps = 37/260 (14%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
+ ++ E++ +L + + ++ YM+Q GL + H + ++H DIK N
Sbjct: 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157
Query: 74 LLID--NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
++ + ++K+ DFGLA + + + T + PE++ G DMW++
Sbjct: 158 IMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAI 214
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G + LL+G G+++ E L + DE + VS
Sbjct: 215 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP----------------- 257
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEYQ 251
A + ++ +L +P +R++ DAL+ + D +L S Y
Sbjct: 258 ---------EAKDFIKNLLQKEPRKRLTVHDALEHPWL-----KGDHSNLTSRIPSSRYN 303
Query: 252 TKKRRQQQRQHEEATKRQKL 271
+++ +++ + + +
Sbjct: 304 KIRQKIKEKYADWPAPQPAI 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 6e-47
Identities = 53/256 (20%), Positives = 91/256 (35%), Gaps = 38/256 (14%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+ ++V EY + L + +I L GL Y H + ++HRD+K N+
Sbjct: 87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT--KYGPAVDMWSVG 132
L+ G +KL DFG A + V T ++ PE++L +Y VD+WS+G
Sbjct: 147 LLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
EL KP L N L I + S+
Sbjct: 202 ITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQSGHWSEY----------------- 242
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKY--ESSHEY 250
++ L P R +++ L + + P L + ++ E
Sbjct: 243 ---------FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVREL 293
Query: 251 QTKKRRQQQR-QHEEA 265
+ R+ ++ +EA
Sbjct: 294 DNLQYRKMKKILFQEA 309
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (407), Expect = 1e-46
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 14/222 (6%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+VFE++++ + T I+ YM ++L L YCH ++HRD+K N++ID+
Sbjct: 108 ALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 164
Query: 79 EGN-LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
E L+L D+GLA + RV + +++ PELL+ Y ++DMWS+GC+ A
Sbjct: 165 EHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
Query: 138 LLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR---- 192
++ K P G + +QL +I ++ G+ D + + F R R
Sbjct: 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282
Query: 193 ---EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231
E AL+ L+K+L D R++A++A++ YF+T
Sbjct: 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (402), Expect = 1e-46
Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 34/215 (15%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y++ EY + +F + Y+ +L L YCH +V+HRDIK NL
Sbjct: 78 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 137
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
L+ + G LK+ADFG + TL TL Y PPE++ G + VD+WS+G +
Sbjct: 138 LLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEG-RMHDEKVDLWSLGVL 193
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
E L GKP E +I + + +
Sbjct: 194 CYEFLVGKPPFEANTYQETYKRISRVEFTFPD---------------------------- 225
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
A +L+ ++L +PSQR ++ L+ +
Sbjct: 226 --FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 7e-46
Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 18/267 (6%)
Query: 5 FLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQV 64
+ Y+V E MD L + ++ + Q+L G+ + H +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 65 LHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 124
+HRD+K SN+++ ++ LK+ DFGLAR+ + +T V+T +YR PE++LG Y
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MGYKE 197
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG--------VSKMP 176
VD+WSVGCI E++ K + PG++ +Q +K+ E G+P V P
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257
Query: 177 AYNHFKPSRTMKRRV----REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232
Y + + E + A +LL KML++DP++RIS DAL Y
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317
Query: 233 PLPCDPKSLPKYESSHEYQTKKRRQQQ 259
P + ++ P + ++ ++
Sbjct: 318 YDPAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-45
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 15 RGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
++V EY+ L D QI ++ L L + H NQV+HRDIK N
Sbjct: 89 GDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
+L+ +G++KL DFG + + + + V T ++ PE++ YGP VD+WS+G
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGI 204
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
+ E++ G+P +N L I G+P+ +S
Sbjct: 205 MAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSA------------------- 244
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
+ L + L +D +R SAK+ L ++
Sbjct: 245 -------IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-44
Identities = 50/220 (22%), Positives = 87/220 (39%), Gaps = 32/220 (14%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
Y Y + R F + Y ++++ L Y H ++HRD+K N+
Sbjct: 80 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGC 133
L++ + ++++ DFG A+ S + N + T Y PELL + D+W++GC
Sbjct: 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGC 198
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
I +L+ G P NE KI +L E +P
Sbjct: 199 IIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----------------------- 235
Query: 194 VFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233
A +L+EK+L+LD ++R+ ++ P
Sbjct: 236 -------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-44
Identities = 52/219 (23%), Positives = 84/219 (38%), Gaps = 40/219 (18%)
Query: 19 YMVFEYMD----HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCH-----VNQVLHRDI 69
Y+V EY + + + + M QL L CH + VLHRD+
Sbjct: 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 140
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
K +N+ +D + N+KL DFGLAR + + V T +Y PE + Y D+W
Sbjct: 141 KPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIW 198
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
S+GC+ EL P ++ E KI +
Sbjct: 199 SLGCLLYELCALMPPFTAFSQKELAGKI-----------------------------REG 229
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEY 228
+ R + + E++ +ML L R S ++ L++
Sbjct: 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-43
Identities = 41/229 (17%), Positives = 88/229 (38%), Gaps = 35/229 (15%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+V ++ + L +F + ++ +Q G+ Y H ++HRD+K +N+ +
Sbjct: 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH 138
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVI-TLWYRPPELLLG--ATKYGPAVDMWSVGCI 134
+ +K+ DFGLA S + ++ ++ + PE++ Y D+++ G +
Sbjct: 139 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
EL+ G+ N +Q+ + + P +SK+ +
Sbjct: 199 LYELMTGQLPYSNINNRDQIIFMVG-----RGYLSPDLSKVRS----------------- 236
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPK 243
+ + L+ + L +R L S + +SLPK
Sbjct: 237 --NCPKAMKRLMAECLKKKRDERPLFPQILAS-------IELLARSLPK 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 1e-42
Identities = 56/258 (21%), Positives = 96/258 (37%), Gaps = 34/258 (13%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
G Y++ + + +L G +T + Q+L + Y H ++HRD+K N
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPEN 137
Query: 74 LLI---DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
LL D + + ++DFGL++ D + L+ T Y PE+L Y AVD WS
Sbjct: 138 LLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWS 194
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+G I LL G P +N+A+ +I + D W +S
Sbjct: 195 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD---------------- 238
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEY 250
A + + ++ DP +R + + AL + D E +
Sbjct: 239 ----------SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKN 288
Query: 251 QTKKRRQQQRQHEEATKR 268
K + +Q +
Sbjct: 289 FAKSKWKQAFNATAVVRH 306
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-41
Identities = 41/223 (18%), Positives = 78/223 (34%), Gaps = 35/223 (15%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN--QVLHR 67
K + +V E M + + ++ + +Q+L GL + H ++HR
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 138
Query: 68 DIKGSNLLIDNE-GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAV 126
D+K N+ I G++K+ D GLA + + T + PE+ KY +V
Sbjct: 139 DLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYEE--KYDESV 193
Query: 127 DMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRT 186
D+++ G E+ + A Q+ + G +
Sbjct: 194 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TSGVKPASFDKVAIP------------ 240
Query: 187 MKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229
E++E + + +R S KD L+ +F
Sbjct: 241 --------------EVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-41
Identities = 62/281 (22%), Positives = 104/281 (37%), Gaps = 36/281 (12%)
Query: 10 DGNKYRGSTYMVFEYMDH-DL-TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67
+ R +V E +D +L + + DR FT + MK + + Y H + HR
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 135
Query: 68 DIKGSNLLID---NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGP 124
D+K NLL LKL DFG A+ +N+LT T +Y PE+L KY
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPYYVAPEVLGP-EKYDK 192
Query: 125 AVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPS 184
+ DMWS+G I LL G P + + I G + P
Sbjct: 193 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-------IRMGQYEFP-------- 237
Query: 185 RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD-PLPCDPKSLPK 243
+ L+ +L +P+QR++ + ++ + +P P
Sbjct: 238 -------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP----- 285
Query: 244 YESSHEYQTKKRRQQQRQHEEATKRQKLHHPQPHGRLPPIQ 284
+S + K R + + E + + ++ I+
Sbjct: 286 LHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIE 326
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-40
Identities = 50/239 (20%), Positives = 94/239 (39%), Gaps = 38/239 (15%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+ ++ E + T + ++KQ+L G++Y H Q+ H D+K N+
Sbjct: 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144
Query: 75 LIDNEG----NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWS 130
++ + +K+ DFGLA D N N T + PE++ G DMWS
Sbjct: 145 MLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWS 201
Query: 131 VGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
+G I LL+G G + E L+ + + ++ + S +
Sbjct: 202 IGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL--------------- 246
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF----WTDPLPCDPKSLPKYE 245
A + + ++L+ DP +R++ +D+L + L S P++E
Sbjct: 247 -----------AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS-SAWSHPQFE 293
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 138 bits (349), Expect = 6e-38
Identities = 45/221 (20%), Positives = 86/221 (38%), Gaps = 35/221 (15%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+ + M+ F+ ++ Y +++ GL + H V++RD+K +N+
Sbjct: 79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
L+D G+++++D GLA FS V T Y PE+L Y + D +S+GC+
Sbjct: 139 LLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
+LL G ++ +I + + + S
Sbjct: 196 LFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP-------------------- 234
Query: 195 FRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFW 230
LLE +L D ++R+ A++ +S +F
Sbjct: 235 ------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-35
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+ + + V EY++ + +F + + Y +++ GL + H +++RD+K N+
Sbjct: 75 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 134
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
L+D +G++K+ADFG+ + + T Y PE+LLG KY +VD WS G +
Sbjct: 135 LLDKDGHIKIADFGMCKENM-LGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVL 192
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
E+L G+ G++E E I D +P
Sbjct: 193 LYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYP------------------------ 223
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDAL 224
R ++ A +LL K+ + +P +R+ + +
Sbjct: 224 -RWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-35
Identities = 49/230 (21%), Positives = 79/230 (34%), Gaps = 43/230 (18%)
Query: 15 RGSTYMVFEYMD--HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
S ++ E + DL G + + Q+L + +CH VLHRDIK
Sbjct: 81 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 139
Query: 73 NLLID-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
N+LID N G LKL DFG + T+ T Y PPE + +G + +WS+
Sbjct: 140 NILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196
Query: 132 GCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
G + +++ G E + F
Sbjct: 197 GILLYDMVCGDIPFEHDEEIIRGQVFFR-------------------------------- 224
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 241
+ L+ L L PS R + ++ + + LP + +
Sbjct: 225 ----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-35
Identities = 45/225 (20%), Positives = 78/225 (34%), Gaps = 35/225 (15%)
Query: 19 YMVFEYMDHDLTGLA--DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y+V EYM G +PQ+ Q+ +G+ Y +HRD++ +N+L+
Sbjct: 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 146
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
K+ADFGLAR + + + PE L ++ D+WS G +
Sbjct: 147 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLT 205
Query: 137 ELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
EL G+ PG E L ++ P +
Sbjct: 206 ELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPE--------------------- 241
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALD--SEYFWTDPLPCDP 238
+L+ + +P +R + + +YF + P
Sbjct: 242 -----SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 126 bits (317), Expect = 4e-34
Identities = 43/217 (19%), Positives = 75/217 (34%), Gaps = 29/217 (13%)
Query: 10 DGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDI 69
Y+V EY+D T + + L++ H N ++HRD+
Sbjct: 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDV 137
Query: 70 KGSNLLIDNEGNLKLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVD 127
K +N++I +K+ DFG+AR+ + N+ + T Y PE G D
Sbjct: 138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSD 196
Query: 128 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 187
++S+GC+ E+L G+P G + + P G+S
Sbjct: 197 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA------------- 243
Query: 188 KRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
++ K L +P R +
Sbjct: 244 -------------DLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-33
Identities = 45/221 (20%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+++ +Y++ RFT +++ Y+ +++ L + H +++RDIK N+
Sbjct: 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160
Query: 75 LIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
L+D+ G++ L DFGL++ F + + + P + G + + AVD WS+G
Sbjct: 161 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220
Query: 134 IFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVRE 193
+ ELL G E ++I + +S
Sbjct: 221 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA------------------- 261
Query: 194 VFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYF 229
A +L++++LM DP +R+ A + + +F
Sbjct: 262 -------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-33
Identities = 39/214 (18%), Positives = 73/214 (34%), Gaps = 37/214 (17%)
Query: 15 RGSTYMVFEYMDHD--LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+G Y+V EYM + L R + + + + Y N +HRD+
Sbjct: 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 132
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N+L+ + K++DFGL + S +T + + + PE L K+ D+WS G
Sbjct: 133 NVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFG 187
Query: 133 CIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
+ E+ G+ P + + ++ K
Sbjct: 188 ILLWEIYSFGRVPYPRIPLKDVVPRV-----------------------------EKGYK 218
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+ E+++ LD + R S +
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (315), Expect = 1e-33
Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 40/220 (18%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
+M+ +Y++ R RF P K Y ++ L Y H +++RD+K N+
Sbjct: 76 AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
L+D G++K+ DFG A+ + T Y PE++ Y ++D WS G +
Sbjct: 136 LLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGIL 190
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
E+L G N + KI + P ++
Sbjct: 191 IYEMLAGYTPFYDSNTMKTYEKILN----AELRFPPFFNE-------------------- 226
Query: 195 FRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYF 229
+LL +++ D SQR+ +D + +F
Sbjct: 227 ------DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (316), Expect = 2e-33
Identities = 57/252 (22%), Positives = 99/252 (39%), Gaps = 31/252 (12%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ-VLHRDIKGSNLLID 77
+ ++ L + + +K KQLL GL Y H ++H DIK N+L++
Sbjct: 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160
Query: 78 NEG------NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
+K+AD G A + + N++ R YR PE+LLGA +G D+WS
Sbjct: 161 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTR----EYRSPEVLLGA-PWGCGADIWST 215
Query: 132 GCIFAELLNGKPILPGK------NEAEQLSKIFELCGSPDETIWPGVSKMPAYNH----- 180
C+ EL+ G + + + +++I EL G + + +
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 181 -------FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDP 233
F P + + + + + L ML LDP +R A ++ + D
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL-KDT 334
Query: 234 LPCDPKSLPKYE 245
L + +P E
Sbjct: 335 LGMEEIRVPDRE 346
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 6e-33
Identities = 39/216 (18%), Positives = 80/216 (37%), Gaps = 35/216 (16%)
Query: 19 YMVFEYMDHDLTG--LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76
Y++ EYM++ L G++ T+ ++ Q+ G+ + +HRD++ +N+L+
Sbjct: 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV 142
Query: 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFA 136
+ + K+ADFGLAR + + + PE + + D+WS G +
Sbjct: 143 SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLT 201
Query: 137 ELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVF 195
E++ +G+ PG E + + Y +P
Sbjct: 202 EIVTHGRIPYPGMTNPEVIQNLER-----------------GYRMVRPD----------- 233
Query: 196 RHFDRHALELLEKMLMLDPSQRISAKDALD--SEYF 229
+ +L+ P R + ++F
Sbjct: 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 51/220 (23%), Positives = 84/220 (38%), Gaps = 37/220 (16%)
Query: 15 RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
V EY + FT + + Y ++++ L Y H V++RDIK NL
Sbjct: 77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134
++D +G++K+ DFGL + T+ T Y PE+L YG AVD W +G +
Sbjct: 137 MLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVV 194
Query: 135 FAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
E++ G+ ++ I + +S
Sbjct: 195 MYEMMCGRLPFYNQDHERLFELIL----MEEIRFPRTLSP-------------------- 230
Query: 195 FRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYF 229
A LL +L DP QR+ AK+ ++ +F
Sbjct: 231 ------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (307), Expect = 1e-32
Identities = 38/210 (18%), Positives = 64/210 (30%), Gaps = 34/210 (16%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
+V + + L L D G +F+V + KQ+L + H +++RDIK N LI
Sbjct: 77 VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 136
Query: 79 -----EGNLKLADFGLARSFSYD------HNNTLTNRVITLWYRPPELLLGATKYGPAVD 127
+ + DFG+ + + N T Y LG + D
Sbjct: 137 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDD 195
Query: 128 MWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTM 187
+ ++G +F L G G A K +
Sbjct: 196 LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK----------------------Q 233
Query: 188 KRRVREVFRHFDRHALELLEKMLMLDPSQR 217
+RE+ F + + L
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-32
Identities = 39/214 (18%), Positives = 68/214 (31%), Gaps = 33/214 (15%)
Query: 16 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
MV E L + F + + Y Q+ G+ Y + +HRD+ NL
Sbjct: 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142
Query: 75 LIDNEGNLKLADFGLARSFSYDHNNTL--TNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
L+ +K+ DFGL R+ + ++ + +R + + PE L + A D W G
Sbjct: 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFG 201
Query: 133 CIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRV 191
E+ G+ G N ++ L KI +
Sbjct: 202 VTLWEMFTYGQEPWIGLNGSQILHKI--DKEGERLPRPEDCPQ----------------- 242
Query: 192 REVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
++ + P R + D
Sbjct: 243 ---------DIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-32
Identities = 41/212 (19%), Positives = 76/212 (35%), Gaps = 32/212 (15%)
Query: 15 RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
+ +VFE+M+H L+ F + + G+ Y V+HRD+ N
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 131
Query: 74 LLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGC 133
L+ +K++DFG+ R D + T + + PE+ ++Y D+WS G
Sbjct: 132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGV 190
Query: 134 IFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
+ E+ + GK ++ +E + I + +KP
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVEDI-----------------STGFRLYKP--------- 224
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
R H +++ P R + L
Sbjct: 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-32
Identities = 40/209 (19%), Positives = 74/209 (35%), Gaps = 32/209 (15%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+++ EYM + L RF Q+ K + + Y Q LHRD+ N L++
Sbjct: 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
++G +K++DFGL+R D + + + PPE+L+ +K+ D+W+ G + E
Sbjct: 135 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWE 193
Query: 138 LL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
+ GK +E I + +
Sbjct: 194 IYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS-------------------------- 227
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALD 225
++ +R + K L
Sbjct: 228 ---EKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-31
Identities = 36/222 (16%), Positives = 71/222 (31%), Gaps = 36/222 (16%)
Query: 14 YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73
S +V E + + I + Q+ G+ Y + +HRD+ N
Sbjct: 78 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 137
Query: 74 LLIDNEGNLKLADFGLARSFS--YDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
+L+ + K++DFGL+++ ++ T+ + + PE + K+ D+WS
Sbjct: 138 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSF 196
Query: 132 GCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
G + E + G+ G +E + + K
Sbjct: 197 GVLMWEAFSYGQKPYRGMKGSEVTAML-----------------------------EKGE 227
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKD---ALDSEYF 229
R +L+ D R L + Y+
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-31
Identities = 46/234 (19%), Positives = 83/234 (35%), Gaps = 27/234 (11%)
Query: 9 TDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV------ 61
N ++V +Y +H L +R + TV + +GL + H+
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 62 --NQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNT---LTNRVITLWYRPPELL 116
+ HRD+K N+L+ G +AD GLA + +RV T Y PE+L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 117 LGA-----TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPG 171
+ + D++++G +F E+ I G +E QL + P
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 172 VSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
V P+R V +++ + + + R++A
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMA-------KIMRECWYANGAARLTALRIKK 290
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-31
Identities = 38/209 (18%), Positives = 69/209 (33%), Gaps = 32/209 (15%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+++ E +L + + Y QL T L Y + +HRDI N+L+
Sbjct: 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 142
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137
+ +KL DFGL+R + + + + PE + ++ A D+W G E
Sbjct: 143 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWE 201
Query: 138 LL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFR 196
+L +G G + + +I +
Sbjct: 202 ILMHGVKPFQGVKNNDVIGRI-----------------------------ENGERLPMPP 232
Query: 197 HFDRHALELLEKMLMLDPSQRISAKDALD 225
+ L+ K DPS+R +
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 5e-31
Identities = 40/229 (17%), Positives = 85/229 (37%), Gaps = 40/229 (17%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++ E+M++ L + +FTV Q+ ++ + G+ Y +HRD+ N+L++
Sbjct: 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN 162
Query: 78 NEGNLKLADFGLARSFSYDHNNTLTNRV----ITLWYRPPELLLGATKYGPAVDMWSVGC 133
+ K++DFGL+R D ++ I + + PE + K+ A D+WS G
Sbjct: 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGI 221
Query: 134 IFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
+ E+++ G+ + ++ I +
Sbjct: 222 VMWEVMSYGERPYWDMTNQDVINAI-----------------------------EQDYRL 252
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSL 241
+L+ D + R +++ D + +P SL
Sbjct: 253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT----LDKMIRNPNSL 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 3e-30
Identities = 41/232 (17%), Positives = 73/232 (31%), Gaps = 56/232 (24%)
Query: 19 YMVFEYMDH-DLTGLADRPGLR-----------------------FTVPQIKCYMKQLLT 54
++FEYM + DL + + C +Q+
Sbjct: 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 151
Query: 55 GLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPP 113
G+ Y + +HRD+ N L+ +K+ADFGL+R+ S D+ N I + + PP
Sbjct: 152 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211
Query: 114 ELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGV 172
E + +Y D+W+ G + E+ + G G E + +
Sbjct: 212 ESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV--------------- 255
Query: 173 SKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224
+ + L+ P+ R S
Sbjct: 256 --------------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 3e-30
Identities = 35/211 (16%), Positives = 63/211 (29%), Gaps = 34/211 (16%)
Query: 19 YMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
+V E L V + + Q+ G+ Y +HRD+ N+L+
Sbjct: 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 143
Query: 78 NEGNLKLADFGLARSFSYD--HNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
N K++DFGL+++ D + + L + PE + K+ D+WS G
Sbjct: 144 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTM 202
Query: 136 AELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
E L+ G+ E ++ I + + E
Sbjct: 203 WEALSYGQKPYKKMKGPEVMAFI-----------------------------EQGKRMEC 233
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALD 225
L+ + R
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 5e-30
Identities = 43/240 (17%), Positives = 90/240 (37%), Gaps = 8/240 (3%)
Query: 14 YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
+ ++ + M L + + Q+ G++Y +++HRD+
Sbjct: 81 LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 140
Query: 73 NLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
N+L+ ++K+ DFGLA+ + + + + + E +L Y D+WS
Sbjct: 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSY 199
Query: 132 GCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
G EL+ G G +E S + + P I M + + +
Sbjct: 200 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK 259
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEY 250
RE+ F + A + ++ L++ +R+ DS ++ D + + + EY
Sbjct: 260 FRELIIEFSKMARD-PQRYLVIQGDERMHLPSPTDSNFY---RALMDEEDMDDVVDADEY 315
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 8e-30
Identities = 35/216 (16%), Positives = 65/216 (30%), Gaps = 32/216 (14%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI-- 76
MV E + L L + +F++ + Q+++ + Y H +HRD+K N L+
Sbjct: 79 VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 138
Query: 77 -DNEGNLKLADFGLARSF------SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMW 129
+ + DFGLA+ + + N T Y LG + D+
Sbjct: 139 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLE 197
Query: 130 SVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKR 189
S+G + G G A + K + + M
Sbjct: 198 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----------------------KKMST 235
Query: 190 RVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+ + + + L L +
Sbjct: 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-29
Identities = 45/215 (20%), Positives = 75/215 (34%), Gaps = 35/215 (16%)
Query: 16 GSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNL 74
GS +V YM H DL TV + + Q+ G+ + + +HRD+ N
Sbjct: 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNC 161
Query: 75 LIDNEGNLKLADFGLARSF---SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSV 131
++D + +K+ADFGLAR +D + T + + + E L K+ D+WS
Sbjct: 162 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSF 220
Query: 132 GCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRR 190
G + EL+ G P P N + + + P
Sbjct: 221 GVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP-------------------- 260
Query: 191 VREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
E++ K R S + +
Sbjct: 261 ---------DPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-29
Identities = 43/236 (18%), Positives = 76/236 (32%), Gaps = 54/236 (22%)
Query: 15 RGSTYMVFEYMDH-----------------------DLTGLADRPGLRFTVPQIKCYMKQ 51
G Y++FEY + + T + C+ Q
Sbjct: 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 172
Query: 52 LLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL-TNRVITLWY 110
+ G+ + +HRD+ N+L+ + +K+ DFGLAR D N + N + + +
Sbjct: 173 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 111 RPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIW 169
PE L Y D+WS G + E+ + G PG K+ +
Sbjct: 233 MAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ---------- 281
Query: 170 PGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
N FK + + +++ D +R S +
Sbjct: 282 ---------NGFKMDQP---------FYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 2e-28
Identities = 45/218 (20%), Positives = 79/218 (36%), Gaps = 14/218 (6%)
Query: 39 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98
RF+ P + Y Q++ Y H +++RD+K NLLID +G +++ DFG A+
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VK 192
Query: 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158
T PE++L Y AVD W++G + E+ G P + KI
Sbjct: 193 GRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
Query: 159 ELCGSPDETIWPG----VSKMPAYNHFKPSRTMKRRVREVFRH--FDRHALELLEKMLML 212
+ + + K +K V ++ H F + + +
Sbjct: 252 SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR-KV 310
Query: 213 DPSQRISAKDALDSEYFWTDPLPCDPKSLPKYESSHEY 250
+ K D+ F D + + E +
Sbjct: 311 EAPFIPKFKGPGDTSNF--DDYEEEEIRVSINEKCGKE 346
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (276), Expect = 2e-28
Identities = 37/213 (17%), Positives = 69/213 (32%), Gaps = 31/213 (14%)
Query: 15 RGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72
Y++ E+M + L L + + + Q+ + + Y +HRD+
Sbjct: 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVG 132
N L+ +K+ADFGL+R + D + + PE L K+ D+W+ G
Sbjct: 145 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFG 203
Query: 133 CIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVR 192
+ E+ + Q+ ++ L G +
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYEL--LEKDYRMERPEGCPE------------------ 243
Query: 193 EVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
EL+ +PS R S +
Sbjct: 244 --------KVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 4e-27
Identities = 45/231 (19%), Positives = 77/231 (33%), Gaps = 49/231 (21%)
Query: 13 KYRGSTYMVFEYMDH----------------DLTGLADRPGLRFTVPQIKCYMKQLLTGL 56
++RG Y+ EY H +A+ + Q+ + + G+
Sbjct: 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 140
Query: 57 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELL 116
Y Q +HRD+ N+L+ K+ADFGL+R + T + + + E L
Sbjct: 141 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPVRWMAIESL 198
Query: 117 LGATKYGPAVDMWSVGCIFAELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKM 175
+ Y D+WS G + E++ G G AE K+
Sbjct: 199 NY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL------------------ 239
Query: 176 PAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226
+ E + D +L+ + P +R S L S
Sbjct: 240 -----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 7e-27
Identities = 36/211 (17%), Positives = 75/211 (35%), Gaps = 34/211 (16%)
Query: 19 YMVFEYMDHDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77
++ EYM++ F+V Q+ ++ + G+ Y +HRD+ N+L++
Sbjct: 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 144
Query: 78 NEGNLKLADFGLARSF--SYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIF 135
+ K++DFGL+R + T + I + + PE + K+ A D+WS G +
Sbjct: 145 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVM 203
Query: 136 AELL-NGKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREV 194
E++ G+ + E + I
Sbjct: 204 WEVMTYGERPYWELSNHEVMKAI-----------------------------NDGFRLPT 234
Query: 195 FRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+L+ + + ++R D +
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-26
Identities = 35/194 (18%), Positives = 67/194 (34%), Gaps = 31/194 (15%)
Query: 34 DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSF 93
D T+ + CY Q+ G+ + + +HRD+ N+L+ + +K+ DFGLAR
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 94 SYDHNNTLTNRVI-TLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEA 151
D + L + PE + Y D+WS G + E+ + PG
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 152 EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLM 211
E+ + + + + + +
Sbjct: 244 EEFCRRLK----------------------------EGTRMRAPDYTTPEMYQTMLDCWH 275
Query: 212 LDPSQRISAKDALD 225
+PSQR + + ++
Sbjct: 276 GEPSQRPTFSELVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 5e-26
Identities = 40/225 (17%), Positives = 72/225 (32%), Gaps = 48/225 (21%)
Query: 19 YMVFEYMDH----------------DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVN 62
Y++ EY + P + + + Q+ G+ Y
Sbjct: 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 154
Query: 63 QVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLT-NRVITLWYRPPELLLGATK 121
+ +HRD+ N+L+ + +K+ADFGLAR + T N + + + PE L
Sbjct: 155 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RI 213
Query: 122 YGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNH 180
Y D+WS G + E+ G PG E +
Sbjct: 214 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL----------------------- 250
Query: 181 FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225
+ + + ++ PSQR + K ++
Sbjct: 251 ------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 42/231 (18%), Positives = 77/231 (33%), Gaps = 51/231 (22%)
Query: 15 RGSTYMVFEYMDH------------------DLTGLADRPGLRFTVPQIKCYMKQLLTGL 56
G T ++ EY + + + L + + + Q+ G+
Sbjct: 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158
Query: 57 HYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTL-TNRVITLWYRPPEL 115
+ +HRD+ N+L+ + K+ DFGLAR D N + N + + + PE
Sbjct: 159 AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES 218
Query: 116 LLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSK 174
+ Y D+WS G EL + G PG + K+
Sbjct: 219 IFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM----------------- 260
Query: 175 MPAYNHFKPSRTMKRRVREVF-RHFDRHALELLEKMLMLDPSQRISAKDAL 224
+K R + H ++++ DP +R + K +
Sbjct: 261 ------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 1e-22
Identities = 34/237 (14%), Positives = 77/237 (32%), Gaps = 42/237 (17%)
Query: 14 YRGSTYMVFEYMD----------HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ 63
T ++ E M + ++ ++ ++ G+ Y + N+
Sbjct: 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 153
Query: 64 VLHRDIKGSNLLIDNEGNLKLADFGLARSF-SYDHNNTLTNRVITLWYRPPELLLGATKY 122
+HRD+ N ++ + +K+ DFG+ R D+ ++ + + PE L +
Sbjct: 154 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VF 212
Query: 123 GPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHF 181
D+WS G + E+ + G + + L +
Sbjct: 213 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------------------------ 248
Query: 182 KPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDP 238
M+ + + + EL+ +P R S + + S +P +
Sbjct: 249 -----MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 9e-18
Identities = 18/117 (15%), Positives = 38/117 (32%), Gaps = 19/117 (16%)
Query: 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78
++ E +D R V + +L + + ++H D+ N+L+
Sbjct: 86 AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138
Query: 79 EGNLKLADFGLARSFSYDHNNTLTNR---VITLWYRPPELLLGATKYGPAVDMWSVG 132
EG + + DF + + + R I ++ Y D+ S
Sbjct: 139 EG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.92 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 82.68 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=375.83 Aligned_cols=237 Identities=41% Similarity=0.747 Sum_probs=206.3
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
-|||++++.+..++++|||||||.++++..+......+++.+++.|++||+.||+|||++||+||||||+|||++.++.+
T Consensus 60 pnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~ 139 (299)
T d1ua2a_ 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL 139 (299)
T ss_dssp TTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred CCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCcc
Confidence 38999999999999999999999998888888777789999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+...... ......++|+.|+|||++.....|+.++||||||||+|||++|+.||.+.++.+++.+|.+.++
T Consensus 140 KL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~ 218 (299)
T d1ua2a_ 140 KLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218 (299)
T ss_dssp EECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccccCccccccCCCc-ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcC
Confidence 999999998765432 2344567899999999998666789999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCDPKSLP 242 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~~~~~~ 242 (417)
.+....|+.......+..+.... .......+..+++++++||++||..||++|+|++|+|+|+||+..+.++....++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p 296 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296 (299)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred CCChhhccchhccchhhhhccCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCC
Confidence 99988888777665544443221 2234556667899999999999999999999999999999999888877665554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=355.45 Aligned_cols=201 Identities=28% Similarity=0.463 Sum_probs=166.0
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.++.++.+|||||||++ +|.+++. ....|++.+++.+++||+.||+|||++||+||||||+||||+.+++
T Consensus 63 pnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~ 141 (271)
T d1nvra_ 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 141 (271)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred CCEeeEeeeeccCceeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC
Confidence 3899999999999999999999986 6655554 4457999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
+||+|||+|+.+..... ......+||+.|||||++.+...++.++||||||||||||++|+.||...++..........
T Consensus 142 ~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~ 221 (271)
T d1nvra_ 142 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 221 (271)
T ss_dssp EEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT
T ss_pred EEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence 99999999987654332 33455689999999999987555678899999999999999999999876654433332221
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
... ....+..++.++++||++||..||++|||++|||+|+||+.
T Consensus 222 ~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 222 KKT---------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp TCT---------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred CCC---------------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 100 01113457889999999999999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=355.38 Aligned_cols=193 Identities=28% Similarity=0.451 Sum_probs=167.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+..++++|||||||++ +|.+++.+. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.
T Consensus 66 pnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~ 144 (263)
T d2j4za1 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE 144 (263)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred CCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC
Confidence 3899999999999999999999986 666665543 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+|+.... ......+||+.|||||++.+ ..++.++|||||||+||||++|+.||.+.+..+++..+.+..
T Consensus 145 ~kl~DFG~a~~~~~---~~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 220 (263)
T d2j4za1 145 LKIADFGWSVHAPS---SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 220 (263)
T ss_dssp EEECCCCSCSCCCC---CCCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred EeecccceeeecCC---CcccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999976543 23345678999999999986 578999999999999999999999999999888888775421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
.. +...+++++++||.+||..||++|||++|||+||||.
T Consensus 221 ~~------------------------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 221 FT------------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp CC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred CC------------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 11 1123678899999999999999999999999999995
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=352.03 Aligned_cols=197 Identities=27% Similarity=0.446 Sum_probs=168.9
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.+...+++|||||||.+ +|..++.+. .|++.+++.|++||+.||+|||++||+||||||+||||+.++++
T Consensus 78 nIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~v 155 (293)
T d1yhwa1 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV 155 (293)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE
T ss_pred CEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcE
Confidence 899999999999999999999986 555554432 59999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+.+... .......+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+..+.....
T Consensus 156 kl~DFG~a~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 156 KLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (293)
T ss_dssp EECCCTTCEECCST-TCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred eeccchhheeeccc-cccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999999876533 234456689999999999986 6789999999999999999999999999998887777654321
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
... .....++.++++||++||..||++|+|+.|||+|+||+.
T Consensus 234 ~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 234 PEL---------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp CCC---------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCC---------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 100 112347889999999999999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=350.30 Aligned_cols=229 Identities=44% Similarity=0.806 Sum_probs=195.7
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLAD-RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~-~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++++..++++|||||||+++++.++. .....|++.+++.++.||+.||+|||++|||||||||+|||++.++++
T Consensus 62 ~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~ 141 (298)
T d1gz8a_ 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI 141 (298)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred cEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcc
Confidence 7899999999999999999999988777664 445579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+.... ........++|+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+++..+....+
T Consensus 142 kl~DFG~a~~~~~-~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~ 220 (298)
T d1gz8a_ 142 KLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220 (298)
T ss_dssp EECSTTHHHHHCC-CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eeccCCcceeccC-CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999987643 233455568899999999988766778999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPL 234 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~ 234 (417)
.+++..|......+.+...... ............++.++++||++||..||++|+|+.|||+|+||.....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 221 TPDEVVWPGVTSMPDYKPSFPK-WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCCTTTSTTGGGSTTCCTTSCC-CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CCchhhcccccccccccccccc-ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 9998888877665543322221 1223345556678899999999999999999999999999999975433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-44 Score=355.74 Aligned_cols=205 Identities=25% Similarity=0.416 Sum_probs=176.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--CC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN--EG 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~--~~ 80 (417)
|||+++++++.++++|||||||++ +|.+++.+....|++.+++.|++||+.||+|||++|||||||||+||||+. ++
T Consensus 84 nIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~ 163 (350)
T d1koaa2 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 163 (350)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSC
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCC
Confidence 799999999999999999999985 777777666667999999999999999999999999999999999999964 57
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||+|+.+.. .......++|+.|||||++.+ ..++.++||||||||+|||++|+.||.+.+..+++..|...
T Consensus 164 ~vkL~DFG~a~~~~~--~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 240 (350)
T d1koaa2 164 ELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240 (350)
T ss_dssp CEEECCCTTCEECCT--TSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred eEEEeecchheeccc--ccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 899999999987653 234455788999999999987 57899999999999999999999999999999998888764
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 237 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~ 237 (417)
...+.. ..+..+++++++||++||..||++|||++|||+|+||.....+..
T Consensus 241 ~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 241 DWNMDD--------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp CCCSCC--------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSC
T ss_pred CCCCCc--------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCc
Confidence 333221 122457789999999999999999999999999999987654443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=349.20 Aligned_cols=200 Identities=23% Similarity=0.341 Sum_probs=168.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++++..++.+|||||||++ +|..++.+....|++.+++.|+.||+.||+|||++||+||||||+||||+.++++
T Consensus 70 nIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~ 149 (288)
T d2jfla1 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDI 149 (288)
T ss_dssp TBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred CCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCE
Confidence 899999999999999999999986 5555555555579999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcC----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
||+|||+|+..... .......+||+.|+|||++.. ...|+.++|||||||+||||++|+.||.+.+..+++.++.
T Consensus 150 Kl~DFG~a~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~ 228 (288)
T d2jfla1 150 KLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228 (288)
T ss_dssp EECCCTTCEECHHH-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred EEEechhhhccCCC-cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 99999999765321 122345678999999999852 2458899999999999999999999999999888887775
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
....... .....++.++++||++||+.||++|+|+.|||+|+||..
T Consensus 229 ~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 229 KSEPPTL---------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HSCCCCC---------------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred cCCCCCC---------------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 5211000 012346789999999999999999999999999999954
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-44 Score=347.38 Aligned_cols=198 Identities=24% Similarity=0.380 Sum_probs=158.5
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---CC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID---NE 79 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~---~~ 79 (417)
|||++++.++.++++|||||||+ ++|.+++.+. ..|++.+++.|+.||+.||+|||+++|+||||||+|||+. .+
T Consensus 68 nIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~ 146 (307)
T d1a06a_ 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED 146 (307)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT
T ss_pred CCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCC
Confidence 89999999999999999999998 5777777654 4699999999999999999999999999999999999995 46
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
+.+||+|||+|+..... ......+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..++...+..
T Consensus 147 ~~vkl~DFG~a~~~~~~--~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 147 SKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp CCEEECCC--------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred ceEEEeccceeEEccCC--CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 78999999999865432 23445789999999999986 5789999999999999999999999999998888888765
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
....+... .+..+++++++||++||..||++|||++|+|+|+||..
T Consensus 224 ~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 224 AEYEFDSP--------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp TCCCCCTT--------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred cCCCCCCc--------------------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 33222111 12346789999999999999999999999999999965
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-44 Score=354.96 Aligned_cols=200 Identities=23% Similarity=0.418 Sum_probs=174.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID--NEG 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~--~~~ 80 (417)
|||+++++|+.++++|||||||++ +|.+.+.+...+|++.+++.|+.||+.||+|||++|||||||||+||||+ .++
T Consensus 87 nIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~ 166 (352)
T d1koba_ 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS 166 (352)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCC
Confidence 799999999999999999999985 67677777666799999999999999999999999999999999999998 568
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||+|+.+... .......+|+.|+|||++.+ ..++.++||||||||||||++|+.||.+.+..+++..|...
T Consensus 167 ~vkL~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 243 (352)
T d1koba_ 167 SVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 243 (352)
T ss_dssp CEEECCCTTCEECCTT--SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred eEEEeecccceecCCC--CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 8999999999876532 33455678999999999986 67899999999999999999999999999999998888764
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
...+.... +..++.++++||++||..||++|+|+.|||+|+||...
T Consensus 244 ~~~~~~~~--------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 244 DWEFDEDA--------------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CCCCCSST--------------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCCCCccc--------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 43333222 23467899999999999999999999999999999754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=346.30 Aligned_cols=225 Identities=48% Similarity=0.943 Sum_probs=182.3
Q ss_pred eecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCccc
Q 014871 13 KYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARS 92 (417)
Q Consensus 13 ~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~ 92 (417)
..++++|||||||.++++.........+++.+++.+++||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 34568999999999999888888778899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCC---CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 014871 93 FSYDH---NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGSPDETIW 169 (417)
Q Consensus 93 ~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 169 (417)
+.... .......++|+.|+|||++.+...++.++||||||||+|||++|+.||.+.++.+.+..+.+..+.+....+
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 65322 223334578999999999987667999999999999999999999999999999999999999999888777
Q ss_pred CCCCCCCccccCCCchhhhhhHHHhh--hhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014871 170 PGVSKMPAYNHFKPSRTMKRRVREVF--RHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLPCD 237 (417)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~~~ 237 (417)
........+................+ ...+.+++|||++||..||++|+|++|||+||||+..+.|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~ 316 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 316 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence 76665444433332222222222222 235778999999999999999999999999999998877764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-44 Score=344.22 Aligned_cols=226 Identities=42% Similarity=0.789 Sum_probs=191.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.|||++++.+...+++||||||+.++++..+.+....|++.+++.+++||+.||+|||+++||||||||+||||+.++.+
T Consensus 60 pnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~ 139 (286)
T d1ob3a_ 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139 (286)
T ss_dssp TTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred CcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCE
Confidence 58999999999999999999999999998888877889999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|...... .......++++.|+|||++.+...++.++|||||||++|||++|+.||.+.++.+++.++....+
T Consensus 140 kl~DfG~a~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~ 218 (286)
T d1ob3a_ 140 KIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218 (286)
T ss_dssp EECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EecccccceecccC-ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence 99999999876532 22334456899999999998777789999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
.+....|........+...... ............++.+++|||++||..||++|+|++|||+||||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 219 TPNSKNWPNVTELPKYDPNFTV-YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCC-CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred CCChhhccchhhhhhccccccc-ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 9888888776665443322211 112234455667889999999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=353.42 Aligned_cols=196 Identities=27% Similarity=0.414 Sum_probs=169.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.|||++++.++.++++|||||||.++ |..++. ....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.
T Consensus 65 p~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~ 143 (337)
T d1o6la_ 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143 (337)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC
T ss_pred CCEEEEEeeeccccccccceeccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC
Confidence 58999999999999999999999964 555544 4456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+|+..... .......+||+.|+|||++.+ ..|+.++||||||||||||++|+.||.+.+..+++..+....
T Consensus 144 vkl~DFG~a~~~~~~-~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 144 IKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221 (337)
T ss_dssp EEECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEeecccccccccC-CcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC
Confidence 999999999875432 234456789999999999986 578999999999999999999999999999988888776521
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
-. ++..++.++++||++||++||++|+ ++.||++|+||..
T Consensus 222 ~~------------------------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 222 IR------------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CC------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CC------------------------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 11 1234678999999999999999999 4999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=356.34 Aligned_cols=222 Identities=23% Similarity=0.332 Sum_probs=160.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~~~~~ 81 (417)
|||++++.|+.++++|||||||.+ +|.+++.+. ..|++.+++.++.||+.||+|||+ ++|+||||||+||||+.+++
T Consensus 65 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~ 143 (322)
T d1s9ja_ 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 143 (322)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC
Confidence 799999999999999999999996 566655543 469999999999999999999997 59999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS-KIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~-~i~~~ 160 (417)
+||+|||+|+..... ...+.+||+.|||||++.+ ..|+.++||||||||+|||++|+.||.+.+..+... .+...
T Consensus 144 vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 219 (322)
T d1s9ja_ 144 IKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219 (322)
T ss_dssp EEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred EEEeeCCCccccCCC---ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 999999999876432 2345689999999999987 679999999999999999999999998776544322 12222
Q ss_pred cCCCCCCC----CCCCCCCCccccCCCchhhhhhHHHhh---------hhhhHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 014871 161 CGSPDETI----WPGVSKMPAYNHFKPSRTMKRRVREVF---------RHFDRHALELLEKMLMLDPSQRISAKDALDSE 227 (417)
Q Consensus 161 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~ 227 (417)
.+...... +.......................... ..++.+++|||++||..||++|||++|+|+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp --------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 22111110 000000000000000001111111111 23678999999999999999999999999999
Q ss_pred CCC
Q 014871 228 YFW 230 (417)
Q Consensus 228 ~f~ 230 (417)
||+
T Consensus 300 f~~ 302 (322)
T d1s9ja_ 300 FIK 302 (322)
T ss_dssp HHH
T ss_pred hhC
Confidence 994
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=350.52 Aligned_cols=196 Identities=26% Similarity=0.434 Sum_probs=165.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||+++++++.++++|||||||++ +|.+++... ..|++.+++.++.||+.||+|||+++|+||||||+||||++++.+
T Consensus 69 nIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~v 147 (288)
T d1uu3a_ 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI 147 (288)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred CeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceE
Confidence 899999999999999999999986 666665544 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+|+.+..... ......+||+.|+|||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.+|.+..
T Consensus 148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp EECCCTTCEECC----------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred EecccccceecccCCcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC
Confidence 9999999987654332 33445689999999999986 578999999999999999999999999999988888876421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHH------HhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKD------ALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e------lL~h~~f~~ 231 (417)
.. +...+++++++||++||..||++|+|++| |++||||..
T Consensus 227 ~~------------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 227 YD------------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp CC------------------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred CC------------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 11 11236778999999999999999999987 578999955
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=343.91 Aligned_cols=222 Identities=39% Similarity=0.684 Sum_probs=186.0
Q ss_pred cEeecccCce-----ecCeEEEEEcCCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNK-----YRGSTYMVFEYMDHDLTGLA-DRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~-----~~~~~yiV~Ey~~g~l~~~~-~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
|||++++.+. ...++||+||||+++++.+. ......+++.+++.+++||+.||+|||+++|+||||||+|||++
T Consensus 71 nIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~ 150 (305)
T d1blxa_ 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 150 (305)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc
Confidence 7888887774 34578999999998876544 44556799999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++.... .......+||+.|+|||++.+ ..|+.++||||||||||||++|+.||.+.+..+++..+
T Consensus 151 ~~~~~kl~dfg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 227 (305)
T d1blxa_ 151 SSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227 (305)
T ss_dssp TTCCEEECSCCSCCCCCG--GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCeeecchhhhhhhcc--cccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999999876542 234456788999999999986 67999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.+.++.+....|+............. .......+...+++.+++||++||..||++|+|+.|||+||||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSK---SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCC---CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHhhCCCchhcccccccchhhhhccc---cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 99999988887776655443221111 112233455678899999999999999999999999999999965
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-44 Score=348.53 Aligned_cols=195 Identities=24% Similarity=0.352 Sum_probs=168.8
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||++++++..++++|||||||.+++++.+......|++.+++.|++||+.||+|||++|||||||||+||||+.++++|
T Consensus 76 nIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~K 155 (309)
T d1u5ra_ 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 155 (309)
T ss_dssp TBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEE
T ss_pred CEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEE
Confidence 79999999999999999999999887776665566799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
|+|||+|+.... ....+||+.|||||++.+. ..|+.++|||||||+||||++|+.||.+.+..+.+..+....
T Consensus 156 l~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~ 230 (309)
T d1u5ra_ 156 LGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230 (309)
T ss_dssp ECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred EeecccccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 999999986542 2346789999999998642 458999999999999999999999999998888877775422
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.... ....+++++++||++||..||++|||+.|||+|+||..
T Consensus 231 ~~~~----------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 231 SPAL----------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp CCCC----------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCC----------------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1110 01236778999999999999999999999999999965
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=339.22 Aligned_cols=194 Identities=22% Similarity=0.333 Sum_probs=156.8
Q ss_pred cEeecccCcee----cCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEE
Q 014871 4 TFLETTDGNKY----RGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQ--VLHRDIKGSNLLI 76 (417)
Q Consensus 4 niv~~~~~~~~----~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~g--ivHrDlkp~NILl 76 (417)
|||++++.++. +..+|||||||++ +|.+++.+ ...+++.+++.|+.||+.||+|||+++ |+||||||+||||
T Consensus 69 nIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl 147 (270)
T d1t4ha_ 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147 (270)
T ss_dssp TBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE
T ss_pred CeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhcee
Confidence 78999988765 4568999999986 55555544 346999999999999999999999998 9999999999999
Q ss_pred c-CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 77 D-NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 77 ~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
+ .++.+||+|||+|+... .......+||+.|||||++.+ .++.++||||||||||||++|+.||........+.
T Consensus 148 ~~~~~~~Kl~DFGla~~~~---~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~ 222 (270)
T d1t4ha_ 148 TGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222 (270)
T ss_dssp SSTTSCEEECCTTGGGGCC---TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred eCCCCCEEEeecCcceecc---CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH
Confidence 7 47899999999997643 223445689999999999864 58999999999999999999999998765544443
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFW 230 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~ 230 (417)
+.......+ ..+...+++++++||++||..||++|||++|||+||||+
T Consensus 223 ~~i~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 223 RRVTSGVKP---------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHTTTCCC---------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHcCCCC---------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 322110000 112234677899999999999999999999999999994
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-44 Score=345.89 Aligned_cols=193 Identities=24% Similarity=0.399 Sum_probs=169.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 83 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vk 83 (417)
|||++++++..++.+|||||||.++.+..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus 65 nIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEE
T ss_pred ChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEE
Confidence 79999999999999999999999766665555556799999999999999999999999999999999999999999999
Q ss_pred EeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 014871 84 LADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCGS 163 (417)
Q Consensus 84 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~~ 163 (417)
|+|||+|+.... .....+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+++.++......
T Consensus 145 L~DFG~a~~~~~----~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~ 219 (316)
T d1fota_ 145 ITDFGFAKYVPD----VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR 219 (316)
T ss_dssp ECCCSSCEECSS----CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC
T ss_pred EecCccceEecc----ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC
Confidence 999999987643 2345689999999999976 57899999999999999999999999999999988888652111
Q ss_pred CCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 164 PDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
+...++.++++||++||.+||++|+ |+++||+||||+.
T Consensus 220 ------------------------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 220 ------------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp ------------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ------------------------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 1123677899999999999999996 9999999999965
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-43 Score=350.31 Aligned_cols=198 Identities=24% Similarity=0.362 Sum_probs=164.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||+++++++.++.+|||||||++ +|..++.+. ..+++.+++.|+.||+.||+|||+++||||||||+||||+.++.+
T Consensus 68 nIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~i 146 (364)
T d1omwa3 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 146 (364)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCE
T ss_pred cEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcE
Confidence 789999999999999999999985 666665543 469999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+.+... .....+||+.|+|||++.....|+.++||||||||||||++|+.||.+.+..+....+.....
T Consensus 147 Kl~DFGla~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~ 223 (364)
T d1omwa3 147 RISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223 (364)
T ss_dssp EECCCTTCEECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS
T ss_pred EEeeeceeeecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 99999999876532 334567999999999997656789999999999999999999999987665444332222111
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRIS-----AKDALDSEYFWTD 232 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~h~~f~~~ 232 (417)
... .+...+++++++||.+||..||++|+| |+|||+|+||+..
T Consensus 224 ~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 224 MAV---------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp CCC---------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred CCC---------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 111 011246789999999999999999999 7999999999653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=338.78 Aligned_cols=198 Identities=24% Similarity=0.413 Sum_probs=170.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG-- 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~-- 80 (417)
|||+++++++.++++|||||||++ +|.+++.+. ..+++.+++.+++||+.||+|||+++|+||||||+||||+.++
T Consensus 74 nIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~ 152 (293)
T d1jksa_ 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVP 152 (293)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSS
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCc
Confidence 899999999999999999999985 666666543 4699999999999999999999999999999999999998776
Q ss_pred --CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014871 81 --NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 81 --~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~ 158 (417)
.+||+|||+|+..... .......+|+.|+|||++.+ ..++.++||||||||||||++|+.||.+.+..+++..+.
T Consensus 153 ~~~vkl~DfG~a~~~~~~--~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 229 (293)
T d1jksa_ 153 KPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229 (293)
T ss_dssp SCCEEECCCTTCEECTTS--CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccceEecchhhhhhcCCC--ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 4999999999876532 23445678999999999986 678999999999999999999999999999999888876
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
...... ....+..++..+++||++||..||++|||++|||+|+||+.
T Consensus 230 ~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 230 AVNYEF--------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp TTCCCC--------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred hcCCCC--------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 532111 12334567889999999999999999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=336.30 Aligned_cols=195 Identities=29% Similarity=0.424 Sum_probs=152.8
Q ss_pred cEeecccCce--ecCeEEEEEcCCCC-CHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCC
Q 014871 4 TFLETTDGNK--YRGSTYMVFEYMDH-DLTGLADR---PGLRFTVPQIKCYMKQLLTGLHYCHVNQ-----VLHRDIKGS 72 (417)
Q Consensus 4 niv~~~~~~~--~~~~~yiV~Ey~~g-~l~~~~~~---~~~~l~~~~i~~i~~Qil~gL~~LH~~g-----ivHrDlkp~ 72 (417)
|||++++.+. .++.+|||||||++ +|.+++.+ ....|++.+++.++.||+.||+|||+++ ||||||||+
T Consensus 64 nIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp TBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred CEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 7889998774 35678999999985 67666543 3456999999999999999999999876 999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 152 (417)
||||+.++.+||+|||+|+.+... .......++|+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+..+
T Consensus 144 NIll~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~ 221 (269)
T d2java1 144 NVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221 (269)
T ss_dssp GEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred hcCcCCCCcEEEeeccceeecccC-CCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH
Confidence 999999999999999999876532 223345688999999999976 678999999999999999999999999999888
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYF 229 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f 229 (417)
+..++.+.... .+...+++++++||++||..||++|||+.|||+|||+
T Consensus 222 ~~~~i~~~~~~-----------------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 222 LAGKIREGKFR-----------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHcCCCC-----------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 88777552111 0112367899999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-43 Score=334.99 Aligned_cols=200 Identities=25% Similarity=0.426 Sum_probs=171.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
.|||+++++++.++++|||||||++ +|.+++... ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.
T Consensus 70 pnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred CCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC
Confidence 4899999999999999999999985 777777654 46999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLG-----ATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+||+|||+|+.+.... .....++|..|+|||++.+ ...++.++||||||||||||++|+.||.+.+..+.+..
T Consensus 149 ~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226 (277)
T ss_dssp EEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence 9999999998765422 3455788999999999862 34578899999999999999999999999999888887
Q ss_pred HHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.+....... .....+++++++||.+||+.||++|+|++|||+|+||+.
T Consensus 227 i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 227 IMSGNYQFGS--------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHTCCCCCT--------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHhCCCCCCC--------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 7653221111 113357889999999999999999999999999999954
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-43 Score=346.55 Aligned_cols=193 Identities=27% Similarity=0.408 Sum_probs=167.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++.+...+.+|+||||+.+ +|...+.+ ...|++.+++.|+.||+.||+|||+++||||||||+||||+.++.
T Consensus 101 pnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ 179 (350)
T d1rdqe_ 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY 179 (350)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred CcEeecccccccccccccccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC
Confidence 3789999999999999999999986 45555544 346999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
+||+|||+|+.+.. .....+||+.|||||++.+ ..++.++||||||||||||++|+.||.+.+...++.+|....
T Consensus 180 ikL~DFG~a~~~~~----~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 254 (350)
T d1rdqe_ 180 IQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254 (350)
T ss_dssp EEECCCTTCEECSS----CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEeeeceeeeeccc----ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Confidence 99999999987653 2345688999999999986 678999999999999999999999999999988888886532
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
... ...+++++.+||++||..||++|+ |++|||+|+||..
T Consensus 255 ~~~------------------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 255 VRF------------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CCC------------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCC------------------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 111 123678999999999999999995 9999999999964
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=341.36 Aligned_cols=200 Identities=21% Similarity=0.388 Sum_probs=173.2
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-- 79 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-- 79 (417)
-|||++++.|+.++++|||||||++ +|.+++.+.+..|++.+++.|+.||+.||+|||++||+||||||+||||+.+
T Consensus 61 pnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~ 140 (321)
T d1tkia_ 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS 140 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC
T ss_pred CCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCc
Confidence 3899999999999999999999985 7777777666679999999999999999999999999999999999999854
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
..+||+|||+++.... .......++|+.|+|||++.+ ..|+.++||||||||||+|++|+.||.+.+..+++..|.+
T Consensus 141 ~~ikl~DFG~~~~~~~--~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~ 217 (321)
T d1tkia_ 141 STIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217 (321)
T ss_dssp CCEEECCCTTCEECCT--TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred eEEEEcccchhhcccc--CCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 4799999999987543 233445678999999999876 6789999999999999999999999999999999888876
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
....++ ...+..++.++++||++||..||++|+|+.|+|+|+||..
T Consensus 218 ~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 218 AEYTFD--------------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp TCCCCC--------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CCCCCC--------------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 332221 2334557889999999999999999999999999999965
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=344.01 Aligned_cols=195 Identities=27% Similarity=0.486 Sum_probs=168.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||+++++++.++++|||||||++ +|.+++. ....+++.+++.++.||+.||+|||+++|+||||||+|||++.++++
T Consensus 64 ~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~ 142 (320)
T d1xjda_ 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI 142 (320)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE
T ss_pred cEEEEEEEEccCCceeEEEeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCce
Confidence 699999999999999999999986 5655554 44569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELCG 162 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~~ 162 (417)
||+|||+|+..... .......+||+.|+|||++.+ ..++.++||||||||+|||++|+.||.+.+..+++.+|....
T Consensus 143 kl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~- 219 (320)
T d1xjda_ 143 KIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN- 219 (320)
T ss_dssp EECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-
T ss_pred eccccchhhhcccc-cccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999999865433 234455688999999999986 678999999999999999999999999999988888875421
Q ss_pred CCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCC
Q 014871 163 SPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAK-DALDSEYFWT 231 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~-elL~h~~f~~ 231 (417)
+. +...++.++++||++||..||++|+|+. +|++||||+.
T Consensus 220 -~~----------------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 220 -PF----------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp -CC----------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred -CC----------------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 10 1124678999999999999999999995 8999999965
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=339.02 Aligned_cols=204 Identities=25% Similarity=0.377 Sum_probs=162.2
Q ss_pred ccEeecccCcee----cCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKY----RGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~----~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
-|||+++++|+. +.++|||||||++ +|.+++.+. ...|++.+++.|++||+.||+|||++||+||||||+|||+
T Consensus 65 pnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll 144 (335)
T d2ozaa1 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 144 (335)
T ss_dssp TTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccc
Confidence 378999988875 5779999999985 788877654 3569999999999999999999999999999999999999
Q ss_pred cC---CCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 014871 77 DN---EGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQ 153 (417)
Q Consensus 77 ~~---~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 153 (417)
+. ++.+||+|||+|+..... ......+||+.|||||++.+ ..|+.++||||||||||+|+||+.||.+.+..+.
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCC--CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred ccccccccccccccceeeeccCC--CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 86 456999999999876533 33456789999999999875 5789999999999999999999999988776665
Q ss_pred HHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 154 LSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 154 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
...+.......... . ....+..+++++++||++||..||++|+|+.|||+|+||..
T Consensus 222 ~~~~~~~i~~~~~~-------~---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 222 SPGMKTRIRMGQYE-------F---------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp ------CCCSCSSS-------C---------------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHhcCCCC-------C---------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 55543321111000 0 01123457889999999999999999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=341.95 Aligned_cols=227 Identities=33% Similarity=0.562 Sum_probs=179.9
Q ss_pred ccEeecccCceecC------eEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKYRG------STYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~~~------~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
.|||+++++|...+ ++|||||||+.+|..++.+. +|++..++.+++||+.||+|||++||+||||||+|||+
T Consensus 77 pniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~ 154 (346)
T d1cm8a_ 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 154 (346)
T ss_dssp TTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCeeEEEEEeccCccccccceEEEEEecccccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc
Confidence 37888888877655 57999999977777666543 59999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+.++.+||+|||+|+.... ..+..++|+.|+|||++.+...++.++||||||||+|||++|+.||.+.+..+.+..
T Consensus 155 ~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~ 230 (346)
T d1cm8a_ 155 NEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230 (346)
T ss_dssp CTTCCEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccccccccccccceeccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH
Confidence 9999999999999987643 334567899999999998767789999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCcccc-CCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNH-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
+....+.+....+........... ..........+...+..++.+++|||++||..||++|||+.|||+||||+.-..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 988887776544332221000000 0000000112233445678899999999999999999999999999999764433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-43 Score=342.37 Aligned_cols=226 Identities=30% Similarity=0.511 Sum_probs=177.0
Q ss_pred ccEeecccCcee------cCeEEEEEcCCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 014871 3 CTFLETTDGNKY------RGSTYMVFEYMDHDLTGLAD---RPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSN 73 (417)
Q Consensus 3 cniv~~~~~~~~------~~~~yiV~Ey~~g~l~~~~~---~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~N 73 (417)
.|||++++.|.. ..++|||||||++++...+. .....|++.+++.|++||+.||+|||++||+||||||+|
T Consensus 73 ~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~N 152 (350)
T d1q5ka_ 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152 (350)
T ss_dssp TTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred CCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcce
Confidence 367888777643 34589999999987666543 355579999999999999999999999999999999999
Q ss_pred EEEcCCC-CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHH
Q 014871 74 LLIDNEG-NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAE 152 (417)
Q Consensus 74 ILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 152 (417)
|||+.++ .+||+|||+|+.+... ......++|..|+|||++.+...++.++||||||||+|||++|+.||...+..+
T Consensus 153 ILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~ 230 (350)
T d1q5ka_ 153 LLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230 (350)
T ss_dssp EEECTTTCCEEECCCTTCEECCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH
T ss_pred EEEecCCCceeEecccchhhccCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH
Confidence 9999775 8999999999876432 234456889999999999876789999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCCCccccCCCc-hhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 153 QLSKIFELCGSPDETIWPGVSKMPAYNHFKPS-RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 153 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
++..+++.++.+....|...... +...... .............+++++++||++||.+||++|+|+.|+|+|+||..
T Consensus 231 ~l~~i~~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 231 QLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCC-----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHHHHHhCCChHHhhhhhccc--hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 99999988887765444322210 0000000 00000111223457889999999999999999999999999999965
Q ss_pred C
Q 014871 232 D 232 (417)
Q Consensus 232 ~ 232 (417)
.
T Consensus 309 ~ 309 (350)
T d1q5ka_ 309 L 309 (350)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=333.37 Aligned_cols=188 Identities=24% Similarity=0.327 Sum_probs=156.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC--CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-C
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH--DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE-G 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g--~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~-~ 80 (417)
|||++++.++..+++||||||+.+ ++..++.+ ...+++.+++.|+.||+.||+|||+++|+||||||+||||+.+ +
T Consensus 70 nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred CccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC
Confidence 799999999999999999999975 45455444 3469999999999999999999999999999999999999854 6
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~ 160 (417)
.+||+|||+|+.... ....+.+||+.|+|||++.+...++.++|||||||+||||++|+.||...+. +...
T Consensus 149 ~vkl~DFG~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~ 219 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG 219 (273)
T ss_dssp EEEECCCTTCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC
T ss_pred eEEECccccceeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhc
Confidence 899999999986542 2345678999999999998655567889999999999999999999975321 2211
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
.. .+...+++++++||++||..||++|||++|||+||||+.
T Consensus 220 ~~------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 220 QV------------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp CC------------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred cc------------------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 00 011236789999999999999999999999999999965
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=322.32 Aligned_cols=227 Identities=40% Similarity=0.728 Sum_probs=191.9
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
.|||++++.+....++||||||+.++++..+......+++.+++.+++||+.||+|||+++|+||||||+||||+.++.+
T Consensus 61 ~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~ 140 (292)
T d1unla_ 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140 (292)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE
T ss_pred CCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCce
Confidence 48899999999999999999999988888777777789999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~p-f~~~~~~~~~~~i~~~~ 161 (417)
||+|||+|+...... .......++..|+|||++.....++.++|||||||++|||++|+.| |.+.+..+++.++....
T Consensus 141 kl~DFG~a~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 219 (292)
T d1unla_ 141 KLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp EECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred eeeecchhhcccCCC-ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence 999999998765332 2333456688999999998766689999999999999999998876 67778888899999999
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~ 231 (417)
+.+....|+.......+....... ...........+++.+++||++||+.||++|+||+|||+||||..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 220 GTPTEEQWPSMTKLPDYKPYPMYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred CCCChhhhhhhhhccccccccccc-ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 988888887776665544332221 122334445668899999999999999999999999999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=330.71 Aligned_cols=230 Identities=37% Similarity=0.622 Sum_probs=177.5
Q ss_pred cEeecccCceec-----CeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 014871 4 TFLETTDGNKYR-----GSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN 78 (417)
Q Consensus 4 niv~~~~~~~~~-----~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~ 78 (417)
|||++++++... .++||+||+++++|.+++... +|++.+++.++.||+.||+|||++|||||||||+||||++
T Consensus 67 ~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp TBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC
Confidence 567777665543 457888888888998887654 5999999999999999999999999999999999999999
Q ss_pred CCCEEEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 79 EGNLKLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 79 ~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
++.+||+|||+|+....... ......++|+.|+|||++.....++.++||||+|||+|||++|+.||.+.+..++...
T Consensus 145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~ 224 (345)
T d1pmea_ 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224 (345)
T ss_dssp TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH
Confidence 99999999999986543222 2345567899999999987667789999999999999999999999999999998888
Q ss_pred HHHhcCCCCCCCCCCCCCCCccc-cCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYN-HFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
+......+............... ...........+...+..++.++++||.+||..||++|+|+.|||+|+||.....+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 87776665433221111100000 00000011122344566788999999999999999999999999999999765443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=319.56 Aligned_cols=198 Identities=18% Similarity=0.253 Sum_probs=156.2
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.. .++.+|||||||+ ++|.+++......+++.++..|+.||+.||+|||+++||||||||+||||+.++++
T Consensus 65 nIv~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~ 143 (276)
T d1uwha_ 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTV 143 (276)
T ss_dssp TBCCEEEEE-CSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSE
T ss_pred CEeeeeEEE-eccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCE
Confidence 788887654 4567999999998 57777777666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC-CcccccccccCCCCchhhcCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGA--TKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+|+....... .......+|+.|||||++... ..|+.++|||||||+||||+||+.||.+.+....+..+..
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~ 223 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223 (276)
T ss_dssp EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 9999999987653322 234456789999999998642 3578999999999999999999999998877666655543
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
...... ........+++++.+||.+||..||++|||+.||+++
T Consensus 224 ~~~~~p------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 224 RGYLSP------------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HTSCCC------------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC------------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 221111 0112233467899999999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-41 Score=316.19 Aligned_cols=193 Identities=20% Similarity=0.322 Sum_probs=153.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++++..++.+|||||||.+ +|.+++......+++..+..|+.||+.||+|||+++|+||||||+||||+.++++
T Consensus 61 nIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~ 140 (263)
T d1sm2a_ 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 140 (263)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCE
T ss_pred CcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCe
Confidence 899999999999999999999985 6777777666779999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+|+..............+|..|+|||++.+ ..++.++|||||||+||||+| |+++|...+..+.+..+....
T Consensus 141 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~ 219 (263)
T d1sm2a_ 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 219 (263)
T ss_dssp EECSCC------------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC
T ss_pred EecccchheeccCCCceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC
Confidence 999999998765544444445678999999999986 578999999999999999999 677888888877777775522
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.... ...++.++.+||.+||..||++|||++||++|
T Consensus 220 ~~~~-----------------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 RLYK-----------------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-----------------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1111 12356789999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=326.33 Aligned_cols=194 Identities=22% Similarity=0.352 Sum_probs=161.6
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPG----------------------LRFTVPQIKCYMKQLLTGLHYCH 60 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~----------------------~~l~~~~i~~i~~Qil~gL~~LH 60 (417)
|||++++.+...+.+|||||||++ +|.+++.... ..|++.+++.|+.||+.||+|||
T Consensus 102 nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH 181 (325)
T d1rjba_ 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181 (325)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred cEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 899999999999999999999985 7777765432 24889999999999999999999
Q ss_pred HCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHH
Q 014871 61 VNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELL 139 (417)
Q Consensus 61 ~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell 139 (417)
+++||||||||+|||++.++++||+|||+|+........ ......+|+.|||||++.+ ..++.++||||||||||||+
T Consensus 182 ~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 182 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHT
T ss_pred hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHH
Confidence 999999999999999999999999999999876544332 2334567999999999876 67899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC
Q 014871 140 N-GKPILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI 218 (417)
Q Consensus 140 t-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp 218 (417)
+ |+.||.+.+..+.+.++......++ ....+++++++||++||+.||++||
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------~p~~~~~~l~~li~~cl~~dP~~RP 312 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGFKMD----------------------------QPFYATEEIYIIMQSCWAFDSRKRP 312 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCC----------------------------CCCcCCHHHHHHHHHHcCCChhHCc
Confidence 7 8999998877776666654221111 1123677899999999999999999
Q ss_pred CHHHHhcC
Q 014871 219 SAKDALDS 226 (417)
Q Consensus 219 ta~elL~h 226 (417)
|++||++|
T Consensus 313 t~~ei~~~ 320 (325)
T d1rjba_ 313 SFPNLTSF 320 (325)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-41 Score=325.88 Aligned_cols=224 Identities=29% Similarity=0.472 Sum_probs=165.5
Q ss_pred cEeecccCcee--cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-
Q 014871 4 TFLETTDGNKY--RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG- 80 (417)
Q Consensus 4 niv~~~~~~~~--~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~- 80 (417)
||+++++.|+. ..++|||||||.++.+..+. ..|++.+++.+++||+.||+|||++||+||||||+||||+.++
T Consensus 91 nIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~ 167 (328)
T d3bqca1 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 167 (328)
T ss_dssp TBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred CCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC
Confidence 78888888874 45799999999976544433 3599999999999999999999999999999999999998765
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~-~~~~~~~~i~~ 159 (417)
.+||+|||+|+..... ......++|..|+|||++.+...++.++|||||||++|||++|+.||... +..++...+..
T Consensus 168 ~vkl~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~ 245 (328)
T d3bqca1 168 KLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245 (328)
T ss_dssp EEEECCGGGCEECCTT--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred eeeecccccceeccCC--CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH
Confidence 5999999999876533 23455678999999999987677899999999999999999999988654 45555666655
Q ss_pred hcCCCCCCCCCCCCC---CCccccCCC---c-hhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 014871 160 LCGSPDETIWPGVSK---MPAYNHFKP---S-RTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~---~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~ 232 (417)
.++.+....+..... ...+..... . .............++++++|||++||..||++|+|++|||+||||+..
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 544321111100000 000000000 0 000011112234578899999999999999999999999999999763
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=325.89 Aligned_cols=227 Identities=36% Similarity=0.603 Sum_probs=172.4
Q ss_pred ccEeecccCcee------cCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 014871 3 CTFLETTDGNKY------RGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLI 76 (417)
Q Consensus 3 cniv~~~~~~~~------~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl 76 (417)
.|+|++++++.. .+.+||++|+++++|.+++.. .+|++.+++.+++||+.||+|||++||+||||||+|||+
T Consensus 77 ~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi 154 (348)
T d2gfsa1 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154 (348)
T ss_dssp TTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc
Confidence 467777776643 344666666666777776643 369999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014871 77 DNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSK 156 (417)
Q Consensus 77 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~ 156 (417)
+.++.+||+|||+|.... .......+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......
T Consensus 155 ~~~~~~kl~dfg~a~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~ 230 (348)
T d2gfsa1 155 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230 (348)
T ss_dssp CTTCCEEECCC----CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccchhcccC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999997643 2344567899999999988766789999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCcccc-CCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 014871 157 IFELCGSPDETIWPGVSKMPAYNH-FKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDSEYFWTDPLP 235 (417)
Q Consensus 157 i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h~~f~~~~~~ 235 (417)
+....+.+....+........... ..........+...+..++.+++|||++||..||++|+|+.|||+||||.....+
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 988777665443332221100000 0000011222344456688999999999999999999999999999999765433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-40 Score=317.22 Aligned_cols=192 Identities=19% Similarity=0.310 Sum_probs=152.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.+...+.+|||||||++ +|.+++.+....+++.++..|+.||+.||+|||+++|+||||||+||||+.++++
T Consensus 88 nIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~ 167 (299)
T d1jpaa_ 88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVC 167 (299)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred CCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcE
Confidence 899999999999999999999986 5666666666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC----cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNN----TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKI 157 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i 157 (417)
||+|||+|+.+...... ......+|..|||||++.. ..++.++||||||||||||+| |+.||.+.+..+++..+
T Consensus 168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp EECCC-----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred EECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999876533221 1122356899999999986 678999999999999999998 89999999988888777
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+....+. ...++.++.+||.+||..||++|||+.||++
T Consensus 247 ~~~~~~~~-----------------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 247 EQDYRLPP-----------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp HTTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HcCCCCCC-----------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 54221111 1235678999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=329.82 Aligned_cols=223 Identities=30% Similarity=0.522 Sum_probs=168.4
Q ss_pred cEeecccCce------ecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNK------YRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~------~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
|||+++++|. ..+++|||||||.++++..+.. .|++.+++.+++||+.||+|||++||+||||||+|||++
T Consensus 77 nIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp TBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CeeEEEEEEecccccccCceeEEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence 5777787775 4478999999999998887753 599999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKI 157 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i 157 (417)
.++.+||+|||+++..... ......++|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+...++.++
T Consensus 154 ~~~~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i 230 (355)
T d2b1pa1 154 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_dssp TTCCEEECCCCC-----------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccceeeechhhhhccccc--cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH
Confidence 9999999999998875532 33445678999999999987 67899999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCC--------ccccCCCch----hhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 158 FELCGSPDETIWPGVSKMP--------AYNHFKPSR----TMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
......+....|....... ......... ............++.++++||++||..||++|+||+|||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 8877766554443322100 000000000 0001111223456889999999999999999999999999
Q ss_pred CCCCCCC
Q 014871 226 SEYFWTD 232 (417)
Q Consensus 226 h~~f~~~ 232 (417)
||||...
T Consensus 311 Hpw~~~~ 317 (355)
T d2b1pa1 311 HPYINVW 317 (355)
T ss_dssp STTTGGG
T ss_pred CcccCCC
Confidence 9999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=309.25 Aligned_cols=193 Identities=21% Similarity=0.324 Sum_probs=166.7
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++++..++.+||||||+++ ++..++......+++..+++++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 60 nIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~ 139 (258)
T d1k2pa_ 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 139 (258)
T ss_dssp TBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCE
T ss_pred ceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcE
Confidence 799999999999999999999985 6666766666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+|+.+............+|..|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..++..++.+..
T Consensus 140 kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~ 218 (258)
T d1k2pa_ 140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218 (258)
T ss_dssp EECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EECcchhheeccCCCceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence 999999998766544445555678999999999986 578999999999999999998 899999999988888776532
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
..+. ...+++++.+||++||+.||++|||+.+||+|
T Consensus 219 ~~~~-----------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 RLYR-----------------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CCCC-----------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCC-----------------------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 2111 12356789999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-40 Score=316.50 Aligned_cols=192 Identities=19% Similarity=0.277 Sum_probs=157.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++++++...+++|||||||++ +|..++.+ ....+++..++.|+.||+.||+|||+++|+||||||+||||+.+++
T Consensus 74 nIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~ 153 (287)
T d1opja_ 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 153 (287)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc
Confidence 789999999999999999999985 67766654 3456999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHh
Q 014871 82 LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPI-LPGKNEAEQLSKIFEL 160 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~p-f~~~~~~~~~~~i~~~ 160 (417)
+||+|||+|+..............+|..|+|||++.+ ..|+.++|||||||+||||+++..| |.+.+...+...+...
T Consensus 154 ~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~ 232 (287)
T d1opja_ 154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 232 (287)
T ss_dssp EEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EEEccccceeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC
Confidence 9999999998766544444444567899999999886 5789999999999999999996555 5555555444444221
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
. .+ .....++.++++||++||..||++|||+.||++
T Consensus 233 ~-~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 233 Y-RM----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp C-CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CC----------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1 00 012346778999999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=321.13 Aligned_cols=201 Identities=24% Similarity=0.412 Sum_probs=165.8
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
||+++++.++.+..+|+|||||.+ +|...+.. ...+++..++.+++||+.||+|||+++|+||||||+||||+.++.+
T Consensus 90 nIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~v 168 (322)
T d1vzoa_ 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 168 (322)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred eEEEeeeeeccCCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCE
Confidence 799999999999999999999986 55555544 3468999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGAT-KYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+|+.+............+++.|++||++.... .++.++|||||||+||||++|+.||.+.+..+....+....
T Consensus 169 kL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~ 248 (322)
T d1vzoa_ 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248 (322)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999877655555556678899999999997533 57889999999999999999999998877655555554321
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-----SAKDALDSEYFWT 231 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~h~~f~~ 231 (417)
.... ......++.++++||++||..||++|+ |++|||+|+||..
T Consensus 249 ~~~~--------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 249 LKSE--------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHCC--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ccCC--------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 1110 011234788999999999999999999 5899999999954
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=311.74 Aligned_cols=192 Identities=20% Similarity=0.324 Sum_probs=150.4
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.+. ++.+|||||||.+ ++..++......+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 69 nIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~ 147 (273)
T d1mp8a_ 69 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 147 (273)
T ss_dssp TBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred CEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcE
Confidence 7888998875 5789999999985 5666666666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 014871 83 KLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFELC 161 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~~ 161 (417)
||+|||+|+.+............+|+.|+|||++.. ..++.++|||||||+||||++ |.+||.+.+..+++.++.+..
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~ 226 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEccchhheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998765444444455667999999999975 678999999999999999998 899999999988888775421
Q ss_pred CCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 162 GSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
..+ .+..++.++.+||.+||..||++|||+.||+++
T Consensus 227 ~~~-----------------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 RLP-----------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-----------------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 123467789999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=313.55 Aligned_cols=189 Identities=19% Similarity=0.252 Sum_probs=154.2
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||+++++++ .+..|||||||++ +|.+++.+ ...+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 69 nIv~~~g~~~-~~~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~ 146 (277)
T d1xbba_ 69 YIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 146 (277)
T ss_dssp TBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred CCceEEEEec-cCCEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcc
Confidence 7888988875 4578999999986 56555544 4569999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+|+.+...... ......+|+.|||||++.. ..++.++|||||||++|||++ |+.||.+.+..++...+.+
T Consensus 147 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~ 225 (277)
T d1xbba_ 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225 (277)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred cccchhhhhhccccccccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999876533222 2223467899999999976 578999999999999999997 8999999988877776643
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
.... .....++.++.+||.+||..||++|||+.+|+
T Consensus 226 ~~~~-----------------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 226 GERM-----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261 (277)
T ss_dssp TCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCC-----------------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 1100 01123677899999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.4e-40 Score=310.01 Aligned_cols=194 Identities=22% Similarity=0.356 Sum_probs=150.9
Q ss_pred ccEeecccCceecCe----EEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 014871 3 CTFLETTDGNKYRGS----TYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLID 77 (417)
Q Consensus 3 cniv~~~~~~~~~~~----~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~ 77 (417)
.|||++++.+..++. +|||||||+++ |...+.. ...+++.+++.|+.||+.||+|||++||+||||||+||||+
T Consensus 67 pniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~ 145 (277)
T d1o6ya_ 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 145 (277)
T ss_dssp TTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC
Confidence 378999988887654 89999999964 5544443 44699999999999999999999999999999999999999
Q ss_pred CCCCEEEeeccCcccccCCC--CCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 014871 78 NEGNLKLADFGLARSFSYDH--NNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQLS 155 (417)
Q Consensus 78 ~~~~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~ 155 (417)
.++.++|+|||++....... .......+||+.|+|||++.+ ..++.++||||||||||||+||+.||.+.+..+.+.
T Consensus 146 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 224 (277)
T d1o6ya_ 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224 (277)
T ss_dssp TTSCEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH
Confidence 99999999999987654322 223445678999999999976 578999999999999999999999999999888877
Q ss_pred HHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCC-CHHHHh
Q 014871 156 KIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRI-SAKDAL 224 (417)
Q Consensus 156 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-ta~elL 224 (417)
++......+.. .....+++++++||++||..||++|| |+++++
T Consensus 225 ~~~~~~~~~~~--------------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 225 QHVREDPIPPS--------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp HHHHCCCCCGG--------------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHhcCCCCCc--------------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH
Confidence 77553222111 11234778999999999999999999 566554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=311.89 Aligned_cols=197 Identities=19% Similarity=0.367 Sum_probs=159.4
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
-|||++++++. ++.+|||||||.+ +|.+++... ...|++.++..|+.||+.||+|||+++|+||||||+||||++++
T Consensus 68 pnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~ 146 (272)
T d1qpca_ 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 146 (272)
T ss_dssp TTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred CCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc
Confidence 37899988654 5678999999986 555544332 23599999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
.+||+|||+|+..............+|..|+|||++.. ..++.++||||||||||||+| |+++|...+..+.+..+..
T Consensus 147 ~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~ 225 (272)
T d1qpca_ 147 SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225 (272)
T ss_dssp CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred ceeeccccceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999998776444344445678999999999875 578999999999999999999 5667777777777776644
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYFW 230 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~--h~~f~ 230 (417)
....+. ...+++++.+||++||+.||++|||+++|++ ++||.
T Consensus 226 ~~~~~~-----------------------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 GYRMVR-----------------------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCC-----------------------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 211110 1236678999999999999999999999987 67763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=309.00 Aligned_cols=190 Identities=18% Similarity=0.231 Sum_probs=158.1
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||+++++++. +.+|||||||++ +|.+++......+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 70 nIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~ 148 (285)
T d1u59a_ 70 YIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 148 (285)
T ss_dssp TBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE
T ss_pred CEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCce
Confidence 78899887764 578999999996 6766666666679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCC--CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHN--NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+|+.+..... .......+|..|+|||++.. ..++.++|||||||+||||+| |+.||.+.+..+++..+.+
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~ 227 (285)
T d1u59a_ 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227 (285)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred eeccchhhhcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987654322 22234467899999999875 578999999999999999998 9999999888877777643
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
.... .....++.++.+||.+||..||++|||+.+|+
T Consensus 228 ~~~~-----------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 228 GKRM-----------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVE 263 (285)
T ss_dssp TCCC-----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred CCCC-----------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 2110 01224677899999999999999999998884
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=307.33 Aligned_cols=199 Identities=22% Similarity=0.351 Sum_probs=155.7
Q ss_pred ccEeecccCceecCeEEEEEcCCCCC-HHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHD-LTGLADR-PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEG 80 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~-~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~ 80 (417)
+|||++++.+. ++.+|||||||.++ +..++.. ....|++.++..++.||+.||+|||+++|+||||||+||||+.++
T Consensus 72 ~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~ 150 (285)
T d1fmka3 72 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 150 (285)
T ss_dssp TTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred CCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC
Confidence 68999999875 56789999999864 5555443 234599999999999999999999999999999999999999999
Q ss_pred CEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 014871 81 NLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG-~~pf~~~~~~~~~~~i~~ 159 (417)
++||+|||+|+..............+|..|+|||++.. ..++.++||||||||||||++| +++|...+..+++..+..
T Consensus 151 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~ 229 (285)
T d1fmka3 151 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229 (285)
T ss_dssp CEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred cEEEcccchhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999998765444444455678999999999985 6789999999999999999995 666777777777777654
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCC
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD--SEYFWTD 232 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~--h~~f~~~ 232 (417)
....+ ....+++++++||.+||..||++|||+++|++ ++||...
T Consensus 230 ~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 230 GYRMP-----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cCCCC-----------------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 22111 11236778999999999999999999999988 8888653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=312.38 Aligned_cols=194 Identities=19% Similarity=0.333 Sum_probs=148.0
Q ss_pred cEeecccCce-ecCeEEEEEcCCCC-CHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014871 4 TFLETTDGNK-YRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLH 66 (417)
Q Consensus 4 niv~~~~~~~-~~~~~yiV~Ey~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givH 66 (417)
|||.++..+. .++.+|||||||++ +|.+++... ...|++.+++.|+.||+.||+|||+++|||
T Consensus 78 ~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivH 157 (299)
T d1ywna1 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 157 (299)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 6677766544 44578999999984 676666432 234899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhC-CCC
Q 014871 67 RDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPI 144 (417)
Q Consensus 67 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG-~~p 144 (417)
|||||+||||+.++++||+|||+|+....... ......++|+.|+|||++.+ ..++.++||||||||+|||+++ .+|
T Consensus 158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp SCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCC
Confidence 99999999999999999999999987654333 23345678999999999986 6789999999999999999986 578
Q ss_pred CCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 145 LPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 145 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
|.+.+..+.+..+......+. ....+++++++||.+||..||++|||+.||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil 288 (299)
T d1ywna1 237 YPGVKIDEEFCRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288 (299)
T ss_dssp STTCCCSHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 887776665554443211111 1123567899999999999999999999999
Q ss_pred cC
Q 014871 225 DS 226 (417)
Q Consensus 225 ~h 226 (417)
+|
T Consensus 289 ~~ 290 (299)
T d1ywna1 289 EH 290 (299)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=300.72 Aligned_cols=192 Identities=20% Similarity=0.301 Sum_probs=150.5
Q ss_pred cEeecccCceecCeEEEEEcCCCCC-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHD-LTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~-l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++.+...+.+|+|||||.++ +.+.+......+++.++..++.||+.||+|||+++|+||||||+||||+.++++
T Consensus 70 nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred CEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeE
Confidence 8999999999999999999999875 555555566679999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC--cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 014871 83 KLADFGLARSFSYDHNN--TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNEAEQLSKIFE 159 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG-~~pf~~~~~~~~~~~i~~ 159 (417)
||+|||+|+........ ......+|..|||||++.+ ..++.++||||||||||||+++ .++|...+..+++..+.+
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~ 228 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc
Confidence 99999999876433221 2233457899999999986 6789999999999999999995 556666666666665543
Q ss_pred hcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 160 LCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
....+ ....++..+.+||.+||..||++|||+.||++
T Consensus 229 ~~~~~-----------------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 229 GFRLP-----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCCCC-----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCC-----------------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 21111 11235678999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-38 Score=300.65 Aligned_cols=192 Identities=22% Similarity=0.359 Sum_probs=160.5
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
|||++++++..++.+|+|||||++ +|.+++... ...|++.+++.|+.||+.||+|||+++||||
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr 159 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence 899999999999999999999985 666666433 2358999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPIL 145 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf 145 (417)
||||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+ ..|+.++||||||||||||++ |.+||
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 99999999999999999999999877543332 2344567899999999976 679999999999999999998 79999
Q ss_pred CCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 146 PGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 146 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+..++...+.+..... ....+++++++||.+||+.||++|||+.||++
T Consensus 239 ~~~~~~~~~~~i~~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 239 PGVPVEELFKLLKEGHRMD-----------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TTCCHHHHHHHHHTTCCCC-----------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCC-----------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9888877766654321110 01236678999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-38 Score=303.31 Aligned_cols=192 Identities=18% Similarity=0.235 Sum_probs=156.6
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCE
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNL 82 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~v 82 (417)
|||++++++... ..++||||+. ++|++.+......+++.+++.|+.||+.||+|||+++||||||||+||||+.++.+
T Consensus 72 nIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 72 HVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp TBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE
T ss_pred CEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCe
Confidence 788999888754 5666667765 67888888777789999999999999999999999999999999999999999999
Q ss_pred EEeeccCcccccCCCCC-cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 014871 83 KLADFGLARSFSYDHNN-TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIFEL 160 (417)
Q Consensus 83 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~~~ 160 (417)
||+|||+|+........ ......+|..|+|||++.+ ..++.++|||||||+||||+| |..||.+.+..++...+...
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~ 229 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 229 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT
T ss_pred EeeccccceecccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876543332 2233467999999999986 578999999999999999998 89999988877776666442
Q ss_pred cCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 161 CGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
...+ ....++.++.+||.+||..||++|||+.||++|
T Consensus 230 ~~~~-----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 ERLP-----------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CCCC-----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-----------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1111 112366789999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=297.65 Aligned_cols=193 Identities=20% Similarity=0.280 Sum_probs=158.6
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
-|||++++++.. +.+|||||||+ +++.+.+......|++.++..++.||+.||+|||+++|+||||||+||||+.++.
T Consensus 71 ~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 71 RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp TTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE
T ss_pred CCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc
Confidence 478999988864 57899999998 4667666655556999999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCCc--ccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNNT--LTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+||+|||+++.+....... .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+.
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~ 228 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH
Confidence 9999999998765433221 223456889999999986 678999999999999999998 899999999999888876
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.....++ ....++.++++||.+||..||++|||+.+|++
T Consensus 229 ~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 229 KEGERLP----------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TSCCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCC----------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5322111 11246678999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-37 Score=293.55 Aligned_cols=203 Identities=17% Similarity=0.214 Sum_probs=157.4
Q ss_pred cEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CC
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---EG 80 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~---~~ 80 (417)
+|+.+..++...+..|||||||++++...+......|++.++..++.||+.||+|||++|||||||||+|||++. +.
T Consensus 64 ~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~ 143 (299)
T d1ckia_ 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN 143 (299)
T ss_dssp TCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT
T ss_pred cccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCc
Confidence 345556777888899999999999999888877778999999999999999999999999999999999999864 44
Q ss_pred CEEEeeccCcccccCCCC------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 014871 81 NLKLADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEAEQL 154 (417)
Q Consensus 81 ~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~ 154 (417)
.+||+|||+|+.+..... ......+||+.|||||++.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 144 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp CEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred eeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 699999999987654322 12345578999999999986 56899999999999999999999999876655544
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHH---hcCCCC
Q 014871 155 SKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA---LDSEYF 229 (417)
Q Consensus 155 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el---L~h~~f 229 (417)
..+.... ..........+...+++++.+||.+||..||++||++.+| |++.|.
T Consensus 223 ~~~~~~~----------------------~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 223 QKYERIS----------------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp --HHHHH----------------------HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHhh----------------------cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 3332210 0011122344456688999999999999999999998754 555443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-37 Score=296.70 Aligned_cols=191 Identities=23% Similarity=0.305 Sum_probs=157.6
Q ss_pred cEeecccCceecCeEEEEEcCCC-CCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP---------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVLHR 67 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~---------------~~~l~~~~i~~i~~Qil~gL~~LH~~givHr 67 (417)
|||++++++..++.+|||||||+ ++|.+++.+. ...|++.++..++.||+.||+|||+++|+||
T Consensus 72 nIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHr 151 (309)
T d1fvra_ 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 151 (309)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccc
Confidence 89999999999999999999998 4677766432 3569999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCC-CCCC
Q 014871 68 DIKGSNLLIDNEGNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGK-PILP 146 (417)
Q Consensus 68 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~-~pf~ 146 (417)
||||+|||++.++.+||+|||+|+....... .....+|..|+|||++.. ..++.++||||||||+|||++|. +||.
T Consensus 152 Dlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 152 DLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccceEEEcCCCceEEcccccccccccccc--ccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999976543222 223467999999999976 67899999999999999999965 6788
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 147 GKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 147 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
+.+..+++..+.+... + .....+++++++||.+||..||++|||++||+++
T Consensus 229 ~~~~~~~~~~i~~~~~-~----------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 229 GMTCAELYEKLPQGYR-L----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCHHHHHHHGGGTCC-C----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCC-C----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8888887776643111 0 0112367789999999999999999999999964
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-37 Score=294.15 Aligned_cols=193 Identities=20% Similarity=0.281 Sum_probs=158.7
Q ss_pred ccEeecccCceecCeEEEEEcCCC-CCHHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHH
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMD-HDLTGLADRP-----------------------GLRFTVPQIKCYMKQLLTGLHY 58 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~-g~l~~~~~~~-----------------------~~~l~~~~i~~i~~Qil~gL~~ 58 (417)
.|||++++.+...+.+++||||+. ++|.+++... ...|++.++..|+.||+.||+|
T Consensus 76 ~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 155 (301)
T d1lufa_ 76 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 155 (301)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhh
Confidence 589999999999999999999998 4677666432 1248999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHH
Q 014871 59 CHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAE 137 (417)
Q Consensus 59 LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 137 (417)
||+++||||||||+||||+.++++||+|||+|+....... .......+|..|+|||++.+ ..|+.++|||||||||||
T Consensus 156 lH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 156 LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHH
T ss_pred cccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHH
Confidence 9999999999999999999999999999999986543322 23334567899999999986 679999999999999999
Q ss_pred HHhCC-CCCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCC
Q 014871 138 LLNGK-PILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQ 216 (417)
Q Consensus 138 lltG~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 216 (417)
|+++. +||.+.+..+.+..+.+.... .....++.++.+||.+||..||++
T Consensus 235 ll~~~~~p~~~~~~~e~~~~v~~~~~~-----------------------------~~p~~~~~~~~~li~~cl~~~P~~ 285 (301)
T d1lufa_ 235 IFSYGLQPYYGMAHEEVIYYVRDGNIL-----------------------------ACPENCPLELYNLMRLCWSKLPAD 285 (301)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHccCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCccchHHHHHHHHHHcCCChhH
Confidence 99984 789999988888777542111 012346678999999999999999
Q ss_pred CCCHHHHhc
Q 014871 217 RISAKDALD 225 (417)
Q Consensus 217 Rpta~elL~ 225 (417)
|||+.||++
T Consensus 286 RPt~~ev~~ 294 (301)
T d1lufa_ 286 RPSFCSIHR 294 (301)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999965
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=293.76 Aligned_cols=193 Identities=22% Similarity=0.358 Sum_probs=159.3
Q ss_pred cEeecccCceecCeEEEEEcCCCC-CHHHHHhcC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 014871 4 TFLETTDGNKYRGSTYMVFEYMDH-DLTGLADRP-----------------GLRFTVPQIKCYMKQLLTGLHYCHVNQVL 65 (417)
Q Consensus 4 niv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~~-----------------~~~l~~~~i~~i~~Qil~gL~~LH~~giv 65 (417)
|||++++++..++.+|||||||++ +|..++.+. ...+++.++..|+.||+.||+|||+++||
T Consensus 88 nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~iv 167 (311)
T d1t46a_ 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (311)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 789999999999999999999986 566655432 12589999999999999999999999999
Q ss_pred ecCCCCCcEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCC
Q 014871 66 HRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKP 143 (417)
Q Consensus 66 HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~ 143 (417)
||||||+|||++.++.+||+|||+++....... ......++|+.|+|||++.. ..++.++|||||||++|||+| |.+
T Consensus 168 HrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCC
Confidence 999999999999999999999999987654333 22334577999999999985 678999999999999999998 778
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHH
Q 014871 144 ILPGKNEAEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDA 223 (417)
Q Consensus 144 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el 223 (417)
+|...+..+.+.++.+....+.. ...++.++++||.+||..||++|||+++|
T Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 247 PYPGMPVDSKFYKMIKEGFRMLS----------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp SSTTCCSSHHHHHHHHHTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCC----------------------------cccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 88888877777666543211110 12356789999999999999999999999
Q ss_pred hc
Q 014871 224 LD 225 (417)
Q Consensus 224 L~ 225 (417)
++
T Consensus 299 l~ 300 (311)
T d1t46a_ 299 VQ 300 (311)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5e-36 Score=286.60 Aligned_cols=196 Identities=20% Similarity=0.216 Sum_probs=159.8
Q ss_pred ccEeecccCceecCeEEEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC----
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDN---- 78 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~---- 78 (417)
.+++.+++.+..+.+.|+|||||+++|.+++...+..+++.++..++.||+.||+|||++||+||||||+||||+.
T Consensus 61 ~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~ 140 (293)
T d1csna_ 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSK 140 (293)
T ss_dssp TTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSST
T ss_pred CCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccc
Confidence 3677888899999999999999999999988877778999999999999999999999999999999999999964
Q ss_pred -CCCEEEeeccCcccccCCCC------CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCChH
Q 014871 79 -EGNLKLADFGLARSFSYDHN------NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKNEA 151 (417)
Q Consensus 79 -~~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 151 (417)
++.+||+|||+|+.+..... ......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+....
T Consensus 141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 56799999999987653221 22345678999999999986 67999999999999999999999999865443
Q ss_pred H---HHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHh
Q 014871 152 E---QLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDAL 224 (417)
Q Consensus 152 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 224 (417)
. ...++.+. .......++...+++++.+||..|+..+|++||+.+.+.
T Consensus 220 ~~~~~~~~i~~~-------------------------~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 220 TNKQKYERIGEK-------------------------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp CHHHHHHHHHHH-------------------------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hHHHHHHHHHhc-------------------------cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 2 23333221 011123445566888999999999999999999876654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-37 Score=288.05 Aligned_cols=189 Identities=20% Similarity=0.317 Sum_probs=148.2
Q ss_pred ccEeecccCc-eecCeEEEEEcCCCC-CHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 014871 3 CTFLETTDGN-KYRGSTYMVFEYMDH-DLTGLADRPG-LRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNE 79 (417)
Q Consensus 3 cniv~~~~~~-~~~~~~yiV~Ey~~g-~l~~~~~~~~-~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~ 79 (417)
-|||++++.+ +.++.+||||||+++ +|.+++.+.. ..+++..++.|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 60 pnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~ 139 (262)
T d1byga_ 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 139 (262)
T ss_dssp TTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC
Confidence 4889999866 456678999999985 6776664432 248999999999999999999999999999999999999999
Q ss_pred CCEEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014871 80 GNLKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLN-GKPILPGKNEAEQLSKIF 158 (417)
Q Consensus 80 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~i~ 158 (417)
+.+||+|||+++..... .....+|..|+|||++.+ ..++.++|||||||++|||+| |+.||...+..+....+.
T Consensus 140 ~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~ 214 (262)
T d1byga_ 140 NVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214 (262)
T ss_dssp SCEEECCCCC----------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred CCEeecccccceecCCC----CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 99999999999865432 223456889999999986 578999999999999999998 789998888877777763
Q ss_pred HhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 159 ELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
+.... ++...++.++++||++||..||++|||+.+|++
T Consensus 215 ~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 215 KGYKM-----------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp TTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCC-----------------------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 31100 112235678999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-36 Score=289.12 Aligned_cols=193 Identities=21% Similarity=0.256 Sum_probs=151.3
Q ss_pred cEeecccCce-ecCeEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCC
Q 014871 4 TFLETTDGNK-YRGSTYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGN 81 (417)
Q Consensus 4 niv~~~~~~~-~~~~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~ 81 (417)
|||++++.+. .++.+|||||||++ +|.+++......+++.++..++.||+.||.|||+++|+||||||+||||++++.
T Consensus 89 nIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~ 168 (311)
T d1r0pa_ 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 168 (311)
T ss_dssp TBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC
T ss_pred CEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC
Confidence 7888887754 46789999999985 566666666667889999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccccCCCCC---cccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHH
Q 014871 82 LKLADFGLARSFSYDHNN---TLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGK-NEAEQLSKI 157 (417)
Q Consensus 82 vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~-~~~~~~~~i 157 (417)
+||+|||+++........ ......+|..|+|||++.. ..++.++||||||||||||+++..||... +..+....+
T Consensus 169 ~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i 247 (311)
T d1r0pa_ 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247 (311)
T ss_dssp EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH
T ss_pred EEEecccchhhccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 999999999876543222 2233567999999999875 67899999999999999999976666543 333344444
Q ss_pred HHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 014871 158 FELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALDS 226 (417)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 226 (417)
.+..... ....+++++.+||.+||..||++|||+.||+++
T Consensus 248 ~~g~~~~-----------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 248 LQGRRLL-----------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCC-----------------------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3211100 012356789999999999999999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-36 Score=287.50 Aligned_cols=193 Identities=17% Similarity=0.249 Sum_probs=159.6
Q ss_pred ccEeecccCceecCeEEEEEcCCCC-CHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 014871 3 CTFLETTDGNKYRGSTYMVFEYMDH-DLTGLADR---------PGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGS 72 (417)
Q Consensus 3 cniv~~~~~~~~~~~~yiV~Ey~~g-~l~~~~~~---------~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~ 72 (417)
-|||++++.+..++.+|||||||.+ +|..++.. .-..+++.++..++.||+.||+|||+++|+|||||++
T Consensus 83 ~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~ 162 (308)
T d1p4oa_ 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 162 (308)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred CCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC
Confidence 3789999999999999999999985 66665542 1134789999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeeccCcccccCCCC-CcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCh
Q 014871 73 NLLIDNEGNLKLADFGLARSFSYDHN-NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNG-KPILPGKNE 150 (417)
Q Consensus 73 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG-~~pf~~~~~ 150 (417)
||||+.++++||+|||+|+....... ......++|+.|+|||++.+ ..++.++||||||||||||+++ ++||.+.+.
T Consensus 163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999986643322 22333467999999999986 6789999999999999999998 588999998
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHHHhcccCCCCCCCHHHHhc
Q 014871 151 AEQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLEKMLMLDPSQRISAKDALD 225 (417)
Q Consensus 151 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 225 (417)
.+.+..+.+..... ....++..+.+||.+||+.||++|||+.+|++
T Consensus 242 ~~~~~~i~~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 242 EQVLRFVMEGGLLD-----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCC-----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888775421110 11235678999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-35 Score=286.53 Aligned_cols=224 Identities=25% Similarity=0.404 Sum_probs=159.9
Q ss_pred cEeecccCceec--CeEEEEEcCCC--CCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEc
Q 014871 4 TFLETTDGNKYR--GSTYMVFEYMD--HDLTG-LADRPGLRFTVPQIKCYMKQLLTGLHYCHV-NQVLHRDIKGSNLLID 77 (417)
Q Consensus 4 niv~~~~~~~~~--~~~yiV~Ey~~--g~l~~-~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~-~givHrDlkp~NILl~ 77 (417)
|||+++++++.. ...+++|+++. ++... ........+++..++.+++||+.||+|||+ +||+||||||+||||+
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 578888777654 34555555554 33333 334445679999999999999999999998 8999999999999998
Q ss_pred CCCC------EEEeeccCcccccCCCCCcccccccccCCCCchhhcCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--
Q 014871 78 NEGN------LKLADFGLARSFSYDHNNTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCIFAELLNGKPILPGKN-- 149 (417)
Q Consensus 78 ~~~~------vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-- 149 (417)
.++. +||+|||.|..... .....++|+.|+|||++.. ..++.++|||||||++++|++|+.||...+
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccCcccccceeeEeeccccccccc----ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 7653 99999999976543 2344678999999999986 678999999999999999999999997543
Q ss_pred ----hHHHHHHHHHhcCCCCCCCCCCCCCCC-------cccc-----CCCchhhhhhHHHhhhhhhHHHHHHHHHhcccC
Q 014871 150 ----EAEQLSKIFELCGSPDETIWPGVSKMP-------AYNH-----FKPSRTMKRRVREVFRHFDRHALELLEKMLMLD 213 (417)
Q Consensus 150 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~-------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 213 (417)
..+.+..++..++.+....+....... .... ..................+.+++|||++||.+|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 345566666666665433322111100 0000 011111111122233567889999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 014871 214 PSQRISAKDALDSEYFWTD 232 (417)
Q Consensus 214 P~~Rpta~elL~h~~f~~~ 232 (417)
|.+|||++|||+||||+..
T Consensus 316 P~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTC
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999744
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=277.74 Aligned_cols=199 Identities=21% Similarity=0.271 Sum_probs=144.9
Q ss_pred ccEeecccCceecC----eEEEEEcCCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCC
Q 014871 3 CTFLETTDGNKYRG----STYMVFEYMDH-DLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHV--------NQVLHRDI 69 (417)
Q Consensus 3 cniv~~~~~~~~~~----~~yiV~Ey~~g-~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~--------~givHrDl 69 (417)
-|||++++.+..++ .+|||||||.+ +|.+++.+. .+++.++..++.||+.||+|||+ ++||||||
T Consensus 57 pnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDl 134 (303)
T d1vjya_ 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 134 (303)
T ss_dssp TTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred CcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecccc
Confidence 37899888877665 58999999985 666666543 58999999999999999999996 69999999
Q ss_pred CCCcEEEcCCCCEEEeeccCcccccCCCC---CcccccccccCCCCchhhcCCC-----CCCCccchhhHHHHHHHHHhC
Q 014871 70 KGSNLLIDNEGNLKLADFGLARSFSYDHN---NTLTNRVITLWYRPPELLLGAT-----KYGPAVDMWSVGCIFAELLNG 141 (417)
Q Consensus 70 kp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~elltG 141 (417)
||+||||+.++.+||+|||+++....... ......++|+.|+|||++.+.. .++.++||||||||||||+||
T Consensus 135 Kp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg 214 (303)
T d1vjya_ 135 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214 (303)
T ss_dssp CGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhC
Confidence 99999999999999999999987654332 1234567899999999987532 246689999999999999999
Q ss_pred CCCCCCCChH--------------HHHHHHHHhcCCCCCCCCCCCCCCCccccCCCchhhhhhHHHhhhhhhHHHHHHHH
Q 014871 142 KPILPGKNEA--------------EQLSKIFELCGSPDETIWPGVSKMPAYNHFKPSRTMKRRVREVFRHFDRHALELLE 207 (417)
Q Consensus 142 ~~pf~~~~~~--------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~ 207 (417)
..||...... +.+....... ..++.. .. ..........+.+||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~p~~--~~--~~~~~~~~~~l~~li~ 272 (303)
T d1vjya_ 215 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ------------------KLRPNI--PN--RWQSCEALRVMAKIMR 272 (303)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS------------------CCCCCC--CG--GGGGCHHHHHHHHHHH
T ss_pred CCCCCcccccccchhhcccccchHHHHHHHHhcc------------------ccCCCC--Cc--ccCChHHHHHHHHHHH
Confidence 8877432211 1111111000 000000 00 0001224467889999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 014871 208 KMLMLDPSQRISAKDALD 225 (417)
Q Consensus 208 ~~L~~dP~~Rpta~elL~ 225 (417)
+||..||++|||+.||++
T Consensus 273 ~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 273 ECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTCCSSGGGSCCHHHHHH
T ss_pred HHcccCHhHCcCHHHHHH
Confidence 999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.60 E-value=5.1e-17 Score=143.77 Aligned_cols=103 Identities=16% Similarity=0.150 Sum_probs=72.8
Q ss_pred EEEEcCCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCCEEEeeccCcccccCCCC
Q 014871 19 YMVFEYMDHDLTGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSYDHN 98 (417)
Q Consensus 19 yiV~Ey~~g~l~~~~~~~~~~l~~~~i~~i~~Qil~gL~~LH~~givHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 98 (417)
+|||||+++.... .+++..+..++.||+.+|+|||++||+||||||+|||++++ .++|+|||+|+.......
T Consensus 86 ~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~ 157 (191)
T d1zara2 86 AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157 (191)
T ss_dssp EEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH
T ss_pred EEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCc
Confidence 7999999975432 25556678899999999999999999999999999999976 599999999976542221
Q ss_pred CcccccccccCCCCchhhcCCCCCCCccchhhHHHH
Q 014871 99 NTLTNRVITLWYRPPELLLGATKYGPAVDMWSVGCI 134 (417)
Q Consensus 99 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i 134 (417)
.....+-.+. --|.+. ..|+.++|+||+.--
T Consensus 158 ~~~l~rd~~~---~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 158 REILERDVRN---IITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp HHHHHHHHHH---HHHHHH--HHHCCCCCHHHHHHH
T ss_pred HHHHHHHHHH---HHHHHc--CCCCCcccHHHHHHH
Confidence 1111100000 012222 457889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.27 E-value=0.0001 Score=65.77 Aligned_cols=28 Identities=21% Similarity=0.373 Sum_probs=24.4
Q ss_pred ceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 64 VLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 64 ivHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 7899999999999987666799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.45 E-value=0.00086 Score=59.14 Aligned_cols=28 Identities=25% Similarity=0.268 Sum_probs=24.6
Q ss_pred ceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 64 VLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 64 ivHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
++|+|+.+.|||++++..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.94 E-value=0.0062 Score=57.62 Aligned_cols=28 Identities=18% Similarity=0.344 Sum_probs=24.8
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.++|+|+++.|||++.+ .++|+||.+|.
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence 58999999999999876 59999998774
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.92 E-value=0.0059 Score=55.56 Aligned_cols=30 Identities=27% Similarity=0.310 Sum_probs=26.6
Q ss_pred CCceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 62 NQVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 62 ~givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
.||||+|+.++|||++.+..+-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999998777899999774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.25 E-value=0.046 Score=49.77 Aligned_cols=27 Identities=30% Similarity=0.356 Sum_probs=22.9
Q ss_pred CceecCCCCCcEEEcCCCCEEEeeccCcc
Q 014871 63 QVLHRDIKGSNLLIDNEGNLKLADFGLAR 91 (417)
Q Consensus 63 givHrDlkp~NILl~~~~~vkL~DFGla~ 91 (417)
++||+|+++.|||++++ ..|+||+.|.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 68999999999999753 5689998774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=82.68 E-value=0.2 Score=46.64 Aligned_cols=15 Identities=27% Similarity=0.600 Sum_probs=13.1
Q ss_pred ceecCCCCCcEEEcC
Q 014871 64 VLHRDIKGSNLLIDN 78 (417)
Q Consensus 64 ivHrDlkp~NILl~~ 78 (417)
++|+|+++.|||+..
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 579999999999854
|